data_2lcq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 119.413 -0.327 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 m -56.53 139.49 49.39 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.76 -1.212 . . . . 0.0 108.598 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -158.96 143.3 15.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.72 142.25 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.58 137.41 49.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 108.281 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -89.11 164.72 14.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.88 0.848 . . . . 0.0 111.032 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.49 165.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -57.12 -26.31 60.29 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.39 -37.17 64.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 120.213 1.37 . . . . 0.0 109.405 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -77.37 -12.78 59.99 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.5 1.52 . . . . 0.0 112.538 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.45 -45.53 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.227 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.49 -20.39 50.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.979 1.718 . . . . 0.0 114.25 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.62 40.9 5.54 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 128.375 2.893 . . . . 0.0 112.097 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.2 100.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 119.944 1.872 . . . . 0.0 107.211 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 111.63 1.02 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.399 0.68 . . . . 0.0 110.328 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.401 HD11 ' H ' ' A' ' 23' ' ' GLU . 5.7 tp -155.69 170.23 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 126.189 1.796 . . . . 0.0 107.978 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' H ' HD11 ' A' ' 22' ' ' ILE . 54.3 mt-10 -115.03 162.63 16.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.624 2.37 . . . . 0.0 108.96 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.85 -132.83 4.27 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 118.456 0.571 . . . . 0.0 112.067 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.7 151.61 47.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.734 1.613 . . . . 0.0 109.971 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -129.36 149.78 51.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.973 1.709 . . . . 0.0 111.138 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.61 116.5 66.34 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 126.492 1.917 . . . . 0.0 109.318 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -16.79 56.66 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.934 1.756 . . . . 0.0 112.379 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -53.57 52.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.152 1.381 . . . . 0.0 110.608 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.35 -35.5 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 O-C-N 121.611 -0.681 . . . . 0.0 109.424 -169.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -63.08 -20.5 25.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.768 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -69.67 -21.35 63.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.118 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.48 -7.36 31.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.532 1.533 . . . . 0.0 110.923 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.13 99.94 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.677 1.191 . . . . 0.0 108.455 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 -13.49 15.57 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.08 -176.08 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.054 1.342 . . . . 0.0 110.466 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -101.28 -43.21 6.04 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.391 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -56.9 -60.86 2.95 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 120.1 1.318 . . . . 0.0 107.702 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m -62.25 -11.29 14.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -89.37 -66.7 0.9 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.4 mt -52.37 -48.79 44.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 124.892 1.277 . . . . 0.0 107.659 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -56.58 -54.57 44.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.013 0.925 . . . . 0.0 112.553 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.15 -54.04 51.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.895 1.278 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.26 -39.79 83.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.484 1.514 . . . . 0.0 111.477 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.2 m -68.77 -45.38 71.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 120.687 -1.258 . . . . 0.0 112.005 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -38.28 90.46 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 124.452 1.101 . . . . 0.0 110.039 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.76 -56.69 11.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.776 0.831 . . . . 0.0 108.933 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 m -68.03 -26.07 65.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.992 0.517 . . . . 0.0 111.938 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 -2.25 39.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.895 1.678 . . . . 0.0 112.616 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.67 23.37 68.85 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 125.421 1.486 . . . . 0.0 113.464 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -72.41 -35.35 68.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 108.841 171.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -134.95 136.92 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -114.67 156.71 24.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.331 1.053 . . . . 0.0 111.207 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.3 mm -83.31 129.55 37.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 119.182 0.901 . . . . 0.0 109.656 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.28 124.15 6.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.258 1.023 . . . . 0.0 111.192 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.61 152.58 38.42 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.832 1.253 . . . . 0.0 109.636 166.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.55 166.83 28.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.782 3.654 . . . . 0.0 114.02 -171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -75.39 158.69 32.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.94 0.876 . . . . 0.0 111.395 162.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -44.15 95.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.576 1.151 . . . . 0.0 110.352 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.53 -32.8 71.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.591 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -48.17 74.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.383 0.673 . . . . 0.0 110.417 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -50.73 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.3 -32.31 69.93 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -45.63 80.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.667 1.121 . . . . 0.0 110.492 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.61 -45.41 95.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -54.01 -38.1 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.512 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -64.93 -59.18 4.46 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.899 1.227 . . . . 0.0 109.207 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.12 -33.55 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.828 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.64 -48.51 76.99 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.123 1.369 . . . . 0.0 110.807 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -27.53 68.38 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.194 -0.941 . . . . 0.0 110.645 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -70.26 -37.06 74.82 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.187 0.903 . . . . 0.0 111.844 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -87.26 -14.95 39.54 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.851 1.205 . . . . 0.0 112.714 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 -59.73 0.6 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 125.057 1.313 . . . . 0.0 112.807 165.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -75.67 92.65 2.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.68 -43.79 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 123.53 0.732 . . . . 0.0 112.764 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.56 7.34 6.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.064 0.546 . . . . 0.0 110.149 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -69.91 -3.77 17.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 112.088 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.55 150.81 21.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.58 1.552 . . . . 0.0 108.972 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -69.94 157.83 36.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.744 0.783 . . . . 0.0 110.92 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -64.63 -50.88 65.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.171 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.61 -42.29 55.82 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.788 0.835 . . . . 0.0 111.453 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -59.08 5.18 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.824 1.65 . . . . 0.0 109.827 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.93 -44.86 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.78 1.232 . . . . 0.0 108.856 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -60.26 -52.64 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.609 1.563 . . . . 0.0 111.524 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.74 -54.26 37.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.257 1.023 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.23 -51.85 68.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.866 0.867 . . . . 0.0 109.419 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -48.78 -52.76 22.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 112.218 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -50.91 68.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 123.494 0.496 . . . . 0.0 110.028 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.91 -31.45 70.95 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.558 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 9.6 m-30 -69.39 -33.86 73.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.613 0.642 . . . . 0.0 110.558 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.71 -31.71 72.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.483 0.583 . . . . 0.0 112.53 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.06 -15.83 33.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.651 1.181 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.71 24.2 1.62 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 112.65 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.52 -102.21 0.87 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.079 0.847 . . . . 0.0 111.786 -169.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -153.48 166.28 33.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.202 1.001 . . . . 0.0 110.515 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -135.43 156.67 38.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.539 1.536 . . . . 0.0 107.379 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 124.68 30.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.867 1.267 . . . . 0.0 107.878 164.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.0 t -163.28 175.28 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.373 1.069 . . . . 0.0 110.54 165.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -147.34 63.21 1.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.554 1.142 . . . . 0.0 112.8 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.0 157.95 31.57 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.384 1.074 . . . . 0.0 109.3 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -72.79 -45.06 60.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.566 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.377 1.071 . . . . 0.0 110.784 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.02 -41.66 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.436 1.016 . . . . 0.0 109.354 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.67 -43.51 96.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.61 0.764 . . . . 0.0 110.139 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -64.69 -53.76 42.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.754 0.821 . . . . 0.0 110.027 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.51 -55.15 16.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.951 0.901 . . . . 0.0 109.112 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.49 65.66 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.47 1.486 . . . . 0.0 113.565 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 t -57.5 -63.25 1.3 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.528 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -21.24 66.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.852 1.66 . . . . 0.0 113.036 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.558 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mm? -85.47 -6.25 59.21 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.292 1.037 . . . . 0.0 112.522 175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.48 9.15 84.54 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.881 -1.511 . . . . 0.0 113.988 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.86 120.62 32.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.09 1.945 . . . . 0.0 111.418 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 134.95 57.59 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.95 1.3 . . . . 0.0 109.892 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -147.81 170.88 16.67 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 122.885 0.474 . . . . 0.0 110.262 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.2 mtt-85 -109.42 154.38 22.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.548 1.139 . . . . 0.0 109.647 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.443 -0.784 0 O-C-N 123.965 0.791 . . . . 0.0 109.41 172.298 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -159.13 14.53 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -141.53 150.5 42.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.008 1.276 . . . . 0.0 110.42 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.44 129.33 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.413 1.085 . . . . 0.0 108.262 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -62.07 153.37 30.03 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 165.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.79 88.32 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 122.804 1.288 . . . . 0.0 109.374 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.2 -75.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 p -93.75 -3.91 51.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.094 0.958 . . . . 0.0 113.031 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.66 26.59 72.06 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 125.707 1.622 . . . . 0.0 114.106 170.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -66.09 136.14 55.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.291 0.636 . . . . 0.0 109.506 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.8 141.03 31.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.489 1.116 . . . . 0.0 108.162 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -136.03 152.7 51.17 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -94.65 -17.82 21.91 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.74 -0.6 . . . . 0.0 111.726 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 45.4 p -128.02 169.21 14.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.514 1.126 . . . . 0.0 108.989 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.13 119.74 72.76 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.56 172.31 9.43 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.919 1.746 . . . . 0.0 110.269 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.46 138.19 83.24 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.032 1.821 . . . . 0.0 110.597 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.07 -5.34 1.34 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.56 1.076 . . . . 0.0 113.926 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.34 51.1 38.24 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-O 117.41 -1.772 . . . . 0.0 110.626 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 m -126.62 158.51 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 118.853 1.326 . . . . 0.0 108.065 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' A' ' 149' ' ' ASP . 35.2 t -77.78 111.95 21.37 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 125.216 1.406 . . . . 0.0 111.835 -167.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.48 23.26 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.97 3.113 . . . . 0.0 115.231 167.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 147' ' ' CYS . 1.1 t70 -140.82 -18.04 0.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.412 1.485 . . . . 0.0 113.336 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 13.0 p -151.83 -2.34 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.99 -17.8 5.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.856 1.217 . . . . 0.0 114.618 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -62.53 162.0 11.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.413 1.606 . . . . 0.0 112.901 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -61.64 155.92 21.26 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.62 -0.675 . . . . 0.0 110.771 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.34 144.41 21.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -133.79 164.18 27.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.196 1.398 . . . . 0.0 110.357 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.8 tt -78.91 155.37 29.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.537 1.135 . . . . 0.0 110.218 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.6 pt . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 127.372 2.269 . . . . 0.0 110.943 -178.412 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -51.62 124.89 13.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.788 1.235 . . . . 0.0 108.598 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 tp -149.4 142.72 25.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.382 1.873 . . . . 0.0 106.494 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.06 150.52 19.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.15 150.66 37.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.709 1.604 . . . . 0.0 108.591 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.82 161.12 13.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.004 0.522 . . . . 0.0 111.736 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -37.14 -55.31 0.97 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.857 2.463 . . . . 0.0 112.158 164.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.4 m -56.62 -28.01 59.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.227 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.42 -45.36 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.662 1.119 . . . . 0.0 109.43 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.36 -33.51 71.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.576 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.68 -41.62 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.051 0.941 . . . . 0.0 110.446 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -75.65 -30.26 59.4 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.977 -0.452 . . . . 0.0 110.485 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.04 29.42 15.22 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 124.975 1.274 . . . . 0.0 111.187 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.5 110.06 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.19 121.22 9.56 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.411 1.484 . . . . 0.0 109.178 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 23' ' ' GLU . 8.3 tp -158.83 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.755 2.022 . . . . 0.0 109.669 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' H ' HG13 ' A' ' 22' ' ' ILE . 1.7 mp0 -135.77 159.19 42.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 108.99 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.41 -134.13 5.37 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 120.795 1.634 . . . . 0.0 114.376 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -129.0 154.99 46.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.6 1.96 . . . . 0.0 109.351 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -141.6 153.89 45.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.901 0.88 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.4 p -86.89 118.22 69.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.904 0.882 . . . . 0.0 110.455 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.88 -27.85 74.43 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.098 1.199 . . . . 0.0 110.794 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -71.88 -24.11 61.61 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.44 -31.12 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 121.33 1.877 . . . . 0.0 109.326 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.71 -22.1 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 119.211 0.914 . . . . 0.0 111.043 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.75 -14.9 16.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.629 -1.294 . . . . 0.0 112.746 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.53 -30.56 7.58 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.534 -1.354 . . . . 0.0 112.411 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -55.29 111.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 120.099 1.318 . . . . 0.0 110.399 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -12.81 6.96 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.113 1.365 . . . . 0.0 112.615 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.99 122.69 17.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.8 mtt-85 -52.72 -49.68 64.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.169 0.988 . . . . 0.0 110.366 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.69 -52.74 64.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.265 0.978 . . . . 0.0 109.098 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 t -53.8 -49.14 68.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -65.18 -53.9 37.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.675 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.15 -54.1 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 33.2 t80 -57.26 -49.22 76.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.263 1.025 . . . . 0.0 111.103 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.7 tp -50.49 -60.77 2.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 109.98 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.63 78.78 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.302 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.9 m -57.37 -49.66 75.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.471 1.108 . . . . 0.0 110.654 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 26.2 mt -63.2 -41.98 99.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.785 0.434 . . . . 0.0 110.228 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.59 -50.35 67.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 p -64.09 -33.93 76.88 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.132 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.592 0.757 . . . . 0.0 110.058 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.99 16.5 6.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 124.18 0.895 . . . . 0.0 112.276 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -86.29 -27.54 24.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.374 1.087 . . . . 0.0 110.803 -173.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.95 148.97 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -129.66 146.41 51.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.415 1.086 . . . . 0.0 112.01 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.47 125.79 36.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.214 1.806 . . . . 0.0 108.119 -175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.5 118.53 5.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.263 1.025 . . . . 0.0 109.928 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -86.26 155.13 57.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.373 -0.829 . . . . 0.0 110.027 163.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.41 163.52 36.24 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 124.605 3.537 . . . . 0.0 111.301 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -83.94 166.7 17.61 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.741 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -57.73 -50.42 73.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.185 1.394 . . . . 0.0 110.628 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.2 -27.6 67.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.51 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.499 ' HG ' ' HG3' ' A' ' 91' ' ' GLU . 1.2 m -68.14 -51.13 49.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.609 0.764 . . . . 0.0 109.404 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.64 -46.78 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.965 . . . . 0.0 109.744 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.34 -34.42 68.75 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.081 -0.387 . . . . 0.0 111.721 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -44.52 86.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.819 0.448 . . . . 0.0 110.945 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.95 -36.31 75.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.36 -47.7 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.01 -45.14 86.74 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.412 1.005 . . . . 0.0 111.728 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -40.42 79.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 O-C-N 121.164 -0.96 . . . . 0.0 110.379 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.06 89.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -27.37 58.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.256 -0.903 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.71 -13.52 62.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.792 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 t -125.19 -15.79 6.17 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.992 1.724 . . . . 0.0 114.964 -174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.37 -90.14 0.15 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.109 1.322 . . . . 0.0 110.786 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -77.16 58.11 1.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.581 1.953 . . . . 0.0 113.212 -161.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.5 p -45.45 -37.75 2.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.82 1.648 . . . . 0.0 114.944 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -128.79 11.1 6.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.09 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.04 -9.46 59.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.703 0.683 . . . . 0.0 111.989 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 144.3 27.02 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 m -67.62 161.47 25.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.245 1.021 . . . . 0.0 111.034 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 5.6 ttpp -61.26 -55.58 30.29 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.327 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.34 -37.99 68.16 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 123.888 0.742 . . . . 0.0 110.386 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -61.96 -53.95 48.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.569 0.748 . . . . 0.0 109.027 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.55 -43.7 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.238 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 80' ' ' LYS . 75.3 mt-10 -63.21 -54.98 28.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.13 0.972 . . . . 0.0 112.238 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.18 -49.52 83.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 109.799 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.04 -49.42 77.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.79 0.836 . . . . 0.0 111.806 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.1 tp -51.09 -52.65 41.43 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.655 0.782 . . . . 0.0 109.82 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.23 69.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.6 m-30 -84.61 -18.43 35.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.131 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.499 ' HG3' ' HG ' ' A' ' 61' ' ' SER . 1.2 tt0 -70.01 -37.17 75.58 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.74 1.155 . . . . 0.0 109.229 164.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 -17.58 45.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.034 1.334 . . . . 0.0 112.474 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.17 46.65 5.18 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.066 2.146 . . . . 0.0 110.753 -169.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.53 -114.69 3.97 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.383 0.516 . . . . 0.0 112.113 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.44 164.21 31.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.07 1.748 . . . . 0.0 106.409 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.0 mt -136.6 155.95 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 116.85 15.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -156.27 -173.37 4.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.536 0.734 . . . . 0.0 109.947 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -144.53 -13.75 0.58 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.3 160.59 32.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.616 1.553 . . . . 0.0 114.684 -168.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -62.53 -46.09 90.0 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 119.929 -1.732 . . . . 0.0 110.936 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -72.16 -53.97 11.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -41.63 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.879 0.872 . . . . 0.0 111.318 -168.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.66 -38.88 64.81 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.933 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -66.86 -51.13 59.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 117.531 -1.223 . . . . 0.0 108.055 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -48.16 -59.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.44 63.75 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.841 1.655 . . . . 0.0 112.681 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -65.28 -53.32 45.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.277 -1.344 . . . . 0.0 112.719 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -35.69 79.26 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 121.518 1.963 . . . . 0.0 109.962 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.495 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -71.11 -19.38 62.45 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.37 14.87 79.55 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.201 -1.333 . . . . 0.0 113.502 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.68 163.81 27.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.138 1.469 . . . . 0.0 109.213 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.68 128.81 53.88 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -151.18 -176.39 5.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.204 0.202 . . . . 0.0 110.762 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -119.79 154.37 34.34 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.559 1.544 . . . . 0.0 109.663 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -160.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -156.0 14.78 0.34 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -136.03 147.36 47.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.772 1.169 . . . . 0.0 110.831 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.11 134.73 47.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.755 1.222 . . . . 0.0 108.329 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -66.85 129.66 40.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.121 0.968 . . . . 0.0 108.416 165.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 pt -84.03 111.14 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 160.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.84 -93.66 0.17 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 106.543 -2.623 . . . . 0.0 106.543 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 3.6 p -76.34 -13.74 60.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.212 0.605 . . . . 0.0 111.952 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.87 73.84 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 124.69 1.138 . . . . 0.0 115.305 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -68.81 129.75 40.82 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 110.631 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -71.42 147.13 48.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.375 1.07 . . . . 0.0 110.198 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -139.89 156.04 46.89 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.145 0.978 . . . . 0.0 109.553 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 p -97.54 -24.83 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.235 0.614 . . . . 0.0 112.053 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.91 129.85 5.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -158.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.82 123.24 80.98 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 126.099 1.76 . . . . 0.0 110.43 -168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.3 171.75 17.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.61 3.54 . . . . 0.0 113.121 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.54 87.76 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.429 3.419 . . . . 0.0 110.505 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.27 -28.77 2.67 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 126.363 1.935 . . . . 0.0 111.113 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.72 32.05 61.31 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 121.462 -1.022 . . . . 0.0 112.275 -168.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 178.54 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 126.179 1.791 . . . . 0.0 107.906 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.9 t -83.21 103.97 3.23 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.304 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.63 -2.5 0.72 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.072 1.848 . . . . 0.0 114.589 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.77 -31.5 13.17 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.826 1.25 . . . . 0.0 112.682 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 14.1 p -134.8 -35.98 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.815 0.846 . . . . 0.0 113.069 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 113.22 -15.91 22.69 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.143 2.306 . . . . 0.0 113.599 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.1 m -67.77 169.86 8.92 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.765 1.782 . . . . 0.0 113.178 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -74.13 142.45 45.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.372 1.069 . . . . 0.0 111.536 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.17 147.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.718 1.607 . . . . 0.0 106.763 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -122.89 160.81 25.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.632 1.173 . . . . 0.0 108.807 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.02 151.56 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 125.116 1.366 . . . . 0.0 110.584 176.124 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -53.76 129.16 32.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.349 1.06 . . . . 0.0 110.372 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.1 tp -149.74 149.44 30.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 151.07 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.94 158.61 26.37 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.655 1.582 . . . . 0.0 109.007 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -118.62 169.28 9.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.306 1.442 . . . . 0.0 111.295 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 p -55.52 -46.74 77.0 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.966 1.306 . . . . 0.0 112.459 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -27.06 62.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.806 -1.092 . . . . 0.0 112.526 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.96 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.503 1.501 . . . . 0.0 109.109 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -72.4 -33.0 66.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.406 0.682 . . . . 0.0 111.23 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.25 -49.63 83.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.924 0.889 . . . . 0.0 109.722 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.69 -13.73 61.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.297 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.55 22.8 57.76 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.582 0.611 . . . . 0.0 113.346 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.2 mt -77.77 107.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 108.4 1.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 171.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -154.22 154.96 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -98.89 164.15 12.32 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 126.431 1.892 . . . . 0.0 111.15 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.71 -139.39 9.34 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-O 121.28 0.378 . . . . 0.0 112.255 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -125.83 151.32 46.96 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.961 1.305 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 t -135.89 147.08 48.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.396 0.678 . . . . 0.0 109.301 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 114.09 48.12 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.484 1.914 . . . . 0.0 111.025 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.67 -20.99 45.08 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.002 1.802 . . . . 0.0 113.801 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -87.9 -12.95 43.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.16 -38.01 10.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 120.667 1.576 . . . . 0.0 108.154 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.97 -20.54 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.633 0.773 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.09 -24.16 38.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.539 1.135 . . . . 0.0 113.101 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.52 7.12 10.58 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.322 0.964 . . . . 0.0 112.7 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 mt -74.72 88.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -10.75 45.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.651 1.98 . . . . 0.0 112.686 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -73.7 124.52 26.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -67.82 -43.84 78.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 117.693 -1.146 . . . . 0.0 111.634 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -57.15 -55.43 34.9 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -55.57 -52.48 63.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.711 0.804 . . . . 0.0 111.208 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -58.69 -56.7 18.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.178 0.991 . . . . 0.0 110.076 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.08 -53.93 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.425 ' CZ ' HD12 ' A' ' 46' ' ' LEU . 30.7 t80 -56.01 -49.69 72.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.404 0.682 . . . . 0.0 111.341 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.98 -56.29 21.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.541 1.136 . . . . 0.0 110.066 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.32 -38.66 87.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.832 0.453 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.3 m -58.77 -41.64 87.1 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.837 0.855 . . . . 0.0 111.259 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 HD12 ' CZ ' ' A' ' 42' ' ' PHE . 11.6 mt -64.35 -43.14 95.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.826 0.739 . . . . 0.0 110.629 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.32 -52.08 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.9 m -61.78 -32.13 72.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.427 1.091 . . . . 0.0 111.65 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.08 69.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.648 1.179 . . . . 0.0 110.836 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.16 -16.45 3.43 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 123.703 0.668 . . . . 0.0 113.343 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -71.85 -34.95 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.612 0.706 . . . . 0.0 110.774 -160.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 162.29 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.44 141.03 33.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.981 0.912 . . . . 0.0 108.853 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.43 124.68 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.887 0.875 . . . . 0.0 109.748 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.42 136.02 17.06 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.35 160.13 28.31 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.857 0.863 . . . . 0.0 112.177 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.74 -177.03 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.674 3.583 . . . . 0.0 112.575 168.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 t -122.02 166.81 13.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.76 1.224 . . . . 0.0 109.748 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -49.53 73.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.303 1.041 . . . . 0.0 110.311 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.13 -22.42 62.07 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.724 -0.61 . . . . 0.0 112.061 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -50.75 66.83 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mm -59.09 -49.6 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.04 0.936 . . . . 0.0 108.67 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -27.88 67.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.118 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -48.84 79.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.319 1.418 . . . . 0.0 110.612 173.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.82 -33.04 60.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.78 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.417 -0.802 . . . . 0.0 109.696 170.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -57.28 -49.62 75.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.861 1.21 . . . . 0.0 110.582 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 p -72.2 -41.27 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.87 -0.519 . . . . 0.0 110.632 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.36 -25.22 61.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 111.076 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 -25.98 41.54 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.245 0.929 . . . . 0.0 110.335 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.18 -5.61 5.21 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.284 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.266 10.8 t -127.56 -58.79 1.24 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.123 1.329 . . . . 0.0 111.365 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.43 -21.57 0.64 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 120.348 1.431 . . . . 0.0 115.585 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.48 20.32 0.43 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.094 1.447 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -33.36 -57.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 128.044 2.538 . . . . 0.0 115.864 -163.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -121.58 11.47 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.846 0.859 . . . . 0.0 109.794 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.31 -34.98 76.12 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.069 0.948 . . . . 0.0 109.82 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mp -64.88 149.75 48.98 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 111.86 -173.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -51.66 133.42 30.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.888 1.275 . . . . 0.0 108.633 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -44.86 84.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.842 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.53 60.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.1 0.56 . . . . 0.0 111.48 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.12 -50.0 73.66 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.184 1.394 . . . . 0.0 108.812 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.9 mt -53.42 -45.77 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.642 0.777 . . . . 0.0 109.252 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -67.48 -44.25 78.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.208 1.403 . . . . 0.0 111.787 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.84 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.389 1.075 . . . . 0.0 108.895 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.19 -53.29 59.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.36 1.064 . . . . 0.0 109.295 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.04 61.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.455 1.502 . . . . 0.0 111.825 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.1 tp -51.57 -56.05 15.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.03 86.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.253 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.497 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.1 m-30 -66.35 -33.69 76.3 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.956 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 -42.76 83.31 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.43 1.014 . . . . 0.0 109.495 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.92 -18.28 50.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.361 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt 53.99 26.38 6.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.48 1.112 . . . . 0.0 111.116 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.46 -159.36 27.96 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 127.654 2.55 . . . . 0.0 113.13 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.11 173.62 7.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 110.232 165.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.13 163.47 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.292 2.237 . . . . 0.0 108.002 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.57 115.89 11.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.166 2.187 . . . . 0.0 106.984 165.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t -158.37 177.96 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.906 1.283 . . . . 0.0 109.673 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -150.62 23.59 0.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.823 -1.173 . . . . 0.0 113.335 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.481 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 4.0 t0 -87.84 156.14 19.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.792 -1.192 . . . . 0.0 109.59 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -64.39 -47.77 77.95 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.034 1.288 . . . . 0.0 109.654 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.69 -53.27 35.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.258 1.423 . . . . 0.0 110.544 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.481 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.4 p -54.3 -41.81 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.03 1.287 . . . . 0.0 110.316 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -69.6 -36.5 76.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.073 0.949 . . . . 0.0 110.843 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.02 -55.25 11.39 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 mm -49.59 -60.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 C-N-CA 125.094 1.358 . . . . 0.0 109.49 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.0 56.76 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.076 1.307 . . . . 0.0 112.163 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -48.13 75.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.974 -1.489 . . . . 0.0 113.705 172.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -33.03 74.9 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 122.609 2.459 . . . . 0.0 110.631 174.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.1 mm? -75.5 -3.89 36.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.902 1.281 . . . . 0.0 113.032 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.03 -2.72 8.06 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.208 1.385 . . . . 0.0 115.226 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 127.86 34.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 120.14 1.97 . . . . 0.0 110.319 -167.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 129.52 39.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.68 -179.37 5.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.637 0.256 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.02 152.79 32.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.339 1.856 . . . . 0.0 107.993 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.321 -0.66 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.399 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 4.0 p-90 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -140.65 12.18 2.29 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.92 140.69 45.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 120.532 1.515 . . . . 0.0 111.675 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.29 139.43 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.929 2.092 . . . . 0.0 109.577 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 4.4 t -81.97 119.98 24.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 161.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.22 127.24 31.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 157.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 134.85 -81.8 0.3 Allowed Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 106.714 -2.555 . . . . 0.0 106.714 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.6 p -80.75 -19.48 44.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.351 -0.5 . . . . 0.0 110.73 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.22 18.54 62.47 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 121.398 -0.813 . . . . 0.0 113.766 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -84.75 162.0 19.79 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.611 1.564 . . . . 0.0 111.109 -165.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -112.29 142.1 45.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 110.481 -164.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -143.82 155.35 44.1 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.614 1.165 . . . . 0.0 109.784 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 1.8 p -104.88 -13.26 15.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.642 0.777 . . . . 0.0 112.977 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.7 p -147.07 175.61 10.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.893 2.477 . . . . 0.0 106.671 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.9 tp -80.19 133.65 56.98 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.3 170.51 20.18 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.612 2.208 . . . . 0.0 109.222 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -56.18 134.78 66.31 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.71 1.607 . . . . 0.0 109.632 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.07 -13.64 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.047 0.832 . . . . 0.0 113.901 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.06 27.89 71.21 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.264 1.532 . . . . 0.0 114.004 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 156.11 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.299 1.44 . . . . 0.0 107.597 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.62 117.88 51.84 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.97 -18.33 60.79 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.146 1.231 . . . . 0.0 113.246 171.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -81.69 -46.1 14.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.026 -1.046 . . . . 0.0 109.4 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.0 p -136.1 -1.5 2.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.66 0.784 . . . . 0.0 113.059 -159.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.15 -11.49 16.04 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.64 1.59 . . . . 0.0 114.624 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.2 m -75.7 163.91 26.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.483 1.142 . . . . 0.0 113.246 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -68.74 148.01 50.97 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.011 -1.055 . . . . 0.0 111.511 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 t -108.39 148.66 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.86 161.46 42.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.335 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.0 151.71 23.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.708 . . . . 0.0 110.595 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 124.336 1.054 . . . . 0.0 110.925 179.438 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -48.63 118.07 2.34 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.547 1.939 . . . . 0.0 109.03 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 tp -140.79 139.2 34.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.713 2.005 . . . . 0.0 107.667 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.7 153.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -135.58 145.65 47.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.219 1.808 . . . . 0.0 107.567 -167.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -110.0 166.48 10.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.507 . . . . 0.0 111.743 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -46.21 -46.78 17.78 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.247 1.819 . . . . 0.0 109.414 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -50.25 -34.94 24.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.617 1.167 . . . . 0.0 113.829 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 t -65.36 -43.79 94.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.209 0.913 . . . . 0.0 108.975 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.36 -36.59 71.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.964 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.51 -38.91 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.035 0.934 . . . . 0.0 110.667 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -83.2 -23.26 32.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.905 . . . . 0.0 112.825 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.23 24.04 27.83 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.88 0.764 . . . . 0.0 112.486 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -77.28 106.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.11 103.93 1.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.858 1.263 . . . . 0.0 108.467 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 tp -151.86 130.09 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -73.75 136.51 43.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.757 1.623 . . . . 0.0 110.815 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.26 -161.61 34.17 Favored Glycine 0 CA--C 1.521 0.453 0 O-C-N 120.721 -1.237 . . . . 0.0 112.101 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.28 151.24 42.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.481 0.712 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -142.89 152.5 42.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.565 1.146 . . . . 0.0 110.162 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.9 p -84.32 126.43 69.47 Favored Pre-proline 0 C--O 1.249 1.055 0 C-N-CA 123.192 0.597 . . . . 0.0 111.037 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.01 -30.16 92.63 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 120.409 0.739 . . . . 0.0 111.093 170.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 m -61.82 -43.95 97.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.697 1.135 . . . . 0.0 113.56 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.89 -38.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -64.09 -26.54 40.73 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.123 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.37 -28.73 69.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.995 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -89.64 -22.89 22.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 111.401 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.11 133.47 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.531 1.158 . . . . 0.0 108.471 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -3.2 0.61 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.878 1.671 . . . . 0.0 112.098 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -70.56 120.35 16.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.9 mtm-85 -66.19 -40.5 90.48 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.552 -170.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.45 -57.01 14.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.0 t -52.37 -54.66 28.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.385 1.474 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -58.65 -57.84 11.21 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.068 0.947 . . . . 0.0 111.37 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.6 -49.38 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.48 -44.54 93.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.726 0.694 . . . . 0.0 112.493 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.38 -56.12 26.21 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.327 1.051 . . . . 0.0 108.81 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.51 -40.68 87.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.511 0.725 . . . . 0.0 109.868 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -53.06 -48.41 67.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.161 1.384 . . . . 0.0 110.45 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.81 -42.45 99.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.83 0.741 . . . . 0.0 111.424 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.37 -46.52 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 t -58.63 -44.48 90.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 109.991 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.14 99.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.353 1.461 . . . . 0.0 110.015 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.18 2.25 7.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.643 1.116 . . . . 0.0 113.887 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.1 -37.38 17.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 117.894 0.847 . . . . 0.0 109.932 -164.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -120.08 153.6 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -140.66 141.06 35.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.617 0.767 . . . . 0.0 110.643 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.39 134.07 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.52 126.59 9.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.501 1.12 . . . . 0.0 109.225 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 151.08 48.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.069 0.948 . . . . 0.0 111.335 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.89 -175.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.572 3.514 . . . . 0.0 110.548 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -125.63 161.43 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.448 2.299 . . . . 0.0 108.241 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -58.99 -40.42 84.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.299 -0.875 . . . . 0.0 110.436 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.21 -33.67 71.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.4 p -75.51 -35.49 60.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.265 0.939 . . . . 0.0 109.862 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.07 -50.11 80.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.44 -37.01 72.13 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.774 0.43 . . . . 0.0 111.059 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -42.67 65.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 111.026 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 mm -67.08 -48.6 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.05 -39.34 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.877 0.871 . . . . 0.0 110.28 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -54.8 -63.49 1.14 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.836 0.854 . . . . 0.0 109.974 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.89 -30.9 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.18 72.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.42 -0.8 . . . . 0.0 110.791 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.18 67.54 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 120.817 -1.177 . . . . 0.0 110.659 173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -72.26 0.81 8.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.372 1.069 . . . . 0.0 112.514 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.272 2.9 t -121.05 -49.6 2.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.868 1.213 . . . . 0.0 109.51 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.3 -58.0 0.29 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.132 0.878 . . . . 0.0 112.499 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -69.62 39.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.399 2.68 . . . . 0.0 114.686 -171.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 p -39.77 -49.46 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.127 2.171 . . . . 0.0 115.062 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.8 28.19 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.176 0.99 . . . . 0.0 108.655 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.1 -28.35 63.24 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.632 -1.292 . . . . 0.0 110.4 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 160.26 30.75 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 t -66.51 154.56 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 109.974 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 13.8 ttpt -63.49 -51.49 65.36 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.771 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.27 -45.55 45.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.227 0.954 . . . . 0.0 109.439 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' CG ' HD21 ' A' ' 102' ' ' ASN . 38.7 t70 -58.17 -54.04 51.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.437 0.695 . . . . 0.0 111.447 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.17 -41.36 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.495 1.118 . . . . 0.0 109.645 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 47.5 mt-10 -65.5 -44.9 85.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.394 1.078 . . . . 0.0 111.548 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.1 -48.41 83.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 119.1 0.863 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.99 -48.97 79.38 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.558 0.743 . . . . 0.0 109.756 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.31 -57.79 6.23 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.948 1.299 . . . . 0.0 110.917 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.8 tp -47.62 -52.35 18.22 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.474 0.71 . . . . 0.0 110.36 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.58 70.8 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.9 m-30 -80.81 -29.55 35.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.505 0.593 . . . . 0.0 111.131 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.31 -42.68 91.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.877 0.846 . . . . 0.0 109.217 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.95 -14.52 44.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 112.894 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 43.2 55.36 4.67 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.328 1.451 . . . . 0.0 110.394 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -135.61 8.8 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 121.856 0.698 . . . . 0.0 111.465 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -129.47 170.19 14.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.3 mt -131.52 156.03 42.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.64 118.39 18.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.035 1.334 . . . . 0.0 108.256 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 t -166.37 -170.08 1.57 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.646 1.578 . . . . 0.0 108.997 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -150.62 10.85 0.66 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 161.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -53.39 150.83 6.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.368 1.467 . . . . 0.0 114.727 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -63.19 -30.78 71.86 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.473 -1.392 . . . . 0.0 112.263 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 HD21 ' CG ' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -80.15 -56.12 4.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.751 1.62 . . . . 0.0 110.215 171.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.8 p -52.69 -41.29 37.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 119.92 1.236 . . . . 0.0 112.664 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -64.66 -46.69 81.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.08 -52.81 57.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 117.425 -1.274 . . . . 0.0 107.784 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.5 mm -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 119.604 1.093 . . . . 0.0 110.328 -175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.55 68.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.668 1.122 . . . . 0.0 112.153 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.18 -39.12 78.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.957 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -44.55 91.39 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 122.437 2.38 . . . . 0.0 107.721 170.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -69.02 -29.12 67.23 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -167.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.53 18.65 37.67 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 117.999 -1.445 . . . . 0.0 112.766 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.01 127.82 38.66 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.02 1.41 . . . . 0.0 110.627 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 128.93 38.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.284 1.833 . . . . 0.0 109.585 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.86 179.62 6.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.626 0.77 . . . . 0.0 111.092 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -123.37 133.09 54.15 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.422 1.489 . . . . 0.0 108.834 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.239 0.549 0 C-N-CA 124.62 1.168 . . . . 0.0 108.775 170.409 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -147.43 0.49 0.69 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.336 -1.316 . . . . 0.0 113.952 -158.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -142.33 135.39 28.63 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.937 0.789 . . . . 0.0 108.984 -170.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.53 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.082 0.953 . . . . 0.0 108.66 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.7 OUTLIER -73.6 127.89 33.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.736 0.814 . . . . 0.0 108.813 171.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.14 -9.67 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.62 -15.14 27.88 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.938 -0.923 . . . . 0.0 113.826 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.8 p -147.24 2.66 0.77 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.59 1.195 . . . . 0.0 113.075 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.88 64.57 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.702 1.62 . . . . 0.0 115.039 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -72.08 145.81 47.97 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 117.681 0.741 . . . . 0.0 110.464 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -93.54 145.62 24.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.647 -169.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -141.85 148.82 39.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.989 1.316 . . . . 0.0 108.223 170.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 p -98.74 -15.3 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.523 -0.736 . . . . 0.0 111.739 168.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.5 p -137.6 152.53 49.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.708 1.203 . . . . 0.0 108.601 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 120.05 62.86 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 113.475 -1.693 . . . . 0.0 106.717 174.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.69 169.09 19.65 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.023 2.482 . . . . 0.0 109.121 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -55.5 134.21 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.656 1.571 . . . . 0.0 109.599 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.84 -10.61 8.77 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.515 -1.158 . . . . 0.0 114.226 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.01 38.22 93.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.969 1.885 . . . . 0.0 112.624 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.01 163.09 32.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.538 1.135 . . . . 0.0 109.28 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.9 t -72.99 113.32 20.6 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 110.179 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.68 -12.35 28.11 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.775 0.955 . . . . 0.0 111.86 163.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.27 -22.65 18.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.334 1.454 . . . . 0.0 111.895 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 3.4 p -156.17 5.31 0.18 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.07 -11.04 2.15 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.714 2.102 . . . . 0.0 116.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 168.61 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.312 1.556 . . . . 0.0 112.41 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -77.98 144.96 36.31 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 t -94.3 158.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -140.47 167.31 22.46 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.013 -1.679 . . . . 0.0 109.123 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.14 154.46 26.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.239 1.016 . . . . 0.0 109.673 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 CA--C 1.548 0.881 0 C-N-CA 125.21 1.404 . . . . 0.0 112.42 178.285 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -48.24 128.34 14.07 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.261 1.824 . . . . 0.0 110.808 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' CD2' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -153.62 144.71 22.88 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.677 0.791 . . . . 0.0 110.212 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.36 147.53 30.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.557 0.743 . . . . 0.0 110.012 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.75 129.48 51.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.593 1.957 . . . . 0.0 109.682 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -84.23 165.35 18.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.601 0.76 . . . . 0.0 109.134 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t -46.63 -45.26 18.97 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.393 1.877 . . . . 0.0 110.265 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -49.86 -34.23 19.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.781 1.632 . . . . 0.0 111.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.5 -39.59 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.441 1.096 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.14 -24.93 47.19 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.2 1.0 . . . . 0.0 111.238 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.57 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.679 0.791 . . . . 0.0 109.075 171.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.79 -23.7 36.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.745 0.702 . . . . 0.0 112.389 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.19 18.88 52.4 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.433 1.016 . . . . 0.0 113.167 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.44 112.89 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.045 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -62.49 106.63 0.79 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 109.133 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 tp -155.08 149.22 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -111.45 120.61 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.066 1.346 . . . . 0.0 109.316 -166.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 176.09 -161.08 29.38 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.339 0.972 . . . . 0.0 113.57 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.2 150.04 21.34 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.4 -0.471 . . . . 0.0 112.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -132.38 147.91 52.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.12 2.168 . . . . 0.0 108.514 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 115.98 62.39 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 126.554 1.941 . . . . 0.0 107.632 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.83 -33.85 72.86 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.454 1.436 . . . . 0.0 110.273 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.23 -36.37 41.4 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.905 3.282 . . . . 0.0 114.432 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.75 -32.09 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.264 0.938 . . . . 0.0 110.572 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.78 -32.71 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.968 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -28.61 10.01 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -89.85 -23.39 21.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 117.745 -1.121 . . . . 0.0 111.508 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.264 5.5 mt -62.7 85.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.655 1.582 . . . . 0.0 110.113 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.33 -11.5 57.61 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 129.115 2.966 . . . . 0.0 110.966 174.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 124.2 26.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -45.42 70.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.671 -0.643 . . . . 0.0 110.332 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.27 -48.99 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.296 1.038 . . . . 0.0 108.39 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -68.76 -49.82 55.57 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.79 0.836 . . . . 0.0 111.842 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -59.97 -55.63 31.71 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.834 0.454 . . . . 0.0 110.51 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.2 mt -55.05 -49.16 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -55.47 -57.8 10.42 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 111.613 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tp -51.26 -52.85 41.09 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.118 1.767 . . . . 0.0 110.844 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.5 -37.44 87.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.648 0.779 . . . . 0.0 110.044 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 m -62.82 -43.02 99.9 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.727 0.694 . . . . 0.0 110.198 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -39.42 86.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.42 -44.9 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.327 -0.858 . . . . 0.0 108.717 170.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 t -64.5 -3.74 3.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 112.891 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.58 3.03 13.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.974 1.709 . . . . 0.0 111.566 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.03 87.2 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.827 1.68 . . . . 0.0 112.878 173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -86.11 -28.41 24.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.891 0.846 . . . . 0.0 111.442 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.64 142.4 35.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 14.2 ttmm -143.95 145.25 32.12 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 112.252 -168.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.9 120.48 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.007 1.323 . . . . 0.0 109.482 -168.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.31 128.88 12.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.432 1.493 . . . . 0.0 110.171 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.07 157.0 35.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.967 1.307 . . . . 0.0 112.322 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.95 157.21 62.82 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.789 2.993 . . . . 0.0 113.332 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -84.68 162.06 19.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.347 165.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -51.28 -42.9 61.43 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.365 1.066 . . . . 0.0 111.806 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.46 -27.06 68.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.548 0.739 . . . . 0.0 110.736 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -72.11 -47.53 50.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.168 1.387 . . . . 0.0 110.121 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 mm -58.97 -47.33 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.54 -41.19 53.57 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.043 1.337 . . . . 0.0 110.72 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -48.24 74.52 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.963 1.305 . . . . 0.0 110.182 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -48.56 84.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.2 mt -48.86 -45.38 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.427 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.59 -59.14 5.91 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.476 0.71 . . . . 0.0 110.502 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.08 -31.25 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.41 -53.29 20.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.16 1.384 . . . . 0.0 110.897 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -30.02 70.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -66.92 -20.46 65.91 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.393 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 t -124.41 8.58 8.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.709 1.595 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.99 -85.36 0.34 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.996 -1.065 . . . . 0.0 112.286 164.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.62 92.48 0.33 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.335 1.054 . . . . 0.0 108.756 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.57 -49.02 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 121.717 -0.615 . . . . 0.0 111.528 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -132.72 17.73 4.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.826 0.85 . . . . 0.0 110.157 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -12.51 61.21 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 120.867 0.365 . . . . 0.0 110.378 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp -87.29 149.63 24.42 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.392 1.477 . . . . 0.0 108.058 173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 m -67.65 161.37 25.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.098 0.559 . . . . 0.0 110.913 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 14.0 ttpt -57.69 -58.46 8.24 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 122.764 0.426 . . . . 0.0 109.99 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.77 -39.46 65.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.671 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -58.66 7.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.86 2.064 . . . . 0.0 109.091 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.15 -44.6 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 126.093 1.757 . . . . 0.0 108.69 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 69.6 mt-10 -62.18 -44.9 95.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.108 0.963 . . . . 0.0 111.144 -176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.08 -53.49 47.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.384 0.538 . . . . 0.0 109.87 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' CD2' ' HH ' ' A' ' 90' ' ' TYR . 20.9 mt -58.95 -51.69 68.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.284 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.56 7.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.359 1.464 . . . . 0.0 112.511 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -46.11 81.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.5 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.564 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.524 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.5 m-30 -66.67 -22.12 66.09 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.047 1.294 . . . . 0.0 112.817 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.55 -47.06 74.02 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.93 -20.1 46.47 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 53.9 30.17 11.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.171 1.788 . . . . 0.0 113.49 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.01 -116.35 0.66 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 125.461 1.505 . . . . 0.0 112.427 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -153.9 159.19 41.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.994 1.718 . . . . 0.0 106.996 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.92 150.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.34 120.62 27.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 t -160.16 -166.16 1.63 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.514 1.925 . . . . 0.0 108.61 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.78 11.32 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.124 1.37 . . . . 0.0 114.008 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -104.71 151.27 23.93 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.045 -2.284 . . . . 0.0 113.437 -161.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -56.93 -47.14 81.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.447 -1.408 . . . . 0.0 110.914 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -71.52 -52.22 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.479 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -54.71 -41.41 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.32 0.509 . . . . 0.0 110.239 -173.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.68 -44.39 77.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.068 0.947 . . . . 0.0 109.832 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -61.99 -56.41 19.41 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -48.85 -55.9 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.545 1.138 . . . . 0.0 110.117 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.64 -34.8 65.26 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.598 1.544 . . . . 0.0 113.689 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 t -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.832 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -36.73 79.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.424 1.011 . . . . 0.0 109.938 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.2 mm? -72.25 -14.56 61.81 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.626 0.37 . . . . 0.0 111.074 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.49 2.63 84.85 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.864 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 133.02 34.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.578 1.189 . . . . 0.0 109.68 -168.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -68.07 136.24 53.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.932 0.893 . . . . 0.0 110.616 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.75 168.04 28.62 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.749 -0.594 . . . . 0.0 111.454 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -99.06 163.43 12.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.605 1.162 . . . . 0.0 111.641 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.567 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -153.62 8.68 0.39 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 118.393 -0.813 . . . . 0.0 112.923 -153.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -151.06 151.03 31.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.087 0.858 . . . . 0.0 110.508 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.63 139.08 49.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.211 1.404 . . . . 0.0 109.995 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -69.94 126.08 28.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.196 0.998 . . . . 0.0 108.56 159.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.67 121.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.08 4.29 Favored Glycine 0 N--CA 1.464 0.502 0 C-N-CA 123.905 0.764 . . . . 0.0 112.962 161.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.51 9.48 2.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.751 1.62 . . . . 0.0 111.817 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.31 14.56 57.16 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 126.955 2.217 . . . . 0.0 115.892 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -68.82 127.39 32.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.972 0.886 . . . . 0.0 108.892 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -71.04 146.46 49.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.973 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -139.35 154.77 47.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -20.66 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.331 0.653 . . . . 0.0 111.695 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 59.0 p -136.04 155.24 50.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.33 127.92 77.24 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.06 171.17 14.16 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.99 2.46 . . . . 0.0 111.49 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 145' ' ' GLY . 28.2 Cg_endo -55.8 148.22 57.15 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.339 2.026 . . . . 0.0 109.721 163.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.16 -22.81 0.2 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.483 1.992 . . . . 0.0 113.532 -165.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 143' ' ' PRO . . . 62.92 38.28 96.32 Favored Glycine 0 C--N 1.335 0.528 0 O-C-N 120.982 -1.305 . . . . 0.0 110.159 -158.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.01 154.41 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.595 0.758 . . . . 0.0 110.075 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.4 t -74.97 110.92 11.24 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 125.365 1.466 . . . . 0.0 110.877 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.72 -2.71 2.22 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.424 2.082 . . . . 0.0 115.543 171.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -105.6 -26.35 11.89 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.018 0.927 . . . . 0.0 113.231 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 14.1 p -142.15 -12.82 0.83 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.09 65.7 2.66 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.973 1.273 . . . . 0.0 112.146 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.07 173.82 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.002 1.721 . . . . 0.0 108.495 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -64.45 142.48 58.4 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.172 0.989 . . . . 0.0 111.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.37 145.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.192 1.397 . . . . 0.0 107.428 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.15 158.74 43.74 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 112.209 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.69 111.26 6.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 110.392 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 125.827 1.651 . . . . 0.0 112.365 164.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -45.51 127.89 7.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.028 0.931 . . . . 0.0 111.598 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 tp -153.72 147.36 25.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.194 1.798 . . . . 0.0 107.454 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -122.08 150.75 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.46 139.26 53.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.969 1.708 . . . . 0.0 108.377 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -91.33 158.84 16.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.095 0.958 . . . . 0.0 111.64 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -29.36 -57.85 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.397 2.279 . . . . 0.0 113.219 163.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.7 p -60.11 -28.95 68.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.136 1.774 . . . . 0.0 112.52 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.68 -42.08 94.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -69.91 -34.77 73.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.413 0.685 . . . . 0.0 111.211 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.7 mt -57.09 -47.58 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 110.14 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.98 -24.9 52.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.883 0.765 . . . . 0.0 111.922 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 31.62 13.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 123.289 0.471 . . . . 0.0 112.068 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -76.86 102.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.46 115.2 1.98 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 tp -161.88 170.84 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.552 1.941 . . . . 0.0 106.412 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.83 152.33 48.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 0.0 109.002 -158.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.0 -130.8 3.72 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -168.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.23 152.33 48.21 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.367 1.067 . . . . 0.0 111.003 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -128.66 143.12 50.88 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.556 1.542 . . . . 0.0 107.664 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.55 117.33 67.9 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.79 1.636 . . . . 0.0 108.198 -167.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.81 -32.04 92.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.261 1.974 . . . . 0.0 111.185 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.2 m -68.49 -19.58 64.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.118 -0.989 . . . . 0.0 113.14 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -83.84 -51.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.036 0.935 . . . . 0.0 108.522 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 p -59.08 -28.03 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-N 118.822 0.737 . . . . 0.0 111.197 -175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -66.58 -14.81 62.85 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.81 -28.83 12.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.298 0.954 . . . . 0.0 111.734 169.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -53.88 128.23 13.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 -27.1 2.26 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 126.628 1.971 . . . . 0.0 110.55 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.31 124.94 24.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -75.33 -30.7 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.797 -1.097 . . . . 0.0 112.08 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -60.74 -37.16 80.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.184 1.356 . . . . 0.0 110.481 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -69.99 -58.98 3.2 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.439 0.695 . . . . 0.0 109.685 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -58.27 -55.43 35.04 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.785 0.834 . . . . 0.0 111.879 -170.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.9 mt -54.01 -52.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.039 0.936 . . . . 0.0 108.632 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.445 ' CZ ' HD13 ' A' ' 46' ' ' LEU . 59.6 t80 -55.27 -52.68 62.64 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.584 0.754 . . . . 0.0 110.652 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.42 -56.87 10.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.878 1.671 . . . . 0.0 110.409 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.14 -36.24 81.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.473 0.709 . . . . 0.0 111.421 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 m -64.27 -42.6 96.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.476 1.11 . . . . 0.0 109.843 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.445 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 9.7 mt -65.22 -43.14 92.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.371 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.54 -52.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m -63.61 -25.32 68.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.301 0.64 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.6 -2.6 58.36 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.157 1.783 . . . . 0.0 113.649 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.93 26.16 60.87 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 118.445 0.566 . . . . 0.0 112.111 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -89.95 -52.7 4.83 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.86 162.37 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 C-N-CA 124.676 1.191 . . . . 0.0 108.708 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -133.4 156.29 47.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mm -69.65 133.93 31.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 118.935 0.789 . . . . 0.0 108.949 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.41 128.15 6.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.86 0.464 . . . . 0.0 110.692 162.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.7 156.15 45.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.431 0.692 . . . . 0.0 110.428 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.11 168.2 16.31 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.868 3.046 . . . . 0.0 111.645 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t -86.84 163.26 17.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 164.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -50.42 -45.58 55.8 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.03 0.932 . . . . 0.0 111.53 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.35 -18.8 63.83 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -40.84 35.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.797 0.839 . . . . 0.0 110.593 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.24 -49.71 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -56.4 -32.13 64.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.103 0.961 . . . . 0.0 111.392 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -50.93 71.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.591 1.156 . . . . 0.0 110.181 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -63.74 -42.2 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.23 -41.4 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.584 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -65.17 -50.93 64.06 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.107 1.321 . . . . 0.0 110.926 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.85 -34.19 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.81 -50.48 73.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.538 1.135 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.6 71.66 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.654 -1.279 . . . . 0.0 110.755 174.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.67 -32.98 74.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.255 0.934 . . . . 0.0 109.873 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 t -93.16 -16.72 24.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 -78.3 0.38 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.69 86.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.965 1.306 . . . . 0.0 110.727 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -75.63 -41.69 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 120.824 -1.173 . . . . 0.0 112.297 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -135.6 20.41 3.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.221 1.408 . . . . 0.0 109.192 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -70.83 -19.36 62.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.9 -1.125 . . . . 0.0 110.699 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 153.24 25.03 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.052 0.941 . . . . 0.0 110.115 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -58.88 147.94 32.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 111.305 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 27.2 ttpt -55.67 -53.0 61.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.808 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.33 -34.95 76.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 124.137 0.898 . . . . 0.0 110.212 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -55.23 31.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.34 1.056 . . . . 0.0 109.06 176.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -52.44 -45.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.968 0.907 . . . . 0.0 108.938 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 61.9 mt-10 -64.6 -46.21 83.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 0.0 112.23 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.09 -54.69 31.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.559 1.143 . . . . 0.0 109.496 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.7 mt -57.66 -47.51 82.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.945 0.898 . . . . 0.0 109.258 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.75 -56.13 17.8 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.175 1.39 . . . . 0.0 111.955 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.32 -48.41 74.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.779 0.675 . . . . 0.0 109.737 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.93 -21.88 63.85 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -174.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.513 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.44 -22.99 21.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 117.81 -1.09 . . . . 0.0 111.858 175.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.24 -41.93 97.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.714 1.143 . . . . 0.0 109.78 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.99 10.66 24.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.303 1.041 . . . . 0.0 111.0 -171.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 45.66 49.73 11.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.255 1.822 . . . . 0.0 110.107 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.83 -123.74 4.77 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 124.35 0.976 . . . . 0.0 111.178 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -144.7 168.15 20.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.586 1.954 . . . . 0.0 106.893 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.16 157.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -136.8 107.07 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 108.437 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 t -166.12 172.25 11.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.274 1.43 . . . . 0.0 109.582 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -145.27 4.34 1.06 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -57.11 158.21 5.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.867 1.667 . . . . 0.0 112.821 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -61.67 -45.04 95.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.424 -1.423 . . . . 0.0 110.825 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.524 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.05 -39.27 81.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 119.058 0.845 . . . . 0.0 110.787 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.29 -47.86 72.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -60.07 -58.25 9.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.934 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.05 -54.52 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.15 65.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.349 1.431 . . . . 0.0 113.129 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -52.15 58.47 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.212 1.405 . . . . 0.0 112.403 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -21.7 64.72 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.722 1.601 . . . . 0.0 111.893 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -83.56 -10.63 58.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.752 1.221 . . . . 0.0 112.366 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.81 8.11 84.27 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.326 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 143.78 34.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.776 1.788 . . . . 0.0 109.779 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.25 136.84 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.956 1.302 . . . . 0.0 108.371 174.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -146.6 -172.19 3.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.38 161.02 25.55 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.089 1.355 . . . . 0.0 110.392 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.235 0.302 0 C-N-CA 124.447 1.099 . . . . 0.0 108.862 -178.015 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 119.572 -0.251 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -148.25 17.55 1.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.068 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.95 141.12 47.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 120.339 1.427 . . . . 0.0 110.236 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.39 134.24 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.917 1.287 . . . . 0.0 108.506 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.503 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 3.7 t -67.78 118.45 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.69 124.14 27.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.74 -86.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.4 p -74.2 -18.44 60.76 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.755 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.14 62.38 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 123.416 0.531 . . . . 0.0 112.775 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -74.27 145.35 44.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.511 1.124 . . . . 0.0 110.079 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -90.12 145.62 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 109.176 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.7 149.27 43.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.704 0.802 . . . . 0.0 108.843 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 p -97.29 -13.25 22.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.988 0.915 . . . . 0.0 111.997 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 18.4 p -146.11 165.35 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.757 1.623 . . . . 0.0 107.523 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp -77.34 128.7 79.73 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.12 169.96 16.9 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.528 2.152 . . . . 0.0 111.108 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.62 127.34 20.46 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.696 2.264 . . . . 0.0 109.876 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.42 -8.19 42.18 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.707 0.67 . . . . 0.0 113.395 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.01 54.21 32.63 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.461 1.131 . . . . 0.0 112.045 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.08 160.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.56 114.9 14.74 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.8 -14.16 41.34 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 119.739 0.942 . . . . 0.0 112.435 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.09 -12.4 17.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.79 2.036 . . . . 0.0 112.683 -168.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.503 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 8.5 p -156.19 3.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.82 -16.5 5.26 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.637 1.589 . . . . 0.0 114.745 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.2 m -69.88 161.18 30.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 118.686 1.243 . . . . 0.0 112.701 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -68.35 144.18 54.88 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.69 -1.256 . . . . 0.0 110.01 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.56 143.74 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.08 154.83 51.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.68 1.127 . . . . 0.0 111.052 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.46 134.75 48.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.271 1.028 . . . . 0.0 108.959 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.268 1.027 . . . . 0.0 109.638 170.868 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.236 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -54.96 122.94 11.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.793 1.237 . . . . 0.0 109.777 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.74 147.89 36.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.394 1.478 . . . . 0.0 107.499 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.77 152.88 29.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.727 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.27 150.59 46.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.552 1.941 . . . . 0.0 108.907 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.574 ' CG ' ' HG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -110.62 174.5 5.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.9 p -49.57 -43.81 46.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.652 1.181 . . . . 0.0 113.424 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 t -57.25 -39.3 75.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.757 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 t -54.4 -43.93 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.246 1.018 . . . . 0.0 110.138 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -76.78 -25.92 53.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.219 0.608 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.12 -39.36 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.93 0.786 . . . . 0.0 110.639 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -78.08 -17.85 56.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.524 -0.735 . . . . 0.0 112.105 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.25 63.8 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 123.392 0.52 . . . . 0.0 113.381 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.39 106.87 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.08 118.32 8.99 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -157.8 164.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 0.0 107.569 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -137.1 119.3 15.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 111.077 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.73 -146.16 6.73 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.818 2.627 . . . . 0.0 112.29 -166.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.27 152.06 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.182 1.393 . . . . 0.0 111.69 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 t -121.65 168.32 11.91 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.453 1.901 . . . . 0.0 109.701 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.62 113.96 60.99 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 126.535 1.934 . . . . 0.0 108.048 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -55.57 -35.91 93.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.756 2.304 . . . . 0.0 112.7 -172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.2 m -71.54 -16.97 62.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.788 1.235 . . . . 0.0 113.146 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.6 -51.61 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.66 -37.42 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.563 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.38 -22.01 66.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.549 1.068 . . . . 0.0 111.805 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -94.47 -10.9 30.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.433 1.47 . . . . 0.0 111.93 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 ' CD1' ' A' ' 43' ' ' LEU . 2.7 mt -63.46 116.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 -11.06 5.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.128 0.971 . . . . 0.0 113.073 -166.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.78 130.64 37.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -67.29 -35.5 79.61 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.969 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.74 -52.53 62.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.09 1.356 . . . . 0.0 108.685 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.3 -50.84 70.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.983 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -58.58 -52.62 64.88 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.468 1.107 . . . . 0.0 111.91 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.3 -52.05 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.527 1.531 . . . . 0.0 109.145 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -64.06 -42.77 96.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.237 0.542 . . . . 0.0 111.476 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' CD1' HD12 ' A' ' 34' ' ' ILE . 7.6 tt -59.27 -48.65 80.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.94 -1.1 . . . . 0.0 110.663 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.8 -32.55 72.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.629 0.772 . . . . 0.0 110.285 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.8 t -50.45 -54.55 21.21 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.93 0.892 . . . . 0.0 108.876 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.65 -31.89 70.24 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.17 -53.47 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.6 t -57.74 -38.2 74.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.312 1.045 . . . . 0.0 111.94 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.52 3.72 17.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 113.063 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.12 21.25 78.47 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.903 -0.943 . . . . 0.0 111.833 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.96 -29.82 8.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.155 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.5 96.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.553 1.524 . . . . 0.0 108.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -73.16 155.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.9 mm -82.91 147.84 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.64 125.02 0.58 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.747 2.019 . . . . 0.0 109.795 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 158.64 36.05 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 119.497 1.044 . . . . 0.0 112.518 171.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.72 157.51 61.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 124.915 3.743 . . . . 0.0 111.924 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.21 160.72 31.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.907 0.861 . . . . 0.0 110.391 158.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -44.89 79.0 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 109.697 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -61.54 -32.74 72.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.752 0.705 . . . . 0.0 111.119 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.4 m -66.74 -45.02 79.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 109.653 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.7 mm -58.81 -48.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.91 -33.16 70.24 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.018 -0.426 . . . . 0.0 111.208 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -46.41 80.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.2 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -46.51 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.82 -36.5 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.088 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -66.51 -43.79 84.31 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.278 1.854 . . . . 0.0 111.868 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.0 t -82.51 -37.28 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.21 99.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.29 1.036 . . . . 0.0 110.664 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -31.67 66.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.322 0.964 . . . . 0.0 112.034 174.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.06 -43.91 98.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.074 0.852 . . . . 0.0 109.938 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -80.43 -51.6 8.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.811 0.732 . . . . 0.0 111.117 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.54 -73.54 0.13 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 120.44 1.473 . . . . 0.0 114.305 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -70.54 91.47 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.596 0.698 . . . . 0.0 109.364 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.65 -54.71 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -118.84 18.36 13.31 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.538 0.608 . . . . 0.0 111.116 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -68.94 -31.48 70.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.2 157.86 29.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.037 0.535 . . . . 0.0 110.04 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -65.5 153.82 40.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.573 1.178 . . . . 0.0 110.432 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -60.24 -48.87 79.89 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.719 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.69 68.45 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.529 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -56.89 -55.95 27.88 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.421 1.105 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.72 -39.84 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.048 1.739 . . . . 0.0 110.435 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -61.52 -50.49 72.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.986 1.266 . . . . 0.0 110.984 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.55 -53.29 46.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.89 0.876 . . . . 0.0 109.021 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.17 -54.98 38.64 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.887 1.275 . . . . 0.0 108.786 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.2 57.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.237 1.415 . . . . 0.0 112.493 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -49.7 74.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.92 83.55 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.944 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.2 m-85 -70.98 -29.84 65.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.41 1.005 . . . . 0.0 111.697 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.75 -43.25 99.29 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.176 0.898 . . . . 0.0 109.297 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.845 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm 49.24 34.02 5.75 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.972 1.709 . . . . 0.0 110.609 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.25 -136.72 8.7 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.07 1.795 . . . . 0.0 110.636 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -129.56 161.56 30.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.222 2.209 . . . . 0.0 109.108 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.1 mt -130.06 149.08 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.77 122.59 21.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.925 0.89 . . . . 0.0 109.565 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.574 ' HG ' ' CG ' ' A' ' 12' ' ' ASP . 8.3 t -161.04 175.89 11.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.324 0.39 . . . . 0.0 111.025 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -147.3 102.96 3.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.458 1.503 . . . . 0.0 109.483 166.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.52 154.35 18.44 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.154 1.381 . . . . 0.0 110.279 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -64.16 -46.43 84.08 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.92 -53.76 45.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.691 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.12 -41.27 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.784 0.72 . . . . 0.0 111.186 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -58.54 -49.64 76.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 108.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.64 -55.3 21.11 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.981 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mm -52.98 -54.81 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 119.141 0.882 . . . . 0.0 110.364 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.84 -33.03 68.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.241 1.382 . . . . 0.0 113.708 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 t -57.15 -60.45 3.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.941 -1.028 . . . . 0.0 111.534 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -17.55 63.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.436 1.471 . . . . 0.0 113.075 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.4 mm? -83.36 -9.28 59.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.616 0.766 . . . . 0.0 112.249 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.92 35.42 92.02 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.686 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.33 122.9 47.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.229 1.014 . . . . 0.0 110.585 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.62 113.66 2.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -115.24 179.72 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -118.1 121.08 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.307 1.443 . . . . 0.0 107.334 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--O 1.24 0.601 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.317 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -151.34 22.45 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.126 0.971 . . . . 0.0 112.343 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -139.52 150.15 44.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.876 1.216 . . . . 0.0 111.138 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.74 134.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.356 1.062 . . . . 0.0 109.417 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 1.1 t -65.19 127.2 30.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.09 114.02 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.764 0.792 . . . . 0.0 109.308 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.2 -77.71 0.39 Allowed Glycine 0 C--O 1.229 -0.178 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.48 -15.64 62.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.667 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.75 83.91 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.795 1.188 . . . . 0.0 114.341 165.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -69.55 139.87 53.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 124.758 1.223 . . . . 0.0 109.572 -170.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -78.51 147.02 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.7 1.2 . . . . 0.0 109.584 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -139.52 150.88 45.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.057 0.943 . . . . 0.0 109.409 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -102.88 -0.47 31.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.303 1.441 . . . . 0.0 112.562 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 p -149.57 167.9 25.03 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.446 2.298 . . . . 0.0 106.828 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.82 123.66 87.51 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 165.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.24 172.73 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.228 1.952 . . . . 0.0 110.358 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -54.6 137.28 73.16 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 121.896 1.731 . . . . 0.0 110.048 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.39 -10.15 2.07 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.315 0.96 . . . . 0.0 114.148 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.15 29.21 72.22 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 119.137 1.469 . . . . 0.0 112.393 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.25 161.05 21.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 118.448 1.124 . . . . 0.0 109.289 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 12.7 t -73.54 113.76 25.52 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.376 -1.297 . . . . 0.0 109.33 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.31 -17.41 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.702 1.601 . . . . 0.0 113.52 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.97 -26.2 19.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.539 1.136 . . . . 0.0 111.683 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.9 p -153.63 1.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -167.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.87 -13.16 9.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.48 1.514 . . . . 0.0 114.769 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.26 160.05 32.91 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.803 1.302 . . . . 0.0 112.221 -172.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -64.05 138.95 58.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.484 0.659 . . . . 0.0 109.555 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.45 144.61 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.01 150.19 52.26 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.336 1.054 . . . . 0.0 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.94 132.47 47.39 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 123.091 0.556 . . . . 0.0 109.604 172.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 mptt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.7 m -53.04 132.84 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 122.279 1.037 . . . . 0.0 110.841 -171.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -154.36 144.72 22.13 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.36 146.65 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.71 137.84 53.67 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.728 1.611 . . . . 0.0 107.421 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.51 162.04 13.97 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.359 0.412 . . . . 0.0 110.525 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -40.9 -50.1 3.23 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.484 1.914 . . . . 0.0 112.542 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.96 -43.66 99.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 120.252 1.387 . . . . 0.0 109.366 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -69.09 -32.49 71.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.437 0.695 . . . . 0.0 110.644 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.9 mt -61.38 -45.44 98.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.051 0.54 . . . . 0.0 110.597 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -72.22 -28.22 63.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.266 0.939 . . . . 0.0 111.05 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.72 21.77 22.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.107 0.861 . . . . 0.0 112.416 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.73 114.44 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.847 1.324 . . . . 0.0 108.0 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -73.31 110.23 7.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.154 1.782 . . . . 0.0 107.91 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.79 127.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.135 0.974 . . . . 0.0 109.369 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.47 162.62 28.4 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.589 -1.319 . . . . 0.0 111.138 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.14 -147.89 19.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -124.15 156.4 36.76 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.582 1.153 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -128.05 149.54 50.33 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 107.572 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.1 p -78.65 129.87 72.71 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.93 -23.94 76.43 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.212 1.275 . . . . 0.0 111.274 168.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -71.27 -29.94 65.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.96 -37.09 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 119.522 1.055 . . . . 0.0 109.063 174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -60.39 -24.27 30.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 119.116 0.871 . . . . 0.0 112.199 -172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -56.67 -28.62 61.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 117.929 0.331 . . . . 0.0 111.374 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.48 -10.39 16.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.827 1.651 . . . . 0.0 111.427 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.95 78.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -21.33 52.84 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.985 0.914 . . . . 0.0 111.597 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.7 121.25 12.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.59 -50.28 74.38 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.666 0.786 . . . . 0.0 110.46 -162.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.39 -57.39 12.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.348 1.059 . . . . 0.0 109.525 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -58.67 -45.33 89.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.71 1.204 . . . . 0.0 110.663 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.76 -58.98 4.8 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.072 1.349 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.3 mt -53.37 -47.74 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 124.131 0.972 . . . . 0.0 108.559 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.48 -54.84 42.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.438 0.695 . . . . 0.0 110.661 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.64 -54.09 38.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.585 1.154 . . . . 0.0 109.623 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.35 -27.17 68.39 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 121.304 -0.872 . . . . 0.0 111.76 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 m -69.03 -47.19 66.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.616 0.766 . . . . 0.0 110.065 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.62 88.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.151 0.981 . . . . 0.0 111.077 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.56 -46.65 92.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 118.243 0.474 . . . . 0.0 109.79 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -64.24 -32.58 74.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.7 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.72 -2.47 46.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.578 1.151 . . . . 0.0 112.094 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.74 88.6 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 118.422 -1.21 . . . . 0.0 113.482 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.94 -53.73 51.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.518 1.527 . . . . 0.0 108.176 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -107.12 152.57 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -132.82 156.46 47.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.289 1.036 . . . . 0.0 109.731 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.9 mm -81.1 134.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 124.741 1.216 . . . . 0.0 107.736 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.29 127.79 6.48 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.711 1.204 . . . . 0.0 108.593 165.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.41 155.62 51.3 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.2 167.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -65.2 170.48 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.72 2.947 . . . . 0.0 111.993 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.2 t -86.55 153.04 22.12 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 159.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -47.05 -42.35 18.42 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.237 1.415 . . . . 0.0 111.465 161.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.57 -45.07 95.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 110.134 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -65.56 -38.39 89.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.061 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mm -61.18 -48.31 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 119.629 1.104 . . . . 0.0 108.666 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -57.12 -31.95 65.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.042 0.937 . . . . 0.0 111.623 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -41.7 97.13 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.906 0.882 . . . . 0.0 110.694 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -48.99 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.4 mt -52.29 -36.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.899 1.279 . . . . 0.0 110.938 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -61.33 -62.64 1.69 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.471 1.032 . . . . 0.0 110.973 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.79 -34.88 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -172.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.52 57.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.4 1.48 . . . . 0.0 110.322 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HE3' ' N ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -64.87 -20.66 66.54 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.781 -1.199 . . . . 0.0 112.168 176.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HE3' ' A' ' 70' ' ' LYS . 30.9 tt0 -81.18 -20.4 41.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.714 0.805 . . . . 0.0 111.558 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 t -109.37 -22.56 11.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.282 0.947 . . . . 0.0 111.364 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.67 -83.84 0.17 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.151 0.887 . . . . 0.0 112.221 170.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -74.14 91.86 2.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.469 1.108 . . . . 0.0 108.249 -171.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.49 -45.74 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.26 10.18 4.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.783 1.233 . . . . 0.0 109.828 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 8.15 0.92 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.481 0.712 . . . . 0.0 110.93 164.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.33 147.19 27.39 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.259 1.424 . . . . 0.0 108.632 163.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.7 m -70.04 156.4 39.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.714 1.245 . . . . 0.0 110.15 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 29.0 ttpt -61.57 -48.08 82.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.746 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.56 56.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.225 0.92 . . . . 0.0 112.19 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -63.15 -56.27 18.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.3 mt -52.25 -43.31 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.402 1.481 . . . . 0.0 109.18 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 49.2 mt-10 -66.37 -52.74 43.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.619 1.568 . . . . 0.0 112.14 -174.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.65 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 119.131 0.878 . . . . 0.0 109.462 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.401 ' CD2' ' HH ' ' A' ' 90' ' ' TYR . 45.9 mt -57.67 -56.38 22.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.631 0.772 . . . . 0.0 109.218 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.99 -59.07 3.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.496 1.519 . . . . 0.0 112.023 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -49.62 59.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.865 0.866 . . . . 0.0 109.187 -174.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.27 66.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -77.73 -30.07 51.49 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.766 1.167 . . . . 0.0 110.507 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -42.45 99.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 168.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.15 -7.13 59.61 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 52.12 24.96 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.804 1.642 . . . . 0.0 113.109 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 -106.8 2.57 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 119.387 0.994 . . . . 0.0 113.906 -159.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -142.38 166.86 23.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.518 1.927 . . . . 0.0 108.031 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.5 mt -135.21 154.2 35.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.57 121.24 18.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 t -158.14 -170.42 3.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.823 2.049 . . . . 0.0 106.907 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -154.66 -4.77 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 122.235 2.288 . . . . 0.0 115.781 163.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -61.35 148.77 40.3 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.235 1.834 . . . . 0.0 112.942 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -56.92 -32.61 66.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.759 1.624 . . . . 0.0 114.273 -172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.54 -50.85 12.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.43 1.092 . . . . 0.0 110.171 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -42.15 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.494 0.718 . . . . 0.0 110.768 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -67.17 -35.2 79.16 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.029 0.442 . . . . 0.0 110.347 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 -56.74 11.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -51.68 -55.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.462 1.105 . . . . 0.0 110.018 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.22 68.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.163 1.347 . . . . 0.0 113.164 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 t -60.4 -61.69 2.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.071 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.4 -16.56 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.125 1.33 . . . . 0.0 113.212 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.572 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -86.81 -22.17 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.88 0.872 . . . . 0.0 112.525 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.93 38.98 89.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 118.474 0.579 . . . . 0.0 112.859 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 125.12 39.79 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 161.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 116.07 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.21 -162.99 1.11 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.174 0.989 . . . . 0.0 110.709 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -140.25 162.71 34.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.807 2.443 . . . . 0.0 109.354 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 C-N-CA 127.196 2.198 . . . . 0.0 110.35 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 14.14 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -139.81 135.3 32.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.822 1.192 . . . . 0.0 109.984 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.86 131.99 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.89 140.46 58.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 165.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.8 pt -93.29 -11.62 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 118.206 -0.902 . . . . 0.0 113.192 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.73 -20.61 23.81 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 119.621 1.101 . . . . 0.0 113.962 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.7 p -144.8 6.07 1.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.826 1.313 . . . . 0.0 114.16 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.76 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.596 1.093 . . . . 0.0 115.076 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -68.18 147.37 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.199 1.0 . . . . 0.0 110.723 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -110.79 99.0 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.844 0.858 . . . . 0.0 111.783 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.19 143.63 26.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.859 1.314 . . . . 0.0 109.529 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -89.22 -19.77 24.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.568 172.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.7 p -145.21 163.14 35.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.757 1.623 . . . . 0.0 109.034 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.422 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -73.02 116.63 52.49 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -176.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -66.74 169.0 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.468 2.112 . . . . 0.0 110.507 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -55.22 133.07 55.98 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.99 1.794 . . . . 0.0 109.877 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.57 -18.28 3.79 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.574 -1.125 . . . . 0.0 113.597 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 63.38 44.31 97.02 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 119.789 1.795 . . . . 0.0 111.538 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.83 158.41 43.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 14.2 t -67.63 110.93 6.16 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -61.55 -14.94 38.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.292 1.328 . . . . 0.0 111.746 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -12.41 14.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.659 1.984 . . . . 0.0 112.483 -160.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.52 -14.26 0.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.19 85.42 0.12 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.6 p -152.02 174.99 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -60.73 151.8 28.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.715 -1.24 . . . . 0.0 109.995 160.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.65 147.66 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 159.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.84 154.07 46.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.393 0.997 . . . . 0.0 111.415 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.06 114.02 14.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.584 1.154 . . . . 0.0 108.522 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 118.296 0.498 . . . . 0.0 110.79 172.083 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.236 0.375 0 N-CA-C 110.802 -0.073 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -44.79 122.56 3.26 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.509 1.924 . . . . 0.0 110.219 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 tp -147.3 147.14 30.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 108.013 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 t -116.86 140.33 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -108.07 146.8 32.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.875 1.67 . . . . 0.0 107.632 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.2 161.78 13.43 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.14 0.9 . . . . 0.0 112.179 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 t -43.89 -52.49 6.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 127.801 2.44 . . . . 0.0 111.724 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -60.7 -23.03 64.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.485 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.89 90.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 120.073 1.306 . . . . 0.0 109.456 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -72.37 -36.31 68.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.929 0.891 . . . . 0.0 111.045 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.71 -46.6 93.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.313 1.045 . . . . 0.0 109.835 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -75.96 -23.16 55.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.759 0.709 . . . . 0.0 111.116 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.91 41.73 12.07 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mt -81.82 112.49 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.69 98.91 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.448 1.099 . . . . 0.0 109.437 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.5 tp -153.94 164.63 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.105 1.762 . . . . 0.0 107.264 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -131.45 155.11 47.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.02 2.128 . . . . 0.0 108.698 -160.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.74 -149.14 21.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.24 161.91 15.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 0.0 110.157 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.0 t -141.84 161.1 38.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.825 1.65 . . . . 0.0 108.098 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 p -96.18 123.11 56.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 122.401 0.28 . . . . 0.0 110.889 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.2 -26.39 81.58 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.379 2.053 . . . . 0.0 112.114 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.2 m -62.99 -32.64 74.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.1 1.76 . . . . 0.0 114.598 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.47 -29.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.653 1.115 . . . . 0.0 110.369 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.53 -20.02 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 119.868 1.213 . . . . 0.0 111.187 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.57 -29.29 66.27 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.035 -1.666 . . . . 0.0 114.297 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -102.25 -16.23 16.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.454 1.101 . . . . 0.0 111.517 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.91 105.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 124.269 1.028 . . . . 0.0 108.902 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -13.04 7.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.461 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -61.82 120.18 10.2 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -62.02 -32.91 73.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.66 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.72 -63.36 1.17 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.3 p -53.7 -44.74 70.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.046 1.338 . . . . 0.0 112.515 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -71.45 -54.15 11.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.154 1.381 . . . . 0.0 110.896 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.59 -51.98 30.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -54.9 -54.24 45.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 112.429 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.33 -51.52 58.3 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.947 1.299 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.23 -34.26 77.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.977 0.911 . . . . 0.0 111.929 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -64.12 -45.44 88.56 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -36.77 78.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.477 0.711 . . . . 0.0 111.635 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.38 -51.71 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -67.48 -19.53 65.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.07 0.85 . . . . 0.0 113.24 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -10.07 51.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.517 1.527 . . . . 0.0 111.892 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.75 -0.69 70.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.729 1.157 . . . . 0.0 113.767 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -87.79 -28.3 21.76 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.192 0.997 . . . . 0.0 111.984 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.92 140.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -128.51 151.58 49.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.568 1.547 . . . . 0.0 108.877 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.8 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.77 132.38 5.03 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.106 1.362 . . . . 0.0 108.595 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -92.72 154.95 42.21 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.592 0.757 . . . . 0.0 111.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.76 173.92 11.14 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.285 3.323 . . . . 0.0 111.7 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -108.76 162.68 13.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.492 1.117 . . . . 0.0 109.696 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -53.76 -49.79 67.43 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.937 0.895 . . . . 0.0 111.294 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.65 -27.29 66.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.863 0.465 . . . . 0.0 110.184 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -67.42 -48.34 67.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.531 0.733 . . . . 0.0 109.636 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.6 -45.72 94.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.468 1.107 . . . . 0.0 110.155 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.06 -35.09 74.38 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.88 -0.512 . . . . 0.0 110.62 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -44.89 71.08 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.199 0.6 . . . . 0.0 111.06 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.4 mm -64.37 -45.51 95.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.71 -38.8 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.931 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -63.48 -59.03 5.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.168 1.349 . . . . 0.0 110.813 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.6 -32.54 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -51.83 67.28 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -30.83 71.22 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.669 1.122 . . . . 0.0 111.691 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.39 -15.45 48.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 111.712 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -114.31 -28.77 7.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.19 0.905 . . . . 0.0 111.961 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.64 -99.02 0.19 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 119.991 1.269 . . . . 0.0 110.4 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -58.56 96.56 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.267 2.227 . . . . 0.0 108.797 -168.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.98 -44.06 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.483 1.913 . . . . 0.0 110.706 -167.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -123.61 6.71 8.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.281 0.632 . . . . 0.0 110.111 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.78 -24.83 62.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.581 0.628 . . . . 0.0 111.528 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.27 158.09 31.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.658 1.183 . . . . 0.0 109.757 -174.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -68.56 154.93 40.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.441 0.638 . . . . 0.0 110.75 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -63.01 -53.35 55.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.784 -0.572 . . . . 0.0 109.734 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.59 61.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.779 1.3 . . . . 0.0 109.485 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -59.41 -59.13 5.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.968 1.707 . . . . 0.0 108.455 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -53.75 -40.99 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.771 0.828 . . . . 0.0 110.578 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.35 -43.72 73.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.236 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.72 -49.77 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.5 mt -56.97 -53.58 56.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.757 1.223 . . . . 0.0 108.941 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.72 -52.86 54.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.046 1.338 . . . . 0.0 111.75 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.3 tp -54.36 -49.82 68.92 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.31 62.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.709 0.686 . . . . 0.0 112.638 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.507 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.6 m-30 -96.4 -17.48 20.58 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.32 1.048 . . . . 0.0 111.421 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -58.88 -44.57 91.18 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.13 -4.77 13.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.155 1.782 . . . . 0.0 111.935 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 53.6 49.12 20.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.701 2.001 . . . . 0.0 111.547 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.63 -114.18 2.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.761 1.172 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -148.58 169.89 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 107.79 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.38 163.57 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 0.0 108.194 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 118.57 13.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.92 1.688 . . . . 0.0 107.8 166.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.0 t -175.16 176.82 2.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.183 2.193 . . . . 0.0 109.559 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.62 0.19 0.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.422 ' H ' HG12 ' A' ' 103' ' ' VAL . 1.1 t0 -57.31 162.51 2.71 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.539 1.518 . . . . 0.0 113.911 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -57.69 -52.49 65.21 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.726 -1.234 . . . . 0.0 109.74 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -75.1 -43.32 53.64 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.219 1.007 . . . . 0.0 110.183 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 100' ' ' ASP . 1.4 p -61.57 -47.13 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -169.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.74 -37.04 85.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.85 0.46 . . . . 0.0 109.947 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -70.51 -53.32 16.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -49.57 -51.68 14.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.202 1.001 . . . . 0.0 109.443 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.63 70.4 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.002 1.274 . . . . 0.0 112.481 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.6 t -65.56 -52.44 52.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.205 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.41 -30.22 71.38 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 121.106 1.775 . . . . 0.0 110.613 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.507 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -79.97 -8.96 59.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.366 1.066 . . . . 0.0 112.891 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.89 59.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.023 -1.432 . . . . 0.0 115.499 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.11 119.91 26.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.511 2.156 . . . . 0.0 110.569 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 148.86 41.06 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.671 1.188 . . . . 0.0 111.244 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.74 176.33 12.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 122.038 -0.414 . . . . 0.0 111.475 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -111.9 150.55 30.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.967 1.307 . . . . 0.0 109.887 172.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.235 0.321 0 C-N-CA 125.314 1.446 . . . . 0.0 110.17 -175.377 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.479 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 2.4 p-90 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -175.3 13.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -140.91 152.98 45.47 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.148 1.34 . . . . 0.0 111.858 164.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.14 132.84 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.876 1.27 . . . . 0.0 109.132 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -71.7 128.95 37.43 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 164.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pt -80.39 101.51 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.757 0.708 . . . . 0.0 109.696 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.98 -84.58 0.18 Allowed Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 7.0 p -70.47 -15.26 62.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.031 0.416 . . . . 0.0 110.944 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.11 92.79 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.411 1.005 . . . . 0.0 111.826 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -70.94 145.26 50.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 49.8 mttp -104.95 132.54 51.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.133 1.373 . . . . 0.0 107.564 -176.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.29 162.54 25.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 109.086 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.5 t -113.52 -13.74 12.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.729 0.412 . . . . 0.0 110.604 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.8 p -142.09 158.49 43.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.23 126.1 92.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.03 170.95 17.72 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.285 2.657 . . . . 0.0 111.375 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.65 101.79 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.08 3.186 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.59 28.8 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.76 1.648 . . . . 0.0 111.785 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.97 34.24 87.9 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.093 -1.948 . . . . 0.0 113.008 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.07 165.8 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.691 1.996 . . . . 0.0 108.388 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.75 109.72 7.34 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 125.889 1.676 . . . . 0.0 110.036 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.98 -14.9 44.27 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.805 1.323 . . . . 0.0 112.379 167.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -41.06 17.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.006 0.922 . . . . 0.0 110.006 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.6 p -138.48 4.99 2.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.426 1.012 . . . . 0.0 113.573 -163.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.11 -14.63 1.55 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.198 2.333 . . . . 0.0 116.087 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 163.16 24.73 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.865 1.333 . . . . 0.0 112.7 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -69.45 155.94 39.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.66 145.64 15.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -136.24 168.81 18.7 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.094 1.358 . . . . 0.0 110.173 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.0 tt -77.32 157.87 30.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.991 0.916 . . . . 0.0 109.984 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 127.602 2.361 . . . . 0.0 107.816 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.2 tttt . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.7 116.78 1.92 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.86 1.264 . . . . 0.0 111.597 -170.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.96 143.89 31.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.533 0.733 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.15 154.18 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 O-C-N 124.129 0.893 . . . . 0.0 110.306 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.58 154.6 45.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.397 2.679 . . . . 0.0 107.611 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.41 164.44 14.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.746 0.818 . . . . 0.0 111.153 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.7 p -35.08 -50.12 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.282 2.233 . . . . 0.0 112.654 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -52.2 -40.65 61.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.107 0.963 . . . . 0.0 112.188 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.59 -44.76 97.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.322 1.449 . . . . 0.0 109.699 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.35 -34.25 72.41 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.898 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.61 -50.31 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.732 0.813 . . . . 0.0 109.738 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -70.7 -19.49 62.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.29 0.496 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.2 23.69 47.29 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.478 1.037 . . . . 0.0 112.096 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.62 112.69 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 112.48 1.57 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.827 1.251 . . . . 0.0 108.262 170.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 141.39 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.782 2.033 . . . . 0.0 106.989 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -78.29 164.81 24.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.113 1.365 . . . . 0.0 108.986 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.79 -165.85 31.19 Favored Glycine 0 C--N 1.331 0.264 0 O-C-N 121.032 -1.043 . . . . 0.0 111.048 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -103.23 149.02 25.09 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -142.84 171.54 13.92 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.189 1.396 . . . . 0.0 111.153 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.34 119.44 64.25 Favored Pre-proline 0 C--O 1.251 1.154 0 C-N-CA 126.151 1.781 . . . . 0.0 112.963 -168.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.31 -6.23 16.94 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.247 1.965 . . . . 0.0 113.005 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.9 m -91.96 -29.74 16.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.74 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.24 -39.8 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 120.467 1.485 . . . . 0.0 108.95 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.3 p -58.85 -23.57 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.11 -23.24 63.97 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.758 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.51 -34.96 30.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.851 1.26 . . . . 0.0 109.701 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.17 127.2 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.783 1.233 . . . . 0.0 108.092 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 -19.35 2.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.303 1.041 . . . . 0.0 112.239 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.28 127.49 32.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -59.18 -43.06 92.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.779 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.62 -53.93 51.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -54.66 44.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.624 1.57 . . . . 0.0 110.574 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -57.12 -59.29 5.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.154 0.581 . . . . 0.0 109.581 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.97 -53.19 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -54.1 -47.88 71.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.744 0.818 . . . . 0.0 112.066 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.58 -52.44 65.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.077 1.351 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.31 -40.28 95.79 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.912 -0.492 . . . . 0.0 110.729 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -60.05 -47.96 83.71 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.378 1.471 . . . . 0.0 110.132 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -38.28 89.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.827 0.74 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.21 -45.28 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 118.767 0.712 . . . . 0.0 109.491 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -54.31 -50.05 68.26 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 109.635 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.1 -6.59 34.98 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.246 1.819 . . . . 0.0 113.383 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.17 83.31 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.811 1.187 . . . . 0.0 113.324 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.69 -46.58 87.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.561 1.18 . . . . 0.0 107.91 170.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 147.63 21.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.761 0.824 . . . . 0.0 109.092 -167.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.69 172.27 9.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.112 1.765 . . . . 0.0 108.889 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.76 138.46 44.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.789 1.635 . . . . 0.0 110.47 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.28 123.82 3.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.856 1.662 . . . . 0.0 108.052 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -107.22 147.21 34.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.215 0.916 . . . . 0.0 111.581 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.81 171.57 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.445 3.43 . . . . 0.0 113.044 -170.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -111.7 160.58 17.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.604 1.562 . . . . 0.0 110.262 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -59.88 -45.72 91.61 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.611 -0.681 . . . . 0.0 111.535 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.18 -38.78 65.98 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.608 0.763 . . . . 0.0 110.463 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -70.11 -42.12 73.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.344 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -64.13 -46.88 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.38 77.34 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.81 -0.556 . . . . 0.0 111.118 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.73 -44.53 63.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.133 0.973 . . . . 0.0 111.199 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.75 -50.78 57.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.2 mt -51.46 -36.52 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.573 1.149 . . . . 0.0 110.807 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -66.38 -56.32 11.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.809 1.186 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.31 -38.8 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.96 67.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.617 1.567 . . . . 0.0 111.447 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -24.2 63.05 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.134 -0.979 . . . . 0.0 112.537 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.25 -30.7 54.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 111.389 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.269 14.6 t -75.58 -68.13 0.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.38 0.991 . . . . 0.0 108.526 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.76 -73.19 0.07 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-N 119.482 1.037 . . . . 0.0 111.569 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -69.6 93.83 0.73 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.663 0.785 . . . . 0.0 110.027 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.64 -59.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 122.167 -0.333 . . . . 0.0 111.839 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -114.67 8.18 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.451 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.81 -9.29 58.5 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -92.63 159.79 15.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.256 -0.903 . . . . 0.0 110.746 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -68.69 156.38 38.33 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.525 -0.735 . . . . 0.0 111.95 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.44 -57.42 12.81 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 118.895 -0.574 . . . . 0.0 109.508 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.69 -39.79 52.12 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.073 0.858 . . . . 0.0 111.4 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -61.68 2.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 109.316 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.24 -42.99 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 125.283 1.433 . . . . 0.0 108.759 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -56.2 -62.12 1.93 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.458 1.103 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.15 -47.53 80.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.415 0.686 . . . . 0.0 109.638 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.3 mt -59.13 -52.18 66.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.939 0.896 . . . . 0.0 110.173 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.12 -59.45 4.17 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.133 1.373 . . . . 0.0 112.218 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 tp -46.96 -54.27 10.5 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.58 1.175 . . . . 0.0 110.972 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.25 68.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.395 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.524 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.7 m-85 -64.56 -28.78 69.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.517 0.599 . . . . 0.0 112.015 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.19 -34.52 76.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.141 0.882 . . . . 0.0 110.167 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.97 -18.92 38.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.008 1.323 . . . . 0.0 112.972 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.06 51.39 17.15 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.12 -149.01 11.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.929 1.728 . . . . 0.0 111.254 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -114.21 169.93 8.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.618 1.967 . . . . 0.0 108.465 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 55.0 mt -131.94 153.76 39.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.047 1.339 . . . . 0.0 107.807 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.59 111.82 8.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.735 1.214 . . . . 0.0 108.788 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.2 t -160.92 179.61 8.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.032 2.133 . . . . 0.0 107.534 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -155.74 27.71 0.38 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.351 -1.468 . . . . 0.0 113.599 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.3 t70 -95.44 156.64 16.24 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -170.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -69.41 -40.8 77.08 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.037 1.29 . . . . 0.0 110.223 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -49.41 49.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.135 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.545 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -57.01 -40.01 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.812 1.187 . . . . 0.0 110.927 -173.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -67.32 -40.19 85.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.975 0.51 . . . . 0.0 109.874 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -66.09 -55.05 18.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 mm -53.97 -54.47 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 110.391 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.59 -32.32 68.87 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.111 -1.618 . . . . 0.0 112.777 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 t -60.54 -60.6 3.55 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 117.73 -1.129 . . . . 0.0 110.678 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -31.99 71.09 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 120.022 1.283 . . . . 0.0 110.683 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -76.32 -8.72 57.72 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.82 5.49 88.6 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.707 -1.051 . . . . 0.0 113.511 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.65 130.48 34.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.243 1.521 . . . . 0.0 110.031 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -66.63 132.1 47.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.676 0.79 . . . . 0.0 111.168 173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -144.82 178.51 7.96 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.344 -0.848 . . . . 0.0 110.545 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -115.03 156.27 25.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.331 1.452 . . . . 0.0 108.881 171.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 124.919 1.287 . . . . 0.0 108.732 173.546 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ttt-85 -156.82 9.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.998 1.111 . . . . 0.0 113.998 -164.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -133.65 131.89 40.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.92 0.782 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.21 133.77 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.59 128.71 37.44 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 166.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.11 113.06 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 164.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.28 -79.27 0.21 Allowed Glycine 0 C--O 1.229 -0.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 10.7 p -102.8 -7.06 21.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.636 0.718 . . . . 0.0 112.725 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.34 19.36 66.8 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.865 -1.147 . . . . 0.0 114.388 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 5.0 ttm-85 -63.43 150.29 43.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.455 1.502 . . . . 0.0 110.013 -176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -123.96 97.7 5.47 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.746 0.654 . . . . 0.0 111.315 -152.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -99.48 146.26 26.56 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.421 1.105 . . . . 0.0 108.961 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -98.9 -11.32 21.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.473 0.709 . . . . 0.0 110.345 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.5 p -140.03 162.03 36.19 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 126.496 1.918 . . . . 0.0 108.979 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -79.04 118.48 72.73 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.92 161.46 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.979 1.786 . . . . 0.0 109.403 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.0 107.7 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.873 2.382 . . . . 0.0 108.744 172.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.46 -18.93 11.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.761 2.124 . . . . 0.0 111.927 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 54.78 31.4 54.09 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.759 1.279 . . . . 0.0 113.673 -175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 164.11 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.999 1.32 . . . . 0.0 108.154 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.65 115.01 16.75 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.163 168.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.92 -3.87 2.47 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.193 1.929 . . . . 0.0 113.083 166.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.21 -26.68 5.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.434 1.893 . . . . 0.0 112.814 -170.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 67.9 m -113.01 -18.16 12.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.728 1.211 . . . . 0.0 111.52 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 53.02 50.3 51.88 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.7 t -128.28 162.48 26.93 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.32 139.62 49.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.792 0.806 . . . . 0.0 110.948 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.09 152.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -126.76 156.32 41.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 120.306 -1.496 . . . . 0.0 109.516 166.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.12 120.24 23.99 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.535 0.401 0 O-C-N 123.441 0.463 . . . . 0.0 110.697 177.623 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.0 tttt . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -45.14 119.19 1.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.341 1.456 . . . . 0.0 111.95 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.2 137.56 40.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.568 1.547 . . . . 0.0 107.093 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.41 146.76 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.81 146.78 40.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.733 1.613 . . . . 0.0 108.098 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.73 174.66 7.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.345 0.52 . . . . 0.0 111.706 166.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -55.87 -42.28 75.65 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -61.15 -27.7 68.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.743 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.74 -42.68 82.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 119.984 1.266 . . . . 0.0 110.162 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -72.23 -36.38 69.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.465 1.106 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.3 -26.54 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.552 1.141 . . . . 0.0 110.892 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -92.22 -23.55 19.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.278 0.945 . . . . 0.0 111.829 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.96 45.72 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.304 -0.72 . . . . 0.0 113.02 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.2 mt -67.92 109.98 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.87 91.52 0.65 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.383 1.073 . . . . 0.0 110.191 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.47 165.79 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.832 1.253 . . . . 0.0 109.52 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.45 119.29 21.4 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.475 -166.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.07 -162.39 29.27 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.186 0.898 . . . . 0.0 110.905 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -104.26 150.59 24.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.875 1.27 . . . . 0.0 109.397 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -135.46 149.11 49.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.855 1.262 . . . . 0.0 108.82 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.82 118.93 75.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 125.219 1.408 . . . . 0.0 107.99 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.12 -28.71 71.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 119.749 0.946 . . . . 0.0 110.776 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -48.29 37.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.181 3.392 . . . . 0.0 113.899 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.7 -35.15 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-N 118.77 0.714 . . . . 0.0 110.33 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.27 -26.95 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.867 0.758 . . . . 0.0 110.062 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.5 -20.48 31.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.91 -22.12 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.992 1.317 . . . . 0.0 111.685 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.2 mt -62.58 116.79 2.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 122.211 1.005 . . . . 0.0 108.837 -170.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.84 -16.54 3.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.838 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -66.56 122.01 16.63 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -56.22 -45.34 79.94 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.122 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -56.79 -55.85 29.02 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.77 1.228 . . . . 0.0 109.121 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -61.17 -44.57 97.1 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.371 1.069 . . . . 0.0 110.31 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.41 -55.53 20.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.329 0.652 . . . . 0.0 110.493 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.1 mt -50.27 -55.68 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -55.19 -56.06 24.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.982 0.913 . . . . 0.0 111.613 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -52.55 -57.51 9.72 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.605 1.162 . . . . 0.0 108.836 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -58.06 -41.1 82.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.001 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -62.87 -35.85 81.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.854 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -37.46 63.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.971 0.908 . . . . 0.0 111.209 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.1 -47.3 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -66.52 -34.52 78.11 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.036 0.38 . . . . 0.0 110.976 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.91 -12.41 61.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.071 0.948 . . . . 0.0 112.745 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.13 21.75 48.08 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 119.427 1.012 . . . . 0.0 112.668 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -105.81 -26.59 11.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.913 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -119.87 127.01 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -123.27 144.2 49.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.987 1.267 . . . . 0.0 112.847 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.7 mm -77.4 122.65 32.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.666 1.186 . . . . 0.0 109.412 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 126.88 10.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.783 0.833 . . . . 0.0 110.097 168.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.39 158.14 37.49 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.1 0.56 . . . . 0.0 112.409 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.89 175.0 5.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 125.034 3.823 . . . . 0.0 111.98 170.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.36 165.03 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.36 15.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.913 1.685 . . . . 0.0 111.501 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.17 -30.81 70.0 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.763 0.425 . . . . 0.0 111.582 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -64.96 -48.52 73.74 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.385 1.474 . . . . 0.0 109.492 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.01 -46.9 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 124.439 1.096 . . . . 0.0 108.902 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -34.67 74.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 122.412 -0.18 . . . . 0.0 110.969 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -41.54 75.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.499 0.719 . . . . 0.0 111.443 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -41.13 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 117.33 -1.319 . . . . 0.0 109.803 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.59 -54.03 17.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.334 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -55.32 -55.13 35.0 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.813 1.188 . . . . 0.0 112.13 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 p -67.44 -37.44 78.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.988 -0.445 . . . . 0.0 110.972 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.01 77.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.259 1.024 . . . . 0.0 110.604 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -53.52 57.28 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.106 1.362 . . . . 0.0 109.566 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 1.86 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.654 1.582 . . . . 0.0 112.695 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.94 11.53 3.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.331 1.452 . . . . 0.0 111.107 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.07 -72.67 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 125.908 1.718 . . . . 0.0 112.78 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -77.68 71.56 4.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.86 1.264 . . . . 0.0 110.246 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.43 -39.13 82.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.762 1.625 . . . . 0.0 113.898 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -130.76 12.98 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.885 0.766 . . . . 0.0 110.887 -173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.61 -22.84 61.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.68 0.792 . . . . 0.0 111.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.33 155.83 31.71 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 122.14 -0.35 . . . . 0.0 110.428 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.7 m -63.24 151.13 41.37 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.581 0.705 . . . . 0.0 109.28 170.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -55.75 -45.32 78.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.562 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.38 80.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.203 0.911 . . . . 0.0 113.17 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.27 -57.77 9.95 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -55.92 -45.22 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.373 1.469 . . . . 0.0 109.08 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -68.22 -49.88 57.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.904 1.282 . . . . 0.0 111.943 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.42 -48.02 86.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.346 0.975 . . . . 0.0 108.998 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.74 -57.06 14.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.178 0.991 . . . . 0.0 109.177 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.97 -48.49 52.13 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.914 1.286 . . . . 0.0 111.331 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.42 -51.73 65.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.709 0.804 . . . . 0.0 109.211 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.69 74.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.4 m-30 -76.08 -22.23 55.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.938 0.79 . . . . 0.0 111.91 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.37 -50.23 68.53 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.43 -14.0 59.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.44 1.096 . . . . 0.0 112.779 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? 54.35 30.3 12.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.888 1.675 . . . . 0.0 111.752 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -125.53 5.2 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.158 0.885 . . . . 0.0 111.061 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.98 165.63 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.767 2.027 . . . . 0.0 110.12 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.7 mt -130.09 162.99 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.725 1.21 . . . . 0.0 108.462 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.38 122.75 19.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.207 2.203 . . . . 0.0 106.051 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -163.26 175.76 10.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.66 1.184 . . . . 0.0 110.669 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -160.35 92.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.229 1.412 . . . . 0.0 109.618 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.92 153.04 33.33 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.777 1.231 . . . . 0.0 109.254 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -58.66 -41.71 86.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.0 1.273 . . . . 0.0 111.907 -171.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.89 -55.54 14.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 110.029 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.12 -40.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.492 0.663 . . . . 0.0 110.526 -171.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -69.67 -41.3 75.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.063 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -59.54 -59.79 4.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.708 1.603 . . . . 0.0 107.649 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 mm -53.33 -58.84 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 124.639 1.176 . . . . 0.0 108.841 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.71 67.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.455 1.479 . . . . 0.0 112.793 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -52.98 55.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.764 -1.589 . . . . 0.0 113.102 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -35.23 79.08 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 121.235 1.834 . . . . 0.0 109.784 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -70.14 -22.38 63.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.493 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.97 80.32 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 124.726 1.155 . . . . 0.0 113.847 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.25 118.18 23.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.408 1.104 . . . . 0.0 109.098 177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -68.61 131.75 45.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.778 1.231 . . . . 0.0 108.274 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -146.57 169.74 18.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.926 0.393 . . . . 0.0 111.182 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -101.93 134.27 45.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.607 1.163 . . . . 0.0 108.38 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.45 -0.433 0 O-C-N 124.721 1.263 . . . . 0.0 109.53 164.471 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 5.5 p-90 . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -155.58 25.05 0.4 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.619 -1.182 . . . . 0.0 113.933 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -129.94 140.4 50.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.676 1.125 . . . . 0.0 110.73 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.29 135.29 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.592 1.557 . . . . 0.0 108.886 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.53 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.6 OUTLIER -70.25 140.68 52.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -91.3 102.14 13.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 121.983 0.897 . . . . 0.0 109.045 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.05 -78.72 0.33 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 2.3 p -78.01 -10.72 59.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.621 0.71 . . . . 0.0 111.528 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.66 21.93 71.32 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.919 1.247 . . . . 0.0 114.589 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -63.93 135.16 56.28 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.354 1.062 . . . . 0.0 109.729 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -88.48 136.72 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.66 1.584 . . . . 0.0 108.417 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -130.8 150.02 52.17 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.416 1.086 . . . . 0.0 108.354 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 3.3 p -88.18 -22.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.435 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.4 p -139.58 172.61 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 108.136 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.86 132.34 90.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.12 169.44 21.44 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.912 1.741 . . . . 0.0 110.123 172.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -56.39 137.49 80.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.68 1.587 . . . . 0.0 109.586 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.96 -10.04 4.69 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.88 72.78 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.806 1.803 . . . . 0.0 112.918 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.18 161.63 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.247 1.019 . . . . 0.0 108.947 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.3 t -79.48 113.69 39.09 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.432 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.16 -13.45 15.95 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.366 1.377 . . . . 0.0 114.044 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.53 -25.09 15.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.171 1.388 . . . . 0.0 112.79 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.53 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.9 p -150.71 2.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.57 -11.35 7.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.585 2.04 . . . . 0.0 115.152 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.46 166.75 21.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.588 1.194 . . . . 0.0 112.873 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -61.16 149.21 38.15 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.618 -0.676 . . . . 0.0 109.834 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.48 142.94 22.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 153.5 51.22 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.34 1.056 . . . . 0.0 111.364 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.7 tt -76.08 137.85 40.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.777 0.831 . . . . 0.0 109.214 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 112.768 -177.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -39.79 117.95 0.81 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 126.417 1.887 . . . . 0.0 110.443 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.99 144.15 43.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.13 155.48 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 124.373 1.045 . . . . 0.0 109.903 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.16 146.15 51.28 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.305 1.842 . . . . 0.0 108.671 -166.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.16 171.97 7.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.561 0.744 . . . . 0.0 112.749 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.73 69.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.095 1.358 . . . . 0.0 112.187 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -37.38 72.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.2 -47.38 80.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.942 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -73.19 -31.73 64.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.879 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.01 -47.94 91.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.972 . . . . 0.0 109.518 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.63 -25.02 58.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.198 0.454 . . . . 0.0 111.043 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.88 28.08 14.86 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.39 0.519 . . . . 0.0 113.053 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -72.08 108.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -61.27 115.53 3.89 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 23' ' ' GLU . 3.5 tp -159.48 144.79 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.981 1.713 . . . . 0.0 107.45 174.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' H ' HD11 ' A' ' 22' ' ' ILE . 31.9 mp0 -88.09 142.37 27.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.947 1.299 . . . . 0.0 108.652 175.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.15 -155.61 24.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -117.96 151.72 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.25 1.02 . . . . 0.0 109.858 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 t -129.37 145.79 51.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.163 1.385 . . . . 0.0 110.496 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.13 117.69 68.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.504 1.522 . . . . 0.0 110.035 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.97 -5.67 9.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.884 3.056 . . . . 0.0 115.633 -170.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.99 -4.35 13.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.346 0.976 . . . . 0.0 111.886 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.69 -47.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.55 -19.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.59 -26.11 66.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.127 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -78.18 -40.95 36.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.017 0.927 . . . . 0.0 108.849 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.0 mt -55.67 101.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.609 1.564 . . . . 0.0 108.699 -169.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -9.29 8.9 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 126.025 1.73 . . . . 0.0 110.734 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.31 127.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -58.45 -51.66 68.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.557 0.743 . . . . 0.0 109.355 -170.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.41 -54.89 40.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.637 1.175 . . . . 0.0 108.73 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.381 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -64.73 -58.05 7.33 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.712 0.687 . . . . 0.0 109.469 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.37 -46.65 85.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' A' ' 46' ' ' LEU . 50.4 t80 -59.5 -51.65 68.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.067 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 tt -53.34 -52.12 60.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.103 0.961 . . . . 0.0 109.547 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.8 -37.04 80.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.906 0.882 . . . . 0.0 110.961 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -56.51 -46.53 80.51 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.317 1.447 . . . . 0.0 109.995 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 50.9 mt -67.7 -35.57 79.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.578 0.751 . . . . 0.0 110.784 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.3 -55.36 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -59.5 -38.19 80.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.397 0.544 . . . . 0.0 112.363 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -24.92 66.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.853 1.261 . . . . 0.0 112.383 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 9.0 60.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.531 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.75 -34.76 24.76 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.351 1.076 . . . . 0.0 111.263 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.26 147.76 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -128.17 157.01 41.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.51 1.124 . . . . 0.0 109.759 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mm -78.63 135.06 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.85 127.83 7.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.828 0.851 . . . . 0.0 111.756 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -106.03 154.93 39.21 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.735 1.614 . . . . 0.0 112.17 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.82 163.33 28.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.12 3.88 . . . . 0.0 114.457 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -90.81 166.57 13.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.662 1.985 . . . . 0.0 109.457 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tmpt? -50.17 -44.45 52.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.129 1.372 . . . . 0.0 110.295 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -71.39 -27.58 63.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.989 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.434 ' HG ' ' CG ' ' A' ' 91' ' ' GLU . 4.1 m -66.09 -48.98 69.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.265 0.626 . . . . 0.0 109.664 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.26 -42.09 93.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.51 -33.14 74.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.225 0.466 . . . . 0.0 111.221 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -43.37 61.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.641 1.176 . . . . 0.0 110.307 174.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.21 -44.18 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 119.336 0.971 . . . . 0.0 108.547 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.61 -39.88 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.404 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -57.01 -68.2 0.24 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.5 1.143 . . . . 0.0 109.14 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.39 -29.81 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.091 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.22 60.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.917 . . . . 0.0 111.643 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -25.99 67.7 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.081 -1.012 . . . . 0.0 111.563 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.98 -52.72 63.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.139 0.882 . . . . 0.0 109.088 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -75.57 -39.96 57.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.36 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.55 -76.54 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.532 1.06 . . . . 0.0 113.52 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.01 92.0 0.91 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 122.02 0.914 . . . . 0.0 110.213 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.91 -44.08 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.541 0.736 . . . . 0.0 112.784 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -131.18 12.91 5.13 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.753 0.421 . . . . 0.0 110.899 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.03 -8.31 55.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.25 156.69 23.0 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.267 -0.895 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.77 159.21 19.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.921 1.289 . . . . 0.0 110.605 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -57.9 7.87 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.42 -39.14 75.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 123.959 0.787 . . . . 0.0 111.055 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.68 -52.4 65.61 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 109.729 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.53 -46.35 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.5 -49.64 58.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.638 0.654 . . . . 0.0 112.722 -172.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.58 -50.72 79.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -55.47 -58.57 7.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.15 0.98 . . . . 0.0 109.288 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.44 -55.89 8.08 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.931 1.292 . . . . 0.0 112.005 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.08 -48.07 81.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.295 1.038 . . . . 0.0 110.364 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.19 74.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.242 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.508 ' HH ' HG23 ' A' ' 106' ' ' ILE . 11.4 m-30 -67.76 -27.95 67.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.679 0.672 . . . . 0.0 111.213 -177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.434 ' CG ' ' HG ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -70.54 -30.05 66.69 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.281 0.946 . . . . 0.0 110.89 170.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.69 -14.82 38.85 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.718 1.207 . . . . 0.0 112.284 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.72 0.75 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.149 1.38 . . . . 0.0 111.425 -162.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.97 -162.79 13.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -101.67 167.92 9.8 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 109.043 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.62 150.8 32.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 125.181 1.393 . . . . 0.0 107.3 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.88 124.82 25.6 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.255 1.822 . . . . 0.0 106.29 170.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 t -152.31 -150.21 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.708 2.003 . . . . 0.0 106.884 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.01 -23.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.768 1.167 . . . . 0.0 113.401 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.91 140.73 47.68 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.901 1.681 . . . . 0.0 113.483 -156.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.41 -38.57 54.22 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.057 -1.652 . . . . 0.0 113.257 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.07 -47.79 60.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 111.341 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -37.04 56.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.046 1.294 . . . . 0.0 110.38 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.84 -39.55 79.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -63.94 -56.29 16.33 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.401 0.68 . . . . 0.0 110.324 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.508 HG23 ' HH ' ' A' ' 90' ' ' TYR . 13.8 mm -54.55 -52.67 38.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.494 1.043 . . . . 0.0 109.851 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.71 73.11 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.522 1.51 . . . . 0.0 113.298 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 t -55.8 -62.12 1.91 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.954 172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -25.38 68.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.368 1.44 . . . . 0.0 111.927 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.439 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -83.33 -10.16 58.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.78 82.22 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.563 -1.132 . . . . 0.0 113.879 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.22 135.51 33.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.497 1.648 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.37 131.76 35.3 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.613 1.965 . . . . 0.0 110.435 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.98 -175.28 5.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.664 -0.647 . . . . 0.0 110.986 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -98.98 175.28 5.98 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.161 1.384 . . . . 0.0 114.239 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 124.96 1.304 . . . . 0.0 110.423 171.221 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -0.3 0.11 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.63 150.06 44.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.665 1.575 . . . . 0.0 111.613 -169.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.79 128.42 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.842 1.257 . . . . 0.0 109.436 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 3.1 t -65.91 144.15 56.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 166.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.23 94.92 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.09 -90.78 0.1 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.97 13.24 17.19 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.183 0.993 . . . . 0.0 111.367 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.09 22.93 61.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.013 1.292 . . . . 0.0 115.122 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -65.46 125.78 26.22 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 110.056 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -72.78 150.99 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.938 0.773 . . . . 0.0 109.873 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.31 149.69 38.16 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.501 1.12 . . . . 0.0 109.229 166.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.9 t -86.11 -26.98 24.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.135 0.574 . . . . 0.0 111.674 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.7 p -145.3 160.02 42.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.392 1.477 . . . . 0.0 108.238 -171.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -74.57 123.42 89.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.49 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.91 172.06 15.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.858 2.372 . . . . 0.0 110.206 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.1 137.4 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 121.918 1.745 . . . . 0.0 110.269 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.59 -9.79 1.69 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.544 1.069 . . . . 0.0 114.172 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.8 35.77 87.67 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.87 1.335 . . . . 0.0 111.724 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.56 158.2 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.383 1.073 . . . . 0.0 108.121 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 4.8 t -71.08 113.03 15.69 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 117.252 -1.356 . . . . 0.0 108.082 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.36 -18.81 25.96 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.51 1.474 . . . . 0.0 113.189 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -27.15 15.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.088 1.755 . . . . 0.0 111.882 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 11.7 p -140.4 -2.77 1.39 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.43 -13.9 2.66 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.464 1.983 . . . . 0.0 115.317 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 163.1 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.177 1.489 . . . . 0.0 111.789 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.11 154.34 41.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.524 0.678 . . . . 0.0 109.768 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.8 t -108.17 148.48 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -129.96 160.8 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.335 1.054 . . . . 0.0 110.697 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.45 116.56 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.082 1.353 . . . . 0.0 107.803 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 124.459 1.104 . . . . 0.0 111.657 175.847 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm . . . . . 0 C--O 1.238 0.452 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.8 m -63.48 125.61 24.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -146.37 134.41 21.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.65 152.39 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.72 135.32 50.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.369 2.267 . . . . 0.0 109.409 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.33 161.36 14.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.97 2.108 . . . . 0.0 110.941 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -46.38 -45.17 17.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.399 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -52.19 -35.35 48.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.871 0.868 . . . . 0.0 111.92 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.18 -35.87 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.144 0.978 . . . . 0.0 109.626 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.2 -37.6 25.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.66 0.784 . . . . 0.0 111.025 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.92 -41.95 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.975 0.91 . . . . 0.0 109.205 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -79.13 -13.92 59.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 24.42 65.1 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.274 0.94 . . . . 0.0 113.864 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -78.82 108.19 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 C-N-CA 124.557 1.143 . . . . 0.0 108.417 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.05 111.75 3.52 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tp -154.45 159.62 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 127.348 2.259 . . . . 0.0 106.756 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -128.24 128.62 45.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.641 1.176 . . . . 0.0 110.498 -166.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.13 -147.65 9.08 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.236 1.398 . . . . 0.0 111.943 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.96 158.1 24.65 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.11 1.764 . . . . 0.0 110.144 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -145.74 166.29 26.3 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -90.09 125.56 60.01 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.619 0.724 . . . . 0.0 111.618 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.07 -12.58 30.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.235 1.29 . . . . 0.0 111.163 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -32.94 67.39 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 126.873 2.069 . . . . 0.0 112.698 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -92.8 -34.37 5.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 120.267 1.394 . . . . 0.0 110.632 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.49 -16.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.849 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.392 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.65 -21.69 10.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.461 1.904 . . . . 0.0 110.799 -166.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 mt -67.81 96.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -90.45 -24.76 20.62 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 112.117 165.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.26 129.2 24.12 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.304 1.842 . . . . 0.0 111.549 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -51.4 -72.01 0.06 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 126.208 1.803 . . . . 0.0 110.535 -170.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.98 -48.02 83.76 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -164.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.8 t -50.48 -56.37 11.88 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.988 1.715 . . . . 0.0 110.088 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -61.4 -53.91 50.46 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.358 1.063 . . . . 0.0 110.61 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.5 mt -55.67 -50.17 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.27 1.028 . . . . 0.0 108.621 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.17 -48.41 80.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.7 -48.5 77.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.04 -1.037 . . . . 0.0 110.456 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.43 -40.87 92.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.997 0.919 . . . . 0.0 110.61 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 t -57.68 -51.1 70.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.166 1.386 . . . . 0.0 110.425 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.14 -38.08 89.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.809 0.843 . . . . 0.0 110.616 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.02 -50.97 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.7 t -59.54 -35.82 74.94 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.456 0.702 . . . . 0.0 111.015 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.17 -11.59 59.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.266 1.426 . . . . 0.0 112.725 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.44 87.1 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.721 1.153 . . . . 0.0 113.443 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -78.42 -19.71 52.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.188 0.995 . . . . 0.0 112.07 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.43 136.78 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -125.72 140.9 52.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.52 0.676 . . . . 0.0 110.398 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.48 126.64 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.04 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.37 127.4 9.71 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.102 1.361 . . . . 0.0 109.212 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -99.57 155.05 36.93 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.505 0.722 . . . . 0.0 112.77 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.03 173.75 8.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.23 3.954 . . . . 0.0 112.235 165.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.08 173.16 8.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.887 2.075 . . . . 0.0 110.151 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -54.1 -49.86 68.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.833 -0.542 . . . . 0.0 110.251 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.08 -31.04 71.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.348 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -51.98 53.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.177 0.991 . . . . 0.0 110.31 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.27 -45.68 97.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.36 -39.9 70.64 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.661 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -45.63 46.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.415 1.486 . . . . 0.0 110.556 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -46.85 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.3 mt -53.17 -43.41 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.317 1.047 . . . . 0.0 110.339 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.55 -57.52 12.4 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.571 0.623 . . . . 0.0 110.199 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.74 -37.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.9 71.97 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.411 1.084 . . . . 0.0 111.482 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -35.14 80.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.928 1.24 . . . . 0.0 111.164 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.86 -42.72 94.63 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.741 0.7 . . . . 0.0 110.715 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 t -80.98 -41.03 23.42 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.183 0.447 . . . . 0.0 111.94 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.32 146.18 6.37 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.787 1.661 . . . . 0.0 109.045 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 83.05 50.59 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 130.39 3.476 . . . . 0.0 109.21 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.48 -52.76 48.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 121.153 -0.967 . . . . 0.0 113.413 -170.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.09 11.02 15.17 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.083 0.553 . . . . 0.0 110.528 -167.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -20.74 32.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.534 0.734 . . . . 0.0 112.199 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -73.64 150.78 41.1 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.5 m -58.98 152.17 20.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.299 1.047 . . . . 0.0 110.812 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -59.19 4.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.58 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.56 77.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.888 0.743 . . . . 0.0 111.737 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.97 -55.25 37.1 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.173 0.989 . . . . 0.0 108.522 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.5 -43.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.838 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -65.49 -51.55 59.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.447 0.567 . . . . 0.0 111.435 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.27 -48.83 83.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.322 1.049 . . . . 0.0 109.301 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.1 mt -58.22 -57.45 12.82 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.941 0.897 . . . . 0.0 109.614 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.8 64.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.177 1.391 . . . . 0.0 112.663 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.06 -49.35 78.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.487 1.115 . . . . 0.0 109.167 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.98 75.12 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.709 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.497 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.6 m-30 -69.97 -26.3 64.03 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.109 0.868 . . . . 0.0 110.288 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.41 -7.09 51.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.316 1.046 . . . . 0.0 112.4 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.39 -10.61 8.43 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.266 1.427 . . . . 0.0 112.142 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.9 mttt 51.97 34.84 14.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 110.533 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.59 -130.37 6.66 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.712 1.149 . . . . 0.0 110.456 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -133.85 170.38 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.611 1.964 . . . . 0.0 109.917 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.99 153.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 126.207 1.803 . . . . 0.0 106.489 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.47 115.89 16.08 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 109.289 166.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 t -157.58 -172.53 4.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.061 3.344 . . . . 0.0 108.394 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.91 6.45 0.7 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -168.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.507 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.5 t0 -102.19 160.54 14.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.168 1.349 . . . . 0.0 111.96 -157.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -64.75 -48.55 74.15 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.51 -1.369 . . . . 0.0 111.636 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -69.33 -48.35 61.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.714 1.206 . . . . 0.0 109.78 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.507 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -56.53 -43.55 78.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -172.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.86 -47.79 79.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.32 0.648 . . . . 0.0 110.154 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -56.08 -59.93 4.21 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.196 1.798 . . . . 0.0 108.226 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.16 -53.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 119.753 1.161 . . . . 0.0 111.254 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.37 67.71 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.367 1.44 . . . . 0.0 112.204 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -57.74 10.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -21.92 64.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.15 1.341 . . . . 0.0 111.629 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.8 mm? -81.82 -22.15 37.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.473 0.709 . . . . 0.0 111.454 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.5 9.9 71.5 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.563 1.554 . . . . 0.0 114.232 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.22 123.86 29.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.853 1.327 . . . . 0.0 110.374 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 135.02 55.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.565 1.546 . . . . 0.0 109.05 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -151.23 175.27 12.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -107.35 166.51 10.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -149.82 9.71 0.7 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 117.352 -1.309 . . . . 0.0 113.532 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -133.96 138.94 45.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.907 1.231 . . . . 0.0 111.381 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.39 134.54 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.074 1.35 . . . . 0.0 109.298 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -76.54 122.06 24.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.071 0.949 . . . . 0.0 108.541 173.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.79 108.11 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.12 -80.66 0.2 Allowed Glycine 0 N--CA 1.458 0.136 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.5 p -88.45 -16.76 31.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.14 0.47 . . . . 0.0 111.885 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.11 32.5 43.78 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.546 0.593 . . . . 0.0 113.075 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HD3' ' CZ ' ' A' ' 138' ' ' PHE . 42.5 ttt-85 -70.14 157.6 37.31 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 117.875 0.837 . . . . 0.0 109.772 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -101.32 146.63 27.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.353 1.461 . . . . 0.0 108.838 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CZ ' ' HD3' ' A' ' 136' ' ' ARG . 97.4 m-85 -140.02 148.3 41.64 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.974 1.31 . . . . 0.0 108.321 169.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 t -94.22 -23.61 17.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.672 0.789 . . . . 0.0 110.566 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.9 p -136.97 157.64 46.27 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.615 0.766 . . . . 0.0 109.856 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.59 110.47 9.78 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 172.02 12.21 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.918 3.079 . . . . 0.0 110.536 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.81 120.02 7.51 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.012 1.808 . . . . 0.0 109.632 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.47 -6.89 81.12 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.079 1.324 . . . . 0.0 113.417 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.48 38.54 93.7 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 119.255 1.528 . . . . 0.0 112.43 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -116.11 174.94 3.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 124.694 1.198 . . . . 0.0 108.397 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.444 ' C ' ' H ' ' A' ' 149' ' ' ASP . 49.7 t -89.19 100.31 2.13 Favored Pre-proline 0 CA--C 1.519 -0.239 0 CA-C-N 120.849 1.659 . . . . 0.0 109.355 174.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.14 37.49 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.932 3.754 . . . . 0.0 113.946 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.3 OUTLIER -151.01 -16.08 0.21 Allowed 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.38 2.272 . . . . 0.0 112.004 -175.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 11.8 p -146.73 -31.57 0.34 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.23 92.49 0.96 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.904 1.716 . . . . 0.0 111.128 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.43 174.01 2.85 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.638 1.975 . . . . 0.0 108.042 170.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -76.3 137.63 40.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.03 1.287 . . . . 0.0 111.958 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.35 157.94 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 156.62 44.07 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.699 -1.25 . . . . 0.0 110.969 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.24 146.08 35.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.672 0.789 . . . . 0.0 109.149 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 pt . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 -176.512 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -50.58 125.94 14.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.593 1.557 . . . . 0.0 109.043 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -144.44 142.54 30.37 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.57 148.56 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.18 133.85 53.45 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.464 1.506 . . . . 0.0 108.905 -171.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.52 161.81 20.09 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.88 1.672 . . . . 0.0 111.861 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -45.75 11.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.951 1.7 . . . . 0.0 111.822 171.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.0 p -61.54 -31.73 71.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.334 0.515 . . . . 0.0 111.938 -174.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 t -61.75 -42.56 94.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.656 1.182 . . . . 0.0 109.33 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.53 -37.32 71.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.663 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 91.3 mt -55.31 -54.43 25.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.07 -26.17 65.71 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.84 0.746 . . . . 0.0 111.461 -173.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 42' ' ' PHE . . . 91.23 37.25 6.31 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.79 108.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.35 112.61 7.62 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.33 174.37 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.082 1.353 . . . . 0.0 107.778 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -120.4 149.79 41.8 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.547 1.539 . . . . 0.0 108.339 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.74 -137.64 5.96 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.39 153.5 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.589 1.155 . . . . 0.0 110.452 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -129.38 144.63 51.32 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.522 1.129 . . . . 0.0 109.8 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.9 p -84.38 121.3 75.14 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 124.757 1.223 . . . . 0.0 109.804 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.42 -14.14 43.39 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.62 1.547 . . . . 0.0 113.665 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -74.75 -44.11 51.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.32 -36.11 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 119.402 1.001 . . . . 0.0 109.269 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.21 -20.16 26.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 118.855 -1.138 . . . . 0.0 113.358 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.09 -25.3 68.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.249 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.94 -30.23 65.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.323 1.049 . . . . 0.0 109.893 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.96 82.56 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.973 2.109 . . . . 0.0 109.49 -164.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -20.17 60.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.215 1.406 . . . . 0.0 112.179 169.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.01 133.22 47.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.844 0.858 . . . . 0.0 110.89 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.3 mmt-85 -61.83 -59.65 4.83 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.96 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.19 -45.52 91.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 118.261 -0.876 . . . . 0.0 108.998 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 t -55.9 -56.23 23.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.276 0.63 . . . . 0.0 110.75 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -60.14 -51.43 69.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.624 1.102 . . . . 0.0 111.585 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.21 -57.62 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CE2' ' HA2' ' A' ' 19' ' ' GLY . 68.4 t80 -56.46 -45.68 80.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.139 0.976 . . . . 0.0 112.219 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -54.48 -52.48 61.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.11 0.964 . . . . 0.0 108.525 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -70.48 -28.03 64.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.707 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -61.44 -50.27 73.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.422 1.01 . . . . 0.0 108.548 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -42.73 80.93 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.675 1.19 . . . . 0.0 111.402 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.83 -56.56 17.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -28.52 69.24 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.98 -13.2 60.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.397 1.479 . . . . 0.0 112.103 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.94 -6.7 51.87 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.603 1.573 . . . . 0.0 113.784 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -87.12 -23.42 24.87 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 118.486 1.143 . . . . 0.0 112.99 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.49 149.48 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 120.666 1.575 . . . . 0.0 107.457 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -135.16 156.73 48.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.709 -0.619 . . . . 0.0 111.007 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.35 131.52 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.87 0.868 . . . . 0.0 108.99 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.12 128.19 6.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.847 1.259 . . . . 0.0 110.036 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.33 158.82 32.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.163 0.985 . . . . 0.0 112.584 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -75.34 145.47 30.36 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.238 3.292 . . . . 0.0 112.891 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -65.01 155.35 34.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.156 0.982 . . . . 0.0 109.947 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -65.82 -36.11 82.56 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.904 -1.123 . . . . 0.0 109.479 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -21.74 64.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.973 0.806 . . . . 0.0 111.204 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 p -85.03 -38.17 19.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.102 0.864 . . . . 0.0 112.755 172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.47 1.032 . . . . 0.0 108.263 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -28.32 64.28 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.816 0.446 . . . . 0.0 111.451 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.69 98.72 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.548 -0.72 . . . . 0.0 111.741 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -46.29 84.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -57.27 -28.77 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.737 0.698 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.11 -72.77 0.15 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.215 1.371 . . . . 0.0 108.962 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.62 -36.61 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.508 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.81 92.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.155 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -27.2 61.59 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 121.692 2.042 . . . . 0.0 112.129 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.11 -52.3 59.83 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -69.87 -42.81 72.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.335 0.654 . . . . 0.0 111.586 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.9 -66.02 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.958 0.799 . . . . 0.0 112.452 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -71.47 45.96 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.848 2.859 . . . . 0.0 114.648 -165.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -40.33 -44.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 128.177 2.591 . . . . 0.0 115.988 -167.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -131.31 11.54 4.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.023 0.929 . . . . 0.0 110.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -12.77 61.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.153 0.581 . . . . 0.0 110.503 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 174.3 8.64 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.685 1.194 . . . . 0.0 110.183 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -68.11 154.0 42.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.798 1.285 . . . . 0.0 110.979 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -54.2 -52.6 60.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.137 1.375 . . . . 0.0 110.786 162.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.477 ' N ' ' HE3' ' A' ' 80' ' ' LYS . . . -63.47 -35.79 81.62 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 123.573 0.546 . . . . 0.0 109.566 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.7 -53.99 46.08 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -52.16 -40.05 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.042 0.937 . . . . 0.0 109.311 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.31 -54.93 10.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.404 1.002 . . . . 0.0 113.325 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.64 -50.18 74.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.803 1.241 . . . . 0.0 109.11 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.43 -56.01 27.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.596 1.158 . . . . 0.0 109.62 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.99 -56.38 6.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.463 1.105 . . . . 0.0 111.252 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -48.93 73.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 123.776 0.672 . . . . 0.0 110.051 -174.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.32 72.32 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.212 -0.93 . . . . 0.0 113.174 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.531 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.7 m-30 -73.08 -30.5 63.73 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.931 0.787 . . . . 0.0 110.477 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -31.64 69.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.51 1.124 . . . . 0.0 110.171 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.65 -12.45 21.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.428 1.891 . . . . 0.0 112.738 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.65 28.61 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.836 1.255 . . . . 0.0 112.065 -167.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.25 -144.17 13.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -115.06 166.3 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.912 2.085 . . . . 0.0 109.732 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.9 mt -131.99 160.96 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.26 114.07 13.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 164.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 t -165.36 162.28 19.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -152.48 26.39 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.825 -1.172 . . . . 0.0 112.829 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t0 -88.53 158.52 18.28 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.792 -1.193 . . . . 0.0 110.982 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -62.58 -49.5 75.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.994 1.27 . . . . 0.0 110.083 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -70.58 -46.99 62.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.06 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -60.63 -33.9 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.302 0.955 . . . . 0.0 109.716 -171.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -70.4 -38.95 74.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.41 0.684 . . . . 0.0 109.966 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -68.32 -54.95 13.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.78 -54.79 8.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.464 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.68 -41.78 67.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.822 1.646 . . . . 0.0 113.58 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -54.79 -60.07 3.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.643 0.777 . . . . 0.0 112.023 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -21.12 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.174 1.352 . . . . 0.0 112.613 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.531 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -81.83 3.1 27.26 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.416 1.087 . . . . 0.0 111.986 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.15 29.06 64.96 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.066 -1.408 . . . . 0.0 112.325 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.53 126.24 52.28 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.173 1.487 . . . . 0.0 111.645 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 126.13 30.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.657 1.183 . . . . 0.0 109.138 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -131.22 -170.13 2.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.489 1.516 . . . . 0.0 109.043 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.94 149.17 52.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.242 0.684 0 O-C-N 125.073 1.483 . . . . 0.0 109.161 171.566 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.483 ' CZ3' HD12 ' A' ' 157' ' ' ILE . 5.1 p-90 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.691 0.281 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.9 mtm-85 -141.72 24.92 2.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.171 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -145.06 139.91 27.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.094 1.77 . . . . 0.0 111.426 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.34 130.76 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.845 1.658 . . . . 0.0 107.501 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 8.4 t -70.86 120.63 16.74 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 162.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.09 127.68 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.42 -75.32 0.38 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 4.4 p -80.4 -8.04 59.36 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.138 0.469 . . . . 0.0 112.196 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.61 37.01 92.74 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.153 1.359 . . . . 0.0 112.637 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -77.46 137.42 38.66 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.578 -0.954 . . . . 0.0 108.726 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.79 144.07 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.547 1.139 . . . . 0.0 108.71 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.37 151.75 45.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.085 1.754 . . . . 0.0 107.814 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.6 t -111.82 -7.93 14.16 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.887 -0.508 . . . . 0.0 110.502 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 p -136.05 156.4 48.78 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.824 -1.173 . . . . 0.0 109.755 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.4 tp -74.53 120.11 79.88 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -65.67 169.03 13.63 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.412 2.075 . . . . 0.0 110.087 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.77 112.8 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 111.343 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.74 -5.02 83.77 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.407 1.479 . . . . 0.0 113.116 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.81 45.42 95.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.455 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.91 154.11 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.14 113.71 19.91 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.361 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.27 7.48 2.55 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.146 2.564 . . . . 0.0 112.551 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -117.51 -23.71 7.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.78 1.632 . . . . 0.0 113.02 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 5.0 p -136.8 -24.0 1.16 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.58 79.17 0.52 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -155.4 170.66 21.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.871 0.868 . . . . 0.0 109.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -82.28 132.37 35.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.869 0.842 . . . . 0.0 109.653 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.77 142.89 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.21 170.86 15.3 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.086 1.354 . . . . 0.0 109.528 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.67 153.12 43.99 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.058 1.343 . . . . 0.0 110.825 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.483 HD12 ' CZ3' ' A' ' 127' ' ' TRP . 19.5 mm . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 125.517 1.527 . . . . 0.0 110.284 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.2 mttt . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.1 m -55.78 122.99 12.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 tt -145.65 145.12 30.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.57 161.93 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 124.45 1.094 . . . . 0.0 109.624 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 mt -137.57 145.91 43.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.989 1.715 . . . . 0.0 108.513 -167.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.38 163.05 12.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.912 1.285 . . . . 0.0 112.049 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -51.21 -41.25 60.14 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.35 1.06 . . . . 0.0 111.77 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -67.08 -27.11 67.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.614 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.57 -44.08 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.12 -35.65 74.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.615 0.766 . . . . 0.0 110.773 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.74 -48.56 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.169 0.441 . . . . 0.0 110.21 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -72.82 -27.66 62.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.135 0.425 . . . . 0.0 110.196 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.96 38.9 10.71 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.05 112.23 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.28 92.88 1.83 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.966 1.307 . . . . 0.0 109.366 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 148.78 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.24 1.416 . . . . 0.0 108.42 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -112.34 125.1 53.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 -168.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.98 -179.06 47.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.287 0.949 . . . . 0.0 112.642 -171.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -78.67 152.77 31.46 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.139 -1.212 . . . . 0.0 110.363 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 t -137.1 160.44 38.95 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.784 2.034 . . . . 0.0 108.928 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.67 124.4 52.86 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 125.201 1.4 . . . . 0.0 109.337 -169.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.1 -22.33 55.43 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.783 1.655 . . . . 0.0 111.4 169.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -78.42 -17.08 56.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.656 1.982 . . . . 0.0 114.533 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.26 -33.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.23 1.377 . . . . 0.0 111.783 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -63.51 -15.55 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.767 1.167 . . . . 0.0 111.634 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -63.75 -18.87 64.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.653 -1.28 . . . . 0.0 113.567 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -101.28 -27.34 13.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 0.0 111.26 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.6 mt -62.7 102.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -13.0 6.89 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.058 0.943 . . . . 0.0 112.284 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.75 124.21 19.77 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -59.45 -36.95 76.92 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.984 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -55.02 -58.13 8.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.04 -41.05 91.39 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.46 1.904 . . . . 0.0 111.508 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -69.79 -52.38 25.67 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.38 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -46.76 -51.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.42 -63.2 1.27 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.019 0.927 . . . . 0.0 110.97 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 tp -48.54 -50.64 31.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.407 1.483 . . . . 0.0 112.879 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.31 -41.75 89.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.941 0.896 . . . . 0.0 110.851 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 m -63.27 -43.56 97.58 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.754 0.422 . . . . 0.0 109.926 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.5 99.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 0.0 110.593 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.44 -46.96 94.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -61.48 -46.48 89.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.178 0.991 . . . . 0.0 110.37 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.22 -5.38 38.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.455 1.502 . . . . 0.0 112.179 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.66 19.88 76.88 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 121.001 -1.062 . . . . 0.0 112.024 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -64.72 -38.83 92.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 164.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.78 150.75 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -136.78 147.41 46.62 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.001 0.92 . . . . 0.0 110.165 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.66 123.95 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.87 135.4 17.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.823 1.249 . . . . 0.0 108.517 170.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.3 155.59 37.61 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.411 0.684 . . . . 0.0 110.647 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.51 165.5 17.7 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.831 3.021 . . . . 0.0 112.628 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -81.84 158.5 24.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 164.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -39.04 74.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.541 -0.724 . . . . 0.0 111.539 170.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -29.15 70.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.127 -0.463 . . . . 0.0 111.281 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -65.43 -51.76 57.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.049 1.34 . . . . 0.0 108.238 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.32 -49.26 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.294 0.638 . . . . 0.0 109.908 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -59.39 -38.99 81.95 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.013 -0.429 . . . . 0.0 110.56 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -37.66 68.42 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.424 -0.797 . . . . 0.0 111.734 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.85 -53.44 30.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt -49.77 -36.53 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.548 1.139 . . . . 0.0 111.281 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -57.76 -69.4 0.17 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.672 0.789 . . . . 0.0 109.655 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.76 -31.64 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.136 -0.353 . . . . 0.0 110.405 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.34 75.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.416 1.487 . . . . 0.0 111.076 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -32.88 73.34 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.097 -1.002 . . . . 0.0 110.63 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.83 4.25 2.68 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.304 -0.873 . . . . 0.0 111.773 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 t -126.74 -3.29 6.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.263 1.392 . . . . 0.0 112.632 166.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.06 -86.08 0.39 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.159 1.838 . . . . 0.0 110.365 170.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -64.99 70.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 129.658 3.183 . . . . 0.0 112.369 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.73 -48.89 84.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.336 1.854 . . . . 0.0 113.284 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -123.1 7.8 9.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.903 0.881 . . . . 0.0 109.782 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -6.73 44.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.727 1.611 . . . . 0.0 112.581 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.26 162.37 16.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.297 1.039 . . . . 0.0 109.492 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 t -61.77 147.42 46.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.079 0.951 . . . . 0.0 108.958 168.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 3.9 ttpp -61.24 -44.39 97.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.05 -38.6 68.2 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.686 0.616 . . . . 0.0 110.012 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -63.48 -56.86 12.78 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.383 1.473 . . . . 0.0 110.742 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.35 -40.25 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.465 1.506 . . . . 0.0 109.247 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 80' ' ' LYS . 77.1 mt-10 -69.07 -46.61 67.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 113.173 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.58 -52.54 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 mt -54.51 -55.07 32.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.164 1.386 . . . . 0.0 109.114 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.27 -51.66 57.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.496 1.518 . . . . 0.0 112.616 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.6 tp -50.67 -51.93 44.66 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.34 -17.17 58.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -86.31 -37.43 18.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.459 0.704 . . . . 0.0 110.676 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.27 -42.92 64.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.669 1.187 . . . . 0.0 110.587 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.19 6.26 24.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.916 1.686 . . . . 0.0 111.645 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 43.27 52.82 5.61 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.635 1.974 . . . . 0.0 111.159 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 -119.9 3.89 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.838 1.209 . . . . 0.0 110.675 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -153.57 169.01 24.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.892 1.677 . . . . 0.0 106.682 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 mt -133.91 160.25 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.58 114.38 13.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 167.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 p -169.16 145.72 3.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.377 1.071 . . . . 0.0 108.945 -158.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -143.44 -6.5 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.059 1.754 . . . . 0.0 115.014 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.45 149.17 5.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.03 1.332 . . . . 0.0 112.58 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -57.51 -38.37 74.5 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.692 -1.255 . . . . 0.0 112.374 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -55.02 12.5 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.813 1.245 . . . . 0.0 110.197 173.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -40.92 79.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.238 0.615 . . . . 0.0 110.647 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.46 -40.79 98.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.54 -56.97 9.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.0 mm -52.25 -51.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.599 0.636 . . . . 0.0 110.326 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.95 72.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.161 1.346 . . . . 0.0 112.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -62.8 -58.24 8.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 117.668 -1.158 . . . . 0.0 111.171 175.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -31.57 70.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.329 1.422 . . . . 0.0 111.171 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -73.73 -30.29 62.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.137 0.575 . . . . 0.0 111.327 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.65 5.06 63.37 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.802 1.191 . . . . 0.0 114.108 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 118.05 22.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.649 1.224 . . . . 0.0 109.387 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 140.92 58.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.3 -178.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.166 0.986 . . . . 0.0 109.743 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -115.61 145.16 42.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.189 1.396 . . . . 0.0 109.792 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.239 0.503 0 C-N-CA 124.337 1.055 . . . . 0.0 110.519 178.491 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -161.62 18.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -142.17 157.66 44.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.418 1.008 . . . . 0.0 111.83 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 p -142.89 137.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 124.75 1.22 . . . . 0.0 109.064 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 2.0 t -71.52 125.51 27.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.031 1.332 . . . . 0.0 108.206 163.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.37 118.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.96 -77.95 0.38 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.2 p -75.04 -3.54 33.13 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.52 0.66 . . . . 0.0 111.608 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.13 19.78 57.4 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.431 1.967 . . . . 0.0 114.146 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -77.68 137.68 38.65 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -170.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -74.34 148.35 41.4 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.03 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -140.14 134.68 31.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.939 1.296 . . . . 0.0 108.215 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -25.67 24.65 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.665 1.186 . . . . 0.0 111.137 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.6 p -147.04 173.8 12.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.692 1.997 . . . . 0.0 107.114 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 114.56 65.81 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -163.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.76 168.39 13.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.061 1.841 . . . . 0.0 110.484 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.63 142.28 95.66 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.356 2.037 . . . . 0.0 110.344 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.12 -7.61 0.77 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.236 0.922 . . . . 0.0 113.922 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.8 63.96 3.81 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 117.928 -1.485 . . . . 0.0 109.601 -156.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.08 149.14 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 16.2 t -72.05 112.72 15.51 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.797 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.92 -17.07 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 CA-C-N 121.499 1.571 . . . . 0.0 113.302 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.57 -29.33 13.93 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.392 1.877 . . . . 0.0 111.903 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.8 p -141.89 -3.79 1.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.47 -13.55 50.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.089 1.804 . . . . 0.0 115.472 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.87 162.47 25.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.764 1.782 . . . . 0.0 114.26 -168.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -68.43 135.3 51.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.806 -1.184 . . . . 0.0 112.66 -173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.45 140.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.697 1.199 . . . . 0.0 109.228 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.35 164.93 28.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.656 1.582 . . . . 0.0 110.691 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.22 141.13 32.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.509 1.524 . . . . 0.0 111.479 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.783 1.233 . . . . 0.0 112.471 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.5 m -57.86 130.28 45.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.4 tp -155.24 142.66 19.55 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -121.39 161.35 21.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -137.85 151.18 47.81 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.68 1.592 . . . . 0.0 107.525 -165.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -117.46 167.82 10.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.926 0.89 . . . . 0.0 111.601 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 p -49.0 -48.25 43.7 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.36 1.464 . . . . 0.0 110.805 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -50.85 -37.64 44.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.533 1.133 . . . . 0.0 111.622 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -62.88 -40.03 87.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.837 1.199 . . . . 0.0 110.194 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -76.15 -35.47 59.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.924 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.0 mt -56.74 -50.34 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.878 0.871 . . . . 0.0 109.787 171.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -68.42 -19.12 64.57 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.109 0.564 . . . . 0.0 111.531 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 33.8 42.88 Favored Glycine 0 N--CA 1.446 -0.689 0 O-C-N 121.458 -0.776 . . . . 0.0 111.601 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.5 mt -85.1 105.4 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 113.7 3.15 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.3 177.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.225 1.81 . . . . 0.0 106.536 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.65 138.94 44.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.245 1.818 . . . . 0.0 107.951 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.34 -144.63 8.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -125.82 149.78 48.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 t -130.52 149.01 52.39 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.05 1.74 . . . . 0.0 108.36 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 126.45 72.12 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 123.897 0.879 . . . . 0.0 108.996 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 -31.62 95.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 168.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -27.48 62.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.163 1.785 . . . . 0.0 114.934 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.0 -37.33 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 119.286 0.948 . . . . 0.0 110.146 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.77 -26.82 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.828 1.194 . . . . 0.0 111.736 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.17 -16.64 64.43 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.049 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -86.19 -52.14 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.796 1.638 . . . . 0.0 108.649 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -49.5 99.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.449 2.3 . . . . 0.0 110.955 -170.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -63.6 134.3 55.24 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -57.36 -44.63 84.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.97 -59.65 4.53 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -166.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -55.24 -46.19 76.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.272 2.229 . . . . 0.0 110.454 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -62.58 -58.4 7.68 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.03 0.832 . . . . 0.0 110.972 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.95 -52.91 38.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -60.67 -44.4 96.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.613 0.765 . . . . 0.0 112.108 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 tt -57.88 -53.7 55.3 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -63.76 -31.02 72.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.594 0.358 . . . . 0.0 111.455 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -51.48 64.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 109.29 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.35 -38.6 87.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.843 -1.075 . . . . 0.0 111.224 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.02 -57.58 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 m -67.32 -28.41 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -14.16 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.706 -0.621 . . . . 0.0 112.273 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.44 85.72 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.693 1.616 . . . . 0.0 113.016 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -67.15 -43.15 83.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.379 1.09 . . . . 0.0 108.13 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.57 159.5 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -138.11 157.82 45.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.718 -0.613 . . . . 0.0 111.824 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.53 133.3 31.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.917 1.287 . . . . 0.0 109.206 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.04 128.9 7.92 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.525 1.53 . . . . 0.0 109.869 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.92 155.83 37.13 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.392 1.077 . . . . 0.0 110.996 170.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.96 166.95 22.95 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.158 2.572 . . . . 0.0 111.522 171.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -95.48 165.6 12.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.833 1.253 . . . . 0.0 109.019 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -50.59 65.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.685 1.194 . . . . 0.0 109.303 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.19 -41.47 71.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.144 1.378 . . . . 0.0 111.012 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -62.15 -45.05 95.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.084 0.954 . . . . 0.0 110.955 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -66.07 -45.65 90.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 119.007 0.821 . . . . 0.0 109.373 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -54.14 -42.07 69.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.899 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -46.47 53.39 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.688 1.195 . . . . 0.0 110.762 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mm -64.43 -43.32 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.611 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.3 -36.73 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.525 0.602 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.39 -55.26 33.52 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.744 0.702 . . . . 0.0 109.659 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.26 -35.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.478 0.311 . . . . 0.0 110.641 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.64 93.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.56 80.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.312 1.415 . . . . 0.0 110.622 173.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.52 -26.18 65.11 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.325 -0.86 . . . . 0.0 112.397 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.22 -49.04 3.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.06 0.846 . . . . 0.0 111.23 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.75 139.12 3.41 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -167.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 79.1 39.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.553 2.741 . . . . 0.0 111.82 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -37.68 -48.73 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 127.349 2.259 . . . . 0.0 115.384 -170.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -123.64 10.07 9.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.62 0.768 . . . . 0.0 110.489 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.76 -28.42 58.46 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.033 0.833 . . . . 0.0 111.713 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.27 34.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.181 1.393 . . . . 0.0 107.786 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -67.94 158.43 32.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.956 1.36 . . . . 0.0 111.113 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -58.83 -57.63 12.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.434 -172.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 -34.55 70.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.43 0.456 . . . . 0.0 111.152 -175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.03 -53.1 60.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.279 1.432 . . . . 0.0 108.574 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.5 mt -55.3 -44.99 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -66.31 -48.74 69.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.926 0.89 . . . . 0.0 112.46 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.33 -56.28 14.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.67 1.588 . . . . 0.0 108.071 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.96 -51.39 69.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 122.858 0.463 . . . . 0.0 110.009 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.18 -52.06 9.8 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.351 1.061 . . . . 0.0 112.209 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.6 tp -52.21 -52.5 51.89 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.225 0.466 . . . . 0.0 110.508 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.7 67.73 Favored 'General case' 0 CA--C 1.524 -0.051 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.877 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.513 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -78.81 -25.48 44.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.442 1.019 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.427 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 1.1 tm-20 -65.99 -48.33 71.59 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 164.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.15 -14.73 59.36 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 31.5 mtmt 50.2 29.7 3.84 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.719 2.808 . . . . 0.0 113.766 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.57 -108.01 1.55 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 124.379 0.99 . . . . 0.0 112.5 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -146.98 171.17 15.66 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.82 1.648 . . . . 0.0 107.844 172.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.91 160.97 42.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.693 1.197 . . . . 0.0 108.599 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.06 124.38 23.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.59 1.556 . . . . 0.0 108.659 168.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -162.8 -164.73 1.03 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.214 1.406 . . . . 0.0 110.47 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 -11.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 169.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -68.57 155.35 40.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.556 1.525 . . . . 0.0 115.1 -163.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -62.57 -37.01 84.51 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 119.526 -1.984 . . . . 0.0 112.555 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.57 -41.52 31.74 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.092 0.406 . . . . 0.0 110.659 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -36.77 74.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 118.486 0.585 . . . . 0.0 110.03 -170.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.26 -47.62 60.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 122.742 0.417 . . . . 0.0 109.917 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -59.08 -58.65 7.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.352 1.461 . . . . 0.0 108.722 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.33 -52.18 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.726 0.81 . . . . 0.0 109.976 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.33 67.58 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.758 -1.214 . . . . 0.0 114.008 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 t -67.97 -48.66 65.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 117.428 -1.272 . . . . 0.0 111.89 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -25.37 67.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.655 2.025 . . . . 0.0 112.475 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -82.07 -16.81 48.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.099 0.959 . . . . 0.0 111.723 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.14 18.88 78.23 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 117.886 -1.508 . . . . 0.0 114.348 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.05 132.61 34.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.766 1.783 . . . . 0.0 109.11 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.2 144.6 31.5 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.018 1.727 . . . . 0.0 111.253 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.2 -179.6 7.48 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.12 141.34 47.61 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.463 2.305 . . . . 0.0 107.939 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.241 0.64 0 C-N-CA 123.877 0.871 . . . . 0.0 109.533 -174.526 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 . . . . . 0 C--O 1.24 0.56 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -146.03 17.57 1.4 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 116.411 -1.757 . . . . 0.0 115.215 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -135.0 135.3 41.28 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 121.636 2.016 . . . . 0.0 112.962 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.49 125.61 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.311 1.444 . . . . 0.0 109.903 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.49 121.67 16.84 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 108.813 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pt -82.41 49.04 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.995 1.318 . . . . 0.0 111.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.24 -31.48 0.02 OUTLIER Glycine 0 C--O 1.226 -0.344 0 O-C-N 121.253 -0.904 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 12.5 p -132.77 14.19 4.38 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.693 0.746 . . . . 0.0 112.062 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.99 7.98 33.03 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.366 1.936 . . . . 0.0 115.468 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 46.0 ttt85 -69.47 132.46 46.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.511 1.924 . . . . 0.0 111.662 -165.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.79 143.22 30.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.633 1.173 . . . . 0.0 110.185 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -139.14 156.33 47.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.993 1.717 . . . . 0.0 108.22 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.0 t -109.78 -14.58 14.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.073 0.549 . . . . 0.0 111.133 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.4 p -138.01 166.28 24.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.4 tp -75.79 113.0 22.79 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -65.04 167.83 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.564 2.176 . . . . 0.0 109.472 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.16 136.55 75.51 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.321 2.014 . . . . 0.0 111.002 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.71 -15.78 3.57 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.128 1.347 . . . . 0.0 112.824 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.88 43.44 97.56 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.897 1.237 . . . . 0.0 111.384 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.64 167.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.501 1.12 . . . . 0.0 109.907 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.27 110.79 13.4 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 111.413 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.87 -14.97 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.218 1.279 . . . . 0.0 113.788 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.89 -36.97 16.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.343 1.057 . . . . 0.0 112.676 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.23 -7.38 2.03 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -164.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.11 -3.39 10.51 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.099 2.761 . . . . 0.0 116.43 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.6 m -69.45 162.93 26.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.838 1.319 . . . . 0.0 112.217 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.11 160.68 30.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.65 0.738 . . . . 0.0 111.169 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.49 161.37 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.748 1.619 . . . . 0.0 109.333 173.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.27 166.44 24.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.337 1.455 . . . . 0.0 108.958 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.82 154.45 38.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.23 1.012 . . . . 0.0 111.02 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 126.34 1.856 . . . . 0.0 110.725 169.442 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -52.3 129.65 28.81 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.508 -174.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.21 135.66 15.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.682 -168.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -111.83 145.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.98 147.58 38.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.11 1.764 . . . . 0.0 107.354 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -106.17 166.32 10.6 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.294 0.637 . . . . 0.0 110.423 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -42.16 -46.82 4.5 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.436 1.894 . . . . 0.0 111.477 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -62.13 -28.52 69.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.103 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.84 -39.33 84.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 109.536 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.89 -35.18 62.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.64 0.776 . . . . 0.0 111.101 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -61.7 -35.81 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.194 0.598 . . . . 0.0 110.61 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -82.23 -30.14 30.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.528 0.604 . . . . 0.0 110.749 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.3 32.28 17.12 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.257 0.932 . . . . 0.0 111.335 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.47 113.48 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.51 104.91 0.69 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.845 0.858 . . . . 0.0 109.811 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.476 HD11 ' H ' ' A' ' 23' ' ' GLU . 6.1 tp -149.57 159.78 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.871 1.268 . . . . 0.0 108.02 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' H ' HD11 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -130.54 115.02 16.21 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.844 1.257 . . . . 0.0 108.589 -164.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.31 -158.04 24.18 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.859 1.695 . . . . 0.0 112.514 -164.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.23 149.64 23.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.547 0.674 . . . . 0.0 112.451 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -132.89 149.72 52.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.626 1.97 . . . . 0.0 109.709 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 117.54 68.67 Favored Pre-proline 0 C--O 1.243 0.748 0 C-N-CA 126.702 2.001 . . . . 0.0 109.079 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.27 -32.72 96.58 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.167 1.245 . . . . 0.0 110.508 171.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -68.36 -11.73 60.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.25 -31.03 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 117.51 -1.234 . . . . 0.0 110.832 170.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.28 -28.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.941 1.701 . . . . 0.0 111.09 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -60.31 -22.28 62.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.263 0.483 . . . . 0.0 112.034 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -83.63 -53.23 5.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.923 -1.111 . . . . 0.0 108.965 169.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mt -41.37 114.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.198 1.799 . . . . 0.0 111.37 -162.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 -12.16 1.4 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.932 1.693 . . . . 0.0 112.836 -171.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -53.37 124.53 15.0 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 163.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -56.88 -50.01 73.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.328 0.651 . . . . 0.0 109.856 -171.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -62.24 -54.65 37.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 t -54.94 -42.02 71.79 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.163 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -62.61 -57.49 10.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.778 0.831 . . . . 0.0 109.933 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.89 -55.58 15.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.19 -53.14 57.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.404 1.482 . . . . 0.0 111.759 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.2 -48.88 73.21 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.815 1.246 . . . . 0.0 110.649 177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.39 -45.32 94.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.117 0.567 . . . . 0.0 110.836 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -56.41 -48.57 76.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.929 0.786 . . . . 0.0 109.388 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -42.23 95.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.989 1.315 . . . . 0.0 111.608 -176.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.85 -56.13 18.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -33.22 73.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.283 0.633 . . . . 0.0 111.896 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.18 -10.33 59.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.382 1.873 . . . . 0.0 112.617 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.19 -12.33 57.21 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 124.666 1.127 . . . . 0.0 113.466 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -78.27 -33.29 49.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.768 0.784 . . . . 0.0 111.638 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.05 148.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -141.21 139.54 33.82 Favored 'General case' 0 N--CA 1.46 0.049 0 C-N-CA 124.346 1.058 . . . . 0.0 109.773 -167.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.16 118.17 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.6 18.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.309 1.044 . . . . 0.0 110.744 174.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.9 160.89 27.15 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.373 1.469 . . . . 0.0 110.969 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.91 175.97 4.93 Favored 'Trans proline' 0 C--N 1.347 0.497 1 C-N-CA 125.453 4.102 . . . . 0.0 113.44 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.01 165.96 11.08 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.928 1.291 . . . . 0.0 109.45 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -48.93 24.73 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.863 1.265 . . . . 0.0 111.379 176.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.47 -27.87 65.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.843 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -69.98 -39.78 75.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.97 . . . . 0.0 109.628 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.36 -47.74 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.97 -34.43 73.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.851 -0.531 . . . . 0.0 110.831 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -42.3 64.3 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.15 0.98 . . . . 0.0 111.405 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mm -67.37 -52.65 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.06 -39.56 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.929 1.292 . . . . 0.0 110.493 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -58.75 -60.03 4.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.541 1.064 . . . . 0.0 111.415 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -73.34 -38.2 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.5 73.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.78 1.232 . . . . 0.0 110.692 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -29.07 70.26 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.515 -1.365 . . . . 0.0 112.155 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.02 -7.35 21.98 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.475 1.034 . . . . 0.0 112.208 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -123.45 16.11 9.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 112.009 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.25 -80.3 0.43 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.296 1.427 . . . . 0.0 110.119 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -59.08 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 129.009 2.923 . . . . 0.0 110.678 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.12 -43.91 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.126 1.771 . . . . 0.0 111.529 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -128.21 8.17 6.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.12 0.968 . . . . 0.0 109.721 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.53 -20.79 65.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.73 2.012 . . . . 0.0 111.784 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 165.26 12.35 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.051 1.74 . . . . 0.0 109.971 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -70.03 158.06 36.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.841 0.829 . . . . 0.0 111.849 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 14.1 ttpt -59.7 -54.41 46.7 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.986 1.314 . . . . 0.0 109.571 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.81 -44.03 63.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 110.352 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.42 -56.67 18.6 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.7 mt -52.79 -40.54 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 43.5 mt-10 -69.51 -33.44 72.83 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -57.81 -61.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 118.945 0.793 . . . . 0.0 109.288 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.89 -46.8 87.79 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.211 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.39 32.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.458 1.103 . . . . 0.0 111.535 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.47 -47.74 83.05 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.629 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.24 63.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.285 0.493 . . . . 0.0 111.883 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.06 -25.95 20.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.54 1.136 . . . . 0.0 111.394 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.98 -51.21 68.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.56 4.94 30.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.613 0.765 . . . . 0.0 111.615 -169.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 49.74 46.01 24.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.919 1.687 . . . . 0.0 110.771 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.18 -116.06 1.71 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -156.38 168.35 27.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.4 mt -129.81 152.55 37.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 119.05 20.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.004 1.322 . . . . 0.0 108.108 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -165.45 -170.54 1.88 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.079 1.352 . . . . 0.0 109.925 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -151.52 -1.78 0.32 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -64.39 157.78 25.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.571 -1.331 . . . . 0.0 114.539 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -60.93 -41.15 95.65 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.726 -1.234 . . . . 0.0 110.814 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -84.35 -44.26 13.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 110.989 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 p -60.12 -37.67 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.351 0.978 . . . . 0.0 110.225 -170.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -70.96 -35.72 72.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 110.226 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.09 -55.48 18.53 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.946 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 mm -48.95 -53.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.796 0.838 . . . . 0.0 109.179 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -21.69 64.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.182 -1.407 . . . . 0.0 112.854 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -74.07 -46.59 42.08 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.672 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.4 95.05 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.55 1.977 . . . . 0.0 108.275 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -68.52 -44.39 74.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.62 35.12 14.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 125.774 1.654 . . . . 0.0 111.855 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.77 136.34 33.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 137.53 56.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -145.94 -173.6 4.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.881 0.31 . . . . 0.0 111.243 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -130.61 124.87 32.7 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 125.742 1.617 . . . . 0.0 109.296 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 127.445 2.298 . . . . 0.0 108.448 173.868 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -148.76 8.92 0.78 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -140.3 146.4 38.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.362 0.983 . . . . 0.0 110.72 -171.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -137.27 132.41 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 108.701 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -64.37 120.5 12.35 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 163.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.39 119.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 166.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.46 -84.64 0.32 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.37 -4.81 58.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.98 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.85 20.27 68.35 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 124.78 1.181 . . . . 0.0 114.946 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 137.22 57.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -84.04 148.01 27.09 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.305 1.042 . . . . 0.0 109.341 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -142.03 146.09 35.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.02 -4.11 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 110.827 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.9 p -145.39 160.4 41.61 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.645 2.378 . . . . 0.0 108.224 161.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.424 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -68.85 112.78 12.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -66.33 164.74 27.09 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 109.635 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.34 124.6 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.094 1.863 . . . . 0.0 109.332 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.86 -18.26 57.0 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.287 2.375 . . . . 0.0 112.161 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 62.19 34.86 90.47 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.822 1.311 . . . . 0.0 111.455 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.86 162.0 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.634 1.573 . . . . 0.0 107.544 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.9 t -74.4 112.57 17.73 Favored Pre-proline 0 N--CA 1.443 -0.775 0 C-N-CA 125.365 1.466 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.51 -8.65 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.518 2.145 . . . . 0.0 115.895 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.61 -43.06 6.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.826 1.194 . . . . 0.0 112.065 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.3 p -122.99 -9.44 8.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.991 0.917 . . . . 0.0 111.527 -166.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.23 13.75 82.99 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.791 1.186 . . . . 0.0 113.614 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.79 161.58 14.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.82 1.31 . . . . 0.0 112.203 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -62.81 147.92 48.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.458 0.646 . . . . 0.0 111.15 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.39 147.6 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -133.84 172.9 12.15 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.479 1.512 . . . . 0.0 110.287 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.43 161.32 28.07 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.494 1.117 . . . . 0.0 110.342 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 126.441 1.896 . . . . 0.0 110.684 174.818 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mttt . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -49.93 131.48 22.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.592 1.182 . . . . 0.0 108.965 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -151.25 144.4 24.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.31 151.52 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 138.81 47.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 125.435 1.494 . . . . 0.0 109.669 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.82 -179.69 6.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.03 1.332 . . . . 0.0 111.364 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.0 p -58.43 -41.99 86.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.06 -1.65 . . . . 0.0 110.425 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -60.65 -39.79 89.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.597 1.159 . . . . 0.0 112.234 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.57 -36.13 27.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 119.945 1.248 . . . . 0.0 111.3 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -77.13 -37.12 54.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.13 -31.72 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.899 0.88 . . . . 0.0 109.81 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.42 -21.85 22.83 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.52 24.85 24.99 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.476 -0.624 . . . . 0.0 113.923 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.0 mt -80.92 109.29 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.622 1.211 . . . . 0.0 109.217 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.93 100.99 1.66 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.581 0.752 . . . . 0.0 109.795 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tp -136.91 167.79 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.378 1.471 . . . . 0.0 108.579 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -136.98 120.77 17.42 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.287 1.435 . . . . 0.0 108.526 -166.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.87 -157.88 30.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.61 1.576 . . . . 0.0 111.51 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -109.78 149.85 29.2 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.306 1.043 . . . . 0.0 110.893 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -128.76 168.01 16.47 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.715 1.206 . . . . 0.0 108.816 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.414 ' HG1' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -107.0 121.16 45.69 Favored Pre-proline 0 C--O 1.247 0.951 0 C-N-CA 126.288 1.835 . . . . 0.0 111.01 -165.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -63.22 -15.41 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.82 1.68 . . . . 0.0 113.389 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -89.78 -12.33 39.58 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.675 1.125 . . . . 0.0 112.806 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.77 -36.36 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 121.138 1.79 . . . . 0.0 108.206 167.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.68 -29.6 40.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.898 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.44 -26.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.809 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -11.36 42.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.165 2.186 . . . . 0.0 110.879 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.21 119.24 31.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -21.25 6.03 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.406 1.482 . . . . 0.0 112.494 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.43 169.26 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.279 0.632 . . . . 0.0 110.315 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -84.57 -55.97 3.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.99 -59.36 5.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -168.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -54.69 -35.59 63.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.578 1.151 . . . . 0.0 113.064 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 119.507 1.049 . . . . 0.0 109.433 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.1 mt -52.62 -43.23 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.944 1.298 . . . . 0.0 108.798 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -77.84 -40.24 40.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.609 0.763 . . . . 0.0 113.043 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -53.48 -49.06 68.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.418 1.463 . . . . 0.0 108.477 169.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -65.85 -32.04 73.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.815 -0.612 . . . . 0.0 111.672 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -57.69 -51.03 71.22 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.325 1.45 . . . . 0.0 108.751 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.36 -33.76 76.44 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.73 0.812 . . . . 0.0 111.344 -176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.31 -49.9 62.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 m -57.39 -40.83 79.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.784 -0.573 . . . . 0.0 110.941 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.64 -3.61 35.49 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.104 1.361 . . . . 0.0 113.219 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.44 21.64 77.55 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 112.681 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -96.97 -29.93 13.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.094 1.447 . . . . 0.0 112.638 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.94 130.64 73.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -122.62 142.8 50.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.615 1.166 . . . . 0.0 110.181 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.32 133.18 31.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.8 9.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.681 1.192 . . . . 0.0 109.964 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.01 154.6 38.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.921 0.888 . . . . 0.0 111.344 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.23 164.12 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.805 3.67 . . . . 0.0 113.459 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -84.75 159.07 20.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.092 0.949 . . . . 0.0 111.153 161.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -45.67 84.65 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.972 1.309 . . . . 0.0 111.124 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -58.05 -33.64 69.23 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.775 0.43 . . . . 0.0 111.513 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.23 -45.89 75.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.884 1.273 . . . . 0.0 109.924 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.25 -44.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.995 0.918 . . . . 0.0 109.516 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.41 -33.9 73.17 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.44 -0.788 . . . . 0.0 111.628 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -41.46 89.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.889 0.768 . . . . 0.0 110.541 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -63.87 -46.35 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.16 -38.89 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.475 1.11 . . . . 0.0 110.331 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -62.88 -60.32 3.64 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.142 1.337 . . . . 0.0 110.719 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.43 -34.94 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.63 -174.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.89 77.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.391 0.676 . . . . 0.0 111.548 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.81 66.24 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.781 1.628 . . . . 0.0 111.762 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.27 4.88 11.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.755 0.822 . . . . 0.0 112.212 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -131.95 -22.59 2.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.255 1.389 . . . . 0.0 112.246 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.17 -70.13 0.4 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 119.473 1.033 . . . . 0.0 112.783 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.46 56.86 0.37 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.729 2.012 . . . . 0.0 113.04 -170.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 p -48.53 -44.63 13.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.227 1.811 . . . . 0.0 114.328 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -124.7 4.89 8.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.524 0.729 . . . . 0.0 110.519 -173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.78 -10.82 58.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.605 1.162 . . . . 0.0 112.89 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 165.36 22.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 169.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 t -72.16 159.84 33.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.105 0.866 . . . . 0.0 109.887 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HE2' ' N ' ' A' ' 81' ' ' ALA . 1.7 ttpt -65.03 -48.97 71.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.907 0.883 . . . . 0.0 109.199 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.472 ' N ' ' HE2' ' A' ' 80' ' ' LYS . . . -56.21 -43.23 78.34 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.495 1.118 . . . . 0.0 109.792 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -63.38 -55.07 27.44 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.39 -42.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 124.023 0.929 . . . . 0.0 109.787 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.5 -48.43 72.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.923 0.889 . . . . 0.0 111.999 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' CG2' ' HG1' ' A' ' 27' ' ' THR . 95.1 t -59.1 -47.56 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 119.278 0.944 . . . . 0.0 109.239 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.03 -56.13 25.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.549 1.14 . . . . 0.0 109.474 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.59 -50.15 60.74 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.968 1.307 . . . . 0.0 111.791 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -49.92 75.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.91 91.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.634 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.487 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.1 m-85 -65.53 -31.49 72.58 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.963 1.256 . . . . 0.0 111.663 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.85 -37.36 87.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.421 1.105 . . . . 0.0 111.282 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.27 -12.57 52.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.365 1.066 . . . . 0.0 111.59 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 60.24 12.18 3.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.424 1.489 . . . . 0.0 112.29 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.65 -112.03 0.3 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 128.414 2.912 . . . . 0.0 112.965 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -154.89 167.92 28.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 106.933 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.31 155.97 42.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.478 1.111 . . . . 0.0 108.023 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.84 116.09 14.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.051 1.74 . . . . 0.0 106.97 167.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.4 t -155.78 170.73 21.4 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.225 0.61 . . . . 0.0 109.493 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.09 93.78 2.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.741 1.616 . . . . 0.0 110.694 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -152.66 166.43 32.14 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.873 1.269 . . . . 0.0 108.661 165.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -68.8 -55.23 11.88 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.096 -1.003 . . . . 0.0 109.783 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.52 -35.41 80.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.472 -0.768 . . . . 0.0 110.951 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.1 p -64.75 -43.52 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 118.994 0.815 . . . . 0.0 108.843 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.45 -42.74 87.15 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.507 0.723 . . . . 0.0 110.598 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -59.88 -62.84 1.58 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.943 1.297 . . . . 0.0 108.523 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.401 HG22 ' HH ' ' A' ' 90' ' ' TYR . 15.1 mm -51.09 -50.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.077 0.951 . . . . 0.0 110.421 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.78 72.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.853 1.206 . . . . 0.0 112.532 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 t -59.13 -59.01 6.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.746 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -31.29 72.15 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.223 1.374 . . . . 0.0 111.579 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -72.34 -6.68 45.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.373 0.669 . . . . 0.0 112.315 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.73 73.16 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-O 118.759 -1.023 . . . . 0.0 112.604 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.91 135.41 34.92 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.652 1.726 . . . . 0.0 109.474 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.11 17.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.53 1.132 . . . . 0.0 108.385 169.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.63 174.41 9.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 109.761 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.9 116.93 32.81 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 153.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 . . . . . 0 C--O 1.239 0.539 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -145.68 21.2 1.48 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.489 -1.72 . . . . 0.0 114.693 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -135.16 149.96 50.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 121.989 2.177 . . . . 0.0 112.423 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.51 134.26 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.342 1.457 . . . . 0.0 109.16 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.8 OUTLIER -66.05 142.02 57.95 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.763 0.825 . . . . 0.0 109.151 163.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.435 ' CG2' ' HZ3' ' A' ' 155' ' ' LYS . 1.1 pt -95.26 117.64 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.88 -2.3 33.78 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.306 1.431 . . . . 0.0 113.797 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 -1.96 2.11 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.081 0.94 . . . . 0.0 112.121 154.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.03 11.73 64.04 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 126.004 1.764 . . . . 0.0 115.442 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -69.95 135.23 49.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.015 -0.697 . . . . 0.0 110.134 -168.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -73.97 150.05 40.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.352 1.032 . . . . 0.0 109.872 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.17 147.38 38.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 161.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 p -95.96 -10.18 29.3 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.198 0.999 . . . . 0.0 112.235 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 p -134.69 177.4 7.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.393 1.877 . . . . 0.0 106.739 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 tp -80.7 137.71 50.87 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.06 159.72 51.48 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.518 1.478 . . . . 0.0 109.689 167.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.22 115.82 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.426 2.084 . . . . 0.0 110.863 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.27 66.15 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.86 -175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.75 45.51 90.88 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.165 1.364 . . . . 0.0 112.194 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.37 155.45 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.02 111.93 17.68 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.356 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.32 -20.85 69.95 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.308 1.339 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -18.66 30.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.948 1.299 . . . . 0.0 111.091 -171.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 15.0 p -142.82 -33.06 0.47 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.86 84.66 1.34 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.283 1.421 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.63 171.34 5.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 110.19 172.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -59.32 131.36 50.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.189 1.396 . . . . 0.0 112.828 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.95 146.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 166.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HZ3' ' CG2' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -134.06 157.69 45.48 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.001 -1.062 . . . . 0.0 110.346 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.76 152.49 44.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 C--O 1.235 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 110.489 173.216 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -54.92 130.18 40.43 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.664 0.786 . . . . 0.0 109.768 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.8 tp -151.32 143.32 23.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.95 148.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.29 127.06 53.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.938 1.695 . . . . 0.0 107.898 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.17 167.84 18.3 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.081 0.952 . . . . 0.0 110.951 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -44.05 51.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.567 1.947 . . . . 0.0 110.662 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -53.02 -38.36 62.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.936 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.29 -40.03 86.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 119.591 1.087 . . . . 0.0 109.411 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -73.68 -31.64 63.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 111.046 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.2 mt -59.73 -53.5 47.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.056 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -67.73 -31.2 70.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.144 0.429 . . . . 0.0 110.789 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.66 31.6 8.16 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 123.584 0.612 . . . . 0.0 111.627 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.01 106.69 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.96 104.41 1.72 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.68 167.26 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.822 -1.174 . . . . 0.0 109.161 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.41 148.3 27.29 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.595 1.958 . . . . 0.0 107.992 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.72 -141.84 8.64 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.966 1.257 . . . . 0.0 112.228 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.61 153.16 46.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.06 0.93 . . . . 0.0 112.257 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 t -126.95 147.38 50.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.715 2.006 . . . . 0.0 110.071 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.0 116.22 66.16 Favored Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 127.817 2.447 . . . . 0.0 110.037 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.18 -30.07 89.42 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 121.538 1.492 . . . . 0.0 113.12 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 -15.18 57.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.265 1.826 . . . . 0.0 114.014 -171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.04 -53.15 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 126.113 1.765 . . . . 0.0 108.6 162.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -71.24 -18.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 123.302 0.641 . . . . 0.0 111.722 -160.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -48.71 -38.82 22.58 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.98 0.912 . . . . 0.0 111.75 165.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 -11.98 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.022 1.329 . . . . 0.0 111.362 -166.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.53 97.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.76 -23.09 21.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.449 1.1 . . . . 0.0 112.015 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.72 117.8 4.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.95 -38.42 76.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 117.667 -1.159 . . . . 0.0 110.692 -168.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.4 -56.26 22.16 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 119.513 1.051 . . . . 0.0 108.322 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -61.64 -48.09 82.45 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.516 0.726 . . . . 0.0 110.91 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -57.27 -60.64 3.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.15 1.38 . . . . 0.0 110.342 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.5 mt -62.45 -38.85 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -62.28 -47.86 82.43 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.048 0.939 . . . . 0.0 110.65 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.86 -49.0 74.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.167 -0.958 . . . . 0.0 109.813 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.74 -33.52 76.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 t -54.41 -54.88 34.78 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -59.77 -48.38 81.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.546 1.139 . . . . 0.0 110.736 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.38 -55.36 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 t -64.21 -34.83 78.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.196 0.599 . . . . 0.0 111.306 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.61 -9.8 58.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.274 1.83 . . . . 0.0 112.316 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.41 8.94 60.75 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 124.888 1.232 . . . . 0.0 113.754 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -87.82 -41.14 13.46 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -164.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.15 161.64 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 C-N-CA 125.292 1.437 . . . . 0.0 108.756 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -132.69 158.35 42.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.67 139.27 19.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.85 130.18 4.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.53 1.132 . . . . 0.0 109.301 162.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -98.24 156.37 35.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.572 1.549 . . . . 0.0 111.053 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.57 -176.21 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.776 3.651 . . . . 0.0 111.971 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -120.33 163.9 17.13 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.529 0.732 . . . . 0.0 110.21 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -49.61 10.57 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.559 1.544 . . . . 0.0 111.98 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.93 -27.94 60.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.858 0.863 . . . . 0.0 110.771 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -47.27 85.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 109.246 170.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.87 -44.95 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.336 1.054 . . . . 0.0 109.635 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.96 -32.73 72.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.646 -0.659 . . . . 0.0 111.731 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -44.3 76.17 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 121.419 -0.801 . . . . 0.0 110.909 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.42 -49.03 82.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.34 -46.9 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.244 1.017 . . . . 0.0 110.503 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.07 -48.71 70.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.11 1.323 . . . . 0.0 111.485 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.55 -33.64 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.72 -51.65 61.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.229 1.012 . . . . 0.0 110.116 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -24.7 67.65 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.115 -0.991 . . . . 0.0 111.885 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.96 -28.53 64.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.283 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 t -120.43 -16.42 8.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.77 -76.59 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 119.259 0.936 . . . . 0.0 112.522 164.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -72.26 93.08 1.44 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.773 1.229 . . . . 0.0 109.161 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.11 -50.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 112.059 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.85 14.55 7.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.034 0.933 . . . . 0.0 110.443 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.27 -24.17 59.23 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.833 1.653 . . . . 0.0 111.285 175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.03 165.38 24.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.054 0.941 . . . . 0.0 109.155 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 153.27 40.7 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.048 -1.032 . . . . 0.0 109.48 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -63.32 -46.01 88.66 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.152 -0.967 . . . . 0.0 109.07 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -41.37 70.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.209 0.943 . . . . 0.0 111.268 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.78 -55.1 39.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 109.133 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.58 -42.9 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.792 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -62.58 -49.24 76.03 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.01 0.924 . . . . 0.0 111.046 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.78 -51.14 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 mt -57.02 -50.22 73.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.784 0.834 . . . . 0.0 109.794 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.28 -53.39 36.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.331 1.052 . . . . 0.0 112.028 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.91 -50.25 69.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.977 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.56 65.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.314 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.505 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -67.8 -32.26 72.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.583 0.628 . . . . 0.0 111.339 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -44.13 94.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.956 0.798 . . . . 0.0 109.62 168.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 -10.82 59.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.732 0.813 . . . . 0.0 112.177 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm 58.22 11.8 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.018 2.127 . . . . 0.0 113.236 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.7 -145.47 11.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 127.344 2.402 . . . . 0.0 113.042 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.0 173.37 6.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.448 1.899 . . . . 0.0 111.944 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.5 mt -130.1 161.34 39.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 126.18 1.792 . . . . 0.0 108.981 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.56 121.21 16.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.681 1.992 . . . . 0.0 107.19 166.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t -164.62 177.74 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.761 1.224 . . . . 0.0 109.984 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.06 82.6 1.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.81 -1.181 . . . . 0.0 110.113 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' H ' HG13 ' A' ' 103' ' ' VAL . 3.4 t0 -146.12 156.31 43.35 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.953 0.901 . . . . 0.0 112.102 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -66.55 -36.74 83.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.289 -166.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -49.95 13.98 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 117.212 -1.375 . . . . 0.0 110.568 168.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -51.62 -43.19 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.466 1.03 . . . . 0.0 110.799 -168.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 36.6 mt-30 -63.7 -43.86 95.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.021 0.928 . . . . 0.0 110.177 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -69.23 -50.61 45.62 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.7 mm -52.62 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 125.625 1.57 . . . . 0.0 109.046 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.96 -34.79 66.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.151 1.341 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -54.76 30.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.059 -1.448 . . . . 0.0 112.754 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.83 -33.44 74.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 121.542 1.973 . . . . 0.0 110.302 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.505 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.5 mm? -73.69 -4.88 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.802 0.841 . . . . 0.0 113.255 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.24 3.38 61.17 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.863 -0.965 . . . . 0.0 114.399 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.03 149.91 24.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.033 1.417 . . . . 0.0 110.343 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -94.59 140.52 29.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.009 1.323 . . . . 0.0 110.131 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 15.7 p90 -144.08 178.28 7.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.038 -0.414 . . . . 0.0 110.86 177.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -107.86 121.43 44.73 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.447 1.099 . . . . 0.0 108.619 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.24 0.6 0 O-C-N 125.28 1.612 . . . . 0.0 109.717 157.697 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.403 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 12.8 p-90 . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -154.8 15.07 0.42 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -143.38 150.47 39.15 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.1 136.74 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.615 1.966 . . . . 0.0 108.679 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 2.2 t -76.93 121.95 24.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.035 0.934 . . . . 0.0 110.064 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.47 84.29 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 122.503 1.144 . . . . 0.0 108.608 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.77 -20.12 0.12 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.392 1.472 . . . . 0.0 112.125 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 18.9 p -152.87 0.63 0.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.291 1.046 . . . . 0.0 113.426 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.51 10.52 66.87 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.624 -1.298 . . . . 0.0 114.914 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -71.89 135.24 46.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 52.2 mttp -88.85 139.37 30.53 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.769 1.628 . . . . 0.0 109.364 -173.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.29 149.12 52.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.334 1.054 . . . . 0.0 108.609 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.74 23.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.039 0.936 . . . . 0.0 111.776 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.0 p -141.0 169.77 16.99 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.06 2.544 . . . . 0.0 107.321 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.33 133.51 83.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.72 160.95 47.4 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 121.002 1.394 . . . . 0.0 108.734 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.23 -19.04 65.43 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.201 1.934 . . . . 0.0 114.911 -170.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.1 -3.42 55.73 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.775 0.716 . . . . 0.0 113.265 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.6 17.93 50.2 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 119.122 1.461 . . . . 0.0 113.96 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.85 156.18 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.88 2.072 . . . . 0.0 106.526 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 11.7 t -69.8 113.79 20.03 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 125.534 1.534 . . . . 0.0 108.717 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -66.39 -11.05 29.91 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.855 1.703 . . . . 0.0 112.091 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.82 -24.41 14.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.691 1.196 . . . . 0.0 112.074 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 4.7 p -142.25 -9.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.94 62.52 4.9 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.442 1.019 . . . . 0.0 112.319 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.31 167.76 22.75 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.015 0.926 . . . . 0.0 109.935 164.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -55.55 145.3 23.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.81 1.244 . . . . 0.0 110.668 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.4 t -104.52 138.91 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 167.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 162.53 29.12 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.514 1.126 . . . . 0.0 110.584 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.58 156.47 38.97 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.693 1.197 . . . . 0.0 110.241 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.429 0 C-N-CA 128.245 2.618 . . . . 0.0 108.65 174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 tptt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -60.94 136.14 58.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.466 -1.396 . . . . 0.0 109.943 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' HA3' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -155.3 146.66 22.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.477 1.511 . . . . 0.0 107.181 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.8 t -118.22 147.51 21.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.62 140.05 49.84 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.329 1.452 . . . . 0.0 109.504 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.93 164.49 13.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.902 1.281 . . . . 0.0 111.169 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -42.12 -47.7 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.603 1.961 . . . . 0.0 113.708 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -58.82 -33.92 70.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.37 0.668 . . . . 0.0 110.94 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.36 -41.06 83.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.85 0.86 . . . . 0.0 109.562 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.94 -39.03 64.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.8 mt -57.28 -41.12 77.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.864 0.866 . . . . 0.0 109.799 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -78.7 -26.54 44.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.788 0.722 . . . . 0.0 111.871 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.46 26.74 12.94 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.315 0.959 . . . . 0.0 112.632 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 mt -77.01 110.32 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.459 1.129 . . . . 0.0 108.325 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.59 108.98 2.63 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 6.3 tp -145.28 170.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -137.56 140.72 41.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.589 1.956 . . . . 0.0 107.379 -168.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.486 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 162.23 -148.46 15.68 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 124.424 1.077 . . . . 0.0 114.001 -159.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.49 152.81 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.335 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -130.62 154.18 48.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.926 1.69 . . . . 0.0 111.476 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.26 113.64 59.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 126.218 1.807 . . . . 0.0 112.147 -170.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.04 -11.09 29.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.646 2.897 . . . . 0.0 114.378 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -71.5 -40.78 69.95 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.612 1.165 . . . . 0.0 109.977 166.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.33 -40.68 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.96 -23.45 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 118.519 -1.272 . . . . 0.0 113.48 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.58 -20.44 63.65 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.744 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.05 -36.98 19.36 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.087 1.355 . . . . 0.0 108.805 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -66.53 94.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.908 1.283 . . . . 0.0 109.672 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -22.81 13.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.15 0.98 . . . . 0.0 111.582 169.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.07 122.15 10.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.741 1.216 . . . . 0.0 108.764 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -50.36 -49.05 55.27 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 116.932 -1.509 . . . . 0.0 111.655 -170.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -60.38 -60.7 3.39 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -168.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 t -51.44 -53.83 33.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.875 2.07 . . . . 0.0 110.781 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.15 -62.78 1.58 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.665 1.186 . . . . 0.0 110.959 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mt -55.9 -43.32 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.87 -53.33 59.16 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.787 0.835 . . . . 0.0 111.267 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.93 -44.0 73.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.048 1.339 . . . . 0.0 110.549 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.83 -39.14 90.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.59 -0.694 . . . . 0.0 111.079 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -56.52 -51.33 68.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.537 1.135 . . . . 0.0 109.046 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.02 -36.06 81.29 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 111.131 -171.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.2 mt -62.07 -47.78 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -39.97 85.38 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.802 0.441 . . . . 0.0 112.115 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.25 63.6 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.362 1.065 . . . . 0.0 111.838 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.82 44.44 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.039 0.828 . . . . 0.0 113.658 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 2.8 ptpt -70.82 -39.79 72.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.244 -170.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.62 99.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -167.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -82.37 164.32 21.13 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.164 0.986 . . . . 0.0 110.302 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.42 129.44 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 123.231 0.612 . . . . 0.0 110.729 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.65 128.45 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 109.982 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -101.17 154.78 36.98 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 110.435 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.33 175.95 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 124.736 3.624 . . . . 0.0 112.684 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.05 160.58 14.38 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.398 -1.728 . . . . 0.0 107.975 173.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -39.34 68.14 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.577 -0.702 . . . . 0.0 110.642 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.66 -22.27 43.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.854 0.861 . . . . 0.0 110.379 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -65.57 -49.76 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 108.959 166.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.84 -46.63 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 118.736 0.698 . . . . 0.0 109.405 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -38.35 83.98 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.999 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.05 68.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 0.827 . . . . 0.0 111.761 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.52 -47.54 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.0 mt -51.62 -38.25 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.096 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -63.81 -62.32 1.72 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.698 1.135 . . . . 0.0 110.501 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.01 -40.85 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.19 96.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.612 0.765 . . . . 0.0 111.57 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -32.86 74.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.006 -1.059 . . . . 0.0 110.795 175.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.37 -5.25 38.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.738 0.699 . . . . 0.0 111.277 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -108.37 -41.66 4.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.994 0.815 . . . . 0.0 112.03 168.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.77 -80.4 0.18 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 119.678 1.126 . . . . 0.0 110.418 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -62.43 87.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.832 2.453 . . . . 0.0 109.338 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 p -89.22 -49.98 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.495 1.518 . . . . 0.0 110.926 -173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -130.69 14.63 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.727 0.811 . . . . 0.0 109.556 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -56.95 -33.77 67.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 110.2 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.09 164.51 26.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 111.016 -172.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.7 m -73.03 163.69 27.8 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.99 0.9 . . . . 0.0 112.252 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -61.22 2.45 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 123.552 0.741 . . . . 0.0 109.136 174.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.47 -38.17 63.37 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 125.908 2.005 . . . . 0.0 110.334 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.49 -67.57 0.25 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.427 1.891 . . . . 0.0 109.083 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.67 -29.93 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.925 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -66.57 -49.16 67.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 113.295 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.1 t -50.76 -60.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.088 1.755 . . . . 0.0 108.53 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.18 -47.7 83.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.52 -172.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.11 -59.26 4.09 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.926 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 tp -56.3 -46.47 79.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -28.93 70.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.342 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.534 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.8 m-85 -80.61 -20.87 42.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.009 0.822 . . . . 0.0 111.618 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.73 -40.29 96.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.3 0.955 . . . . 0.0 108.921 164.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.68 -14.91 50.66 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.715 1.206 . . . . 0.0 112.566 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.34 42.98 7.97 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.477 1.511 . . . . 0.0 110.292 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.04 -113.88 3.88 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 126.067 1.794 . . . . 0.0 115.144 -165.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -147.45 167.64 23.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.41 1.484 . . . . 0.0 109.555 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -130.13 158.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 109.184 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.48 115.3 10.14 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 t -160.93 179.66 8.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.93 1.292 . . . . 0.0 108.524 172.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -158.57 89.1 0.95 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.844 -1.16 . . . . 0.0 110.627 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.35 156.02 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.07 0.948 . . . . 0.0 110.699 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -58.75 -48.89 79.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.624 0.77 . . . . 0.0 110.162 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -64.87 -54.82 24.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.663 1.185 . . . . 0.0 109.723 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -36.56 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.823 0.449 . . . . 0.0 110.923 -164.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.04 -44.0 85.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -60.87 -50.57 72.9 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.104 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.58 -51.05 54.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.991 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.61 88.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.085 1.311 . . . . 0.0 111.298 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 t -65.11 -49.4 70.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.426 -0.797 . . . . 0.0 113.022 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -36.81 84.84 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 120.432 1.469 . . . . 0.0 110.723 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.534 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -66.32 -28.66 68.85 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.508 0.323 . . . . 0.0 110.524 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.04 46.38 59.13 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -170.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.01 123.65 49.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.321 1.06 . . . . 0.0 108.484 160.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 140.19 57.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.95 1.3 . . . . 0.0 109.849 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -145.47 178.42 8.12 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.826 0.85 . . . . 0.0 109.741 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.67 146.23 32.32 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.385 1.074 . . . . 0.0 108.771 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 125.11 1.364 . . . . 0.0 108.778 169.661 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -149.06 15.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -143.74 146.46 33.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.688 0.676 . . . . 0.0 109.87 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.45 135.28 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.056 0.942 . . . . 0.0 109.989 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.7 OUTLIER -62.99 130.22 43.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.783 1.233 . . . . 0.0 108.849 169.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.9 pt -87.07 51.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.797 0.839 . . . . 0.0 111.391 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.82 -81.95 0.04 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.44 -7.36 54.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.098 0.559 . . . . 0.0 111.87 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.52 29.04 74.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 125.555 1.55 . . . . 0.0 113.239 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 140.36 53.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -81.9 153.45 26.32 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.919 1.287 . . . . 0.0 109.511 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -146.89 126.12 13.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.897 1.279 . . . . 0.0 107.646 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.4 p -82.51 -23.71 34.49 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.084 -1.01 . . . . 0.0 111.479 170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 p -141.95 159.34 42.43 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 126.511 1.924 . . . . 0.0 108.594 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.5 OUTLIER -65.48 121.84 77.12 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -173.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -63.21 157.57 49.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 CA-C-N 121.011 1.397 . . . . 0.0 109.145 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.12 128.7 26.02 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.348 1.365 . . . . 0.0 108.935 174.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.64 69.18 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.057 1.313 . . . . 0.0 113.215 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 58.58 43.31 96.19 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 118.948 1.374 . . . . 0.0 111.391 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.45 168.25 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' A' ' 149' ' ' ASP . 18.9 t -78.06 110.52 13.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 111.183 -173.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.22 15.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.925 3.084 . . . . 0.0 114.576 167.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.4 OUTLIER -132.33 -20.13 2.41 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.053 1.741 . . . . 0.0 111.765 -175.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 3.5 p -154.16 3.42 0.25 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.83 -14.09 2.18 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.833 1.682 . . . . 0.0 114.919 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.6 m -62.13 149.27 41.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.097 1.448 . . . . 0.0 110.877 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.54 157.52 6.85 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 109.796 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.92 162.83 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.12 163.08 31.17 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.262 -1.523 . . . . 0.0 108.779 164.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.04 148.74 46.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 163.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 109.812 168.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.4 mt 49.95 22.04 0.81 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 0.0 115.813 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -80.79 66.98 6.52 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 120.774 -1.204 . . . . 0.0 109.591 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -70.35 130.03 40.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.9 mt -145.85 157.87 43.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.696 0.799 . . . . 0.0 109.071 166.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.18 176.69 3.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 166.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -58.74 -176.95 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.052 1.341 . . . . 0.0 111.836 162.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 m -56.53 139.49 49.39 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.76 -1.212 . . . . 0.0 108.598 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -158.96 143.3 15.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.72 142.25 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.58 137.41 49.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 108.281 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -89.11 164.72 14.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.88 0.848 . . . . 0.0 111.032 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.49 165.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -57.12 -26.31 60.29 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.39 -37.17 64.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 120.213 1.37 . . . . 0.0 109.405 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -77.37 -12.78 59.99 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.5 1.52 . . . . 0.0 112.538 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.45 -45.53 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.227 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.49 -20.39 50.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.979 1.718 . . . . 0.0 114.25 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.62 40.9 5.54 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 128.375 2.893 . . . . 0.0 112.097 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.2 100.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 119.944 1.872 . . . . 0.0 107.211 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 111.63 1.02 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.399 0.68 . . . . 0.0 110.328 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.401 HD11 ' H ' ' A' ' 23' ' ' GLU . 5.7 tp -155.69 170.23 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 126.189 1.796 . . . . 0.0 107.978 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' H ' HD11 ' A' ' 22' ' ' ILE . 54.3 mt-10 -115.03 162.63 16.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.624 2.37 . . . . 0.0 108.96 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.85 -132.83 4.27 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 118.456 0.571 . . . . 0.0 112.067 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.7 151.61 47.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.734 1.613 . . . . 0.0 109.971 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -129.36 149.78 51.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.973 1.709 . . . . 0.0 111.138 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.61 116.5 66.34 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 126.492 1.917 . . . . 0.0 109.318 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -16.79 56.66 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.934 1.756 . . . . 0.0 112.379 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -53.57 52.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.152 1.381 . . . . 0.0 110.608 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.35 -35.5 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 O-C-N 121.611 -0.681 . . . . 0.0 109.424 -169.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -63.08 -20.5 25.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.768 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -69.67 -21.35 63.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.118 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.48 -7.36 31.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.532 1.533 . . . . 0.0 110.923 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.13 99.94 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.677 1.191 . . . . 0.0 108.455 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 -13.49 15.57 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.08 -176.08 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.054 1.342 . . . . 0.0 110.466 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -101.28 -43.21 6.04 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.391 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -56.9 -60.86 2.95 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 120.1 1.318 . . . . 0.0 107.702 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m -62.25 -11.29 14.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -89.37 -66.7 0.9 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.4 mt -52.37 -48.79 44.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 124.892 1.277 . . . . 0.0 107.659 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -56.58 -54.57 44.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.013 0.925 . . . . 0.0 112.553 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -58.15 -54.04 51.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.895 1.278 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.26 -39.79 83.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.484 1.514 . . . . 0.0 111.477 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.2 m -68.77 -45.38 71.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 120.687 -1.258 . . . . 0.0 112.005 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -38.28 90.46 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 124.452 1.101 . . . . 0.0 110.039 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.76 -56.69 11.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.776 0.831 . . . . 0.0 108.933 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 m -68.03 -26.07 65.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.992 0.517 . . . . 0.0 111.938 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 -2.25 39.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.895 1.678 . . . . 0.0 112.616 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.67 23.37 68.85 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 125.421 1.486 . . . . 0.0 113.464 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -72.41 -35.35 68.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 108.841 171.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -134.95 136.92 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -114.67 156.71 24.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.331 1.053 . . . . 0.0 111.207 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.3 mm -83.31 129.55 37.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 119.182 0.901 . . . . 0.0 109.656 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.28 124.15 6.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.258 1.023 . . . . 0.0 111.192 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.61 152.58 38.42 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.832 1.253 . . . . 0.0 109.636 166.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.55 166.83 28.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.782 3.654 . . . . 0.0 114.02 -171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -75.39 158.69 32.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.94 0.876 . . . . 0.0 111.395 162.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -44.15 95.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.576 1.151 . . . . 0.0 110.352 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.53 -32.8 71.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.591 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -48.17 74.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.383 0.673 . . . . 0.0 110.417 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -50.73 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.3 -32.31 69.93 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -45.63 80.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.667 1.121 . . . . 0.0 110.492 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.61 -45.41 95.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -54.01 -38.1 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.512 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -64.93 -59.18 4.46 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.899 1.227 . . . . 0.0 109.207 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.12 -33.55 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.828 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.64 -48.51 76.99 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.123 1.369 . . . . 0.0 110.807 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -27.53 68.38 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.194 -0.941 . . . . 0.0 110.645 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -70.26 -37.06 74.82 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.187 0.903 . . . . 0.0 111.844 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -87.26 -14.95 39.54 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.851 1.205 . . . . 0.0 112.714 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 -59.73 0.6 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 125.057 1.313 . . . . 0.0 112.807 165.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -75.67 92.65 2.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.68 -43.79 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 123.53 0.732 . . . . 0.0 112.764 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.56 7.34 6.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.064 0.546 . . . . 0.0 110.149 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -69.91 -3.77 17.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 112.088 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.55 150.81 21.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.58 1.552 . . . . 0.0 108.972 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -69.94 157.83 36.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.744 0.783 . . . . 0.0 110.92 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -64.63 -50.88 65.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.171 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.61 -42.29 55.82 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.788 0.835 . . . . 0.0 111.453 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -59.08 5.18 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.824 1.65 . . . . 0.0 109.827 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.93 -44.86 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.78 1.232 . . . . 0.0 108.856 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -60.26 -52.64 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.609 1.563 . . . . 0.0 111.524 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.74 -54.26 37.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.257 1.023 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.23 -51.85 68.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.866 0.867 . . . . 0.0 109.419 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -48.78 -52.76 22.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 112.218 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -50.91 68.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 123.494 0.496 . . . . 0.0 110.028 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.91 -31.45 70.95 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.558 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 9.6 m-30 -69.39 -33.86 73.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.613 0.642 . . . . 0.0 110.558 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.71 -31.71 72.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.483 0.583 . . . . 0.0 112.53 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.06 -15.83 33.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.651 1.181 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.71 24.2 1.62 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 112.65 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.52 -102.21 0.87 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.079 0.847 . . . . 0.0 111.786 -169.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -153.48 166.28 33.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.202 1.001 . . . . 0.0 110.515 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -135.43 156.67 38.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.539 1.536 . . . . 0.0 107.379 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 124.68 30.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.867 1.267 . . . . 0.0 107.878 164.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.0 t -163.28 175.28 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.373 1.069 . . . . 0.0 110.54 165.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -147.34 63.21 1.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.554 1.142 . . . . 0.0 112.8 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.0 157.95 31.57 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.384 1.074 . . . . 0.0 109.3 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -72.79 -45.06 60.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.566 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.377 1.071 . . . . 0.0 110.784 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.02 -41.66 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.436 1.016 . . . . 0.0 109.354 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.67 -43.51 96.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.61 0.764 . . . . 0.0 110.139 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -64.69 -53.76 42.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.754 0.821 . . . . 0.0 110.027 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.51 -55.15 16.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.951 0.901 . . . . 0.0 109.112 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.49 65.66 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.47 1.486 . . . . 0.0 113.565 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 t -57.5 -63.25 1.3 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.528 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -21.24 66.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.852 1.66 . . . . 0.0 113.036 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.558 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mm? -85.47 -6.25 59.21 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.292 1.037 . . . . 0.0 112.522 175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.48 9.15 84.54 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.881 -1.511 . . . . 0.0 113.988 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.86 120.62 32.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.09 1.945 . . . . 0.0 111.418 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 134.95 57.59 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.95 1.3 . . . . 0.0 109.892 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -147.81 170.88 16.67 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 122.885 0.474 . . . . 0.0 110.262 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.2 mtt-85 -109.42 154.38 22.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.548 1.139 . . . . 0.0 109.647 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -144.54 -174.32 4.29 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.965 0.791 . . . . 0.0 109.41 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -104.37 169.14 8.65 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.271 1.029 . . . . 0.0 112.073 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -82.52 76.05 9.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -116.32 175.66 5.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 146.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.24 -52.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.324 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.483 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.4 mm -147.21 141.39 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.467 1.907 . . . . 0.0 106.52 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -130.24 -7.18 4.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.727 1.211 . . . . 0.0 112.002 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -161.19 -32.17 0.05 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.85 1.204 . . . . 0.0 111.949 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 177.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 126.308 1.843 . . . . 0.0 110.157 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG21 ' H ' ' A' ' 126' ' ' LYS . 1.6 mp -131.63 177.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 126.544 1.938 . . . . 0.0 107.159 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' H ' HG21 ' A' ' 125' ' ' ILE . 14.1 mmmm -86.67 175.29 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.212 -1.555 . . . . 0.0 109.672 158.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -156.69 166.37 33.6 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.38 1.472 . . . . 0.0 108.853 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -159.13 14.53 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -141.53 150.5 42.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.008 1.276 . . . . 0.0 110.42 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.44 129.33 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.413 1.085 . . . . 0.0 108.262 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 153.37 30.03 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 165.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.79 88.32 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 122.804 1.288 . . . . 0.0 109.374 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.2 -75.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 p -93.75 -3.91 51.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.094 0.958 . . . . 0.0 113.031 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.66 26.59 72.06 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 125.707 1.622 . . . . 0.0 114.106 170.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -66.09 136.14 55.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.291 0.636 . . . . 0.0 109.506 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.8 141.03 31.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.489 1.116 . . . . 0.0 108.162 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -136.03 152.7 51.17 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -94.65 -17.82 21.91 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.74 -0.6 . . . . 0.0 111.726 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 45.4 p -128.02 169.21 14.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.514 1.126 . . . . 0.0 108.989 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.13 119.74 72.76 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.56 172.31 9.43 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.919 1.746 . . . . 0.0 110.269 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.46 138.19 83.24 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.032 1.821 . . . . 0.0 110.597 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.07 -5.34 1.34 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.56 1.076 . . . . 0.0 113.926 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.34 51.1 38.24 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-O 117.41 -1.772 . . . . 0.0 110.626 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 m -126.62 158.51 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 118.853 1.326 . . . . 0.0 108.065 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' A' ' 149' ' ' ASP . 35.2 t -77.78 111.95 21.37 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 125.216 1.406 . . . . 0.0 111.835 -167.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.48 23.26 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.97 3.113 . . . . 0.0 115.231 167.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 147' ' ' CYS . 1.1 t70 -140.82 -18.04 0.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.412 1.485 . . . . 0.0 113.336 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.83 -2.34 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.99 -17.8 5.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.856 1.217 . . . . 0.0 114.618 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -62.53 162.0 11.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.413 1.606 . . . . 0.0 112.901 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -61.64 155.92 21.26 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.62 -0.675 . . . . 0.0 110.771 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.34 144.41 21.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -133.79 164.18 27.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.196 1.398 . . . . 0.0 110.357 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.8 tt -78.91 155.37 29.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.537 1.135 . . . . 0.0 110.218 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.94 165.35 34.06 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.372 2.269 . . . . 0.0 110.943 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 178.72 6.65 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.062 2.508 . . . . 0.0 112.657 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -42.99 152.31 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.002 2.121 . . . . 0.0 112.358 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -59.73 -53.11 61.8 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.137 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.836 -176.038 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtp . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.13 120.63 22.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -156.64 100.86 1.96 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -146.06 179.2 7.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 69.6 -172.9 0.18 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.101 1.76 . . . . 0.0 113.219 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -138.53 -174.8 3.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.458 1.503 . . . . 0.0 109.973 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -49.37 155.59 0.71 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.431 0.693 . . . . 0.0 111.853 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -51.62 124.89 13.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.788 1.235 . . . . 0.0 108.598 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 tp -149.4 142.72 25.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.382 1.873 . . . . 0.0 106.494 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.06 150.52 19.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.15 150.66 37.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.709 1.604 . . . . 0.0 108.591 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.82 161.12 13.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.004 0.522 . . . . 0.0 111.736 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -37.14 -55.31 0.97 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.857 2.463 . . . . 0.0 112.158 164.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.4 m -56.62 -28.01 59.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.227 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.42 -45.36 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.662 1.119 . . . . 0.0 109.43 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.36 -33.51 71.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.576 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.68 -41.62 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.051 0.941 . . . . 0.0 110.446 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -75.65 -30.26 59.4 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.977 -0.452 . . . . 0.0 110.485 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.04 29.42 15.22 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 124.975 1.274 . . . . 0.0 111.187 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mt -74.5 110.06 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.19 121.22 9.56 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.411 1.484 . . . . 0.0 109.178 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 23' ' ' GLU . 8.3 tp -158.83 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.755 2.022 . . . . 0.0 109.669 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' H ' HG13 ' A' ' 22' ' ' ILE . 1.7 mp0 -135.77 159.19 42.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 108.99 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.41 -134.13 5.37 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 120.795 1.634 . . . . 0.0 114.376 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -129.0 154.99 46.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.6 1.96 . . . . 0.0 109.351 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -141.6 153.89 45.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.901 0.88 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.4 p -86.89 118.22 69.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.904 0.882 . . . . 0.0 110.455 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.88 -27.85 74.43 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.098 1.199 . . . . 0.0 110.794 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -71.88 -24.11 61.61 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.44 -31.12 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 121.33 1.877 . . . . 0.0 109.326 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.71 -22.1 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 119.211 0.914 . . . . 0.0 111.043 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.75 -14.9 16.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.629 -1.294 . . . . 0.0 112.746 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.53 -30.56 7.58 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.534 -1.354 . . . . 0.0 112.411 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -55.29 111.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 120.099 1.318 . . . . 0.0 110.399 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -12.81 6.96 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.113 1.365 . . . . 0.0 112.615 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.99 122.69 17.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.8 mtt-85 -52.72 -49.68 64.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.169 0.988 . . . . 0.0 110.366 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.69 -52.74 64.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.265 0.978 . . . . 0.0 109.098 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 t -53.8 -49.14 68.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -65.18 -53.9 37.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.675 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.15 -54.1 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 33.2 t80 -57.26 -49.22 76.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.263 1.025 . . . . 0.0 111.103 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.7 tp -50.49 -60.77 2.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 109.98 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.63 78.78 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.302 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.9 m -57.37 -49.66 75.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.471 1.108 . . . . 0.0 110.654 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 26.2 mt -63.2 -41.98 99.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.785 0.434 . . . . 0.0 110.228 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.59 -50.35 67.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 p -64.09 -33.93 76.88 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.132 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.592 0.757 . . . . 0.0 110.058 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.99 16.5 6.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 124.18 0.895 . . . . 0.0 112.276 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -86.29 -27.54 24.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.374 1.087 . . . . 0.0 110.803 -173.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.95 148.97 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -129.66 146.41 51.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.415 1.086 . . . . 0.0 112.01 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.47 125.79 36.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.214 1.806 . . . . 0.0 108.119 -175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.5 118.53 5.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.263 1.025 . . . . 0.0 109.928 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -86.26 155.13 57.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.373 -0.829 . . . . 0.0 110.027 163.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.41 163.52 36.24 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 124.605 3.537 . . . . 0.0 111.301 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -83.94 166.7 17.61 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.741 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -57.73 -50.42 73.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.185 1.394 . . . . 0.0 110.628 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.2 -27.6 67.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.51 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.499 ' HG ' ' HG3' ' A' ' 91' ' ' GLU . 1.2 m -68.14 -51.13 49.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.609 0.764 . . . . 0.0 109.404 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.64 -46.78 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.965 . . . . 0.0 109.744 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.34 -34.42 68.75 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.081 -0.387 . . . . 0.0 111.721 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -44.52 86.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.819 0.448 . . . . 0.0 110.945 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.95 -36.31 75.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.36 -47.7 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.01 -45.14 86.74 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.412 1.005 . . . . 0.0 111.728 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.43 -40.42 79.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 O-C-N 121.164 -0.96 . . . . 0.0 110.379 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.06 89.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -27.37 58.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.256 -0.903 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.71 -13.52 62.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.792 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 t -125.19 -15.79 6.17 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.992 1.724 . . . . 0.0 114.964 -174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.37 -90.14 0.15 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.109 1.322 . . . . 0.0 110.786 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -77.16 58.11 1.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.581 1.953 . . . . 0.0 113.212 -161.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.5 p -45.45 -37.75 2.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.82 1.648 . . . . 0.0 114.944 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -128.79 11.1 6.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.09 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.04 -9.46 59.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.703 0.683 . . . . 0.0 111.989 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 144.3 27.02 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 m -67.62 161.47 25.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.245 1.021 . . . . 0.0 111.034 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 5.6 ttpp -61.26 -55.58 30.29 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.327 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.34 -37.99 68.16 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 123.888 0.742 . . . . 0.0 110.386 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -61.96 -53.95 48.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.569 0.748 . . . . 0.0 109.027 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.55 -43.7 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.238 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 80' ' ' LYS . 75.3 mt-10 -63.21 -54.98 28.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.13 0.972 . . . . 0.0 112.238 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.18 -49.52 83.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 109.799 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.04 -49.42 77.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.79 0.836 . . . . 0.0 111.806 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.1 tp -51.09 -52.65 41.43 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.655 0.782 . . . . 0.0 109.82 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.23 69.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.6 m-30 -84.61 -18.43 35.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.131 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.499 ' HG3' ' HG ' ' A' ' 61' ' ' SER . 1.2 tt0 -70.01 -37.17 75.58 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.74 1.155 . . . . 0.0 109.229 164.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 -17.58 45.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.034 1.334 . . . . 0.0 112.474 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.17 46.65 5.18 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.066 2.146 . . . . 0.0 110.753 -169.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.53 -114.69 3.97 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.383 0.516 . . . . 0.0 112.113 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.44 164.21 31.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.07 1.748 . . . . 0.0 106.409 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.0 mt -136.6 155.95 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 116.85 15.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -156.27 -173.37 4.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.536 0.734 . . . . 0.0 109.947 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.403 ' OD2' ' HE2' ' A' ' 118' ' ' LYS . 26.5 t0 -144.53 -13.75 0.58 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.3 160.59 32.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.616 1.553 . . . . 0.0 114.684 -168.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -62.53 -46.09 90.0 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 119.929 -1.732 . . . . 0.0 110.936 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -72.16 -53.97 11.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -41.63 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.879 0.872 . . . . 0.0 111.318 -168.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.66 -38.88 64.81 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.933 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -66.86 -51.13 59.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 117.531 -1.223 . . . . 0.0 108.055 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -48.16 -59.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.44 63.75 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.841 1.655 . . . . 0.0 112.681 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -65.28 -53.32 45.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.277 -1.344 . . . . 0.0 112.719 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -35.69 79.26 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 121.518 1.963 . . . . 0.0 109.962 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.495 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -71.11 -19.38 62.45 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.37 14.87 79.55 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.201 -1.333 . . . . 0.0 113.502 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.68 163.81 27.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.138 1.469 . . . . 0.0 109.213 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.68 128.81 53.88 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -151.18 -176.39 5.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.204 0.202 . . . . 0.0 110.762 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -119.79 154.37 34.34 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.559 1.544 . . . . 0.0 109.663 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.4 p -143.27 111.58 6.23 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -160.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.27 -60.14 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HE2' ' OD2' ' A' ' 99' ' ' ASP . 52.3 mtmt -85.15 -158.34 0.36 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.632 2.773 . . . . 0.0 109.611 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -76.78 175.42 9.44 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.165 -0.959 . . . . 0.0 109.501 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.04 101.15 1.91 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.685 1.136 . . . . 0.0 110.46 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.9 80.5 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.336 1.455 . . . . 0.0 111.186 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -64.6 -50.9 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.935 1.294 . . . . 0.0 111.18 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -130.63 29.82 4.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 108.879 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.9 t -135.28 176.23 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 127.036 2.135 . . . . 0.0 106.435 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.88 147.42 22.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 120.527 -1.358 . . . . 0.0 108.355 -168.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.94 102.71 0.38 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -59.54 161.61 5.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.762 0.825 . . . . 0.0 110.582 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -156.0 14.78 0.34 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -136.03 147.36 47.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.772 1.169 . . . . 0.0 110.831 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.11 134.73 47.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.755 1.222 . . . . 0.0 108.329 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 129.66 40.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.121 0.968 . . . . 0.0 108.416 165.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 pt -84.03 111.14 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 160.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.84 -93.66 0.17 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 106.543 -2.623 . . . . 0.0 106.543 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 3.6 p -76.34 -13.74 60.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.212 0.605 . . . . 0.0 111.952 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.87 73.84 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 124.69 1.138 . . . . 0.0 115.305 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -68.81 129.75 40.82 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 110.631 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -71.42 147.13 48.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.375 1.07 . . . . 0.0 110.198 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -139.89 156.04 46.89 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.145 0.978 . . . . 0.0 109.553 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 p -97.54 -24.83 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.235 0.614 . . . . 0.0 112.053 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.91 129.85 5.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -158.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.82 123.24 80.98 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 126.099 1.76 . . . . 0.0 110.43 -168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.3 171.75 17.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.61 3.54 . . . . 0.0 113.121 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.54 87.76 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.429 3.419 . . . . 0.0 110.505 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.27 -28.77 2.67 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 126.363 1.935 . . . . 0.0 111.113 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.72 32.05 61.31 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 121.462 -1.022 . . . . 0.0 112.275 -168.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 178.54 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 126.179 1.791 . . . . 0.0 107.906 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.9 t -83.21 103.97 3.23 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.304 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.63 -2.5 0.72 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.072 1.848 . . . . 0.0 114.589 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.77 -31.5 13.17 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.826 1.25 . . . . 0.0 112.682 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.8 -35.98 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.815 0.846 . . . . 0.0 113.069 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 113.22 -15.91 22.69 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.143 2.306 . . . . 0.0 113.599 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.1 m -67.77 169.86 8.92 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.765 1.782 . . . . 0.0 113.178 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -74.13 142.45 45.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.372 1.069 . . . . 0.0 111.536 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.17 147.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.718 1.607 . . . . 0.0 106.763 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -122.89 160.81 25.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.632 1.173 . . . . 0.0 108.807 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.02 151.56 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.75 153.0 50.62 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.116 1.366 . . . . 0.0 110.584 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.97 91.35 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.404 2.736 . . . . 0.0 112.59 -171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 52.09 -162.49 0.08 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.134 1.373 . . . . 0.0 110.635 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -127.73 -84.69 0.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.554 1.07 . . . . 0.0 109.337 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-O 115.482 -2.199 . . . . 0.0 109.829 -163.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.3 mt -75.36 65.53 1.67 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.593 1.157 . . . . 0.0 110.963 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -144.3 172.0 13.54 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.196 1.799 . . . . 0.0 108.139 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -150.13 117.48 6.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tp -162.91 153.73 16.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 165.95 14.16 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.447 1.099 . . . . 0.0 112.152 171.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -63.17 170.43 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.0 111.442 161.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -53.76 129.16 32.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.349 1.06 . . . . 0.0 110.372 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.1 tp -149.74 149.44 30.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 151.07 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.94 158.61 26.37 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.655 1.582 . . . . 0.0 109.007 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -118.62 169.28 9.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.306 1.442 . . . . 0.0 111.295 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 p -55.52 -46.74 77.0 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.966 1.306 . . . . 0.0 112.459 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -27.06 62.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.806 -1.092 . . . . 0.0 112.526 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.96 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.503 1.501 . . . . 0.0 109.109 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -72.4 -33.0 66.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.406 0.682 . . . . 0.0 111.23 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.25 -49.63 83.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.924 0.889 . . . . 0.0 109.722 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.69 -13.73 61.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.297 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.55 22.8 57.76 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.582 0.611 . . . . 0.0 113.346 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.2 mt -77.77 107.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 108.4 1.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 171.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -154.22 154.96 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -98.89 164.15 12.32 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 126.431 1.892 . . . . 0.0 111.15 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.71 -139.39 9.34 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-O 121.28 0.378 . . . . 0.0 112.255 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -125.83 151.32 46.96 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.961 1.305 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 t -135.89 147.08 48.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.396 0.678 . . . . 0.0 109.301 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 114.09 48.12 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.484 1.914 . . . . 0.0 111.025 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.67 -20.99 45.08 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.002 1.802 . . . . 0.0 113.801 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -87.9 -12.95 43.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.16 -38.01 10.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 120.667 1.576 . . . . 0.0 108.154 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.97 -20.54 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.633 0.773 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.09 -24.16 38.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.539 1.135 . . . . 0.0 113.101 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.52 7.12 10.58 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.322 0.964 . . . . 0.0 112.7 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 mt -74.72 88.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -10.75 45.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.651 1.98 . . . . 0.0 112.686 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -73.7 124.52 26.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -67.82 -43.84 78.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 117.693 -1.146 . . . . 0.0 111.634 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -57.15 -55.43 34.9 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -55.57 -52.48 63.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.711 0.804 . . . . 0.0 111.208 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -58.69 -56.7 18.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.178 0.991 . . . . 0.0 110.076 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.08 -53.93 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.425 ' CZ ' HD12 ' A' ' 46' ' ' LEU . 30.7 t80 -56.01 -49.69 72.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.404 0.682 . . . . 0.0 111.341 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.98 -56.29 21.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.541 1.136 . . . . 0.0 110.066 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.32 -38.66 87.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.832 0.453 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.3 m -58.77 -41.64 87.1 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.837 0.855 . . . . 0.0 111.259 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 HD12 ' CZ ' ' A' ' 42' ' ' PHE . 11.6 mt -64.35 -43.14 95.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.826 0.739 . . . . 0.0 110.629 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.32 -52.08 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.9 m -61.78 -32.13 72.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.427 1.091 . . . . 0.0 111.65 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.08 69.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.648 1.179 . . . . 0.0 110.836 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.16 -16.45 3.43 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 123.703 0.668 . . . . 0.0 113.343 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -71.85 -34.95 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.612 0.706 . . . . 0.0 110.774 -160.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 162.29 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.44 141.03 33.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.981 0.912 . . . . 0.0 108.853 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.43 124.68 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.887 0.875 . . . . 0.0 109.748 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.42 136.02 17.06 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.35 160.13 28.31 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.857 0.863 . . . . 0.0 112.177 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.74 -177.03 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.674 3.583 . . . . 0.0 112.575 168.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 t -122.02 166.81 13.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.76 1.224 . . . . 0.0 109.748 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -49.53 73.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.303 1.041 . . . . 0.0 110.311 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.13 -22.42 62.07 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.724 -0.61 . . . . 0.0 112.061 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -50.75 66.83 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mm -59.09 -49.6 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.04 0.936 . . . . 0.0 108.67 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -27.88 67.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.118 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -48.84 79.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.319 1.418 . . . . 0.0 110.612 173.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.82 -33.04 60.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.78 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.417 -0.802 . . . . 0.0 109.696 170.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -57.28 -49.62 75.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.861 1.21 . . . . 0.0 110.582 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 p -72.2 -41.27 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.87 -0.519 . . . . 0.0 110.632 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.36 -25.22 61.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 111.076 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 -25.98 41.54 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.245 0.929 . . . . 0.0 110.335 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.18 -5.61 5.21 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.284 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.266 10.8 t -127.56 -58.79 1.24 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.123 1.329 . . . . 0.0 111.365 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.43 -21.57 0.64 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 120.348 1.431 . . . . 0.0 115.585 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.48 20.32 0.43 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.094 1.447 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -33.36 -57.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 128.044 2.538 . . . . 0.0 115.864 -163.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -121.58 11.47 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.846 0.859 . . . . 0.0 109.794 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.31 -34.98 76.12 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.069 0.948 . . . . 0.0 109.82 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mp -64.88 149.75 48.98 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 111.86 -173.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -51.66 133.42 30.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.888 1.275 . . . . 0.0 108.633 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -44.86 84.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.842 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.53 60.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.1 0.56 . . . . 0.0 111.48 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.12 -50.0 73.66 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.184 1.394 . . . . 0.0 108.812 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.9 mt -53.42 -45.77 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.642 0.777 . . . . 0.0 109.252 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -67.48 -44.25 78.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.208 1.403 . . . . 0.0 111.787 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.84 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.389 1.075 . . . . 0.0 108.895 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.19 -53.29 59.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.36 1.064 . . . . 0.0 109.295 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.04 61.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.455 1.502 . . . . 0.0 111.825 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.1 tp -51.57 -56.05 15.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.03 86.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.253 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.497 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.1 m-30 -66.35 -33.69 76.3 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.956 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 -42.76 83.31 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.43 1.014 . . . . 0.0 109.495 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.92 -18.28 50.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.361 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt 53.99 26.38 6.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.48 1.112 . . . . 0.0 111.116 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.46 -159.36 27.96 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 127.654 2.55 . . . . 0.0 113.13 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.11 173.62 7.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 110.232 165.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.7 mt -129.13 163.47 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.292 2.237 . . . . 0.0 108.002 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.57 115.89 11.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.166 2.187 . . . . 0.0 106.984 165.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t -158.37 177.96 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.906 1.283 . . . . 0.0 109.673 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -150.62 23.59 0.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.823 -1.173 . . . . 0.0 113.335 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 4.0 t0 -87.84 156.14 19.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.792 -1.192 . . . . 0.0 109.59 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -64.39 -47.77 77.95 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.034 1.288 . . . . 0.0 109.654 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.69 -53.27 35.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.258 1.423 . . . . 0.0 110.544 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.481 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.4 p -54.3 -41.81 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.03 1.287 . . . . 0.0 110.316 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -69.6 -36.5 76.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.073 0.949 . . . . 0.0 110.843 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.02 -55.25 11.39 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 mm -49.59 -60.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 C-N-CA 125.094 1.358 . . . . 0.0 109.49 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.0 56.76 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.076 1.307 . . . . 0.0 112.163 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -48.13 75.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.974 -1.489 . . . . 0.0 113.705 172.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -33.03 74.9 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 122.609 2.459 . . . . 0.0 110.631 174.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.1 mm? -75.5 -3.89 36.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.902 1.281 . . . . 0.0 113.032 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.03 -2.72 8.06 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.208 1.385 . . . . 0.0 115.226 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.06 127.86 34.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 120.14 1.97 . . . . 0.0 110.319 -167.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 129.52 39.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.68 -179.37 5.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.637 0.256 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.02 152.79 32.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.339 1.856 . . . . 0.0 107.993 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 172.0 16.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.45 166.54 18.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -50.48 137.71 18.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.874 1.27 . . . . 0.0 109.326 169.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 177.43 163.48 0.55 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.658 1.983 . . . . 0.0 108.128 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.82 -80.92 0.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 166.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.1 pt -153.97 172.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.966 1.706 . . . . 0.0 110.93 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -131.14 98.57 4.61 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.5 tttt 74.74 -22.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.741 2.416 . . . . 0.0 114.342 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.48 67.84 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.897 1.279 . . . . 0.0 111.716 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.8 mt -55.07 147.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 120.816 -1.177 . . . . 0.0 110.028 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -49.78 132.22 22.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.34 1.456 . . . . 0.0 109.16 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 4.0 p-90 -125.62 139.2 53.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.598 0.561 . . . . 0.0 110.357 -168.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -140.65 12.18 2.29 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.92 140.69 45.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 120.532 1.515 . . . . 0.0 111.675 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.29 139.43 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.929 2.092 . . . . 0.0 109.577 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 4.4 t -81.97 119.98 24.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 161.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.22 127.24 31.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 157.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 134.85 -81.8 0.3 Allowed Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 106.714 -2.555 . . . . 0.0 106.714 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.6 p -80.75 -19.48 44.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.351 -0.5 . . . . 0.0 110.73 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.22 18.54 62.47 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 121.398 -0.813 . . . . 0.0 113.766 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -84.75 162.0 19.79 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.611 1.564 . . . . 0.0 111.109 -165.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -112.29 142.1 45.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 110.481 -164.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -143.82 155.35 44.1 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.614 1.165 . . . . 0.0 109.784 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 1.8 p -104.88 -13.26 15.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.642 0.777 . . . . 0.0 112.977 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.7 p -147.07 175.61 10.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.893 2.477 . . . . 0.0 106.671 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.9 tp -80.19 133.65 56.98 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.3 170.51 20.18 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.612 2.208 . . . . 0.0 109.222 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -56.18 134.78 66.31 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.71 1.607 . . . . 0.0 109.632 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.07 -13.64 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.047 0.832 . . . . 0.0 113.901 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.06 27.89 71.21 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.264 1.532 . . . . 0.0 114.004 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 156.11 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.299 1.44 . . . . 0.0 107.597 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.62 117.88 51.84 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.97 -18.33 60.79 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.146 1.231 . . . . 0.0 113.246 171.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -81.69 -46.1 14.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.026 -1.046 . . . . 0.0 109.4 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.0 p -136.1 -1.5 2.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.66 0.784 . . . . 0.0 113.059 -159.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.15 -11.49 16.04 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.64 1.59 . . . . 0.0 114.624 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.2 m -75.7 163.91 26.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.483 1.142 . . . . 0.0 113.246 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -68.74 148.01 50.97 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.011 -1.055 . . . . 0.0 111.511 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 t -108.39 148.66 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.86 161.46 42.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.335 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.0 151.71 23.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.708 . . . . 0.0 110.595 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.97 153.39 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 124.336 1.054 . . . . 0.0 110.925 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.32 103.13 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.969 2.446 . . . . 0.0 111.239 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 59.05 174.2 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.504 2.722 . . . . 0.0 111.519 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -56.3 -27.8 56.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.571 1.148 . . . . 0.0 112.052 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 129.941 3.296 . . . . 0.0 110.982 -173.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.97 98.96 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.287 0.949 . . . . 0.0 109.138 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -135.01 -24.38 1.46 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 111.887 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -95.66 21.97 7.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 109.594 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.52 167.09 23.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.028 1.731 . . . . 0.0 107.992 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -122.1 -166.8 1.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.274 1.43 . . . . 0.0 109.693 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.01 155.56 8.02 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.93 0.332 . . . . 0.0 111.5 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -48.63 118.07 2.34 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.547 1.939 . . . . 0.0 109.03 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 tp -140.79 139.2 34.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.713 2.005 . . . . 0.0 107.667 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.7 153.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -135.58 145.65 47.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.219 1.808 . . . . 0.0 107.567 -167.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -110.0 166.48 10.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.507 . . . . 0.0 111.743 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -46.21 -46.78 17.78 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.247 1.819 . . . . 0.0 109.414 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -50.25 -34.94 24.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.617 1.167 . . . . 0.0 113.829 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 t -65.36 -43.79 94.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.209 0.913 . . . . 0.0 108.975 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.36 -36.59 71.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.964 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.51 -38.91 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.035 0.934 . . . . 0.0 110.667 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -83.2 -23.26 32.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.905 . . . . 0.0 112.825 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.23 24.04 27.83 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.88 0.764 . . . . 0.0 112.486 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -77.28 106.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.11 103.93 1.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.858 1.263 . . . . 0.0 108.467 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 tp -151.86 130.09 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -73.75 136.51 43.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.757 1.623 . . . . 0.0 110.815 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.26 -161.61 34.17 Favored Glycine 0 CA--C 1.521 0.453 0 O-C-N 120.721 -1.237 . . . . 0.0 112.101 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.28 151.24 42.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.481 0.712 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -142.89 152.5 42.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.565 1.146 . . . . 0.0 110.162 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.9 p -84.32 126.43 69.47 Favored Pre-proline 0 C--O 1.249 1.055 0 C-N-CA 123.192 0.597 . . . . 0.0 111.037 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.01 -30.16 92.63 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 120.409 0.739 . . . . 0.0 111.093 170.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 m -61.82 -43.95 97.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.697 1.135 . . . . 0.0 113.56 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.89 -38.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -64.09 -26.54 40.73 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.123 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.37 -28.73 69.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.995 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -89.64 -22.89 22.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 111.401 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.11 133.47 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.531 1.158 . . . . 0.0 108.471 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -3.2 0.61 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.878 1.671 . . . . 0.0 112.098 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -70.56 120.35 16.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.9 mtm-85 -66.19 -40.5 90.48 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.552 -170.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.45 -57.01 14.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.0 t -52.37 -54.66 28.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.385 1.474 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -58.65 -57.84 11.21 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.068 0.947 . . . . 0.0 111.37 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.6 -49.38 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.48 -44.54 93.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.726 0.694 . . . . 0.0 112.493 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.38 -56.12 26.21 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.327 1.051 . . . . 0.0 108.81 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.51 -40.68 87.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.511 0.725 . . . . 0.0 109.868 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -53.06 -48.41 67.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.161 1.384 . . . . 0.0 110.45 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.81 -42.45 99.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.83 0.741 . . . . 0.0 111.424 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.37 -46.52 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 t -58.63 -44.48 90.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 109.991 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.14 99.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.353 1.461 . . . . 0.0 110.015 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.18 2.25 7.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.643 1.116 . . . . 0.0 113.887 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.1 -37.38 17.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 117.894 0.847 . . . . 0.0 109.932 -164.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -120.08 153.6 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -140.66 141.06 35.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.617 0.767 . . . . 0.0 110.643 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.39 134.07 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.52 126.59 9.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.501 1.12 . . . . 0.0 109.225 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 151.08 48.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.069 0.948 . . . . 0.0 111.335 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.89 -175.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.572 3.514 . . . . 0.0 110.548 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -125.63 161.43 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.448 2.299 . . . . 0.0 108.241 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -58.99 -40.42 84.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.299 -0.875 . . . . 0.0 110.436 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.21 -33.67 71.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.4 p -75.51 -35.49 60.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.265 0.939 . . . . 0.0 109.862 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.07 -50.11 80.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.44 -37.01 72.13 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.774 0.43 . . . . 0.0 111.059 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -42.67 65.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 111.026 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 mm -67.08 -48.6 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.05 -39.34 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.877 0.871 . . . . 0.0 110.28 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -54.8 -63.49 1.14 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.836 0.854 . . . . 0.0 109.974 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.89 -30.9 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.18 72.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.42 -0.8 . . . . 0.0 110.791 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.18 67.54 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 120.817 -1.177 . . . . 0.0 110.659 173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -72.26 0.81 8.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.372 1.069 . . . . 0.0 112.514 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.272 2.9 t -121.05 -49.6 2.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.868 1.213 . . . . 0.0 109.51 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.3 -58.0 0.29 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.132 0.878 . . . . 0.0 112.499 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -69.62 39.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.399 2.68 . . . . 0.0 114.686 -171.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 p -39.77 -49.46 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.127 2.171 . . . . 0.0 115.062 -168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.8 28.19 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.176 0.99 . . . . 0.0 108.655 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.1 -28.35 63.24 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.632 -1.292 . . . . 0.0 110.4 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 160.26 30.75 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 t -66.51 154.56 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 109.974 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 13.8 ttpt -63.49 -51.49 65.36 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.771 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.27 -45.55 45.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.227 0.954 . . . . 0.0 109.439 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' CG ' HD21 ' A' ' 102' ' ' ASN . 38.7 t70 -58.17 -54.04 51.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.437 0.695 . . . . 0.0 111.447 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.17 -41.36 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.495 1.118 . . . . 0.0 109.645 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 47.5 mt-10 -65.5 -44.9 85.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.394 1.078 . . . . 0.0 111.548 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.1 -48.41 83.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 119.1 0.863 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.99 -48.97 79.38 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.558 0.743 . . . . 0.0 109.756 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.31 -57.79 6.23 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.948 1.299 . . . . 0.0 110.917 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.8 tp -47.62 -52.35 18.22 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.474 0.71 . . . . 0.0 110.36 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.58 70.8 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.9 m-30 -80.81 -29.55 35.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.505 0.593 . . . . 0.0 111.131 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.31 -42.68 91.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.877 0.846 . . . . 0.0 109.217 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.95 -14.52 44.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 112.894 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 43.2 55.36 4.67 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.328 1.451 . . . . 0.0 110.394 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -135.61 8.8 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 121.856 0.698 . . . . 0.0 111.465 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -129.47 170.19 14.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.3 mt -131.52 156.03 42.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.64 118.39 18.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.035 1.334 . . . . 0.0 108.256 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 t -166.37 -170.08 1.57 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.646 1.578 . . . . 0.0 108.997 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -150.62 10.85 0.66 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 161.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -53.39 150.83 6.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.368 1.467 . . . . 0.0 114.727 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -63.19 -30.78 71.86 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.473 -1.392 . . . . 0.0 112.263 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 HD21 ' CG ' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -80.15 -56.12 4.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.751 1.62 . . . . 0.0 110.215 171.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.8 p -52.69 -41.29 37.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 119.92 1.236 . . . . 0.0 112.664 -169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -64.66 -46.69 81.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.08 -52.81 57.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 117.425 -1.274 . . . . 0.0 107.784 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.5 mm -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 119.604 1.093 . . . . 0.0 110.328 -175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.55 68.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.668 1.122 . . . . 0.0 112.153 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.18 -39.12 78.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.957 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -44.55 91.39 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 122.437 2.38 . . . . 0.0 107.721 170.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -69.02 -29.12 67.23 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -167.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.53 18.65 37.67 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 117.999 -1.445 . . . . 0.0 112.766 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.01 127.82 38.66 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.02 1.41 . . . . 0.0 110.627 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 128.93 38.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.284 1.833 . . . . 0.0 109.585 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.86 179.62 6.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.626 0.77 . . . . 0.0 111.092 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -123.37 133.09 54.15 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.422 1.489 . . . . 0.0 108.834 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 p -82.89 146.66 28.74 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.62 1.168 . . . . 0.0 108.775 170.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.3 mt -54.83 -59.11 5.17 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.781 1.232 . . . . 0.0 111.181 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 22.25 -110.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.578 2.751 . . . . 0.0 113.637 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.4 7.04 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 114.058 -166.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.76 -95.18 1.79 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 120.209 -1.557 . . . . 0.0 110.747 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.4 mt -143.67 156.07 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 127.29 2.236 . . . . 0.0 107.391 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 -30.11 2.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -165.5 37.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.119 1.368 . . . . 0.0 108.959 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.82 90.52 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 125' ' ' ILE . 3.3 mp -56.28 144.62 7.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -44.62 107.49 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.138 1.775 . . . . 0.0 109.938 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -75.25 151.53 38.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -147.43 0.49 0.69 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.336 -1.316 . . . . 0.0 113.952 -158.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -142.33 135.39 28.63 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.937 0.789 . . . . 0.0 108.984 -170.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.53 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.082 0.953 . . . . 0.0 108.66 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.6 127.89 33.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.736 0.814 . . . . 0.0 108.813 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.14 -9.67 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.62 -15.14 27.88 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.938 -0.923 . . . . 0.0 113.826 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.8 p -147.24 2.66 0.77 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.59 1.195 . . . . 0.0 113.075 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.88 64.57 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.702 1.62 . . . . 0.0 115.039 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -72.08 145.81 47.97 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 117.681 0.741 . . . . 0.0 110.464 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -93.54 145.62 24.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.647 -169.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -141.85 148.82 39.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.989 1.316 . . . . 0.0 108.223 170.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 p -98.74 -15.3 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.523 -0.736 . . . . 0.0 111.739 168.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.5 p -137.6 152.53 49.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.708 1.203 . . . . 0.0 108.601 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 120.05 62.86 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 113.475 -1.693 . . . . 0.0 106.717 174.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.69 169.09 19.65 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.023 2.482 . . . . 0.0 109.121 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -55.5 134.21 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.656 1.571 . . . . 0.0 109.599 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.84 -10.61 8.77 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.515 -1.158 . . . . 0.0 114.226 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.01 38.22 93.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.969 1.885 . . . . 0.0 112.624 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.01 163.09 32.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.538 1.135 . . . . 0.0 109.28 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 3.9 t -72.99 113.32 20.6 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 110.179 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.68 -12.35 28.11 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.775 0.955 . . . . 0.0 111.86 163.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.27 -22.65 18.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.334 1.454 . . . . 0.0 111.895 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.4 p -156.17 5.31 0.18 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.07 -11.04 2.15 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.714 2.102 . . . . 0.0 116.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 168.61 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.312 1.556 . . . . 0.0 112.41 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -77.98 144.96 36.31 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 t -94.3 158.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -140.47 167.31 22.46 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.013 -1.679 . . . . 0.0 109.123 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.14 154.46 26.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.239 1.016 . . . . 0.0 109.673 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 pt -121.85 155.38 60.52 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.21 1.404 . . . . 0.0 112.42 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.85 102.99 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.665 1 C-N-CA 125.434 4.089 . . . . 0.0 112.664 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 61.03 -71.29 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.21 2.204 . . . . 0.0 112.196 -173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -46.43 0.08 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.429 1.092 . . . . 0.0 111.88 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.894 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.2 mt -130.66 139.33 50.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.488 1.494 . . . . 0.0 110.697 -167.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.2 mtm-85 -142.32 100.55 3.73 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.05 1.74 . . . . 0.0 107.969 -165.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -135.19 -178.13 4.96 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.623 1.169 . . . . 0.0 107.899 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.66 177.94 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.012 1.725 . . . . 0.0 110.683 -171.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -103.9 -178.08 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.08 -1.012 . . . . 0.0 109.551 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.3 156.48 4.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.26 1.024 . . . . 0.0 110.235 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -48.24 128.34 14.07 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.261 1.824 . . . . 0.0 110.808 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' CD2' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -153.62 144.71 22.88 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.677 0.791 . . . . 0.0 110.212 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.36 147.53 30.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.557 0.743 . . . . 0.0 110.012 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.75 129.48 51.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.593 1.957 . . . . 0.0 109.682 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -84.23 165.35 18.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.601 0.76 . . . . 0.0 109.134 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 t -46.63 -45.26 18.97 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.393 1.877 . . . . 0.0 110.265 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -49.86 -34.23 19.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.781 1.632 . . . . 0.0 111.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.5 -39.59 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.441 1.096 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.14 -24.93 47.19 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.2 1.0 . . . . 0.0 111.238 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.57 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.679 0.791 . . . . 0.0 109.075 171.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.79 -23.7 36.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.745 0.702 . . . . 0.0 112.389 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.19 18.88 52.4 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.433 1.016 . . . . 0.0 113.167 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.44 112.89 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.045 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -62.49 106.63 0.79 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 109.133 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 tp -155.08 149.22 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -111.45 120.61 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.066 1.346 . . . . 0.0 109.316 -166.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 176.09 -161.08 29.38 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.339 0.972 . . . . 0.0 113.57 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.2 150.04 21.34 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.4 -0.471 . . . . 0.0 112.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -132.38 147.91 52.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.12 2.168 . . . . 0.0 108.514 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 115.98 62.39 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 126.554 1.941 . . . . 0.0 107.632 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.83 -33.85 72.86 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.454 1.436 . . . . 0.0 110.273 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.23 -36.37 41.4 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.905 3.282 . . . . 0.0 114.432 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.75 -32.09 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.264 0.938 . . . . 0.0 110.572 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.78 -32.71 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.968 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -28.61 10.01 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -89.85 -23.39 21.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 117.745 -1.121 . . . . 0.0 111.508 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.264 5.5 mt -62.7 85.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.655 1.582 . . . . 0.0 110.113 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.33 -11.5 57.61 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 129.115 2.966 . . . . 0.0 110.966 174.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 124.2 26.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -45.42 70.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.671 -0.643 . . . . 0.0 110.332 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.27 -48.99 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.296 1.038 . . . . 0.0 108.39 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -68.76 -49.82 55.57 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.79 0.836 . . . . 0.0 111.842 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -59.97 -55.63 31.71 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.834 0.454 . . . . 0.0 110.51 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.2 mt -55.05 -49.16 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -55.47 -57.8 10.42 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 111.613 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tp -51.26 -52.85 41.09 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.118 1.767 . . . . 0.0 110.844 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.5 -37.44 87.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.648 0.779 . . . . 0.0 110.044 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 m -62.82 -43.02 99.9 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.727 0.694 . . . . 0.0 110.198 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -39.42 86.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.42 -44.9 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.327 -0.858 . . . . 0.0 108.717 170.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 t -64.5 -3.74 3.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 112.891 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.58 3.03 13.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.974 1.709 . . . . 0.0 111.566 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.03 87.2 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.827 1.68 . . . . 0.0 112.878 173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -86.11 -28.41 24.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.891 0.846 . . . . 0.0 111.442 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.64 142.4 35.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 14.2 ttmm -143.95 145.25 32.12 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 112.252 -168.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.9 120.48 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.007 1.323 . . . . 0.0 109.482 -168.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.31 128.88 12.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.432 1.493 . . . . 0.0 110.171 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.07 157.0 35.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.967 1.307 . . . . 0.0 112.322 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.95 157.21 62.82 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.789 2.993 . . . . 0.0 113.332 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -84.68 162.06 19.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.347 165.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -51.28 -42.9 61.43 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.365 1.066 . . . . 0.0 111.806 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.46 -27.06 68.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.548 0.739 . . . . 0.0 110.736 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -72.11 -47.53 50.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.168 1.387 . . . . 0.0 110.121 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 mm -58.97 -47.33 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.54 -41.19 53.57 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.043 1.337 . . . . 0.0 110.72 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -48.24 74.52 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.963 1.305 . . . . 0.0 110.182 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.73 -48.56 84.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.2 mt -48.86 -45.38 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.427 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.59 -59.14 5.91 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.476 0.71 . . . . 0.0 110.502 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.08 -31.25 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.41 -53.29 20.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.16 1.384 . . . . 0.0 110.897 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -30.02 70.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -66.92 -20.46 65.91 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.393 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 t -124.41 8.58 8.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.709 1.595 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.99 -85.36 0.34 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.996 -1.065 . . . . 0.0 112.286 164.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.62 92.48 0.33 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.335 1.054 . . . . 0.0 108.756 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.57 -49.02 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 121.717 -0.615 . . . . 0.0 111.528 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -132.72 17.73 4.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.826 0.85 . . . . 0.0 110.157 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -12.51 61.21 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 120.867 0.365 . . . . 0.0 110.378 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp -87.29 149.63 24.42 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.392 1.477 . . . . 0.0 108.058 173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 m -67.65 161.37 25.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.098 0.559 . . . . 0.0 110.913 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 14.0 ttpt -57.69 -58.46 8.24 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 122.764 0.426 . . . . 0.0 109.99 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.77 -39.46 65.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.671 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -58.66 7.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.86 2.064 . . . . 0.0 109.091 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.15 -44.6 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 126.093 1.757 . . . . 0.0 108.69 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 69.6 mt-10 -62.18 -44.9 95.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.108 0.963 . . . . 0.0 111.144 -176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.08 -53.49 47.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.384 0.538 . . . . 0.0 109.87 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' CD2' ' HH ' ' A' ' 90' ' ' TYR . 20.9 mt -58.95 -51.69 68.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.284 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.56 7.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.359 1.464 . . . . 0.0 112.511 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -46.11 81.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.5 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.564 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.524 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.5 m-30 -66.67 -22.12 66.09 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.047 1.294 . . . . 0.0 112.817 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.55 -47.06 74.02 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.93 -20.1 46.47 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 53.9 30.17 11.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.171 1.788 . . . . 0.0 113.49 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.01 -116.35 0.66 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 125.461 1.505 . . . . 0.0 112.427 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -153.9 159.19 41.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.994 1.718 . . . . 0.0 106.996 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.92 150.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.34 120.62 27.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 t -160.16 -166.16 1.63 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.514 1.925 . . . . 0.0 108.61 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.78 11.32 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.124 1.37 . . . . 0.0 114.008 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -104.71 151.27 23.93 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.045 -2.284 . . . . 0.0 113.437 -161.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -56.93 -47.14 81.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.447 -1.408 . . . . 0.0 110.914 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -71.52 -52.22 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.479 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -54.71 -41.41 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.32 0.509 . . . . 0.0 110.239 -173.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.68 -44.39 77.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.068 0.947 . . . . 0.0 109.832 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -61.99 -56.41 19.41 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -48.85 -55.9 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.545 1.138 . . . . 0.0 110.117 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.64 -34.8 65.26 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.598 1.544 . . . . 0.0 113.689 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 t -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.832 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -36.73 79.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.424 1.011 . . . . 0.0 109.938 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.2 mm? -72.25 -14.56 61.81 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.626 0.37 . . . . 0.0 111.074 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.49 2.63 84.85 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.864 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.4 133.02 34.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.578 1.189 . . . . 0.0 109.68 -168.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -68.07 136.24 53.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.932 0.893 . . . . 0.0 110.616 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.75 168.04 28.62 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.749 -0.594 . . . . 0.0 111.454 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -99.06 163.43 12.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.605 1.162 . . . . 0.0 111.641 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 130.05 21.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.95 166.77 22.89 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.601 0.715 . . . . 0.0 110.367 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HG2' ' H ' ' A' ' 119' ' ' ARG . 19.2 ttpt 60.99 -177.0 0.11 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.365 1.866 . . . . 0.0 111.221 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -73.39 169.95 16.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.261 -0.899 . . . . 0.0 110.569 170.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.08 -163.64 50.86 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.1 -6.83 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 52.88 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.012 2.125 . . . . 0.0 112.616 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -121.93 -6.46 9.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.242 1.383 . . . . 0.0 113.227 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.6 t -69.93 163.04 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.4 mt -99.53 172.53 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -56.35 160.75 2.9 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 120.593 -1.317 . . . . 0.0 110.479 158.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -129.11 155.57 45.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -153.62 8.68 0.39 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 118.393 -0.813 . . . . 0.0 112.923 -153.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -151.06 151.03 31.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.087 0.858 . . . . 0.0 110.508 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.63 139.08 49.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.211 1.404 . . . . 0.0 109.995 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 126.08 28.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.196 0.998 . . . . 0.0 108.56 159.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.67 121.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.08 4.29 Favored Glycine 0 N--CA 1.464 0.502 0 C-N-CA 123.905 0.764 . . . . 0.0 112.962 161.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.51 9.48 2.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.751 1.62 . . . . 0.0 111.817 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.31 14.56 57.16 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 126.955 2.217 . . . . 0.0 115.892 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -68.82 127.39 32.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.972 0.886 . . . . 0.0 108.892 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -71.04 146.46 49.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.973 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -139.35 154.77 47.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -20.66 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.331 0.653 . . . . 0.0 111.695 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 59.0 p -136.04 155.24 50.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.33 127.92 77.24 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.06 171.17 14.16 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.99 2.46 . . . . 0.0 111.49 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 145' ' ' GLY . 28.2 Cg_endo -55.8 148.22 57.15 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.339 2.026 . . . . 0.0 109.721 163.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.16 -22.81 0.2 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.483 1.992 . . . . 0.0 113.532 -165.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 143' ' ' PRO . . . 62.92 38.28 96.32 Favored Glycine 0 C--N 1.335 0.528 0 O-C-N 120.982 -1.305 . . . . 0.0 110.159 -158.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.01 154.41 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.595 0.758 . . . . 0.0 110.075 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.4 t -74.97 110.92 11.24 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 125.365 1.466 . . . . 0.0 110.877 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.72 -2.71 2.22 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.424 2.082 . . . . 0.0 115.543 171.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -105.6 -26.35 11.89 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.018 0.927 . . . . 0.0 113.231 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -142.15 -12.82 0.83 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.09 65.7 2.66 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.973 1.273 . . . . 0.0 112.146 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.07 173.82 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.002 1.721 . . . . 0.0 108.495 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -64.45 142.48 58.4 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.172 0.989 . . . . 0.0 111.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.37 145.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.192 1.397 . . . . 0.0 107.428 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.15 158.74 43.74 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 112.209 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.69 111.26 6.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 110.392 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.07 163.59 64.08 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 125.827 1.651 . . . . 0.0 112.365 164.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.93 123.67 10.62 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.093 1.862 . . . . 0.0 109.938 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 36.51 -99.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 128.374 2.67 . . . . 0.0 112.483 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 -34.43 0.77 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.041 1.336 . . . . 0.0 112.831 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -176.579 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.92 165.48 26.41 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 111.08 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.01 -38.16 0.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.303 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -142.27 -42.4 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.942 166.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt 40.77 74.38 0.1 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.901 2.08 . . . . 0.0 111.153 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 156.26 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 176.39 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -45.51 127.89 7.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.028 0.931 . . . . 0.0 111.598 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 tp -153.72 147.36 25.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.194 1.798 . . . . 0.0 107.454 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -122.08 150.75 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.46 139.26 53.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.969 1.708 . . . . 0.0 108.377 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -91.33 158.84 16.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.095 0.958 . . . . 0.0 111.64 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -29.36 -57.85 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.397 2.279 . . . . 0.0 113.219 163.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.7 p -60.11 -28.95 68.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.136 1.774 . . . . 0.0 112.52 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.68 -42.08 94.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -69.91 -34.77 73.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.413 0.685 . . . . 0.0 111.211 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.7 mt -57.09 -47.58 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 110.14 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.98 -24.9 52.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.883 0.765 . . . . 0.0 111.922 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 31.62 13.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 123.289 0.471 . . . . 0.0 112.068 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -76.86 102.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.46 115.2 1.98 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 tp -161.88 170.84 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.552 1.941 . . . . 0.0 106.412 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.83 152.33 48.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 0.0 109.002 -158.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.0 -130.8 3.72 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -168.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.23 152.33 48.21 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.367 1.067 . . . . 0.0 111.003 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -128.66 143.12 50.88 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.556 1.542 . . . . 0.0 107.664 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.55 117.33 67.9 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.79 1.636 . . . . 0.0 108.198 -167.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.81 -32.04 92.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.261 1.974 . . . . 0.0 111.185 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.2 m -68.49 -19.58 64.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.118 -0.989 . . . . 0.0 113.14 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -83.84 -51.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.036 0.935 . . . . 0.0 108.522 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 p -59.08 -28.03 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-N 118.822 0.737 . . . . 0.0 111.197 -175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -66.58 -14.81 62.85 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.81 -28.83 12.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.298 0.954 . . . . 0.0 111.734 169.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -53.88 128.23 13.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 -27.1 2.26 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 126.628 1.971 . . . . 0.0 110.55 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.31 124.94 24.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -75.33 -30.7 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.797 -1.097 . . . . 0.0 112.08 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -60.74 -37.16 80.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.184 1.356 . . . . 0.0 110.481 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -69.99 -58.98 3.2 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.439 0.695 . . . . 0.0 109.685 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -58.27 -55.43 35.04 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.785 0.834 . . . . 0.0 111.879 -170.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.9 mt -54.01 -52.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.039 0.936 . . . . 0.0 108.632 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.445 ' CZ ' HD13 ' A' ' 46' ' ' LEU . 59.6 t80 -55.27 -52.68 62.64 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.584 0.754 . . . . 0.0 110.652 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.42 -56.87 10.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.878 1.671 . . . . 0.0 110.409 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.14 -36.24 81.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.473 0.709 . . . . 0.0 111.421 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 m -64.27 -42.6 96.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.476 1.11 . . . . 0.0 109.843 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.445 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 9.7 mt -65.22 -43.14 92.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.371 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.54 -52.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m -63.61 -25.32 68.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.301 0.64 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.6 -2.6 58.36 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.157 1.783 . . . . 0.0 113.649 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.93 26.16 60.87 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 118.445 0.566 . . . . 0.0 112.111 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -89.95 -52.7 4.83 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.86 162.37 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 C-N-CA 124.676 1.191 . . . . 0.0 108.708 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -133.4 156.29 47.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mm -69.65 133.93 31.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 118.935 0.789 . . . . 0.0 108.949 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.41 128.15 6.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.86 0.464 . . . . 0.0 110.692 162.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.7 156.15 45.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.431 0.692 . . . . 0.0 110.428 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.11 168.2 16.31 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.868 3.046 . . . . 0.0 111.645 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t -86.84 163.26 17.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 164.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -50.42 -45.58 55.8 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.03 0.932 . . . . 0.0 111.53 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.35 -18.8 63.83 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -40.84 35.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.797 0.839 . . . . 0.0 110.593 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.24 -49.71 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -56.4 -32.13 64.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.103 0.961 . . . . 0.0 111.392 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -50.93 71.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.591 1.156 . . . . 0.0 110.181 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -63.74 -42.2 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.23 -41.4 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.584 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -65.17 -50.93 64.06 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.107 1.321 . . . . 0.0 110.926 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.85 -34.19 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.81 -50.48 73.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.538 1.135 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.6 71.66 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.654 -1.279 . . . . 0.0 110.755 174.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.67 -32.98 74.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.255 0.934 . . . . 0.0 109.873 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 t -93.16 -16.72 24.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 -78.3 0.38 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.69 86.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.965 1.306 . . . . 0.0 110.727 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -75.63 -41.69 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 120.824 -1.173 . . . . 0.0 112.297 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -135.6 20.41 3.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.221 1.408 . . . . 0.0 109.192 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -70.83 -19.36 62.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.9 -1.125 . . . . 0.0 110.699 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 153.24 25.03 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.052 0.941 . . . . 0.0 110.115 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -58.88 147.94 32.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 111.305 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 27.2 ttpt -55.67 -53.0 61.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.808 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.33 -34.95 76.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 124.137 0.898 . . . . 0.0 110.212 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -55.23 31.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.34 1.056 . . . . 0.0 109.06 176.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -52.44 -45.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.968 0.907 . . . . 0.0 108.938 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 61.9 mt-10 -64.6 -46.21 83.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 0.0 112.23 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.09 -54.69 31.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.559 1.143 . . . . 0.0 109.496 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.7 mt -57.66 -47.51 82.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.945 0.898 . . . . 0.0 109.258 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.75 -56.13 17.8 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.175 1.39 . . . . 0.0 111.955 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.32 -48.41 74.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.779 0.675 . . . . 0.0 109.737 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.93 -21.88 63.85 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -174.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.513 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.44 -22.99 21.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 117.81 -1.09 . . . . 0.0 111.858 175.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.24 -41.93 97.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.714 1.143 . . . . 0.0 109.78 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.99 10.66 24.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.303 1.041 . . . . 0.0 111.0 -171.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 45.66 49.73 11.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.255 1.822 . . . . 0.0 110.107 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.83 -123.74 4.77 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 124.35 0.976 . . . . 0.0 111.178 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -144.7 168.15 20.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.586 1.954 . . . . 0.0 106.893 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.9 mt -134.16 157.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -136.8 107.07 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 108.437 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 t -166.12 172.25 11.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.274 1.43 . . . . 0.0 109.582 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -145.27 4.34 1.06 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -57.11 158.21 5.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.867 1.667 . . . . 0.0 112.821 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -61.67 -45.04 95.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.424 -1.423 . . . . 0.0 110.825 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.524 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.05 -39.27 81.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 119.058 0.845 . . . . 0.0 110.787 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.29 -47.86 72.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -60.07 -58.25 9.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.934 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.05 -54.52 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.15 65.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.349 1.431 . . . . 0.0 113.129 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -52.15 58.47 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.212 1.405 . . . . 0.0 112.403 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -21.7 64.72 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.722 1.601 . . . . 0.0 111.893 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -83.56 -10.63 58.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.752 1.221 . . . . 0.0 112.366 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.81 8.11 84.27 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.326 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 143.78 34.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.776 1.788 . . . . 0.0 109.779 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.25 136.84 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.956 1.302 . . . . 0.0 108.371 174.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -146.6 -172.19 3.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.38 161.02 25.55 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.089 1.355 . . . . 0.0 110.392 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 p -137.86 151.77 48.39 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.447 1.099 . . . . 0.0 108.862 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.4 mp -76.89 138.51 39.79 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.256 1.422 . . . . 0.0 108.842 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 24.92 70.13 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.311 2.644 . . . . 0.0 112.025 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 175.8 8.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.276 -0.89 . . . . 0.0 111.969 -165.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.31 -81.11 1.5 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.2 pt -127.71 17.27 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.895 0.878 . . . . 0.0 112.513 -171.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 42.54 0.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.956 2.102 . . . . 0.0 112.791 -175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 46.06 78.15 0.07 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.071 1.748 . . . . 0.0 111.524 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.2 38.38 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.02 121.13 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -68.95 120.53 14.97 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -74.89 150.73 39.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.44 0.296 . . . . 0.0 110.559 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -148.25 17.55 1.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.068 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.95 141.12 47.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 120.339 1.427 . . . . 0.0 110.236 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.39 134.24 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.917 1.287 . . . . 0.0 108.506 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.78 118.45 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.69 124.14 27.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.74 -86.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.4 p -74.2 -18.44 60.76 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.755 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.14 62.38 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 123.416 0.531 . . . . 0.0 112.775 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -74.27 145.35 44.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.511 1.124 . . . . 0.0 110.079 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -90.12 145.62 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 109.176 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.7 149.27 43.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.704 0.802 . . . . 0.0 108.843 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 p -97.29 -13.25 22.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.988 0.915 . . . . 0.0 111.997 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 18.4 p -146.11 165.35 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.757 1.623 . . . . 0.0 107.523 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp -77.34 128.7 79.73 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.12 169.96 16.9 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.528 2.152 . . . . 0.0 111.108 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.62 127.34 20.46 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.696 2.264 . . . . 0.0 109.876 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.42 -8.19 42.18 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.707 0.67 . . . . 0.0 113.395 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.01 54.21 32.63 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.461 1.131 . . . . 0.0 112.045 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.08 160.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.56 114.9 14.74 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.8 -14.16 41.34 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 119.739 0.942 . . . . 0.0 112.435 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.09 -12.4 17.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.79 2.036 . . . . 0.0 112.683 -168.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.5 p -156.19 3.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.82 -16.5 5.26 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.637 1.589 . . . . 0.0 114.745 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.2 m -69.88 161.18 30.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 118.686 1.243 . . . . 0.0 112.701 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -68.35 144.18 54.88 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.69 -1.256 . . . . 0.0 110.01 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.56 143.74 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.08 154.83 51.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.68 1.127 . . . . 0.0 111.052 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.46 134.75 48.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.271 1.028 . . . . 0.0 108.959 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -101.5 159.08 30.48 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 124.268 1.027 . . . . 0.0 109.638 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.72 62.8 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.366 2.711 . . . . 0.0 110.937 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 64.77 176.35 0.19 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.43 1.892 . . . . 0.0 112.14 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -75.44 -55.16 5.96 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.24 -1.838 . . . . 0.0 106.428 178.788 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.86 -64.44 0.94 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 63.02 -44.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.159 2.584 . . . . 0.0 112.008 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -69.53 -161.69 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.462 2.705 . . . . 0.0 109.349 161.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.28 81.65 0.03 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.962 2.505 . . . . 0.0 113.185 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 7' ' ' LYS . 6.6 ptmt -62.59 -172.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 122.233 1.016 . . . . 0.0 110.904 168.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' HE2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -55.86 167.18 0.61 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 176.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -54.96 122.94 11.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.793 1.237 . . . . 0.0 109.777 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.74 147.89 36.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.394 1.478 . . . . 0.0 107.499 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.77 152.88 29.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.727 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.27 150.59 46.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.552 1.941 . . . . 0.0 108.907 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.574 ' CG ' ' HG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -110.62 174.5 5.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.9 p -49.57 -43.81 46.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.652 1.181 . . . . 0.0 113.424 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 t -57.25 -39.3 75.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.757 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 t -54.4 -43.93 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.246 1.018 . . . . 0.0 110.138 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -76.78 -25.92 53.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.219 0.608 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.12 -39.36 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.93 0.786 . . . . 0.0 110.639 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -78.08 -17.85 56.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.524 -0.735 . . . . 0.0 112.105 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.25 63.8 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 123.392 0.52 . . . . 0.0 113.381 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.39 106.87 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.08 118.32 8.99 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -157.8 164.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 0.0 107.569 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -137.1 119.3 15.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 111.077 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.73 -146.16 6.73 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.818 2.627 . . . . 0.0 112.29 -166.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.27 152.06 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.182 1.393 . . . . 0.0 111.69 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 t -121.65 168.32 11.91 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.453 1.901 . . . . 0.0 109.701 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.62 113.96 60.99 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 126.535 1.934 . . . . 0.0 108.048 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -55.57 -35.91 93.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.756 2.304 . . . . 0.0 112.7 -172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.2 m -71.54 -16.97 62.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.788 1.235 . . . . 0.0 113.146 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.6 -51.61 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.66 -37.42 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.563 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.38 -22.01 66.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.549 1.068 . . . . 0.0 111.805 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -94.47 -10.9 30.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.433 1.47 . . . . 0.0 111.93 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 ' CD1' ' A' ' 43' ' ' LEU . 2.7 mt -63.46 116.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 -11.06 5.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.128 0.971 . . . . 0.0 113.073 -166.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.78 130.64 37.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -67.29 -35.5 79.61 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.969 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.74 -52.53 62.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.09 1.356 . . . . 0.0 108.685 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.3 -50.84 70.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.983 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -58.58 -52.62 64.88 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.468 1.107 . . . . 0.0 111.91 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.3 -52.05 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.527 1.531 . . . . 0.0 109.145 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -64.06 -42.77 96.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.237 0.542 . . . . 0.0 111.476 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' CD1' HD12 ' A' ' 34' ' ' ILE . 7.6 tt -59.27 -48.65 80.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.94 -1.1 . . . . 0.0 110.663 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.8 -32.55 72.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.629 0.772 . . . . 0.0 110.285 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.8 t -50.45 -54.55 21.21 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.93 0.892 . . . . 0.0 108.876 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.65 -31.89 70.24 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.17 -53.47 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.6 t -57.74 -38.2 74.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.312 1.045 . . . . 0.0 111.94 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.52 3.72 17.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 113.063 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.12 21.25 78.47 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.903 -0.943 . . . . 0.0 111.833 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.96 -29.82 8.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.155 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.5 96.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.553 1.524 . . . . 0.0 108.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -73.16 155.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.9 mm -82.91 147.84 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.64 125.02 0.58 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.747 2.019 . . . . 0.0 109.795 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 158.64 36.05 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 119.497 1.044 . . . . 0.0 112.518 171.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.72 157.51 61.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 124.915 3.743 . . . . 0.0 111.924 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.21 160.72 31.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.907 0.861 . . . . 0.0 110.391 158.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -44.89 79.0 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 109.697 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -61.54 -32.74 72.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.752 0.705 . . . . 0.0 111.119 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.4 m -66.74 -45.02 79.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 109.653 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.7 mm -58.81 -48.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.91 -33.16 70.24 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.018 -0.426 . . . . 0.0 111.208 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -46.41 80.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.2 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -46.51 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.82 -36.5 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.088 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -66.51 -43.79 84.31 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.278 1.854 . . . . 0.0 111.868 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.0 t -82.51 -37.28 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.21 99.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.29 1.036 . . . . 0.0 110.664 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -31.67 66.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.322 0.964 . . . . 0.0 112.034 174.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.06 -43.91 98.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.074 0.852 . . . . 0.0 109.938 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -80.43 -51.6 8.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.811 0.732 . . . . 0.0 111.117 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.54 -73.54 0.13 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 120.44 1.473 . . . . 0.0 114.305 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -70.54 91.47 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.596 0.698 . . . . 0.0 109.364 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.65 -54.71 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -118.84 18.36 13.31 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.538 0.608 . . . . 0.0 111.116 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -68.94 -31.48 70.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.2 157.86 29.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.037 0.535 . . . . 0.0 110.04 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -65.5 153.82 40.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.573 1.178 . . . . 0.0 110.432 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -60.24 -48.87 79.89 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.719 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.69 68.45 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.529 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -56.89 -55.95 27.88 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.421 1.105 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.72 -39.84 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.048 1.739 . . . . 0.0 110.435 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -61.52 -50.49 72.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.986 1.266 . . . . 0.0 110.984 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.55 -53.29 46.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.89 0.876 . . . . 0.0 109.021 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.17 -54.98 38.64 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.887 1.275 . . . . 0.0 108.786 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.2 57.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.237 1.415 . . . . 0.0 112.493 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -49.7 74.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.92 83.55 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.944 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.2 m-85 -70.98 -29.84 65.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.41 1.005 . . . . 0.0 111.697 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.75 -43.25 99.29 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.176 0.898 . . . . 0.0 109.297 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.845 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm 49.24 34.02 5.75 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.972 1.709 . . . . 0.0 110.609 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.25 -136.72 8.7 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.07 1.795 . . . . 0.0 110.636 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -129.56 161.56 30.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.222 2.209 . . . . 0.0 109.108 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.1 mt -130.06 149.08 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.77 122.59 21.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.925 0.89 . . . . 0.0 109.565 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.574 ' HG ' ' CG ' ' A' ' 12' ' ' ASP . 8.3 t -161.04 175.89 11.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.324 0.39 . . . . 0.0 111.025 -175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -147.3 102.96 3.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.458 1.503 . . . . 0.0 109.483 166.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.52 154.35 18.44 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.154 1.381 . . . . 0.0 110.279 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -64.16 -46.43 84.08 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.92 -53.76 45.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.691 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.12 -41.27 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.784 0.72 . . . . 0.0 111.186 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -58.54 -49.64 76.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 108.889 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.64 -55.3 21.11 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.981 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mm -52.98 -54.81 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 119.141 0.882 . . . . 0.0 110.364 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.84 -33.03 68.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.241 1.382 . . . . 0.0 113.708 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 t -57.15 -60.45 3.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.941 -1.028 . . . . 0.0 111.534 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -17.55 63.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.436 1.471 . . . . 0.0 113.075 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.4 mm? -83.36 -9.28 59.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.616 0.766 . . . . 0.0 112.249 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.92 35.42 92.02 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.686 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.33 122.9 47.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.229 1.014 . . . . 0.0 110.585 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.62 113.66 2.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -115.24 179.72 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -118.1 121.08 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.307 1.443 . . . . 0.0 107.334 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 p -81.67 143.11 32.13 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -71.55 176.2 4.95 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 163.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt 57.02 94.12 0.03 OUTLIER 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.554 1.942 . . . . 0.0 109.093 -172.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -54.21 165.99 0.45 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.629 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.0 152.25 13.84 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.281 5.5 mm 66.67 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.547 2.339 . . . . 0.0 110.743 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 65.41 17.44 10.97 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.055 1.342 . . . . 0.0 112.603 -159.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -161.67 -56.54 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.782 0.833 . . . . 0.0 108.9 158.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.88 159.51 5.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.548 0.689 . . . . 0.0 110.358 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.97 114.04 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -72.45 131.97 43.27 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -74.58 155.28 38.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.353 1.061 . . . . 0.0 110.164 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -151.34 22.45 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.126 0.971 . . . . 0.0 112.343 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -139.52 150.15 44.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.876 1.216 . . . . 0.0 111.138 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.74 134.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.356 1.062 . . . . 0.0 109.417 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.1 t -65.19 127.2 30.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.09 114.02 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.764 0.792 . . . . 0.0 109.308 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.2 -77.71 0.39 Allowed Glycine 0 C--O 1.229 -0.178 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.48 -15.64 62.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.667 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.75 83.91 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.795 1.188 . . . . 0.0 114.341 165.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -69.55 139.87 53.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 124.758 1.223 . . . . 0.0 109.572 -170.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -78.51 147.02 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.7 1.2 . . . . 0.0 109.584 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -139.52 150.88 45.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.057 0.943 . . . . 0.0 109.409 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -102.88 -0.47 31.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.303 1.441 . . . . 0.0 112.562 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 p -149.57 167.9 25.03 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.446 2.298 . . . . 0.0 106.828 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.82 123.66 87.51 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 165.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.24 172.73 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.228 1.952 . . . . 0.0 110.358 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -54.6 137.28 73.16 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 121.896 1.731 . . . . 0.0 110.048 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.39 -10.15 2.07 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.315 0.96 . . . . 0.0 114.148 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.15 29.21 72.22 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 119.137 1.469 . . . . 0.0 112.393 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.25 161.05 21.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 118.448 1.124 . . . . 0.0 109.289 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 12.7 t -73.54 113.76 25.52 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.376 -1.297 . . . . 0.0 109.33 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.31 -17.41 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.702 1.601 . . . . 0.0 113.52 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.97 -26.2 19.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.539 1.136 . . . . 0.0 111.683 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.9 p -153.63 1.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -167.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.87 -13.16 9.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.48 1.514 . . . . 0.0 114.769 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.26 160.05 32.91 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.803 1.302 . . . . 0.0 112.221 -172.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -64.05 138.95 58.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.484 0.659 . . . . 0.0 109.555 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.45 144.61 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.01 150.19 52.26 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.336 1.054 . . . . 0.0 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.94 132.47 47.39 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -99.56 156.42 35.4 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.091 0.556 . . . . 0.0 109.604 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.29 74.92 4.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.177 2.585 . . . . 0.0 110.231 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 63.86 169.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.239 2.216 . . . . 0.0 112.689 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.65 -45.17 87.91 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.721 1.209 . . . . 0.0 111.464 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 . . . . . 0 CA--C 1.502 -0.888 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.729 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.2 mt -122.57 165.81 15.84 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.304 0.956 . . . . 0.0 111.365 -161.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 145.33 26.51 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.107 0.563 . . . . 0.0 110.474 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -157.86 149.97 22.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.173 1.789 . . . . 0.0 107.888 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.75 144.59 13.59 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.58 1.952 . . . . 0.0 108.223 166.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 163.39 12.29 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.977 0.894 . . . . 0.0 110.444 172.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -60.97 157.69 14.9 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.083 0.953 . . . . 0.0 109.181 165.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.7 m -53.04 132.84 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 122.279 1.037 . . . . 0.0 110.841 -171.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -154.36 144.72 22.13 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.36 146.65 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.71 137.84 53.67 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.728 1.611 . . . . 0.0 107.421 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.51 162.04 13.97 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.359 0.412 . . . . 0.0 110.525 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -40.9 -50.1 3.23 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.484 1.914 . . . . 0.0 112.542 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.96 -43.66 99.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 120.252 1.387 . . . . 0.0 109.366 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -69.09 -32.49 71.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.437 0.695 . . . . 0.0 110.644 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.9 mt -61.38 -45.44 98.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.051 0.54 . . . . 0.0 110.597 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -72.22 -28.22 63.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.266 0.939 . . . . 0.0 111.05 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.72 21.77 22.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.107 0.861 . . . . 0.0 112.416 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.73 114.44 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.847 1.324 . . . . 0.0 108.0 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -73.31 110.23 7.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.154 1.782 . . . . 0.0 107.91 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.79 127.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.135 0.974 . . . . 0.0 109.369 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.47 162.62 28.4 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.589 -1.319 . . . . 0.0 111.138 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.14 -147.89 19.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -124.15 156.4 36.76 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.582 1.153 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -128.05 149.54 50.33 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 107.572 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.1 p -78.65 129.87 72.71 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -61.93 -23.94 76.43 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.212 1.275 . . . . 0.0 111.274 168.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -71.27 -29.94 65.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.96 -37.09 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 119.522 1.055 . . . . 0.0 109.063 174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -60.39 -24.27 30.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 119.116 0.871 . . . . 0.0 112.199 -172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -56.67 -28.62 61.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 117.929 0.331 . . . . 0.0 111.374 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.48 -10.39 16.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.827 1.651 . . . . 0.0 111.427 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.95 78.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -21.33 52.84 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.985 0.914 . . . . 0.0 111.597 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.7 121.25 12.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.59 -50.28 74.38 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.666 0.786 . . . . 0.0 110.46 -162.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.39 -57.39 12.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.348 1.059 . . . . 0.0 109.525 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -58.67 -45.33 89.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.71 1.204 . . . . 0.0 110.663 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.76 -58.98 4.8 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.072 1.349 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.3 mt -53.37 -47.74 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 124.131 0.972 . . . . 0.0 108.559 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.48 -54.84 42.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.438 0.695 . . . . 0.0 110.661 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.64 -54.09 38.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.585 1.154 . . . . 0.0 109.623 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.35 -27.17 68.39 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 121.304 -0.872 . . . . 0.0 111.76 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 m -69.03 -47.19 66.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.616 0.766 . . . . 0.0 110.065 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.62 88.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.151 0.981 . . . . 0.0 111.077 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.56 -46.65 92.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 118.243 0.474 . . . . 0.0 109.79 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -64.24 -32.58 74.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.7 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.72 -2.47 46.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.578 1.151 . . . . 0.0 112.094 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.74 88.6 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 118.422 -1.21 . . . . 0.0 113.482 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.94 -53.73 51.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.518 1.527 . . . . 0.0 108.176 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -107.12 152.57 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -132.82 156.46 47.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.289 1.036 . . . . 0.0 109.731 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.9 mm -81.1 134.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 124.741 1.216 . . . . 0.0 107.736 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.29 127.79 6.48 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.711 1.204 . . . . 0.0 108.593 165.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.41 155.62 51.3 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.2 167.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -65.2 170.48 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.72 2.947 . . . . 0.0 111.993 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.2 t -86.55 153.04 22.12 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 159.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -47.05 -42.35 18.42 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.237 1.415 . . . . 0.0 111.465 161.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.57 -45.07 95.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 110.134 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -65.56 -38.39 89.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.061 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mm -61.18 -48.31 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 119.629 1.104 . . . . 0.0 108.666 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -57.12 -31.95 65.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.042 0.937 . . . . 0.0 111.623 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -41.7 97.13 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.906 0.882 . . . . 0.0 110.694 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -48.99 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.4 mt -52.29 -36.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.899 1.279 . . . . 0.0 110.938 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -61.33 -62.64 1.69 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.471 1.032 . . . . 0.0 110.973 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.79 -34.88 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -172.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.52 57.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.4 1.48 . . . . 0.0 110.322 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HE3' ' N ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -64.87 -20.66 66.54 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.781 -1.199 . . . . 0.0 112.168 176.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HE3' ' A' ' 70' ' ' LYS . 30.9 tt0 -81.18 -20.4 41.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.714 0.805 . . . . 0.0 111.558 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 t -109.37 -22.56 11.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.282 0.947 . . . . 0.0 111.364 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.67 -83.84 0.17 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.151 0.887 . . . . 0.0 112.221 170.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -74.14 91.86 2.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.469 1.108 . . . . 0.0 108.249 -171.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.49 -45.74 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.26 10.18 4.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.783 1.233 . . . . 0.0 109.828 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 8.15 0.92 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.481 0.712 . . . . 0.0 110.93 164.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.33 147.19 27.39 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.259 1.424 . . . . 0.0 108.632 163.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.7 m -70.04 156.4 39.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.714 1.245 . . . . 0.0 110.15 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 29.0 ttpt -61.57 -48.08 82.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.746 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.56 56.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.225 0.92 . . . . 0.0 112.19 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -63.15 -56.27 18.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.3 mt -52.25 -43.31 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.402 1.481 . . . . 0.0 109.18 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 49.2 mt-10 -66.37 -52.74 43.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.619 1.568 . . . . 0.0 112.14 -174.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.65 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 119.131 0.878 . . . . 0.0 109.462 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.401 ' CD2' ' HH ' ' A' ' 90' ' ' TYR . 45.9 mt -57.67 -56.38 22.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.631 0.772 . . . . 0.0 109.218 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.99 -59.07 3.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.496 1.519 . . . . 0.0 112.023 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -49.62 59.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.865 0.866 . . . . 0.0 109.187 -174.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.27 66.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -77.73 -30.07 51.49 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.766 1.167 . . . . 0.0 110.507 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -42.45 99.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 168.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.15 -7.13 59.61 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 52.12 24.96 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.804 1.642 . . . . 0.0 113.109 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 -106.8 2.57 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 119.387 0.994 . . . . 0.0 113.906 -159.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -142.38 166.86 23.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.518 1.927 . . . . 0.0 108.031 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.5 mt -135.21 154.2 35.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.57 121.24 18.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 t -158.14 -170.42 3.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.823 2.049 . . . . 0.0 106.907 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -154.66 -4.77 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 122.235 2.288 . . . . 0.0 115.781 163.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -61.35 148.77 40.3 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.235 1.834 . . . . 0.0 112.942 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -56.92 -32.61 66.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.759 1.624 . . . . 0.0 114.273 -172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.54 -50.85 12.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.43 1.092 . . . . 0.0 110.171 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -42.15 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.494 0.718 . . . . 0.0 110.768 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -67.17 -35.2 79.16 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.029 0.442 . . . . 0.0 110.347 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 -56.74 11.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -51.68 -55.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.462 1.105 . . . . 0.0 110.018 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.22 68.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.163 1.347 . . . . 0.0 113.164 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 t -60.4 -61.69 2.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.071 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.4 -16.56 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.125 1.33 . . . . 0.0 113.212 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.572 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -86.81 -22.17 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.88 0.872 . . . . 0.0 112.525 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.93 38.98 89.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 118.474 0.579 . . . . 0.0 112.859 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 125.12 39.79 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 161.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 116.07 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.21 -162.99 1.11 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.174 0.989 . . . . 0.0 110.709 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -140.25 162.71 34.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.807 2.443 . . . . 0.0 109.354 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.59 162.18 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.196 2.198 . . . . 0.0 110.35 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.05 -12.73 29.85 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.157 1.383 . . . . 0.0 112.917 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -38.93 115.33 0.47 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.913 2.085 . . . . 0.0 111.107 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -48.92 137.74 12.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.501 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.36 -87.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.171 1.843 . . . . 0.0 113.026 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.4 mt -147.93 145.83 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -137.8 -16.02 1.33 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -162.75 19.03 0.09 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.923 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.9 m -137.9 165.75 25.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 120.352 -1.467 . . . . 0.0 109.599 -162.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.96 149.3 6.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 71.68 0.66 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -58.19 154.77 12.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.644 1.577 . . . . 0.0 110.875 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 14.14 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -139.81 135.3 32.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.822 1.192 . . . . 0.0 109.984 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.86 131.99 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.89 140.46 58.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 165.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.8 pt -93.29 -11.62 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 118.206 -0.902 . . . . 0.0 113.192 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.73 -20.61 23.81 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 119.621 1.101 . . . . 0.0 113.962 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.7 p -144.8 6.07 1.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.826 1.313 . . . . 0.0 114.16 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.76 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.596 1.093 . . . . 0.0 115.076 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -68.18 147.37 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.199 1.0 . . . . 0.0 110.723 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -110.79 99.0 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.844 0.858 . . . . 0.0 111.783 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.19 143.63 26.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.859 1.314 . . . . 0.0 109.529 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -89.22 -19.77 24.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.568 172.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.7 p -145.21 163.14 35.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.757 1.623 . . . . 0.0 109.034 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.422 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -73.02 116.63 52.49 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -176.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -66.74 169.0 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.468 2.112 . . . . 0.0 110.507 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -55.22 133.07 55.98 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.99 1.794 . . . . 0.0 109.877 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.57 -18.28 3.79 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.574 -1.125 . . . . 0.0 113.597 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 63.38 44.31 97.02 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 119.789 1.795 . . . . 0.0 111.538 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.83 158.41 43.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 14.2 t -67.63 110.93 6.16 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -61.55 -14.94 38.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.292 1.328 . . . . 0.0 111.746 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -12.41 14.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.659 1.984 . . . . 0.0 112.483 -160.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.52 -14.26 0.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.19 85.42 0.12 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.6 p -152.02 174.99 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -60.73 151.8 28.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.715 -1.24 . . . . 0.0 109.995 160.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.65 147.66 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 159.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.84 154.07 46.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.393 0.997 . . . . 0.0 111.415 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.06 114.02 14.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.584 1.154 . . . . 0.0 108.522 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.39 159.0 68.33 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 118.296 0.498 . . . . 0.0 110.79 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.23 91.57 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.485 2.79 . . . . 0.0 111.695 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 30.65 84.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.745 2.418 . . . . 0.0 113.267 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? 72.52 -39.63 0.45 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.857 2.063 . . . . 0.0 114.311 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.221 -159.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 58.99 90.42 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.844 2.458 . . . . 0.0 113.201 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.55 169.76 17.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.237 1.015 . . . . 0.0 108.747 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.2 t30 164.79 108.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 128.375 2.67 . . . . 0.0 109.192 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.87 169.17 9.43 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 109.258 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -94.57 177.36 5.95 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.202 1.801 . . . . 0.0 109.981 171.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -57.41 166.41 1.23 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.761 0.824 . . . . 0.0 110.802 159.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -44.79 122.56 3.26 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.509 1.924 . . . . 0.0 110.219 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 6' ' ' LYS . 19.0 tp -147.3 147.14 30.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 108.013 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 t -116.86 140.33 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -108.07 146.8 32.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.875 1.67 . . . . 0.0 107.632 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.2 161.78 13.43 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.14 0.9 . . . . 0.0 112.179 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.6 t -43.89 -52.49 6.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 127.801 2.44 . . . . 0.0 111.724 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -60.7 -23.03 64.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.485 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.89 90.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 120.073 1.306 . . . . 0.0 109.456 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -72.37 -36.31 68.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.929 0.891 . . . . 0.0 111.045 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.71 -46.6 93.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.313 1.045 . . . . 0.0 109.835 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -75.96 -23.16 55.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.759 0.709 . . . . 0.0 111.116 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.91 41.73 12.07 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mt -81.82 112.49 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.69 98.91 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.448 1.099 . . . . 0.0 109.437 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.5 tp -153.94 164.63 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.105 1.762 . . . . 0.0 107.264 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -131.45 155.11 47.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.02 2.128 . . . . 0.0 108.698 -160.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.74 -149.14 21.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.24 161.91 15.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 0.0 110.157 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.0 t -141.84 161.1 38.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.825 1.65 . . . . 0.0 108.098 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 p -96.18 123.11 56.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 122.401 0.28 . . . . 0.0 110.889 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.2 -26.39 81.58 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.379 2.053 . . . . 0.0 112.114 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.2 m -62.99 -32.64 74.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.1 1.76 . . . . 0.0 114.598 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.47 -29.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.653 1.115 . . . . 0.0 110.369 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.53 -20.02 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 119.868 1.213 . . . . 0.0 111.187 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.57 -29.29 66.27 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.035 -1.666 . . . . 0.0 114.297 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -102.25 -16.23 16.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.454 1.101 . . . . 0.0 111.517 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.91 105.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 124.269 1.028 . . . . 0.0 108.902 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -13.04 7.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.461 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -61.82 120.18 10.2 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -62.02 -32.91 73.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.66 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.72 -63.36 1.17 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.3 p -53.7 -44.74 70.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.046 1.338 . . . . 0.0 112.515 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -71.45 -54.15 11.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.154 1.381 . . . . 0.0 110.896 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.59 -51.98 30.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -54.9 -54.24 45.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 112.429 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.33 -51.52 58.3 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.947 1.299 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.23 -34.26 77.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.977 0.911 . . . . 0.0 111.929 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -64.12 -45.44 88.56 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -36.77 78.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.477 0.711 . . . . 0.0 111.635 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.38 -51.71 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -67.48 -19.53 65.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.07 0.85 . . . . 0.0 113.24 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -10.07 51.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.517 1.527 . . . . 0.0 111.892 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.75 -0.69 70.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.729 1.157 . . . . 0.0 113.767 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -87.79 -28.3 21.76 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.192 0.997 . . . . 0.0 111.984 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.92 140.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -128.51 151.58 49.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.568 1.547 . . . . 0.0 108.877 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.8 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.77 132.38 5.03 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.106 1.362 . . . . 0.0 108.595 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -92.72 154.95 42.21 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.592 0.757 . . . . 0.0 111.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.76 173.92 11.14 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.285 3.323 . . . . 0.0 111.7 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -108.76 162.68 13.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.492 1.117 . . . . 0.0 109.696 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -53.76 -49.79 67.43 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.937 0.895 . . . . 0.0 111.294 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.65 -27.29 66.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.863 0.465 . . . . 0.0 110.184 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -67.42 -48.34 67.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.531 0.733 . . . . 0.0 109.636 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.6 -45.72 94.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.468 1.107 . . . . 0.0 110.155 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.06 -35.09 74.38 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.88 -0.512 . . . . 0.0 110.62 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -44.89 71.08 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.199 0.6 . . . . 0.0 111.06 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.4 mm -64.37 -45.51 95.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.71 -38.8 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.931 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -63.48 -59.03 5.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.168 1.349 . . . . 0.0 110.813 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.6 -32.54 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -51.83 67.28 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -30.83 71.22 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.669 1.122 . . . . 0.0 111.691 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.39 -15.45 48.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 111.712 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -114.31 -28.77 7.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.19 0.905 . . . . 0.0 111.961 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.64 -99.02 0.19 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 119.991 1.269 . . . . 0.0 110.4 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -58.56 96.56 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.267 2.227 . . . . 0.0 108.797 -168.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.98 -44.06 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.483 1.913 . . . . 0.0 110.706 -167.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -123.61 6.71 8.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.281 0.632 . . . . 0.0 110.111 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.78 -24.83 62.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.581 0.628 . . . . 0.0 111.528 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.27 158.09 31.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.658 1.183 . . . . 0.0 109.757 -174.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -68.56 154.93 40.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.441 0.638 . . . . 0.0 110.75 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -63.01 -53.35 55.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.784 -0.572 . . . . 0.0 109.734 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.59 61.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.779 1.3 . . . . 0.0 109.485 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -59.41 -59.13 5.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.968 1.707 . . . . 0.0 108.455 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -53.75 -40.99 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.771 0.828 . . . . 0.0 110.578 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.35 -43.72 73.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.236 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.72 -49.77 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.5 mt -56.97 -53.58 56.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.757 1.223 . . . . 0.0 108.941 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.72 -52.86 54.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.046 1.338 . . . . 0.0 111.75 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.3 tp -54.36 -49.82 68.92 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.4 -16.31 62.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.709 0.686 . . . . 0.0 112.638 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.507 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.6 m-30 -96.4 -17.48 20.58 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.32 1.048 . . . . 0.0 111.421 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -58.88 -44.57 91.18 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.13 -4.77 13.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.155 1.782 . . . . 0.0 111.935 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 53.6 49.12 20.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.701 2.001 . . . . 0.0 111.547 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.63 -114.18 2.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.761 1.172 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -148.58 169.89 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 107.79 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.38 163.57 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 0.0 108.194 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 118.57 13.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.92 1.688 . . . . 0.0 107.8 166.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.0 t -175.16 176.82 2.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.183 2.193 . . . . 0.0 109.559 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.62 0.19 0.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.422 ' H ' HG12 ' A' ' 103' ' ' VAL . 1.1 t0 -57.31 162.51 2.71 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.539 1.518 . . . . 0.0 113.911 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -57.69 -52.49 65.21 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.726 -1.234 . . . . 0.0 109.74 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -75.1 -43.32 53.64 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.219 1.007 . . . . 0.0 110.183 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' ' 100' ' ' ASP . 1.4 p -61.57 -47.13 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -169.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.74 -37.04 85.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.85 0.46 . . . . 0.0 109.947 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -70.51 -53.32 16.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -49.57 -51.68 14.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.202 1.001 . . . . 0.0 109.443 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.63 70.4 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.002 1.274 . . . . 0.0 112.481 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.6 t -65.56 -52.44 52.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.205 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.41 -30.22 71.38 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 121.106 1.775 . . . . 0.0 110.613 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.507 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -79.97 -8.96 59.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.366 1.066 . . . . 0.0 112.891 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.89 59.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.023 -1.432 . . . . 0.0 115.499 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.11 119.91 26.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.511 2.156 . . . . 0.0 110.569 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 148.86 41.06 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.671 1.188 . . . . 0.0 111.244 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.74 176.33 12.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 122.038 -0.414 . . . . 0.0 111.475 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -111.9 150.55 30.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.967 1.307 . . . . 0.0 109.887 172.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p -112.68 158.68 19.73 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.314 1.446 . . . . 0.0 110.17 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.7 mp -77.38 166.68 22.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.158 0.983 . . . . 0.0 109.102 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -96.85 1.44 50.61 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.601 -1.19 . . . . 0.0 113.812 -169.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -111.69 152.78 27.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 122.424 2.374 . . . . 0.0 111.628 -167.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.71 -168.6 9.38 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 121.887 0.715 . . . . 0.0 111.532 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.81 149.89 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -130.04 -51.16 1.12 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.759 1.624 . . . . 0.0 108.178 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -139.78 41.4 2.0 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.46 1.104 . . . . 0.0 111.578 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -121.23 168.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -63.94 112.63 3.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.67 -1.269 . . . . 0.0 108.105 157.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.479 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 2.4 p-90 -61.77 154.63 25.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 154.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -175.3 13.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -140.91 152.98 45.47 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.148 1.34 . . . . 0.0 111.858 164.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.14 132.84 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.876 1.27 . . . . 0.0 109.132 -176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 128.95 37.43 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 164.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pt -80.39 101.51 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.757 0.708 . . . . 0.0 109.696 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.98 -84.58 0.18 Allowed Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 7.0 p -70.47 -15.26 62.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.031 0.416 . . . . 0.0 110.944 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.11 92.79 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.411 1.005 . . . . 0.0 111.826 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -70.94 145.26 50.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 49.8 mttp -104.95 132.54 51.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.133 1.373 . . . . 0.0 107.564 -176.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.29 162.54 25.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 109.086 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.5 t -113.52 -13.74 12.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.729 0.412 . . . . 0.0 110.604 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.8 p -142.09 158.49 43.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.23 126.1 92.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.03 170.95 17.72 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.285 2.657 . . . . 0.0 111.375 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.65 101.79 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.08 3.186 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.59 28.8 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.76 1.648 . . . . 0.0 111.785 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.97 34.24 87.9 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.093 -1.948 . . . . 0.0 113.008 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.07 165.8 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.691 1.996 . . . . 0.0 108.388 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.75 109.72 7.34 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 125.889 1.676 . . . . 0.0 110.036 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.98 -14.9 44.27 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.805 1.323 . . . . 0.0 112.379 167.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -41.06 17.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.006 0.922 . . . . 0.0 110.006 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.48 4.99 2.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.426 1.012 . . . . 0.0 113.573 -163.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.11 -14.63 1.55 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.198 2.333 . . . . 0.0 116.087 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 163.16 24.73 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.865 1.333 . . . . 0.0 112.7 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -69.45 155.94 39.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.66 145.64 15.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -136.24 168.81 18.7 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.094 1.358 . . . . 0.0 110.173 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.0 tt -77.32 157.87 30.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.991 0.916 . . . . 0.0 109.984 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.26 159.34 67.77 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.602 2.361 . . . . 0.0 107.816 173.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.65 178.85 7.08 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.73 1.62 . . . . 0.0 113.474 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -37.8 131.98 0.96 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.477 2.311 . . . . 0.0 113.69 -172.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -47.27 84.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 171.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.25 1.115 0 CA-C-N 118.952 0.796 . . . . 0.0 110.958 -170.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 ttp . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.3 mt 52.23 88.65 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.726 2.41 . . . . 0.0 112.365 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.12 -178.05 5.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.515 2.326 . . . . 0.0 109.694 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.2 t30 20.78 95.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.957 3.303 . . . . 0.0 113.783 -168.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 146.56 31.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -69.03 168.69 13.29 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -51.52 170.44 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.553 1.941 . . . . 0.0 112.373 166.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.7 116.78 1.92 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.86 1.264 . . . . 0.0 111.597 -170.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.96 143.89 31.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.533 0.733 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.15 154.18 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 O-C-N 124.129 0.893 . . . . 0.0 110.306 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.58 154.6 45.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.397 2.679 . . . . 0.0 107.611 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.41 164.44 14.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.746 0.818 . . . . 0.0 111.153 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.7 p -35.08 -50.12 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.282 2.233 . . . . 0.0 112.654 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -52.2 -40.65 61.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.107 0.963 . . . . 0.0 112.188 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.59 -44.76 97.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.322 1.449 . . . . 0.0 109.699 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.35 -34.25 72.41 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.898 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.61 -50.31 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.732 0.813 . . . . 0.0 109.738 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -70.7 -19.49 62.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.29 0.496 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.2 23.69 47.29 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.478 1.037 . . . . 0.0 112.096 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.62 112.69 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 112.48 1.57 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.827 1.251 . . . . 0.0 108.262 170.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 141.39 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.782 2.033 . . . . 0.0 106.989 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -78.29 164.81 24.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.113 1.365 . . . . 0.0 108.986 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.79 -165.85 31.19 Favored Glycine 0 C--N 1.331 0.264 0 O-C-N 121.032 -1.043 . . . . 0.0 111.048 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -103.23 149.02 25.09 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -142.84 171.54 13.92 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.189 1.396 . . . . 0.0 111.153 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.34 119.44 64.25 Favored Pre-proline 0 C--O 1.251 1.154 0 C-N-CA 126.151 1.781 . . . . 0.0 112.963 -168.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.31 -6.23 16.94 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.247 1.965 . . . . 0.0 113.005 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.9 m -91.96 -29.74 16.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.74 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.24 -39.8 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 120.467 1.485 . . . . 0.0 108.95 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.3 p -58.85 -23.57 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.11 -23.24 63.97 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.758 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.51 -34.96 30.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.851 1.26 . . . . 0.0 109.701 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.17 127.2 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.783 1.233 . . . . 0.0 108.092 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 -19.35 2.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.303 1.041 . . . . 0.0 112.239 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.28 127.49 32.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -59.18 -43.06 92.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.779 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.62 -53.93 51.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -54.66 44.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.624 1.57 . . . . 0.0 110.574 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -57.12 -59.29 5.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.154 0.581 . . . . 0.0 109.581 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.97 -53.19 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -54.1 -47.88 71.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.744 0.818 . . . . 0.0 112.066 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.58 -52.44 65.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.077 1.351 . . . . 0.0 108.851 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.31 -40.28 95.79 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.912 -0.492 . . . . 0.0 110.729 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -60.05 -47.96 83.71 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.378 1.471 . . . . 0.0 110.132 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -38.28 89.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.827 0.74 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.21 -45.28 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 118.767 0.712 . . . . 0.0 109.491 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -54.31 -50.05 68.26 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 109.635 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.1 -6.59 34.98 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.246 1.819 . . . . 0.0 113.383 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.17 83.31 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.811 1.187 . . . . 0.0 113.324 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.69 -46.58 87.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.561 1.18 . . . . 0.0 107.91 170.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 147.63 21.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.761 0.824 . . . . 0.0 109.092 -167.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.69 172.27 9.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.112 1.765 . . . . 0.0 108.889 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.76 138.46 44.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.789 1.635 . . . . 0.0 110.47 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.28 123.82 3.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.856 1.662 . . . . 0.0 108.052 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -107.22 147.21 34.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.215 0.916 . . . . 0.0 111.581 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.81 171.57 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.445 3.43 . . . . 0.0 113.044 -170.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -111.7 160.58 17.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.604 1.562 . . . . 0.0 110.262 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -59.88 -45.72 91.61 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.611 -0.681 . . . . 0.0 111.535 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.18 -38.78 65.98 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.608 0.763 . . . . 0.0 110.463 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -70.11 -42.12 73.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.344 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -64.13 -46.88 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.38 77.34 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.81 -0.556 . . . . 0.0 111.118 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.73 -44.53 63.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.133 0.973 . . . . 0.0 111.199 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.75 -50.78 57.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.2 mt -51.46 -36.52 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.573 1.149 . . . . 0.0 110.807 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -66.38 -56.32 11.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.809 1.186 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.31 -38.8 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.96 67.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.617 1.567 . . . . 0.0 111.447 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -24.2 63.05 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.134 -0.979 . . . . 0.0 112.537 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.25 -30.7 54.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 111.389 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.269 14.6 t -75.58 -68.13 0.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.38 0.991 . . . . 0.0 108.526 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.76 -73.19 0.07 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-N 119.482 1.037 . . . . 0.0 111.569 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -69.6 93.83 0.73 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.663 0.785 . . . . 0.0 110.027 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.64 -59.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 122.167 -0.333 . . . . 0.0 111.839 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -114.67 8.18 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.451 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.81 -9.29 58.5 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -92.63 159.79 15.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.256 -0.903 . . . . 0.0 110.746 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -68.69 156.38 38.33 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.525 -0.735 . . . . 0.0 111.95 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.44 -57.42 12.81 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 118.895 -0.574 . . . . 0.0 109.508 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.69 -39.79 52.12 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.073 0.858 . . . . 0.0 111.4 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -61.68 2.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 109.316 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.24 -42.99 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 125.283 1.433 . . . . 0.0 108.759 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -56.2 -62.12 1.93 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.458 1.103 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.15 -47.53 80.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.415 0.686 . . . . 0.0 109.638 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.3 mt -59.13 -52.18 66.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.939 0.896 . . . . 0.0 110.173 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.12 -59.45 4.17 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.133 1.373 . . . . 0.0 112.218 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 tp -46.96 -54.27 10.5 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.58 1.175 . . . . 0.0 110.972 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.25 68.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.395 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.524 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.7 m-85 -64.56 -28.78 69.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.517 0.599 . . . . 0.0 112.015 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.19 -34.52 76.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.141 0.882 . . . . 0.0 110.167 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.97 -18.92 38.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.008 1.323 . . . . 0.0 112.972 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.06 51.39 17.15 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.12 -149.01 11.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.929 1.728 . . . . 0.0 111.254 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -114.21 169.93 8.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.618 1.967 . . . . 0.0 108.465 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 55.0 mt -131.94 153.76 39.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.047 1.339 . . . . 0.0 107.807 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.59 111.82 8.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.735 1.214 . . . . 0.0 108.788 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.2 t -160.92 179.61 8.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.032 2.133 . . . . 0.0 107.534 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -155.74 27.71 0.38 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.351 -1.468 . . . . 0.0 113.599 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.3 t70 -95.44 156.64 16.24 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -170.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -69.41 -40.8 77.08 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.037 1.29 . . . . 0.0 110.223 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -49.41 49.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.135 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.545 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -57.01 -40.01 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.812 1.187 . . . . 0.0 110.927 -173.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -67.32 -40.19 85.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.975 0.51 . . . . 0.0 109.874 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -66.09 -55.05 18.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 mm -53.97 -54.47 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 110.391 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.59 -32.32 68.87 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.111 -1.618 . . . . 0.0 112.777 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 t -60.54 -60.6 3.55 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 117.73 -1.129 . . . . 0.0 110.678 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -31.99 71.09 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 120.022 1.283 . . . . 0.0 110.683 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -76.32 -8.72 57.72 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.82 5.49 88.6 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.707 -1.051 . . . . 0.0 113.511 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.65 130.48 34.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.243 1.521 . . . . 0.0 110.031 -170.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -66.63 132.1 47.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.676 0.79 . . . . 0.0 111.168 173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -144.82 178.51 7.96 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.344 -0.848 . . . . 0.0 110.545 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -115.03 156.27 25.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.331 1.452 . . . . 0.0 108.881 171.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.9 p -122.4 160.57 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.919 1.287 . . . . 0.0 108.732 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.23 -51.71 9.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.924 -0.485 . . . . 0.0 110.285 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -59.92 155.38 16.64 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.85 177.38 5.58 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.366 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.03 178.66 30.44 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -157.73 157.51 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.451 2.3 . . . . 0.0 107.237 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -128.99 -26.67 2.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -153.95 39.33 0.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.034 0.834 . . . . 0.0 109.692 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.86 137.64 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -164.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.96 125.7 37.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 117.52 23.84 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.247 1.019 . . . . 0.0 109.68 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -50.69 144.85 7.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.216 1.006 . . . . 0.0 111.931 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ttt-85 -156.82 9.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.998 1.111 . . . . 0.0 113.998 -164.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -133.65 131.89 40.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.92 0.782 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.21 133.77 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.59 128.71 37.44 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 166.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.11 113.06 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 164.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.28 -79.27 0.21 Allowed Glycine 0 C--O 1.229 -0.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 10.7 p -102.8 -7.06 21.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.636 0.718 . . . . 0.0 112.725 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.34 19.36 66.8 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.865 -1.147 . . . . 0.0 114.388 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 5.0 ttm-85 -63.43 150.29 43.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.455 1.502 . . . . 0.0 110.013 -176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -123.96 97.7 5.47 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.746 0.654 . . . . 0.0 111.315 -152.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -99.48 146.26 26.56 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.421 1.105 . . . . 0.0 108.961 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -98.9 -11.32 21.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.473 0.709 . . . . 0.0 110.345 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.5 p -140.03 162.03 36.19 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 126.496 1.918 . . . . 0.0 108.979 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -79.04 118.48 72.73 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.92 161.46 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.979 1.786 . . . . 0.0 109.403 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.0 107.7 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.873 2.382 . . . . 0.0 108.744 172.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.46 -18.93 11.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.761 2.124 . . . . 0.0 111.927 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.421 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 54.78 31.4 54.09 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.759 1.279 . . . . 0.0 113.673 -175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 164.11 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.999 1.32 . . . . 0.0 108.154 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.65 115.01 16.75 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.163 168.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.92 -3.87 2.47 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.193 1.929 . . . . 0.0 113.083 166.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.21 -26.68 5.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.434 1.893 . . . . 0.0 112.814 -170.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 67.9 m -113.01 -18.16 12.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.728 1.211 . . . . 0.0 111.52 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 53.02 50.3 51.88 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.7 t -128.28 162.48 26.93 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.32 139.62 49.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.792 0.806 . . . . 0.0 110.948 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.09 152.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -126.76 156.32 41.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 120.306 -1.496 . . . . 0.0 109.516 166.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.12 120.24 23.99 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -82.35 156.16 68.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.441 0.463 . . . . 0.0 110.697 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.06 80.61 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.981 2.454 . . . . 0.0 109.84 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 56.74 170.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.222 2.209 . . . . 0.0 111.813 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -67.16 -74.69 0.11 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 162.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 . . . . . 0 C--O 1.244 0.804 0 C-N-CA 124.582 1.153 . . . . 0.0 108.661 -176.269 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptp . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mp -129.03 -102.41 0.32 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 159.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -104.37 0.64 29.31 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -71.05 165.78 22.76 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.478 0.711 . . . . 0.0 110.553 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp 78.63 104.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 131.264 3.826 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.84 162.48 27.6 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.366 -0.833 . . . . 0.0 110.689 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -53.71 160.86 1.23 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.557 1.143 . . . . 0.0 110.121 164.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -45.14 119.19 1.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.341 1.456 . . . . 0.0 111.95 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.2 137.56 40.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.568 1.547 . . . . 0.0 107.093 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.41 146.76 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.81 146.78 40.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.733 1.613 . . . . 0.0 108.098 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.73 174.66 7.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.345 0.52 . . . . 0.0 111.706 166.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -55.87 -42.28 75.65 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -61.15 -27.7 68.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.743 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.74 -42.68 82.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 119.984 1.266 . . . . 0.0 110.162 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -72.23 -36.38 69.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.465 1.106 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.3 -26.54 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.552 1.141 . . . . 0.0 110.892 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -92.22 -23.55 19.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.278 0.945 . . . . 0.0 111.829 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.96 45.72 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.304 -0.72 . . . . 0.0 113.02 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.2 mt -67.92 109.98 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.87 91.52 0.65 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.383 1.073 . . . . 0.0 110.191 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.47 165.79 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.832 1.253 . . . . 0.0 109.52 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.45 119.29 21.4 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.475 -166.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.07 -162.39 29.27 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.186 0.898 . . . . 0.0 110.905 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -104.26 150.59 24.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.875 1.27 . . . . 0.0 109.397 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -135.46 149.11 49.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.855 1.262 . . . . 0.0 108.82 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.82 118.93 75.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 125.219 1.408 . . . . 0.0 107.99 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.12 -28.71 71.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 119.749 0.946 . . . . 0.0 110.776 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -48.29 37.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.181 3.392 . . . . 0.0 113.899 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.7 -35.15 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-N 118.77 0.714 . . . . 0.0 110.33 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.27 -26.95 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.867 0.758 . . . . 0.0 110.062 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.5 -20.48 31.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.91 -22.12 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.992 1.317 . . . . 0.0 111.685 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.2 mt -62.58 116.79 2.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 122.211 1.005 . . . . 0.0 108.837 -170.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.84 -16.54 3.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.838 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -66.56 122.01 16.63 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -56.22 -45.34 79.94 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.122 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -56.79 -55.85 29.02 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.77 1.228 . . . . 0.0 109.121 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -61.17 -44.57 97.1 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.371 1.069 . . . . 0.0 110.31 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.41 -55.53 20.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.329 0.652 . . . . 0.0 110.493 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.1 mt -50.27 -55.68 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -55.19 -56.06 24.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.982 0.913 . . . . 0.0 111.613 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -52.55 -57.51 9.72 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.605 1.162 . . . . 0.0 108.836 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -58.06 -41.1 82.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.001 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -62.87 -35.85 81.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.854 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -37.46 63.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.971 0.908 . . . . 0.0 111.209 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.1 -47.3 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -66.52 -34.52 78.11 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.036 0.38 . . . . 0.0 110.976 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.91 -12.41 61.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.071 0.948 . . . . 0.0 112.745 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.13 21.75 48.08 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 119.427 1.012 . . . . 0.0 112.668 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -105.81 -26.59 11.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.913 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -119.87 127.01 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -123.27 144.2 49.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.987 1.267 . . . . 0.0 112.847 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.7 mm -77.4 122.65 32.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.666 1.186 . . . . 0.0 109.412 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 126.88 10.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.783 0.833 . . . . 0.0 110.097 168.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.39 158.14 37.49 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.1 0.56 . . . . 0.0 112.409 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.89 175.0 5.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 125.034 3.823 . . . . 0.0 111.98 170.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.36 165.03 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.36 15.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.913 1.685 . . . . 0.0 111.501 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.17 -30.81 70.0 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.763 0.425 . . . . 0.0 111.582 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -64.96 -48.52 73.74 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.385 1.474 . . . . 0.0 109.492 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.01 -46.9 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 124.439 1.096 . . . . 0.0 108.902 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -34.67 74.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 122.412 -0.18 . . . . 0.0 110.969 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -41.54 75.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.499 0.719 . . . . 0.0 111.443 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -41.13 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 117.33 -1.319 . . . . 0.0 109.803 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.59 -54.03 17.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.334 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -55.32 -55.13 35.0 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.813 1.188 . . . . 0.0 112.13 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 p -67.44 -37.44 78.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.988 -0.445 . . . . 0.0 110.972 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.01 77.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.259 1.024 . . . . 0.0 110.604 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -53.52 57.28 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.106 1.362 . . . . 0.0 109.566 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 1.86 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.654 1.582 . . . . 0.0 112.695 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.94 11.53 3.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.331 1.452 . . . . 0.0 111.107 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.07 -72.67 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 125.908 1.718 . . . . 0.0 112.78 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -77.68 71.56 4.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.86 1.264 . . . . 0.0 110.246 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.43 -39.13 82.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.762 1.625 . . . . 0.0 113.898 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -130.76 12.98 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.885 0.766 . . . . 0.0 110.887 -173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.61 -22.84 61.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.68 0.792 . . . . 0.0 111.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.33 155.83 31.71 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 122.14 -0.35 . . . . 0.0 110.428 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.7 m -63.24 151.13 41.37 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.581 0.705 . . . . 0.0 109.28 170.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -55.75 -45.32 78.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.562 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.38 80.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.203 0.911 . . . . 0.0 113.17 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.27 -57.77 9.95 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -55.92 -45.22 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.373 1.469 . . . . 0.0 109.08 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -68.22 -49.88 57.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.904 1.282 . . . . 0.0 111.943 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.42 -48.02 86.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.346 0.975 . . . . 0.0 108.998 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.74 -57.06 14.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.178 0.991 . . . . 0.0 109.177 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.97 -48.49 52.13 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.914 1.286 . . . . 0.0 111.331 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.42 -51.73 65.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.709 0.804 . . . . 0.0 109.211 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.69 74.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.4 m-30 -76.08 -22.23 55.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.938 0.79 . . . . 0.0 111.91 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.37 -50.23 68.53 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.43 -14.0 59.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.44 1.096 . . . . 0.0 112.779 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? 54.35 30.3 12.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.888 1.675 . . . . 0.0 111.752 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -125.53 5.2 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.158 0.885 . . . . 0.0 111.061 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.98 165.63 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.767 2.027 . . . . 0.0 110.12 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.7 mt -130.09 162.99 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.725 1.21 . . . . 0.0 108.462 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.38 122.75 19.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.207 2.203 . . . . 0.0 106.051 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -163.26 175.76 10.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.66 1.184 . . . . 0.0 110.669 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -160.35 92.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.229 1.412 . . . . 0.0 109.618 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.92 153.04 33.33 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.777 1.231 . . . . 0.0 109.254 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -58.66 -41.71 86.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.0 1.273 . . . . 0.0 111.907 -171.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.89 -55.54 14.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 110.029 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.12 -40.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.492 0.663 . . . . 0.0 110.526 -171.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -69.67 -41.3 75.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.063 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -59.54 -59.79 4.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.708 1.603 . . . . 0.0 107.649 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 mm -53.33 -58.84 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 124.639 1.176 . . . . 0.0 108.841 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.71 67.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.455 1.479 . . . . 0.0 112.793 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -52.98 55.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.764 -1.589 . . . . 0.0 113.102 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -35.23 79.08 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 121.235 1.834 . . . . 0.0 109.784 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -70.14 -22.38 63.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.493 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.97 80.32 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 124.726 1.155 . . . . 0.0 113.847 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.25 118.18 23.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.408 1.104 . . . . 0.0 109.098 177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -68.61 131.75 45.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.778 1.231 . . . . 0.0 108.274 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -146.57 169.74 18.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.926 0.393 . . . . 0.0 111.182 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -101.93 134.27 45.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.607 1.163 . . . . 0.0 108.38 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 p -92.16 169.11 10.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 124.721 1.263 . . . . 0.0 109.53 164.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.46 -49.64 7.45 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.34 0.518 . . . . 0.0 111.494 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -60.0 145.56 45.82 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.058 0.543 . . . . 0.0 110.764 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -65.23 -33.8 76.85 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.931 -0.48 . . . . 0.0 111.358 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.2 0.26 56.26 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.67 -1.072 . . . . 0.0 115.178 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.8 mt -143.97 134.86 21.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 126.898 2.079 . . . . 0.0 106.862 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.41 -59.88 1.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.567 157.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -148.31 2.32 0.65 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.16 1.346 . . . . 0.0 113.962 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.82 120.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.44 161.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -54.37 104.83 0.12 Allowed 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 5.5 p-90 -80.73 143.78 32.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -155.58 25.05 0.4 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.619 -1.182 . . . . 0.0 113.933 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -129.94 140.4 50.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.676 1.125 . . . . 0.0 110.73 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.29 135.29 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.592 1.557 . . . . 0.0 108.886 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.25 140.68 52.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -91.3 102.14 13.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 121.983 0.897 . . . . 0.0 109.045 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.05 -78.72 0.33 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 2.3 p -78.01 -10.72 59.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.621 0.71 . . . . 0.0 111.528 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.66 21.93 71.32 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.919 1.247 . . . . 0.0 114.589 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -63.93 135.16 56.28 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.354 1.062 . . . . 0.0 109.729 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -88.48 136.72 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.66 1.584 . . . . 0.0 108.417 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -130.8 150.02 52.17 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.416 1.086 . . . . 0.0 108.354 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 3.3 p -88.18 -22.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.435 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.4 p -139.58 172.61 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 108.136 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.86 132.34 90.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.12 169.44 21.44 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.912 1.741 . . . . 0.0 110.123 172.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -56.39 137.49 80.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.68 1.587 . . . . 0.0 109.586 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.96 -10.04 4.69 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.88 72.78 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.806 1.803 . . . . 0.0 112.918 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.18 161.63 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.247 1.019 . . . . 0.0 108.947 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.3 t -79.48 113.69 39.09 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.432 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.16 -13.45 15.95 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.366 1.377 . . . . 0.0 114.044 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.53 -25.09 15.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.171 1.388 . . . . 0.0 112.79 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.9 p -150.71 2.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.57 -11.35 7.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.585 2.04 . . . . 0.0 115.152 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.46 166.75 21.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.588 1.194 . . . . 0.0 112.873 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -61.16 149.21 38.15 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.618 -0.676 . . . . 0.0 109.834 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.48 142.94 22.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 153.5 51.22 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.34 1.056 . . . . 0.0 111.364 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.7 tt -76.08 137.85 40.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.777 0.831 . . . . 0.0 109.214 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 pt -108.05 158.58 33.23 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 112.768 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.25 123.84 11.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.887 3.058 . . . . 0.0 111.272 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 45.07 -128.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.814 2.046 . . . . 0.0 111.264 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -31.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 . . . . . 0 C--O 1.251 1.18 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 171.901 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.963 0.411 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.23 175.62 2.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.731 1.212 . . . . 0.0 110.956 169.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.6 170.16 16.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 156.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -125.34 177.28 6.24 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.663 1.185 . . . . 0.0 109.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.57 164.07 32.81 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 112.324 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -75.12 -173.64 2.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.028 0.931 . . . . 0.0 113.219 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -48.74 154.95 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.22 1.008 . . . . 0.0 112.5 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -39.79 117.95 0.81 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 126.417 1.887 . . . . 0.0 110.443 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.99 144.15 43.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.13 155.48 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 124.373 1.045 . . . . 0.0 109.903 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.16 146.15 51.28 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.305 1.842 . . . . 0.0 108.671 -166.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.16 171.97 7.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.561 0.744 . . . . 0.0 112.749 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.73 69.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.095 1.358 . . . . 0.0 112.187 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -37.38 72.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.2 -47.38 80.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.942 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -73.19 -31.73 64.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.879 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.01 -47.94 91.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.972 . . . . 0.0 109.518 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.63 -25.02 58.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.198 0.454 . . . . 0.0 111.043 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.88 28.08 14.86 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.39 0.519 . . . . 0.0 113.053 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -72.08 108.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -61.27 115.53 3.89 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 23' ' ' GLU . 3.5 tp -159.48 144.79 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.981 1.713 . . . . 0.0 107.45 174.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' H ' HD11 ' A' ' 22' ' ' ILE . 31.9 mp0 -88.09 142.37 27.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.947 1.299 . . . . 0.0 108.652 175.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.15 -155.61 24.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -117.96 151.72 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.25 1.02 . . . . 0.0 109.858 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 t -129.37 145.79 51.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.163 1.385 . . . . 0.0 110.496 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.13 117.69 68.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.504 1.522 . . . . 0.0 110.035 -168.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.97 -5.67 9.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.884 3.056 . . . . 0.0 115.633 -170.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.99 -4.35 13.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.346 0.976 . . . . 0.0 111.886 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.69 -47.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.55 -19.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.59 -26.11 66.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.127 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -78.18 -40.95 36.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.017 0.927 . . . . 0.0 108.849 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.0 mt -55.67 101.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.609 1.564 . . . . 0.0 108.699 -169.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -9.29 8.9 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 126.025 1.73 . . . . 0.0 110.734 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.31 127.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -58.45 -51.66 68.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.557 0.743 . . . . 0.0 109.355 -170.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.41 -54.89 40.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.637 1.175 . . . . 0.0 108.73 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.381 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -64.73 -58.05 7.33 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.712 0.687 . . . . 0.0 109.469 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.37 -46.65 85.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' A' ' 46' ' ' LEU . 50.4 t80 -59.5 -51.65 68.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.067 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 tt -53.34 -52.12 60.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.103 0.961 . . . . 0.0 109.547 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.8 -37.04 80.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.906 0.882 . . . . 0.0 110.961 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -56.51 -46.53 80.51 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.317 1.447 . . . . 0.0 109.995 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 50.9 mt -67.7 -35.57 79.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.578 0.751 . . . . 0.0 110.784 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.3 -55.36 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -59.5 -38.19 80.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.397 0.544 . . . . 0.0 112.363 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -24.92 66.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.853 1.261 . . . . 0.0 112.383 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 9.0 60.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.531 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.75 -34.76 24.76 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.351 1.076 . . . . 0.0 111.263 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.26 147.76 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -128.17 157.01 41.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.51 1.124 . . . . 0.0 109.759 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mm -78.63 135.06 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.85 127.83 7.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.828 0.851 . . . . 0.0 111.756 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -106.03 154.93 39.21 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.735 1.614 . . . . 0.0 112.17 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.82 163.33 28.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.12 3.88 . . . . 0.0 114.457 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -90.81 166.57 13.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.662 1.985 . . . . 0.0 109.457 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tmpt? -50.17 -44.45 52.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.129 1.372 . . . . 0.0 110.295 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -71.39 -27.58 63.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.989 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.434 ' HG ' ' CG ' ' A' ' 91' ' ' GLU . 4.1 m -66.09 -48.98 69.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.265 0.626 . . . . 0.0 109.664 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.26 -42.09 93.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.51 -33.14 74.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.225 0.466 . . . . 0.0 111.221 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -43.37 61.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.641 1.176 . . . . 0.0 110.307 174.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.21 -44.18 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 119.336 0.971 . . . . 0.0 108.547 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.61 -39.88 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.404 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -57.01 -68.2 0.24 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.5 1.143 . . . . 0.0 109.14 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.39 -29.81 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.091 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.22 60.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.917 . . . . 0.0 111.643 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -25.99 67.7 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.081 -1.012 . . . . 0.0 111.563 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.98 -52.72 63.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.139 0.882 . . . . 0.0 109.088 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -75.57 -39.96 57.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.36 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.55 -76.54 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.532 1.06 . . . . 0.0 113.52 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.01 92.0 0.91 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 122.02 0.914 . . . . 0.0 110.213 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.91 -44.08 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.541 0.736 . . . . 0.0 112.784 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -131.18 12.91 5.13 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.753 0.421 . . . . 0.0 110.899 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.03 -8.31 55.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.25 156.69 23.0 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.267 -0.895 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.77 159.21 19.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.921 1.289 . . . . 0.0 110.605 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -57.9 7.87 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.42 -39.14 75.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 123.959 0.787 . . . . 0.0 111.055 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.68 -52.4 65.61 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 109.729 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.53 -46.35 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.5 -49.64 58.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.638 0.654 . . . . 0.0 112.722 -172.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.58 -50.72 79.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -55.47 -58.57 7.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.15 0.98 . . . . 0.0 109.288 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.44 -55.89 8.08 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.931 1.292 . . . . 0.0 112.005 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.08 -48.07 81.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.295 1.038 . . . . 0.0 110.364 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.19 74.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.242 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.508 ' HH ' HG23 ' A' ' 106' ' ' ILE . 11.4 m-30 -67.76 -27.95 67.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.679 0.672 . . . . 0.0 111.213 -177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.434 ' CG ' ' HG ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -70.54 -30.05 66.69 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.281 0.946 . . . . 0.0 110.89 170.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.69 -14.82 38.85 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.718 1.207 . . . . 0.0 112.284 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.72 0.75 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.149 1.38 . . . . 0.0 111.425 -162.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.97 -162.79 13.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -101.67 167.92 9.8 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 109.043 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.62 150.8 32.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 125.181 1.393 . . . . 0.0 107.3 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.88 124.82 25.6 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.255 1.822 . . . . 0.0 106.29 170.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 t -152.31 -150.21 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.708 2.003 . . . . 0.0 106.884 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.01 -23.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.768 1.167 . . . . 0.0 113.401 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.91 140.73 47.68 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.901 1.681 . . . . 0.0 113.483 -156.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.41 -38.57 54.22 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.057 -1.652 . . . . 0.0 113.257 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.07 -47.79 60.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 111.341 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -37.04 56.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.046 1.294 . . . . 0.0 110.38 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -68.84 -39.55 79.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -63.94 -56.29 16.33 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.401 0.68 . . . . 0.0 110.324 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.508 HG23 ' HH ' ' A' ' 90' ' ' TYR . 13.8 mm -54.55 -52.67 38.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.494 1.043 . . . . 0.0 109.851 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.71 73.11 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.522 1.51 . . . . 0.0 113.298 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 t -55.8 -62.12 1.91 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.954 172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -25.38 68.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.368 1.44 . . . . 0.0 111.927 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.439 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -83.33 -10.16 58.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.78 82.22 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.563 -1.132 . . . . 0.0 113.879 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.22 135.51 33.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.497 1.648 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.37 131.76 35.3 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.613 1.965 . . . . 0.0 110.435 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.98 -175.28 5.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.664 -0.647 . . . . 0.0 110.986 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -98.98 175.28 5.98 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.161 1.384 . . . . 0.0 114.239 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p -142.24 115.22 8.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.96 1.304 . . . . 0.0 110.423 171.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -61.83 -60.68 3.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.153 0.981 . . . . 0.0 109.181 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -77.32 178.59 7.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.618 1.167 . . . . 0.0 109.149 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -53.18 141.39 23.45 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.18 -0.95 . . . . 0.0 108.633 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.6 98.25 0.11 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 104.991 -3.244 . . . . 0.0 104.991 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 pt -67.88 155.67 7.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.041 0.936 . . . . 0.0 110.226 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -138.15 -26.18 0.93 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.768 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -141.87 24.44 2.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.164 1.347 . . . . 0.0 112.663 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.61 150.3 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.21 159.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -63.03 151.53 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.074 -1.016 . . . . 0.0 109.664 169.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -157.01 171.56 20.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.947 0.499 . . . . 0.0 109.924 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -0.3 0.11 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.63 150.06 44.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.665 1.575 . . . . 0.0 111.613 -169.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.79 128.42 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.842 1.257 . . . . 0.0 109.436 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.1 t -65.91 144.15 56.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 166.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.23 94.92 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.09 -90.78 0.1 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.97 13.24 17.19 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.183 0.993 . . . . 0.0 111.367 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.09 22.93 61.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.013 1.292 . . . . 0.0 115.122 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -65.46 125.78 26.22 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 110.056 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -72.78 150.99 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.938 0.773 . . . . 0.0 109.873 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.31 149.69 38.16 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.501 1.12 . . . . 0.0 109.229 166.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.9 t -86.11 -26.98 24.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.135 0.574 . . . . 0.0 111.674 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.7 p -145.3 160.02 42.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.392 1.477 . . . . 0.0 108.238 -171.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -74.57 123.42 89.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.49 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.91 172.06 15.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.858 2.372 . . . . 0.0 110.206 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.1 137.4 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 121.918 1.745 . . . . 0.0 110.269 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.59 -9.79 1.69 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.544 1.069 . . . . 0.0 114.172 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.8 35.77 87.67 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.87 1.335 . . . . 0.0 111.724 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.56 158.2 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.383 1.073 . . . . 0.0 108.121 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.8 t -71.08 113.03 15.69 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 117.252 -1.356 . . . . 0.0 108.082 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.36 -18.81 25.96 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.51 1.474 . . . . 0.0 113.189 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -27.15 15.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.088 1.755 . . . . 0.0 111.882 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.7 p -140.4 -2.77 1.39 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.43 -13.9 2.66 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.464 1.983 . . . . 0.0 115.317 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 163.1 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.177 1.489 . . . . 0.0 111.789 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.11 154.34 41.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.524 0.678 . . . . 0.0 109.768 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.8 t -108.17 148.48 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -129.96 160.8 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.335 1.054 . . . . 0.0 110.697 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.45 116.56 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.082 1.353 . . . . 0.0 107.803 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.5 168.41 24.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.459 1.104 . . . . 0.0 111.657 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.48 59.76 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.885 3.724 . . . . 0.0 112.24 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 56.27 -166.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.705 1.602 . . . . 0.0 110.884 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 -35.94 0.53 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.143 2.177 . . . . 0.0 113.376 -166.235 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.94 110.76 16.67 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.955 2.102 . . . . 0.0 106.336 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -133.62 83.8 2.08 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.779 1.172 . . . . 0.0 108.12 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -152.37 -63.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.769 1.168 . . . . 0.0 109.439 -177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.9 149.17 37.14 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.97 -34.36 5.44 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -155.24 179.72 8.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.8 m -63.48 125.61 24.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -146.37 134.41 21.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.65 152.39 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.72 135.32 50.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.369 2.267 . . . . 0.0 109.409 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.33 161.36 14.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.97 2.108 . . . . 0.0 110.941 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -46.38 -45.17 17.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.399 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -52.19 -35.35 48.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.871 0.868 . . . . 0.0 111.92 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.18 -35.87 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.144 0.978 . . . . 0.0 109.626 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.2 -37.6 25.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.66 0.784 . . . . 0.0 111.025 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.92 -41.95 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.975 0.91 . . . . 0.0 109.205 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -79.13 -13.92 59.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 24.42 65.1 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.274 0.94 . . . . 0.0 113.864 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -78.82 108.19 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 C-N-CA 124.557 1.143 . . . . 0.0 108.417 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.05 111.75 3.52 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tp -154.45 159.62 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 127.348 2.259 . . . . 0.0 106.756 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -128.24 128.62 45.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.641 1.176 . . . . 0.0 110.498 -166.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.13 -147.65 9.08 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.236 1.398 . . . . 0.0 111.943 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.96 158.1 24.65 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.11 1.764 . . . . 0.0 110.144 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -145.74 166.29 26.3 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -90.09 125.56 60.01 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.619 0.724 . . . . 0.0 111.618 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.07 -12.58 30.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.235 1.29 . . . . 0.0 111.163 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -32.94 67.39 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 126.873 2.069 . . . . 0.0 112.698 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -92.8 -34.37 5.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 120.267 1.394 . . . . 0.0 110.632 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.49 -16.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.849 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.392 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.65 -21.69 10.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.461 1.904 . . . . 0.0 110.799 -166.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 mt -67.81 96.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -90.45 -24.76 20.62 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 112.117 165.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.26 129.2 24.12 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.304 1.842 . . . . 0.0 111.549 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -51.4 -72.01 0.06 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 126.208 1.803 . . . . 0.0 110.535 -170.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.98 -48.02 83.76 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -164.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.8 t -50.48 -56.37 11.88 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.988 1.715 . . . . 0.0 110.088 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -61.4 -53.91 50.46 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.358 1.063 . . . . 0.0 110.61 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.5 mt -55.67 -50.17 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.27 1.028 . . . . 0.0 108.621 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.17 -48.41 80.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.7 -48.5 77.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.04 -1.037 . . . . 0.0 110.456 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.43 -40.87 92.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.997 0.919 . . . . 0.0 110.61 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 t -57.68 -51.1 70.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.166 1.386 . . . . 0.0 110.425 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.14 -38.08 89.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.809 0.843 . . . . 0.0 110.616 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.02 -50.97 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.7 t -59.54 -35.82 74.94 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.456 0.702 . . . . 0.0 111.015 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.17 -11.59 59.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.266 1.426 . . . . 0.0 112.725 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.44 87.1 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.721 1.153 . . . . 0.0 113.443 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -78.42 -19.71 52.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.188 0.995 . . . . 0.0 112.07 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.43 136.78 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -125.72 140.9 52.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.52 0.676 . . . . 0.0 110.398 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.48 126.64 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.04 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.37 127.4 9.71 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.102 1.361 . . . . 0.0 109.212 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -99.57 155.05 36.93 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.505 0.722 . . . . 0.0 112.77 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.03 173.75 8.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.23 3.954 . . . . 0.0 112.235 165.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.08 173.16 8.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.887 2.075 . . . . 0.0 110.151 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -54.1 -49.86 68.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.833 -0.542 . . . . 0.0 110.251 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.08 -31.04 71.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.348 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -51.98 53.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.177 0.991 . . . . 0.0 110.31 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.27 -45.68 97.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.36 -39.9 70.64 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.661 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -45.63 46.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.415 1.486 . . . . 0.0 110.556 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.42 -46.85 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.3 mt -53.17 -43.41 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.317 1.047 . . . . 0.0 110.339 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.55 -57.52 12.4 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.571 0.623 . . . . 0.0 110.199 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.74 -37.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.9 71.97 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.411 1.084 . . . . 0.0 111.482 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -35.14 80.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.928 1.24 . . . . 0.0 111.164 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.86 -42.72 94.63 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.741 0.7 . . . . 0.0 110.715 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 t -80.98 -41.03 23.42 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.183 0.447 . . . . 0.0 111.94 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.32 146.18 6.37 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.787 1.661 . . . . 0.0 109.045 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 83.05 50.59 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 130.39 3.476 . . . . 0.0 109.21 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.48 -52.76 48.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 121.153 -0.967 . . . . 0.0 113.413 -170.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.09 11.02 15.17 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.083 0.553 . . . . 0.0 110.528 -167.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -20.74 32.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.534 0.734 . . . . 0.0 112.199 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -73.64 150.78 41.1 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.5 m -58.98 152.17 20.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.299 1.047 . . . . 0.0 110.812 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -59.19 4.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.58 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.56 77.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.888 0.743 . . . . 0.0 111.737 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.97 -55.25 37.1 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.173 0.989 . . . . 0.0 108.522 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.5 -43.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.838 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -65.49 -51.55 59.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.447 0.567 . . . . 0.0 111.435 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.27 -48.83 83.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.322 1.049 . . . . 0.0 109.301 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.1 mt -58.22 -57.45 12.82 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.941 0.897 . . . . 0.0 109.614 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.8 64.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.177 1.391 . . . . 0.0 112.663 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.06 -49.35 78.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.487 1.115 . . . . 0.0 109.167 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.98 75.12 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.709 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.497 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.6 m-30 -69.97 -26.3 64.03 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.109 0.868 . . . . 0.0 110.288 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.41 -7.09 51.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.316 1.046 . . . . 0.0 112.4 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.39 -10.61 8.43 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.266 1.427 . . . . 0.0 112.142 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.9 mttt 51.97 34.84 14.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 110.533 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.59 -130.37 6.66 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.712 1.149 . . . . 0.0 110.456 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -133.85 170.38 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.611 1.964 . . . . 0.0 109.917 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.99 153.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 126.207 1.803 . . . . 0.0 106.489 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.47 115.89 16.08 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 109.289 166.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 t -157.58 -172.53 4.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.061 3.344 . . . . 0.0 108.394 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.91 6.45 0.7 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -168.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.507 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.5 t0 -102.19 160.54 14.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.168 1.349 . . . . 0.0 111.96 -157.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -64.75 -48.55 74.15 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.51 -1.369 . . . . 0.0 111.636 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -69.33 -48.35 61.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.714 1.206 . . . . 0.0 109.78 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.507 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -56.53 -43.55 78.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -172.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.86 -47.79 79.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.32 0.648 . . . . 0.0 110.154 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -56.08 -59.93 4.21 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.196 1.798 . . . . 0.0 108.226 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.16 -53.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 119.753 1.161 . . . . 0.0 111.254 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.37 67.71 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.367 1.44 . . . . 0.0 112.204 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -57.74 10.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -21.92 64.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.15 1.341 . . . . 0.0 111.629 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.8 mm? -81.82 -22.15 37.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.473 0.709 . . . . 0.0 111.454 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.5 9.9 71.5 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.563 1.554 . . . . 0.0 114.232 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.22 123.86 29.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.853 1.327 . . . . 0.0 110.374 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 135.02 55.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.565 1.546 . . . . 0.0 109.05 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -151.23 175.27 12.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -107.35 166.51 10.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.62 155.49 44.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.97 -168.55 0.29 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.794 0.837 . . . . 0.0 109.859 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.24 88.92 0.09 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.678 1.591 . . . . 0.0 109.221 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -55.77 -20.96 16.74 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.737 1.615 . . . . 0.0 112.968 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.3 -128.83 3.13 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.09 157.25 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.237 1.415 . . . . 0.0 107.648 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -64.53 0.69 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.66 0.784 . . . . 0.0 109.195 167.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -135.77 65.53 1.54 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.94 152.15 14.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -71.12 168.22 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -55.81 -179.78 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.562 1.545 . . . . 0.0 111.023 158.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -150.34 154.38 37.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -149.82 9.71 0.7 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 117.352 -1.309 . . . . 0.0 113.532 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -133.96 138.94 45.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.907 1.231 . . . . 0.0 111.381 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.39 134.54 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.074 1.35 . . . . 0.0 109.298 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 122.06 24.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.071 0.949 . . . . 0.0 108.541 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.79 108.11 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.12 -80.66 0.2 Allowed Glycine 0 N--CA 1.458 0.136 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.5 p -88.45 -16.76 31.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.14 0.47 . . . . 0.0 111.885 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.11 32.5 43.78 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.546 0.593 . . . . 0.0 113.075 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HD3' ' CZ ' ' A' ' 138' ' ' PHE . 42.5 ttt-85 -70.14 157.6 37.31 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 117.875 0.837 . . . . 0.0 109.772 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -101.32 146.63 27.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.353 1.461 . . . . 0.0 108.838 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CZ ' ' HD3' ' A' ' 136' ' ' ARG . 97.4 m-85 -140.02 148.3 41.64 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.974 1.31 . . . . 0.0 108.321 169.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 t -94.22 -23.61 17.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.672 0.789 . . . . 0.0 110.566 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.9 p -136.97 157.64 46.27 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.615 0.766 . . . . 0.0 109.856 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.59 110.47 9.78 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.62 172.02 12.21 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.918 3.079 . . . . 0.0 110.536 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.81 120.02 7.51 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.012 1.808 . . . . 0.0 109.632 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.47 -6.89 81.12 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.079 1.324 . . . . 0.0 113.417 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.48 38.54 93.7 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 119.255 1.528 . . . . 0.0 112.43 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -116.11 174.94 3.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 124.694 1.198 . . . . 0.0 108.397 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.444 ' C ' ' H ' ' A' ' 149' ' ' ASP . 49.7 t -89.19 100.31 2.13 Favored Pre-proline 0 CA--C 1.519 -0.239 0 CA-C-N 120.849 1.659 . . . . 0.0 109.355 174.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.14 37.49 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.932 3.754 . . . . 0.0 113.946 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.3 OUTLIER -151.01 -16.08 0.21 Allowed 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.38 2.272 . . . . 0.0 112.004 -175.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.8 p -146.73 -31.57 0.34 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.23 92.49 0.96 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.904 1.716 . . . . 0.0 111.128 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.43 174.01 2.85 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.638 1.975 . . . . 0.0 108.042 170.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -76.3 137.63 40.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.03 1.287 . . . . 0.0 111.958 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.35 157.94 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 156.62 44.07 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.699 -1.25 . . . . 0.0 110.969 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.24 146.08 35.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.672 0.789 . . . . 0.0 109.149 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 pt -114.02 163.27 19.34 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 93.34 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.49 2.794 . . . . 0.0 111.209 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 61.84 -175.74 0.13 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.122 1.369 . . . . 0.0 110.58 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.418 ' O ' ' HE3' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -69.38 -27.12 65.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.898 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 124.19 0.996 . . . . 0.0 109.615 -146.732 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttp . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp 43.4 71.52 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.585 1.954 . . . . 0.0 111.653 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -138.81 99.78 3.88 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.31 -39.36 92.38 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.869 -176.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -150.05 -45.7 0.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.032 0.833 . . . . 0.0 110.201 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.94 -164.52 1.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.861 2.065 . . . . 0.0 109.796 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -59.29 159.48 7.73 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.724 -0.61 . . . . 0.0 111.545 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -50.58 125.94 14.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.593 1.557 . . . . 0.0 109.043 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -144.44 142.54 30.37 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.57 148.56 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.18 133.85 53.45 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.464 1.506 . . . . 0.0 108.905 -171.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.52 161.81 20.09 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.88 1.672 . . . . 0.0 111.861 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -45.75 11.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.951 1.7 . . . . 0.0 111.822 171.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.0 p -61.54 -31.73 71.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.334 0.515 . . . . 0.0 111.938 -174.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 t -61.75 -42.56 94.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.656 1.182 . . . . 0.0 109.33 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.53 -37.32 71.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.663 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 91.3 mt -55.31 -54.43 25.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.07 -26.17 65.71 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.84 0.746 . . . . 0.0 111.461 -173.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 42' ' ' PHE . . . 91.23 37.25 6.31 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.79 108.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.35 112.61 7.62 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.33 174.37 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.082 1.353 . . . . 0.0 107.778 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -120.4 149.79 41.8 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.547 1.539 . . . . 0.0 108.339 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.74 -137.64 5.96 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.39 153.5 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.589 1.155 . . . . 0.0 110.452 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -129.38 144.63 51.32 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.522 1.129 . . . . 0.0 109.8 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.9 p -84.38 121.3 75.14 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 124.757 1.223 . . . . 0.0 109.804 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -65.42 -14.14 43.39 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.62 1.547 . . . . 0.0 113.665 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -74.75 -44.11 51.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.32 -36.11 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 119.402 1.001 . . . . 0.0 109.269 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.21 -20.16 26.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 118.855 -1.138 . . . . 0.0 113.358 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.09 -25.3 68.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.249 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.94 -30.23 65.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.323 1.049 . . . . 0.0 109.893 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.96 82.56 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.973 2.109 . . . . 0.0 109.49 -164.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -20.17 60.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.215 1.406 . . . . 0.0 112.179 169.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.01 133.22 47.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.844 0.858 . . . . 0.0 110.89 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.3 mmt-85 -61.83 -59.65 4.83 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.96 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.19 -45.52 91.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 118.261 -0.876 . . . . 0.0 108.998 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 t -55.9 -56.23 23.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.276 0.63 . . . . 0.0 110.75 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -60.14 -51.43 69.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.624 1.102 . . . . 0.0 111.585 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.21 -57.62 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CE2' ' HA2' ' A' ' 19' ' ' GLY . 68.4 t80 -56.46 -45.68 80.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.139 0.976 . . . . 0.0 112.219 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tt -54.48 -52.48 61.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.11 0.964 . . . . 0.0 108.525 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -70.48 -28.03 64.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.707 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -61.44 -50.27 73.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.422 1.01 . . . . 0.0 108.548 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -42.73 80.93 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.675 1.19 . . . . 0.0 111.402 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.83 -56.56 17.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -28.52 69.24 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.98 -13.2 60.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.397 1.479 . . . . 0.0 112.103 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.94 -6.7 51.87 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.603 1.573 . . . . 0.0 113.784 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -87.12 -23.42 24.87 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 118.486 1.143 . . . . 0.0 112.99 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.49 149.48 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 120.666 1.575 . . . . 0.0 107.457 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -135.16 156.73 48.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.709 -0.619 . . . . 0.0 111.007 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.35 131.52 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.87 0.868 . . . . 0.0 108.99 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.12 128.19 6.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.847 1.259 . . . . 0.0 110.036 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.33 158.82 32.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.163 0.985 . . . . 0.0 112.584 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -75.34 145.47 30.36 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.238 3.292 . . . . 0.0 112.891 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -65.01 155.35 34.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.156 0.982 . . . . 0.0 109.947 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -65.82 -36.11 82.56 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.904 -1.123 . . . . 0.0 109.479 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -21.74 64.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.973 0.806 . . . . 0.0 111.204 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 p -85.03 -38.17 19.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.102 0.864 . . . . 0.0 112.755 172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.47 1.032 . . . . 0.0 108.263 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -28.32 64.28 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.816 0.446 . . . . 0.0 111.451 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.69 98.72 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.548 -0.72 . . . . 0.0 111.741 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -46.29 84.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -57.27 -28.77 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.737 0.698 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.11 -72.77 0.15 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.215 1.371 . . . . 0.0 108.962 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.62 -36.61 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.508 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.81 92.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.155 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -27.2 61.59 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 121.692 2.042 . . . . 0.0 112.129 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.11 -52.3 59.83 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -69.87 -42.81 72.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.335 0.654 . . . . 0.0 111.586 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.9 -66.02 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.958 0.799 . . . . 0.0 112.452 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -71.47 45.96 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.848 2.859 . . . . 0.0 114.648 -165.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -40.33 -44.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 128.177 2.591 . . . . 0.0 115.988 -167.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -131.31 11.54 4.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.023 0.929 . . . . 0.0 110.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -12.77 61.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.153 0.581 . . . . 0.0 110.503 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 174.3 8.64 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.685 1.194 . . . . 0.0 110.183 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -68.11 154.0 42.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.798 1.285 . . . . 0.0 110.979 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -54.2 -52.6 60.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.137 1.375 . . . . 0.0 110.786 162.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.477 ' N ' ' HE3' ' A' ' 80' ' ' LYS . . . -63.47 -35.79 81.62 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 123.573 0.546 . . . . 0.0 109.566 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.7 -53.99 46.08 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -52.16 -40.05 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.042 0.937 . . . . 0.0 109.311 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.31 -54.93 10.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.404 1.002 . . . . 0.0 113.325 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.64 -50.18 74.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.803 1.241 . . . . 0.0 109.11 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.43 -56.01 27.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.596 1.158 . . . . 0.0 109.62 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.99 -56.38 6.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.463 1.105 . . . . 0.0 111.252 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -48.93 73.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 123.776 0.672 . . . . 0.0 110.051 -174.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.32 72.32 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.212 -0.93 . . . . 0.0 113.174 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.531 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.7 m-30 -73.08 -30.5 63.73 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.931 0.787 . . . . 0.0 110.477 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -31.64 69.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.51 1.124 . . . . 0.0 110.171 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.65 -12.45 21.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.428 1.891 . . . . 0.0 112.738 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.65 28.61 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.836 1.255 . . . . 0.0 112.065 -167.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.25 -144.17 13.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -115.06 166.3 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.912 2.085 . . . . 0.0 109.732 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.9 mt -131.99 160.96 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.26 114.07 13.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 164.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 t -165.36 162.28 19.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -152.48 26.39 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.825 -1.172 . . . . 0.0 112.829 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t0 -88.53 158.52 18.28 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.792 -1.193 . . . . 0.0 110.982 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -62.58 -49.5 75.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.994 1.27 . . . . 0.0 110.083 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -70.58 -46.99 62.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.06 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -60.63 -33.9 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.302 0.955 . . . . 0.0 109.716 -171.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -70.4 -38.95 74.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.41 0.684 . . . . 0.0 109.966 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -68.32 -54.95 13.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.78 -54.79 8.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.464 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.68 -41.78 67.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.822 1.646 . . . . 0.0 113.58 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -54.79 -60.07 3.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.643 0.777 . . . . 0.0 112.023 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -21.12 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.174 1.352 . . . . 0.0 112.613 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.531 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -81.83 3.1 27.26 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.416 1.087 . . . . 0.0 111.986 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.15 29.06 64.96 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.066 -1.408 . . . . 0.0 112.325 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.53 126.24 52.28 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.173 1.487 . . . . 0.0 111.645 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 126.13 30.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.657 1.183 . . . . 0.0 109.138 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -131.22 -170.13 2.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.489 1.516 . . . . 0.0 109.043 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.94 149.17 52.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.4 p -108.31 -174.86 2.62 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 125.073 1.483 . . . . 0.0 109.161 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -148.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.935 2.094 . . . . 0.0 111.119 -173.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 tttm 42.26 80.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.917 2.487 . . . . 0.0 112.139 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.88 156.98 3.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.939 0.896 . . . . 0.0 109.104 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.59 40.67 1.35 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.296 1.427 . . . . 0.0 112.17 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.3 mm 57.55 154.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 130.251 3.42 . . . . 0.0 113.012 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -143.07 -61.67 0.42 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.782 -1.199 . . . . 0.0 108.491 162.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.45 -4.85 15.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 125' ' ' ILE . 1.5 t -101.23 -175.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 126.054 1.742 . . . . 0.0 107.248 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 ' H ' HG12 ' A' ' 124' ' ' VAL 0.281 16.8 mt 29.27 77.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 129.495 3.118 . . . . 0.0 113.066 176.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 81.53 1.67 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.852 1.661 . . . . 0.0 108.717 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.483 ' CZ3' HD12 ' A' ' 157' ' ' ILE . 5.1 p-90 -54.69 141.01 33.78 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.287 2.235 . . . . 0.0 111.725 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.9 mtm-85 -141.72 24.92 2.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.171 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -145.06 139.91 27.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.094 1.77 . . . . 0.0 111.426 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.34 130.76 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.845 1.658 . . . . 0.0 107.501 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.86 120.63 16.74 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 162.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.09 127.68 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.42 -75.32 0.38 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 4.4 p -80.4 -8.04 59.36 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.138 0.469 . . . . 0.0 112.196 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.61 37.01 92.74 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.153 1.359 . . . . 0.0 112.637 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -77.46 137.42 38.66 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.578 -0.954 . . . . 0.0 108.726 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.79 144.07 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.547 1.139 . . . . 0.0 108.71 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.37 151.75 45.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.085 1.754 . . . . 0.0 107.814 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.6 t -111.82 -7.93 14.16 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.887 -0.508 . . . . 0.0 110.502 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 p -136.05 156.4 48.78 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.824 -1.173 . . . . 0.0 109.755 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.4 tp -74.53 120.11 79.88 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -65.67 169.03 13.63 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.412 2.075 . . . . 0.0 110.087 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.77 112.8 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 111.343 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.74 -5.02 83.77 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.407 1.479 . . . . 0.0 113.116 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.81 45.42 95.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.455 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.91 154.11 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.14 113.71 19.91 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.361 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.27 7.48 2.55 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.146 2.564 . . . . 0.0 112.551 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -117.51 -23.71 7.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.78 1.632 . . . . 0.0 113.02 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.8 -24.0 1.16 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.58 79.17 0.52 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -155.4 170.66 21.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.871 0.868 . . . . 0.0 109.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -82.28 132.37 35.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.869 0.842 . . . . 0.0 109.653 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.77 142.89 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.21 170.86 15.3 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.086 1.354 . . . . 0.0 109.528 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.67 153.12 43.99 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.058 1.343 . . . . 0.0 110.825 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.483 HD12 ' CZ3' ' A' ' 127' ' ' TRP . 19.5 mm -75.24 152.07 85.93 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.517 1.527 . . . . 0.0 110.284 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.17 88.1 0.59 Allowed 'Trans proline' 0 N--CA 1.431 -2.149 0 O-C-N 123.138 1.073 . . . . 0.0 110.072 164.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 39.14 78.4 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.792 2.837 . . . . 0.0 113.563 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -52.2 65.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.065 0.936 . . . . 0.0 110.63 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 . . . . . 0 C--O 1.251 1.148 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 168.367 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 mmt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 120.218 0.056 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.45 64.31 0.84 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.117 0.967 . . . . 0.0 110.161 -160.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.15 158.55 43.66 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 159.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -138.81 111.15 7.45 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.84 168.21 25.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.489 0.716 . . . . 0.0 110.806 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -53.9 1.29 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.286 . . . . 0.0 108.384 162.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -137.58 166.36 24.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.768 0.827 . . . . 0.0 109.95 167.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.1 m -55.78 122.99 12.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 tt -145.65 145.12 30.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.57 161.93 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 124.45 1.094 . . . . 0.0 109.624 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 mt -137.57 145.91 43.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.989 1.715 . . . . 0.0 108.513 -167.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.38 163.05 12.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.912 1.285 . . . . 0.0 112.049 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -51.21 -41.25 60.14 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.35 1.06 . . . . 0.0 111.77 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -67.08 -27.11 67.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.614 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.57 -44.08 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.12 -35.65 74.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.615 0.766 . . . . 0.0 110.773 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.74 -48.56 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.169 0.441 . . . . 0.0 110.21 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -72.82 -27.66 62.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.135 0.425 . . . . 0.0 110.196 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.96 38.9 10.71 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.05 112.23 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.28 92.88 1.83 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.966 1.307 . . . . 0.0 109.366 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 148.78 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.24 1.416 . . . . 0.0 108.42 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -112.34 125.1 53.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 -168.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.98 -179.06 47.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.287 0.949 . . . . 0.0 112.642 -171.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -78.67 152.77 31.46 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.139 -1.212 . . . . 0.0 110.363 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 t -137.1 160.44 38.95 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.784 2.034 . . . . 0.0 108.928 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.67 124.4 52.86 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 125.201 1.4 . . . . 0.0 109.337 -169.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.1 -22.33 55.43 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.783 1.655 . . . . 0.0 111.4 169.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -78.42 -17.08 56.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.656 1.982 . . . . 0.0 114.533 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.26 -33.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.23 1.377 . . . . 0.0 111.783 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -63.51 -15.55 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.767 1.167 . . . . 0.0 111.634 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -63.75 -18.87 64.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.653 -1.28 . . . . 0.0 113.567 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -101.28 -27.34 13.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 0.0 111.26 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.6 mt -62.7 102.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -13.0 6.89 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.058 0.943 . . . . 0.0 112.284 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.75 124.21 19.77 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -59.45 -36.95 76.92 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.984 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -55.02 -58.13 8.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.04 -41.05 91.39 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.46 1.904 . . . . 0.0 111.508 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -69.79 -52.38 25.67 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.38 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -46.76 -51.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.42 -63.2 1.27 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.019 0.927 . . . . 0.0 110.97 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 tp -48.54 -50.64 31.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.407 1.483 . . . . 0.0 112.879 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.31 -41.75 89.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.941 0.896 . . . . 0.0 110.851 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 m -63.27 -43.56 97.58 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.754 0.422 . . . . 0.0 109.926 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.5 99.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 0.0 110.593 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.44 -46.96 94.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -61.48 -46.48 89.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.178 0.991 . . . . 0.0 110.37 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.22 -5.38 38.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.455 1.502 . . . . 0.0 112.179 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.66 19.88 76.88 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 121.001 -1.062 . . . . 0.0 112.024 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -64.72 -38.83 92.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 164.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.78 150.75 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -136.78 147.41 46.62 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.001 0.92 . . . . 0.0 110.165 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.66 123.95 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.87 135.4 17.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.823 1.249 . . . . 0.0 108.517 170.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.3 155.59 37.61 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.411 0.684 . . . . 0.0 110.647 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.51 165.5 17.7 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.831 3.021 . . . . 0.0 112.628 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -81.84 158.5 24.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 164.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -39.04 74.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.541 -0.724 . . . . 0.0 111.539 170.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -29.15 70.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.127 -0.463 . . . . 0.0 111.281 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -65.43 -51.76 57.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.049 1.34 . . . . 0.0 108.238 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.32 -49.26 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.294 0.638 . . . . 0.0 109.908 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -59.39 -38.99 81.95 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.013 -0.429 . . . . 0.0 110.56 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -37.66 68.42 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.424 -0.797 . . . . 0.0 111.734 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.85 -53.44 30.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt -49.77 -36.53 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.548 1.139 . . . . 0.0 111.281 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -57.76 -69.4 0.17 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.672 0.789 . . . . 0.0 109.655 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.76 -31.64 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.136 -0.353 . . . . 0.0 110.405 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.34 75.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.416 1.487 . . . . 0.0 111.076 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -32.88 73.34 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.097 -1.002 . . . . 0.0 110.63 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.83 4.25 2.68 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.304 -0.873 . . . . 0.0 111.773 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 t -126.74 -3.29 6.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.263 1.392 . . . . 0.0 112.632 166.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.06 -86.08 0.39 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.159 1.838 . . . . 0.0 110.365 170.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -64.99 70.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 129.658 3.183 . . . . 0.0 112.369 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.73 -48.89 84.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.336 1.854 . . . . 0.0 113.284 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -123.1 7.8 9.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.903 0.881 . . . . 0.0 109.782 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -6.73 44.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.727 1.611 . . . . 0.0 112.581 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.26 162.37 16.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.297 1.039 . . . . 0.0 109.492 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 t -61.77 147.42 46.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.079 0.951 . . . . 0.0 108.958 168.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.43 ' HZ2' ' CD ' ' A' ' 84' ' ' GLU . 3.9 ttpp -61.24 -44.39 97.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.05 -38.6 68.2 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.686 0.616 . . . . 0.0 110.012 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -63.48 -56.86 12.78 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.383 1.473 . . . . 0.0 110.742 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.35 -40.25 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.465 1.506 . . . . 0.0 109.247 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' CD ' ' HZ2' ' A' ' 80' ' ' LYS . 77.1 mt-10 -69.07 -46.61 67.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 113.173 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.58 -52.54 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 mt -54.51 -55.07 32.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.164 1.386 . . . . 0.0 109.114 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.27 -51.66 57.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.496 1.518 . . . . 0.0 112.616 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.6 tp -50.67 -51.93 44.66 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.34 -17.17 58.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -86.31 -37.43 18.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.459 0.704 . . . . 0.0 110.676 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.27 -42.92 64.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.669 1.187 . . . . 0.0 110.587 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.19 6.26 24.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.916 1.686 . . . . 0.0 111.645 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 43.27 52.82 5.61 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.635 1.974 . . . . 0.0 111.159 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 -119.9 3.89 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.838 1.209 . . . . 0.0 110.675 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -153.57 169.01 24.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.892 1.677 . . . . 0.0 106.682 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.5 mt -133.91 160.25 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.58 114.38 13.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 167.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 p -169.16 145.72 3.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.377 1.071 . . . . 0.0 108.945 -158.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -143.44 -6.5 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.059 1.754 . . . . 0.0 115.014 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.45 149.17 5.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.03 1.332 . . . . 0.0 112.58 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -57.51 -38.37 74.5 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.692 -1.255 . . . . 0.0 112.374 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -55.02 12.5 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.813 1.245 . . . . 0.0 110.197 173.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -40.92 79.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.238 0.615 . . . . 0.0 110.647 -167.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.46 -40.79 98.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.54 -56.97 9.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.0 mm -52.25 -51.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.599 0.636 . . . . 0.0 110.326 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.95 72.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.161 1.346 . . . . 0.0 112.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -62.8 -58.24 8.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 117.668 -1.158 . . . . 0.0 111.171 175.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -31.57 70.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.329 1.422 . . . . 0.0 111.171 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -73.73 -30.29 62.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.137 0.575 . . . . 0.0 111.327 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.65 5.06 63.37 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.802 1.191 . . . . 0.0 114.108 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 118.05 22.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.649 1.224 . . . . 0.0 109.387 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 140.92 58.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.3 -178.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.166 0.986 . . . . 0.0 109.743 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -115.61 145.16 42.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.189 1.396 . . . . 0.0 109.792 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -111.34 169.94 8.45 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.337 1.055 . . . . 0.0 110.519 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.82 -174.96 5.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.424 1.09 . . . . 0.0 110.053 166.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -76.48 62.1 1.83 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.408 1.883 . . . . 0.0 112.817 -173.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -73.36 -149.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.056 -1.027 . . . . 0.0 109.284 166.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.15 -4.55 75.86 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.12 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mm 59.84 99.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 127.253 2.221 . . . . 0.0 110.505 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -119.16 -13.2 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.125 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -145.19 -59.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.514 1.052 . . . . 0.0 110.331 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.44 148.05 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.474 0.71 . . . . 0.0 111.078 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 126' ' ' LYS . 1.4 mt -126.83 172.95 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.186 2.194 . . . . 0.0 105.77 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.401 ' H ' HG22 ' A' ' 125' ' ' ILE . 10.2 mmtp -143.72 111.43 6.03 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -54.01 161.87 1.12 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.474 2.309 . . . . 0.0 113.477 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -161.62 18.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -142.17 157.66 44.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.418 1.008 . . . . 0.0 111.83 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 p -142.89 137.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 124.75 1.22 . . . . 0.0 109.064 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.0 t -71.52 125.51 27.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.031 1.332 . . . . 0.0 108.206 163.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.37 118.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.96 -77.95 0.38 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.2 p -75.04 -3.54 33.13 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.52 0.66 . . . . 0.0 111.608 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.13 19.78 57.4 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.431 1.967 . . . . 0.0 114.146 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -77.68 137.68 38.65 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -170.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -74.34 148.35 41.4 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.03 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -140.14 134.68 31.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.939 1.296 . . . . 0.0 108.215 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -25.67 24.65 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.665 1.186 . . . . 0.0 111.137 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.6 p -147.04 173.8 12.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.692 1.997 . . . . 0.0 107.114 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 114.56 65.81 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -163.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.76 168.39 13.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.061 1.841 . . . . 0.0 110.484 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.63 142.28 95.66 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.356 2.037 . . . . 0.0 110.344 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.12 -7.61 0.77 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.236 0.922 . . . . 0.0 113.922 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.8 63.96 3.81 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 117.928 -1.485 . . . . 0.0 109.601 -156.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.08 149.14 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 16.2 t -72.05 112.72 15.51 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.797 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.92 -17.07 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 CA-C-N 121.499 1.571 . . . . 0.0 113.302 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.57 -29.33 13.93 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.392 1.877 . . . . 0.0 111.903 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.89 -3.79 1.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.47 -13.55 50.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.089 1.804 . . . . 0.0 115.472 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.87 162.47 25.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.764 1.782 . . . . 0.0 114.26 -168.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -68.43 135.3 51.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.806 -1.184 . . . . 0.0 112.66 -173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.45 140.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.697 1.199 . . . . 0.0 109.228 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.35 164.93 28.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.656 1.582 . . . . 0.0 110.691 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.22 141.13 32.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.509 1.524 . . . . 0.0 111.479 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.27 163.0 19.36 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.783 1.233 . . . . 0.0 112.471 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.07 69.35 3.13 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.734 3.623 . . . . 0.0 112.126 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 54.3 179.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.54 1.936 . . . . 0.0 113.762 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.9 -56.08 5.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 C--O 1.244 0.794 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -175.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 mtm . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 tp -89.23 47.97 1.56 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -175.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 65.38 -39.37 0.28 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.362 2.665 . . . . 0.0 114.22 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 m120 42.05 71.31 0.22 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 129.907 3.283 . . . . 0.0 111.933 164.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 167.19 22.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.064 0.945 . . . . 0.0 113.308 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.39 -178.96 6.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.351 1.46 . . . . 0.0 110.725 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -56.67 169.84 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.859 1.664 . . . . 0.0 114.179 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.5 m -57.86 130.28 45.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.4 tp -155.24 142.66 19.55 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -121.39 161.35 21.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -137.85 151.18 47.81 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.68 1.592 . . . . 0.0 107.525 -165.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -117.46 167.82 10.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.926 0.89 . . . . 0.0 111.601 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 p -49.0 -48.25 43.7 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.36 1.464 . . . . 0.0 110.805 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -50.85 -37.64 44.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.533 1.133 . . . . 0.0 111.622 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -62.88 -40.03 87.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.837 1.199 . . . . 0.0 110.194 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -76.15 -35.47 59.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.924 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.0 mt -56.74 -50.34 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.878 0.871 . . . . 0.0 109.787 171.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -68.42 -19.12 64.57 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.109 0.564 . . . . 0.0 111.531 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 33.8 42.88 Favored Glycine 0 N--CA 1.446 -0.689 0 O-C-N 121.458 -0.776 . . . . 0.0 111.601 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.5 mt -85.1 105.4 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 113.7 3.15 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.3 177.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.225 1.81 . . . . 0.0 106.536 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.65 138.94 44.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.245 1.818 . . . . 0.0 107.951 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.34 -144.63 8.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -125.82 149.78 48.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 t -130.52 149.01 52.39 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.05 1.74 . . . . 0.0 108.36 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 126.45 72.12 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 123.897 0.879 . . . . 0.0 108.996 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 -31.62 95.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 168.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -27.48 62.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.163 1.785 . . . . 0.0 114.934 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.0 -37.33 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 119.286 0.948 . . . . 0.0 110.146 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.77 -26.82 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.828 1.194 . . . . 0.0 111.736 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.17 -16.64 64.43 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.049 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -86.19 -52.14 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.796 1.638 . . . . 0.0 108.649 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -49.5 99.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.449 2.3 . . . . 0.0 110.955 -170.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -63.6 134.3 55.24 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -57.36 -44.63 84.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.97 -59.65 4.53 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -166.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -55.24 -46.19 76.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.272 2.229 . . . . 0.0 110.454 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -62.58 -58.4 7.68 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.03 0.832 . . . . 0.0 110.972 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.95 -52.91 38.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -60.67 -44.4 96.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.613 0.765 . . . . 0.0 112.108 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 tt -57.88 -53.7 55.3 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -63.76 -31.02 72.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.594 0.358 . . . . 0.0 111.455 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -51.48 64.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 109.29 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.35 -38.6 87.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.843 -1.075 . . . . 0.0 111.224 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.02 -57.58 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 m -67.32 -28.41 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -14.16 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.706 -0.621 . . . . 0.0 112.273 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.44 85.72 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.693 1.616 . . . . 0.0 113.016 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -67.15 -43.15 83.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.379 1.09 . . . . 0.0 108.13 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.57 159.5 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -138.11 157.82 45.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.718 -0.613 . . . . 0.0 111.824 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.53 133.3 31.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.917 1.287 . . . . 0.0 109.206 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.04 128.9 7.92 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.525 1.53 . . . . 0.0 109.869 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.92 155.83 37.13 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.392 1.077 . . . . 0.0 110.996 170.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.96 166.95 22.95 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.158 2.572 . . . . 0.0 111.522 171.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -95.48 165.6 12.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.833 1.253 . . . . 0.0 109.019 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -50.59 65.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.685 1.194 . . . . 0.0 109.303 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.19 -41.47 71.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.144 1.378 . . . . 0.0 111.012 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -62.15 -45.05 95.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.084 0.954 . . . . 0.0 110.955 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -66.07 -45.65 90.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 119.007 0.821 . . . . 0.0 109.373 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -54.14 -42.07 69.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.899 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -46.47 53.39 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.688 1.195 . . . . 0.0 110.762 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mm -64.43 -43.32 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.611 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.3 -36.73 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.525 0.602 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.39 -55.26 33.52 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.744 0.702 . . . . 0.0 109.659 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.26 -35.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.478 0.311 . . . . 0.0 110.641 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.48 -43.64 93.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.56 80.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.312 1.415 . . . . 0.0 110.622 173.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.52 -26.18 65.11 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.325 -0.86 . . . . 0.0 112.397 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.22 -49.04 3.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.06 0.846 . . . . 0.0 111.23 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.75 139.12 3.41 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -167.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 79.1 39.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.553 2.741 . . . . 0.0 111.82 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -37.68 -48.73 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 127.349 2.259 . . . . 0.0 115.384 -170.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -123.64 10.07 9.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.62 0.768 . . . . 0.0 110.489 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.76 -28.42 58.46 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.033 0.833 . . . . 0.0 111.713 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.27 34.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.181 1.393 . . . . 0.0 107.786 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -67.94 158.43 32.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.956 1.36 . . . . 0.0 111.113 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -58.83 -57.63 12.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.434 -172.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 -34.55 70.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.43 0.456 . . . . 0.0 111.152 -175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.03 -53.1 60.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.279 1.432 . . . . 0.0 108.574 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.5 mt -55.3 -44.99 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -66.31 -48.74 69.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.926 0.89 . . . . 0.0 112.46 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.33 -56.28 14.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.67 1.588 . . . . 0.0 108.071 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.96 -51.39 69.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 122.858 0.463 . . . . 0.0 110.009 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -45.18 -52.06 9.8 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.351 1.061 . . . . 0.0 112.209 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.6 tp -52.21 -52.5 51.89 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.225 0.466 . . . . 0.0 110.508 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.7 67.73 Favored 'General case' 0 CA--C 1.524 -0.051 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.877 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.513 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -78.81 -25.48 44.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.442 1.019 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.427 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 1.1 tm-20 -65.99 -48.33 71.59 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 164.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.15 -14.73 59.36 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 31.5 mtmt 50.2 29.7 3.84 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.719 2.808 . . . . 0.0 113.766 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.57 -108.01 1.55 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 124.379 0.99 . . . . 0.0 112.5 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -146.98 171.17 15.66 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.82 1.648 . . . . 0.0 107.844 172.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.91 160.97 42.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.693 1.197 . . . . 0.0 108.599 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.06 124.38 23.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.59 1.556 . . . . 0.0 108.659 168.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -162.8 -164.73 1.03 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.214 1.406 . . . . 0.0 110.47 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 -11.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 169.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -68.57 155.35 40.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.556 1.525 . . . . 0.0 115.1 -163.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -62.57 -37.01 84.51 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 119.526 -1.984 . . . . 0.0 112.555 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.57 -41.52 31.74 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.092 0.406 . . . . 0.0 110.659 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -36.77 74.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 118.486 0.585 . . . . 0.0 110.03 -170.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.26 -47.62 60.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 122.742 0.417 . . . . 0.0 109.917 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -59.08 -58.65 7.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.352 1.461 . . . . 0.0 108.722 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.33 -52.18 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.726 0.81 . . . . 0.0 109.976 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.33 67.58 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.758 -1.214 . . . . 0.0 114.008 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 t -67.97 -48.66 65.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 117.428 -1.272 . . . . 0.0 111.89 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -25.37 67.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.655 2.025 . . . . 0.0 112.475 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -82.07 -16.81 48.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.099 0.959 . . . . 0.0 111.723 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.14 18.88 78.23 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 117.886 -1.508 . . . . 0.0 114.348 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.05 132.61 34.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.766 1.783 . . . . 0.0 109.11 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.2 144.6 31.5 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.018 1.727 . . . . 0.0 111.253 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.2 -179.6 7.48 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.12 141.34 47.61 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.463 2.305 . . . . 0.0 107.939 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.39 166.02 16.7 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.877 0.871 . . . . 0.0 109.533 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 mt -81.44 -158.12 0.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? 59.59 -156.83 0.34 Allowed 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.913 -1.117 . . . . 0.0 108.868 -170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.31 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.4 87.31 0.87 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.03 -1.669 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mt -69.49 146.4 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.039 0.935 . . . . 0.0 109.183 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -71.43 -34.09 70.0 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -129.07 11.99 6.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.979 1.263 . . . . 0.0 111.996 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.259 47.3 t 48.78 81.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 C-N-CA 127.746 2.418 . . . . 0.0 111.461 172.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.5 mt -137.09 139.49 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.678 0.791 . . . . 0.0 108.985 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.2 141.43 55.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 167.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -117.56 162.51 17.87 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.671 1.988 . . . . 0.0 109.438 -170.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -146.03 17.57 1.4 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 116.411 -1.757 . . . . 0.0 115.215 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -135.0 135.3 41.28 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 121.636 2.016 . . . . 0.0 112.962 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.49 125.61 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.311 1.444 . . . . 0.0 109.903 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.49 121.67 16.84 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 108.813 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pt -82.41 49.04 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.995 1.318 . . . . 0.0 111.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.24 -31.48 0.02 OUTLIER Glycine 0 C--O 1.226 -0.344 0 O-C-N 121.253 -0.904 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 12.5 p -132.77 14.19 4.38 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.693 0.746 . . . . 0.0 112.062 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.99 7.98 33.03 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.366 1.936 . . . . 0.0 115.468 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 46.0 ttt85 -69.47 132.46 46.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.511 1.924 . . . . 0.0 111.662 -165.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.79 143.22 30.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.633 1.173 . . . . 0.0 110.185 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -139.14 156.33 47.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.993 1.717 . . . . 0.0 108.22 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.0 t -109.78 -14.58 14.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.073 0.549 . . . . 0.0 111.133 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.4 p -138.01 166.28 24.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.4 tp -75.79 113.0 22.79 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -65.04 167.83 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.564 2.176 . . . . 0.0 109.472 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.16 136.55 75.51 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.321 2.014 . . . . 0.0 111.002 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.71 -15.78 3.57 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.128 1.347 . . . . 0.0 112.824 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.88 43.44 97.56 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.897 1.237 . . . . 0.0 111.384 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.64 167.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.501 1.12 . . . . 0.0 109.907 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.27 110.79 13.4 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 111.413 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.87 -14.97 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.218 1.279 . . . . 0.0 113.788 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.89 -36.97 16.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.343 1.057 . . . . 0.0 112.676 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.23 -7.38 2.03 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -164.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.11 -3.39 10.51 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.099 2.761 . . . . 0.0 116.43 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.6 m -69.45 162.93 26.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.838 1.319 . . . . 0.0 112.217 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.11 160.68 30.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.65 0.738 . . . . 0.0 111.169 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.49 161.37 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.748 1.619 . . . . 0.0 109.333 173.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.27 166.44 24.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.337 1.455 . . . . 0.0 108.958 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.82 154.45 38.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.23 1.012 . . . . 0.0 111.02 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.99 162.3 34.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.34 1.856 . . . . 0.0 110.725 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.65 -164.17 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.968 3.112 . . . . 0.0 111.859 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -51.75 145.66 9.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 111.164 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -48.74 47.83 Favored 'General case' 0 CA--C 1.524 -0.042 0 C-N-CA 123.932 0.893 . . . . 0.0 109.524 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 117.174 -1.393 . . . . 0.0 110.599 -165.784 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp 60.56 171.0 0.09 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.894 1.225 . . . . 0.0 109.919 -160.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -117.9 168.92 10.06 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.999 1.319 . . . . 0.0 108.542 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.7 161.64 24.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 168.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.8 173.74 6.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.42 1.088 . . . . 0.0 109.993 -164.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.19 -173.39 2.41 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.373 1.869 . . . . 0.0 110.453 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.48 160.82 1.61 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.649 1.179 . . . . 0.0 112.083 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -52.3 129.65 28.81 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.508 -174.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.21 135.66 15.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.682 -168.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -111.83 145.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.98 147.58 38.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.11 1.764 . . . . 0.0 107.354 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -106.17 166.32 10.6 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.294 0.637 . . . . 0.0 110.423 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -42.16 -46.82 4.5 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.436 1.894 . . . . 0.0 111.477 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -62.13 -28.52 69.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.103 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.84 -39.33 84.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 109.536 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.89 -35.18 62.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.64 0.776 . . . . 0.0 111.101 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -61.7 -35.81 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.194 0.598 . . . . 0.0 110.61 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -82.23 -30.14 30.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.528 0.604 . . . . 0.0 110.749 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.3 32.28 17.12 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.257 0.932 . . . . 0.0 111.335 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.47 113.48 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.51 104.91 0.69 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.845 0.858 . . . . 0.0 109.811 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.476 HD11 ' H ' ' A' ' 23' ' ' GLU . 6.1 tp -149.57 159.78 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.871 1.268 . . . . 0.0 108.02 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' H ' HD11 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -130.54 115.02 16.21 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.844 1.257 . . . . 0.0 108.589 -164.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.31 -158.04 24.18 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.859 1.695 . . . . 0.0 112.514 -164.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.23 149.64 23.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.547 0.674 . . . . 0.0 112.451 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -132.89 149.72 52.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.626 1.97 . . . . 0.0 109.709 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 117.54 68.67 Favored Pre-proline 0 C--O 1.243 0.748 0 C-N-CA 126.702 2.001 . . . . 0.0 109.079 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.27 -32.72 96.58 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.167 1.245 . . . . 0.0 110.508 171.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -68.36 -11.73 60.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.8 p -106.25 -31.03 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 117.51 -1.234 . . . . 0.0 110.832 170.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.28 -28.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.941 1.701 . . . . 0.0 111.09 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -60.31 -22.28 62.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.263 0.483 . . . . 0.0 112.034 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -83.63 -53.23 5.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.923 -1.111 . . . . 0.0 108.965 169.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mt -41.37 114.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.198 1.799 . . . . 0.0 111.37 -162.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 -12.16 1.4 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.932 1.693 . . . . 0.0 112.836 -171.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -53.37 124.53 15.0 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 163.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -56.88 -50.01 73.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.328 0.651 . . . . 0.0 109.856 -171.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -62.24 -54.65 37.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 t -54.94 -42.02 71.79 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.163 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -62.61 -57.49 10.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.778 0.831 . . . . 0.0 109.933 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.89 -55.58 15.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.19 -53.14 57.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.404 1.482 . . . . 0.0 111.759 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.2 -48.88 73.21 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.815 1.246 . . . . 0.0 110.649 177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.39 -45.32 94.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.117 0.567 . . . . 0.0 110.836 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -56.41 -48.57 76.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.929 0.786 . . . . 0.0 109.388 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -42.23 95.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.989 1.315 . . . . 0.0 111.608 -176.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.85 -56.13 18.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -33.22 73.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.283 0.633 . . . . 0.0 111.896 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.18 -10.33 59.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.382 1.873 . . . . 0.0 112.617 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.19 -12.33 57.21 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 124.666 1.127 . . . . 0.0 113.466 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -78.27 -33.29 49.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.768 0.784 . . . . 0.0 111.638 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.05 148.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -141.21 139.54 33.82 Favored 'General case' 0 N--CA 1.46 0.049 0 C-N-CA 124.346 1.058 . . . . 0.0 109.773 -167.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.16 118.17 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.6 18.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.309 1.044 . . . . 0.0 110.744 174.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.9 160.89 27.15 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.373 1.469 . . . . 0.0 110.969 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.91 175.97 4.93 Favored 'Trans proline' 0 C--N 1.347 0.497 1 C-N-CA 125.453 4.102 . . . . 0.0 113.44 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.01 165.96 11.08 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.928 1.291 . . . . 0.0 109.45 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -48.93 24.73 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.863 1.265 . . . . 0.0 111.379 176.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.47 -27.87 65.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.843 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -69.98 -39.78 75.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.97 . . . . 0.0 109.628 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.36 -47.74 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.97 -34.43 73.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.851 -0.531 . . . . 0.0 110.831 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -42.3 64.3 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.15 0.98 . . . . 0.0 111.405 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mm -67.37 -52.65 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.06 -39.56 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.929 1.292 . . . . 0.0 110.493 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -58.75 -60.03 4.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.541 1.064 . . . . 0.0 111.415 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -73.34 -38.2 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.5 73.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.78 1.232 . . . . 0.0 110.692 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -29.07 70.26 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.515 -1.365 . . . . 0.0 112.155 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.02 -7.35 21.98 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.475 1.034 . . . . 0.0 112.208 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -123.45 16.11 9.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 112.009 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.25 -80.3 0.43 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.296 1.427 . . . . 0.0 110.119 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -59.08 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 129.009 2.923 . . . . 0.0 110.678 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.12 -43.91 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.126 1.771 . . . . 0.0 111.529 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -128.21 8.17 6.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.12 0.968 . . . . 0.0 109.721 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.53 -20.79 65.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.73 2.012 . . . . 0.0 111.784 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.97 165.26 12.35 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.051 1.74 . . . . 0.0 109.971 -175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -70.03 158.06 36.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.841 0.829 . . . . 0.0 111.849 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 14.1 ttpt -59.7 -54.41 46.7 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.986 1.314 . . . . 0.0 109.571 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.81 -44.03 63.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 110.352 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.42 -56.67 18.6 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.7 mt -52.79 -40.54 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 43.5 mt-10 -69.51 -33.44 72.83 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -57.81 -61.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 118.945 0.793 . . . . 0.0 109.288 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.89 -46.8 87.79 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.211 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.39 32.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.458 1.103 . . . . 0.0 111.535 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.47 -47.74 83.05 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.629 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.24 63.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.285 0.493 . . . . 0.0 111.883 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.06 -25.95 20.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.54 1.136 . . . . 0.0 111.394 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.98 -51.21 68.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.56 4.94 30.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.613 0.765 . . . . 0.0 111.615 -169.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 49.74 46.01 24.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.919 1.687 . . . . 0.0 110.771 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.18 -116.06 1.71 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -156.38 168.35 27.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.4 mt -129.81 152.55 37.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 119.05 20.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.004 1.322 . . . . 0.0 108.108 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -165.45 -170.54 1.88 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.079 1.352 . . . . 0.0 109.925 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -151.52 -1.78 0.32 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -64.39 157.78 25.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.571 -1.331 . . . . 0.0 114.539 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -60.93 -41.15 95.65 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.726 -1.234 . . . . 0.0 110.814 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -84.35 -44.26 13.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 110.989 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 p -60.12 -37.67 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.351 0.978 . . . . 0.0 110.225 -170.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -70.96 -35.72 72.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 110.226 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.09 -55.48 18.53 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.946 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 mm -48.95 -53.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.796 0.838 . . . . 0.0 109.179 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -21.69 64.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.182 -1.407 . . . . 0.0 112.854 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -74.07 -46.59 42.08 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.672 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.4 95.05 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.55 1.977 . . . . 0.0 108.275 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -68.52 -44.39 74.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.62 35.12 14.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 125.774 1.654 . . . . 0.0 111.855 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.77 136.34 33.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 137.53 56.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -145.94 -173.6 4.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.881 0.31 . . . . 0.0 111.243 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -130.61 124.87 32.7 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 125.742 1.617 . . . . 0.0 109.296 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.7 m -90.12 159.67 16.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.445 2.298 . . . . 0.0 108.448 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -91.8 -179.41 5.31 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.009 -1.057 . . . . 0.0 109.631 173.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -53.08 -66.72 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.575 -1.328 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 168.67 148.52 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.124 2.569 . . . . 0.0 107.184 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.31 94.69 0.15 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.02 177.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.581 0.752 . . . . 0.0 111.416 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -130.68 57.01 1.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.986 1.715 . . . . 0.0 108.712 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 47.06 43.21 13.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.618 1.567 . . . . 0.0 110.738 -167.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -109.42 -179.09 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.137 1.375 . . . . 0.0 107.525 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.439 ' CG2' ' H ' ' A' ' 126' ' ' LYS 0.274 61.7 mt -89.99 -174.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.439 ' H ' ' CG2' ' A' ' 125' ' ' ILE . 15.4 mtmt -118.79 127.96 54.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -68.41 154.99 40.74 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.621 0.576 . . . . 0.0 110.074 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -148.76 8.92 0.78 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -140.3 146.4 38.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.362 0.983 . . . . 0.0 110.72 -171.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -137.27 132.41 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 108.701 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.37 120.5 12.35 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 163.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.39 119.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 166.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.46 -84.64 0.32 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.37 -4.81 58.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.98 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.85 20.27 68.35 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 124.78 1.181 . . . . 0.0 114.946 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 137.22 57.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -84.04 148.01 27.09 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.305 1.042 . . . . 0.0 109.341 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -142.03 146.09 35.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.02 -4.11 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 110.827 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.9 p -145.39 160.4 41.61 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.645 2.378 . . . . 0.0 108.224 161.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.424 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -68.85 112.78 12.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -66.33 164.74 27.09 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 109.635 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.34 124.6 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.094 1.863 . . . . 0.0 109.332 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.86 -18.26 57.0 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.287 2.375 . . . . 0.0 112.161 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 62.19 34.86 90.47 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.822 1.311 . . . . 0.0 111.455 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.86 162.0 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.634 1.573 . . . . 0.0 107.544 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.9 t -74.4 112.57 17.73 Favored Pre-proline 0 N--CA 1.443 -0.775 0 C-N-CA 125.365 1.466 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.51 -8.65 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.518 2.145 . . . . 0.0 115.895 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.61 -43.06 6.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.826 1.194 . . . . 0.0 112.065 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.3 p -122.99 -9.44 8.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.991 0.917 . . . . 0.0 111.527 -166.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.23 13.75 82.99 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.791 1.186 . . . . 0.0 113.614 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.79 161.58 14.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.82 1.31 . . . . 0.0 112.203 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -62.81 147.92 48.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.458 0.646 . . . . 0.0 111.15 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.39 147.6 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -133.84 172.9 12.15 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.479 1.512 . . . . 0.0 110.287 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.43 161.32 28.07 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.494 1.117 . . . . 0.0 110.342 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -128.24 159.12 68.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.441 1.896 . . . . 0.0 110.684 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.76 100.46 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.392 2.728 . . . . 0.0 110.62 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 49.45 -123.61 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.866 -1.146 . . . . 0.0 109.291 -168.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 -23.24 6.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 . . . . . 0 C--N 1.312 -1.022 0 C-N-CA 126.861 2.064 . . . . 0.0 108.209 -177.355 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.445 ' CD2' ' HH ' ' A' ' 25' ' ' TYR . 1.1 tp -115.15 8.98 15.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 77.51 92.23 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.798 2.039 . . . . 0.0 108.705 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.16 14.71 3.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.46 1.504 . . . . 0.0 111.313 -168.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.31 -70.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 130.266 3.426 . . . . 0.0 111.318 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -27.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 128.562 2.745 . . . . 0.0 112.038 -169.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -178.46 161.83 1.4 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -49.93 131.48 22.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.592 1.182 . . . . 0.0 108.965 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -151.25 144.4 24.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.31 151.52 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.59 138.81 47.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 125.435 1.494 . . . . 0.0 109.669 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.82 -179.69 6.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.03 1.332 . . . . 0.0 111.364 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.0 p -58.43 -41.99 86.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.06 -1.65 . . . . 0.0 110.425 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -60.65 -39.79 89.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.597 1.159 . . . . 0.0 112.234 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.57 -36.13 27.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 119.945 1.248 . . . . 0.0 111.3 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -77.13 -37.12 54.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.13 -31.72 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.899 0.88 . . . . 0.0 109.81 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.42 -21.85 22.83 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.52 24.85 24.99 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.476 -0.624 . . . . 0.0 113.923 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.0 mt -80.92 109.29 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.622 1.211 . . . . 0.0 109.217 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.93 100.99 1.66 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.581 0.752 . . . . 0.0 109.795 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tp -136.91 167.79 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.378 1.471 . . . . 0.0 108.579 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -136.98 120.77 17.42 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.287 1.435 . . . . 0.0 108.526 -166.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.87 -157.88 30.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.61 1.576 . . . . 0.0 111.51 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' HH ' ' CD2' ' A' ' 2' ' ' LEU . 91.4 m-85 -109.78 149.85 29.2 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.306 1.043 . . . . 0.0 110.893 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -128.76 168.01 16.47 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.715 1.206 . . . . 0.0 108.816 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.414 ' HG1' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -107.0 121.16 45.69 Favored Pre-proline 0 C--O 1.247 0.951 0 C-N-CA 126.288 1.835 . . . . 0.0 111.01 -165.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -63.22 -15.41 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.82 1.68 . . . . 0.0 113.389 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -89.78 -12.33 39.58 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.675 1.125 . . . . 0.0 112.806 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.77 -36.36 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 121.138 1.79 . . . . 0.0 108.206 167.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.68 -29.6 40.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.898 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.44 -26.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.809 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -11.36 42.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.165 2.186 . . . . 0.0 110.879 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.21 119.24 31.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -21.25 6.03 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.406 1.482 . . . . 0.0 112.494 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.43 169.26 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.279 0.632 . . . . 0.0 110.315 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -84.57 -55.97 3.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.99 -59.36 5.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -168.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -54.69 -35.59 63.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.578 1.151 . . . . 0.0 113.064 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 119.507 1.049 . . . . 0.0 109.433 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.1 mt -52.62 -43.23 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.944 1.298 . . . . 0.0 108.798 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -77.84 -40.24 40.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.609 0.763 . . . . 0.0 113.043 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -53.48 -49.06 68.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.418 1.463 . . . . 0.0 108.477 169.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -65.85 -32.04 73.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.815 -0.612 . . . . 0.0 111.672 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -57.69 -51.03 71.22 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.325 1.45 . . . . 0.0 108.751 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.36 -33.76 76.44 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.73 0.812 . . . . 0.0 111.344 -176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.31 -49.9 62.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 m -57.39 -40.83 79.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.784 -0.573 . . . . 0.0 110.941 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.64 -3.61 35.49 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.104 1.361 . . . . 0.0 113.219 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.44 21.64 77.55 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 112.681 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -96.97 -29.93 13.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.094 1.447 . . . . 0.0 112.638 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.94 130.64 73.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -122.62 142.8 50.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.615 1.166 . . . . 0.0 110.181 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.32 133.18 31.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.8 9.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.681 1.192 . . . . 0.0 109.964 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.01 154.6 38.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.921 0.888 . . . . 0.0 111.344 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.23 164.12 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.805 3.67 . . . . 0.0 113.459 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -84.75 159.07 20.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.092 0.949 . . . . 0.0 111.153 161.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -45.67 84.65 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.972 1.309 . . . . 0.0 111.124 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -58.05 -33.64 69.23 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.775 0.43 . . . . 0.0 111.513 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.23 -45.89 75.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.884 1.273 . . . . 0.0 109.924 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.25 -44.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.995 0.918 . . . . 0.0 109.516 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.41 -33.9 73.17 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.44 -0.788 . . . . 0.0 111.628 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -41.46 89.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.889 0.768 . . . . 0.0 110.541 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -63.87 -46.35 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.16 -38.89 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.475 1.11 . . . . 0.0 110.331 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -62.88 -60.32 3.64 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.142 1.337 . . . . 0.0 110.719 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.43 -34.94 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.63 -174.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.89 77.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.391 0.676 . . . . 0.0 111.548 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.81 66.24 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.781 1.628 . . . . 0.0 111.762 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.27 4.88 11.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.755 0.822 . . . . 0.0 112.212 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -131.95 -22.59 2.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.255 1.389 . . . . 0.0 112.246 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.17 -70.13 0.4 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 119.473 1.033 . . . . 0.0 112.783 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.46 56.86 0.37 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.729 2.012 . . . . 0.0 113.04 -170.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 p -48.53 -44.63 13.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.227 1.811 . . . . 0.0 114.328 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -124.7 4.89 8.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.524 0.729 . . . . 0.0 110.519 -173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.78 -10.82 58.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.605 1.162 . . . . 0.0 112.89 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 165.36 22.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 169.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 t -72.16 159.84 33.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.105 0.866 . . . . 0.0 109.887 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HE2' ' N ' ' A' ' 81' ' ' ALA . 1.7 ttpt -65.03 -48.97 71.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.907 0.883 . . . . 0.0 109.199 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.472 ' N ' ' HE2' ' A' ' 80' ' ' LYS . . . -56.21 -43.23 78.34 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.495 1.118 . . . . 0.0 109.792 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -63.38 -55.07 27.44 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.39 -42.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 124.023 0.929 . . . . 0.0 109.787 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.5 -48.43 72.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.923 0.889 . . . . 0.0 111.999 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' CG2' ' HG1' ' A' ' 27' ' ' THR . 95.1 t -59.1 -47.56 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 119.278 0.944 . . . . 0.0 109.239 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.03 -56.13 25.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.549 1.14 . . . . 0.0 109.474 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.59 -50.15 60.74 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.968 1.307 . . . . 0.0 111.791 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -49.92 75.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.91 91.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.634 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.487 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.1 m-85 -65.53 -31.49 72.58 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.963 1.256 . . . . 0.0 111.663 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.85 -37.36 87.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.421 1.105 . . . . 0.0 111.282 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.27 -12.57 52.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.365 1.066 . . . . 0.0 111.59 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 60.24 12.18 3.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.424 1.489 . . . . 0.0 112.29 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.65 -112.03 0.3 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 128.414 2.912 . . . . 0.0 112.965 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -154.89 167.92 28.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 106.933 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.31 155.97 42.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.478 1.111 . . . . 0.0 108.023 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.84 116.09 14.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.051 1.74 . . . . 0.0 106.97 167.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.4 t -155.78 170.73 21.4 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.225 0.61 . . . . 0.0 109.493 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.09 93.78 2.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.741 1.616 . . . . 0.0 110.694 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -152.66 166.43 32.14 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.873 1.269 . . . . 0.0 108.661 165.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -68.8 -55.23 11.88 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.096 -1.003 . . . . 0.0 109.783 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.52 -35.41 80.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.472 -0.768 . . . . 0.0 110.951 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.1 p -64.75 -43.52 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 118.994 0.815 . . . . 0.0 108.843 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.45 -42.74 87.15 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.507 0.723 . . . . 0.0 110.598 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -59.88 -62.84 1.58 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.943 1.297 . . . . 0.0 108.523 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.401 HG22 ' HH ' ' A' ' 90' ' ' TYR . 15.1 mm -51.09 -50.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.077 0.951 . . . . 0.0 110.421 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.78 72.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.853 1.206 . . . . 0.0 112.532 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 t -59.13 -59.01 6.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.746 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.68 -31.29 72.15 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.223 1.374 . . . . 0.0 111.579 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -72.34 -6.68 45.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.373 0.669 . . . . 0.0 112.315 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.73 73.16 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-O 118.759 -1.023 . . . . 0.0 112.604 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.91 135.41 34.92 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.652 1.726 . . . . 0.0 109.474 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.11 17.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.53 1.132 . . . . 0.0 108.385 169.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.63 174.41 9.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 109.761 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.9 116.93 32.81 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.76 152.72 22.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 153.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' CD1' ' H ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -76.12 171.02 15.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.344 168.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' H ' ' CD1' ' A' ' 117' ' ' LEU . 2.5 tptm 61.64 -160.9 0.3 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.548 1.939 . . . . 0.0 111.02 157.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 48.58 -115.08 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.476 1.511 . . . . 0.0 111.249 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.16 -129.11 9.04 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 -167.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 25.7 mt -125.1 153.5 32.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 125.793 1.637 . . . . 0.0 108.357 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -121.47 -38.65 2.75 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.15 -1.405 . . . . 0.0 112.27 165.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -148.9 -4.58 0.42 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.822 1.646 . . . . 0.0 114.279 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.03 158.3 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.7 mt -84.1 158.94 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -67.0 93.26 0.27 Allowed 'General case' 0 N--CA 1.46 0.066 0 O-C-N 121.109 -0.994 . . . . 0.0 108.679 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.49 153.93 18.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.693 1.997 . . . . 0.0 111.59 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -145.68 21.2 1.48 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.489 -1.72 . . . . 0.0 114.693 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -135.16 149.96 50.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 121.989 2.177 . . . . 0.0 112.423 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.51 134.26 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.342 1.457 . . . . 0.0 109.16 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.05 142.02 57.95 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.763 0.825 . . . . 0.0 109.151 163.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.435 ' CG2' ' HZ3' ' A' ' 155' ' ' LYS . 1.1 pt -95.26 117.64 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.88 -2.3 33.78 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.306 1.431 . . . . 0.0 113.797 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 -1.96 2.11 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.081 0.94 . . . . 0.0 112.121 154.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.03 11.73 64.04 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 126.004 1.764 . . . . 0.0 115.442 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -69.95 135.23 49.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.015 -0.697 . . . . 0.0 110.134 -168.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -73.97 150.05 40.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.352 1.032 . . . . 0.0 109.872 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.17 147.38 38.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 161.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 p -95.96 -10.18 29.3 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.198 0.999 . . . . 0.0 112.235 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 p -134.69 177.4 7.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.393 1.877 . . . . 0.0 106.739 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 tp -80.7 137.71 50.87 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.06 159.72 51.48 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.518 1.478 . . . . 0.0 109.689 167.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.22 115.82 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.426 2.084 . . . . 0.0 110.863 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.27 66.15 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.86 -175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.75 45.51 90.88 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.165 1.364 . . . . 0.0 112.194 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.37 155.45 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.02 111.93 17.68 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.356 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.32 -20.85 69.95 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.308 1.339 . . . . 0.0 112.39 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -18.66 30.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.948 1.299 . . . . 0.0 111.091 -171.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.0 p -142.82 -33.06 0.47 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.86 84.66 1.34 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.283 1.421 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.63 171.34 5.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 110.19 172.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -59.32 131.36 50.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.189 1.396 . . . . 0.0 112.828 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.95 146.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 166.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HZ3' ' CG2' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -134.06 157.69 45.48 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.001 -1.062 . . . . 0.0 110.346 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.76 152.49 44.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -123.22 157.07 62.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 110.489 173.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 172.59 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.967 2.444 . . . . 0.0 111.81 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.01 134.04 4.81 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.541 2.336 . . . . 0.0 113.173 -168.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.04 -63.13 1.23 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.405 2.282 . . . . 0.0 110.961 175.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.915 0 C-N-CA 126.811 2.044 . . . . 0.0 111.908 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 mtt . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.9 162.54 23.96 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.637 -1.29 . . . . 0.0 110.098 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -146.69 10.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.51 -162.69 0.88 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tt 53.97 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.008 2.523 . . . . 0.0 112.772 -177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -76.25 178.51 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 111.471 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -54.63 168.1 0.3 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.035 0.934 . . . . 0.0 110.846 164.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -54.92 130.18 40.43 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.664 0.786 . . . . 0.0 109.768 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.8 tp -151.32 143.32 23.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.95 148.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.29 127.06 53.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.938 1.695 . . . . 0.0 107.898 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.17 167.84 18.3 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.081 0.952 . . . . 0.0 110.951 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -44.05 51.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.567 1.947 . . . . 0.0 110.662 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -53.02 -38.36 62.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.936 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.29 -40.03 86.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 119.591 1.087 . . . . 0.0 109.411 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -73.68 -31.64 63.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 111.046 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.2 mt -59.73 -53.5 47.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.056 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -67.73 -31.2 70.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.144 0.429 . . . . 0.0 110.789 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.66 31.6 8.16 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 123.584 0.612 . . . . 0.0 111.627 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.01 106.69 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.96 104.41 1.72 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.68 167.26 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.822 -1.174 . . . . 0.0 109.161 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.41 148.3 27.29 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.595 1.958 . . . . 0.0 107.992 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.72 -141.84 8.64 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.966 1.257 . . . . 0.0 112.228 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.61 153.16 46.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.06 0.93 . . . . 0.0 112.257 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 t -126.95 147.38 50.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.715 2.006 . . . . 0.0 110.071 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.0 116.22 66.16 Favored Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 127.817 2.447 . . . . 0.0 110.037 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.18 -30.07 89.42 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 121.538 1.492 . . . . 0.0 113.12 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 -15.18 57.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.265 1.826 . . . . 0.0 114.014 -171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.04 -53.15 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 126.113 1.765 . . . . 0.0 108.6 162.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -71.24 -18.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 123.302 0.641 . . . . 0.0 111.722 -160.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -48.71 -38.82 22.58 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.98 0.912 . . . . 0.0 111.75 165.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 -11.98 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.022 1.329 . . . . 0.0 111.362 -166.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.53 97.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.76 -23.09 21.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.449 1.1 . . . . 0.0 112.015 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.72 117.8 4.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.95 -38.42 76.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 117.667 -1.159 . . . . 0.0 110.692 -168.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.4 -56.26 22.16 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 119.513 1.051 . . . . 0.0 108.322 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -61.64 -48.09 82.45 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.516 0.726 . . . . 0.0 110.91 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -57.27 -60.64 3.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.15 1.38 . . . . 0.0 110.342 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.5 mt -62.45 -38.85 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -62.28 -47.86 82.43 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.048 0.939 . . . . 0.0 110.65 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.86 -49.0 74.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.167 -0.958 . . . . 0.0 109.813 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.74 -33.52 76.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 t -54.41 -54.88 34.78 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -59.77 -48.38 81.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.546 1.139 . . . . 0.0 110.736 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.38 -55.36 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 t -64.21 -34.83 78.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.196 0.599 . . . . 0.0 111.306 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.61 -9.8 58.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.274 1.83 . . . . 0.0 112.316 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.41 8.94 60.75 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 124.888 1.232 . . . . 0.0 113.754 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -87.82 -41.14 13.46 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -164.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.15 161.64 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 C-N-CA 125.292 1.437 . . . . 0.0 108.756 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -132.69 158.35 42.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.67 139.27 19.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.85 130.18 4.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.53 1.132 . . . . 0.0 109.301 162.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -98.24 156.37 35.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.572 1.549 . . . . 0.0 111.053 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.57 -176.21 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.776 3.651 . . . . 0.0 111.971 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -120.33 163.9 17.13 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.529 0.732 . . . . 0.0 110.21 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -49.61 10.57 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.559 1.544 . . . . 0.0 111.98 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.93 -27.94 60.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.858 0.863 . . . . 0.0 110.771 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -47.27 85.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 109.246 170.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.87 -44.95 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.336 1.054 . . . . 0.0 109.635 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.96 -32.73 72.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.646 -0.659 . . . . 0.0 111.731 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -44.3 76.17 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 121.419 -0.801 . . . . 0.0 110.909 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.42 -49.03 82.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.34 -46.9 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.244 1.017 . . . . 0.0 110.503 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.07 -48.71 70.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.11 1.323 . . . . 0.0 111.485 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.55 -33.64 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.72 -51.65 61.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.229 1.012 . . . . 0.0 110.116 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -24.7 67.65 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.115 -0.991 . . . . 0.0 111.885 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.96 -28.53 64.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.283 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 t -120.43 -16.42 8.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.77 -76.59 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 119.259 0.936 . . . . 0.0 112.522 164.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -72.26 93.08 1.44 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.773 1.229 . . . . 0.0 109.161 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.11 -50.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 112.059 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.85 14.55 7.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.034 0.933 . . . . 0.0 110.443 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.27 -24.17 59.23 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.833 1.653 . . . . 0.0 111.285 175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.03 165.38 24.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.054 0.941 . . . . 0.0 109.155 -173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 153.27 40.7 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.048 -1.032 . . . . 0.0 109.48 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -63.32 -46.01 88.66 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.152 -0.967 . . . . 0.0 109.07 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -41.37 70.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.209 0.943 . . . . 0.0 111.268 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.78 -55.1 39.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 109.133 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.58 -42.9 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.792 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -62.58 -49.24 76.03 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.01 0.924 . . . . 0.0 111.046 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.78 -51.14 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 mt -57.02 -50.22 73.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.784 0.834 . . . . 0.0 109.794 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.28 -53.39 36.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.331 1.052 . . . . 0.0 112.028 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.91 -50.25 69.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.977 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.56 65.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.314 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.505 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -67.8 -32.26 72.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.583 0.628 . . . . 0.0 111.339 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -44.13 94.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.956 0.798 . . . . 0.0 109.62 168.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 -10.82 59.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.732 0.813 . . . . 0.0 112.177 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm 58.22 11.8 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.018 2.127 . . . . 0.0 113.236 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.7 -145.47 11.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 127.344 2.402 . . . . 0.0 113.042 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.0 173.37 6.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.448 1.899 . . . . 0.0 111.944 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.5 mt -130.1 161.34 39.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 126.18 1.792 . . . . 0.0 108.981 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.56 121.21 16.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.681 1.992 . . . . 0.0 107.19 166.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t -164.62 177.74 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.761 1.224 . . . . 0.0 109.984 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.06 82.6 1.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.81 -1.181 . . . . 0.0 110.113 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' H ' HG13 ' A' ' 103' ' ' VAL . 3.4 t0 -146.12 156.31 43.35 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.953 0.901 . . . . 0.0 112.102 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -66.55 -36.74 83.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.289 -166.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -49.95 13.98 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 117.212 -1.375 . . . . 0.0 110.568 168.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -51.62 -43.19 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.466 1.03 . . . . 0.0 110.799 -168.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 36.6 mt-30 -63.7 -43.86 95.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.021 0.928 . . . . 0.0 110.177 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -69.23 -50.61 45.62 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.7 mm -52.62 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 125.625 1.57 . . . . 0.0 109.046 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.96 -34.79 66.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.151 1.341 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -54.76 30.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.059 -1.448 . . . . 0.0 112.754 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.83 -33.44 74.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 121.542 1.973 . . . . 0.0 110.302 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.505 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.5 mm? -73.69 -4.88 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.802 0.841 . . . . 0.0 113.255 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.24 3.38 61.17 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.863 -0.965 . . . . 0.0 114.399 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.03 149.91 24.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.033 1.417 . . . . 0.0 110.343 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -94.59 140.52 29.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.009 1.323 . . . . 0.0 110.131 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 15.7 p90 -144.08 178.28 7.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.038 -0.414 . . . . 0.0 110.86 177.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -107.86 121.43 44.73 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.447 1.099 . . . . 0.0 108.619 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -71.95 160.3 32.76 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 125.28 1.612 . . . . 0.0 109.717 157.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -167.69 1.71 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.121 0.962 . . . . 0.0 110.309 163.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -49.89 158.03 0.54 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.825 1.65 . . . . 0.0 111.233 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -55.26 148.41 14.65 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.143 1.377 . . . . 0.0 110.568 166.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.46 160.99 24.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.8 mt -140.53 145.97 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 126.827 2.051 . . . . 0.0 107.122 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -109.45 -78.71 0.59 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.998 164.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -131.78 62.84 1.62 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.689 1.586 . . . . 0.0 111.099 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.01 179.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.847 1.659 . . . . 0.0 108.024 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.56 144.04 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE3' ' CG ' ' A' ' 160' ' ' LYS . 10.2 mmtm -79.0 107.65 11.91 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.509 1.049 . . . . 0.0 108.192 165.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.403 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 12.8 p-90 -64.67 163.96 12.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.695 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -154.8 15.07 0.42 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -143.38 150.47 39.15 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.1 136.74 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.615 1.966 . . . . 0.0 108.679 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.2 t -76.93 121.95 24.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.035 0.934 . . . . 0.0 110.064 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.47 84.29 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 122.503 1.144 . . . . 0.0 108.608 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.77 -20.12 0.12 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.392 1.472 . . . . 0.0 112.125 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 18.9 p -152.87 0.63 0.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.291 1.046 . . . . 0.0 113.426 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.51 10.52 66.87 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.624 -1.298 . . . . 0.0 114.914 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -71.89 135.24 46.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 52.2 mttp -88.85 139.37 30.53 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.769 1.628 . . . . 0.0 109.364 -173.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.29 149.12 52.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.334 1.054 . . . . 0.0 108.609 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.74 23.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.039 0.936 . . . . 0.0 111.776 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.0 p -141.0 169.77 16.99 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.06 2.544 . . . . 0.0 107.321 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.33 133.51 83.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.72 160.95 47.4 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 121.002 1.394 . . . . 0.0 108.734 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.23 -19.04 65.43 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.201 1.934 . . . . 0.0 114.911 -170.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.1 -3.42 55.73 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.775 0.716 . . . . 0.0 113.265 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.6 17.93 50.2 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 119.122 1.461 . . . . 0.0 113.96 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.85 156.18 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.88 2.072 . . . . 0.0 106.526 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 11.7 t -69.8 113.79 20.03 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 125.534 1.534 . . . . 0.0 108.717 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -66.39 -11.05 29.91 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.855 1.703 . . . . 0.0 112.091 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.82 -24.41 14.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.691 1.196 . . . . 0.0 112.074 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.7 p -142.25 -9.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.94 62.52 4.9 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.442 1.019 . . . . 0.0 112.319 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.31 167.76 22.75 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.015 0.926 . . . . 0.0 109.935 164.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -55.55 145.3 23.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.81 1.244 . . . . 0.0 110.668 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.4 t -104.52 138.91 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 167.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 162.53 29.12 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.514 1.126 . . . . 0.0 110.584 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.58 156.47 38.97 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.693 1.197 . . . . 0.0 110.241 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.82 159.0 66.5 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 128.245 2.618 . . . . 0.0 108.65 174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.65 -161.49 0.15 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.621 1.547 . . . . 0.0 112.299 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -46.4 143.0 2.72 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.541 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.438 ' CG ' ' HE3' ' A' ' 126' ' ' LYS . 44.5 tptt -101.5 -83.72 0.45 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 117.554 -1.212 . . . . 0.0 108.485 175.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 117.671 -1.157 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.31 112.43 0.01 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.662 2.385 . . . . 0.0 113.622 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.15 -156.41 0.24 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -169.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 68.65 163.98 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.023 2.129 . . . . 0.0 111.202 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.47 176.44 10.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.275 1.03 . . . . 0.0 110.177 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 7' ' ' LYS . 7.0 ttpt -70.19 179.03 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.491 0.716 . . . . 0.0 109.183 171.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' HE2' ' A' ' 6' ' ' LYS . 20.3 tptt -61.97 -176.9 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.25 160.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -60.94 136.14 58.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.466 -1.396 . . . . 0.0 109.943 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' HA3' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -155.3 146.66 22.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.477 1.511 . . . . 0.0 107.181 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.8 t -118.22 147.51 21.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.62 140.05 49.84 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.329 1.452 . . . . 0.0 109.504 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.93 164.49 13.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.902 1.281 . . . . 0.0 111.169 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -42.12 -47.7 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.603 1.961 . . . . 0.0 113.708 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -58.82 -33.92 70.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.37 0.668 . . . . 0.0 110.94 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.36 -41.06 83.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.85 0.86 . . . . 0.0 109.562 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.94 -39.03 64.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.8 mt -57.28 -41.12 77.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.864 0.866 . . . . 0.0 109.799 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -78.7 -26.54 44.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.788 0.722 . . . . 0.0 111.871 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.46 26.74 12.94 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.315 0.959 . . . . 0.0 112.632 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 mt -77.01 110.32 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.459 1.129 . . . . 0.0 108.325 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.59 108.98 2.63 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 6.3 tp -145.28 170.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -137.56 140.72 41.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.589 1.956 . . . . 0.0 107.379 -168.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.486 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 162.23 -148.46 15.68 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 124.424 1.077 . . . . 0.0 114.001 -159.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.49 152.81 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.335 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -130.62 154.18 48.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.926 1.69 . . . . 0.0 111.476 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.26 113.64 59.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 126.218 1.807 . . . . 0.0 112.147 -170.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.04 -11.09 29.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.646 2.897 . . . . 0.0 114.378 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -71.5 -40.78 69.95 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.612 1.165 . . . . 0.0 109.977 166.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.33 -40.68 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.96 -23.45 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 118.519 -1.272 . . . . 0.0 113.48 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.58 -20.44 63.65 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.744 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.05 -36.98 19.36 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.087 1.355 . . . . 0.0 108.805 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -66.53 94.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.908 1.283 . . . . 0.0 109.672 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -22.81 13.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.15 0.98 . . . . 0.0 111.582 169.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.07 122.15 10.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.741 1.216 . . . . 0.0 108.764 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -50.36 -49.05 55.27 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 116.932 -1.509 . . . . 0.0 111.655 -170.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -60.38 -60.7 3.39 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -168.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 t -51.44 -53.83 33.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.875 2.07 . . . . 0.0 110.781 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.15 -62.78 1.58 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.665 1.186 . . . . 0.0 110.959 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mt -55.9 -43.32 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.87 -53.33 59.16 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.787 0.835 . . . . 0.0 111.267 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.93 -44.0 73.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.048 1.339 . . . . 0.0 110.549 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.83 -39.14 90.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.59 -0.694 . . . . 0.0 111.079 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -56.52 -51.33 68.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.537 1.135 . . . . 0.0 109.046 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.02 -36.06 81.29 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 111.131 -171.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.2 mt -62.07 -47.78 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -39.97 85.38 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.802 0.441 . . . . 0.0 112.115 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.25 63.6 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.362 1.065 . . . . 0.0 111.838 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.82 44.44 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.039 0.828 . . . . 0.0 113.658 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 2.8 ptpt -70.82 -39.79 72.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.244 -170.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.62 99.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -167.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -82.37 164.32 21.13 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.164 0.986 . . . . 0.0 110.302 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.42 129.44 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 123.231 0.612 . . . . 0.0 110.729 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.65 128.45 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 109.982 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -101.17 154.78 36.98 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 110.435 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.33 175.95 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 124.736 3.624 . . . . 0.0 112.684 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.05 160.58 14.38 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.398 -1.728 . . . . 0.0 107.975 173.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -39.34 68.14 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.577 -0.702 . . . . 0.0 110.642 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.66 -22.27 43.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.854 0.861 . . . . 0.0 110.379 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -65.57 -49.76 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 108.959 166.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.84 -46.63 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 118.736 0.698 . . . . 0.0 109.405 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -38.35 83.98 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.999 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.05 68.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 0.827 . . . . 0.0 111.761 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mm -67.52 -47.54 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.0 mt -51.62 -38.25 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.096 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -63.81 -62.32 1.72 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.698 1.135 . . . . 0.0 110.501 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.01 -40.85 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.19 96.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.612 0.765 . . . . 0.0 111.57 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -32.86 74.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.006 -1.059 . . . . 0.0 110.795 175.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.37 -5.25 38.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.738 0.699 . . . . 0.0 111.277 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -108.37 -41.66 4.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.994 0.815 . . . . 0.0 112.03 168.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.77 -80.4 0.18 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 119.678 1.126 . . . . 0.0 110.418 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -62.43 87.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.832 2.453 . . . . 0.0 109.338 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 p -89.22 -49.98 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.495 1.518 . . . . 0.0 110.926 -173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -130.69 14.63 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.727 0.811 . . . . 0.0 109.556 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -56.95 -33.77 67.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 110.2 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.09 164.51 26.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 111.016 -172.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.7 m -73.03 163.69 27.8 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.99 0.9 . . . . 0.0 112.252 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -61.22 2.45 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 123.552 0.741 . . . . 0.0 109.136 174.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.47 -38.17 63.37 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 125.908 2.005 . . . . 0.0 110.334 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.49 -67.57 0.25 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.427 1.891 . . . . 0.0 109.083 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.67 -29.93 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.925 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -66.57 -49.16 67.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 113.295 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.1 t -50.76 -60.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.088 1.755 . . . . 0.0 108.53 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.18 -47.7 83.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.52 -172.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.11 -59.26 4.09 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.926 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 tp -56.3 -46.47 79.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -28.93 70.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.342 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.534 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.8 m-85 -80.61 -20.87 42.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.009 0.822 . . . . 0.0 111.618 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.73 -40.29 96.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.3 0.955 . . . . 0.0 108.921 164.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.68 -14.91 50.66 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.715 1.206 . . . . 0.0 112.566 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.34 42.98 7.97 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.477 1.511 . . . . 0.0 110.292 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.04 -113.88 3.88 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 126.067 1.794 . . . . 0.0 115.144 -165.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -147.45 167.64 23.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.41 1.484 . . . . 0.0 109.555 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -130.13 158.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 109.184 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.48 115.3 10.14 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 t -160.93 179.66 8.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.93 1.292 . . . . 0.0 108.524 172.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -158.57 89.1 0.95 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.844 -1.16 . . . . 0.0 110.627 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.35 156.02 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.07 0.948 . . . . 0.0 110.699 176.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -58.75 -48.89 79.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.624 0.77 . . . . 0.0 110.162 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -64.87 -54.82 24.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.663 1.185 . . . . 0.0 109.723 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -36.56 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.823 0.449 . . . . 0.0 110.923 -164.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.04 -44.0 85.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -60.87 -50.57 72.9 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.104 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.58 -51.05 54.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.991 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.61 88.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.085 1.311 . . . . 0.0 111.298 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 t -65.11 -49.4 70.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.426 -0.797 . . . . 0.0 113.022 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -36.81 84.84 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 120.432 1.469 . . . . 0.0 110.723 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.534 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -66.32 -28.66 68.85 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.508 0.323 . . . . 0.0 110.524 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.04 46.38 59.13 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -170.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.01 123.65 49.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.321 1.06 . . . . 0.0 108.484 160.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 140.19 57.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.95 1.3 . . . . 0.0 109.849 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -145.47 178.42 8.12 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.826 0.85 . . . . 0.0 109.741 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.67 146.23 32.32 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.385 1.074 . . . . 0.0 108.771 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -123.47 142.97 50.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.11 1.364 . . . . 0.0 108.778 169.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.84 167.52 2.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.333 1.453 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 8.1 mtpm? -82.75 63.5 6.9 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.219 -0.925 . . . . 0.0 109.39 162.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.12 149.42 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 163.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.92 -96.66 0.1 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.6 pt -136.09 161.59 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 110.43 -167.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -140.21 -18.67 0.89 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.864 -172.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -159.35 19.75 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.076 1.307 . . . . 0.0 112.149 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.6 p -151.29 128.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.63 121.12 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -76.42 139.99 41.12 Favored 'General case' 0 C--N 1.335 -0.058 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 165.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -150.01 163.05 39.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.645 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -149.06 15.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -143.74 146.46 33.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.688 0.676 . . . . 0.0 109.87 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.45 135.28 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.056 0.942 . . . . 0.0 109.989 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.99 130.22 43.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.783 1.233 . . . . 0.0 108.849 169.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.9 pt -87.07 51.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.797 0.839 . . . . 0.0 111.391 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.82 -81.95 0.04 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.44 -7.36 54.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.098 0.559 . . . . 0.0 111.87 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.52 29.04 74.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 125.555 1.55 . . . . 0.0 113.239 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 140.36 53.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -81.9 153.45 26.32 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.919 1.287 . . . . 0.0 109.511 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -146.89 126.12 13.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.897 1.279 . . . . 0.0 107.646 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.4 p -82.51 -23.71 34.49 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.084 -1.01 . . . . 0.0 111.479 170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 p -141.95 159.34 42.43 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 126.511 1.924 . . . . 0.0 108.594 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD2' ' HA2' ' A' ' 145' ' ' GLY . 0.5 OUTLIER -65.48 121.84 77.12 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -173.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -63.21 157.57 49.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 CA-C-N 121.011 1.397 . . . . 0.0 109.145 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.12 128.7 26.02 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.348 1.365 . . . . 0.0 108.935 174.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.64 69.18 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.057 1.313 . . . . 0.0 113.215 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 58.58 43.31 96.19 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 118.948 1.374 . . . . 0.0 111.391 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.45 168.25 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' A' ' 149' ' ' ASP . 18.9 t -78.06 110.52 13.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 111.183 -173.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.22 15.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.925 3.084 . . . . 0.0 114.576 167.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.4 OUTLIER -132.33 -20.13 2.41 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.053 1.741 . . . . 0.0 111.765 -175.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.16 3.42 0.25 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.83 -14.09 2.18 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.833 1.682 . . . . 0.0 114.919 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.6 m -62.13 149.27 41.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.097 1.448 . . . . 0.0 110.877 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.54 157.52 6.85 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 109.796 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.92 162.83 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.12 163.08 31.17 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.262 -1.523 . . . . 0.0 108.779 164.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.04 148.74 46.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 163.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -109.36 160.88 26.03 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 109.812 168.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.03 -166.6 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.108 2.539 . . . . 0.0 109.96 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.66 145.26 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.825 -0.547 . . . . 0.0 111.103 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 128.13 54.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 157.873 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 119.413 -0.327 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 m -56.53 139.49 49.39 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.76 -1.212 . . . . 0.0 108.598 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -158.96 143.3 15.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.72 142.25 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.58 137.41 49.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 108.281 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -89.11 164.72 14.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.88 0.848 . . . . 0.0 111.032 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.49 165.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -57.12 -26.31 60.29 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.39 -37.17 64.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 120.213 1.37 . . . . 0.0 109.405 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -77.37 -12.78 59.99 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.5 1.52 . . . . 0.0 112.538 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.45 -45.53 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.227 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.49 -20.39 50.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.979 1.718 . . . . 0.0 114.25 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.62 40.9 5.54 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 128.375 2.893 . . . . 0.0 112.097 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.2 100.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 119.944 1.872 . . . . 0.0 107.211 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 111.63 1.02 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.399 0.68 . . . . 0.0 110.328 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 23' ' ' GLU . 5.7 tp -155.69 170.23 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 126.189 1.796 . . . . 0.0 107.978 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 22' ' ' ILE . 54.3 mt-10 -115.03 162.63 16.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.624 2.37 . . . . 0.0 108.96 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.85 -132.83 4.27 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 118.456 0.571 . . . . 0.0 112.067 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.7 151.61 47.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.734 1.613 . . . . 0.0 109.971 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -129.36 149.78 51.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.973 1.709 . . . . 0.0 111.138 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.61 116.5 66.34 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 126.492 1.917 . . . . 0.0 109.318 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 31' ' ' VAL . 38.2 Cg_endo -63.09 -16.79 56.66 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.934 1.756 . . . . 0.0 112.379 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -53.57 52.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.152 1.381 . . . . 0.0 110.608 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.35 -35.5 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 O-C-N 121.611 -0.681 . . . . 0.0 109.424 -169.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG23 HD21 ' A' ' 43' ' ' LEU . 7.0 p -63.08 -20.5 25.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.768 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -69.67 -21.35 63.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.118 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.48 -7.36 31.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.532 1.533 . . . . 0.0 110.923 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.13 99.94 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.677 1.191 . . . . 0.0 108.455 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 -13.49 15.57 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.08 -176.08 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.054 1.342 . . . . 0.0 110.466 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -101.28 -43.21 6.04 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.391 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -56.9 -60.86 2.95 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 120.1 1.318 . . . . 0.0 107.702 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m -62.25 -11.29 14.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -89.37 -66.7 0.9 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.4 mt -52.37 -48.79 44.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 124.892 1.277 . . . . 0.0 107.659 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -56.58 -54.57 44.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.013 0.925 . . . . 0.0 112.553 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 31' ' ' VAL . 14.3 tp -58.15 -54.04 51.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.895 1.278 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.26 -39.79 83.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.484 1.514 . . . . 0.0 111.477 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.2 m -68.77 -45.38 71.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 120.687 -1.258 . . . . 0.0 112.005 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -38.28 90.46 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 124.452 1.101 . . . . 0.0 110.039 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.76 -56.69 11.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.776 0.831 . . . . 0.0 108.933 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 m -68.03 -26.07 65.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.992 0.517 . . . . 0.0 111.938 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 -2.25 39.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.895 1.678 . . . . 0.0 112.616 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.67 23.37 68.85 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 125.421 1.486 . . . . 0.0 113.464 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -72.41 -35.35 68.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 108.841 171.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -134.95 136.92 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -114.67 156.71 24.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.331 1.053 . . . . 0.0 111.207 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.3 mm -83.31 129.55 37.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 119.182 0.901 . . . . 0.0 109.656 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.28 124.15 6.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.258 1.023 . . . . 0.0 111.192 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.61 152.58 38.42 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.832 1.253 . . . . 0.0 109.636 166.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.55 166.83 28.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.782 3.654 . . . . 0.0 114.02 -171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -75.39 158.69 32.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.94 0.876 . . . . 0.0 111.395 162.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -44.15 95.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.576 1.151 . . . . 0.0 110.352 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.53 -32.8 71.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.591 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -48.17 74.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.383 0.673 . . . . 0.0 110.417 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -50.73 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.3 -32.31 69.93 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -45.63 80.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.667 1.121 . . . . 0.0 110.492 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -64.61 -45.41 95.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -54.01 -38.1 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.512 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -64.93 -59.18 4.46 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.899 1.227 . . . . 0.0 109.207 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.12 -33.55 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.828 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -63.64 -48.51 76.99 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.123 1.369 . . . . 0.0 110.807 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -27.53 68.38 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.194 -0.941 . . . . 0.0 110.645 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -70.26 -37.06 74.82 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.187 0.903 . . . . 0.0 111.844 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' ALA . 7.5 t -87.26 -14.95 39.54 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.851 1.205 . . . . 0.0 112.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 -59.73 0.6 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 125.057 1.313 . . . . 0.0 112.807 165.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -75.67 92.65 2.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.68 -43.79 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 123.53 0.732 . . . . 0.0 112.764 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.56 7.34 6.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.064 0.546 . . . . 0.0 110.149 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -69.91 -3.77 17.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 112.088 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.55 150.81 21.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.58 1.552 . . . . 0.0 108.972 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -69.94 157.83 36.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.744 0.783 . . . . 0.0 110.92 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -64.63 -50.88 65.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.171 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.61 -42.29 55.82 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.788 0.835 . . . . 0.0 111.453 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -59.08 5.18 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.824 1.65 . . . . 0.0 109.827 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.93 -44.86 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.78 1.232 . . . . 0.0 108.856 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -60.26 -52.64 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.609 1.563 . . . . 0.0 111.524 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.74 -54.26 37.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.257 1.023 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 96' ' ' ILE . 57.7 mt -58.23 -51.85 68.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.866 0.867 . . . . 0.0 109.419 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.78 -52.76 22.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 112.218 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -50.91 68.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 123.494 0.496 . . . . 0.0 110.028 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.91 -31.45 70.95 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 9.6 m-30 -69.39 -33.86 73.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.613 0.642 . . . . 0.0 110.558 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.71 -31.71 72.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.483 0.583 . . . . 0.0 112.53 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.06 -15.83 33.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.651 1.181 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.71 24.2 1.62 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 112.65 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.52 -102.21 0.87 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.079 0.847 . . . . 0.0 111.786 -169.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -153.48 166.28 33.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.202 1.001 . . . . 0.0 110.515 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 86' ' ' LEU . 48.4 mt -135.43 156.67 38.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.539 1.536 . . . . 0.0 107.379 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 124.68 30.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.867 1.267 . . . . 0.0 107.878 164.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.0 t -163.28 175.28 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.373 1.069 . . . . 0.0 110.54 165.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -147.34 63.21 1.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.554 1.142 . . . . 0.0 112.8 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.45 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -123.0 157.95 31.57 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.384 1.074 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -72.79 -45.06 60.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.566 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.377 1.071 . . . . 0.0 110.784 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -55.02 -41.66 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.436 1.016 . . . . 0.0 109.354 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.67 -43.51 96.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.61 0.764 . . . . 0.0 110.139 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 51.6 t30 -64.69 -53.76 42.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.754 0.821 . . . . 0.0 110.027 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.51 -55.15 16.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.951 0.901 . . . . 0.0 109.112 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.49 65.66 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.47 1.486 . . . . 0.0 113.565 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 t -57.5 -63.25 1.3 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.528 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -64.5 -21.24 66.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.852 1.66 . . . . 0.0 113.036 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mm? -85.47 -6.25 59.21 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.292 1.037 . . . . 0.0 112.522 175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.48 9.15 84.54 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.881 -1.511 . . . . 0.0 113.988 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.86 120.62 32.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.09 1.945 . . . . 0.0 111.418 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 134.95 57.59 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.95 1.3 . . . . 0.0 109.892 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -147.81 170.88 16.67 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 122.885 0.474 . . . . 0.0 110.262 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.2 mtt-85 -109.42 154.38 22.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.548 1.139 . . . . 0.0 109.647 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.443 -0.784 0 O-C-N 123.965 0.791 . . . . 0.0 109.41 172.298 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -159.13 14.53 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -141.53 150.5 42.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.008 1.276 . . . . 0.0 110.42 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.44 129.33 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.413 1.085 . . . . 0.0 108.262 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -62.07 153.37 30.03 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 165.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.79 88.32 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 122.804 1.288 . . . . 0.0 109.374 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.2 -75.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 p -93.75 -3.91 51.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.094 0.958 . . . . 0.0 113.031 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.66 26.59 72.06 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 125.707 1.622 . . . . 0.0 114.106 170.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -66.09 136.14 55.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.291 0.636 . . . . 0.0 109.506 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.8 141.03 31.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.489 1.116 . . . . 0.0 108.162 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -136.03 152.7 51.17 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -94.65 -17.82 21.91 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.74 -0.6 . . . . 0.0 111.726 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 45.4 p -128.02 169.21 14.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.514 1.126 . . . . 0.0 108.989 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.13 119.74 72.76 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.56 172.31 9.43 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.919 1.746 . . . . 0.0 110.269 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.46 138.19 83.24 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.032 1.821 . . . . 0.0 110.597 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.07 -5.34 1.34 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.56 1.076 . . . . 0.0 113.926 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.34 51.1 38.24 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-O 117.41 -1.772 . . . . 0.0 110.626 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 m -126.62 158.51 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 118.853 1.326 . . . . 0.0 108.065 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 35.2 t -77.78 111.95 21.37 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 125.216 1.406 . . . . 0.0 111.835 -167.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 44.0 Cg_endo -64.48 23.26 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.97 3.113 . . . . 0.0 115.231 167.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.82 -18.04 0.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.412 1.485 . . . . 0.0 113.336 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 13.0 p -151.83 -2.34 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.99 -17.8 5.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.856 1.217 . . . . 0.0 114.618 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -62.53 162.0 11.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.413 1.606 . . . . 0.0 112.901 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -61.64 155.92 21.26 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.62 -0.675 . . . . 0.0 110.771 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.34 144.41 21.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -133.79 164.18 27.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.196 1.398 . . . . 0.0 110.357 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.8 tt -78.91 155.37 29.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.537 1.135 . . . . 0.0 110.218 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.6 pt . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 127.372 2.269 . . . . 0.0 110.943 -178.412 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -51.62 124.89 13.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.788 1.235 . . . . 0.0 108.598 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 tp -149.4 142.72 25.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.382 1.873 . . . . 0.0 106.494 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.06 150.52 19.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.15 150.66 37.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.709 1.604 . . . . 0.0 108.591 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.82 161.12 13.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.004 0.522 . . . . 0.0 111.736 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.569 ' HB2' HG21 ' A' ' 30' ' ' VAL . 29.1 t -37.14 -55.31 0.97 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.857 2.463 . . . . 0.0 112.158 164.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.4 m -56.62 -28.01 59.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.227 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' ILE . 21.0 t -63.42 -45.36 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.662 1.119 . . . . 0.0 109.43 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.36 -33.51 71.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.576 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.68 -41.62 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.051 0.941 . . . . 0.0 110.446 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -75.65 -30.26 59.4 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.977 -0.452 . . . . 0.0 110.485 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.04 29.42 15.22 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 124.975 1.274 . . . . 0.0 111.187 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.5 mt -74.5 110.06 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.19 121.22 9.56 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.411 1.484 . . . . 0.0 109.178 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 23' ' ' GLU . 8.3 tp -158.83 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.755 2.022 . . . . 0.0 109.669 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' H ' HG13 ' A' ' 22' ' ' ILE . 1.7 mp0 -135.77 159.19 42.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 108.99 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.41 -134.13 5.37 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 120.795 1.634 . . . . 0.0 114.376 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -129.0 154.99 46.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.6 1.96 . . . . 0.0 109.351 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -141.6 153.89 45.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.901 0.88 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.4 p -86.89 118.22 69.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.904 0.882 . . . . 0.0 110.455 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.88 -27.85 74.43 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.098 1.199 . . . . 0.0 110.794 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -71.88 -24.11 61.61 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 13' ' ' SER . 7.4 p -86.44 -31.12 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 121.33 1.877 . . . . 0.0 109.326 166.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.71 -22.1 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 119.211 0.914 . . . . 0.0 111.043 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.75 -14.9 16.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.629 -1.294 . . . . 0.0 112.746 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.53 -30.56 7.58 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.534 -1.354 . . . . 0.0 112.411 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -55.29 111.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 120.099 1.318 . . . . 0.0 110.399 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -12.81 6.96 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.113 1.365 . . . . 0.0 112.615 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.99 122.69 17.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.8 mtt-85 -52.72 -49.68 64.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.169 0.988 . . . . 0.0 110.366 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.69 -52.74 64.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.265 0.978 . . . . 0.0 109.098 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 t -53.8 -49.14 68.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -65.18 -53.9 37.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.675 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.15 -54.1 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 33.2 t80 -57.26 -49.22 76.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.263 1.025 . . . . 0.0 111.103 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.7 tp -50.49 -60.77 2.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 109.98 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.63 78.78 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.302 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.9 m -57.37 -49.66 75.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.471 1.108 . . . . 0.0 110.654 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 26.2 mt -63.2 -41.98 99.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.785 0.434 . . . . 0.0 110.228 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.59 -50.35 67.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 p -64.09 -33.93 76.88 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.132 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.592 0.757 . . . . 0.0 110.058 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.99 16.5 6.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 124.18 0.895 . . . . 0.0 112.276 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -86.29 -27.54 24.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.374 1.087 . . . . 0.0 110.803 -173.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.95 148.97 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -129.66 146.41 51.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.415 1.086 . . . . 0.0 112.01 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.47 125.79 36.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.214 1.806 . . . . 0.0 108.119 -175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.5 118.53 5.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.263 1.025 . . . . 0.0 109.928 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -86.26 155.13 57.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.373 -0.829 . . . . 0.0 110.027 163.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.41 163.52 36.24 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 124.605 3.537 . . . . 0.0 111.301 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -83.94 166.7 17.61 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.741 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -57.73 -50.42 73.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.185 1.394 . . . . 0.0 110.628 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.2 -27.6 67.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.51 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.14 -51.13 49.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.609 0.764 . . . . 0.0 109.404 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.64 -46.78 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.965 . . . . 0.0 109.744 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.34 -34.42 68.75 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.081 -0.387 . . . . 0.0 111.721 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -44.52 86.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.819 0.448 . . . . 0.0 110.945 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.95 -36.31 75.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.36 -47.7 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -65.01 -45.14 86.74 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.412 1.005 . . . . 0.0 111.728 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.985 HG11 HD21 ' A' ' 110' ' ' LEU . 9.9 p -69.43 -40.42 79.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 O-C-N 121.164 -0.96 . . . . 0.0 110.379 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.06 89.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -27.37 58.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.256 -0.903 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.71 -13.52 62.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.792 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 t -125.19 -15.79 6.17 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.992 1.724 . . . . 0.0 114.964 -174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.37 -90.14 0.15 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.109 1.322 . . . . 0.0 110.786 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -77.16 58.11 1.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.581 1.953 . . . . 0.0 113.212 -161.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.5 p -45.45 -37.75 2.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.82 1.648 . . . . 0.0 114.944 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -128.79 11.1 6.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.09 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.04 -9.46 59.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.703 0.683 . . . . 0.0 111.989 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 144.3 27.02 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 m -67.62 161.47 25.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.245 1.021 . . . . 0.0 111.034 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -61.26 -55.58 30.29 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.327 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.34 -37.99 68.16 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 123.888 0.742 . . . . 0.0 110.386 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -61.96 -53.95 48.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.569 0.748 . . . . 0.0 109.027 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.55 -43.7 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.238 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -63.21 -54.98 28.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.13 0.972 . . . . 0.0 112.238 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.18 -49.52 83.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 109.799 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 HD13 ' A' ' 96' ' ' ILE . 94.9 mt -61.04 -49.42 77.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -53.33 -53.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.79 0.836 . . . . 0.0 111.806 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.1 tp -51.09 -52.65 41.43 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.655 0.782 . . . . 0.0 109.82 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.23 69.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.514 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.6 m-30 -84.61 -18.43 35.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.131 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.01 -37.17 75.58 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.74 1.155 . . . . 0.0 109.229 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 -17.58 45.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.034 1.334 . . . . 0.0 112.474 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.17 46.65 5.18 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.066 2.146 . . . . 0.0 110.753 -169.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.53 -114.69 3.97 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.383 0.516 . . . . 0.0 112.113 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.44 164.21 31.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.07 1.748 . . . . 0.0 106.409 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.519 HD13 HD23 ' A' ' 86' ' ' LEU . 80.0 mt -136.6 155.95 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 116.85 15.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -156.27 -173.37 4.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.536 0.734 . . . . 0.0 109.947 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -144.53 -13.75 0.58 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.3 160.59 32.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.616 1.553 . . . . 0.0 114.684 -168.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -62.53 -46.09 90.0 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 119.929 -1.732 . . . . 0.0 110.936 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -72.16 -53.97 11.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -41.63 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.879 0.872 . . . . 0.0 111.318 -168.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.66 -38.88 64.81 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.933 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 109' ' ' LEU . 15.2 t30 -66.86 -51.13 59.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 117.531 -1.223 . . . . 0.0 108.055 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -48.16 -59.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.44 63.75 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.841 1.655 . . . . 0.0 112.681 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -65.28 -53.32 45.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.277 -1.344 . . . . 0.0 112.719 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -61.98 -35.69 79.26 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 121.518 1.963 . . . . 0.0 109.962 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.985 HD21 HG11 ' A' ' 68' ' ' VAL . 2.3 mm? -71.11 -19.38 62.45 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.37 14.87 79.55 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.201 -1.333 . . . . 0.0 113.502 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -72.68 163.81 27.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.138 1.469 . . . . 0.0 109.213 176.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.562 ' H ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -105.68 128.81 53.88 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -151.18 -176.39 5.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.204 0.202 . . . . 0.0 110.762 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -119.79 154.37 34.34 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.559 1.544 . . . . 0.0 109.663 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -160.883 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -156.0 14.78 0.34 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -136.03 147.36 47.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.772 1.169 . . . . 0.0 110.831 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.11 134.73 47.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.755 1.222 . . . . 0.0 108.329 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 129.66 40.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.121 0.968 . . . . 0.0 108.416 165.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 pt -84.03 111.14 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 160.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.84 -93.66 0.17 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 106.543 -2.623 . . . . 0.0 106.543 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 3.6 p -76.34 -13.74 60.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.212 0.605 . . . . 0.0 111.952 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.87 73.84 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 124.69 1.138 . . . . 0.0 115.305 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -68.81 129.75 40.82 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 110.631 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -71.42 147.13 48.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.375 1.07 . . . . 0.0 110.198 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -139.89 156.04 46.89 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.145 0.978 . . . . 0.0 109.553 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 p -97.54 -24.83 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.235 0.614 . . . . 0.0 112.053 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.91 129.85 5.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -158.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.82 123.24 80.98 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 126.099 1.76 . . . . 0.0 110.43 -168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.3 171.75 17.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.61 3.54 . . . . 0.0 113.121 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.54 87.76 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.429 3.419 . . . . 0.0 110.505 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.27 -28.77 2.67 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 126.363 1.935 . . . . 0.0 111.113 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.72 32.05 61.31 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 121.462 -1.022 . . . . 0.0 112.275 -168.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 178.54 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 126.179 1.791 . . . . 0.0 107.906 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.9 t -83.21 103.97 3.23 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.304 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.63 -2.5 0.72 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.072 1.848 . . . . 0.0 114.589 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.77 -31.5 13.17 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.826 1.25 . . . . 0.0 112.682 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.8 -35.98 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.815 0.846 . . . . 0.0 113.069 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 113.22 -15.91 22.69 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.143 2.306 . . . . 0.0 113.599 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.1 m -67.77 169.86 8.92 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.765 1.782 . . . . 0.0 113.178 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -74.13 142.45 45.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.372 1.069 . . . . 0.0 111.536 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.17 147.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.718 1.607 . . . . 0.0 106.763 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -122.89 160.81 25.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.632 1.173 . . . . 0.0 108.807 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.02 151.56 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 125.116 1.366 . . . . 0.0 110.584 176.124 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -53.76 129.16 32.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.349 1.06 . . . . 0.0 110.372 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.1 tp -149.74 149.44 30.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 151.07 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.94 158.61 26.37 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.655 1.582 . . . . 0.0 109.007 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -118.62 169.28 9.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.306 1.442 . . . . 0.0 111.295 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 p -55.52 -46.74 77.0 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.966 1.306 . . . . 0.0 112.459 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -27.06 62.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.806 -1.092 . . . . 0.0 112.526 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.96 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.503 1.501 . . . . 0.0 109.109 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' HD12 ' A' ' 43' ' ' LEU . 38.2 m-85 -72.4 -33.0 66.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.406 0.682 . . . . 0.0 111.23 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.25 -49.63 83.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.924 0.889 . . . . 0.0 109.722 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.69 -13.73 61.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.297 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.55 22.8 57.76 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.582 0.611 . . . . 0.0 113.346 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.2 mt -77.77 107.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 108.4 1.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 171.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -154.22 154.96 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -98.89 164.15 12.32 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 126.431 1.892 . . . . 0.0 111.15 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.71 -139.39 9.34 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-O 121.28 0.378 . . . . 0.0 112.255 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -125.83 151.32 46.96 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.961 1.305 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 t -135.89 147.08 48.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.396 0.678 . . . . 0.0 109.301 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 114.09 48.12 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.484 1.914 . . . . 0.0 111.025 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.67 -20.99 45.08 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.002 1.802 . . . . 0.0 113.801 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -87.9 -12.95 43.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.16 -38.01 10.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 120.667 1.576 . . . . 0.0 108.154 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.97 -20.54 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.633 0.773 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.09 -24.16 38.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.539 1.135 . . . . 0.0 113.101 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.52 7.12 10.58 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.322 0.964 . . . . 0.0 112.7 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 mt -74.72 88.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -10.75 45.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.651 1.98 . . . . 0.0 112.686 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -73.7 124.52 26.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -67.82 -43.84 78.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 117.693 -1.146 . . . . 0.0 111.634 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -57.15 -55.43 34.9 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -55.57 -52.48 63.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.711 0.804 . . . . 0.0 111.208 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -58.69 -56.7 18.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.178 0.991 . . . . 0.0 110.076 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.08 -53.93 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 30.7 t80 -56.01 -49.69 72.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.404 0.682 . . . . 0.0 111.341 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' CD2' ' A' ' 16' ' ' PHE . 6.7 tt -54.98 -56.29 21.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.541 1.136 . . . . 0.0 110.066 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.32 -38.66 87.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.832 0.453 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.3 m -58.77 -41.64 87.1 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.837 0.855 . . . . 0.0 111.259 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.512 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 11.6 mt -64.35 -43.14 95.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.826 0.739 . . . . 0.0 110.629 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.32 -52.08 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.9 m -61.78 -32.13 72.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.427 1.091 . . . . 0.0 111.65 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.08 69.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.648 1.179 . . . . 0.0 110.836 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.16 -16.45 3.43 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 123.703 0.668 . . . . 0.0 113.343 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -71.85 -34.95 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.612 0.706 . . . . 0.0 110.774 -160.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 162.29 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.44 141.03 33.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.981 0.912 . . . . 0.0 108.853 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.43 124.68 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.887 0.875 . . . . 0.0 109.748 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.42 136.02 17.06 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.35 160.13 28.31 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.857 0.863 . . . . 0.0 112.177 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.74 -177.03 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.674 3.583 . . . . 0.0 112.575 168.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 t -122.02 166.81 13.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.76 1.224 . . . . 0.0 109.748 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' C ' ' HE2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -56.17 -49.53 73.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.303 1.041 . . . . 0.0 110.311 -173.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.13 -22.42 62.07 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.724 -0.61 . . . . 0.0 112.061 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -50.75 66.83 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mm -59.09 -49.6 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.04 0.936 . . . . 0.0 108.67 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -27.88 67.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.118 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -48.84 79.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.319 1.418 . . . . 0.0 110.612 173.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -64.82 -33.04 60.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.78 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.417 -0.802 . . . . 0.0 109.696 170.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -57.28 -49.62 75.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.861 1.21 . . . . 0.0 110.582 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.921 HG11 HD21 ' A' ' 110' ' ' LEU . 5.2 p -72.2 -41.27 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.87 -0.519 . . . . 0.0 110.632 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.36 -25.22 61.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 111.076 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 -25.98 41.54 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.245 0.929 . . . . 0.0 110.335 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.18 -5.61 5.21 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.284 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.266 10.8 t -127.56 -58.79 1.24 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.123 1.329 . . . . 0.0 111.365 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.43 -21.57 0.64 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 120.348 1.431 . . . . 0.0 115.585 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.48 20.32 0.43 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.094 1.447 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -33.36 -57.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 128.044 2.538 . . . . 0.0 115.864 -163.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -121.58 11.47 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.846 0.859 . . . . 0.0 109.794 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.31 -34.98 76.12 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.069 0.948 . . . . 0.0 109.82 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -64.88 149.75 48.98 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 111.86 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -51.66 133.42 30.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.888 1.275 . . . . 0.0 108.633 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -44.86 84.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.842 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.53 60.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.1 0.56 . . . . 0.0 111.48 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.12 -50.0 73.66 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.184 1.394 . . . . 0.0 108.812 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.9 mt -53.42 -45.77 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.642 0.777 . . . . 0.0 109.252 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -67.48 -44.25 78.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.208 1.403 . . . . 0.0 111.787 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.84 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.389 1.075 . . . . 0.0 108.895 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 96' ' ' ILE . 75.7 mt -59.19 -53.29 59.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.36 1.064 . . . . 0.0 109.295 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.36 -51.04 61.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.455 1.502 . . . . 0.0 111.825 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.1 tp -51.57 -56.05 15.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.03 86.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.253 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.1 m-30 -66.35 -33.69 76.3 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.956 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 -42.76 83.31 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.43 1.014 . . . . 0.0 109.495 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.92 -18.28 50.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.361 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt 53.99 26.38 6.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.48 1.112 . . . . 0.0 111.116 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.46 -159.36 27.96 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 127.654 2.55 . . . . 0.0 113.13 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.11 173.62 7.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 110.232 165.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.558 HD13 HD23 ' A' ' 86' ' ' LEU . 41.7 mt -129.13 163.47 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.292 2.237 . . . . 0.0 108.002 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.57 115.89 11.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.166 2.187 . . . . 0.0 106.984 165.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t -158.37 177.96 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.906 1.283 . . . . 0.0 109.673 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -150.62 23.59 0.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.823 -1.173 . . . . 0.0 113.335 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 4.0 t0 -87.84 156.14 19.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.792 -1.192 . . . . 0.0 109.59 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -64.39 -47.77 77.95 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.034 1.288 . . . . 0.0 109.654 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.69 -53.27 35.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.258 1.423 . . . . 0.0 110.544 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.4 p -54.3 -41.81 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.03 1.287 . . . . 0.0 110.316 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 114' ' ' PHE . 37.9 mt-30 -69.6 -36.5 76.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.073 0.949 . . . . 0.0 110.843 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.444 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.1 t-20 -69.02 -55.25 11.39 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 HD21 ' A' ' 78' ' ' LEU . 9.7 mm -49.59 -60.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 C-N-CA 125.094 1.358 . . . . 0.0 109.49 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.0 56.76 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.076 1.307 . . . . 0.0 112.163 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -48.13 75.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.974 -1.489 . . . . 0.0 113.705 172.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -65.89 -33.03 74.9 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 122.609 2.459 . . . . 0.0 110.631 174.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.921 HD21 HG11 ' A' ' 68' ' ' VAL . 1.1 mm? -75.5 -3.89 36.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.902 1.281 . . . . 0.0 113.032 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.03 -2.72 8.06 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.208 1.385 . . . . 0.0 115.226 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -74.06 127.86 34.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 120.14 1.97 . . . . 0.0 110.319 -167.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 129.52 39.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 104' ' ' GLN . 32.7 p90 -134.68 -179.37 5.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.637 0.256 . . . . 0.0 111.15 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.02 152.79 32.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.339 1.856 . . . . 0.0 107.993 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.321 -0.66 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.399 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 4.0 p-90 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -140.65 12.18 2.29 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.92 140.69 45.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 120.532 1.515 . . . . 0.0 111.675 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.29 139.43 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.929 2.092 . . . . 0.0 109.577 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 4.4 t -81.97 119.98 24.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 161.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.22 127.24 31.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 157.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 134.85 -81.8 0.3 Allowed Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 106.714 -2.555 . . . . 0.0 106.714 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.6 p -80.75 -19.48 44.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.351 -0.5 . . . . 0.0 110.73 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.22 18.54 62.47 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 121.398 -0.813 . . . . 0.0 113.766 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -84.75 162.0 19.79 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.611 1.564 . . . . 0.0 111.109 -165.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -112.29 142.1 45.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 110.481 -164.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -143.82 155.35 44.1 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.614 1.165 . . . . 0.0 109.784 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 1.8 p -104.88 -13.26 15.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.642 0.777 . . . . 0.0 112.977 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.7 p -147.07 175.61 10.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.893 2.477 . . . . 0.0 106.671 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.9 tp -80.19 133.65 56.98 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.3 170.51 20.18 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.612 2.208 . . . . 0.0 109.222 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -56.18 134.78 66.31 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.71 1.607 . . . . 0.0 109.632 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.07 -13.64 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.047 0.832 . . . . 0.0 113.901 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.06 27.89 71.21 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.264 1.532 . . . . 0.0 114.004 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 156.11 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.299 1.44 . . . . 0.0 107.597 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.62 117.88 51.84 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.97 -18.33 60.79 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.146 1.231 . . . . 0.0 113.246 171.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -81.69 -46.1 14.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.026 -1.046 . . . . 0.0 109.4 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.0 p -136.1 -1.5 2.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.66 0.784 . . . . 0.0 113.059 -159.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.15 -11.49 16.04 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.64 1.59 . . . . 0.0 114.624 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.2 m -75.7 163.91 26.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.483 1.142 . . . . 0.0 113.246 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -68.74 148.01 50.97 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.011 -1.055 . . . . 0.0 111.511 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 t -108.39 148.66 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.86 161.46 42.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.335 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.0 151.71 23.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.708 . . . . 0.0 110.595 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 124.336 1.054 . . . . 0.0 110.925 179.438 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -48.63 118.07 2.34 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.547 1.939 . . . . 0.0 109.03 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 tp -140.79 139.2 34.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.713 2.005 . . . . 0.0 107.667 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.7 153.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -135.58 145.65 47.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.219 1.808 . . . . 0.0 107.567 -167.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -110.0 166.48 10.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.507 . . . . 0.0 111.743 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -46.21 -46.78 17.78 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.247 1.819 . . . . 0.0 109.414 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -50.25 -34.94 24.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.617 1.167 . . . . 0.0 113.829 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 t -65.36 -43.79 94.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.209 0.913 . . . . 0.0 108.975 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.36 -36.59 71.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.964 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.51 -38.91 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.035 0.934 . . . . 0.0 110.667 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -83.2 -23.26 32.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.905 . . . . 0.0 112.825 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.23 24.04 27.83 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.88 0.764 . . . . 0.0 112.486 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -77.28 106.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.11 103.93 1.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.858 1.263 . . . . 0.0 108.467 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 tp -151.86 130.09 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -73.75 136.51 43.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.757 1.623 . . . . 0.0 110.815 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.26 -161.61 34.17 Favored Glycine 0 CA--C 1.521 0.453 0 O-C-N 120.721 -1.237 . . . . 0.0 112.101 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.28 151.24 42.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.481 0.712 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -142.89 152.5 42.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.565 1.146 . . . . 0.0 110.162 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.9 p -84.32 126.43 69.47 Favored Pre-proline 0 C--O 1.249 1.055 0 C-N-CA 123.192 0.597 . . . . 0.0 111.037 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -59.01 -30.16 92.63 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 120.409 0.739 . . . . 0.0 111.093 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 m -61.82 -43.95 97.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.697 1.135 . . . . 0.0 113.56 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.89 -38.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 43' ' ' LEU . 4.5 p -64.09 -26.54 40.73 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.123 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.37 -28.73 69.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.995 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -89.64 -22.89 22.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 111.401 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.11 133.47 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.531 1.158 . . . . 0.0 108.471 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -3.2 0.61 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.878 1.671 . . . . 0.0 112.098 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -70.56 120.35 16.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.9 mtm-85 -66.19 -40.5 90.48 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.552 -170.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.45 -57.01 14.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.0 t -52.37 -54.66 28.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.385 1.474 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -58.65 -57.84 11.21 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.068 0.947 . . . . 0.0 111.37 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.6 -49.38 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 43.8 t80 -59.48 -44.54 93.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.726 0.694 . . . . 0.0 112.493 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.511 HD13 HG23 ' A' ' 31' ' ' VAL . 5.2 tt -58.38 -56.12 26.21 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.327 1.051 . . . . 0.0 108.81 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.51 -40.68 87.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.511 0.725 . . . . 0.0 109.868 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -53.06 -48.41 67.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.161 1.384 . . . . 0.0 110.45 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.515 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 12.6 mt -62.81 -42.45 99.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.83 0.741 . . . . 0.0 111.424 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.37 -46.52 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 t -58.63 -44.48 90.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 109.991 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.14 99.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.353 1.461 . . . . 0.0 110.015 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.18 2.25 7.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.643 1.116 . . . . 0.0 113.887 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.1 -37.38 17.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 117.894 0.847 . . . . 0.0 109.932 -164.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -120.08 153.6 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -140.66 141.06 35.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.617 0.767 . . . . 0.0 110.643 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.39 134.07 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.52 126.59 9.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.501 1.12 . . . . 0.0 109.225 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 151.08 48.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.069 0.948 . . . . 0.0 111.335 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.89 -175.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.572 3.514 . . . . 0.0 110.548 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -125.63 161.43 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.448 2.299 . . . . 0.0 108.241 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -58.99 -40.42 84.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.299 -0.875 . . . . 0.0 110.436 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.21 -33.67 71.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.4 p -75.51 -35.49 60.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.265 0.939 . . . . 0.0 109.862 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.07 -50.11 80.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.44 -37.01 72.13 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.774 0.43 . . . . 0.0 111.059 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -42.67 65.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 111.026 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.0 mm -67.08 -48.6 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.05 -39.34 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.877 0.871 . . . . 0.0 110.28 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -54.8 -63.49 1.14 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.836 0.854 . . . . 0.0 109.974 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.89 -30.9 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -67.04 -47.18 72.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.42 -0.8 . . . . 0.0 110.791 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.18 67.54 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 120.817 -1.177 . . . . 0.0 110.659 173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -72.26 0.81 8.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.372 1.069 . . . . 0.0 112.514 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.272 2.9 t -121.05 -49.6 2.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.868 1.213 . . . . 0.0 109.51 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.3 -58.0 0.29 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.132 0.878 . . . . 0.0 112.499 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -69.62 39.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.399 2.68 . . . . 0.0 114.686 -171.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 10.7 p -39.77 -49.46 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.127 2.171 . . . . 0.0 115.062 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.8 28.19 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.176 0.99 . . . . 0.0 108.655 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.1 -28.35 63.24 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.632 -1.292 . . . . 0.0 110.4 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 160.26 30.75 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 t -66.51 154.56 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 109.974 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 13.8 ttpt -63.49 -51.49 65.36 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.771 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.27 -45.55 45.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.227 0.954 . . . . 0.0 109.439 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.17 -54.04 51.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.437 0.695 . . . . 0.0 111.447 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.17 -41.36 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.495 1.118 . . . . 0.0 109.645 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.44 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 47.5 mt-10 -65.5 -44.9 85.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.394 1.078 . . . . 0.0 111.548 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.1 -48.41 83.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 119.1 0.863 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.633 HD23 HD13 ' A' ' 96' ' ' ILE . 42.0 mt -60.99 -48.97 79.38 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.558 0.743 . . . . 0.0 109.756 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.31 -57.79 6.23 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.948 1.299 . . . . 0.0 110.917 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.8 tp -47.62 -52.35 18.22 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.474 0.71 . . . . 0.0 110.36 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.58 70.8 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.9 m-30 -80.81 -29.55 35.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.505 0.593 . . . . 0.0 111.131 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.31 -42.68 91.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.877 0.846 . . . . 0.0 109.217 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.95 -14.52 44.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 112.894 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 43.2 55.36 4.67 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.328 1.451 . . . . 0.0 110.394 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -135.61 8.8 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 121.856 0.698 . . . . 0.0 111.465 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -129.47 170.19 14.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.633 HD13 HD23 ' A' ' 86' ' ' LEU . 74.3 mt -131.52 156.03 42.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.64 118.39 18.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.035 1.334 . . . . 0.0 108.256 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 6.8 t -166.37 -170.08 1.57 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.646 1.578 . . . . 0.0 108.997 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -150.62 10.85 0.66 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 161.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -53.39 150.83 6.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.368 1.467 . . . . 0.0 114.727 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -63.19 -30.78 71.86 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.473 -1.392 . . . . 0.0 112.263 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -80.15 -56.12 4.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.751 1.62 . . . . 0.0 110.215 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 1.8 p -52.69 -41.29 37.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 119.92 1.236 . . . . 0.0 112.664 -169.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -64.66 -46.69 81.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.4 t-20 -64.08 -52.81 57.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 117.425 -1.274 . . . . 0.0 107.784 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.5 mm -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 119.604 1.093 . . . . 0.0 110.328 -175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.55 68.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.668 1.122 . . . . 0.0 112.153 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.18 -39.12 78.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.957 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -64.27 -44.55 91.39 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 122.437 2.38 . . . . 0.0 107.721 170.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -69.02 -29.12 67.23 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -167.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.53 18.65 37.67 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 117.999 -1.445 . . . . 0.0 112.766 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.01 127.82 38.66 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.02 1.41 . . . . 0.0 110.627 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 128.93 38.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.284 1.833 . . . . 0.0 109.585 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.86 179.62 6.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.626 0.77 . . . . 0.0 111.092 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -123.37 133.09 54.15 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.422 1.489 . . . . 0.0 108.834 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.239 0.549 0 C-N-CA 124.62 1.168 . . . . 0.0 108.775 170.409 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -147.43 0.49 0.69 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.336 -1.316 . . . . 0.0 113.952 -158.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -142.33 135.39 28.63 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.937 0.789 . . . . 0.0 108.984 -170.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.53 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.082 0.953 . . . . 0.0 108.66 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.7 OUTLIER -73.6 127.89 33.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.736 0.814 . . . . 0.0 108.813 171.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.14 -9.67 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.62 -15.14 27.88 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.938 -0.923 . . . . 0.0 113.826 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 13.8 p -147.24 2.66 0.77 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.59 1.195 . . . . 0.0 113.075 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.88 64.57 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.702 1.62 . . . . 0.0 115.039 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 54.1 ttt-85 -72.08 145.81 47.97 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 117.681 0.741 . . . . 0.0 110.464 -167.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -93.54 145.62 24.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.647 -169.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -141.85 148.82 39.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.989 1.316 . . . . 0.0 108.223 170.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 p -98.74 -15.3 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.523 -0.736 . . . . 0.0 111.739 168.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.5 p -137.6 152.53 49.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.708 1.203 . . . . 0.0 108.601 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -64.75 120.05 62.86 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 113.475 -1.693 . . . . 0.0 106.717 174.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 141' ' ' LEU . 92.0 Cg_endo -69.69 169.09 19.65 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.023 2.482 . . . . 0.0 109.121 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -55.5 134.21 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.656 1.571 . . . . 0.0 109.599 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.84 -10.61 8.77 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.515 -1.158 . . . . 0.0 114.226 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.01 38.22 93.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.969 1.885 . . . . 0.0 112.624 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.01 163.09 32.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.538 1.135 . . . . 0.0 109.28 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 3.9 t -72.99 113.32 20.6 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 110.179 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 36.4 Cg_endo -62.68 -12.35 28.11 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.775 0.955 . . . . 0.0 111.86 163.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.27 -22.65 18.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.334 1.454 . . . . 0.0 111.895 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 3.4 p -156.17 5.31 0.18 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.07 -11.04 2.15 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.714 2.102 . . . . 0.0 116.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 168.61 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.312 1.556 . . . . 0.0 112.41 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -77.98 144.96 36.31 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 t -94.3 158.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -140.47 167.31 22.46 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.013 -1.679 . . . . 0.0 109.123 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.14 154.46 26.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.239 1.016 . . . . 0.0 109.673 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 CA--C 1.548 0.881 0 C-N-CA 125.21 1.404 . . . . 0.0 112.42 178.285 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -48.24 128.34 14.07 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.261 1.824 . . . . 0.0 110.808 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -153.62 144.71 22.88 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.677 0.791 . . . . 0.0 110.212 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.36 147.53 30.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.557 0.743 . . . . 0.0 110.012 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 HD21 ' A' ' 9' ' ' LEU . 1.3 mm? -122.75 129.48 51.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.593 1.957 . . . . 0.0 109.682 -174.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -84.23 165.35 18.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.601 0.76 . . . . 0.0 109.134 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 30' ' ' VAL . 26.2 t -46.63 -45.26 18.97 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.393 1.877 . . . . 0.0 110.265 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -49.86 -34.23 19.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.781 1.632 . . . . 0.0 111.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.5 -39.59 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.441 1.096 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.14 -24.93 47.19 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.2 1.0 . . . . 0.0 111.238 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.57 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.679 0.791 . . . . 0.0 109.075 171.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.79 -23.7 36.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.745 0.702 . . . . 0.0 112.389 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.19 18.88 52.4 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.433 1.016 . . . . 0.0 113.167 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.44 112.89 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.045 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -62.49 106.63 0.79 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 109.133 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 tp -155.08 149.22 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' HD22 ' A' ' 9' ' ' LEU . 5.8 pt-20 -111.45 120.61 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.066 1.346 . . . . 0.0 109.316 -166.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.09 -161.08 29.38 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.339 0.972 . . . . 0.0 113.57 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.2 150.04 21.34 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.4 -0.471 . . . . 0.0 112.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -132.38 147.91 52.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.12 2.168 . . . . 0.0 108.514 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 115.98 62.39 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 126.554 1.941 . . . . 0.0 107.632 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.83 -33.85 72.86 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.454 1.436 . . . . 0.0 110.273 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.23 -36.37 41.4 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.905 3.282 . . . . 0.0 114.432 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 13' ' ' SER . 14.8 p -98.75 -32.09 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.264 0.938 . . . . 0.0 110.572 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.78 -32.71 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.968 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -28.61 10.01 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -89.85 -23.39 21.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 117.745 -1.121 . . . . 0.0 111.508 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.264 5.5 mt -62.7 85.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.655 1.582 . . . . 0.0 110.113 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.33 -11.5 57.61 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 129.115 2.966 . . . . 0.0 110.966 174.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 124.2 26.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -45.42 70.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.671 -0.643 . . . . 0.0 110.332 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.27 -48.99 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.296 1.038 . . . . 0.0 108.39 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -68.76 -49.82 55.57 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.79 0.836 . . . . 0.0 111.842 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -59.97 -55.63 31.71 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.834 0.454 . . . . 0.0 110.51 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.2 mt -55.05 -49.16 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -55.47 -57.8 10.42 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 111.613 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tp -51.26 -52.85 41.09 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.118 1.767 . . . . 0.0 110.844 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.5 -37.44 87.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.648 0.779 . . . . 0.0 110.044 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 m -62.82 -43.02 99.9 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.727 0.694 . . . . 0.0 110.198 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -39.42 86.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.42 -44.9 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.327 -0.858 . . . . 0.0 108.717 170.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 t -64.5 -3.74 3.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 112.891 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.58 3.03 13.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.974 1.709 . . . . 0.0 111.566 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.03 87.2 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.827 1.68 . . . . 0.0 112.878 173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -86.11 -28.41 24.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.891 0.846 . . . . 0.0 111.442 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.64 142.4 35.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 14.2 ttmm -143.95 145.25 32.12 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 112.252 -168.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.9 120.48 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.007 1.323 . . . . 0.0 109.482 -168.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.31 128.88 12.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.432 1.493 . . . . 0.0 110.171 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.07 157.0 35.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.967 1.307 . . . . 0.0 112.322 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.95 157.21 62.82 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.789 2.993 . . . . 0.0 113.332 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -84.68 162.06 19.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.347 165.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -51.28 -42.9 61.43 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.365 1.066 . . . . 0.0 111.806 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.46 -27.06 68.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.548 0.739 . . . . 0.0 110.736 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -72.11 -47.53 50.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.168 1.387 . . . . 0.0 110.121 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 mm -58.97 -47.33 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.54 -41.19 53.57 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.043 1.337 . . . . 0.0 110.72 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -48.24 74.52 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.963 1.305 . . . . 0.0 110.182 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -64.73 -48.56 84.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.2 mt -48.86 -45.38 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.427 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.59 -59.14 5.91 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.476 0.71 . . . . 0.0 110.502 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.08 -31.25 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.41 -53.29 20.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.16 1.384 . . . . 0.0 110.897 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -30.02 70.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -66.92 -20.46 65.91 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.393 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 t -124.41 8.58 8.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.709 1.595 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.99 -85.36 0.34 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.996 -1.065 . . . . 0.0 112.286 164.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.62 92.48 0.33 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.335 1.054 . . . . 0.0 108.756 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.57 -49.02 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 121.717 -0.615 . . . . 0.0 111.528 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -132.72 17.73 4.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.826 0.85 . . . . 0.0 110.157 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -12.51 61.21 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 120.867 0.365 . . . . 0.0 110.378 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.0 mp -87.29 149.63 24.42 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.392 1.477 . . . . 0.0 108.058 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 m -67.65 161.37 25.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.098 0.559 . . . . 0.0 110.913 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -57.69 -58.46 8.24 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 122.764 0.426 . . . . 0.0 109.99 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.77 -39.46 65.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.671 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -58.66 7.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.86 2.064 . . . . 0.0 109.091 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.15 -44.6 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 126.093 1.757 . . . . 0.0 108.69 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -62.18 -44.9 95.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.108 0.963 . . . . 0.0 111.144 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.08 -53.49 47.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.384 0.538 . . . . 0.0 109.87 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD23 HD13 ' A' ' 96' ' ' ILE . 20.9 mt -58.95 -51.69 68.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.284 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.26 -56.56 7.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.359 1.464 . . . . 0.0 112.511 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -46.11 81.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.5 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.564 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.5 m-30 -66.67 -22.12 66.09 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.047 1.294 . . . . 0.0 112.817 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.55 -47.06 74.02 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.93 -20.1 46.47 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 53.9 30.17 11.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.171 1.788 . . . . 0.0 113.49 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.01 -116.35 0.66 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 125.461 1.505 . . . . 0.0 112.427 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -153.9 159.19 41.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.994 1.718 . . . . 0.0 106.996 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.611 HD13 HD23 ' A' ' 86' ' ' LEU . 69.8 mt -126.92 150.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.34 120.62 27.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 t -160.16 -166.16 1.63 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.514 1.925 . . . . 0.0 108.61 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.78 11.32 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.124 1.37 . . . . 0.0 114.008 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -104.71 151.27 23.93 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.045 -2.284 . . . . 0.0 113.437 -161.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -56.93 -47.14 81.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.447 -1.408 . . . . 0.0 110.914 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -71.52 -52.22 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.523 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -54.71 -41.41 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.32 0.509 . . . . 0.0 110.239 -173.04 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -67.68 -44.39 77.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.068 0.947 . . . . 0.0 109.832 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -61.99 -56.41 19.41 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -48.85 -55.9 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.545 1.138 . . . . 0.0 110.117 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.64 -34.8 65.26 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.598 1.544 . . . . 0.0 113.689 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 t -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.832 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -60.7 -36.73 79.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.424 1.011 . . . . 0.0 109.938 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.2 mm? -72.25 -14.56 61.81 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.626 0.37 . . . . 0.0 111.074 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.49 2.63 84.85 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.864 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -85.4 133.02 34.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.578 1.189 . . . . 0.0 109.68 -168.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.401 ' N ' HD13 ' A' ' 112' ' ' LEU . 22.1 ttt180 -68.07 136.24 53.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.932 0.893 . . . . 0.0 110.616 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.75 168.04 28.62 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.749 -0.594 . . . . 0.0 111.454 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -99.06 163.43 12.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.605 1.162 . . . . 0.0 111.641 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.567 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.436 ' CH2' HD13 ' A' ' 157' ' ' ILE . 16.0 p-90 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -153.62 8.68 0.39 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 118.393 -0.813 . . . . 0.0 112.923 -153.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -151.06 151.03 31.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.087 0.858 . . . . 0.0 110.508 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.63 139.08 49.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.211 1.404 . . . . 0.0 109.995 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -69.94 126.08 28.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.196 0.998 . . . . 0.0 108.56 159.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.67 121.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.08 4.29 Favored Glycine 0 N--CA 1.464 0.502 0 C-N-CA 123.905 0.764 . . . . 0.0 112.962 161.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.51 9.48 2.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.751 1.62 . . . . 0.0 111.817 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.31 14.56 57.16 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 126.955 2.217 . . . . 0.0 115.892 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -68.82 127.39 32.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.972 0.886 . . . . 0.0 108.892 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -71.04 146.46 49.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.973 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -139.35 154.77 47.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -103.38 -20.66 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.331 0.653 . . . . 0.0 111.695 176.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 59.0 p -136.04 155.24 50.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.33 127.92 77.24 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.06 171.17 14.16 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.99 2.46 . . . . 0.0 111.49 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.8 148.22 57.15 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.339 2.026 . . . . 0.0 109.721 163.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.16 -22.81 0.2 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.483 1.992 . . . . 0.0 113.532 -165.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.92 38.28 96.32 Favored Glycine 0 C--N 1.335 0.528 0 O-C-N 120.982 -1.305 . . . . 0.0 110.159 -158.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.01 154.41 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.595 0.758 . . . . 0.0 110.075 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 49.4 t -74.97 110.92 11.24 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 125.365 1.466 . . . . 0.0 110.877 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 20.0 Cg_endo -60.72 -2.71 2.22 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.424 2.082 . . . . 0.0 115.543 171.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -105.6 -26.35 11.89 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.018 0.927 . . . . 0.0 113.231 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 14.1 p -142.15 -12.82 0.83 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.09 65.7 2.66 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.973 1.273 . . . . 0.0 112.146 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.07 173.82 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.002 1.721 . . . . 0.0 108.495 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -64.45 142.48 58.4 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.172 0.989 . . . . 0.0 111.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.37 145.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.192 1.397 . . . . 0.0 107.428 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.15 158.74 43.74 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 112.209 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.69 111.26 6.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 110.392 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.436 HD13 ' CH2' ' A' ' 127' ' ' TRP . 1.1 pt . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 125.827 1.651 . . . . 0.0 112.365 164.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -45.51 127.89 7.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.028 0.931 . . . . 0.0 111.598 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 tp -153.72 147.36 25.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.194 1.798 . . . . 0.0 107.454 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -122.08 150.75 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.46 139.26 53.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.969 1.708 . . . . 0.0 108.377 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -91.33 158.84 16.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.095 0.958 . . . . 0.0 111.64 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -29.36 -57.85 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.397 2.279 . . . . 0.0 113.219 163.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.7 p -60.11 -28.95 68.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.136 1.774 . . . . 0.0 112.52 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.68 -42.08 94.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -69.91 -34.77 73.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.413 0.685 . . . . 0.0 111.211 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.7 mt -57.09 -47.58 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 110.14 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.98 -24.9 52.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.883 0.765 . . . . 0.0 111.922 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 31.62 13.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 123.289 0.471 . . . . 0.0 112.068 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -76.86 102.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.46 115.2 1.98 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 tp -161.88 170.84 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.552 1.941 . . . . 0.0 106.412 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.83 152.33 48.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 0.0 109.002 -158.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.0 -130.8 3.72 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -168.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.23 152.33 48.21 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.367 1.067 . . . . 0.0 111.003 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -128.66 143.12 50.88 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.556 1.542 . . . . 0.0 107.664 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.55 117.33 67.9 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.79 1.636 . . . . 0.0 108.198 -167.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 31' ' ' VAL . 23.7 Cg_endo -60.81 -32.04 92.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.261 1.974 . . . . 0.0 111.185 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.2 m -68.49 -19.58 64.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.118 -0.989 . . . . 0.0 113.14 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.516 HG22 ' HB1' ' A' ' 81' ' ' ALA . 20.6 t -83.84 -51.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.036 0.935 . . . . 0.0 108.522 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.1 p -59.08 -28.03 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-N 118.822 0.737 . . . . 0.0 111.197 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -66.58 -14.81 62.85 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.81 -28.83 12.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.298 0.954 . . . . 0.0 111.734 169.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -53.88 128.23 13.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 -27.1 2.26 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 126.628 1.971 . . . . 0.0 110.55 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.31 124.94 24.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -75.33 -30.7 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.797 -1.097 . . . . 0.0 112.08 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -60.74 -37.16 80.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.184 1.356 . . . . 0.0 110.481 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -69.99 -58.98 3.2 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.439 0.695 . . . . 0.0 109.685 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -58.27 -55.43 35.04 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.785 0.834 . . . . 0.0 111.879 -170.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.9 mt -54.01 -52.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.039 0.936 . . . . 0.0 108.632 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 59.6 t80 -55.27 -52.68 62.64 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.584 0.754 . . . . 0.0 110.652 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 tt -51.42 -56.87 10.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.878 1.671 . . . . 0.0 110.409 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.14 -36.24 81.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.473 0.709 . . . . 0.0 111.421 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 m -64.27 -42.6 96.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.476 1.11 . . . . 0.0 109.843 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 9.7 mt -65.22 -43.14 92.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.371 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.54 -52.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m -63.61 -25.32 68.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.301 0.64 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.6 -2.6 58.36 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.157 1.783 . . . . 0.0 113.649 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.93 26.16 60.87 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 118.445 0.566 . . . . 0.0 112.111 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -89.95 -52.7 4.83 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.86 162.37 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 C-N-CA 124.676 1.191 . . . . 0.0 108.708 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -133.4 156.29 47.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mm -69.65 133.93 31.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 118.935 0.789 . . . . 0.0 108.949 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.41 128.15 6.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.86 0.464 . . . . 0.0 110.692 162.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.7 156.15 45.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.431 0.692 . . . . 0.0 110.428 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.11 168.2 16.31 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.868 3.046 . . . . 0.0 111.645 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t -86.84 163.26 17.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 164.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -50.42 -45.58 55.8 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.03 0.932 . . . . 0.0 111.53 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.35 -18.8 63.83 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -40.84 35.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.797 0.839 . . . . 0.0 110.593 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.24 -49.71 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -56.4 -32.13 64.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.103 0.961 . . . . 0.0 111.392 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -50.93 71.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.591 1.156 . . . . 0.0 110.181 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.74 -42.2 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.23 -41.4 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.584 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -65.17 -50.93 64.06 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.107 1.321 . . . . 0.0 110.926 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 109' ' ' LEU . 2.4 t -75.85 -34.19 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.81 -50.48 73.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.538 1.135 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.6 71.66 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.654 -1.279 . . . . 0.0 110.755 174.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.67 -32.98 74.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.255 0.934 . . . . 0.0 109.873 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 t -93.16 -16.72 24.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 -78.3 0.38 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.69 86.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.965 1.306 . . . . 0.0 110.727 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -75.63 -41.69 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 120.824 -1.173 . . . . 0.0 112.297 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -135.6 20.41 3.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.221 1.408 . . . . 0.0 109.192 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -70.83 -19.36 62.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.9 -1.125 . . . . 0.0 110.699 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -83.03 153.24 25.03 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.052 0.941 . . . . 0.0 110.115 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -58.88 147.94 32.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 111.305 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 27.2 ttpt -55.67 -53.0 61.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.808 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -61.33 -34.95 76.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 124.137 0.898 . . . . 0.0 110.212 -172.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -55.23 31.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.34 1.056 . . . . 0.0 109.06 176.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -52.44 -45.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.968 0.907 . . . . 0.0 108.938 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 61.9 mt-10 -64.6 -46.21 83.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 0.0 112.23 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.09 -54.69 31.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.559 1.143 . . . . 0.0 109.496 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.409 HD23 HD13 ' A' ' 96' ' ' ILE . 26.7 mt -57.66 -47.51 82.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.945 0.898 . . . . 0.0 109.258 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.75 -56.13 17.8 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.175 1.39 . . . . 0.0 111.955 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.32 -48.41 74.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.779 0.675 . . . . 0.0 109.737 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -60.93 -21.88 63.85 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.54 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.44 -22.99 21.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 117.81 -1.09 . . . . 0.0 111.858 175.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.24 -41.93 97.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.714 1.143 . . . . 0.0 109.78 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -109.99 10.66 24.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.303 1.041 . . . . 0.0 111.0 -171.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 45.66 49.73 11.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.255 1.822 . . . . 0.0 110.107 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.83 -123.74 4.77 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 124.35 0.976 . . . . 0.0 111.178 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -144.7 168.15 20.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.586 1.954 . . . . 0.0 106.893 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.409 HD13 HD23 ' A' ' 86' ' ' LEU . 30.9 mt -134.16 157.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -136.8 107.07 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 108.437 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 t -166.12 172.25 11.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.274 1.43 . . . . 0.0 109.582 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -145.27 4.34 1.06 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -57.11 158.21 5.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.867 1.667 . . . . 0.0 112.821 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -61.67 -45.04 95.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.424 -1.423 . . . . 0.0 110.825 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.524 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.05 -39.27 81.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 119.058 0.845 . . . . 0.0 110.787 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.29 -47.86 72.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 109' ' ' LEU . 44.3 t30 -60.07 -58.25 9.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.934 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.05 -54.52 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.15 65.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.349 1.431 . . . . 0.0 113.129 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -52.15 58.47 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.212 1.405 . . . . 0.0 112.403 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -68.34 -21.7 64.72 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.722 1.601 . . . . 0.0 111.893 178.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -83.56 -10.63 58.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.752 1.221 . . . . 0.0 112.366 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.81 8.11 84.27 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.326 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.43 143.78 34.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.776 1.788 . . . . 0.0 109.779 -175.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.25 136.84 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.956 1.302 . . . . 0.0 108.371 174.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -146.6 -172.19 3.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.38 161.02 25.55 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.089 1.355 . . . . 0.0 110.392 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.235 0.302 0 C-N-CA 124.447 1.099 . . . . 0.0 108.862 -178.015 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 119.572 -0.251 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -148.25 17.55 1.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.068 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.95 141.12 47.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 120.339 1.427 . . . . 0.0 110.236 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.39 134.24 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.917 1.287 . . . . 0.0 108.506 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.503 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 3.7 t -67.78 118.45 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.69 124.14 27.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.74 -86.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.4 p -74.2 -18.44 60.76 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.755 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.14 62.38 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 123.416 0.531 . . . . 0.0 112.775 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -74.27 145.35 44.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.511 1.124 . . . . 0.0 110.079 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -90.12 145.62 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 109.176 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.7 149.27 43.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.704 0.802 . . . . 0.0 108.843 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 p -97.29 -13.25 22.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.988 0.915 . . . . 0.0 111.997 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 18.4 p -146.11 165.35 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.757 1.623 . . . . 0.0 107.523 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp -77.34 128.7 79.73 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.12 169.96 16.9 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.528 2.152 . . . . 0.0 111.108 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.62 127.34 20.46 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.696 2.264 . . . . 0.0 109.876 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.42 -8.19 42.18 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.707 0.67 . . . . 0.0 113.395 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.01 54.21 32.63 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.461 1.131 . . . . 0.0 112.045 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.08 160.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.56 114.9 14.74 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.8 -14.16 41.34 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 119.739 0.942 . . . . 0.0 112.435 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.09 -12.4 17.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.79 2.036 . . . . 0.0 112.683 -168.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.503 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 8.5 p -156.19 3.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.82 -16.5 5.26 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.637 1.589 . . . . 0.0 114.745 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.2 m -69.88 161.18 30.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 118.686 1.243 . . . . 0.0 112.701 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -68.35 144.18 54.88 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.69 -1.256 . . . . 0.0 110.01 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.56 143.74 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.08 154.83 51.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.68 1.127 . . . . 0.0 111.052 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.46 134.75 48.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.271 1.028 . . . . 0.0 108.959 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.268 1.027 . . . . 0.0 109.638 170.868 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.236 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -54.96 122.94 11.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.793 1.237 . . . . 0.0 109.777 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.649 HD21 HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.74 147.89 36.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.394 1.478 . . . . 0.0 107.499 -177.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.77 152.88 29.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.727 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.649 HD11 HD21 ' A' ' 9' ' ' LEU . 1.6 mm? -125.27 150.59 46.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.552 1.941 . . . . 0.0 108.907 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.62 174.5 5.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.9 p -49.57 -43.81 46.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.652 1.181 . . . . 0.0 113.424 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 t -57.25 -39.3 75.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.757 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 t -54.4 -43.93 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.246 1.018 . . . . 0.0 110.138 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -76.78 -25.92 53.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.219 0.608 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.12 -39.36 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.93 0.786 . . . . 0.0 110.639 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -78.08 -17.85 56.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.524 -0.735 . . . . 0.0 112.105 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.25 63.8 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 123.392 0.52 . . . . 0.0 113.381 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.39 106.87 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.08 118.32 8.99 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -157.8 164.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 0.0 107.569 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -137.1 119.3 15.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 111.077 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -179.73 -146.16 6.73 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.818 2.627 . . . . 0.0 112.29 -166.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.27 152.06 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.182 1.393 . . . . 0.0 111.69 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 t -121.65 168.32 11.91 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.453 1.901 . . . . 0.0 109.701 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.62 113.96 60.99 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 126.535 1.934 . . . . 0.0 108.048 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -55.57 -35.91 93.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.756 2.304 . . . . 0.0 112.7 -172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.2 m -71.54 -16.97 62.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.788 1.235 . . . . 0.0 113.146 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.6 -51.61 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.66 -37.42 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.563 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.38 -22.01 66.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.549 1.068 . . . . 0.0 111.805 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -94.47 -10.9 30.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.433 1.47 . . . . 0.0 111.93 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 43' ' ' LEU . 2.7 mt -63.46 116.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 -11.06 5.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.128 0.971 . . . . 0.0 113.073 -166.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.78 130.64 37.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -67.29 -35.5 79.61 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.969 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.74 -52.53 62.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.09 1.356 . . . . 0.0 108.685 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.3 -50.84 70.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.983 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -58.58 -52.62 64.88 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.468 1.107 . . . . 0.0 111.91 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.3 -52.05 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.527 1.531 . . . . 0.0 109.145 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -64.06 -42.77 96.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.237 0.542 . . . . 0.0 111.476 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' CD1' HD12 ' A' ' 34' ' ' ILE . 7.6 tt -59.27 -48.65 80.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.94 -1.1 . . . . 0.0 110.663 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.8 -32.55 72.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.629 0.772 . . . . 0.0 110.285 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.8 t -50.45 -54.55 21.21 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.93 0.892 . . . . 0.0 108.876 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.65 -31.89 70.24 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.17 -53.47 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.6 t -57.74 -38.2 74.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.312 1.045 . . . . 0.0 111.94 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.52 3.72 17.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 113.063 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.12 21.25 78.47 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.903 -0.943 . . . . 0.0 111.833 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -107.96 -29.82 8.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.155 -175.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.5 96.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.553 1.524 . . . . 0.0 108.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -73.16 155.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.9 mm -82.91 147.84 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.64 125.02 0.58 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.747 2.019 . . . . 0.0 109.795 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 158.64 36.05 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 119.497 1.044 . . . . 0.0 112.518 171.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.72 157.51 61.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 124.915 3.743 . . . . 0.0 111.924 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.21 160.72 31.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.907 0.861 . . . . 0.0 110.391 158.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -44.89 79.0 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 109.697 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -61.54 -32.74 72.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.752 0.705 . . . . 0.0 111.119 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.4 m -66.74 -45.02 79.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 109.653 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.7 mm -58.81 -48.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.91 -33.16 70.24 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.018 -0.426 . . . . 0.0 111.208 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -46.41 80.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.2 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -62.41 -46.51 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.459 HG23 ' CG2' ' A' ' 75' ' ' VAL . 74.5 mt -54.82 -36.5 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.088 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -66.51 -43.79 84.31 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.278 1.854 . . . . 0.0 111.868 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 109' ' ' LEU . 2.0 t -82.51 -37.28 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.21 99.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.29 1.036 . . . . 0.0 110.664 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -31.67 66.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.322 0.964 . . . . 0.0 112.034 174.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.06 -43.91 98.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.074 0.852 . . . . 0.0 109.938 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -80.43 -51.6 8.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.811 0.732 . . . . 0.0 111.117 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.54 -73.54 0.13 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 120.44 1.473 . . . . 0.0 114.305 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -70.54 91.47 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.596 0.698 . . . . 0.0 109.364 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 66' ' ' ILE . 5.5 p -74.65 -54.71 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -118.84 18.36 13.31 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.538 0.608 . . . . 0.0 111.116 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -68.94 -31.48 70.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -78.2 157.86 29.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.037 0.535 . . . . 0.0 110.04 -172.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -65.5 153.82 40.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.573 1.178 . . . . 0.0 110.432 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -60.24 -48.87 79.89 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.719 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.69 68.45 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.529 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -56.89 -55.95 27.88 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.421 1.105 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.72 -39.84 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.048 1.739 . . . . 0.0 110.435 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -61.52 -50.49 72.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.986 1.266 . . . . 0.0 110.984 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.55 -53.29 46.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.89 0.876 . . . . 0.0 109.021 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.17 -54.98 38.64 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.887 1.275 . . . . 0.0 108.786 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.79 -52.2 57.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.237 1.415 . . . . 0.0 112.493 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -49.7 74.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.92 83.55 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.944 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.612 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.2 m-85 -70.98 -29.84 65.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.41 1.005 . . . . 0.0 111.697 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.75 -43.25 99.29 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.176 0.898 . . . . 0.0 109.297 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.845 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm 49.24 34.02 5.75 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.972 1.709 . . . . 0.0 110.609 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.25 -136.72 8.7 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.07 1.795 . . . . 0.0 110.636 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -129.56 161.56 30.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.222 2.209 . . . . 0.0 109.108 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.1 mt -130.06 149.08 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -135.77 122.59 21.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.925 0.89 . . . . 0.0 109.565 174.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 t -161.04 175.89 11.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.324 0.39 . . . . 0.0 111.025 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -147.3 102.96 3.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.458 1.503 . . . . 0.0 109.483 166.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.52 154.35 18.44 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.154 1.381 . . . . 0.0 110.279 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -64.16 -46.43 84.08 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.92 -53.76 45.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.691 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.12 -41.27 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.784 0.72 . . . . 0.0 111.186 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 46.3 mt-30 -58.54 -49.64 76.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 108.889 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.64 -55.3 21.11 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.981 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mm -52.98 -54.81 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 119.141 0.882 . . . . 0.0 110.364 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.84 -33.03 68.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.241 1.382 . . . . 0.0 113.708 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 t -57.15 -60.45 3.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.941 -1.028 . . . . 0.0 111.534 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.401 HD12 ' CG1' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -69.6 -17.55 63.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.436 1.471 . . . . 0.0 113.075 -175.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.612 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.4 mm? -83.36 -9.28 59.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.616 0.766 . . . . 0.0 112.249 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.92 35.42 92.02 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.686 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -106.33 122.9 47.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.229 1.014 . . . . 0.0 110.585 172.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.419 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -61.62 113.66 2.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 16.9 p90 -115.24 179.72 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 66.0 mtt180 -118.1 121.08 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.307 1.443 . . . . 0.0 107.334 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--O 1.24 0.601 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.317 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -151.34 22.45 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.126 0.971 . . . . 0.0 112.343 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -139.52 150.15 44.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.876 1.216 . . . . 0.0 111.138 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.74 134.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.356 1.062 . . . . 0.0 109.417 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 1.1 t -65.19 127.2 30.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.09 114.02 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.764 0.792 . . . . 0.0 109.308 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.2 -77.71 0.39 Allowed Glycine 0 C--O 1.229 -0.178 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.48 -15.64 62.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.667 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.75 83.91 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.795 1.188 . . . . 0.0 114.341 165.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -69.55 139.87 53.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 124.758 1.223 . . . . 0.0 109.572 -170.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -78.51 147.02 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.7 1.2 . . . . 0.0 109.584 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -139.52 150.88 45.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.057 0.943 . . . . 0.0 109.409 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -102.88 -0.47 31.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.303 1.441 . . . . 0.0 112.562 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 p -149.57 167.9 25.03 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.446 2.298 . . . . 0.0 106.828 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.82 123.66 87.51 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 165.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.24 172.73 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.228 1.952 . . . . 0.0 110.358 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -54.6 137.28 73.16 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 121.896 1.731 . . . . 0.0 110.048 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.39 -10.15 2.07 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.315 0.96 . . . . 0.0 114.148 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.15 29.21 72.22 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 119.137 1.469 . . . . 0.0 112.393 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.25 161.05 21.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 118.448 1.124 . . . . 0.0 109.289 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 12.7 t -73.54 113.76 25.52 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.376 -1.297 . . . . 0.0 109.33 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.31 -17.41 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.702 1.601 . . . . 0.0 113.52 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.97 -26.2 19.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.539 1.136 . . . . 0.0 111.683 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.9 p -153.63 1.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -167.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.87 -13.16 9.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.48 1.514 . . . . 0.0 114.769 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.26 160.05 32.91 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.803 1.302 . . . . 0.0 112.221 -172.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -64.05 138.95 58.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.484 0.659 . . . . 0.0 109.555 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.45 144.61 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.01 150.19 52.26 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.336 1.054 . . . . 0.0 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.94 132.47 47.39 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 123.091 0.556 . . . . 0.0 109.604 172.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 mptt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.7 m -53.04 132.84 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 122.279 1.037 . . . . 0.0 110.841 -171.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -154.36 144.72 22.13 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.36 146.65 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.71 137.84 53.67 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.728 1.611 . . . . 0.0 107.421 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.51 162.04 13.97 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.359 0.412 . . . . 0.0 110.525 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -40.9 -50.1 3.23 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.484 1.914 . . . . 0.0 112.542 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.96 -43.66 99.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 120.252 1.387 . . . . 0.0 109.366 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -69.09 -32.49 71.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.437 0.695 . . . . 0.0 110.644 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.9 mt -61.38 -45.44 98.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.051 0.54 . . . . 0.0 110.597 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -72.22 -28.22 63.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.266 0.939 . . . . 0.0 111.05 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.72 21.77 22.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.107 0.861 . . . . 0.0 112.416 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.73 114.44 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.847 1.324 . . . . 0.0 108.0 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -73.31 110.23 7.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.154 1.782 . . . . 0.0 107.91 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.79 127.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.135 0.974 . . . . 0.0 109.369 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.47 162.62 28.4 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.589 -1.319 . . . . 0.0 111.138 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.14 -147.89 19.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -124.15 156.4 36.76 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.582 1.153 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -128.05 149.54 50.33 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 107.572 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.1 p -78.65 129.87 72.71 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HA ' HG12 ' A' ' 31' ' ' VAL . 15.9 Cg_endo -61.93 -23.94 76.43 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.212 1.275 . . . . 0.0 111.274 168.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -71.27 -29.94 65.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.96 -37.09 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 119.522 1.055 . . . . 0.0 109.063 174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 28' ' ' PRO . 5.7 p -60.39 -24.27 30.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 119.116 0.871 . . . . 0.0 112.199 -172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -56.67 -28.62 61.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 117.929 0.331 . . . . 0.0 111.374 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.48 -10.39 16.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.827 1.651 . . . . 0.0 111.427 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.95 78.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -21.33 52.84 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.985 0.914 . . . . 0.0 111.597 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.7 121.25 12.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.59 -50.28 74.38 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.666 0.786 . . . . 0.0 110.46 -162.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.39 -57.39 12.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.348 1.059 . . . . 0.0 109.525 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -58.67 -45.33 89.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.71 1.204 . . . . 0.0 110.663 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.76 -58.98 4.8 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.072 1.349 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.3 mt -53.37 -47.74 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 124.131 0.972 . . . . 0.0 108.559 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.48 -54.84 42.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.438 0.695 . . . . 0.0 110.661 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 31' ' ' VAL . 5.4 tt -52.64 -54.09 38.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.585 1.154 . . . . 0.0 109.623 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.35 -27.17 68.39 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 121.304 -0.872 . . . . 0.0 111.76 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 m -69.03 -47.19 66.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.616 0.766 . . . . 0.0 110.065 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.62 88.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.151 0.981 . . . . 0.0 111.077 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.56 -46.65 92.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 118.243 0.474 . . . . 0.0 109.79 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -64.24 -32.58 74.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.7 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.72 -2.47 46.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.578 1.151 . . . . 0.0 112.094 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.74 88.6 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 118.422 -1.21 . . . . 0.0 113.482 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.94 -53.73 51.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.518 1.527 . . . . 0.0 108.176 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -107.12 152.57 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -132.82 156.46 47.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.289 1.036 . . . . 0.0 109.731 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.9 mm -81.1 134.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 124.741 1.216 . . . . 0.0 107.736 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.29 127.79 6.48 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.711 1.204 . . . . 0.0 108.593 165.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.41 155.62 51.3 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.2 167.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -65.2 170.48 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.72 2.947 . . . . 0.0 111.993 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.2 t -86.55 153.04 22.12 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 159.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -47.05 -42.35 18.42 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.237 1.415 . . . . 0.0 111.465 161.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.57 -45.07 95.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 110.134 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -65.56 -38.39 89.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.061 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mm -61.18 -48.31 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 119.629 1.104 . . . . 0.0 108.666 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' HD12 ' A' ' 66' ' ' ILE . 64.7 m-20 -57.12 -31.95 65.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.042 0.937 . . . . 0.0 111.623 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -41.7 97.13 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.906 0.882 . . . . 0.0 110.694 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.39 -48.99 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 63' ' ' ASP . 50.4 mt -52.29 -36.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.899 1.279 . . . . 0.0 110.938 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -61.33 -62.64 1.69 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.471 1.032 . . . . 0.0 110.973 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.79 -34.88 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -172.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.52 57.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.4 1.48 . . . . 0.0 110.322 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' N ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -64.87 -20.66 66.54 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.781 -1.199 . . . . 0.0 112.168 176.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.452 ' N ' ' HE3' ' A' ' 70' ' ' LYS . 30.9 tt0 -81.18 -20.4 41.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.714 0.805 . . . . 0.0 111.558 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 t -109.37 -22.56 11.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.282 0.947 . . . . 0.0 111.364 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.67 -83.84 0.17 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.151 0.887 . . . . 0.0 112.221 170.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -74.14 91.86 2.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.469 1.108 . . . . 0.0 108.249 -171.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.49 -45.74 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.26 10.18 4.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.783 1.233 . . . . 0.0 109.828 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 8.15 0.92 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.481 0.712 . . . . 0.0 110.93 164.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.33 147.19 27.39 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.259 1.424 . . . . 0.0 108.632 163.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.7 m -70.04 156.4 39.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.714 1.245 . . . . 0.0 110.15 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.57 -48.08 82.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.746 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.56 56.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.225 0.92 . . . . 0.0 112.19 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -63.15 -56.27 18.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.3 mt -52.25 -43.31 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.402 1.481 . . . . 0.0 109.18 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.37 -52.74 43.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.619 1.568 . . . . 0.0 112.14 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.65 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 119.131 0.878 . . . . 0.0 109.462 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 96' ' ' ILE . 45.9 mt -57.67 -56.38 22.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.631 0.772 . . . . 0.0 109.218 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -59.07 3.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.496 1.519 . . . . 0.0 112.023 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -49.62 59.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.865 0.866 . . . . 0.0 109.187 -174.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.27 66.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.618 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -77.73 -30.07 51.49 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.766 1.167 . . . . 0.0 110.507 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -42.45 99.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 168.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.15 -7.13 59.61 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 52.12 24.96 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.804 1.642 . . . . 0.0 113.109 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 -106.8 2.57 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 119.387 0.994 . . . . 0.0 113.906 -159.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -142.38 166.86 23.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.518 1.927 . . . . 0.0 108.031 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.639 HD13 HD23 ' A' ' 86' ' ' LEU . 82.5 mt -135.21 154.2 35.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.57 121.24 18.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 t -158.14 -170.42 3.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.823 2.049 . . . . 0.0 106.907 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -154.66 -4.77 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 122.235 2.288 . . . . 0.0 115.781 163.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -61.35 148.77 40.3 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.235 1.834 . . . . 0.0 112.942 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -56.92 -32.61 66.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.759 1.624 . . . . 0.0 114.273 -172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.54 -50.85 12.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.43 1.092 . . . . 0.0 110.171 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -42.15 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.494 0.718 . . . . 0.0 110.768 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -67.17 -35.2 79.16 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.029 0.442 . . . . 0.0 110.347 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.5 t30 -65.09 -56.74 11.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -51.68 -55.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.462 1.105 . . . . 0.0 110.018 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.22 68.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.163 1.347 . . . . 0.0 113.164 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 t -60.4 -61.69 2.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.071 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.5 OUTLIER -67.4 -16.56 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.125 1.33 . . . . 0.0 113.212 -175.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -86.81 -22.17 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.88 0.872 . . . . 0.0 112.525 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.93 38.98 89.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 118.474 0.579 . . . . 0.0 112.859 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 125.12 39.79 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 161.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 116.07 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.21 -162.99 1.11 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.174 0.989 . . . . 0.0 110.709 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -140.25 162.71 34.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.807 2.443 . . . . 0.0 109.354 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 C-N-CA 127.196 2.198 . . . . 0.0 110.35 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 14.14 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -139.81 135.3 32.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.822 1.192 . . . . 0.0 109.984 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.86 131.99 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.89 140.46 58.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 165.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.8 pt -93.29 -11.62 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 118.206 -0.902 . . . . 0.0 113.192 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.73 -20.61 23.81 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 119.621 1.101 . . . . 0.0 113.962 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.7 p -144.8 6.07 1.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.826 1.313 . . . . 0.0 114.16 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.76 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.596 1.093 . . . . 0.0 115.076 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -68.18 147.37 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.199 1.0 . . . . 0.0 110.723 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -110.79 99.0 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.844 0.858 . . . . 0.0 111.783 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.19 143.63 26.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.859 1.314 . . . . 0.0 109.529 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -89.22 -19.77 24.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.568 172.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.7 p -145.21 163.14 35.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.757 1.623 . . . . 0.0 109.034 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.582 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -73.02 116.63 52.49 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -176.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.582 ' HD2' HD23 ' A' ' 141' ' ' LEU . 89.8 Cg_endo -66.74 169.0 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.468 2.112 . . . . 0.0 110.507 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -55.22 133.07 55.98 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.99 1.794 . . . . 0.0 109.877 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.57 -18.28 3.79 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.574 -1.125 . . . . 0.0 113.597 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 63.38 44.31 97.02 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 119.789 1.795 . . . . 0.0 111.538 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.83 158.41 43.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 14.2 t -67.63 110.93 6.16 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -61.55 -14.94 38.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.292 1.328 . . . . 0.0 111.746 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -12.41 14.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.659 1.984 . . . . 0.0 112.483 -160.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.52 -14.26 0.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.19 85.42 0.12 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.6 p -152.02 174.99 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -60.73 151.8 28.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.715 -1.24 . . . . 0.0 109.995 160.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.65 147.66 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 159.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.84 154.07 46.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.393 0.997 . . . . 0.0 111.415 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.06 114.02 14.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.584 1.154 . . . . 0.0 108.522 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 118.296 0.498 . . . . 0.0 110.79 172.083 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.236 0.375 0 N-CA-C 110.802 -0.073 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -44.79 122.56 3.26 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.509 1.924 . . . . 0.0 110.219 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 tp -147.3 147.14 30.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 108.013 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 t -116.86 140.33 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -108.07 146.8 32.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.875 1.67 . . . . 0.0 107.632 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.2 161.78 13.43 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.14 0.9 . . . . 0.0 112.179 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.475 ' HB2' HG21 ' A' ' 30' ' ' VAL . 12.6 t -43.89 -52.49 6.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 127.801 2.44 . . . . 0.0 111.724 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -60.7 -23.03 64.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.485 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.89 90.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 120.073 1.306 . . . . 0.0 109.456 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -72.37 -36.31 68.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.929 0.891 . . . . 0.0 111.045 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.71 -46.6 93.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.313 1.045 . . . . 0.0 109.835 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -75.96 -23.16 55.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.759 0.709 . . . . 0.0 111.116 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.91 41.73 12.07 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mt -81.82 112.49 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.69 98.91 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.448 1.099 . . . . 0.0 109.437 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.5 tp -153.94 164.63 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.105 1.762 . . . . 0.0 107.264 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -131.45 155.11 47.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.02 2.128 . . . . 0.0 108.698 -160.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.74 -149.14 21.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.24 161.91 15.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 0.0 110.157 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.0 t -141.84 161.1 38.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.825 1.65 . . . . 0.0 108.098 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 p -96.18 123.11 56.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 122.401 0.28 . . . . 0.0 110.889 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.2 -26.39 81.58 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.379 2.053 . . . . 0.0 112.114 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.2 m -62.99 -32.64 74.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.1 1.76 . . . . 0.0 114.598 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 13' ' ' SER . 12.6 p -94.47 -29.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.653 1.115 . . . . 0.0 110.369 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.53 -20.02 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 119.868 1.213 . . . . 0.0 111.187 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.57 -29.29 66.27 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.035 -1.666 . . . . 0.0 114.297 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -102.25 -16.23 16.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.454 1.101 . . . . 0.0 111.517 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.91 105.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 124.269 1.028 . . . . 0.0 108.902 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -13.04 7.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.461 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -61.82 120.18 10.2 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -62.02 -32.91 73.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.66 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.72 -63.36 1.17 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.3 p -53.7 -44.74 70.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.046 1.338 . . . . 0.0 112.515 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -71.45 -54.15 11.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.154 1.381 . . . . 0.0 110.896 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.59 -51.98 30.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -54.9 -54.24 45.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 112.429 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.33 -51.52 58.3 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.947 1.299 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.23 -34.26 77.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.977 0.911 . . . . 0.0 111.929 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -64.12 -45.44 88.56 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -36.77 78.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.477 0.711 . . . . 0.0 111.635 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.38 -51.71 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -67.48 -19.53 65.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.07 0.85 . . . . 0.0 113.24 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -10.07 51.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.517 1.527 . . . . 0.0 111.892 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.75 -0.69 70.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.729 1.157 . . . . 0.0 113.767 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -87.79 -28.3 21.76 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.192 0.997 . . . . 0.0 111.984 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.92 140.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -128.51 151.58 49.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.568 1.547 . . . . 0.0 108.877 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.8 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.77 132.38 5.03 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.106 1.362 . . . . 0.0 108.595 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -92.72 154.95 42.21 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.592 0.757 . . . . 0.0 111.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.76 173.92 11.14 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.285 3.323 . . . . 0.0 111.7 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -108.76 162.68 13.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.492 1.117 . . . . 0.0 109.696 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -53.76 -49.79 67.43 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.937 0.895 . . . . 0.0 111.294 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.65 -27.29 66.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.863 0.465 . . . . 0.0 110.184 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -67.42 -48.34 67.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.531 0.733 . . . . 0.0 109.636 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.6 -45.72 94.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.468 1.107 . . . . 0.0 110.155 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.06 -35.09 74.38 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.88 -0.512 . . . . 0.0 110.62 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -44.89 71.08 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.199 0.6 . . . . 0.0 111.06 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.4 mm -64.37 -45.51 95.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.71 -38.8 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.931 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -63.48 -59.03 5.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.168 1.349 . . . . 0.0 110.813 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 109' ' ' LEU . 3.8 t -73.6 -32.54 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -51.83 67.28 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -30.83 71.22 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.669 1.122 . . . . 0.0 111.691 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.39 -15.45 48.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 111.712 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -114.31 -28.77 7.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.19 0.905 . . . . 0.0 111.961 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.64 -99.02 0.19 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 119.991 1.269 . . . . 0.0 110.4 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -58.56 96.56 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.267 2.227 . . . . 0.0 108.797 -168.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.98 -44.06 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.483 1.913 . . . . 0.0 110.706 -167.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -123.61 6.71 8.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.281 0.632 . . . . 0.0 110.111 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.78 -24.83 62.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.581 0.628 . . . . 0.0 111.528 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.27 158.09 31.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.658 1.183 . . . . 0.0 109.757 -174.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -68.56 154.93 40.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.441 0.638 . . . . 0.0 110.75 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -63.01 -53.35 55.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.784 -0.572 . . . . 0.0 109.734 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.59 61.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.779 1.3 . . . . 0.0 109.485 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -59.41 -59.13 5.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.968 1.707 . . . . 0.0 108.455 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -53.75 -40.99 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.771 0.828 . . . . 0.0 110.578 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.35 -43.72 73.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.236 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.72 -49.77 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.573 HD23 HD13 ' A' ' 96' ' ' ILE . 56.5 mt -56.97 -53.58 56.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.757 1.223 . . . . 0.0 108.941 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.598 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.72 -52.86 54.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.046 1.338 . . . . 0.0 111.75 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.3 tp -54.36 -49.82 68.92 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -64.4 -16.31 62.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.709 0.686 . . . . 0.0 112.638 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.6 m-30 -96.4 -17.48 20.58 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.32 1.048 . . . . 0.0 111.421 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -58.88 -44.57 91.18 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -114.13 -4.77 13.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.155 1.782 . . . . 0.0 111.935 -168.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 53.6 49.12 20.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.701 2.001 . . . . 0.0 111.547 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.63 -114.18 2.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.761 1.172 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -148.58 169.89 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 107.79 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.573 HD13 HD23 ' A' ' 86' ' ' LEU . 28.7 mt -130.38 163.57 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 0.0 108.194 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 118.57 13.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.92 1.688 . . . . 0.0 107.8 166.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.0 t -175.16 176.82 2.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.183 2.193 . . . . 0.0 109.559 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.62 0.19 0.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -57.31 162.51 2.71 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.539 1.518 . . . . 0.0 113.911 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -57.69 -52.49 65.21 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.726 -1.234 . . . . 0.0 109.74 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -75.1 -43.32 53.64 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.219 1.007 . . . . 0.0 110.183 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 p -61.57 -47.13 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.74 -37.04 85.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.85 0.46 . . . . 0.0 109.947 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.1 t30 -70.51 -53.32 16.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -49.57 -51.68 14.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.202 1.001 . . . . 0.0 109.443 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.63 70.4 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.002 1.274 . . . . 0.0 112.481 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.6 t -65.56 -52.44 52.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.205 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.477 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -63.41 -30.22 71.38 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 121.106 1.775 . . . . 0.0 110.613 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.526 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -79.97 -8.96 59.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.366 1.066 . . . . 0.0 112.891 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.89 59.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.023 -1.432 . . . . 0.0 115.499 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.11 119.91 26.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.511 2.156 . . . . 0.0 110.569 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 148.86 41.06 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.671 1.188 . . . . 0.0 111.244 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.74 176.33 12.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 122.038 -0.414 . . . . 0.0 111.475 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -111.9 150.55 30.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.967 1.307 . . . . 0.0 109.887 172.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.235 0.321 0 C-N-CA 125.314 1.446 . . . . 0.0 110.17 -175.377 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.47 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 2.4 p-90 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -175.3 13.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -140.91 152.98 45.47 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.148 1.34 . . . . 0.0 111.858 164.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' HD12 ' A' ' 157' ' ' ILE . 9.9 p -131.14 132.84 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.876 1.27 . . . . 0.0 109.132 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -71.7 128.95 37.43 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 164.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pt -80.39 101.51 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.757 0.708 . . . . 0.0 109.696 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.98 -84.58 0.18 Allowed Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 7.0 p -70.47 -15.26 62.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.031 0.416 . . . . 0.0 110.944 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.11 92.79 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.411 1.005 . . . . 0.0 111.826 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -70.94 145.26 50.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 49.8 mttp -104.95 132.54 51.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.133 1.373 . . . . 0.0 107.564 -176.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.29 162.54 25.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 109.086 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.5 t -113.52 -13.74 12.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.729 0.412 . . . . 0.0 110.604 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.8 p -142.09 158.49 43.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.23 126.1 92.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.03 170.95 17.72 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.285 2.657 . . . . 0.0 111.375 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.65 101.79 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.08 3.186 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.59 28.8 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.76 1.648 . . . . 0.0 111.785 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.97 34.24 87.9 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.093 -1.948 . . . . 0.0 113.008 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.07 165.8 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.691 1.996 . . . . 0.0 108.388 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.75 109.72 7.34 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 125.889 1.676 . . . . 0.0 110.036 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.98 -14.9 44.27 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.805 1.323 . . . . 0.0 112.379 167.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -41.06 17.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.006 0.922 . . . . 0.0 110.006 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.6 p -138.48 4.99 2.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.426 1.012 . . . . 0.0 113.573 -163.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.11 -14.63 1.55 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.198 2.333 . . . . 0.0 116.087 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 163.16 24.73 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.865 1.333 . . . . 0.0 112.7 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -69.45 155.94 39.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.66 145.64 15.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -136.24 168.81 18.7 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.094 1.358 . . . . 0.0 110.173 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.0 tt -77.32 157.87 30.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.991 0.916 . . . . 0.0 109.984 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 127.602 2.361 . . . . 0.0 107.816 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.2 tttt . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.7 116.78 1.92 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.86 1.264 . . . . 0.0 111.597 -170.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.96 143.89 31.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.533 0.733 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.15 154.18 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 O-C-N 124.129 0.893 . . . . 0.0 110.306 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.58 154.6 45.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.397 2.679 . . . . 0.0 107.611 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.41 164.44 14.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.746 0.818 . . . . 0.0 111.153 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.7 p -35.08 -50.12 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.282 2.233 . . . . 0.0 112.654 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -52.2 -40.65 61.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.107 0.963 . . . . 0.0 112.188 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.59 -44.76 97.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.322 1.449 . . . . 0.0 109.699 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.35 -34.25 72.41 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.898 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.61 -50.31 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.732 0.813 . . . . 0.0 109.738 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -70.7 -19.49 62.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.29 0.496 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.2 23.69 47.29 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.478 1.037 . . . . 0.0 112.096 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.62 112.69 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 112.48 1.57 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.827 1.251 . . . . 0.0 108.262 170.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 141.39 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.782 2.033 . . . . 0.0 106.989 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -78.29 164.81 24.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.113 1.365 . . . . 0.0 108.986 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.79 -165.85 31.19 Favored Glycine 0 C--N 1.331 0.264 0 O-C-N 121.032 -1.043 . . . . 0.0 111.048 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -103.23 149.02 25.09 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -142.84 171.54 13.92 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.189 1.396 . . . . 0.0 111.153 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.34 119.44 64.25 Favored Pre-proline 0 C--O 1.251 1.154 0 C-N-CA 126.151 1.781 . . . . 0.0 112.963 -168.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.31 -6.23 16.94 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.247 1.965 . . . . 0.0 113.005 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.9 m -91.96 -29.74 16.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.74 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.24 -39.8 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 120.467 1.485 . . . . 0.0 108.95 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG23 HD13 ' A' ' 43' ' ' LEU . 13.3 p -58.85 -23.57 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.11 -23.24 63.97 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.758 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.51 -34.96 30.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.851 1.26 . . . . 0.0 109.701 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.17 127.2 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.783 1.233 . . . . 0.0 108.092 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 -19.35 2.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.303 1.041 . . . . 0.0 112.239 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.28 127.49 32.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -59.18 -43.06 92.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.779 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.62 -53.93 51.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -54.66 44.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.624 1.57 . . . . 0.0 110.574 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -57.12 -59.29 5.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.154 0.581 . . . . 0.0 109.581 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.97 -53.19 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -54.1 -47.88 71.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.744 0.818 . . . . 0.0 112.066 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 31' ' ' VAL . 5.7 tt -58.58 -52.44 65.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.077 1.351 . . . . 0.0 108.851 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.31 -40.28 95.79 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.912 -0.492 . . . . 0.0 110.729 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -60.05 -47.96 83.71 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.378 1.471 . . . . 0.0 110.132 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -38.28 89.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.827 0.74 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.21 -45.28 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 118.767 0.712 . . . . 0.0 109.491 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -54.31 -50.05 68.26 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 109.635 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.1 -6.59 34.98 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.246 1.819 . . . . 0.0 113.383 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.17 83.31 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.811 1.187 . . . . 0.0 113.324 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.69 -46.58 87.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.561 1.18 . . . . 0.0 107.91 170.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 147.63 21.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.761 0.824 . . . . 0.0 109.092 -167.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.69 172.27 9.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.112 1.765 . . . . 0.0 108.889 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.76 138.46 44.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.789 1.635 . . . . 0.0 110.47 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.28 123.82 3.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.856 1.662 . . . . 0.0 108.052 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -107.22 147.21 34.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.215 0.916 . . . . 0.0 111.581 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.81 171.57 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.445 3.43 . . . . 0.0 113.044 -170.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -111.7 160.58 17.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.604 1.562 . . . . 0.0 110.262 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -59.88 -45.72 91.61 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.611 -0.681 . . . . 0.0 111.535 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.18 -38.78 65.98 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.608 0.763 . . . . 0.0 110.463 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -70.11 -42.12 73.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.344 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -64.13 -46.88 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.38 77.34 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.81 -0.556 . . . . 0.0 111.118 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.73 -44.53 63.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.133 0.973 . . . . 0.0 111.199 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.75 -50.78 57.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.2 mt -51.46 -36.52 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.573 1.149 . . . . 0.0 110.807 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -66.38 -56.32 11.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.809 1.186 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.31 -38.8 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.96 67.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.617 1.567 . . . . 0.0 111.447 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -24.2 63.05 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.134 -0.979 . . . . 0.0 112.537 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.25 -30.7 54.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 111.389 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.269 14.6 t -75.58 -68.13 0.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.38 0.991 . . . . 0.0 108.526 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.76 -73.19 0.07 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-N 119.482 1.037 . . . . 0.0 111.569 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -69.6 93.83 0.73 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.663 0.785 . . . . 0.0 110.027 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.64 -59.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 122.167 -0.333 . . . . 0.0 111.839 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -114.67 8.18 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.451 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.81 -9.29 58.5 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 78' ' ' LEU . 3.3 mp -92.63 159.79 15.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.256 -0.903 . . . . 0.0 110.746 -174.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -68.69 156.38 38.33 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.525 -0.735 . . . . 0.0 111.95 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.44 -57.42 12.81 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 118.895 -0.574 . . . . 0.0 109.508 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.69 -39.79 52.12 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.073 0.858 . . . . 0.0 111.4 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -61.68 2.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 109.316 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.24 -42.99 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 125.283 1.433 . . . . 0.0 108.759 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -56.2 -62.12 1.93 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.458 1.103 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.15 -47.53 80.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.415 0.686 . . . . 0.0 109.638 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 96' ' ' ILE . 42.3 mt -59.13 -52.18 66.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.939 0.896 . . . . 0.0 110.173 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.779 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.12 -59.45 4.17 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.133 1.373 . . . . 0.0 112.218 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 tp -46.96 -54.27 10.5 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.58 1.175 . . . . 0.0 110.972 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.25 68.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.395 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.7 m-85 -64.56 -28.78 69.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.517 0.599 . . . . 0.0 112.015 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.19 -34.52 76.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.141 0.882 . . . . 0.0 110.167 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.97 -18.92 38.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.008 1.323 . . . . 0.0 112.972 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.06 51.39 17.15 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.12 -149.01 11.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.929 1.728 . . . . 0.0 111.254 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -114.21 169.93 8.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.618 1.967 . . . . 0.0 108.465 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.482 HD13 HD23 ' A' ' 86' ' ' LEU . 55.0 mt -131.94 153.76 39.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.047 1.339 . . . . 0.0 107.807 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.59 111.82 8.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.735 1.214 . . . . 0.0 108.788 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.2 t -160.92 179.61 8.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.032 2.133 . . . . 0.0 107.534 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -155.74 27.71 0.38 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.351 -1.468 . . . . 0.0 113.599 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.582 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.3 t70 -95.44 156.64 16.24 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -170.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -69.41 -40.8 77.08 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.037 1.29 . . . . 0.0 110.223 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.33 -49.41 49.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.135 173.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -57.01 -40.01 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.812 1.187 . . . . 0.0 110.927 -173.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -67.32 -40.19 85.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.975 0.51 . . . . 0.0 109.874 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.414 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.6 t-20 -66.09 -55.05 18.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 mm -53.97 -54.47 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 110.391 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.59 -32.32 68.87 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.111 -1.618 . . . . 0.0 112.777 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 t -60.54 -60.6 3.55 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 117.73 -1.129 . . . . 0.0 110.678 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -60.57 -31.99 71.09 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 120.022 1.283 . . . . 0.0 110.683 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.554 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -76.32 -8.72 57.72 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.82 5.49 88.6 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.707 -1.051 . . . . 0.0 113.511 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.65 130.48 34.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.243 1.521 . . . . 0.0 110.031 -170.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.496 ' N ' HD13 ' A' ' 112' ' ' LEU . 11.0 ttt85 -66.63 132.1 47.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.676 0.79 . . . . 0.0 111.168 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -144.82 178.51 7.96 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.344 -0.848 . . . . 0.0 110.545 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -115.03 156.27 25.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.331 1.452 . . . . 0.0 108.881 171.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 124.919 1.287 . . . . 0.0 108.732 173.546 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ttt-85 -156.82 9.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.998 1.111 . . . . 0.0 113.998 -164.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -133.65 131.89 40.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.92 0.782 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.21 133.77 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.59 128.71 37.44 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 166.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.11 113.06 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 164.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.28 -79.27 0.21 Allowed Glycine 0 C--O 1.229 -0.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 10.7 p -102.8 -7.06 21.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.636 0.718 . . . . 0.0 112.725 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.34 19.36 66.8 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.865 -1.147 . . . . 0.0 114.388 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 5.0 ttm-85 -63.43 150.29 43.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.455 1.502 . . . . 0.0 110.013 -176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -123.96 97.7 5.47 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.746 0.654 . . . . 0.0 111.315 -152.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -99.48 146.26 26.56 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.421 1.105 . . . . 0.0 108.961 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -98.9 -11.32 21.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.473 0.709 . . . . 0.0 110.345 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.5 p -140.03 162.03 36.19 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 126.496 1.918 . . . . 0.0 108.979 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -79.04 118.48 72.73 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 141' ' ' LEU . 81.2 Cg_endo -67.92 161.46 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.979 1.786 . . . . 0.0 109.403 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.0 107.7 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.873 2.382 . . . . 0.0 108.744 172.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.46 -18.93 11.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.761 2.124 . . . . 0.0 111.927 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 54.78 31.4 54.09 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.759 1.279 . . . . 0.0 113.673 -175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 164.11 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.999 1.32 . . . . 0.0 108.154 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 150' ' ' CYS . 2.4 t -64.65 115.01 16.75 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.163 168.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.92 -3.87 2.47 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.193 1.929 . . . . 0.0 113.083 166.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.21 -26.68 5.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.434 1.893 . . . . 0.0 112.814 -170.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 67.9 m -113.01 -18.16 12.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.728 1.211 . . . . 0.0 111.52 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 53.02 50.3 51.88 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.7 t -128.28 162.48 26.93 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.32 139.62 49.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.792 0.806 . . . . 0.0 110.948 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.09 152.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -126.76 156.32 41.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 120.306 -1.496 . . . . 0.0 109.516 166.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.12 120.24 23.99 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.535 0.401 0 O-C-N 123.441 0.463 . . . . 0.0 110.697 177.623 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.0 tttt . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -45.14 119.19 1.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.341 1.456 . . . . 0.0 111.95 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.2 137.56 40.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.568 1.547 . . . . 0.0 107.093 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.41 146.76 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.81 146.78 40.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.733 1.613 . . . . 0.0 108.098 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.73 174.66 7.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.345 0.52 . . . . 0.0 111.706 166.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -55.87 -42.28 75.65 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -61.15 -27.7 68.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.743 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.74 -42.68 82.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 119.984 1.266 . . . . 0.0 110.162 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -72.23 -36.38 69.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.465 1.106 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.3 -26.54 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.552 1.141 . . . . 0.0 110.892 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -92.22 -23.55 19.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.278 0.945 . . . . 0.0 111.829 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.96 45.72 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.304 -0.72 . . . . 0.0 113.02 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.2 mt -67.92 109.98 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.87 91.52 0.65 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.383 1.073 . . . . 0.0 110.191 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.47 165.79 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.832 1.253 . . . . 0.0 109.52 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.45 119.29 21.4 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.475 -166.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.07 -162.39 29.27 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.186 0.898 . . . . 0.0 110.905 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -104.26 150.59 24.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.875 1.27 . . . . 0.0 109.397 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -135.46 149.11 49.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.855 1.262 . . . . 0.0 108.82 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.82 118.93 75.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 125.219 1.408 . . . . 0.0 107.99 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.12 -28.71 71.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 119.749 0.946 . . . . 0.0 110.776 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -48.29 37.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.181 3.392 . . . . 0.0 113.899 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.7 -35.15 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-N 118.77 0.714 . . . . 0.0 110.33 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.27 -26.95 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.867 0.758 . . . . 0.0 110.062 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.5 -20.48 31.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.91 -22.12 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.992 1.317 . . . . 0.0 111.685 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.2 mt -62.58 116.79 2.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 122.211 1.005 . . . . 0.0 108.837 -170.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.84 -16.54 3.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.838 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -66.56 122.01 16.63 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -56.22 -45.34 79.94 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.122 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -56.79 -55.85 29.02 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.77 1.228 . . . . 0.0 109.121 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -61.17 -44.57 97.1 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.371 1.069 . . . . 0.0 110.31 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.41 -55.53 20.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.329 0.652 . . . . 0.0 110.493 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.1 mt -50.27 -55.68 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -55.19 -56.06 24.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.982 0.913 . . . . 0.0 111.613 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -52.55 -57.51 9.72 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.605 1.162 . . . . 0.0 108.836 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -58.06 -41.1 82.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.001 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -62.87 -35.85 81.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.854 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -37.46 63.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.971 0.908 . . . . 0.0 111.209 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.1 -47.3 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -66.52 -34.52 78.11 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.036 0.38 . . . . 0.0 110.976 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.91 -12.41 61.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.071 0.948 . . . . 0.0 112.745 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.13 21.75 48.08 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 119.427 1.012 . . . . 0.0 112.668 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -105.81 -26.59 11.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.913 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -119.87 127.01 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -123.27 144.2 49.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.987 1.267 . . . . 0.0 112.847 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.7 mm -77.4 122.65 32.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.666 1.186 . . . . 0.0 109.412 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 126.88 10.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.783 0.833 . . . . 0.0 110.097 168.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.39 158.14 37.49 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.1 0.56 . . . . 0.0 112.409 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.89 175.0 5.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 125.034 3.823 . . . . 0.0 111.98 170.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.36 165.03 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.36 15.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.913 1.685 . . . . 0.0 111.501 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.17 -30.81 70.0 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.763 0.425 . . . . 0.0 111.582 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -64.96 -48.52 73.74 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.385 1.474 . . . . 0.0 109.492 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.01 -46.9 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 124.439 1.096 . . . . 0.0 108.902 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -34.67 74.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 122.412 -0.18 . . . . 0.0 110.969 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -41.54 75.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.499 0.719 . . . . 0.0 111.443 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -70.58 -41.13 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 117.33 -1.319 . . . . 0.0 109.803 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.59 -54.03 17.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.334 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -55.32 -55.13 35.0 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.813 1.188 . . . . 0.0 112.13 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.993 HG11 HD21 ' A' ' 110' ' ' LEU . 4.6 p -67.44 -37.44 78.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.988 -0.445 . . . . 0.0 110.972 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -65.2 -34.01 77.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.259 1.024 . . . . 0.0 110.604 175.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -53.52 57.28 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.106 1.362 . . . . 0.0 109.566 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 1.86 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.654 1.582 . . . . 0.0 112.695 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.94 11.53 3.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.331 1.452 . . . . 0.0 111.107 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.07 -72.67 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 125.908 1.718 . . . . 0.0 112.78 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -77.68 71.56 4.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.86 1.264 . . . . 0.0 110.246 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.43 -39.13 82.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.762 1.625 . . . . 0.0 113.898 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -130.76 12.98 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.885 0.766 . . . . 0.0 110.887 -173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.61 -22.84 61.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.68 0.792 . . . . 0.0 111.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 78' ' ' LEU . 2.1 mp -77.33 155.83 31.71 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 122.14 -0.35 . . . . 0.0 110.428 -174.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.7 m -63.24 151.13 41.37 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.581 0.705 . . . . 0.0 109.28 170.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -55.75 -45.32 78.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.562 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.38 80.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.203 0.911 . . . . 0.0 113.17 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.27 -57.77 9.95 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -55.92 -45.22 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.373 1.469 . . . . 0.0 109.08 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -68.22 -49.88 57.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.904 1.282 . . . . 0.0 111.943 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.42 -48.02 86.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.346 0.975 . . . . 0.0 108.998 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.74 -57.06 14.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.178 0.991 . . . . 0.0 109.177 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.97 -48.49 52.13 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.914 1.286 . . . . 0.0 111.331 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.42 -51.73 65.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.709 0.804 . . . . 0.0 109.211 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.69 74.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.518 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.4 m-30 -76.08 -22.23 55.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.938 0.79 . . . . 0.0 111.91 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.37 -50.23 68.53 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.43 -14.0 59.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.44 1.096 . . . . 0.0 112.779 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? 54.35 30.3 12.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.888 1.675 . . . . 0.0 111.752 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -125.53 5.2 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.158 0.885 . . . . 0.0 111.061 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.98 165.63 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.767 2.027 . . . . 0.0 110.12 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.7 mt -130.09 162.99 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.725 1.21 . . . . 0.0 108.462 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.38 122.75 19.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.207 2.203 . . . . 0.0 106.051 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -163.26 175.76 10.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.66 1.184 . . . . 0.0 110.669 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -160.35 92.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.229 1.412 . . . . 0.0 109.618 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -151.92 153.04 33.33 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.777 1.231 . . . . 0.0 109.254 163.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -58.66 -41.71 86.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.0 1.273 . . . . 0.0 111.907 -171.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' HD23 ' A' ' 78' ' ' LEU . 5.5 p-10 -66.89 -55.54 14.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 110.029 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -54.12 -40.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.492 0.663 . . . . 0.0 110.526 -171.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -69.67 -41.3 75.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.063 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -59.54 -59.79 4.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.708 1.603 . . . . 0.0 107.649 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 mm -53.33 -58.84 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 124.639 1.176 . . . . 0.0 108.841 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.71 67.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.455 1.479 . . . . 0.0 112.793 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -52.98 55.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.764 -1.589 . . . . 0.0 113.102 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -35.23 79.08 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 121.235 1.834 . . . . 0.0 109.784 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.993 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -70.14 -22.38 63.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.493 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.97 80.32 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 124.726 1.155 . . . . 0.0 113.847 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -83.25 118.18 23.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.408 1.104 . . . . 0.0 109.098 177.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -68.61 131.75 45.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.778 1.231 . . . . 0.0 108.274 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -146.57 169.74 18.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.926 0.393 . . . . 0.0 111.182 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -101.93 134.27 45.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.607 1.163 . . . . 0.0 108.38 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.45 -0.433 0 O-C-N 124.721 1.263 . . . . 0.0 109.53 164.471 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 5.5 p-90 . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -155.58 25.05 0.4 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.619 -1.182 . . . . 0.0 113.933 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -129.94 140.4 50.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.676 1.125 . . . . 0.0 110.73 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.29 135.29 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.592 1.557 . . . . 0.0 108.886 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.53 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.6 OUTLIER -70.25 140.68 52.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -91.3 102.14 13.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 121.983 0.897 . . . . 0.0 109.045 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.05 -78.72 0.33 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 2.3 p -78.01 -10.72 59.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.621 0.71 . . . . 0.0 111.528 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.66 21.93 71.32 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.919 1.247 . . . . 0.0 114.589 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -63.93 135.16 56.28 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.354 1.062 . . . . 0.0 109.729 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -88.48 136.72 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.66 1.584 . . . . 0.0 108.417 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -130.8 150.02 52.17 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.416 1.086 . . . . 0.0 108.354 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 3.3 p -88.18 -22.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.435 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.4 p -139.58 172.61 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 108.136 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.86 132.34 90.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.12 169.44 21.44 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.912 1.741 . . . . 0.0 110.123 172.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -56.39 137.49 80.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.68 1.587 . . . . 0.0 109.586 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.96 -10.04 4.69 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.88 72.78 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.806 1.803 . . . . 0.0 112.918 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.18 161.63 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.247 1.019 . . . . 0.0 108.947 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.3 t -79.48 113.69 39.09 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.432 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.16 -13.45 15.95 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.366 1.377 . . . . 0.0 114.044 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.53 -25.09 15.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.171 1.388 . . . . 0.0 112.79 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.53 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.9 p -150.71 2.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.57 -11.35 7.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.585 2.04 . . . . 0.0 115.152 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.46 166.75 21.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.588 1.194 . . . . 0.0 112.873 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -61.16 149.21 38.15 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.618 -0.676 . . . . 0.0 109.834 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.48 142.94 22.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 153.5 51.22 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.34 1.056 . . . . 0.0 111.364 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.7 tt -76.08 137.85 40.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.777 0.831 . . . . 0.0 109.214 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 112.768 -177.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -39.79 117.95 0.81 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 126.417 1.887 . . . . 0.0 110.443 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.99 144.15 43.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.13 155.48 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 124.373 1.045 . . . . 0.0 109.903 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.16 146.15 51.28 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.305 1.842 . . . . 0.0 108.671 -166.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.16 171.97 7.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.561 0.744 . . . . 0.0 112.749 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.73 69.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.095 1.358 . . . . 0.0 112.187 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -37.38 72.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.2 -47.38 80.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.942 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -73.19 -31.73 64.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.879 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.01 -47.94 91.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.972 . . . . 0.0 109.518 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.63 -25.02 58.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.198 0.454 . . . . 0.0 111.043 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.88 28.08 14.86 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.39 0.519 . . . . 0.0 113.053 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -72.08 108.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -61.27 115.53 3.89 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 23' ' ' GLU . 3.5 tp -159.48 144.79 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.981 1.713 . . . . 0.0 107.45 174.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' H ' HD12 ' A' ' 22' ' ' ILE . 31.9 mp0 -88.09 142.37 27.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.947 1.299 . . . . 0.0 108.652 175.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.15 -155.61 24.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -117.96 151.72 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.25 1.02 . . . . 0.0 109.858 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 t -129.37 145.79 51.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.163 1.385 . . . . 0.0 110.496 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.502 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -91.13 117.69 68.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.504 1.522 . . . . 0.0 110.035 -168.127 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.4 Cg_endo -63.97 -5.67 9.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.884 3.056 . . . . 0.0 115.633 -170.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.99 -4.35 13.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.346 0.976 . . . . 0.0 111.886 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.69 -47.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 HD13 ' A' ' 43' ' ' LEU . 6.0 p -65.55 -19.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -170.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.59 -26.11 66.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.127 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -78.18 -40.95 36.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.017 0.927 . . . . 0.0 108.849 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.0 mt -55.67 101.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.609 1.564 . . . . 0.0 108.699 -169.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -9.29 8.9 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 126.025 1.73 . . . . 0.0 110.734 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.31 127.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -58.45 -51.66 68.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.557 0.743 . . . . 0.0 109.355 -170.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.41 -54.89 40.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.637 1.175 . . . . 0.0 108.73 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.381 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -64.73 -58.05 7.33 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.712 0.687 . . . . 0.0 109.469 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.37 -46.65 85.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 50.4 t80 -59.5 -51.65 68.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.067 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.547 HD13 HG23 ' A' ' 31' ' ' VAL . 6.8 tt -53.34 -52.12 60.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.103 0.961 . . . . 0.0 109.547 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.8 -37.04 80.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.906 0.882 . . . . 0.0 110.961 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -56.51 -46.53 80.51 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.317 1.447 . . . . 0.0 109.995 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 50.9 mt -67.7 -35.57 79.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.578 0.751 . . . . 0.0 110.784 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.3 -55.36 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -59.5 -38.19 80.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.397 0.544 . . . . 0.0 112.363 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -24.92 66.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.853 1.261 . . . . 0.0 112.383 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 9.0 60.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.531 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -83.75 -34.76 24.76 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.351 1.076 . . . . 0.0 111.263 178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.26 147.76 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -128.17 157.01 41.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.51 1.124 . . . . 0.0 109.759 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mm -78.63 135.06 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.85 127.83 7.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.828 0.851 . . . . 0.0 111.756 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -106.03 154.93 39.21 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.735 1.614 . . . . 0.0 112.17 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.82 163.33 28.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.12 3.88 . . . . 0.0 114.457 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -90.81 166.57 13.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.662 1.985 . . . . 0.0 109.457 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tmpt? -50.17 -44.45 52.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.129 1.372 . . . . 0.0 110.295 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -71.39 -27.58 63.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.989 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -66.09 -48.98 69.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.265 0.626 . . . . 0.0 109.664 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.26 -42.09 93.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.51 -33.14 74.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.225 0.466 . . . . 0.0 111.221 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -43.37 61.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.641 1.176 . . . . 0.0 110.307 174.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -72.21 -44.18 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 119.336 0.971 . . . . 0.0 108.547 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.61 -39.88 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.404 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -57.01 -68.2 0.24 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.5 1.143 . . . . 0.0 109.14 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.39 -29.81 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.091 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.22 60.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.917 . . . . 0.0 111.643 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -65.52 -25.99 67.7 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.081 -1.012 . . . . 0.0 111.563 -177.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 43.2 mt-10 -60.98 -52.72 63.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.139 0.882 . . . . 0.0 109.088 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -75.57 -39.96 57.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.36 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.55 -76.54 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.532 1.06 . . . . 0.0 113.52 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.01 92.0 0.91 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 122.02 0.914 . . . . 0.0 110.213 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.91 -44.08 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.541 0.736 . . . . 0.0 112.784 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -131.18 12.91 5.13 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.753 0.421 . . . . 0.0 110.899 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.03 -8.31 55.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 106' ' ' ILE . 5.4 mp -83.25 156.69 23.0 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.267 -0.895 . . . . 0.0 110.592 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.77 159.21 19.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.921 1.289 . . . . 0.0 110.605 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.54 -57.9 7.87 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.42 -39.14 75.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 123.959 0.787 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.68 -52.4 65.61 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 109.729 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.53 -46.35 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.5 -49.64 58.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.638 0.654 . . . . 0.0 112.722 -172.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG22 ' OG1' ' A' ' 27' ' ' THR . 93.7 t -60.58 -50.72 79.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -55.47 -58.57 7.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.15 0.98 . . . . 0.0 109.288 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -47.44 -55.89 8.08 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.931 1.292 . . . . 0.0 112.005 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.08 -48.07 81.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.295 1.038 . . . . 0.0 110.364 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.19 74.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.242 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.4 m-30 -67.76 -27.95 67.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.679 0.672 . . . . 0.0 111.213 -177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -30.05 66.69 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.281 0.946 . . . . 0.0 110.89 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.69 -14.82 38.85 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.718 1.207 . . . . 0.0 112.284 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.72 0.75 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.149 1.38 . . . . 0.0 111.425 -162.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.97 -162.79 13.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -101.67 167.92 9.8 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 109.043 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 86' ' ' LEU . 72.8 mt -133.62 150.8 32.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 125.181 1.393 . . . . 0.0 107.3 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.88 124.82 25.6 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.255 1.822 . . . . 0.0 106.29 170.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 16.5 t -152.31 -150.21 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.708 2.003 . . . . 0.0 106.884 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.01 -23.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.768 1.167 . . . . 0.0 113.401 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 103' ' ' VAL . 1.4 m-20 -72.91 140.73 47.68 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.901 1.681 . . . . 0.0 113.483 -156.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.41 -38.57 54.22 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.057 -1.652 . . . . 0.0 113.257 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.07 -47.79 60.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 111.341 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 0.3 OUTLIER -57.56 -37.04 56.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.046 1.294 . . . . 0.0 110.38 -177.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 35.7 mt-30 -68.84 -39.55 79.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -63.94 -56.29 16.33 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.401 0.68 . . . . 0.0 110.324 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 78' ' ' LEU . 13.8 mm -54.55 -52.67 38.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.494 1.043 . . . . 0.0 109.851 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.71 73.11 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.522 1.51 . . . . 0.0 113.298 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 t -55.8 -62.12 1.91 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.954 172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -25.38 68.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.368 1.44 . . . . 0.0 111.927 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -83.33 -10.16 58.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.78 82.22 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.563 -1.132 . . . . 0.0 113.879 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.568 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -92.22 135.51 33.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.497 1.648 . . . . 0.0 111.13 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.568 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -81.37 131.76 35.3 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.613 1.965 . . . . 0.0 110.435 177.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 26.7 p90 -150.98 -175.28 5.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.664 -0.647 . . . . 0.0 110.986 -174.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -98.98 175.28 5.98 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.161 1.384 . . . . 0.0 114.239 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 124.96 1.304 . . . . 0.0 110.423 171.221 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 7.8 p-90 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -0.3 0.11 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.63 150.06 44.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.665 1.575 . . . . 0.0 111.613 -169.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.79 128.42 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.842 1.257 . . . . 0.0 109.436 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 3.1 t -65.91 144.15 56.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 166.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.23 94.92 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.09 -90.78 0.1 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.97 13.24 17.19 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.183 0.993 . . . . 0.0 111.367 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.09 22.93 61.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.013 1.292 . . . . 0.0 115.122 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -65.46 125.78 26.22 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 110.056 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -72.78 150.99 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.938 0.773 . . . . 0.0 109.873 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.31 149.69 38.16 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.501 1.12 . . . . 0.0 109.229 166.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 42.9 t -86.11 -26.98 24.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.135 0.574 . . . . 0.0 111.674 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.7 p -145.3 160.02 42.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.392 1.477 . . . . 0.0 108.238 -171.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -74.57 123.42 89.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.49 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.91 172.06 15.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.858 2.372 . . . . 0.0 110.206 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.1 137.4 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 121.918 1.745 . . . . 0.0 110.269 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.59 -9.79 1.69 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.544 1.069 . . . . 0.0 114.172 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.8 35.77 87.67 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.87 1.335 . . . . 0.0 111.724 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.56 158.2 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.383 1.073 . . . . 0.0 108.121 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 4.8 t -71.08 113.03 15.69 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 117.252 -1.356 . . . . 0.0 108.082 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.36 -18.81 25.96 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.51 1.474 . . . . 0.0 113.189 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -27.15 15.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.088 1.755 . . . . 0.0 111.882 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 11.7 p -140.4 -2.77 1.39 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.43 -13.9 2.66 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.464 1.983 . . . . 0.0 115.317 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 163.1 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.177 1.489 . . . . 0.0 111.789 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.11 154.34 41.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.524 0.678 . . . . 0.0 109.768 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.8 t -108.17 148.48 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -129.96 160.8 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.335 1.054 . . . . 0.0 110.697 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.45 116.56 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.082 1.353 . . . . 0.0 107.803 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 124.459 1.104 . . . . 0.0 111.657 175.847 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm . . . . . 0 C--O 1.238 0.452 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.8 m -63.48 125.61 24.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -146.37 134.41 21.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.65 152.39 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.72 135.32 50.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.369 2.267 . . . . 0.0 109.409 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.33 161.36 14.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.97 2.108 . . . . 0.0 110.941 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.504 ' HB2' HG21 ' A' ' 30' ' ' VAL . 28.6 t -46.38 -45.17 17.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.399 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -52.19 -35.35 48.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.871 0.868 . . . . 0.0 111.92 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.18 -35.87 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.144 0.978 . . . . 0.0 109.626 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.2 -37.6 25.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.66 0.784 . . . . 0.0 111.025 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.92 -41.95 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.975 0.91 . . . . 0.0 109.205 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -79.13 -13.92 59.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 24.42 65.1 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.274 0.94 . . . . 0.0 113.864 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -78.82 108.19 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 C-N-CA 124.557 1.143 . . . . 0.0 108.417 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.05 111.75 3.52 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tp -154.45 159.62 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 127.348 2.259 . . . . 0.0 106.756 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -128.24 128.62 45.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.641 1.176 . . . . 0.0 110.498 -166.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.13 -147.65 9.08 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.236 1.398 . . . . 0.0 111.943 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.96 158.1 24.65 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.11 1.764 . . . . 0.0 110.144 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -145.74 166.29 26.3 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -90.09 125.56 60.01 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.619 0.724 . . . . 0.0 111.618 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG12 ' A' ' 31' ' ' VAL . 55.8 Cg_endo -63.07 -12.58 30.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.235 1.29 . . . . 0.0 111.163 166.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -32.94 67.39 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 126.873 2.069 . . . . 0.0 112.698 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.504 HG21 ' HB2' ' A' ' 13' ' ' SER . 11.3 p -92.8 -34.37 5.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 120.267 1.394 . . . . 0.0 110.632 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 28' ' ' PRO . 7.7 p -61.49 -16.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.849 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.392 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.65 -21.69 10.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.461 1.904 . . . . 0.0 110.799 -166.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 mt -67.81 96.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -90.45 -24.76 20.62 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 112.117 165.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.26 129.2 24.12 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.304 1.842 . . . . 0.0 111.549 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -51.4 -72.01 0.06 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 126.208 1.803 . . . . 0.0 110.535 -170.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.98 -48.02 83.76 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -164.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.8 t -50.48 -56.37 11.88 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.988 1.715 . . . . 0.0 110.088 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -61.4 -53.91 50.46 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.358 1.063 . . . . 0.0 110.61 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.5 mt -55.67 -50.17 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.27 1.028 . . . . 0.0 108.621 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.17 -48.41 80.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.7 -48.5 77.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.04 -1.037 . . . . 0.0 110.456 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.43 -40.87 92.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.997 0.919 . . . . 0.0 110.61 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 t -57.68 -51.1 70.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.166 1.386 . . . . 0.0 110.425 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.14 -38.08 89.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.809 0.843 . . . . 0.0 110.616 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.02 -50.97 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.7 t -59.54 -35.82 74.94 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.456 0.702 . . . . 0.0 111.015 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.17 -11.59 59.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.266 1.426 . . . . 0.0 112.725 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.44 87.1 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.721 1.153 . . . . 0.0 113.443 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 3.3 ptpt -78.42 -19.71 52.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.188 0.995 . . . . 0.0 112.07 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.43 136.78 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -125.72 140.9 52.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.52 0.676 . . . . 0.0 110.398 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.48 126.64 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.04 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.37 127.4 9.71 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.102 1.361 . . . . 0.0 109.212 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -99.57 155.05 36.93 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.505 0.722 . . . . 0.0 112.77 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.03 173.75 8.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.23 3.954 . . . . 0.0 112.235 165.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.08 173.16 8.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.887 2.075 . . . . 0.0 110.151 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -54.1 -49.86 68.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.833 -0.542 . . . . 0.0 110.251 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.08 -31.04 71.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.348 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -51.98 53.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.177 0.991 . . . . 0.0 110.31 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.27 -45.68 97.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.36 -39.9 70.64 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.661 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -45.63 46.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.415 1.486 . . . . 0.0 110.556 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -71.42 -46.85 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -177.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.3 mt -53.17 -43.41 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.317 1.047 . . . . 0.0 110.339 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.55 -57.52 12.4 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.571 0.623 . . . . 0.0 110.199 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.74 -37.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.9 71.97 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.411 1.084 . . . . 0.0 111.482 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -35.14 80.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.928 1.24 . . . . 0.0 111.164 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.86 -42.72 94.63 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.741 0.7 . . . . 0.0 110.715 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 t -80.98 -41.03 23.42 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.183 0.447 . . . . 0.0 111.94 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.32 146.18 6.37 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.787 1.661 . . . . 0.0 109.045 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 83.05 50.59 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 130.39 3.476 . . . . 0.0 109.21 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.48 -52.76 48.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 121.153 -0.967 . . . . 0.0 113.413 -170.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.09 11.02 15.17 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.083 0.553 . . . . 0.0 110.528 -167.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -20.74 32.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.534 0.734 . . . . 0.0 112.199 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -73.64 150.78 41.1 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.5 m -58.98 152.17 20.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.299 1.047 . . . . 0.0 110.812 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -59.19 4.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.58 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.56 77.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.888 0.743 . . . . 0.0 111.737 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.97 -55.25 37.1 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.173 0.989 . . . . 0.0 108.522 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.5 -43.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.838 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -65.49 -51.55 59.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.447 0.567 . . . . 0.0 111.435 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.27 -48.83 83.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.322 1.049 . . . . 0.0 109.301 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 96' ' ' ILE . 81.1 mt -58.22 -57.45 12.82 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.941 0.897 . . . . 0.0 109.614 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.92 -46.8 64.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.177 1.391 . . . . 0.0 112.663 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.06 -49.35 78.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.487 1.115 . . . . 0.0 109.167 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.98 75.12 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.709 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.504 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.6 m-30 -69.97 -26.3 64.03 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.109 0.868 . . . . 0.0 110.288 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.41 -7.09 51.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.316 1.046 . . . . 0.0 112.4 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.39 -10.61 8.43 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.266 1.427 . . . . 0.0 112.142 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.9 mttt 51.97 34.84 14.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 110.533 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.59 -130.37 6.66 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.712 1.149 . . . . 0.0 110.456 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -133.85 170.38 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.611 1.964 . . . . 0.0 109.917 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.461 HD13 HD23 ' A' ' 86' ' ' LEU . 66.5 mt -133.99 153.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 126.207 1.803 . . . . 0.0 106.489 -172.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.47 115.89 16.08 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 109.289 166.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 t -157.58 -172.53 4.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.061 3.344 . . . . 0.0 108.394 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.91 6.45 0.7 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -168.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.551 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.5 t0 -102.19 160.54 14.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.168 1.349 . . . . 0.0 111.96 -157.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -64.75 -48.55 74.15 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.51 -1.369 . . . . 0.0 111.636 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -69.33 -48.35 61.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.714 1.206 . . . . 0.0 109.78 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.551 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -56.53 -43.55 78.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -172.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.401 ' HG2' ' HE2' ' A' ' 114' ' ' PHE . 34.8 mt-30 -63.86 -47.79 79.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.32 0.648 . . . . 0.0 110.154 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.6 t-20 -56.08 -59.93 4.21 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.196 1.798 . . . . 0.0 108.226 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.16 -53.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 119.753 1.161 . . . . 0.0 111.254 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.37 67.71 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.367 1.44 . . . . 0.0 112.204 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -57.74 10.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -68.52 -21.92 64.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.15 1.341 . . . . 0.0 111.629 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.504 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.8 mm? -81.82 -22.15 37.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.473 0.709 . . . . 0.0 111.454 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.5 9.9 71.5 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.563 1.554 . . . . 0.0 114.232 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.22 123.86 29.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.853 1.327 . . . . 0.0 110.374 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 135.02 55.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.565 1.546 . . . . 0.0 109.05 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.401 ' HE2' ' HG2' ' A' ' 104' ' ' GLN . 18.3 p90 -151.23 175.27 12.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -107.35 166.51 10.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -149.82 9.71 0.7 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 117.352 -1.309 . . . . 0.0 113.532 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -133.96 138.94 45.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.907 1.231 . . . . 0.0 111.381 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.39 134.54 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.074 1.35 . . . . 0.0 109.298 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.433 ' HG ' ' HG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -76.54 122.06 24.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.071 0.949 . . . . 0.0 108.541 173.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.79 108.11 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.12 -80.66 0.2 Allowed Glycine 0 N--CA 1.458 0.136 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.5 p -88.45 -16.76 31.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.14 0.47 . . . . 0.0 111.885 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.11 32.5 43.78 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.546 0.593 . . . . 0.0 113.075 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 138' ' ' PHE . 42.5 ttt-85 -70.14 157.6 37.31 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 117.875 0.837 . . . . 0.0 109.772 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -101.32 146.63 27.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.353 1.461 . . . . 0.0 108.838 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 136' ' ' ARG . 97.4 m-85 -140.02 148.3 41.64 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.974 1.31 . . . . 0.0 108.321 169.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 t -94.22 -23.61 17.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.672 0.789 . . . . 0.0 110.566 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.9 p -136.97 157.64 46.27 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.615 0.766 . . . . 0.0 109.856 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -74.59 110.47 9.78 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.49 ' HD2' HD23 ' A' ' 141' ' ' LEU . 88.5 Cg_endo -68.62 172.02 12.21 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.918 3.079 . . . . 0.0 110.536 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.81 120.02 7.51 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.012 1.808 . . . . 0.0 109.632 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.47 -6.89 81.12 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.079 1.324 . . . . 0.0 113.417 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 59.48 38.54 93.7 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 119.255 1.528 . . . . 0.0 112.43 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -116.11 174.94 3.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 124.694 1.198 . . . . 0.0 108.397 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.19 100.31 2.13 Favored Pre-proline 0 CA--C 1.519 -0.239 0 CA-C-N 120.849 1.659 . . . . 0.0 109.355 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.14 37.49 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.932 3.754 . . . . 0.0 113.946 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.01 -16.08 0.21 Allowed 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.38 2.272 . . . . 0.0 112.004 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.433 ' HG ' ' HG ' ' A' ' 131' ' ' CYS . 11.8 p -146.73 -31.57 0.34 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.23 92.49 0.96 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.904 1.716 . . . . 0.0 111.128 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.43 174.01 2.85 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.638 1.975 . . . . 0.0 108.042 170.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -76.3 137.63 40.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.03 1.287 . . . . 0.0 111.958 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.35 157.94 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 156.62 44.07 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.699 -1.25 . . . . 0.0 110.969 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.24 146.08 35.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.672 0.789 . . . . 0.0 109.149 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 pt . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 -176.512 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -50.58 125.94 14.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.593 1.557 . . . . 0.0 109.043 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -144.44 142.54 30.37 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.57 148.56 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.18 133.85 53.45 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.464 1.506 . . . . 0.0 108.905 -171.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.52 161.81 20.09 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.88 1.672 . . . . 0.0 111.861 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -45.75 11.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.951 1.7 . . . . 0.0 111.822 171.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.0 p -61.54 -31.73 71.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.334 0.515 . . . . 0.0 111.938 -174.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 t -61.75 -42.56 94.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.656 1.182 . . . . 0.0 109.33 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.53 -37.32 71.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.663 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 91.3 mt -55.31 -54.43 25.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.07 -26.17 65.71 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.84 0.746 . . . . 0.0 111.461 -173.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 42' ' ' PHE . . . 91.23 37.25 6.31 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.79 108.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.35 112.61 7.62 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.33 174.37 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.082 1.353 . . . . 0.0 107.778 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -120.4 149.79 41.8 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.547 1.539 . . . . 0.0 108.339 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.74 -137.64 5.96 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.39 153.5 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.589 1.155 . . . . 0.0 110.452 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -129.38 144.63 51.32 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.522 1.129 . . . . 0.0 109.8 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.9 p -84.38 121.3 75.14 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 124.757 1.223 . . . . 0.0 109.804 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 31' ' ' VAL . 19.0 Cg_endo -65.42 -14.14 43.39 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.62 1.547 . . . . 0.0 113.665 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -74.75 -44.11 51.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.32 -36.11 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 119.402 1.001 . . . . 0.0 109.269 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 28' ' ' PRO . 10.0 p -64.21 -20.16 26.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 118.855 -1.138 . . . . 0.0 113.358 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.09 -25.3 68.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.249 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.94 -30.23 65.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.323 1.049 . . . . 0.0 109.893 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.96 82.56 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.973 2.109 . . . . 0.0 109.49 -164.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -20.17 60.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.215 1.406 . . . . 0.0 112.179 169.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.01 133.22 47.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.844 0.858 . . . . 0.0 110.89 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.3 mmt-85 -61.83 -59.65 4.83 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.96 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.19 -45.52 91.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 118.261 -0.876 . . . . 0.0 108.998 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 t -55.9 -56.23 23.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.276 0.63 . . . . 0.0 110.75 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -60.14 -51.43 69.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.624 1.102 . . . . 0.0 111.585 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.21 -57.62 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.414 ' CE2' ' HA2' ' A' ' 19' ' ' GLY . 68.4 t80 -56.46 -45.68 80.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.139 0.976 . . . . 0.0 112.219 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 31' ' ' VAL . 6.4 tt -54.48 -52.48 61.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.11 0.964 . . . . 0.0 108.525 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -70.48 -28.03 64.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.707 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -61.44 -50.27 73.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.422 1.01 . . . . 0.0 108.548 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -42.73 80.93 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.675 1.19 . . . . 0.0 111.402 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.83 -56.56 17.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -28.52 69.24 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.98 -13.2 60.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.397 1.479 . . . . 0.0 112.103 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.94 -6.7 51.87 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.603 1.573 . . . . 0.0 113.784 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -87.12 -23.42 24.87 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 118.486 1.143 . . . . 0.0 112.99 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.49 149.48 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 120.666 1.575 . . . . 0.0 107.457 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -135.16 156.73 48.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.709 -0.619 . . . . 0.0 111.007 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.35 131.52 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.87 0.868 . . . . 0.0 108.99 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.12 128.19 6.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.847 1.259 . . . . 0.0 110.036 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.33 158.82 32.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.163 0.985 . . . . 0.0 112.584 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -75.34 145.47 30.36 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.238 3.292 . . . . 0.0 112.891 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -65.01 155.35 34.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.156 0.982 . . . . 0.0 109.947 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -65.82 -36.11 82.56 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.904 -1.123 . . . . 0.0 109.479 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -21.74 64.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.973 0.806 . . . . 0.0 111.204 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 p -85.03 -38.17 19.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.102 0.864 . . . . 0.0 112.755 172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.47 1.032 . . . . 0.0 108.263 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -28.32 64.28 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.816 0.446 . . . . 0.0 111.451 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.69 98.72 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.548 -0.72 . . . . 0.0 111.741 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -67.24 -46.29 84.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.212 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -57.27 -28.77 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.737 0.698 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.11 -72.77 0.15 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.215 1.371 . . . . 0.0 108.962 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.62 -36.61 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.508 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -65.77 -40.81 92.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -27.2 61.59 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 121.692 2.042 . . . . 0.0 112.129 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.11 -52.3 59.83 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -69.87 -42.81 72.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.335 0.654 . . . . 0.0 111.586 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.9 -66.02 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.958 0.799 . . . . 0.0 112.452 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -71.47 45.96 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.848 2.859 . . . . 0.0 114.648 -165.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.4 p -40.33 -44.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 128.177 2.591 . . . . 0.0 115.988 -167.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -131.31 11.54 4.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.023 0.929 . . . . 0.0 110.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -12.77 61.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.153 0.581 . . . . 0.0 110.503 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 174.3 8.64 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.685 1.194 . . . . 0.0 110.183 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -68.11 154.0 42.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.798 1.285 . . . . 0.0 110.979 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HE3' ' N ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -54.2 -52.6 60.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.137 1.375 . . . . 0.0 110.786 162.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' N ' ' HE3' ' A' ' 80' ' ' LYS . . . -63.47 -35.79 81.62 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 123.573 0.546 . . . . 0.0 109.566 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.7 -53.99 46.08 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -52.16 -40.05 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.042 0.937 . . . . 0.0 109.311 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.31 -54.93 10.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.404 1.002 . . . . 0.0 113.325 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.64 -50.18 74.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.803 1.241 . . . . 0.0 109.11 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 96' ' ' ILE . 82.1 mt -59.43 -56.01 27.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.596 1.158 . . . . 0.0 109.62 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -56.38 6.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.463 1.105 . . . . 0.0 111.252 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -48.93 73.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 123.776 0.672 . . . . 0.0 110.051 -174.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.32 72.32 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.212 -0.93 . . . . 0.0 113.174 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.7 m-30 -73.08 -30.5 63.73 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.931 0.787 . . . . 0.0 110.477 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -31.64 69.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.51 1.124 . . . . 0.0 110.171 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.65 -12.45 21.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.428 1.891 . . . . 0.0 112.738 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.65 28.61 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.836 1.255 . . . . 0.0 112.065 -167.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.25 -144.17 13.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -115.06 166.3 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.912 2.085 . . . . 0.0 109.732 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.481 HD13 HD23 ' A' ' 86' ' ' LEU . 28.9 mt -131.99 160.96 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.26 114.07 13.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 164.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 t -165.36 162.28 19.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -152.48 26.39 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.825 -1.172 . . . . 0.0 112.829 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t0 -88.53 158.52 18.28 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.792 -1.193 . . . . 0.0 110.982 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -62.58 -49.5 75.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.994 1.27 . . . . 0.0 110.083 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -70.58 -46.99 62.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.06 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -60.63 -33.9 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.302 0.955 . . . . 0.0 109.716 -171.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -70.4 -38.95 74.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.41 0.684 . . . . 0.0 109.966 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -68.32 -54.95 13.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.78 -54.79 8.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.464 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.68 -41.78 67.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.822 1.646 . . . . 0.0 113.58 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -54.79 -60.07 3.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.643 0.777 . . . . 0.0 112.023 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -21.12 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.174 1.352 . . . . 0.0 112.613 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -81.83 3.1 27.26 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.416 1.087 . . . . 0.0 111.986 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.15 29.06 64.96 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.066 -1.408 . . . . 0.0 112.325 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.53 126.24 52.28 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.173 1.487 . . . . 0.0 111.645 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 126.13 30.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.657 1.183 . . . . 0.0 109.138 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -131.22 -170.13 2.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.489 1.516 . . . . 0.0 109.043 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.94 149.17 52.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.242 0.684 0 O-C-N 125.073 1.483 . . . . 0.0 109.161 171.566 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.691 0.281 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' C ' HG12 ' A' ' 157' ' ' ILE . 75.9 mtm-85 -141.72 24.92 2.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.171 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.481 ' C ' HD11 ' A' ' 157' ' ' ILE . 7.9 m-85 -145.06 139.91 27.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.094 1.77 . . . . 0.0 111.426 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 157' ' ' ILE . 7.4 p -128.34 130.76 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.845 1.658 . . . . 0.0 107.501 -176.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 8.4 t -70.86 120.63 16.74 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 162.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.09 127.68 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.42 -75.32 0.38 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 4.4 p -80.4 -8.04 59.36 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.138 0.469 . . . . 0.0 112.196 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.61 37.01 92.74 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.153 1.359 . . . . 0.0 112.637 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -77.46 137.42 38.66 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.578 -0.954 . . . . 0.0 108.726 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.79 144.07 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.547 1.139 . . . . 0.0 108.71 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.37 151.75 45.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.085 1.754 . . . . 0.0 107.814 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.6 t -111.82 -7.93 14.16 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.887 -0.508 . . . . 0.0 110.502 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 p -136.05 156.4 48.78 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.824 -1.173 . . . . 0.0 109.755 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.4 tp -74.53 120.11 79.88 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -65.67 169.03 13.63 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.412 2.075 . . . . 0.0 110.087 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.77 112.8 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 111.343 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.74 -5.02 83.77 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.407 1.479 . . . . 0.0 113.116 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.81 45.42 95.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.455 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.91 154.11 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.14 113.71 19.91 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.361 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.27 7.48 2.55 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.146 2.564 . . . . 0.0 112.551 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -117.51 -23.71 7.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.78 1.632 . . . . 0.0 113.02 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 5.0 p -136.8 -24.0 1.16 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.58 79.17 0.52 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -155.4 170.66 21.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.871 0.868 . . . . 0.0 109.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -82.28 132.37 35.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.869 0.842 . . . . 0.0 109.653 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.77 142.89 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.21 170.86 15.3 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.086 1.354 . . . . 0.0 109.528 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.67 153.12 43.99 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.058 1.343 . . . . 0.0 110.825 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 129' ' ' TYR . 19.5 mm . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 125.517 1.527 . . . . 0.0 110.284 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.2 mttt . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.1 m -55.78 122.99 12.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 tt -145.65 145.12 30.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.57 161.93 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 124.45 1.094 . . . . 0.0 109.624 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 mt -137.57 145.91 43.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.989 1.715 . . . . 0.0 108.513 -167.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.38 163.05 12.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.912 1.285 . . . . 0.0 112.049 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 30' ' ' VAL . 1.4 p -51.21 -41.25 60.14 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.35 1.06 . . . . 0.0 111.77 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -67.08 -27.11 67.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.614 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.57 -44.08 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.12 -35.65 74.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.615 0.766 . . . . 0.0 110.773 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.74 -48.56 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.169 0.441 . . . . 0.0 110.21 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -72.82 -27.66 62.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.135 0.425 . . . . 0.0 110.196 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.96 38.9 10.71 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.05 112.23 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.28 92.88 1.83 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.966 1.307 . . . . 0.0 109.366 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 148.78 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.24 1.416 . . . . 0.0 108.42 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -112.34 125.1 53.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 -168.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' VAL . . . 175.98 -179.06 47.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.287 0.949 . . . . 0.0 112.642 -171.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -78.67 152.77 31.46 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.139 -1.212 . . . . 0.0 110.363 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 t -137.1 160.44 38.95 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.784 2.034 . . . . 0.0 108.928 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.67 124.4 52.86 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 125.201 1.4 . . . . 0.0 109.337 -169.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.1 -22.33 55.43 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.783 1.655 . . . . 0.0 111.4 169.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -78.42 -17.08 56.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.656 1.982 . . . . 0.0 114.533 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.5 p -107.26 -33.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.23 1.377 . . . . 0.0 111.783 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -63.51 -15.55 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.767 1.167 . . . . 0.0 111.634 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -63.75 -18.87 64.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.653 -1.28 . . . . 0.0 113.567 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -101.28 -27.34 13.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 0.0 111.26 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.6 mt -62.7 102.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -13.0 6.89 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.058 0.943 . . . . 0.0 112.284 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.75 124.21 19.77 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -59.45 -36.95 76.92 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.984 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -55.02 -58.13 8.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.04 -41.05 91.39 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.46 1.904 . . . . 0.0 111.508 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -69.79 -52.38 25.67 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.38 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -46.76 -51.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.42 -63.2 1.27 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.019 0.927 . . . . 0.0 110.97 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 tp -48.54 -50.64 31.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.407 1.483 . . . . 0.0 112.879 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.31 -41.75 89.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.941 0.896 . . . . 0.0 110.851 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 m -63.27 -43.56 97.58 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.754 0.422 . . . . 0.0 109.926 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.5 99.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 0.0 110.593 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.44 -46.96 94.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -61.48 -46.48 89.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.178 0.991 . . . . 0.0 110.37 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.22 -5.38 38.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.455 1.502 . . . . 0.0 112.179 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.66 19.88 76.88 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 121.001 -1.062 . . . . 0.0 112.024 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -64.72 -38.83 92.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 164.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 70.4 t -122.78 150.75 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -136.78 147.41 46.62 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.001 0.92 . . . . 0.0 110.165 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.66 123.95 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.87 135.4 17.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.823 1.249 . . . . 0.0 108.517 170.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.3 155.59 37.61 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.411 0.684 . . . . 0.0 110.647 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.51 165.5 17.7 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.831 3.021 . . . . 0.0 112.628 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -81.84 158.5 24.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 164.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -39.04 74.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.541 -0.724 . . . . 0.0 111.539 170.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -29.15 70.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.127 -0.463 . . . . 0.0 111.281 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -65.43 -51.76 57.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.049 1.34 . . . . 0.0 108.238 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.32 -49.26 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.294 0.638 . . . . 0.0 109.908 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -59.39 -38.99 81.95 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.013 -0.429 . . . . 0.0 110.56 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -37.66 68.42 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.424 -0.797 . . . . 0.0 111.734 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.85 -53.44 30.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt -49.77 -36.53 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.548 1.139 . . . . 0.0 111.281 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -57.76 -69.4 0.17 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.672 0.789 . . . . 0.0 109.655 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.76 -31.64 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.136 -0.353 . . . . 0.0 110.405 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.34 75.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.416 1.487 . . . . 0.0 111.076 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -32.88 73.34 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.097 -1.002 . . . . 0.0 110.63 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.83 4.25 2.68 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.304 -0.873 . . . . 0.0 111.773 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 t -126.74 -3.29 6.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.263 1.392 . . . . 0.0 112.632 166.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.06 -86.08 0.39 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.159 1.838 . . . . 0.0 110.365 170.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -64.99 70.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 129.658 3.183 . . . . 0.0 112.369 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.73 -48.89 84.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.336 1.854 . . . . 0.0 113.284 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -123.1 7.8 9.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.903 0.881 . . . . 0.0 109.782 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -6.73 44.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.727 1.611 . . . . 0.0 112.581 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.26 162.37 16.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.297 1.039 . . . . 0.0 109.492 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 t -61.77 147.42 46.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.079 0.951 . . . . 0.0 108.958 168.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -61.24 -44.39 97.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.05 -38.6 68.2 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.686 0.616 . . . . 0.0 110.012 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -63.48 -56.86 12.78 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.383 1.473 . . . . 0.0 110.742 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.35 -40.25 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.465 1.506 . . . . 0.0 109.247 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -69.07 -46.61 67.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 113.173 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.58 -52.54 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 96' ' ' ILE . 64.1 mt -54.51 -55.07 32.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.164 1.386 . . . . 0.0 109.114 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.27 -51.66 57.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.496 1.518 . . . . 0.0 112.616 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.6 tp -50.67 -51.93 44.66 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -62.34 -17.17 58.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -86.31 -37.43 18.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.459 0.704 . . . . 0.0 110.676 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.27 -42.92 64.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.669 1.187 . . . . 0.0 110.587 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 89' ' ' ALA . 1.1 pp -109.19 6.26 24.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.916 1.686 . . . . 0.0 111.645 -171.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 43.27 52.82 5.61 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.635 1.974 . . . . 0.0 111.159 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 -119.9 3.89 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.838 1.209 . . . . 0.0 110.675 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -153.57 169.01 24.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.892 1.677 . . . . 0.0 106.682 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 86' ' ' LEU . 31.5 mt -133.91 160.25 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.58 114.38 13.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 167.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 p -169.16 145.72 3.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.377 1.071 . . . . 0.0 108.945 -158.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -143.44 -6.5 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.059 1.754 . . . . 0.0 115.014 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.45 149.17 5.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.03 1.332 . . . . 0.0 112.58 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -57.51 -38.37 74.5 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.692 -1.255 . . . . 0.0 112.374 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -55.02 12.5 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.813 1.245 . . . . 0.0 110.197 173.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -58.35 -40.92 79.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.238 0.615 . . . . 0.0 110.647 -167.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.46 -40.79 98.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.54 -56.97 9.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.0 mm -52.25 -51.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.599 0.636 . . . . 0.0 110.326 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.95 72.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.161 1.346 . . . . 0.0 112.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -62.8 -58.24 8.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 117.668 -1.158 . . . . 0.0 111.171 175.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -31.57 70.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.329 1.422 . . . . 0.0 111.171 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -73.73 -30.29 62.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.137 0.575 . . . . 0.0 111.327 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.65 5.06 63.37 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.802 1.191 . . . . 0.0 114.108 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 118.05 22.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.649 1.224 . . . . 0.0 109.387 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 140.92 58.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.3 -178.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.166 0.986 . . . . 0.0 109.743 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -115.61 145.16 42.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.189 1.396 . . . . 0.0 109.792 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.239 0.503 0 C-N-CA 124.337 1.055 . . . . 0.0 110.519 178.491 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -161.62 18.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -142.17 157.66 44.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.418 1.008 . . . . 0.0 111.83 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 p -142.89 137.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 124.75 1.22 . . . . 0.0 109.064 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 2.0 t -71.52 125.51 27.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.031 1.332 . . . . 0.0 108.206 163.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.37 118.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.96 -77.95 0.38 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 1.2 p -75.04 -3.54 33.13 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.52 0.66 . . . . 0.0 111.608 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.13 19.78 57.4 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.431 1.967 . . . . 0.0 114.146 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 11.9 ttt-85 -77.68 137.68 38.65 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -74.34 148.35 41.4 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.03 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -140.14 134.68 31.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.939 1.296 . . . . 0.0 108.215 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -25.67 24.65 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.665 1.186 . . . . 0.0 111.137 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.6 p -147.04 173.8 12.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.692 1.997 . . . . 0.0 107.114 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 114.56 65.81 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -163.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.76 168.39 13.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.061 1.841 . . . . 0.0 110.484 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.63 142.28 95.66 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.356 2.037 . . . . 0.0 110.344 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.12 -7.61 0.77 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.236 0.922 . . . . 0.0 113.922 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.8 63.96 3.81 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 117.928 -1.485 . . . . 0.0 109.601 -156.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.08 149.14 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 16.2 t -72.05 112.72 15.51 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.797 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.92 -17.07 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 CA-C-N 121.499 1.571 . . . . 0.0 113.302 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.57 -29.33 13.93 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.392 1.877 . . . . 0.0 111.903 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.8 p -141.89 -3.79 1.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.47 -13.55 50.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.089 1.804 . . . . 0.0 115.472 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.87 162.47 25.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.764 1.782 . . . . 0.0 114.26 -168.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -68.43 135.3 51.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.806 -1.184 . . . . 0.0 112.66 -173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.45 140.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.697 1.199 . . . . 0.0 109.228 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.35 164.93 28.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.656 1.582 . . . . 0.0 110.691 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.22 141.13 32.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.509 1.524 . . . . 0.0 111.479 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.783 1.233 . . . . 0.0 112.471 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.5 m -57.86 130.28 45.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.4 tp -155.24 142.66 19.55 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -121.39 161.35 21.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -137.85 151.18 47.81 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.68 1.592 . . . . 0.0 107.525 -165.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -117.46 167.82 10.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.926 0.89 . . . . 0.0 111.601 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' HG21 ' A' ' 30' ' ' VAL . 48.6 p -49.0 -48.25 43.7 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.36 1.464 . . . . 0.0 110.805 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -50.85 -37.64 44.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.533 1.133 . . . . 0.0 111.622 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -62.88 -40.03 87.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.837 1.199 . . . . 0.0 110.194 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -76.15 -35.47 59.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.924 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.0 mt -56.74 -50.34 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.878 0.871 . . . . 0.0 109.787 171.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -68.42 -19.12 64.57 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.109 0.564 . . . . 0.0 111.531 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 33.8 42.88 Favored Glycine 0 N--CA 1.446 -0.689 0 O-C-N 121.458 -0.776 . . . . 0.0 111.601 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.5 mt -85.1 105.4 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 113.7 3.15 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.3 177.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.225 1.81 . . . . 0.0 106.536 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.65 138.94 44.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.245 1.818 . . . . 0.0 107.951 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.34 -144.63 8.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -125.82 149.78 48.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 t -130.52 149.01 52.39 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.05 1.74 . . . . 0.0 108.36 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 126.45 72.12 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 123.897 0.879 . . . . 0.0 108.996 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HA ' HG12 ' A' ' 31' ' ' VAL . 18.9 Cg_endo -58.97 -31.62 95.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 168.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -27.48 62.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.163 1.785 . . . . 0.0 114.934 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 13' ' ' SER . 11.4 p -98.0 -37.33 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 119.286 0.948 . . . . 0.0 110.146 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.629 HG23 HD13 ' A' ' 43' ' ' LEU . 4.3 p -63.77 -26.82 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.828 1.194 . . . . 0.0 111.736 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.17 -16.64 64.43 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.049 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -86.19 -52.14 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.796 1.638 . . . . 0.0 108.649 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -49.5 99.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.449 2.3 . . . . 0.0 110.955 -170.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -63.6 134.3 55.24 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -57.36 -44.63 84.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.97 -59.65 4.53 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -166.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -55.24 -46.19 76.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.272 2.229 . . . . 0.0 110.454 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -62.58 -58.4 7.68 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.03 0.832 . . . . 0.0 110.972 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.95 -52.91 38.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 68.6 t80 -60.67 -44.4 96.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.613 0.765 . . . . 0.0 112.108 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD13 HG23 ' A' ' 31' ' ' VAL . 5.8 tt -57.88 -53.7 55.3 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -63.76 -31.02 72.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.594 0.358 . . . . 0.0 111.455 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -51.48 64.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 109.29 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 96.6 mt -66.35 -38.6 87.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.843 -1.075 . . . . 0.0 111.224 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.02 -57.58 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 m -67.32 -28.41 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -14.16 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.706 -0.621 . . . . 0.0 112.273 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.44 85.72 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.693 1.616 . . . . 0.0 113.016 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -67.15 -43.15 83.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.379 1.09 . . . . 0.0 108.13 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.57 159.5 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -138.11 157.82 45.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.718 -0.613 . . . . 0.0 111.824 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.53 133.3 31.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.917 1.287 . . . . 0.0 109.206 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.04 128.9 7.92 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.525 1.53 . . . . 0.0 109.869 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.92 155.83 37.13 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.392 1.077 . . . . 0.0 110.996 170.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.96 166.95 22.95 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.158 2.572 . . . . 0.0 111.522 171.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -95.48 165.6 12.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.833 1.253 . . . . 0.0 109.019 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -50.59 65.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.685 1.194 . . . . 0.0 109.303 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.19 -41.47 71.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.144 1.378 . . . . 0.0 111.012 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -62.15 -45.05 95.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.084 0.954 . . . . 0.0 110.955 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -66.07 -45.65 90.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 119.007 0.821 . . . . 0.0 109.373 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -54.14 -42.07 69.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.899 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -46.47 53.39 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.688 1.195 . . . . 0.0 110.762 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.1 mm -64.43 -43.32 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.611 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.3 -36.73 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.525 0.602 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.39 -55.26 33.52 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.744 0.702 . . . . 0.0 109.659 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.26 -35.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.478 0.311 . . . . 0.0 110.641 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -64.48 -43.64 93.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.56 80.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.312 1.415 . . . . 0.0 110.622 173.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.52 -26.18 65.11 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.325 -0.86 . . . . 0.0 112.397 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.22 -49.04 3.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.06 0.846 . . . . 0.0 111.23 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.75 139.12 3.41 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -167.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 79.1 39.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.553 2.741 . . . . 0.0 111.82 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.413 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.8 p -37.68 -48.73 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 127.349 2.259 . . . . 0.0 115.384 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -123.64 10.07 9.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.62 0.768 . . . . 0.0 110.489 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.76 -28.42 58.46 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.033 0.833 . . . . 0.0 111.713 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.27 34.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.181 1.393 . . . . 0.0 107.786 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -67.94 158.43 32.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.956 1.36 . . . . 0.0 111.113 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -58.83 -57.63 12.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.434 -172.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 -34.55 70.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.43 0.456 . . . . 0.0 111.152 -175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.03 -53.1 60.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.279 1.432 . . . . 0.0 108.574 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.5 mt -55.3 -44.99 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -66.31 -48.74 69.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.926 0.89 . . . . 0.0 112.46 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.33 -56.28 14.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.67 1.588 . . . . 0.0 108.071 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.597 HD23 HD13 ' A' ' 96' ' ' ILE . 74.3 mt -60.96 -51.39 69.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 122.858 0.463 . . . . 0.0 110.009 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -45.18 -52.06 9.8 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.351 1.061 . . . . 0.0 112.209 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.6 tp -52.21 -52.5 51.89 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.225 0.466 . . . . 0.0 110.508 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.7 67.73 Favored 'General case' 0 CA--C 1.524 -0.051 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.877 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.538 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -78.81 -25.48 44.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.442 1.019 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 1.1 tm-20 -65.99 -48.33 71.59 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 164.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.15 -14.73 59.36 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 31.5 mtmt 50.2 29.7 3.84 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.719 2.808 . . . . 0.0 113.766 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.57 -108.01 1.55 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 124.379 0.99 . . . . 0.0 112.5 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -146.98 171.17 15.66 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.82 1.648 . . . . 0.0 107.844 172.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.597 HD13 HD23 ' A' ' 86' ' ' LEU . 31.2 mt -131.91 160.97 42.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.693 1.197 . . . . 0.0 108.599 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.06 124.38 23.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.59 1.556 . . . . 0.0 108.659 168.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -162.8 -164.73 1.03 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.214 1.406 . . . . 0.0 110.47 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 -11.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 169.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -68.57 155.35 40.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.556 1.525 . . . . 0.0 115.1 -163.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -62.57 -37.01 84.51 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 119.526 -1.984 . . . . 0.0 112.555 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.57 -41.52 31.74 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.092 0.406 . . . . 0.0 110.659 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -36.77 74.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 118.486 0.585 . . . . 0.0 110.03 -170.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.26 -47.62 60.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 122.742 0.417 . . . . 0.0 109.917 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -59.08 -58.65 7.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.352 1.461 . . . . 0.0 108.722 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.33 -52.18 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.726 0.81 . . . . 0.0 109.976 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.33 67.58 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.758 -1.214 . . . . 0.0 114.008 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 t -67.97 -48.66 65.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 117.428 -1.272 . . . . 0.0 111.89 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -25.37 67.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.655 2.025 . . . . 0.0 112.475 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -82.07 -16.81 48.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.099 0.959 . . . . 0.0 111.723 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.14 18.88 78.23 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 117.886 -1.508 . . . . 0.0 114.348 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.05 132.61 34.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.766 1.783 . . . . 0.0 109.11 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.2 144.6 31.5 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.018 1.727 . . . . 0.0 111.253 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.2 -179.6 7.48 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.12 141.34 47.61 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.463 2.305 . . . . 0.0 107.939 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.241 0.64 0 C-N-CA 123.877 0.871 . . . . 0.0 109.533 -174.526 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 . . . . . 0 C--O 1.24 0.56 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -146.03 17.57 1.4 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 116.411 -1.757 . . . . 0.0 115.215 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -135.0 135.3 41.28 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 121.636 2.016 . . . . 0.0 112.962 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.49 125.61 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.311 1.444 . . . . 0.0 109.903 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.49 121.67 16.84 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 108.813 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pt -82.41 49.04 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.995 1.318 . . . . 0.0 111.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.24 -31.48 0.02 OUTLIER Glycine 0 C--O 1.226 -0.344 0 O-C-N 121.253 -0.904 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 12.5 p -132.77 14.19 4.38 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.693 0.746 . . . . 0.0 112.062 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.99 7.98 33.03 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.366 1.936 . . . . 0.0 115.468 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 46.0 ttt85 -69.47 132.46 46.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.511 1.924 . . . . 0.0 111.662 -165.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.79 143.22 30.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.633 1.173 . . . . 0.0 110.185 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -139.14 156.33 47.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.993 1.717 . . . . 0.0 108.22 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.0 t -109.78 -14.58 14.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.073 0.549 . . . . 0.0 111.133 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.4 p -138.01 166.28 24.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.4 tp -75.79 113.0 22.79 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -65.04 167.83 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.564 2.176 . . . . 0.0 109.472 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.16 136.55 75.51 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.321 2.014 . . . . 0.0 111.002 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.71 -15.78 3.57 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.128 1.347 . . . . 0.0 112.824 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.88 43.44 97.56 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.897 1.237 . . . . 0.0 111.384 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.64 167.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.501 1.12 . . . . 0.0 109.907 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.27 110.79 13.4 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 111.413 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.87 -14.97 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.218 1.279 . . . . 0.0 113.788 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.89 -36.97 16.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.343 1.057 . . . . 0.0 112.676 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.23 -7.38 2.03 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -164.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.11 -3.39 10.51 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.099 2.761 . . . . 0.0 116.43 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.6 m -69.45 162.93 26.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.838 1.319 . . . . 0.0 112.217 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.11 160.68 30.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.65 0.738 . . . . 0.0 111.169 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.49 161.37 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.748 1.619 . . . . 0.0 109.333 173.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.27 166.44 24.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.337 1.455 . . . . 0.0 108.958 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.82 154.45 38.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.23 1.012 . . . . 0.0 111.02 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 126.34 1.856 . . . . 0.0 110.725 169.442 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -52.3 129.65 28.81 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.508 -174.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.686 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -153.21 135.66 15.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.682 -168.017 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -111.83 145.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 9' ' ' LEU . 1.1 mm? -113.98 147.58 38.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.11 1.764 . . . . 0.0 107.354 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -106.17 166.32 10.6 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.294 0.637 . . . . 0.0 110.423 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 30' ' ' VAL . 22.7 t -42.16 -46.82 4.5 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.436 1.894 . . . . 0.0 111.477 174.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -62.13 -28.52 69.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.103 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.84 -39.33 84.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 109.536 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.89 -35.18 62.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.64 0.776 . . . . 0.0 111.101 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -61.7 -35.81 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.194 0.598 . . . . 0.0 110.61 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -82.23 -30.14 30.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.528 0.604 . . . . 0.0 110.749 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.3 32.28 17.12 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.257 0.932 . . . . 0.0 111.335 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.47 113.48 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.51 104.91 0.69 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.845 0.858 . . . . 0.0 109.811 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 tp -149.57 159.78 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.871 1.268 . . . . 0.0 108.02 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.54 115.02 16.21 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.844 1.257 . . . . 0.0 108.589 -164.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.686 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.31 -158.04 24.18 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.859 1.695 . . . . 0.0 112.514 -164.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.23 149.64 23.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.547 0.674 . . . . 0.0 112.451 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -132.89 149.72 52.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.626 1.97 . . . . 0.0 109.709 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 117.54 68.67 Favored Pre-proline 0 C--O 1.243 0.748 0 C-N-CA 126.702 2.001 . . . . 0.0 109.079 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -58.27 -32.72 96.58 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.167 1.245 . . . . 0.0 110.508 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -68.36 -11.73 60.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 13' ' ' SER . 8.8 p -106.25 -31.03 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 117.51 -1.234 . . . . 0.0 110.832 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 28' ' ' PRO . 8.5 p -59.28 -28.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.941 1.701 . . . . 0.0 111.09 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -60.31 -22.28 62.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.263 0.483 . . . . 0.0 112.034 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -83.63 -53.23 5.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.923 -1.111 . . . . 0.0 108.965 169.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mt -41.37 114.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.198 1.799 . . . . 0.0 111.37 -162.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 -12.16 1.4 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.932 1.693 . . . . 0.0 112.836 -171.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -53.37 124.53 15.0 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 163.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -56.88 -50.01 73.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.328 0.651 . . . . 0.0 109.856 -171.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -62.24 -54.65 37.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 t -54.94 -42.02 71.79 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.163 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -62.61 -57.49 10.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.778 0.831 . . . . 0.0 109.933 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.89 -55.58 15.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.19 -53.14 57.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.404 1.482 . . . . 0.0 111.759 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.2 -48.88 73.21 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.815 1.246 . . . . 0.0 110.649 177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.39 -45.32 94.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.117 0.567 . . . . 0.0 110.836 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -56.41 -48.57 76.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.929 0.786 . . . . 0.0 109.388 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -42.23 95.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.989 1.315 . . . . 0.0 111.608 -176.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.85 -56.13 18.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -33.22 73.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.283 0.633 . . . . 0.0 111.896 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.18 -10.33 59.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.382 1.873 . . . . 0.0 112.617 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.19 -12.33 57.21 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 124.666 1.127 . . . . 0.0 113.466 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -78.27 -33.29 49.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.768 0.784 . . . . 0.0 111.638 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.05 148.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -141.21 139.54 33.82 Favored 'General case' 0 N--CA 1.46 0.049 0 C-N-CA 124.346 1.058 . . . . 0.0 109.773 -167.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.16 118.17 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.6 18.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.309 1.044 . . . . 0.0 110.744 174.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.9 160.89 27.15 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.373 1.469 . . . . 0.0 110.969 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.91 175.97 4.93 Favored 'Trans proline' 0 C--N 1.347 0.497 1 C-N-CA 125.453 4.102 . . . . 0.0 113.44 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.01 165.96 11.08 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.928 1.291 . . . . 0.0 109.45 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -47.29 -48.93 24.73 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.863 1.265 . . . . 0.0 111.379 176.036 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.47 -27.87 65.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.843 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -69.98 -39.78 75.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.97 . . . . 0.0 109.628 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.36 -47.74 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.97 -34.43 73.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.851 -0.531 . . . . 0.0 110.831 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -42.3 64.3 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.15 0.98 . . . . 0.0 111.405 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 87' ' ' ALA . 3.1 mm -67.37 -52.65 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.06 -39.56 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.929 1.292 . . . . 0.0 110.493 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -58.75 -60.03 4.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.541 1.064 . . . . 0.0 111.415 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -73.34 -38.2 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.5 73.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.78 1.232 . . . . 0.0 110.692 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -29.07 70.26 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.515 -1.365 . . . . 0.0 112.155 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.02 -7.35 21.98 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.475 1.034 . . . . 0.0 112.208 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -123.45 16.11 9.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 112.009 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.25 -80.3 0.43 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.296 1.427 . . . . 0.0 110.119 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -59.08 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 129.009 2.923 . . . . 0.0 110.678 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.12 -43.91 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.126 1.771 . . . . 0.0 111.529 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -128.21 8.17 6.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.12 0.968 . . . . 0.0 109.721 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.53 -20.79 65.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.73 2.012 . . . . 0.0 111.784 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -95.97 165.26 12.35 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.051 1.74 . . . . 0.0 109.971 -175.11 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -70.03 158.06 36.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.841 0.829 . . . . 0.0 111.849 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -59.7 -54.41 46.7 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.986 1.314 . . . . 0.0 109.571 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.81 -44.03 63.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 110.352 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.436 ' O ' HD22 ' A' ' 86' ' ' LEU . 71.5 m-20 -60.42 -56.67 18.6 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.7 mt -52.79 -40.54 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.51 -33.44 72.83 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -57.81 -61.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 118.945 0.793 . . . . 0.0 109.288 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.4 mm? -61.89 -46.8 87.79 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.211 -169.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.83 -53.39 32.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.458 1.103 . . . . 0.0 111.535 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.47 -47.74 83.05 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.629 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.24 63.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.285 0.493 . . . . 0.0 111.883 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.06 -25.95 20.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.54 1.136 . . . . 0.0 111.394 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.98 -51.21 68.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.56 4.94 30.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.613 0.765 . . . . 0.0 111.615 -169.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 49.74 46.01 24.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.919 1.687 . . . . 0.0 110.771 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.18 -116.06 1.71 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -156.38 168.35 27.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 ' CD1' ' A' ' 86' ' ' LEU . 53.4 mt -129.81 152.55 37.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 119.05 20.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.004 1.322 . . . . 0.0 108.108 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.4 t -165.45 -170.54 1.88 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.079 1.352 . . . . 0.0 109.925 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -151.52 -1.78 0.32 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -64.39 157.78 25.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.571 -1.331 . . . . 0.0 114.539 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -60.93 -41.15 95.65 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.726 -1.234 . . . . 0.0 110.814 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -84.35 -44.26 13.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 110.989 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.443 HG11 ' OG ' ' A' ' 98' ' ' SER . 2.6 p -60.12 -37.67 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.351 0.978 . . . . 0.0 110.225 -170.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -70.96 -35.72 72.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 110.226 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.09 -55.48 18.53 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.946 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 mm -48.95 -53.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.796 0.838 . . . . 0.0 109.179 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -21.69 64.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.182 -1.407 . . . . 0.0 112.854 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -74.07 -46.59 42.08 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.672 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.4 95.05 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.55 1.977 . . . . 0.0 108.275 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -68.52 -44.39 74.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.62 35.12 14.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 125.774 1.654 . . . . 0.0 111.855 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -85.77 136.34 33.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.038 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 137.53 56.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -145.94 -173.6 4.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.881 0.31 . . . . 0.0 111.243 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -130.61 124.87 32.7 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 125.742 1.617 . . . . 0.0 109.296 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 127.445 2.298 . . . . 0.0 108.448 173.868 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -148.76 8.92 0.78 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -140.3 146.4 38.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.362 0.983 . . . . 0.0 110.72 -171.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -137.27 132.41 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 108.701 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -64.37 120.5 12.35 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 163.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.39 119.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 166.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.46 -84.64 0.32 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.37 -4.81 58.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.98 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.85 20.27 68.35 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 124.78 1.181 . . . . 0.0 114.946 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 137.22 57.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -84.04 148.01 27.09 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.305 1.042 . . . . 0.0 109.341 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -142.03 146.09 35.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.02 -4.11 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 110.827 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.9 p -145.39 160.4 41.61 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.645 2.378 . . . . 0.0 108.224 161.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.533 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -68.85 112.78 12.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' HD23 ' A' ' 141' ' ' LEU . 90.5 Cg_endo -66.33 164.74 27.09 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 109.635 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.34 124.6 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.094 1.863 . . . . 0.0 109.332 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.86 -18.26 57.0 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.287 2.375 . . . . 0.0 112.161 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 62.19 34.86 90.47 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.822 1.311 . . . . 0.0 111.455 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.86 162.0 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.634 1.573 . . . . 0.0 107.544 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.9 t -74.4 112.57 17.73 Favored Pre-proline 0 N--CA 1.443 -0.775 0 C-N-CA 125.365 1.466 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.51 -8.65 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.518 2.145 . . . . 0.0 115.895 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.61 -43.06 6.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.826 1.194 . . . . 0.0 112.065 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.3 p -122.99 -9.44 8.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.991 0.917 . . . . 0.0 111.527 -166.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.23 13.75 82.99 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.791 1.186 . . . . 0.0 113.614 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.79 161.58 14.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.82 1.31 . . . . 0.0 112.203 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -62.81 147.92 48.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.458 0.646 . . . . 0.0 111.15 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.39 147.6 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -133.84 172.9 12.15 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.479 1.512 . . . . 0.0 110.287 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.43 161.32 28.07 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.494 1.117 . . . . 0.0 110.342 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 126.441 1.896 . . . . 0.0 110.684 174.818 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mttt . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -49.93 131.48 22.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.592 1.182 . . . . 0.0 108.965 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -151.25 144.4 24.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.31 151.52 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.956 ' HB3' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -132.59 138.81 47.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 125.435 1.494 . . . . 0.0 109.669 -173.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 15' ' ' VAL . 4.5 t0 -88.82 -179.69 6.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.03 1.332 . . . . 0.0 111.364 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.0 p -58.43 -41.99 86.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.06 -1.65 . . . . 0.0 110.425 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -60.65 -39.79 89.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.597 1.159 . . . . 0.0 112.234 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.956 HG11 ' HB3' ' A' ' 11' ' ' LEU . 7.5 p -53.57 -36.13 27.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 119.945 1.248 . . . . 0.0 111.3 177.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 15' ' ' VAL . 6.4 m-85 -77.13 -37.12 54.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.395 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.13 -31.72 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.899 0.88 . . . . 0.0 109.81 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.42 -21.85 22.83 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.52 24.85 24.99 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.476 -0.624 . . . . 0.0 113.923 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.0 mt -80.92 109.29 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.622 1.211 . . . . 0.0 109.217 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.93 100.99 1.66 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.581 0.752 . . . . 0.0 109.795 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tp -136.91 167.79 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.378 1.471 . . . . 0.0 108.579 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -136.98 120.77 17.42 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.287 1.435 . . . . 0.0 108.526 -166.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.87 -157.88 30.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.61 1.576 . . . . 0.0 111.51 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -109.78 149.85 29.2 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.306 1.043 . . . . 0.0 110.893 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -128.76 168.01 16.47 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.715 1.206 . . . . 0.0 108.816 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -107.0 121.16 45.69 Favored Pre-proline 0 C--O 1.247 0.951 0 C-N-CA 126.288 1.835 . . . . 0.0 111.01 -165.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HA ' HG12 ' A' ' 31' ' ' VAL . 12.1 Cg_endo -63.22 -15.41 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.82 1.68 . . . . 0.0 113.389 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -89.78 -12.33 39.58 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.675 1.125 . . . . 0.0 112.806 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.77 -36.36 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 121.138 1.79 . . . . 0.0 108.206 167.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 28' ' ' PRO . 12.6 p -58.68 -29.6 40.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.898 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.44 -26.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.809 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -11.36 42.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.165 2.186 . . . . 0.0 110.879 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.21 119.24 31.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -21.25 6.03 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.406 1.482 . . . . 0.0 112.494 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.43 169.26 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.279 0.632 . . . . 0.0 110.315 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -84.57 -55.97 3.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.99 -59.36 5.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -168.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -54.69 -35.59 63.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.578 1.151 . . . . 0.0 113.064 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 119.507 1.049 . . . . 0.0 109.433 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.1 mt -52.62 -43.23 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.944 1.298 . . . . 0.0 108.798 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -77.84 -40.24 40.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.609 0.763 . . . . 0.0 113.043 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -53.48 -49.06 68.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.418 1.463 . . . . 0.0 108.477 169.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -65.85 -32.04 73.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.815 -0.612 . . . . 0.0 111.672 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -57.69 -51.03 71.22 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.325 1.45 . . . . 0.0 108.751 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.36 -33.76 76.44 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.73 0.812 . . . . 0.0 111.344 -176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.31 -49.9 62.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 m -57.39 -40.83 79.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.784 -0.573 . . . . 0.0 110.941 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.64 -3.61 35.49 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.104 1.361 . . . . 0.0 113.219 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.44 21.64 77.55 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 112.681 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 5.0 ptpt -96.97 -29.93 13.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.094 1.447 . . . . 0.0 112.638 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.94 130.64 73.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -122.62 142.8 50.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.615 1.166 . . . . 0.0 110.181 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.32 133.18 31.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.8 9.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.681 1.192 . . . . 0.0 109.964 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.01 154.6 38.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.921 0.888 . . . . 0.0 111.344 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.23 164.12 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.805 3.67 . . . . 0.0 113.459 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -84.75 159.07 20.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.092 0.949 . . . . 0.0 111.153 161.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -45.67 84.65 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.972 1.309 . . . . 0.0 111.124 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -58.05 -33.64 69.23 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.775 0.43 . . . . 0.0 111.513 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.23 -45.89 75.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.884 1.273 . . . . 0.0 109.924 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.25 -44.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.995 0.918 . . . . 0.0 109.516 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.41 -33.9 73.17 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.44 -0.788 . . . . 0.0 111.628 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -41.46 89.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.889 0.768 . . . . 0.0 110.541 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.87 -46.35 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.16 -38.89 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.475 1.11 . . . . 0.0 110.331 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -62.88 -60.32 3.64 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.142 1.337 . . . . 0.0 110.719 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 109' ' ' LEU . 4.0 t -67.43 -34.94 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.63 -174.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.89 77.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.391 0.676 . . . . 0.0 111.548 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.81 66.24 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.781 1.628 . . . . 0.0 111.762 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.27 4.88 11.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.755 0.822 . . . . 0.0 112.212 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -131.95 -22.59 2.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.255 1.389 . . . . 0.0 112.246 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.17 -70.13 0.4 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 119.473 1.033 . . . . 0.0 112.783 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.46 56.86 0.37 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.729 2.012 . . . . 0.0 113.04 -170.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 p -48.53 -44.63 13.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.227 1.811 . . . . 0.0 114.328 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -124.7 4.89 8.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.524 0.729 . . . . 0.0 110.519 -173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.78 -10.82 58.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.605 1.162 . . . . 0.0 112.89 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 165.36 22.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 169.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 t -72.16 159.84 33.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.105 0.866 . . . . 0.0 109.887 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 81' ' ' ALA . 1.7 ttpt -65.03 -48.97 71.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.907 0.883 . . . . 0.0 109.199 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' N ' ' HE2' ' A' ' 80' ' ' LYS . . . -56.21 -43.23 78.34 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.495 1.118 . . . . 0.0 109.792 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -63.38 -55.07 27.44 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.39 -42.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 124.023 0.929 . . . . 0.0 109.787 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.5 -48.43 72.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.923 0.889 . . . . 0.0 111.999 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG22 ' OG1' ' A' ' 27' ' ' THR . 95.1 t -59.1 -47.56 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 119.278 0.944 . . . . 0.0 109.239 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 96' ' ' ILE . 87.5 mt -60.03 -56.13 25.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.549 1.14 . . . . 0.0 109.474 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.59 -50.15 60.74 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.968 1.307 . . . . 0.0 111.791 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -49.92 75.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.91 91.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.634 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.485 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.1 m-85 -65.53 -31.49 72.58 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.963 1.256 . . . . 0.0 111.663 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.85 -37.36 87.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.421 1.105 . . . . 0.0 111.282 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.27 -12.57 52.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.365 1.066 . . . . 0.0 111.59 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 60.24 12.18 3.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.424 1.489 . . . . 0.0 112.29 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.65 -112.03 0.3 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 128.414 2.912 . . . . 0.0 112.965 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -154.89 167.92 28.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 106.933 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.526 HD13 HD23 ' A' ' 86' ' ' LEU . 20.6 mt -131.31 155.97 42.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.478 1.111 . . . . 0.0 108.023 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.84 116.09 14.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.051 1.74 . . . . 0.0 106.97 167.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.4 t -155.78 170.73 21.4 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.225 0.61 . . . . 0.0 109.493 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.09 93.78 2.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.741 1.616 . . . . 0.0 110.694 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -152.66 166.43 32.14 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.873 1.269 . . . . 0.0 108.661 165.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -68.8 -55.23 11.88 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.096 -1.003 . . . . 0.0 109.783 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.52 -35.41 80.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.472 -0.768 . . . . 0.0 110.951 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.1 p -64.75 -43.52 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 118.994 0.815 . . . . 0.0 108.843 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -66.45 -42.74 87.15 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.507 0.723 . . . . 0.0 110.598 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' HD23 ' A' ' 109' ' ' LEU . 28.8 t30 -59.88 -62.84 1.58 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.943 1.297 . . . . 0.0 108.523 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.1 mm -51.09 -50.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.077 0.951 . . . . 0.0 110.421 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.78 72.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.853 1.206 . . . . 0.0 112.532 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 t -59.13 -59.01 6.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.746 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.458 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -62.68 -31.29 72.15 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.223 1.374 . . . . 0.0 111.579 -176.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -72.34 -6.68 45.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.373 0.669 . . . . 0.0 112.315 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.73 73.16 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-O 118.759 -1.023 . . . . 0.0 112.604 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -82.91 135.41 34.92 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.652 1.726 . . . . 0.0 109.474 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.409 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -75.84 117.11 17.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.53 1.132 . . . . 0.0 108.385 169.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.63 174.41 9.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 109.761 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.9 116.93 32.81 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 153.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 . . . . . 0 C--O 1.239 0.539 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -145.68 21.2 1.48 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.489 -1.72 . . . . 0.0 114.693 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -135.16 149.96 50.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 121.989 2.177 . . . . 0.0 112.423 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.51 134.26 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.342 1.457 . . . . 0.0 109.16 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.8 OUTLIER -66.05 142.02 57.95 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.763 0.825 . . . . 0.0 109.151 163.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.26 117.64 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.88 -2.3 33.78 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.306 1.431 . . . . 0.0 113.797 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 -1.96 2.11 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.081 0.94 . . . . 0.0 112.121 154.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.03 11.73 64.04 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 126.004 1.764 . . . . 0.0 115.442 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -69.95 135.23 49.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.015 -0.697 . . . . 0.0 110.134 -168.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -73.97 150.05 40.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.352 1.032 . . . . 0.0 109.872 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.17 147.38 38.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 161.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 p -95.96 -10.18 29.3 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.198 0.999 . . . . 0.0 112.235 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 p -134.69 177.4 7.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.393 1.877 . . . . 0.0 106.739 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 tp -80.7 137.71 50.87 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.06 159.72 51.48 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.518 1.478 . . . . 0.0 109.689 167.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.22 115.82 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.426 2.084 . . . . 0.0 110.863 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.27 66.15 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.86 -175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.75 45.51 90.88 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.165 1.364 . . . . 0.0 112.194 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.37 155.45 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 42.4 t -76.02 111.93 17.68 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.356 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 56.6 Cg_endo -61.32 -20.85 69.95 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.308 1.339 . . . . 0.0 112.39 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -18.66 30.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.948 1.299 . . . . 0.0 111.091 -171.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 15.0 p -142.82 -33.06 0.47 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.86 84.66 1.34 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.283 1.421 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.63 171.34 5.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 110.19 172.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -59.32 131.36 50.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.189 1.396 . . . . 0.0 112.828 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.95 146.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 166.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.06 157.69 45.48 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.001 -1.062 . . . . 0.0 110.346 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.76 152.49 44.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 C--O 1.235 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 110.489 173.216 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -54.92 130.18 40.43 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.664 0.786 . . . . 0.0 109.768 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 95' ' ' GLU . 16.8 tp -151.32 143.32 23.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.95 148.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.29 127.06 53.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.938 1.695 . . . . 0.0 107.898 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.17 167.84 18.3 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.081 0.952 . . . . 0.0 110.951 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -44.05 51.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.567 1.947 . . . . 0.0 110.662 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -53.02 -38.36 62.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.936 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.29 -40.03 86.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 119.591 1.087 . . . . 0.0 109.411 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 43' ' ' LEU . 30.0 m-85 -73.68 -31.64 63.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 111.046 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.2 mt -59.73 -53.5 47.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.056 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -67.73 -31.2 70.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.144 0.429 . . . . 0.0 110.789 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.66 31.6 8.16 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 123.584 0.612 . . . . 0.0 111.627 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.01 106.69 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.96 104.41 1.72 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.68 167.26 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.822 -1.174 . . . . 0.0 109.161 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.41 148.3 27.29 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.595 1.958 . . . . 0.0 107.992 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.72 -141.84 8.64 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.966 1.257 . . . . 0.0 112.228 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.61 153.16 46.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.06 0.93 . . . . 0.0 112.257 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 t -126.95 147.38 50.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.715 2.006 . . . . 0.0 110.071 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.0 116.22 66.16 Favored Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 127.817 2.447 . . . . 0.0 110.037 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.18 -30.07 89.42 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 121.538 1.492 . . . . 0.0 113.12 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 -15.18 57.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.265 1.826 . . . . 0.0 114.014 -171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' CB ' ' A' ' 81' ' ' ALA . 59.6 t -83.04 -53.15 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 126.113 1.765 . . . . 0.0 108.6 162.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -71.24 -18.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 123.302 0.641 . . . . 0.0 111.722 -160.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -48.71 -38.82 22.58 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.98 0.912 . . . . 0.0 111.75 165.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 -11.98 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.022 1.329 . . . . 0.0 111.362 -166.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.53 97.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.76 -23.09 21.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.449 1.1 . . . . 0.0 112.015 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.72 117.8 4.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.95 -38.42 76.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 117.667 -1.159 . . . . 0.0 110.692 -168.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.4 -56.26 22.16 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 119.513 1.051 . . . . 0.0 108.322 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -61.64 -48.09 82.45 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.516 0.726 . . . . 0.0 110.91 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -57.27 -60.64 3.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.15 1.38 . . . . 0.0 110.342 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.5 mt -62.45 -38.85 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 58.9 t80 -62.28 -47.86 82.43 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.048 0.939 . . . . 0.0 110.65 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.477 HD12 ' CG ' ' A' ' 16' ' ' PHE . 6.8 tt -63.86 -49.0 74.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.167 -0.958 . . . . 0.0 109.813 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.74 -33.52 76.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 t -54.41 -54.88 34.78 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 25.6 mt -59.77 -48.38 81.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.546 1.139 . . . . 0.0 110.736 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.38 -55.36 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 t -64.21 -34.83 78.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.196 0.599 . . . . 0.0 111.306 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.61 -9.8 58.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.274 1.83 . . . . 0.0 112.316 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.41 8.94 60.75 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 124.888 1.232 . . . . 0.0 113.754 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -87.82 -41.14 13.46 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -164.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.15 161.64 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 C-N-CA 125.292 1.437 . . . . 0.0 108.756 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -132.69 158.35 42.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.67 139.27 19.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.85 130.18 4.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.53 1.132 . . . . 0.0 109.301 162.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -98.24 156.37 35.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.572 1.549 . . . . 0.0 111.053 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.57 -176.21 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.776 3.651 . . . . 0.0 111.971 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -120.33 163.9 17.13 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.529 0.732 . . . . 0.0 110.21 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -49.61 10.57 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.559 1.544 . . . . 0.0 111.98 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.93 -27.94 60.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.858 0.863 . . . . 0.0 110.771 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -47.27 85.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 109.246 170.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.87 -44.95 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.336 1.054 . . . . 0.0 109.635 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.96 -32.73 72.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.646 -0.659 . . . . 0.0 111.731 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -44.3 76.17 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 121.419 -0.801 . . . . 0.0 110.909 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -64.42 -49.03 82.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.34 -46.9 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.244 1.017 . . . . 0.0 110.503 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.07 -48.71 70.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.11 1.323 . . . . 0.0 111.485 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 t -74.55 -33.64 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.72 -51.65 61.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.229 1.012 . . . . 0.0 110.116 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -24.7 67.65 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.115 -0.991 . . . . 0.0 111.885 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.96 -28.53 64.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.283 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 t -120.43 -16.42 8.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.77 -76.59 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 119.259 0.936 . . . . 0.0 112.522 164.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -72.26 93.08 1.44 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.773 1.229 . . . . 0.0 109.161 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.11 -50.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 112.059 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.85 14.55 7.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.034 0.933 . . . . 0.0 110.443 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.27 -24.17 59.23 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.833 1.653 . . . . 0.0 111.285 175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' LEU . 1.5 mp -77.03 165.38 24.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.054 0.941 . . . . 0.0 109.155 -173.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 153.27 40.7 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.048 -1.032 . . . . 0.0 109.48 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -63.32 -46.01 88.66 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.152 -0.967 . . . . 0.0 109.07 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -54.71 -41.37 70.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.209 0.943 . . . . 0.0 111.268 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.78 -55.1 39.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 109.133 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.58 -42.9 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.792 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -62.58 -49.24 76.03 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.01 0.924 . . . . 0.0 111.046 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.78 -51.14 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 96' ' ' ILE . 20.0 mt -57.02 -50.22 73.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.784 0.834 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.28 -53.39 36.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.331 1.052 . . . . 0.0 112.028 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.91 -50.25 69.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.977 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.56 65.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.314 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -67.8 -32.26 72.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.583 0.628 . . . . 0.0 111.339 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -44.13 94.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.956 0.798 . . . . 0.0 109.62 168.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 -10.82 59.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.732 0.813 . . . . 0.0 112.177 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm 58.22 11.8 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.018 2.127 . . . . 0.0 113.236 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.7 -145.47 11.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 127.344 2.402 . . . . 0.0 113.042 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 9' ' ' LEU . 2.5 mp0 -106.0 173.37 6.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.448 1.899 . . . . 0.0 111.944 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 86' ' ' LEU . 23.5 mt -130.1 161.34 39.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 126.18 1.792 . . . . 0.0 108.981 173.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.56 121.21 16.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.681 1.992 . . . . 0.0 107.19 166.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t -164.62 177.74 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.761 1.224 . . . . 0.0 109.984 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.06 82.6 1.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.81 -1.181 . . . . 0.0 110.113 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 103' ' ' VAL . 3.4 t0 -146.12 156.31 43.35 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.953 0.901 . . . . 0.0 112.102 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -66.55 -36.74 83.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.289 -166.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -49.95 13.98 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 117.212 -1.375 . . . . 0.0 110.568 168.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -51.62 -43.19 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.466 1.03 . . . . 0.0 110.799 -168.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 36.6 mt-30 -63.7 -43.86 95.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.021 0.928 . . . . 0.0 110.177 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.421 ' O ' HD23 ' A' ' 109' ' ' LEU . 21.1 t30 -69.23 -50.61 45.62 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.7 mm -52.62 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 125.625 1.57 . . . . 0.0 109.046 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.96 -34.79 66.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.151 1.341 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -54.76 30.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.059 -1.448 . . . . 0.0 112.754 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.433 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -61.83 -33.44 74.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 121.542 1.973 . . . . 0.0 110.302 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.5 mm? -73.69 -4.88 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.802 0.841 . . . . 0.0 113.255 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.24 3.38 61.17 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.863 -0.965 . . . . 0.0 114.399 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.03 149.91 24.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.033 1.417 . . . . 0.0 110.343 -175.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.46 ' N ' HD13 ' A' ' 112' ' ' LEU . 5.8 tmm_? -94.59 140.52 29.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.009 1.323 . . . . 0.0 110.131 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 15.7 p90 -144.08 178.28 7.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.038 -0.414 . . . . 0.0 110.86 177.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -107.86 121.43 44.73 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.447 1.099 . . . . 0.0 108.619 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.24 0.6 0 O-C-N 125.28 1.612 . . . . 0.0 109.717 157.697 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 12.8 p-90 . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -154.8 15.07 0.42 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.405 ' N ' HD11 ' A' ' 157' ' ' ILE . 52.8 m-85 -143.38 150.47 39.15 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.1 136.74 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.615 1.966 . . . . 0.0 108.679 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 2.2 t -76.93 121.95 24.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.035 0.934 . . . . 0.0 110.064 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.47 84.29 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 122.503 1.144 . . . . 0.0 108.608 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.77 -20.12 0.12 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.392 1.472 . . . . 0.0 112.125 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 18.9 p -152.87 0.63 0.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.291 1.046 . . . . 0.0 113.426 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.51 10.52 66.87 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.624 -1.298 . . . . 0.0 114.914 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.483 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 13.8 ttt85 -71.89 135.24 46.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -88.85 139.37 30.53 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.769 1.628 . . . . 0.0 109.364 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.29 149.12 52.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.334 1.054 . . . . 0.0 108.609 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -99.43 -9.74 23.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.039 0.936 . . . . 0.0 111.776 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.0 p -141.0 169.77 16.99 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.06 2.544 . . . . 0.0 107.321 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.33 133.51 83.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.72 160.95 47.4 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 121.002 1.394 . . . . 0.0 108.734 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.23 -19.04 65.43 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.201 1.934 . . . . 0.0 114.911 -170.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.1 -3.42 55.73 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.775 0.716 . . . . 0.0 113.265 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.6 17.93 50.2 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 119.122 1.461 . . . . 0.0 113.96 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.85 156.18 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.88 2.072 . . . . 0.0 106.526 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 11.7 t -69.8 113.79 20.03 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 125.534 1.534 . . . . 0.0 108.717 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 80.4 Cg_endo -66.39 -11.05 29.91 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.855 1.703 . . . . 0.0 112.091 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.82 -24.41 14.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.691 1.196 . . . . 0.0 112.074 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 4.7 p -142.25 -9.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.94 62.52 4.9 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.442 1.019 . . . . 0.0 112.319 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.31 167.76 22.75 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.015 0.926 . . . . 0.0 109.935 164.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -55.55 145.3 23.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.81 1.244 . . . . 0.0 110.668 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.4 t -104.52 138.91 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 167.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 162.53 29.12 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.514 1.126 . . . . 0.0 110.584 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.58 156.47 38.97 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.693 1.197 . . . . 0.0 110.241 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.429 0 C-N-CA 128.245 2.618 . . . . 0.0 108.65 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 tptt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -60.94 136.14 58.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.466 -1.396 . . . . 0.0 109.943 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -155.3 146.66 22.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.477 1.511 . . . . 0.0 107.181 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.8 t -118.22 147.51 21.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' CD1' HD21 ' A' ' 9' ' ' LEU . 1.8 mm? -116.62 140.05 49.84 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.329 1.452 . . . . 0.0 109.504 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.93 164.49 13.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.902 1.281 . . . . 0.0 111.169 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -42.12 -47.7 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.603 1.961 . . . . 0.0 113.708 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -58.82 -33.92 70.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.37 0.668 . . . . 0.0 110.94 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.36 -41.06 83.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.85 0.86 . . . . 0.0 109.562 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.94 -39.03 64.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.8 mt -57.28 -41.12 77.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.864 0.866 . . . . 0.0 109.799 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -78.7 -26.54 44.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.788 0.722 . . . . 0.0 111.871 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.46 26.74 12.94 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.315 0.959 . . . . 0.0 112.632 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 mt -77.01 110.32 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.459 1.129 . . . . 0.0 108.325 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.59 108.98 2.63 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 6.3 tp -145.28 170.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.592 ' O ' HD22 ' A' ' 9' ' ' LEU . 21.0 pt-20 -137.56 140.72 41.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.589 1.956 . . . . 0.0 107.379 -168.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 162.23 -148.46 15.68 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 124.424 1.077 . . . . 0.0 114.001 -159.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.49 152.81 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.335 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -130.62 154.18 48.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.926 1.69 . . . . 0.0 111.476 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.26 113.64 59.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 126.218 1.807 . . . . 0.0 112.147 -170.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.04 -11.09 29.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.646 2.897 . . . . 0.0 114.378 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -71.5 -40.78 69.95 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.612 1.165 . . . . 0.0 109.977 166.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG22 ' CB ' ' A' ' 81' ' ' ALA . 38.5 t -74.33 -40.68 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -170.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.96 -23.45 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 118.519 -1.272 . . . . 0.0 113.48 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.58 -20.44 63.65 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.744 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.05 -36.98 19.36 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.087 1.355 . . . . 0.0 108.805 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -66.53 94.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.908 1.283 . . . . 0.0 109.672 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -22.81 13.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.15 0.98 . . . . 0.0 111.582 169.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.07 122.15 10.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.741 1.216 . . . . 0.0 108.764 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -50.36 -49.05 55.27 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 116.932 -1.509 . . . . 0.0 111.655 -170.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -60.38 -60.7 3.39 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -168.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 t -51.44 -53.83 33.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.875 2.07 . . . . 0.0 110.781 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.15 -62.78 1.58 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.665 1.186 . . . . 0.0 110.959 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mt -55.9 -43.32 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.87 -53.33 59.16 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.787 0.835 . . . . 0.0 111.267 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.93 -44.0 73.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.048 1.339 . . . . 0.0 110.549 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.83 -39.14 90.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.59 -0.694 . . . . 0.0 111.079 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -56.52 -51.33 68.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.537 1.135 . . . . 0.0 109.046 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.02 -36.06 81.29 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 111.131 -171.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.2 mt -62.07 -47.78 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -39.97 85.38 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.802 0.441 . . . . 0.0 112.115 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.25 63.6 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.362 1.065 . . . . 0.0 111.838 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.82 44.44 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.039 0.828 . . . . 0.0 113.658 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 2.8 ptpt -70.82 -39.79 72.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.244 -170.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.62 99.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -167.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 4.3 mmmm -82.37 164.32 21.13 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.164 0.986 . . . . 0.0 110.302 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.42 129.44 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 123.231 0.612 . . . . 0.0 110.729 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.65 128.45 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 109.982 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -101.17 154.78 36.98 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 110.435 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.33 175.95 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 124.736 3.624 . . . . 0.0 112.684 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.05 160.58 14.38 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.398 -1.728 . . . . 0.0 107.975 173.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -39.34 68.14 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.577 -0.702 . . . . 0.0 110.642 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.66 -22.27 43.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.854 0.861 . . . . 0.0 110.379 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -65.57 -49.76 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 108.959 166.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.84 -46.63 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 118.736 0.698 . . . . 0.0 109.405 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -38.35 83.98 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.999 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.05 68.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 0.827 . . . . 0.0 111.761 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -67.52 -47.54 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.0 mt -51.62 -38.25 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.096 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -63.81 -62.32 1.72 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.698 1.135 . . . . 0.0 110.501 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.01 -40.85 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.19 96.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.612 0.765 . . . . 0.0 111.57 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -32.86 74.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.006 -1.059 . . . . 0.0 110.795 175.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.37 -5.25 38.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.738 0.699 . . . . 0.0 111.277 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -108.37 -41.66 4.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.994 0.815 . . . . 0.0 112.03 168.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.77 -80.4 0.18 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 119.678 1.126 . . . . 0.0 110.418 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -62.43 87.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.832 2.453 . . . . 0.0 109.338 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 p -89.22 -49.98 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.495 1.518 . . . . 0.0 110.926 -173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -130.69 14.63 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.727 0.811 . . . . 0.0 109.556 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -56.95 -33.77 67.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 110.2 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.6 mp -76.09 164.51 26.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 111.016 -172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.7 m -73.03 163.69 27.8 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.99 0.9 . . . . 0.0 112.252 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -61.22 2.45 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 123.552 0.741 . . . . 0.0 109.136 174.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.511 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -53.47 -38.17 63.37 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 125.908 2.005 . . . . 0.0 110.334 -171.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.49 -67.57 0.25 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.427 1.891 . . . . 0.0 109.083 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.67 -29.93 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.925 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -66.57 -49.16 67.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 113.295 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.1 t -50.76 -60.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.088 1.755 . . . . 0.0 108.53 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.2 mm? -62.18 -47.7 83.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.52 -172.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.11 -59.26 4.09 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.926 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 tp -56.3 -46.47 79.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -28.93 70.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.342 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' HE2' HD12 ' A' ' 65' ' ' ILE . 4.8 m-85 -80.61 -20.87 42.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.009 0.822 . . . . 0.0 111.618 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.73 -40.29 96.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.3 0.955 . . . . 0.0 108.921 164.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.68 -14.91 50.66 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.715 1.206 . . . . 0.0 112.566 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.34 42.98 7.97 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.477 1.511 . . . . 0.0 110.292 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.04 -113.88 3.88 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 126.067 1.794 . . . . 0.0 115.144 -165.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -147.45 167.64 23.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.41 1.484 . . . . 0.0 109.555 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 86' ' ' LEU . 58.6 mt -130.13 158.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 109.184 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.48 115.3 10.14 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 t -160.93 179.66 8.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.93 1.292 . . . . 0.0 108.524 172.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -158.57 89.1 0.95 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.844 -1.16 . . . . 0.0 110.627 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -153.35 156.02 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.07 0.948 . . . . 0.0 110.699 176.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -58.75 -48.89 79.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.624 0.77 . . . . 0.0 110.162 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -64.87 -54.82 24.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.663 1.185 . . . . 0.0 109.723 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -63.01 -36.56 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.823 0.449 . . . . 0.0 110.923 -164.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.04 -44.0 85.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -60.87 -50.57 72.9 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.104 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 HD21 ' A' ' 78' ' ' LEU . 10.1 mm -54.58 -51.05 54.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.991 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.61 88.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.085 1.311 . . . . 0.0 111.298 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 t -65.11 -49.4 70.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.426 -0.797 . . . . 0.0 113.022 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -36.81 84.84 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 120.432 1.469 . . . . 0.0 110.723 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -66.32 -28.66 68.85 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.508 0.323 . . . . 0.0 110.524 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.04 46.38 59.13 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -170.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.01 123.65 49.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.321 1.06 . . . . 0.0 108.484 160.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 140.19 57.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.95 1.3 . . . . 0.0 109.849 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -145.47 178.42 8.12 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.826 0.85 . . . . 0.0 109.741 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.67 146.23 32.32 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.385 1.074 . . . . 0.0 108.771 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 125.11 1.364 . . . . 0.0 108.778 169.661 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.497 ' CH2' HD13 ' A' ' 157' ' ' ILE . 22.7 p-90 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -149.06 15.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -143.74 146.46 33.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.688 0.676 . . . . 0.0 109.87 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.45 135.28 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.056 0.942 . . . . 0.0 109.989 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.7 OUTLIER -62.99 130.22 43.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.783 1.233 . . . . 0.0 108.849 169.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.9 pt -87.07 51.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.797 0.839 . . . . 0.0 111.391 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.82 -81.95 0.04 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.44 -7.36 54.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.098 0.559 . . . . 0.0 111.87 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.52 29.04 74.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 125.555 1.55 . . . . 0.0 113.239 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 140.36 53.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -81.9 153.45 26.32 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.919 1.287 . . . . 0.0 109.511 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -146.89 126.12 13.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.897 1.279 . . . . 0.0 107.646 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.4 p -82.51 -23.71 34.49 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.084 -1.01 . . . . 0.0 111.479 170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 p -141.95 159.34 42.43 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 126.511 1.924 . . . . 0.0 108.594 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.5 OUTLIER -65.48 121.84 77.12 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -173.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 141' ' ' LEU . 63.8 Cg_endo -63.21 157.57 49.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 CA-C-N 121.011 1.397 . . . . 0.0 109.145 171.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.12 128.7 26.02 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.348 1.365 . . . . 0.0 108.935 174.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.64 69.18 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.057 1.313 . . . . 0.0 113.215 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 58.58 43.31 96.19 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 118.948 1.374 . . . . 0.0 111.391 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.45 168.25 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 18.9 t -78.06 110.52 13.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 111.183 -173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 37.9 Cg_endo -63.22 15.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.925 3.084 . . . . 0.0 114.576 167.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.4 OUTLIER -132.33 -20.13 2.41 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.053 1.741 . . . . 0.0 111.765 -175.409 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 3.5 p -154.16 3.42 0.25 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.83 -14.09 2.18 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.833 1.682 . . . . 0.0 114.919 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.6 m -62.13 149.27 41.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.097 1.448 . . . . 0.0 110.877 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.54 157.52 6.85 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 109.796 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.92 162.83 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.12 163.08 31.17 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.262 -1.523 . . . . 0.0 108.779 164.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.04 148.74 46.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 163.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.497 HD13 ' CH2' ' A' ' 127' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 109.812 168.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.4 mt 49.95 22.04 0.81 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 0.0 115.813 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -80.79 66.98 6.52 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 120.774 -1.204 . . . . 0.0 109.591 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -70.35 130.03 40.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.9 mt -145.85 157.87 43.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.696 0.799 . . . . 0.0 109.071 166.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.18 176.69 3.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 166.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -58.74 -176.95 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.052 1.341 . . . . 0.0 111.836 162.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 m -56.53 139.49 49.39 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.76 -1.212 . . . . 0.0 108.598 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -158.96 143.3 15.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.72 142.25 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.58 137.41 49.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 108.281 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -89.11 164.72 14.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.88 0.848 . . . . 0.0 111.032 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.49 165.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -57.12 -26.31 60.29 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.39 -37.17 64.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 120.213 1.37 . . . . 0.0 109.405 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -77.37 -12.78 59.99 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.5 1.52 . . . . 0.0 112.538 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.45 -45.53 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.227 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.49 -20.39 50.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.979 1.718 . . . . 0.0 114.25 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.62 40.9 5.54 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 128.375 2.893 . . . . 0.0 112.097 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' CD1' HD21 ' A' ' 117' ' ' LEU . 7.3 mt -95.2 100.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 119.944 1.872 . . . . 0.0 107.211 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 111.63 1.02 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.399 0.68 . . . . 0.0 110.328 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 23' ' ' GLU . 5.7 tp -155.69 170.23 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 126.189 1.796 . . . . 0.0 107.978 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 22' ' ' ILE . 54.3 mt-10 -115.03 162.63 16.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.624 2.37 . . . . 0.0 108.96 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.85 -132.83 4.27 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 118.456 0.571 . . . . 0.0 112.067 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.7 151.61 47.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.734 1.613 . . . . 0.0 109.971 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -129.36 149.78 51.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.973 1.709 . . . . 0.0 111.138 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.61 116.5 66.34 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 126.492 1.917 . . . . 0.0 109.318 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 31' ' ' VAL . 38.2 Cg_endo -63.09 -16.79 56.66 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.934 1.756 . . . . 0.0 112.379 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -53.57 52.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.152 1.381 . . . . 0.0 110.608 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.35 -35.5 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 O-C-N 121.611 -0.681 . . . . 0.0 109.424 -169.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG23 HD21 ' A' ' 43' ' ' LEU . 7.0 p -63.08 -20.5 25.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.768 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -69.67 -21.35 63.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.118 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.48 -7.36 31.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.532 1.533 . . . . 0.0 110.923 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.13 99.94 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.677 1.191 . . . . 0.0 108.455 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 -13.49 15.57 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.08 -176.08 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.054 1.342 . . . . 0.0 110.466 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -101.28 -43.21 6.04 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.391 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -56.9 -60.86 2.95 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 120.1 1.318 . . . . 0.0 107.702 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m -62.25 -11.29 14.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -89.37 -66.7 0.9 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.4 mt -52.37 -48.79 44.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 124.892 1.277 . . . . 0.0 107.659 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -56.58 -54.57 44.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.013 0.925 . . . . 0.0 112.553 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 31' ' ' VAL . 14.3 tp -58.15 -54.04 51.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.895 1.278 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.26 -39.79 83.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.484 1.514 . . . . 0.0 111.477 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.2 m -68.77 -45.38 71.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 120.687 -1.258 . . . . 0.0 112.005 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -38.28 90.46 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 124.452 1.101 . . . . 0.0 110.039 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.76 -56.69 11.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.776 0.831 . . . . 0.0 108.933 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 m -68.03 -26.07 65.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.992 0.517 . . . . 0.0 111.938 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 -2.25 39.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.895 1.678 . . . . 0.0 112.616 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.67 23.37 68.85 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 125.421 1.486 . . . . 0.0 113.464 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -72.41 -35.35 68.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 108.841 171.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -134.95 136.92 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -114.67 156.71 24.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.331 1.053 . . . . 0.0 111.207 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.3 mm -83.31 129.55 37.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 119.182 0.901 . . . . 0.0 109.656 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.28 124.15 6.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.258 1.023 . . . . 0.0 111.192 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.61 152.58 38.42 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.832 1.253 . . . . 0.0 109.636 166.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.55 166.83 28.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.782 3.654 . . . . 0.0 114.02 -171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -75.39 158.69 32.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.94 0.876 . . . . 0.0 111.395 162.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -44.15 95.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.576 1.151 . . . . 0.0 110.352 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.53 -32.8 71.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.591 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -48.17 74.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.383 0.673 . . . . 0.0 110.417 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -50.73 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.3 -32.31 69.93 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -45.63 80.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.667 1.121 . . . . 0.0 110.492 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -64.61 -45.41 95.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -54.01 -38.1 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.512 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -64.93 -59.18 4.46 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.899 1.227 . . . . 0.0 109.207 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.12 -33.55 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.828 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -63.64 -48.51 76.99 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.123 1.369 . . . . 0.0 110.807 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -27.53 68.38 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.194 -0.941 . . . . 0.0 110.645 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -70.26 -37.06 74.82 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.187 0.903 . . . . 0.0 111.844 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' ALA . 7.5 t -87.26 -14.95 39.54 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.851 1.205 . . . . 0.0 112.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 -59.73 0.6 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 125.057 1.313 . . . . 0.0 112.807 165.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -75.67 92.65 2.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.68 -43.79 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 123.53 0.732 . . . . 0.0 112.764 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.56 7.34 6.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.064 0.546 . . . . 0.0 110.149 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -69.91 -3.77 17.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 112.088 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.55 150.81 21.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.58 1.552 . . . . 0.0 108.972 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -69.94 157.83 36.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.744 0.783 . . . . 0.0 110.92 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -64.63 -50.88 65.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.171 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.61 -42.29 55.82 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.788 0.835 . . . . 0.0 111.453 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -59.08 5.18 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.824 1.65 . . . . 0.0 109.827 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.93 -44.86 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.78 1.232 . . . . 0.0 108.856 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -60.26 -52.64 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.609 1.563 . . . . 0.0 111.524 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.74 -54.26 37.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.257 1.023 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 96' ' ' ILE . 57.7 mt -58.23 -51.85 68.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.866 0.867 . . . . 0.0 109.419 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.78 -52.76 22.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 112.218 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -50.91 68.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 123.494 0.496 . . . . 0.0 110.028 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.91 -31.45 70.95 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 9.6 m-30 -69.39 -33.86 73.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.613 0.642 . . . . 0.0 110.558 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.71 -31.71 72.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.483 0.583 . . . . 0.0 112.53 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.06 -15.83 33.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.651 1.181 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.71 24.2 1.62 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 112.65 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.52 -102.21 0.87 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.079 0.847 . . . . 0.0 111.786 -169.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -153.48 166.28 33.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.202 1.001 . . . . 0.0 110.515 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 86' ' ' LEU . 48.4 mt -135.43 156.67 38.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.539 1.536 . . . . 0.0 107.379 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 124.68 30.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.867 1.267 . . . . 0.0 107.878 164.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.0 t -163.28 175.28 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.373 1.069 . . . . 0.0 110.54 165.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -147.34 63.21 1.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.554 1.142 . . . . 0.0 112.8 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -123.0 157.95 31.57 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.384 1.074 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -72.79 -45.06 60.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.566 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.377 1.071 . . . . 0.0 110.784 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -55.02 -41.66 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.436 1.016 . . . . 0.0 109.354 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.67 -43.51 96.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.61 0.764 . . . . 0.0 110.139 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 51.6 t30 -64.69 -53.76 42.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.754 0.821 . . . . 0.0 110.027 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.51 -55.15 16.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.951 0.901 . . . . 0.0 109.112 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.49 65.66 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.47 1.486 . . . . 0.0 113.565 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 t -57.5 -63.25 1.3 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.528 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -64.5 -21.24 66.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.852 1.66 . . . . 0.0 113.036 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mm? -85.47 -6.25 59.21 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.292 1.037 . . . . 0.0 112.522 175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.48 9.15 84.54 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.881 -1.511 . . . . 0.0 113.988 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.86 120.62 32.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.09 1.945 . . . . 0.0 111.418 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 134.95 57.59 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.95 1.3 . . . . 0.0 109.892 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -147.81 170.88 16.67 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 122.885 0.474 . . . . 0.0 110.262 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.2 mtt-85 -109.42 154.38 22.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.548 1.139 . . . . 0.0 109.647 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -144.54 -174.32 4.29 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.965 0.791 . . . . 0.0 109.41 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 20' ' ' ILE . 2.4 mm? -104.37 169.14 8.65 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.271 1.029 . . . . 0.0 112.073 -159.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -82.52 76.05 9.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -116.32 175.66 5.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 146.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.24 -52.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.324 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.483 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.4 mm -147.21 141.39 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.467 1.907 . . . . 0.0 106.52 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -130.24 -7.18 4.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.727 1.211 . . . . 0.0 112.002 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -161.19 -32.17 0.05 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.85 1.204 . . . . 0.0 111.949 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 177.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 126.308 1.843 . . . . 0.0 110.157 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 mp -131.63 177.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 126.544 1.938 . . . . 0.0 107.159 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.67 175.29 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.212 -1.555 . . . . 0.0 109.672 158.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -156.69 166.37 33.6 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.38 1.472 . . . . 0.0 108.853 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -159.13 14.53 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -141.53 150.5 42.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.008 1.276 . . . . 0.0 110.42 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.44 129.33 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.413 1.085 . . . . 0.0 108.262 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 153.37 30.03 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 165.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.79 88.32 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 122.804 1.288 . . . . 0.0 109.374 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.2 -75.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 p -93.75 -3.91 51.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.094 0.958 . . . . 0.0 113.031 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.66 26.59 72.06 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 125.707 1.622 . . . . 0.0 114.106 170.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -66.09 136.14 55.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.291 0.636 . . . . 0.0 109.506 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.8 141.03 31.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.489 1.116 . . . . 0.0 108.162 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -136.03 152.7 51.17 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -94.65 -17.82 21.91 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.74 -0.6 . . . . 0.0 111.726 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 45.4 p -128.02 169.21 14.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.514 1.126 . . . . 0.0 108.989 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.13 119.74 72.76 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.56 172.31 9.43 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.919 1.746 . . . . 0.0 110.269 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.46 138.19 83.24 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.032 1.821 . . . . 0.0 110.597 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.07 -5.34 1.34 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.56 1.076 . . . . 0.0 113.926 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.34 51.1 38.24 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-O 117.41 -1.772 . . . . 0.0 110.626 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 m -126.62 158.51 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 118.853 1.326 . . . . 0.0 108.065 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 35.2 t -77.78 111.95 21.37 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 125.216 1.406 . . . . 0.0 111.835 -167.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 44.0 Cg_endo -64.48 23.26 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.97 3.113 . . . . 0.0 115.231 167.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.82 -18.04 0.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.412 1.485 . . . . 0.0 113.336 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.83 -2.34 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.99 -17.8 5.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.856 1.217 . . . . 0.0 114.618 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -62.53 162.0 11.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.413 1.606 . . . . 0.0 112.901 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -61.64 155.92 21.26 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.62 -0.675 . . . . 0.0 110.771 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.34 144.41 21.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -133.79 164.18 27.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.196 1.398 . . . . 0.0 110.357 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.8 tt -78.91 155.37 29.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.537 1.135 . . . . 0.0 110.218 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.94 165.35 34.06 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.372 2.269 . . . . 0.0 110.943 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 178.72 6.65 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.062 2.508 . . . . 0.0 112.657 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -42.99 152.31 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.002 2.121 . . . . 0.0 112.358 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -59.73 -53.11 61.8 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.137 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.836 -176.038 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtp . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.13 120.63 22.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -156.64 100.86 1.96 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -146.06 179.2 7.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 69.6 -172.9 0.18 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.101 1.76 . . . . 0.0 113.219 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -138.53 -174.8 3.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.458 1.503 . . . . 0.0 109.973 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -49.37 155.59 0.71 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.431 0.693 . . . . 0.0 111.853 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -51.62 124.89 13.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.788 1.235 . . . . 0.0 108.598 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 tp -149.4 142.72 25.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.382 1.873 . . . . 0.0 106.494 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.06 150.52 19.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.15 150.66 37.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.709 1.604 . . . . 0.0 108.591 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.82 161.12 13.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.004 0.522 . . . . 0.0 111.736 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.569 ' HB2' HG21 ' A' ' 30' ' ' VAL . 29.1 t -37.14 -55.31 0.97 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.857 2.463 . . . . 0.0 112.158 164.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.4 m -56.62 -28.01 59.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.227 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' ILE . 21.0 t -63.42 -45.36 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.662 1.119 . . . . 0.0 109.43 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.36 -33.51 71.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.576 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.68 -41.62 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.051 0.941 . . . . 0.0 110.446 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -75.65 -30.26 59.4 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.977 -0.452 . . . . 0.0 110.485 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.04 29.42 15.22 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 124.975 1.274 . . . . 0.0 111.187 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.5 mt -74.5 110.06 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.19 121.22 9.56 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.411 1.484 . . . . 0.0 109.178 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 23' ' ' GLU . 8.3 tp -158.83 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.755 2.022 . . . . 0.0 109.669 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' H ' HG13 ' A' ' 22' ' ' ILE . 1.7 mp0 -135.77 159.19 42.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 108.99 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.41 -134.13 5.37 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 120.795 1.634 . . . . 0.0 114.376 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -129.0 154.99 46.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.6 1.96 . . . . 0.0 109.351 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -141.6 153.89 45.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.901 0.88 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.4 p -86.89 118.22 69.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.904 0.882 . . . . 0.0 110.455 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.88 -27.85 74.43 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.098 1.199 . . . . 0.0 110.794 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -71.88 -24.11 61.61 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 13' ' ' SER . 7.4 p -86.44 -31.12 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 121.33 1.877 . . . . 0.0 109.326 166.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.71 -22.1 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 119.211 0.914 . . . . 0.0 111.043 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.75 -14.9 16.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.629 -1.294 . . . . 0.0 112.746 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.53 -30.56 7.58 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.534 -1.354 . . . . 0.0 112.411 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -55.29 111.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 120.099 1.318 . . . . 0.0 110.399 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -12.81 6.96 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.113 1.365 . . . . 0.0 112.615 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.99 122.69 17.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.8 mtt-85 -52.72 -49.68 64.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.169 0.988 . . . . 0.0 110.366 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.69 -52.74 64.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.265 0.978 . . . . 0.0 109.098 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 t -53.8 -49.14 68.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -65.18 -53.9 37.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.675 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.15 -54.1 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 33.2 t80 -57.26 -49.22 76.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.263 1.025 . . . . 0.0 111.103 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.7 tp -50.49 -60.77 2.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 109.98 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.63 78.78 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.302 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.9 m -57.37 -49.66 75.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.471 1.108 . . . . 0.0 110.654 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 26.2 mt -63.2 -41.98 99.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.785 0.434 . . . . 0.0 110.228 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.59 -50.35 67.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 p -64.09 -33.93 76.88 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.132 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.592 0.757 . . . . 0.0 110.058 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.99 16.5 6.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 124.18 0.895 . . . . 0.0 112.276 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -86.29 -27.54 24.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.374 1.087 . . . . 0.0 110.803 -173.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.95 148.97 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -129.66 146.41 51.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.415 1.086 . . . . 0.0 112.01 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.47 125.79 36.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.214 1.806 . . . . 0.0 108.119 -175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.5 118.53 5.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.263 1.025 . . . . 0.0 109.928 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -86.26 155.13 57.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.373 -0.829 . . . . 0.0 110.027 163.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.41 163.52 36.24 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 124.605 3.537 . . . . 0.0 111.301 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -83.94 166.7 17.61 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.741 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -57.73 -50.42 73.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.185 1.394 . . . . 0.0 110.628 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.2 -27.6 67.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.51 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.14 -51.13 49.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.609 0.764 . . . . 0.0 109.404 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.64 -46.78 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.965 . . . . 0.0 109.744 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.34 -34.42 68.75 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.081 -0.387 . . . . 0.0 111.721 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -44.52 86.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.819 0.448 . . . . 0.0 110.945 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.95 -36.31 75.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.36 -47.7 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -65.01 -45.14 86.74 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.412 1.005 . . . . 0.0 111.728 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.985 HG11 HD21 ' A' ' 110' ' ' LEU . 9.9 p -69.43 -40.42 79.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 O-C-N 121.164 -0.96 . . . . 0.0 110.379 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.06 89.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -27.37 58.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.256 -0.903 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.71 -13.52 62.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.792 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 t -125.19 -15.79 6.17 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.992 1.724 . . . . 0.0 114.964 -174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.37 -90.14 0.15 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.109 1.322 . . . . 0.0 110.786 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -77.16 58.11 1.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.581 1.953 . . . . 0.0 113.212 -161.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.5 p -45.45 -37.75 2.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.82 1.648 . . . . 0.0 114.944 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -128.79 11.1 6.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.09 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.04 -9.46 59.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.703 0.683 . . . . 0.0 111.989 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 144.3 27.02 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 m -67.62 161.47 25.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.245 1.021 . . . . 0.0 111.034 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -61.26 -55.58 30.29 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.327 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.34 -37.99 68.16 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 123.888 0.742 . . . . 0.0 110.386 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -61.96 -53.95 48.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.569 0.748 . . . . 0.0 109.027 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.55 -43.7 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.238 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -63.21 -54.98 28.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.13 0.972 . . . . 0.0 112.238 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.18 -49.52 83.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 109.799 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 HD13 ' A' ' 96' ' ' ILE . 94.9 mt -61.04 -49.42 77.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -53.33 -53.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.79 0.836 . . . . 0.0 111.806 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.1 tp -51.09 -52.65 41.43 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.655 0.782 . . . . 0.0 109.82 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.23 69.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.514 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.6 m-30 -84.61 -18.43 35.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.131 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.01 -37.17 75.58 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.74 1.155 . . . . 0.0 109.229 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 -17.58 45.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.034 1.334 . . . . 0.0 112.474 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.17 46.65 5.18 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.066 2.146 . . . . 0.0 110.753 -169.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.53 -114.69 3.97 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.383 0.516 . . . . 0.0 112.113 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.44 164.21 31.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.07 1.748 . . . . 0.0 106.409 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.519 HD13 HD23 ' A' ' 86' ' ' LEU . 80.0 mt -136.6 155.95 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 116.85 15.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -156.27 -173.37 4.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.536 0.734 . . . . 0.0 109.947 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.405 ' OD2' ' HE2' ' A' ' 118' ' ' LYS . 26.5 t0 -144.53 -13.75 0.58 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.3 160.59 32.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.616 1.553 . . . . 0.0 114.684 -168.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -62.53 -46.09 90.0 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 119.929 -1.732 . . . . 0.0 110.936 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -72.16 -53.97 11.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -41.63 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.879 0.872 . . . . 0.0 111.318 -168.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.66 -38.88 64.81 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.933 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 109' ' ' LEU . 15.2 t30 -66.86 -51.13 59.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 117.531 -1.223 . . . . 0.0 108.055 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -48.16 -59.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.44 63.75 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.841 1.655 . . . . 0.0 112.681 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -65.28 -53.32 45.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.277 -1.344 . . . . 0.0 112.719 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -61.98 -35.69 79.26 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 121.518 1.963 . . . . 0.0 109.962 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.985 HD21 HG11 ' A' ' 68' ' ' VAL . 2.3 mm? -71.11 -19.38 62.45 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.37 14.87 79.55 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.201 -1.333 . . . . 0.0 113.502 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -72.68 163.81 27.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.138 1.469 . . . . 0.0 109.213 176.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.562 ' H ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -105.68 128.81 53.88 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -151.18 -176.39 5.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.204 0.202 . . . . 0.0 110.762 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -119.79 154.37 34.34 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.559 1.544 . . . . 0.0 109.663 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.4 p -143.27 111.58 6.23 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -160.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.27 -60.14 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HE2' ' OD2' ' A' ' 99' ' ' ASP . 52.3 mtmt -85.15 -158.34 0.36 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.632 2.773 . . . . 0.0 109.611 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -76.78 175.42 9.44 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.165 -0.959 . . . . 0.0 109.501 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.04 101.15 1.91 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.685 1.136 . . . . 0.0 110.46 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.9 80.5 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.336 1.455 . . . . 0.0 111.186 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -64.6 -50.9 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.935 1.294 . . . . 0.0 111.18 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -130.63 29.82 4.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 108.879 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.9 t -135.28 176.23 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 127.036 2.135 . . . . 0.0 106.435 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.88 147.42 22.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 120.527 -1.358 . . . . 0.0 108.355 -168.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.94 102.71 0.38 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -59.54 161.61 5.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.762 0.825 . . . . 0.0 110.582 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -156.0 14.78 0.34 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -136.03 147.36 47.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.772 1.169 . . . . 0.0 110.831 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.11 134.73 47.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.755 1.222 . . . . 0.0 108.329 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 129.66 40.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.121 0.968 . . . . 0.0 108.416 165.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 pt -84.03 111.14 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 160.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.84 -93.66 0.17 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 106.543 -2.623 . . . . 0.0 106.543 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 3.6 p -76.34 -13.74 60.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.212 0.605 . . . . 0.0 111.952 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.87 73.84 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 124.69 1.138 . . . . 0.0 115.305 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -68.81 129.75 40.82 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 110.631 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -71.42 147.13 48.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.375 1.07 . . . . 0.0 110.198 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -139.89 156.04 46.89 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.145 0.978 . . . . 0.0 109.553 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 p -97.54 -24.83 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.235 0.614 . . . . 0.0 112.053 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.91 129.85 5.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -158.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.82 123.24 80.98 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 126.099 1.76 . . . . 0.0 110.43 -168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.3 171.75 17.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.61 3.54 . . . . 0.0 113.121 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.54 87.76 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.429 3.419 . . . . 0.0 110.505 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.27 -28.77 2.67 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 126.363 1.935 . . . . 0.0 111.113 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.72 32.05 61.31 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 121.462 -1.022 . . . . 0.0 112.275 -168.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 178.54 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 126.179 1.791 . . . . 0.0 107.906 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.9 t -83.21 103.97 3.23 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.304 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.63 -2.5 0.72 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.072 1.848 . . . . 0.0 114.589 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.77 -31.5 13.17 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.826 1.25 . . . . 0.0 112.682 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.8 -35.98 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.815 0.846 . . . . 0.0 113.069 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 113.22 -15.91 22.69 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.143 2.306 . . . . 0.0 113.599 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.1 m -67.77 169.86 8.92 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.765 1.782 . . . . 0.0 113.178 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -74.13 142.45 45.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.372 1.069 . . . . 0.0 111.536 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.17 147.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.718 1.607 . . . . 0.0 106.763 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -122.89 160.81 25.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.632 1.173 . . . . 0.0 108.807 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.02 151.56 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.75 153.0 50.62 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.116 1.366 . . . . 0.0 110.584 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.97 91.35 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.404 2.736 . . . . 0.0 112.59 -171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 52.09 -162.49 0.08 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.134 1.373 . . . . 0.0 110.635 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -127.73 -84.69 0.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.554 1.07 . . . . 0.0 109.337 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-O 115.482 -2.199 . . . . 0.0 109.829 -163.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.3 mt -75.36 65.53 1.67 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.593 1.157 . . . . 0.0 110.963 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -144.3 172.0 13.54 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.196 1.799 . . . . 0.0 108.139 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -150.13 117.48 6.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tp -162.91 153.73 16.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 165.95 14.16 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.447 1.099 . . . . 0.0 112.152 171.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -63.17 170.43 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.0 111.442 161.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -53.76 129.16 32.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.349 1.06 . . . . 0.0 110.372 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.1 tp -149.74 149.44 30.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 151.07 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.94 158.61 26.37 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.655 1.582 . . . . 0.0 109.007 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -118.62 169.28 9.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.306 1.442 . . . . 0.0 111.295 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 p -55.52 -46.74 77.0 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.966 1.306 . . . . 0.0 112.459 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -27.06 62.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.806 -1.092 . . . . 0.0 112.526 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.96 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.503 1.501 . . . . 0.0 109.109 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' HD12 ' A' ' 43' ' ' LEU . 38.2 m-85 -72.4 -33.0 66.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.406 0.682 . . . . 0.0 111.23 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.25 -49.63 83.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.924 0.889 . . . . 0.0 109.722 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.69 -13.73 61.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.297 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.55 22.8 57.76 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.582 0.611 . . . . 0.0 113.346 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 117' ' ' LEU . 36.2 mt -77.77 107.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 108.4 1.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 171.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -154.22 154.96 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -98.89 164.15 12.32 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 126.431 1.892 . . . . 0.0 111.15 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.71 -139.39 9.34 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-O 121.28 0.378 . . . . 0.0 112.255 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -125.83 151.32 46.96 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.961 1.305 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 t -135.89 147.08 48.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.396 0.678 . . . . 0.0 109.301 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 114.09 48.12 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.484 1.914 . . . . 0.0 111.025 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.67 -20.99 45.08 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.002 1.802 . . . . 0.0 113.801 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -87.9 -12.95 43.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.16 -38.01 10.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 120.667 1.576 . . . . 0.0 108.154 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.97 -20.54 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.633 0.773 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.09 -24.16 38.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.539 1.135 . . . . 0.0 113.101 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.52 7.12 10.58 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.322 0.964 . . . . 0.0 112.7 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 mt -74.72 88.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -10.75 45.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.651 1.98 . . . . 0.0 112.686 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -73.7 124.52 26.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -67.82 -43.84 78.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 117.693 -1.146 . . . . 0.0 111.634 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -57.15 -55.43 34.9 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -55.57 -52.48 63.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.711 0.804 . . . . 0.0 111.208 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -58.69 -56.7 18.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.178 0.991 . . . . 0.0 110.076 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.08 -53.93 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 30.7 t80 -56.01 -49.69 72.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.404 0.682 . . . . 0.0 111.341 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' CD2' ' A' ' 16' ' ' PHE . 6.7 tt -54.98 -56.29 21.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.541 1.136 . . . . 0.0 110.066 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.32 -38.66 87.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.832 0.453 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.3 m -58.77 -41.64 87.1 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.837 0.855 . . . . 0.0 111.259 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.512 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 11.6 mt -64.35 -43.14 95.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.826 0.739 . . . . 0.0 110.629 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.32 -52.08 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.9 m -61.78 -32.13 72.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.427 1.091 . . . . 0.0 111.65 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.08 69.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.648 1.179 . . . . 0.0 110.836 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.16 -16.45 3.43 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 123.703 0.668 . . . . 0.0 113.343 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -71.85 -34.95 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.612 0.706 . . . . 0.0 110.774 -160.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 162.29 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.44 141.03 33.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.981 0.912 . . . . 0.0 108.853 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.43 124.68 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.887 0.875 . . . . 0.0 109.748 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.42 136.02 17.06 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.35 160.13 28.31 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.857 0.863 . . . . 0.0 112.177 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.74 -177.03 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.674 3.583 . . . . 0.0 112.575 168.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 t -122.02 166.81 13.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.76 1.224 . . . . 0.0 109.748 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' C ' ' HE2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -56.17 -49.53 73.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.303 1.041 . . . . 0.0 110.311 -173.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.13 -22.42 62.07 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.724 -0.61 . . . . 0.0 112.061 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -50.75 66.83 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mm -59.09 -49.6 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.04 0.936 . . . . 0.0 108.67 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -27.88 67.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.118 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -48.84 79.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.319 1.418 . . . . 0.0 110.612 173.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -64.82 -33.04 60.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.78 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.417 -0.802 . . . . 0.0 109.696 170.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -57.28 -49.62 75.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.861 1.21 . . . . 0.0 110.582 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.921 HG11 HD21 ' A' ' 110' ' ' LEU . 5.2 p -72.2 -41.27 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.87 -0.519 . . . . 0.0 110.632 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.36 -25.22 61.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 111.076 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 -25.98 41.54 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.245 0.929 . . . . 0.0 110.335 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.18 -5.61 5.21 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.284 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.266 10.8 t -127.56 -58.79 1.24 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.123 1.329 . . . . 0.0 111.365 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.43 -21.57 0.64 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 120.348 1.431 . . . . 0.0 115.585 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.48 20.32 0.43 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.094 1.447 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -33.36 -57.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 128.044 2.538 . . . . 0.0 115.864 -163.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -121.58 11.47 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.846 0.859 . . . . 0.0 109.794 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.31 -34.98 76.12 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.069 0.948 . . . . 0.0 109.82 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -64.88 149.75 48.98 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 111.86 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -51.66 133.42 30.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.888 1.275 . . . . 0.0 108.633 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -44.86 84.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.842 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.53 60.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.1 0.56 . . . . 0.0 111.48 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.12 -50.0 73.66 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.184 1.394 . . . . 0.0 108.812 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.9 mt -53.42 -45.77 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.642 0.777 . . . . 0.0 109.252 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -67.48 -44.25 78.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.208 1.403 . . . . 0.0 111.787 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.84 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.389 1.075 . . . . 0.0 108.895 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 96' ' ' ILE . 75.7 mt -59.19 -53.29 59.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.36 1.064 . . . . 0.0 109.295 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.36 -51.04 61.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.455 1.502 . . . . 0.0 111.825 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.1 tp -51.57 -56.05 15.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.03 86.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.253 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.1 m-30 -66.35 -33.69 76.3 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.956 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 -42.76 83.31 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.43 1.014 . . . . 0.0 109.495 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.92 -18.28 50.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.361 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt 53.99 26.38 6.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.48 1.112 . . . . 0.0 111.116 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.46 -159.36 27.96 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 127.654 2.55 . . . . 0.0 113.13 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.11 173.62 7.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 110.232 165.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.558 HD13 HD23 ' A' ' 86' ' ' LEU . 41.7 mt -129.13 163.47 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.292 2.237 . . . . 0.0 108.002 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.57 115.89 11.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.166 2.187 . . . . 0.0 106.984 165.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t -158.37 177.96 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.906 1.283 . . . . 0.0 109.673 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -150.62 23.59 0.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.823 -1.173 . . . . 0.0 113.335 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 4.0 t0 -87.84 156.14 19.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.792 -1.192 . . . . 0.0 109.59 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -64.39 -47.77 77.95 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.034 1.288 . . . . 0.0 109.654 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.69 -53.27 35.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.258 1.423 . . . . 0.0 110.544 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.4 p -54.3 -41.81 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.03 1.287 . . . . 0.0 110.316 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 114' ' ' PHE . 62.2 mt-30 -69.6 -36.5 76.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.073 0.949 . . . . 0.0 110.843 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.444 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.1 t-20 -69.02 -55.25 11.39 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 HD21 ' A' ' 78' ' ' LEU . 9.7 mm -49.59 -60.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 C-N-CA 125.094 1.358 . . . . 0.0 109.49 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.0 56.76 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.076 1.307 . . . . 0.0 112.163 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -48.13 75.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.974 -1.489 . . . . 0.0 113.705 172.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -65.89 -33.03 74.9 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 122.609 2.459 . . . . 0.0 110.631 174.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.921 HD21 HG11 ' A' ' 68' ' ' VAL . 1.1 mm? -75.5 -3.89 36.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.902 1.281 . . . . 0.0 113.032 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.03 -2.72 8.06 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.208 1.385 . . . . 0.0 115.226 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -74.06 127.86 34.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 120.14 1.97 . . . . 0.0 110.319 -167.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 129.52 39.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 104' ' ' GLN . 32.7 p90 -134.68 -179.37 5.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.637 0.256 . . . . 0.0 111.15 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.02 152.79 32.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.339 1.856 . . . . 0.0 107.993 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 172.0 16.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 20' ' ' ILE . 4.5 mm? -69.45 166.54 18.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -50.48 137.71 18.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.874 1.27 . . . . 0.0 109.326 169.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 177.43 163.48 0.55 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.658 1.983 . . . . 0.0 108.128 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.82 -80.92 0.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 166.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.1 pt -153.97 172.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.966 1.706 . . . . 0.0 110.93 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -131.14 98.57 4.61 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.5 tttt 74.74 -22.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.741 2.416 . . . . 0.0 114.342 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.48 67.84 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.897 1.279 . . . . 0.0 111.716 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.8 mt -55.07 147.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 120.816 -1.177 . . . . 0.0 110.028 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -49.78 132.22 22.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.34 1.456 . . . . 0.0 109.16 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 4.0 p-90 -125.62 139.2 53.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.598 0.561 . . . . 0.0 110.357 -168.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -140.65 12.18 2.29 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.92 140.69 45.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 120.532 1.515 . . . . 0.0 111.675 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.29 139.43 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.929 2.092 . . . . 0.0 109.577 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 4.4 t -81.97 119.98 24.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 161.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.22 127.24 31.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 157.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 134.85 -81.8 0.3 Allowed Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 106.714 -2.555 . . . . 0.0 106.714 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.6 p -80.75 -19.48 44.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.351 -0.5 . . . . 0.0 110.73 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.22 18.54 62.47 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 121.398 -0.813 . . . . 0.0 113.766 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -84.75 162.0 19.79 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.611 1.564 . . . . 0.0 111.109 -165.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -112.29 142.1 45.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 110.481 -164.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -143.82 155.35 44.1 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.614 1.165 . . . . 0.0 109.784 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 1.8 p -104.88 -13.26 15.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.642 0.777 . . . . 0.0 112.977 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.7 p -147.07 175.61 10.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.893 2.477 . . . . 0.0 106.671 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.9 tp -80.19 133.65 56.98 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.3 170.51 20.18 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.612 2.208 . . . . 0.0 109.222 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -56.18 134.78 66.31 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.71 1.607 . . . . 0.0 109.632 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.07 -13.64 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.047 0.832 . . . . 0.0 113.901 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.06 27.89 71.21 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.264 1.532 . . . . 0.0 114.004 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 156.11 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.299 1.44 . . . . 0.0 107.597 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.62 117.88 51.84 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.97 -18.33 60.79 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.146 1.231 . . . . 0.0 113.246 171.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -81.69 -46.1 14.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.026 -1.046 . . . . 0.0 109.4 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.0 p -136.1 -1.5 2.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.66 0.784 . . . . 0.0 113.059 -159.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.15 -11.49 16.04 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.64 1.59 . . . . 0.0 114.624 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.2 m -75.7 163.91 26.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.483 1.142 . . . . 0.0 113.246 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -68.74 148.01 50.97 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.011 -1.055 . . . . 0.0 111.511 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 t -108.39 148.66 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.86 161.46 42.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.335 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.0 151.71 23.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.708 . . . . 0.0 110.595 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.97 153.39 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 124.336 1.054 . . . . 0.0 110.925 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.32 103.13 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.969 2.446 . . . . 0.0 111.239 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 59.05 174.2 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.504 2.722 . . . . 0.0 111.519 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -56.3 -27.8 56.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.571 1.148 . . . . 0.0 112.052 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 129.941 3.296 . . . . 0.0 110.982 -173.419 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.97 98.96 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.287 0.949 . . . . 0.0 109.138 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -135.01 -24.38 1.46 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 111.887 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -95.66 21.97 7.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 109.594 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.52 167.09 23.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.028 1.731 . . . . 0.0 107.992 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -122.1 -166.8 1.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.274 1.43 . . . . 0.0 109.693 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.01 155.56 8.02 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.93 0.332 . . . . 0.0 111.5 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -48.63 118.07 2.34 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.547 1.939 . . . . 0.0 109.03 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 tp -140.79 139.2 34.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.713 2.005 . . . . 0.0 107.667 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.7 153.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -135.58 145.65 47.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.219 1.808 . . . . 0.0 107.567 -167.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -110.0 166.48 10.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.507 . . . . 0.0 111.743 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -46.21 -46.78 17.78 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.247 1.819 . . . . 0.0 109.414 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.489 ' HB3' HD11 ' A' ' 117' ' ' LEU . 73.7 m -50.25 -34.94 24.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.617 1.167 . . . . 0.0 113.829 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 t -65.36 -43.79 94.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.209 0.913 . . . . 0.0 108.975 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.36 -36.59 71.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.964 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.51 -38.91 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.035 0.934 . . . . 0.0 110.667 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -83.2 -23.26 32.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.905 . . . . 0.0 112.825 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.23 24.04 27.83 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.88 0.764 . . . . 0.0 112.486 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -77.28 106.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.11 103.93 1.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.858 1.263 . . . . 0.0 108.467 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 tp -151.86 130.09 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -73.75 136.51 43.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.757 1.623 . . . . 0.0 110.815 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.26 -161.61 34.17 Favored Glycine 0 CA--C 1.521 0.453 0 O-C-N 120.721 -1.237 . . . . 0.0 112.101 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.28 151.24 42.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.481 0.712 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -142.89 152.5 42.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.565 1.146 . . . . 0.0 110.162 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.9 p -84.32 126.43 69.47 Favored Pre-proline 0 C--O 1.249 1.055 0 C-N-CA 123.192 0.597 . . . . 0.0 111.037 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -59.01 -30.16 92.63 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 120.409 0.739 . . . . 0.0 111.093 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 m -61.82 -43.95 97.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.697 1.135 . . . . 0.0 113.56 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.89 -38.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 43' ' ' LEU . 4.5 p -64.09 -26.54 40.73 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.123 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.37 -28.73 69.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.995 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -89.64 -22.89 22.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 111.401 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.11 133.47 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.531 1.158 . . . . 0.0 108.471 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -3.2 0.61 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.878 1.671 . . . . 0.0 112.098 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -70.56 120.35 16.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.9 mtm-85 -66.19 -40.5 90.48 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.552 -170.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.45 -57.01 14.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.0 t -52.37 -54.66 28.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.385 1.474 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -58.65 -57.84 11.21 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.068 0.947 . . . . 0.0 111.37 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.6 -49.38 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 43.8 t80 -59.48 -44.54 93.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.726 0.694 . . . . 0.0 112.493 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.511 HD13 HG23 ' A' ' 31' ' ' VAL . 5.2 tt -58.38 -56.12 26.21 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.327 1.051 . . . . 0.0 108.81 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.51 -40.68 87.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.511 0.725 . . . . 0.0 109.868 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -53.06 -48.41 67.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.161 1.384 . . . . 0.0 110.45 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.515 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 12.6 mt -62.81 -42.45 99.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.83 0.741 . . . . 0.0 111.424 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.37 -46.52 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 t -58.63 -44.48 90.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 109.991 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.14 99.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.353 1.461 . . . . 0.0 110.015 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.18 2.25 7.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.643 1.116 . . . . 0.0 113.887 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.1 -37.38 17.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 117.894 0.847 . . . . 0.0 109.932 -164.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -120.08 153.6 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -140.66 141.06 35.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.617 0.767 . . . . 0.0 110.643 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.39 134.07 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.52 126.59 9.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.501 1.12 . . . . 0.0 109.225 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 151.08 48.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.069 0.948 . . . . 0.0 111.335 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.89 -175.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.572 3.514 . . . . 0.0 110.548 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -125.63 161.43 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.448 2.299 . . . . 0.0 108.241 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -58.99 -40.42 84.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.299 -0.875 . . . . 0.0 110.436 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.21 -33.67 71.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.4 p -75.51 -35.49 60.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.265 0.939 . . . . 0.0 109.862 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.07 -50.11 80.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.44 -37.01 72.13 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.774 0.43 . . . . 0.0 111.059 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -42.67 65.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 111.026 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.0 mm -67.08 -48.6 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.05 -39.34 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.877 0.871 . . . . 0.0 110.28 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -54.8 -63.49 1.14 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.836 0.854 . . . . 0.0 109.974 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.89 -30.9 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -67.04 -47.18 72.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.42 -0.8 . . . . 0.0 110.791 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.18 67.54 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 120.817 -1.177 . . . . 0.0 110.659 173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -72.26 0.81 8.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.372 1.069 . . . . 0.0 112.514 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.272 2.9 t -121.05 -49.6 2.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.868 1.213 . . . . 0.0 109.51 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.3 -58.0 0.29 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.132 0.878 . . . . 0.0 112.499 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -69.62 39.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.399 2.68 . . . . 0.0 114.686 -171.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 10.7 p -39.77 -49.46 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.127 2.171 . . . . 0.0 115.062 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.8 28.19 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.176 0.99 . . . . 0.0 108.655 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.1 -28.35 63.24 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.632 -1.292 . . . . 0.0 110.4 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 160.26 30.75 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 t -66.51 154.56 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 109.974 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 13.8 ttpt -63.49 -51.49 65.36 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.771 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.27 -45.55 45.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.227 0.954 . . . . 0.0 109.439 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.17 -54.04 51.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.437 0.695 . . . . 0.0 111.447 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.17 -41.36 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.495 1.118 . . . . 0.0 109.645 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.44 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 47.5 mt-10 -65.5 -44.9 85.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.394 1.078 . . . . 0.0 111.548 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.1 -48.41 83.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 119.1 0.863 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.633 HD23 HD13 ' A' ' 96' ' ' ILE . 42.0 mt -60.99 -48.97 79.38 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.558 0.743 . . . . 0.0 109.756 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.31 -57.79 6.23 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.948 1.299 . . . . 0.0 110.917 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.8 tp -47.62 -52.35 18.22 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.474 0.71 . . . . 0.0 110.36 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.58 70.8 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.9 m-30 -80.81 -29.55 35.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.505 0.593 . . . . 0.0 111.131 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.31 -42.68 91.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.877 0.846 . . . . 0.0 109.217 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.95 -14.52 44.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 112.894 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 43.2 55.36 4.67 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.328 1.451 . . . . 0.0 110.394 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -135.61 8.8 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 121.856 0.698 . . . . 0.0 111.465 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -129.47 170.19 14.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.633 HD13 HD23 ' A' ' 86' ' ' LEU . 74.3 mt -131.52 156.03 42.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.64 118.39 18.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.035 1.334 . . . . 0.0 108.256 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 6.8 t -166.37 -170.08 1.57 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.646 1.578 . . . . 0.0 108.997 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -150.62 10.85 0.66 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 161.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -53.39 150.83 6.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.368 1.467 . . . . 0.0 114.727 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -63.19 -30.78 71.86 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.473 -1.392 . . . . 0.0 112.263 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -80.15 -56.12 4.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.751 1.62 . . . . 0.0 110.215 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 1.8 p -52.69 -41.29 37.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 119.92 1.236 . . . . 0.0 112.664 -169.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -64.66 -46.69 81.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.4 t-20 -64.08 -52.81 57.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 117.425 -1.274 . . . . 0.0 107.784 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.5 mm -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 119.604 1.093 . . . . 0.0 110.328 -175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.55 68.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.668 1.122 . . . . 0.0 112.153 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.18 -39.12 78.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.957 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -64.27 -44.55 91.39 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 122.437 2.38 . . . . 0.0 107.721 170.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -69.02 -29.12 67.23 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -167.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.53 18.65 37.67 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 117.999 -1.445 . . . . 0.0 112.766 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.01 127.82 38.66 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.02 1.41 . . . . 0.0 110.627 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 128.93 38.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.284 1.833 . . . . 0.0 109.585 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.86 179.62 6.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.626 0.77 . . . . 0.0 111.092 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -123.37 133.09 54.15 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.422 1.489 . . . . 0.0 108.834 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 p -82.89 146.66 28.74 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.62 1.168 . . . . 0.0 108.775 170.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 14' ' ' SER . 70.3 mt -54.83 -59.11 5.17 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.781 1.232 . . . . 0.0 111.181 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 22.25 -110.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.578 2.751 . . . . 0.0 113.637 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.4 7.04 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 114.058 -166.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.76 -95.18 1.79 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 120.209 -1.557 . . . . 0.0 110.747 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.4 mt -143.67 156.07 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 127.29 2.236 . . . . 0.0 107.391 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 -30.11 2.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -165.5 37.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.119 1.368 . . . . 0.0 108.959 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.82 90.52 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 125' ' ' ILE . 3.3 mp -56.28 144.62 7.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -44.62 107.49 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.138 1.775 . . . . 0.0 109.938 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -75.25 151.53 38.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -147.43 0.49 0.69 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.336 -1.316 . . . . 0.0 113.952 -158.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -142.33 135.39 28.63 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.937 0.789 . . . . 0.0 108.984 -170.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.53 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.082 0.953 . . . . 0.0 108.66 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.6 127.89 33.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.736 0.814 . . . . 0.0 108.813 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.14 -9.67 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.62 -15.14 27.88 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.938 -0.923 . . . . 0.0 113.826 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 13.8 p -147.24 2.66 0.77 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.59 1.195 . . . . 0.0 113.075 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.88 64.57 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.702 1.62 . . . . 0.0 115.039 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 54.1 ttt-85 -72.08 145.81 47.97 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 117.681 0.741 . . . . 0.0 110.464 -167.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -93.54 145.62 24.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.647 -169.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -141.85 148.82 39.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.989 1.316 . . . . 0.0 108.223 170.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 p -98.74 -15.3 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.523 -0.736 . . . . 0.0 111.739 168.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.5 p -137.6 152.53 49.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.708 1.203 . . . . 0.0 108.601 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -64.75 120.05 62.86 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 113.475 -1.693 . . . . 0.0 106.717 174.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 141' ' ' LEU . 92.0 Cg_endo -69.69 169.09 19.65 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.023 2.482 . . . . 0.0 109.121 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -55.5 134.21 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.656 1.571 . . . . 0.0 109.599 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.84 -10.61 8.77 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.515 -1.158 . . . . 0.0 114.226 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.01 38.22 93.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.969 1.885 . . . . 0.0 112.624 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.01 163.09 32.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.538 1.135 . . . . 0.0 109.28 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 3.9 t -72.99 113.32 20.6 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 110.179 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 36.4 Cg_endo -62.68 -12.35 28.11 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.775 0.955 . . . . 0.0 111.86 163.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.27 -22.65 18.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.334 1.454 . . . . 0.0 111.895 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.4 p -156.17 5.31 0.18 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.07 -11.04 2.15 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.714 2.102 . . . . 0.0 116.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 168.61 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.312 1.556 . . . . 0.0 112.41 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -77.98 144.96 36.31 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 t -94.3 158.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -140.47 167.31 22.46 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.013 -1.679 . . . . 0.0 109.123 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.14 154.46 26.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.239 1.016 . . . . 0.0 109.673 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 pt -121.85 155.38 60.52 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.21 1.404 . . . . 0.0 112.42 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.85 102.99 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.665 1 C-N-CA 125.434 4.089 . . . . 0.0 112.664 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 61.03 -71.29 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.21 2.204 . . . . 0.0 112.196 -173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -46.43 0.08 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.429 1.092 . . . . 0.0 111.88 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.894 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.2 mt -130.66 139.33 50.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.488 1.494 . . . . 0.0 110.697 -167.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.2 mtm-85 -142.32 100.55 3.73 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.05 1.74 . . . . 0.0 107.969 -165.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -135.19 -178.13 4.96 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.623 1.169 . . . . 0.0 107.899 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.66 177.94 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.012 1.725 . . . . 0.0 110.683 -171.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -103.9 -178.08 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.08 -1.012 . . . . 0.0 109.551 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.3 156.48 4.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.26 1.024 . . . . 0.0 110.235 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -48.24 128.34 14.07 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.261 1.824 . . . . 0.0 110.808 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -153.62 144.71 22.88 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.677 0.791 . . . . 0.0 110.212 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.36 147.53 30.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.557 0.743 . . . . 0.0 110.012 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 HD21 ' A' ' 9' ' ' LEU . 1.3 mm? -122.75 129.48 51.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.593 1.957 . . . . 0.0 109.682 -174.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -84.23 165.35 18.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.601 0.76 . . . . 0.0 109.134 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 30' ' ' VAL . 26.2 t -46.63 -45.26 18.97 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.393 1.877 . . . . 0.0 110.265 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -49.86 -34.23 19.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.781 1.632 . . . . 0.0 111.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.5 -39.59 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.441 1.096 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.14 -24.93 47.19 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.2 1.0 . . . . 0.0 111.238 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.57 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.679 0.791 . . . . 0.0 109.075 171.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.79 -23.7 36.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.745 0.702 . . . . 0.0 112.389 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.19 18.88 52.4 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.433 1.016 . . . . 0.0 113.167 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.44 112.89 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.045 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -62.49 106.63 0.79 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 109.133 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 tp -155.08 149.22 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' HD22 ' A' ' 9' ' ' LEU . 5.8 pt-20 -111.45 120.61 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.066 1.346 . . . . 0.0 109.316 -166.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.09 -161.08 29.38 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.339 0.972 . . . . 0.0 113.57 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.2 150.04 21.34 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.4 -0.471 . . . . 0.0 112.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -132.38 147.91 52.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.12 2.168 . . . . 0.0 108.514 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 115.98 62.39 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 126.554 1.941 . . . . 0.0 107.632 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.83 -33.85 72.86 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.454 1.436 . . . . 0.0 110.273 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.23 -36.37 41.4 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.905 3.282 . . . . 0.0 114.432 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 13' ' ' SER . 14.8 p -98.75 -32.09 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.264 0.938 . . . . 0.0 110.572 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.78 -32.71 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.968 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -28.61 10.01 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -89.85 -23.39 21.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 117.745 -1.121 . . . . 0.0 111.508 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.264 5.5 mt -62.7 85.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.655 1.582 . . . . 0.0 110.113 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.33 -11.5 57.61 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 129.115 2.966 . . . . 0.0 110.966 174.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 124.2 26.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -45.42 70.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.671 -0.643 . . . . 0.0 110.332 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.27 -48.99 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.296 1.038 . . . . 0.0 108.39 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -68.76 -49.82 55.57 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.79 0.836 . . . . 0.0 111.842 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -59.97 -55.63 31.71 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.834 0.454 . . . . 0.0 110.51 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.2 mt -55.05 -49.16 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -55.47 -57.8 10.42 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 111.613 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tp -51.26 -52.85 41.09 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.118 1.767 . . . . 0.0 110.844 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.5 -37.44 87.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.648 0.779 . . . . 0.0 110.044 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 m -62.82 -43.02 99.9 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.727 0.694 . . . . 0.0 110.198 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -39.42 86.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.42 -44.9 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.327 -0.858 . . . . 0.0 108.717 170.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 t -64.5 -3.74 3.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 112.891 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.58 3.03 13.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.974 1.709 . . . . 0.0 111.566 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.03 87.2 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.827 1.68 . . . . 0.0 112.878 173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -86.11 -28.41 24.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.891 0.846 . . . . 0.0 111.442 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.64 142.4 35.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 14.2 ttmm -143.95 145.25 32.12 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 112.252 -168.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.9 120.48 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.007 1.323 . . . . 0.0 109.482 -168.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.31 128.88 12.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.432 1.493 . . . . 0.0 110.171 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.07 157.0 35.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.967 1.307 . . . . 0.0 112.322 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.95 157.21 62.82 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.789 2.993 . . . . 0.0 113.332 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -84.68 162.06 19.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.347 165.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -51.28 -42.9 61.43 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.365 1.066 . . . . 0.0 111.806 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.46 -27.06 68.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.548 0.739 . . . . 0.0 110.736 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -72.11 -47.53 50.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.168 1.387 . . . . 0.0 110.121 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 mm -58.97 -47.33 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.54 -41.19 53.57 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.043 1.337 . . . . 0.0 110.72 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -48.24 74.52 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.963 1.305 . . . . 0.0 110.182 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -64.73 -48.56 84.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.2 mt -48.86 -45.38 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.427 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.59 -59.14 5.91 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.476 0.71 . . . . 0.0 110.502 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.08 -31.25 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.41 -53.29 20.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.16 1.384 . . . . 0.0 110.897 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -30.02 70.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -66.92 -20.46 65.91 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.393 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 t -124.41 8.58 8.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.709 1.595 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.99 -85.36 0.34 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.996 -1.065 . . . . 0.0 112.286 164.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.62 92.48 0.33 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.335 1.054 . . . . 0.0 108.756 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.57 -49.02 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 121.717 -0.615 . . . . 0.0 111.528 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -132.72 17.73 4.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.826 0.85 . . . . 0.0 110.157 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -12.51 61.21 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 120.867 0.365 . . . . 0.0 110.378 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.0 mp -87.29 149.63 24.42 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.392 1.477 . . . . 0.0 108.058 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 m -67.65 161.37 25.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.098 0.559 . . . . 0.0 110.913 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -57.69 -58.46 8.24 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 122.764 0.426 . . . . 0.0 109.99 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.77 -39.46 65.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.671 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -58.66 7.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.86 2.064 . . . . 0.0 109.091 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.15 -44.6 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 126.093 1.757 . . . . 0.0 108.69 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -62.18 -44.9 95.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.108 0.963 . . . . 0.0 111.144 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.08 -53.49 47.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.384 0.538 . . . . 0.0 109.87 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD23 HD13 ' A' ' 96' ' ' ILE . 20.9 mt -58.95 -51.69 68.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.284 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.26 -56.56 7.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.359 1.464 . . . . 0.0 112.511 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -46.11 81.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.5 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.564 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.5 m-30 -66.67 -22.12 66.09 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.047 1.294 . . . . 0.0 112.817 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.55 -47.06 74.02 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.93 -20.1 46.47 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 53.9 30.17 11.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.171 1.788 . . . . 0.0 113.49 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.01 -116.35 0.66 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 125.461 1.505 . . . . 0.0 112.427 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -153.9 159.19 41.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.994 1.718 . . . . 0.0 106.996 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.611 HD13 HD23 ' A' ' 86' ' ' LEU . 69.8 mt -126.92 150.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.34 120.62 27.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 t -160.16 -166.16 1.63 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.514 1.925 . . . . 0.0 108.61 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.78 11.32 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.124 1.37 . . . . 0.0 114.008 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -104.71 151.27 23.93 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.045 -2.284 . . . . 0.0 113.437 -161.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -56.93 -47.14 81.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.447 -1.408 . . . . 0.0 110.914 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -71.52 -52.22 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.523 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -54.71 -41.41 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.32 0.509 . . . . 0.0 110.239 -173.04 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.68 -44.39 77.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.068 0.947 . . . . 0.0 109.832 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -61.99 -56.41 19.41 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -48.85 -55.9 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.545 1.138 . . . . 0.0 110.117 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.64 -34.8 65.26 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.598 1.544 . . . . 0.0 113.689 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 t -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.832 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -60.7 -36.73 79.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.424 1.011 . . . . 0.0 109.938 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.2 mm? -72.25 -14.56 61.81 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.626 0.37 . . . . 0.0 111.074 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.49 2.63 84.85 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.864 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -85.4 133.02 34.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.578 1.189 . . . . 0.0 109.68 -168.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.401 ' N ' HD13 ' A' ' 112' ' ' LEU . 22.1 ttt180 -68.07 136.24 53.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.932 0.893 . . . . 0.0 110.616 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.75 168.04 28.62 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.749 -0.594 . . . . 0.0 111.454 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -99.06 163.43 12.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.605 1.162 . . . . 0.0 111.641 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 130.05 21.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.95 166.77 22.89 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.601 0.715 . . . . 0.0 110.367 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt 60.99 -177.0 0.11 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.365 1.866 . . . . 0.0 111.221 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.39 169.95 16.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.261 -0.899 . . . . 0.0 110.569 170.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.08 -163.64 50.86 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.1 -6.83 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 52.88 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.012 2.125 . . . . 0.0 112.616 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -121.93 -6.46 9.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.242 1.383 . . . . 0.0 113.227 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.6 t -69.93 163.04 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.4 mt -99.53 172.53 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -56.35 160.75 2.9 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 120.593 -1.317 . . . . 0.0 110.479 158.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.436 ' CH2' HD13 ' A' ' 157' ' ' ILE . 16.0 p-90 -129.11 155.57 45.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -153.62 8.68 0.39 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 118.393 -0.813 . . . . 0.0 112.923 -153.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -151.06 151.03 31.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.087 0.858 . . . . 0.0 110.508 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.63 139.08 49.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.211 1.404 . . . . 0.0 109.995 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 126.08 28.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.196 0.998 . . . . 0.0 108.56 159.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.67 121.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.08 4.29 Favored Glycine 0 N--CA 1.464 0.502 0 C-N-CA 123.905 0.764 . . . . 0.0 112.962 161.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.51 9.48 2.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.751 1.62 . . . . 0.0 111.817 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.31 14.56 57.16 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 126.955 2.217 . . . . 0.0 115.892 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -68.82 127.39 32.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.972 0.886 . . . . 0.0 108.892 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -71.04 146.46 49.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.973 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -139.35 154.77 47.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -103.38 -20.66 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.331 0.653 . . . . 0.0 111.695 176.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 59.0 p -136.04 155.24 50.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.33 127.92 77.24 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.06 171.17 14.16 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.99 2.46 . . . . 0.0 111.49 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.8 148.22 57.15 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.339 2.026 . . . . 0.0 109.721 163.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.16 -22.81 0.2 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.483 1.992 . . . . 0.0 113.532 -165.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.92 38.28 96.32 Favored Glycine 0 C--N 1.335 0.528 0 O-C-N 120.982 -1.305 . . . . 0.0 110.159 -158.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.01 154.41 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.595 0.758 . . . . 0.0 110.075 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 49.4 t -74.97 110.92 11.24 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 125.365 1.466 . . . . 0.0 110.877 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 20.0 Cg_endo -60.72 -2.71 2.22 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.424 2.082 . . . . 0.0 115.543 171.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -105.6 -26.35 11.89 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.018 0.927 . . . . 0.0 113.231 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -142.15 -12.82 0.83 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.09 65.7 2.66 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.973 1.273 . . . . 0.0 112.146 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.07 173.82 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.002 1.721 . . . . 0.0 108.495 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -64.45 142.48 58.4 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.172 0.989 . . . . 0.0 111.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.37 145.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.192 1.397 . . . . 0.0 107.428 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.15 158.74 43.74 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 112.209 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.69 111.26 6.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 110.392 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.436 HD13 ' CH2' ' A' ' 127' ' ' TRP . 1.1 pt -71.07 163.59 64.08 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 125.827 1.651 . . . . 0.0 112.365 164.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.93 123.67 10.62 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.093 1.862 . . . . 0.0 109.938 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 36.51 -99.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 128.374 2.67 . . . . 0.0 112.483 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 -34.43 0.77 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.041 1.336 . . . . 0.0 112.831 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -176.579 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.92 165.48 26.41 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 111.08 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.01 -38.16 0.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.303 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -142.27 -42.4 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.942 166.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt 40.77 74.38 0.1 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.901 2.08 . . . . 0.0 111.153 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 156.26 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 176.39 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -45.51 127.89 7.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.028 0.931 . . . . 0.0 111.598 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 tp -153.72 147.36 25.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.194 1.798 . . . . 0.0 107.454 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -122.08 150.75 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.46 139.26 53.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.969 1.708 . . . . 0.0 108.377 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -91.33 158.84 16.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.095 0.958 . . . . 0.0 111.64 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -29.36 -57.85 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.397 2.279 . . . . 0.0 113.219 163.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.7 p -60.11 -28.95 68.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.136 1.774 . . . . 0.0 112.52 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.68 -42.08 94.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -69.91 -34.77 73.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.413 0.685 . . . . 0.0 111.211 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.7 mt -57.09 -47.58 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 110.14 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.98 -24.9 52.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.883 0.765 . . . . 0.0 111.922 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 31.62 13.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 123.289 0.471 . . . . 0.0 112.068 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -76.86 102.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.46 115.2 1.98 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 tp -161.88 170.84 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.552 1.941 . . . . 0.0 106.412 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.83 152.33 48.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 0.0 109.002 -158.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.0 -130.8 3.72 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -168.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.23 152.33 48.21 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.367 1.067 . . . . 0.0 111.003 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -128.66 143.12 50.88 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.556 1.542 . . . . 0.0 107.664 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.55 117.33 67.9 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.79 1.636 . . . . 0.0 108.198 -167.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 31' ' ' VAL . 23.7 Cg_endo -60.81 -32.04 92.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.261 1.974 . . . . 0.0 111.185 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.2 m -68.49 -19.58 64.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.118 -0.989 . . . . 0.0 113.14 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.516 HG22 ' HB1' ' A' ' 81' ' ' ALA . 20.6 t -83.84 -51.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.036 0.935 . . . . 0.0 108.522 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.1 p -59.08 -28.03 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-N 118.822 0.737 . . . . 0.0 111.197 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -66.58 -14.81 62.85 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.81 -28.83 12.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.298 0.954 . . . . 0.0 111.734 169.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -53.88 128.23 13.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 -27.1 2.26 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 126.628 1.971 . . . . 0.0 110.55 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.31 124.94 24.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -75.33 -30.7 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.797 -1.097 . . . . 0.0 112.08 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -60.74 -37.16 80.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.184 1.356 . . . . 0.0 110.481 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -69.99 -58.98 3.2 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.439 0.695 . . . . 0.0 109.685 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -58.27 -55.43 35.04 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.785 0.834 . . . . 0.0 111.879 -170.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.9 mt -54.01 -52.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.039 0.936 . . . . 0.0 108.632 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 59.6 t80 -55.27 -52.68 62.64 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.584 0.754 . . . . 0.0 110.652 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 tt -51.42 -56.87 10.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.878 1.671 . . . . 0.0 110.409 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.14 -36.24 81.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.473 0.709 . . . . 0.0 111.421 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 m -64.27 -42.6 96.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.476 1.11 . . . . 0.0 109.843 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 9.7 mt -65.22 -43.14 92.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.371 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.54 -52.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m -63.61 -25.32 68.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.301 0.64 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.6 -2.6 58.36 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.157 1.783 . . . . 0.0 113.649 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.93 26.16 60.87 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 118.445 0.566 . . . . 0.0 112.111 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -89.95 -52.7 4.83 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.86 162.37 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 C-N-CA 124.676 1.191 . . . . 0.0 108.708 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -133.4 156.29 47.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mm -69.65 133.93 31.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 118.935 0.789 . . . . 0.0 108.949 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.41 128.15 6.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.86 0.464 . . . . 0.0 110.692 162.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.7 156.15 45.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.431 0.692 . . . . 0.0 110.428 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.11 168.2 16.31 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.868 3.046 . . . . 0.0 111.645 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t -86.84 163.26 17.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 164.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -50.42 -45.58 55.8 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.03 0.932 . . . . 0.0 111.53 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.35 -18.8 63.83 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -40.84 35.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.797 0.839 . . . . 0.0 110.593 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.24 -49.71 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -56.4 -32.13 64.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.103 0.961 . . . . 0.0 111.392 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -50.93 71.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.591 1.156 . . . . 0.0 110.181 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.74 -42.2 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.23 -41.4 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.584 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -65.17 -50.93 64.06 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.107 1.321 . . . . 0.0 110.926 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 109' ' ' LEU . 2.4 t -75.85 -34.19 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.81 -50.48 73.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.538 1.135 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.6 71.66 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.654 -1.279 . . . . 0.0 110.755 174.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.67 -32.98 74.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.255 0.934 . . . . 0.0 109.873 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 t -93.16 -16.72 24.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 -78.3 0.38 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.69 86.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.965 1.306 . . . . 0.0 110.727 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -75.63 -41.69 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 120.824 -1.173 . . . . 0.0 112.297 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -135.6 20.41 3.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.221 1.408 . . . . 0.0 109.192 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -70.83 -19.36 62.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.9 -1.125 . . . . 0.0 110.699 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -83.03 153.24 25.03 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.052 0.941 . . . . 0.0 110.115 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -58.88 147.94 32.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 111.305 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 27.2 ttpt -55.67 -53.0 61.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.808 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -61.33 -34.95 76.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 124.137 0.898 . . . . 0.0 110.212 -172.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -55.23 31.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.34 1.056 . . . . 0.0 109.06 176.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -52.44 -45.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.968 0.907 . . . . 0.0 108.938 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 61.9 mt-10 -64.6 -46.21 83.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 0.0 112.23 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.09 -54.69 31.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.559 1.143 . . . . 0.0 109.496 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.409 HD23 HD13 ' A' ' 96' ' ' ILE . 26.7 mt -57.66 -47.51 82.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.945 0.898 . . . . 0.0 109.258 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.75 -56.13 17.8 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.175 1.39 . . . . 0.0 111.955 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.32 -48.41 74.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.779 0.675 . . . . 0.0 109.737 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -60.93 -21.88 63.85 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.54 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.44 -22.99 21.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 117.81 -1.09 . . . . 0.0 111.858 175.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.24 -41.93 97.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.714 1.143 . . . . 0.0 109.78 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -109.99 10.66 24.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.303 1.041 . . . . 0.0 111.0 -171.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 45.66 49.73 11.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.255 1.822 . . . . 0.0 110.107 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.83 -123.74 4.77 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 124.35 0.976 . . . . 0.0 111.178 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -144.7 168.15 20.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.586 1.954 . . . . 0.0 106.893 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.409 HD13 HD23 ' A' ' 86' ' ' LEU . 30.9 mt -134.16 157.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -136.8 107.07 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 108.437 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 t -166.12 172.25 11.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.274 1.43 . . . . 0.0 109.582 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -145.27 4.34 1.06 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -57.11 158.21 5.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.867 1.667 . . . . 0.0 112.821 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -61.67 -45.04 95.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.424 -1.423 . . . . 0.0 110.825 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.524 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.05 -39.27 81.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 119.058 0.845 . . . . 0.0 110.787 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.29 -47.86 72.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 109' ' ' LEU . 44.3 t30 -60.07 -58.25 9.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.934 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.05 -54.52 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.15 65.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.349 1.431 . . . . 0.0 113.129 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -52.15 58.47 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.212 1.405 . . . . 0.0 112.403 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -68.34 -21.7 64.72 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.722 1.601 . . . . 0.0 111.893 178.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -83.56 -10.63 58.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.752 1.221 . . . . 0.0 112.366 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.81 8.11 84.27 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.326 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.43 143.78 34.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.776 1.788 . . . . 0.0 109.779 -175.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.25 136.84 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.956 1.302 . . . . 0.0 108.371 174.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -146.6 -172.19 3.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.38 161.02 25.55 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.089 1.355 . . . . 0.0 110.392 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 p -137.86 151.77 48.39 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.447 1.099 . . . . 0.0 108.862 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.4 mp -76.89 138.51 39.79 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.256 1.422 . . . . 0.0 108.842 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 24.92 70.13 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.311 2.644 . . . . 0.0 112.025 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 175.8 8.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.276 -0.89 . . . . 0.0 111.969 -165.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.31 -81.11 1.5 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 124' ' ' VAL . 3.2 pt -127.71 17.27 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.895 0.878 . . . . 0.0 112.513 -171.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 42.54 0.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.956 2.102 . . . . 0.0 112.791 -175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 46.06 78.15 0.07 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.071 1.748 . . . . 0.0 111.524 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 121' ' ' ILE . 1.9 p -139.2 38.38 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.02 121.13 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -68.95 120.53 14.97 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -74.89 150.73 39.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.44 0.296 . . . . 0.0 110.559 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -148.25 17.55 1.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.068 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.95 141.12 47.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 120.339 1.427 . . . . 0.0 110.236 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.39 134.24 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.917 1.287 . . . . 0.0 108.506 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.78 118.45 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.69 124.14 27.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.74 -86.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.4 p -74.2 -18.44 60.76 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.755 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.14 62.38 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 123.416 0.531 . . . . 0.0 112.775 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -74.27 145.35 44.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.511 1.124 . . . . 0.0 110.079 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -90.12 145.62 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 109.176 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.7 149.27 43.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.704 0.802 . . . . 0.0 108.843 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 p -97.29 -13.25 22.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.988 0.915 . . . . 0.0 111.997 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 18.4 p -146.11 165.35 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.757 1.623 . . . . 0.0 107.523 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp -77.34 128.7 79.73 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.12 169.96 16.9 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.528 2.152 . . . . 0.0 111.108 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.62 127.34 20.46 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.696 2.264 . . . . 0.0 109.876 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.42 -8.19 42.18 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.707 0.67 . . . . 0.0 113.395 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.01 54.21 32.63 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.461 1.131 . . . . 0.0 112.045 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.08 160.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.56 114.9 14.74 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.8 -14.16 41.34 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 119.739 0.942 . . . . 0.0 112.435 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.09 -12.4 17.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.79 2.036 . . . . 0.0 112.683 -168.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.5 p -156.19 3.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.82 -16.5 5.26 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.637 1.589 . . . . 0.0 114.745 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.2 m -69.88 161.18 30.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 118.686 1.243 . . . . 0.0 112.701 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -68.35 144.18 54.88 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.69 -1.256 . . . . 0.0 110.01 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.56 143.74 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.08 154.83 51.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.68 1.127 . . . . 0.0 111.052 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.46 134.75 48.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.271 1.028 . . . . 0.0 108.959 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -101.5 159.08 30.48 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 124.268 1.027 . . . . 0.0 109.638 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.72 62.8 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.366 2.711 . . . . 0.0 110.937 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 64.77 176.35 0.19 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.43 1.892 . . . . 0.0 112.14 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -75.44 -55.16 5.96 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.24 -1.838 . . . . 0.0 106.428 178.788 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.86 -64.44 0.94 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 63.02 -44.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.159 2.584 . . . . 0.0 112.008 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -69.53 -161.69 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.462 2.705 . . . . 0.0 109.349 161.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.28 81.65 0.03 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.962 2.505 . . . . 0.0 113.185 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 7' ' ' LYS . 6.6 ptmt -62.59 -172.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 122.233 1.016 . . . . 0.0 110.904 168.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' O ' ' HE2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -55.86 167.18 0.61 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 176.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -54.96 122.94 11.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.793 1.237 . . . . 0.0 109.777 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.649 HD21 HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.74 147.89 36.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.394 1.478 . . . . 0.0 107.499 -177.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.77 152.88 29.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.727 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.649 HD11 HD21 ' A' ' 9' ' ' LEU . 1.6 mm? -125.27 150.59 46.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.552 1.941 . . . . 0.0 108.907 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.62 174.5 5.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.9 p -49.57 -43.81 46.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.652 1.181 . . . . 0.0 113.424 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 t -57.25 -39.3 75.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.757 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 t -54.4 -43.93 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.246 1.018 . . . . 0.0 110.138 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -76.78 -25.92 53.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.219 0.608 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.12 -39.36 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.93 0.786 . . . . 0.0 110.639 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -78.08 -17.85 56.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.524 -0.735 . . . . 0.0 112.105 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.25 63.8 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 123.392 0.52 . . . . 0.0 113.381 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.39 106.87 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.08 118.32 8.99 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -157.8 164.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 0.0 107.569 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -137.1 119.3 15.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 111.077 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -179.73 -146.16 6.73 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.818 2.627 . . . . 0.0 112.29 -166.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.27 152.06 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.182 1.393 . . . . 0.0 111.69 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 t -121.65 168.32 11.91 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.453 1.901 . . . . 0.0 109.701 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.62 113.96 60.99 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 126.535 1.934 . . . . 0.0 108.048 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -55.57 -35.91 93.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.756 2.304 . . . . 0.0 112.7 -172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.2 m -71.54 -16.97 62.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.788 1.235 . . . . 0.0 113.146 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.6 -51.61 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.66 -37.42 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.563 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.38 -22.01 66.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.549 1.068 . . . . 0.0 111.805 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -94.47 -10.9 30.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.433 1.47 . . . . 0.0 111.93 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 43' ' ' LEU . 2.7 mt -63.46 116.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 -11.06 5.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.128 0.971 . . . . 0.0 113.073 -166.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.78 130.64 37.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -67.29 -35.5 79.61 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.969 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.74 -52.53 62.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.09 1.356 . . . . 0.0 108.685 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.3 -50.84 70.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.983 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -58.58 -52.62 64.88 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.468 1.107 . . . . 0.0 111.91 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.3 -52.05 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.527 1.531 . . . . 0.0 109.145 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -64.06 -42.77 96.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.237 0.542 . . . . 0.0 111.476 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' CD1' HD12 ' A' ' 34' ' ' ILE . 7.6 tt -59.27 -48.65 80.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.94 -1.1 . . . . 0.0 110.663 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.8 -32.55 72.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.629 0.772 . . . . 0.0 110.285 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.8 t -50.45 -54.55 21.21 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.93 0.892 . . . . 0.0 108.876 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.65 -31.89 70.24 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.17 -53.47 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.6 t -57.74 -38.2 74.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.312 1.045 . . . . 0.0 111.94 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.52 3.72 17.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 113.063 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.12 21.25 78.47 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.903 -0.943 . . . . 0.0 111.833 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -107.96 -29.82 8.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.155 -175.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.5 96.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.553 1.524 . . . . 0.0 108.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -73.16 155.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.9 mm -82.91 147.84 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.64 125.02 0.58 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.747 2.019 . . . . 0.0 109.795 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 158.64 36.05 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 119.497 1.044 . . . . 0.0 112.518 171.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.72 157.51 61.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 124.915 3.743 . . . . 0.0 111.924 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.21 160.72 31.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.907 0.861 . . . . 0.0 110.391 158.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -44.89 79.0 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 109.697 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -61.54 -32.74 72.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.752 0.705 . . . . 0.0 111.119 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.4 m -66.74 -45.02 79.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 109.653 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.7 mm -58.81 -48.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.91 -33.16 70.24 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.018 -0.426 . . . . 0.0 111.208 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -46.41 80.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.2 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -62.41 -46.51 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.459 HG23 ' CG2' ' A' ' 75' ' ' VAL . 74.5 mt -54.82 -36.5 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.088 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -66.51 -43.79 84.31 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.278 1.854 . . . . 0.0 111.868 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 109' ' ' LEU . 2.0 t -82.51 -37.28 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.21 99.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.29 1.036 . . . . 0.0 110.664 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -31.67 66.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.322 0.964 . . . . 0.0 112.034 174.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.06 -43.91 98.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.074 0.852 . . . . 0.0 109.938 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -80.43 -51.6 8.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.811 0.732 . . . . 0.0 111.117 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.54 -73.54 0.13 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 120.44 1.473 . . . . 0.0 114.305 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -70.54 91.47 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.596 0.698 . . . . 0.0 109.364 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 66' ' ' ILE . 5.5 p -74.65 -54.71 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -118.84 18.36 13.31 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.538 0.608 . . . . 0.0 111.116 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -68.94 -31.48 70.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -78.2 157.86 29.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.037 0.535 . . . . 0.0 110.04 -172.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -65.5 153.82 40.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.573 1.178 . . . . 0.0 110.432 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -60.24 -48.87 79.89 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.719 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.69 68.45 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.529 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -56.89 -55.95 27.88 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.421 1.105 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.72 -39.84 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.048 1.739 . . . . 0.0 110.435 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -61.52 -50.49 72.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.986 1.266 . . . . 0.0 110.984 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.55 -53.29 46.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.89 0.876 . . . . 0.0 109.021 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.17 -54.98 38.64 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.887 1.275 . . . . 0.0 108.786 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.79 -52.2 57.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.237 1.415 . . . . 0.0 112.493 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -49.7 74.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.92 83.55 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.944 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.612 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.2 m-85 -70.98 -29.84 65.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.41 1.005 . . . . 0.0 111.697 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.75 -43.25 99.29 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.176 0.898 . . . . 0.0 109.297 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.845 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm 49.24 34.02 5.75 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.972 1.709 . . . . 0.0 110.609 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.25 -136.72 8.7 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.07 1.795 . . . . 0.0 110.636 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -129.56 161.56 30.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.222 2.209 . . . . 0.0 109.108 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.1 mt -130.06 149.08 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -135.77 122.59 21.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.925 0.89 . . . . 0.0 109.565 174.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 t -161.04 175.89 11.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.324 0.39 . . . . 0.0 111.025 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -147.3 102.96 3.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.458 1.503 . . . . 0.0 109.483 166.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.52 154.35 18.44 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.154 1.381 . . . . 0.0 110.279 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -64.16 -46.43 84.08 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.92 -53.76 45.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.691 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.12 -41.27 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.784 0.72 . . . . 0.0 111.186 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 46.3 mt-30 -58.54 -49.64 76.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 108.889 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.64 -55.3 21.11 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.981 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mm -52.98 -54.81 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 119.141 0.882 . . . . 0.0 110.364 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.84 -33.03 68.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.241 1.382 . . . . 0.0 113.708 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 t -57.15 -60.45 3.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.941 -1.028 . . . . 0.0 111.534 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.401 HD12 ' CG1' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -69.6 -17.55 63.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.436 1.471 . . . . 0.0 113.075 -175.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.612 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.4 mm? -83.36 -9.28 59.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.616 0.766 . . . . 0.0 112.249 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.92 35.42 92.02 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.686 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -106.33 122.9 47.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.229 1.014 . . . . 0.0 110.585 172.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.419 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -61.62 113.66 2.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 16.9 p90 -115.24 179.72 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 66.0 mtt180 -118.1 121.08 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.307 1.443 . . . . 0.0 107.334 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 p -81.67 143.11 32.13 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 117' ' ' LEU . 2.1 mm? -71.55 176.2 4.95 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 163.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt 57.02 94.12 0.03 OUTLIER 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.554 1.942 . . . . 0.0 109.093 -172.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -54.21 165.99 0.45 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.629 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.0 152.25 13.84 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 122' ' ' LYS 0.281 5.5 mm 66.67 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.547 2.339 . . . . 0.0 110.743 -176.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.622 ' H ' HG22 ' A' ' 121' ' ' ILE . 37.9 mtmt 65.41 17.44 10.97 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.055 1.342 . . . . 0.0 112.603 -159.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -161.67 -56.54 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.782 0.833 . . . . 0.0 108.9 158.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 121' ' ' ILE . 11.3 m -71.88 159.51 5.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.548 0.689 . . . . 0.0 110.358 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.97 114.04 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -72.45 131.97 43.27 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -74.58 155.28 38.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.353 1.061 . . . . 0.0 110.164 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -151.34 22.45 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.126 0.971 . . . . 0.0 112.343 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -139.52 150.15 44.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.876 1.216 . . . . 0.0 111.138 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.74 134.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.356 1.062 . . . . 0.0 109.417 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.1 t -65.19 127.2 30.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.09 114.02 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.764 0.792 . . . . 0.0 109.308 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.2 -77.71 0.39 Allowed Glycine 0 C--O 1.229 -0.178 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.48 -15.64 62.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.667 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.75 83.91 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.795 1.188 . . . . 0.0 114.341 165.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -69.55 139.87 53.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 124.758 1.223 . . . . 0.0 109.572 -170.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -78.51 147.02 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.7 1.2 . . . . 0.0 109.584 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -139.52 150.88 45.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.057 0.943 . . . . 0.0 109.409 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -102.88 -0.47 31.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.303 1.441 . . . . 0.0 112.562 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 p -149.57 167.9 25.03 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.446 2.298 . . . . 0.0 106.828 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.82 123.66 87.51 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 165.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.24 172.73 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.228 1.952 . . . . 0.0 110.358 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -54.6 137.28 73.16 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 121.896 1.731 . . . . 0.0 110.048 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.39 -10.15 2.07 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.315 0.96 . . . . 0.0 114.148 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.15 29.21 72.22 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 119.137 1.469 . . . . 0.0 112.393 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.25 161.05 21.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 118.448 1.124 . . . . 0.0 109.289 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 12.7 t -73.54 113.76 25.52 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.376 -1.297 . . . . 0.0 109.33 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.31 -17.41 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.702 1.601 . . . . 0.0 113.52 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.97 -26.2 19.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.539 1.136 . . . . 0.0 111.683 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.9 p -153.63 1.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -167.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.87 -13.16 9.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.48 1.514 . . . . 0.0 114.769 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.26 160.05 32.91 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.803 1.302 . . . . 0.0 112.221 -172.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -64.05 138.95 58.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.484 0.659 . . . . 0.0 109.555 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.45 144.61 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.01 150.19 52.26 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.336 1.054 . . . . 0.0 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.94 132.47 47.39 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -99.56 156.42 35.4 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.091 0.556 . . . . 0.0 109.604 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.29 74.92 4.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.177 2.585 . . . . 0.0 110.231 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 63.86 169.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.239 2.216 . . . . 0.0 112.689 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.65 -45.17 87.91 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.721 1.209 . . . . 0.0 111.464 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 . . . . . 0 CA--C 1.502 -0.888 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.729 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.2 mt -122.57 165.81 15.84 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.304 0.956 . . . . 0.0 111.365 -161.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 145.33 26.51 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.107 0.563 . . . . 0.0 110.474 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -157.86 149.97 22.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.173 1.789 . . . . 0.0 107.888 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.75 144.59 13.59 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.58 1.952 . . . . 0.0 108.223 166.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -63.99 163.39 12.29 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.977 0.894 . . . . 0.0 110.444 172.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 12.2 mptt -60.97 157.69 14.9 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.083 0.953 . . . . 0.0 109.181 165.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.7 m -53.04 132.84 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 122.279 1.037 . . . . 0.0 110.841 -171.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -154.36 144.72 22.13 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.36 146.65 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.71 137.84 53.67 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.728 1.611 . . . . 0.0 107.421 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.51 162.04 13.97 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.359 0.412 . . . . 0.0 110.525 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -40.9 -50.1 3.23 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.484 1.914 . . . . 0.0 112.542 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.96 -43.66 99.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 120.252 1.387 . . . . 0.0 109.366 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -69.09 -32.49 71.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.437 0.695 . . . . 0.0 110.644 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.9 mt -61.38 -45.44 98.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.051 0.54 . . . . 0.0 110.597 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -72.22 -28.22 63.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.266 0.939 . . . . 0.0 111.05 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.72 21.77 22.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.107 0.861 . . . . 0.0 112.416 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.636 ' CD1' HD21 ' A' ' 117' ' ' LEU . 10.4 mt -75.73 114.44 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.847 1.324 . . . . 0.0 108.0 -174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -73.31 110.23 7.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.154 1.782 . . . . 0.0 107.91 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.79 127.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.135 0.974 . . . . 0.0 109.369 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.47 162.62 28.4 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.589 -1.319 . . . . 0.0 111.138 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.14 -147.89 19.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -124.15 156.4 36.76 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.582 1.153 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -128.05 149.54 50.33 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 107.572 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.1 p -78.65 129.87 72.71 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HA ' HG12 ' A' ' 31' ' ' VAL . 15.9 Cg_endo -61.93 -23.94 76.43 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.212 1.275 . . . . 0.0 111.274 168.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -71.27 -29.94 65.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.96 -37.09 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 119.522 1.055 . . . . 0.0 109.063 174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 28' ' ' PRO . 5.7 p -60.39 -24.27 30.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 119.116 0.871 . . . . 0.0 112.199 -172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -56.67 -28.62 61.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 117.929 0.331 . . . . 0.0 111.374 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.48 -10.39 16.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.827 1.651 . . . . 0.0 111.427 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.95 78.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -21.33 52.84 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.985 0.914 . . . . 0.0 111.597 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.7 121.25 12.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.59 -50.28 74.38 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.666 0.786 . . . . 0.0 110.46 -162.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.39 -57.39 12.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.348 1.059 . . . . 0.0 109.525 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -58.67 -45.33 89.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.71 1.204 . . . . 0.0 110.663 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.76 -58.98 4.8 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.072 1.349 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.3 mt -53.37 -47.74 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 124.131 0.972 . . . . 0.0 108.559 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.48 -54.84 42.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.438 0.695 . . . . 0.0 110.661 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 31' ' ' VAL . 5.4 tt -52.64 -54.09 38.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.585 1.154 . . . . 0.0 109.623 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.35 -27.17 68.39 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 121.304 -0.872 . . . . 0.0 111.76 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 m -69.03 -47.19 66.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.616 0.766 . . . . 0.0 110.065 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.62 88.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.151 0.981 . . . . 0.0 111.077 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.56 -46.65 92.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 118.243 0.474 . . . . 0.0 109.79 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -64.24 -32.58 74.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.7 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.72 -2.47 46.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.578 1.151 . . . . 0.0 112.094 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.74 88.6 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 118.422 -1.21 . . . . 0.0 113.482 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.94 -53.73 51.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.518 1.527 . . . . 0.0 108.176 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -107.12 152.57 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -132.82 156.46 47.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.289 1.036 . . . . 0.0 109.731 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.9 mm -81.1 134.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 124.741 1.216 . . . . 0.0 107.736 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.29 127.79 6.48 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.711 1.204 . . . . 0.0 108.593 165.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.41 155.62 51.3 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.2 167.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -65.2 170.48 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.72 2.947 . . . . 0.0 111.993 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.2 t -86.55 153.04 22.12 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 159.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -47.05 -42.35 18.42 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.237 1.415 . . . . 0.0 111.465 161.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.57 -45.07 95.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 110.134 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -65.56 -38.39 89.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.061 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mm -61.18 -48.31 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 119.629 1.104 . . . . 0.0 108.666 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' HD12 ' A' ' 66' ' ' ILE . 64.7 m-20 -57.12 -31.95 65.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.042 0.937 . . . . 0.0 111.623 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -41.7 97.13 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.906 0.882 . . . . 0.0 110.694 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.39 -48.99 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 63' ' ' ASP . 50.4 mt -52.29 -36.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.899 1.279 . . . . 0.0 110.938 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -61.33 -62.64 1.69 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.471 1.032 . . . . 0.0 110.973 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.79 -34.88 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -172.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.52 57.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.4 1.48 . . . . 0.0 110.322 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' N ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -64.87 -20.66 66.54 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.781 -1.199 . . . . 0.0 112.168 176.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.452 ' N ' ' HE3' ' A' ' 70' ' ' LYS . 30.9 tt0 -81.18 -20.4 41.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.714 0.805 . . . . 0.0 111.558 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 t -109.37 -22.56 11.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.282 0.947 . . . . 0.0 111.364 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.67 -83.84 0.17 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.151 0.887 . . . . 0.0 112.221 170.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -74.14 91.86 2.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.469 1.108 . . . . 0.0 108.249 -171.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.49 -45.74 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.26 10.18 4.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.783 1.233 . . . . 0.0 109.828 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 8.15 0.92 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.481 0.712 . . . . 0.0 110.93 164.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.33 147.19 27.39 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.259 1.424 . . . . 0.0 108.632 163.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.7 m -70.04 156.4 39.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.714 1.245 . . . . 0.0 110.15 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.57 -48.08 82.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.746 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.56 56.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.225 0.92 . . . . 0.0 112.19 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -63.15 -56.27 18.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.3 mt -52.25 -43.31 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.402 1.481 . . . . 0.0 109.18 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.37 -52.74 43.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.619 1.568 . . . . 0.0 112.14 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.65 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 119.131 0.878 . . . . 0.0 109.462 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 96' ' ' ILE . 45.9 mt -57.67 -56.38 22.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.631 0.772 . . . . 0.0 109.218 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -59.07 3.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.496 1.519 . . . . 0.0 112.023 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -49.62 59.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.865 0.866 . . . . 0.0 109.187 -174.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.27 66.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.618 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -77.73 -30.07 51.49 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.766 1.167 . . . . 0.0 110.507 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -42.45 99.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 168.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.15 -7.13 59.61 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 52.12 24.96 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.804 1.642 . . . . 0.0 113.109 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 -106.8 2.57 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 119.387 0.994 . . . . 0.0 113.906 -159.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -142.38 166.86 23.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.518 1.927 . . . . 0.0 108.031 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.639 HD13 HD23 ' A' ' 86' ' ' LEU . 82.5 mt -135.21 154.2 35.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.57 121.24 18.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 t -158.14 -170.42 3.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.823 2.049 . . . . 0.0 106.907 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -154.66 -4.77 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 122.235 2.288 . . . . 0.0 115.781 163.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -61.35 148.77 40.3 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.235 1.834 . . . . 0.0 112.942 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -56.92 -32.61 66.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.759 1.624 . . . . 0.0 114.273 -172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.54 -50.85 12.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.43 1.092 . . . . 0.0 110.171 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -42.15 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.494 0.718 . . . . 0.0 110.768 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -67.17 -35.2 79.16 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.029 0.442 . . . . 0.0 110.347 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.5 t30 -65.09 -56.74 11.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -51.68 -55.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.462 1.105 . . . . 0.0 110.018 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.22 68.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.163 1.347 . . . . 0.0 113.164 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 t -60.4 -61.69 2.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.071 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.5 OUTLIER -67.4 -16.56 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.125 1.33 . . . . 0.0 113.212 -175.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -86.81 -22.17 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.88 0.872 . . . . 0.0 112.525 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.93 38.98 89.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 118.474 0.579 . . . . 0.0 112.859 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 125.12 39.79 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 161.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 116.07 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.21 -162.99 1.11 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.174 0.989 . . . . 0.0 110.709 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -140.25 162.71 34.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.807 2.443 . . . . 0.0 109.354 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.59 162.18 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.196 2.198 . . . . 0.0 110.35 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -93.05 -12.73 29.85 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.157 1.383 . . . . 0.0 112.917 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -38.93 115.33 0.47 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.913 2.085 . . . . 0.0 111.107 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -48.92 137.74 12.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.501 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.36 -87.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.171 1.843 . . . . 0.0 113.026 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.4 mt -147.93 145.83 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -137.8 -16.02 1.33 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -162.75 19.03 0.09 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.923 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.9 m -137.9 165.75 25.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 120.352 -1.467 . . . . 0.0 109.599 -162.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.96 149.3 6.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 71.68 0.66 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -58.19 154.77 12.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.644 1.577 . . . . 0.0 110.875 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 14.14 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -139.81 135.3 32.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.822 1.192 . . . . 0.0 109.984 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.86 131.99 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.89 140.46 58.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 165.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.8 pt -93.29 -11.62 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 118.206 -0.902 . . . . 0.0 113.192 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.73 -20.61 23.81 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 119.621 1.101 . . . . 0.0 113.962 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.7 p -144.8 6.07 1.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.826 1.313 . . . . 0.0 114.16 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.76 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.596 1.093 . . . . 0.0 115.076 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -68.18 147.37 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.199 1.0 . . . . 0.0 110.723 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -110.79 99.0 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.844 0.858 . . . . 0.0 111.783 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.19 143.63 26.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.859 1.314 . . . . 0.0 109.529 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -89.22 -19.77 24.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.568 172.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.7 p -145.21 163.14 35.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.757 1.623 . . . . 0.0 109.034 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.582 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -73.02 116.63 52.49 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -176.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.582 ' HD2' HD23 ' A' ' 141' ' ' LEU . 89.8 Cg_endo -66.74 169.0 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.468 2.112 . . . . 0.0 110.507 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -55.22 133.07 55.98 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.99 1.794 . . . . 0.0 109.877 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.57 -18.28 3.79 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.574 -1.125 . . . . 0.0 113.597 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 63.38 44.31 97.02 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 119.789 1.795 . . . . 0.0 111.538 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.83 158.41 43.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 14.2 t -67.63 110.93 6.16 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -61.55 -14.94 38.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.292 1.328 . . . . 0.0 111.746 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -12.41 14.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.659 1.984 . . . . 0.0 112.483 -160.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.52 -14.26 0.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.19 85.42 0.12 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.6 p -152.02 174.99 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -60.73 151.8 28.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.715 -1.24 . . . . 0.0 109.995 160.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.65 147.66 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 159.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.84 154.07 46.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.393 0.997 . . . . 0.0 111.415 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.06 114.02 14.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.584 1.154 . . . . 0.0 108.522 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.39 159.0 68.33 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 118.296 0.498 . . . . 0.0 110.79 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.23 91.57 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.485 2.79 . . . . 0.0 111.695 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 30.65 84.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.745 2.418 . . . . 0.0 113.267 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? 72.52 -39.63 0.45 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.857 2.063 . . . . 0.0 114.311 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.221 -159.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 58.99 90.42 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.844 2.458 . . . . 0.0 113.201 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.55 169.76 17.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.237 1.015 . . . . 0.0 108.747 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.2 t30 164.79 108.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 128.375 2.67 . . . . 0.0 109.192 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.87 169.17 9.43 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 109.258 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -94.57 177.36 5.95 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.202 1.801 . . . . 0.0 109.981 171.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -57.41 166.41 1.23 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.761 0.824 . . . . 0.0 110.802 159.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -44.79 122.56 3.26 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.509 1.924 . . . . 0.0 110.219 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 ' HB2' ' HE2' ' A' ' 6' ' ' LYS . 19.0 tp -147.3 147.14 30.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 108.013 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 t -116.86 140.33 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -108.07 146.8 32.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.875 1.67 . . . . 0.0 107.632 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.2 161.78 13.43 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.14 0.9 . . . . 0.0 112.179 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.475 ' HB2' HG21 ' A' ' 30' ' ' VAL . 12.6 t -43.89 -52.49 6.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 127.801 2.44 . . . . 0.0 111.724 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -60.7 -23.03 64.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.485 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.89 90.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 120.073 1.306 . . . . 0.0 109.456 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -72.37 -36.31 68.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.929 0.891 . . . . 0.0 111.045 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.71 -46.6 93.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.313 1.045 . . . . 0.0 109.835 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -75.96 -23.16 55.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.759 0.709 . . . . 0.0 111.116 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.91 41.73 12.07 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mt -81.82 112.49 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.69 98.91 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.448 1.099 . . . . 0.0 109.437 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.5 tp -153.94 164.63 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.105 1.762 . . . . 0.0 107.264 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -131.45 155.11 47.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.02 2.128 . . . . 0.0 108.698 -160.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.74 -149.14 21.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.24 161.91 15.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 0.0 110.157 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.0 t -141.84 161.1 38.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.825 1.65 . . . . 0.0 108.098 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 p -96.18 123.11 56.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 122.401 0.28 . . . . 0.0 110.889 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.2 -26.39 81.58 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.379 2.053 . . . . 0.0 112.114 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.2 m -62.99 -32.64 74.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.1 1.76 . . . . 0.0 114.598 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 13' ' ' SER . 12.6 p -94.47 -29.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.653 1.115 . . . . 0.0 110.369 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.53 -20.02 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 119.868 1.213 . . . . 0.0 111.187 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.57 -29.29 66.27 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.035 -1.666 . . . . 0.0 114.297 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -102.25 -16.23 16.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.454 1.101 . . . . 0.0 111.517 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.91 105.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 124.269 1.028 . . . . 0.0 108.902 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -13.04 7.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.461 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -61.82 120.18 10.2 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -62.02 -32.91 73.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.66 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.72 -63.36 1.17 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.3 p -53.7 -44.74 70.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.046 1.338 . . . . 0.0 112.515 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -71.45 -54.15 11.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.154 1.381 . . . . 0.0 110.896 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.59 -51.98 30.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -54.9 -54.24 45.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 112.429 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.33 -51.52 58.3 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.947 1.299 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.23 -34.26 77.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.977 0.911 . . . . 0.0 111.929 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -64.12 -45.44 88.56 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -36.77 78.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.477 0.711 . . . . 0.0 111.635 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.38 -51.71 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -67.48 -19.53 65.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.07 0.85 . . . . 0.0 113.24 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -10.07 51.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.517 1.527 . . . . 0.0 111.892 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.75 -0.69 70.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.729 1.157 . . . . 0.0 113.767 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -87.79 -28.3 21.76 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.192 0.997 . . . . 0.0 111.984 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.92 140.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -128.51 151.58 49.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.568 1.547 . . . . 0.0 108.877 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.8 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.77 132.38 5.03 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.106 1.362 . . . . 0.0 108.595 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -92.72 154.95 42.21 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.592 0.757 . . . . 0.0 111.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.76 173.92 11.14 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.285 3.323 . . . . 0.0 111.7 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -108.76 162.68 13.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.492 1.117 . . . . 0.0 109.696 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -53.76 -49.79 67.43 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.937 0.895 . . . . 0.0 111.294 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.65 -27.29 66.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.863 0.465 . . . . 0.0 110.184 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -67.42 -48.34 67.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.531 0.733 . . . . 0.0 109.636 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.6 -45.72 94.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.468 1.107 . . . . 0.0 110.155 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.06 -35.09 74.38 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.88 -0.512 . . . . 0.0 110.62 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -44.89 71.08 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.199 0.6 . . . . 0.0 111.06 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.4 mm -64.37 -45.51 95.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.71 -38.8 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.931 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -63.48 -59.03 5.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.168 1.349 . . . . 0.0 110.813 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 109' ' ' LEU . 3.8 t -73.6 -32.54 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -51.83 67.28 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -30.83 71.22 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.669 1.122 . . . . 0.0 111.691 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.39 -15.45 48.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 111.712 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -114.31 -28.77 7.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.19 0.905 . . . . 0.0 111.961 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.64 -99.02 0.19 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 119.991 1.269 . . . . 0.0 110.4 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -58.56 96.56 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.267 2.227 . . . . 0.0 108.797 -168.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.98 -44.06 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.483 1.913 . . . . 0.0 110.706 -167.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -123.61 6.71 8.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.281 0.632 . . . . 0.0 110.111 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.78 -24.83 62.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.581 0.628 . . . . 0.0 111.528 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.27 158.09 31.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.658 1.183 . . . . 0.0 109.757 -174.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -68.56 154.93 40.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.441 0.638 . . . . 0.0 110.75 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -63.01 -53.35 55.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.784 -0.572 . . . . 0.0 109.734 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.59 61.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.779 1.3 . . . . 0.0 109.485 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -59.41 -59.13 5.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.968 1.707 . . . . 0.0 108.455 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -53.75 -40.99 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.771 0.828 . . . . 0.0 110.578 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.35 -43.72 73.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.236 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.72 -49.77 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.573 HD23 HD13 ' A' ' 96' ' ' ILE . 56.5 mt -56.97 -53.58 56.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.757 1.223 . . . . 0.0 108.941 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.598 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.72 -52.86 54.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.046 1.338 . . . . 0.0 111.75 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.3 tp -54.36 -49.82 68.92 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -64.4 -16.31 62.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.709 0.686 . . . . 0.0 112.638 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.6 m-30 -96.4 -17.48 20.58 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.32 1.048 . . . . 0.0 111.421 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -58.88 -44.57 91.18 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -114.13 -4.77 13.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.155 1.782 . . . . 0.0 111.935 -168.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 53.6 49.12 20.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.701 2.001 . . . . 0.0 111.547 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.63 -114.18 2.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.761 1.172 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -148.58 169.89 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 107.79 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.573 HD13 HD23 ' A' ' 86' ' ' LEU . 28.7 mt -130.38 163.57 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 0.0 108.194 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 118.57 13.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.92 1.688 . . . . 0.0 107.8 166.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.0 t -175.16 176.82 2.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.183 2.193 . . . . 0.0 109.559 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.62 0.19 0.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -57.31 162.51 2.71 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.539 1.518 . . . . 0.0 113.911 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -57.69 -52.49 65.21 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.726 -1.234 . . . . 0.0 109.74 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -75.1 -43.32 53.64 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.219 1.007 . . . . 0.0 110.183 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 p -61.57 -47.13 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.74 -37.04 85.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.85 0.46 . . . . 0.0 109.947 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.1 t30 -70.51 -53.32 16.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -49.57 -51.68 14.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.202 1.001 . . . . 0.0 109.443 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.63 70.4 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.002 1.274 . . . . 0.0 112.481 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.6 t -65.56 -52.44 52.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.205 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.477 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -63.41 -30.22 71.38 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 121.106 1.775 . . . . 0.0 110.613 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.526 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -79.97 -8.96 59.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.366 1.066 . . . . 0.0 112.891 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.89 59.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.023 -1.432 . . . . 0.0 115.499 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.11 119.91 26.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.511 2.156 . . . . 0.0 110.569 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 148.86 41.06 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.671 1.188 . . . . 0.0 111.244 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.74 176.33 12.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 122.038 -0.414 . . . . 0.0 111.475 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -111.9 150.55 30.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.967 1.307 . . . . 0.0 109.887 172.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p -112.68 158.68 19.73 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.314 1.446 . . . . 0.0 110.17 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.7 mp -77.38 166.68 22.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.158 0.983 . . . . 0.0 109.102 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -96.85 1.44 50.61 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.601 -1.19 . . . . 0.0 113.812 -169.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -111.69 152.78 27.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 122.424 2.374 . . . . 0.0 111.628 -167.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.71 -168.6 9.38 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 121.887 0.715 . . . . 0.0 111.532 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.81 149.89 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -130.04 -51.16 1.12 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.759 1.624 . . . . 0.0 108.178 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -139.78 41.4 2.0 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.46 1.104 . . . . 0.0 111.578 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -121.23 168.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -63.94 112.63 3.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.67 -1.269 . . . . 0.0 108.105 157.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.47 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 2.4 p-90 -61.77 154.63 25.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 154.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -175.3 13.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -140.91 152.98 45.47 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.148 1.34 . . . . 0.0 111.858 164.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' HD12 ' A' ' 157' ' ' ILE . 9.9 p -131.14 132.84 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.876 1.27 . . . . 0.0 109.132 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 128.95 37.43 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 164.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pt -80.39 101.51 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.757 0.708 . . . . 0.0 109.696 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.98 -84.58 0.18 Allowed Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 7.0 p -70.47 -15.26 62.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.031 0.416 . . . . 0.0 110.944 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.11 92.79 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.411 1.005 . . . . 0.0 111.826 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -70.94 145.26 50.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 49.8 mttp -104.95 132.54 51.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.133 1.373 . . . . 0.0 107.564 -176.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.29 162.54 25.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 109.086 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.5 t -113.52 -13.74 12.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.729 0.412 . . . . 0.0 110.604 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.8 p -142.09 158.49 43.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.23 126.1 92.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.03 170.95 17.72 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.285 2.657 . . . . 0.0 111.375 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.65 101.79 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.08 3.186 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.59 28.8 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.76 1.648 . . . . 0.0 111.785 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.97 34.24 87.9 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.093 -1.948 . . . . 0.0 113.008 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.07 165.8 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.691 1.996 . . . . 0.0 108.388 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.75 109.72 7.34 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 125.889 1.676 . . . . 0.0 110.036 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.98 -14.9 44.27 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.805 1.323 . . . . 0.0 112.379 167.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -41.06 17.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.006 0.922 . . . . 0.0 110.006 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.48 4.99 2.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.426 1.012 . . . . 0.0 113.573 -163.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.11 -14.63 1.55 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.198 2.333 . . . . 0.0 116.087 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 163.16 24.73 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.865 1.333 . . . . 0.0 112.7 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -69.45 155.94 39.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.66 145.64 15.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -136.24 168.81 18.7 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.094 1.358 . . . . 0.0 110.173 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.0 tt -77.32 157.87 30.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.991 0.916 . . . . 0.0 109.984 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -128.26 159.34 67.77 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.602 2.361 . . . . 0.0 107.816 173.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.65 178.85 7.08 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.73 1.62 . . . . 0.0 113.474 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -37.8 131.98 0.96 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.477 2.311 . . . . 0.0 113.69 -172.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -47.27 84.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 171.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.25 1.115 0 CA-C-N 118.952 0.796 . . . . 0.0 110.958 -170.799 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 ttp . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.3 mt 52.23 88.65 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.726 2.41 . . . . 0.0 112.365 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.12 -178.05 5.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.515 2.326 . . . . 0.0 109.694 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.2 t30 20.78 95.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.957 3.303 . . . . 0.0 113.783 -168.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 146.56 31.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -69.03 168.69 13.29 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -51.52 170.44 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.553 1.941 . . . . 0.0 112.373 166.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.7 116.78 1.92 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.86 1.264 . . . . 0.0 111.597 -170.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.96 143.89 31.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.533 0.733 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.15 154.18 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 O-C-N 124.129 0.893 . . . . 0.0 110.306 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.58 154.6 45.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.397 2.679 . . . . 0.0 107.611 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.41 164.44 14.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.746 0.818 . . . . 0.0 111.153 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.7 p -35.08 -50.12 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.282 2.233 . . . . 0.0 112.654 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -52.2 -40.65 61.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.107 0.963 . . . . 0.0 112.188 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.59 -44.76 97.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.322 1.449 . . . . 0.0 109.699 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.35 -34.25 72.41 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.898 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.61 -50.31 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.732 0.813 . . . . 0.0 109.738 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -70.7 -19.49 62.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.29 0.496 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.2 23.69 47.29 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.478 1.037 . . . . 0.0 112.096 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 117' ' ' LEU . 13.7 mt -72.62 112.69 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -170.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 112.48 1.57 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.827 1.251 . . . . 0.0 108.262 170.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 141.39 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.782 2.033 . . . . 0.0 106.989 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -78.29 164.81 24.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.113 1.365 . . . . 0.0 108.986 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.79 -165.85 31.19 Favored Glycine 0 C--N 1.331 0.264 0 O-C-N 121.032 -1.043 . . . . 0.0 111.048 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -103.23 149.02 25.09 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -142.84 171.54 13.92 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.189 1.396 . . . . 0.0 111.153 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.34 119.44 64.25 Favored Pre-proline 0 C--O 1.251 1.154 0 C-N-CA 126.151 1.781 . . . . 0.0 112.963 -168.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.31 -6.23 16.94 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.247 1.965 . . . . 0.0 113.005 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.9 m -91.96 -29.74 16.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.74 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.24 -39.8 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 120.467 1.485 . . . . 0.0 108.95 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG23 HD13 ' A' ' 43' ' ' LEU . 13.3 p -58.85 -23.57 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.11 -23.24 63.97 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.758 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.51 -34.96 30.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.851 1.26 . . . . 0.0 109.701 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.17 127.2 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.783 1.233 . . . . 0.0 108.092 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 -19.35 2.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.303 1.041 . . . . 0.0 112.239 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.28 127.49 32.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -59.18 -43.06 92.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.779 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.62 -53.93 51.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -54.66 44.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.624 1.57 . . . . 0.0 110.574 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -57.12 -59.29 5.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.154 0.581 . . . . 0.0 109.581 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.97 -53.19 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -54.1 -47.88 71.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.744 0.818 . . . . 0.0 112.066 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 31' ' ' VAL . 5.7 tt -58.58 -52.44 65.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.077 1.351 . . . . 0.0 108.851 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.31 -40.28 95.79 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.912 -0.492 . . . . 0.0 110.729 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -60.05 -47.96 83.71 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.378 1.471 . . . . 0.0 110.132 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -38.28 89.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.827 0.74 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.21 -45.28 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 118.767 0.712 . . . . 0.0 109.491 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -54.31 -50.05 68.26 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 109.635 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.1 -6.59 34.98 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.246 1.819 . . . . 0.0 113.383 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.17 83.31 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.811 1.187 . . . . 0.0 113.324 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.69 -46.58 87.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.561 1.18 . . . . 0.0 107.91 170.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 147.63 21.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.761 0.824 . . . . 0.0 109.092 -167.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.69 172.27 9.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.112 1.765 . . . . 0.0 108.889 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.76 138.46 44.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.789 1.635 . . . . 0.0 110.47 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.28 123.82 3.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.856 1.662 . . . . 0.0 108.052 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -107.22 147.21 34.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.215 0.916 . . . . 0.0 111.581 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.81 171.57 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.445 3.43 . . . . 0.0 113.044 -170.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -111.7 160.58 17.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.604 1.562 . . . . 0.0 110.262 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -59.88 -45.72 91.61 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.611 -0.681 . . . . 0.0 111.535 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.18 -38.78 65.98 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.608 0.763 . . . . 0.0 110.463 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -70.11 -42.12 73.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.344 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -64.13 -46.88 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.38 77.34 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.81 -0.556 . . . . 0.0 111.118 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.73 -44.53 63.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.133 0.973 . . . . 0.0 111.199 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.75 -50.78 57.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.2 mt -51.46 -36.52 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.573 1.149 . . . . 0.0 110.807 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -66.38 -56.32 11.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.809 1.186 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.31 -38.8 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.96 67.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.617 1.567 . . . . 0.0 111.447 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -24.2 63.05 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.134 -0.979 . . . . 0.0 112.537 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.25 -30.7 54.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 111.389 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.269 14.6 t -75.58 -68.13 0.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.38 0.991 . . . . 0.0 108.526 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.76 -73.19 0.07 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-N 119.482 1.037 . . . . 0.0 111.569 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -69.6 93.83 0.73 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.663 0.785 . . . . 0.0 110.027 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.64 -59.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 122.167 -0.333 . . . . 0.0 111.839 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -114.67 8.18 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.451 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.81 -9.29 58.5 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 78' ' ' LEU . 3.3 mp -92.63 159.79 15.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.256 -0.903 . . . . 0.0 110.746 -174.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -68.69 156.38 38.33 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.525 -0.735 . . . . 0.0 111.95 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.44 -57.42 12.81 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 118.895 -0.574 . . . . 0.0 109.508 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.69 -39.79 52.12 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.073 0.858 . . . . 0.0 111.4 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -61.68 2.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 109.316 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.24 -42.99 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 125.283 1.433 . . . . 0.0 108.759 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -56.2 -62.12 1.93 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.458 1.103 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.15 -47.53 80.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.415 0.686 . . . . 0.0 109.638 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 96' ' ' ILE . 42.3 mt -59.13 -52.18 66.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.939 0.896 . . . . 0.0 110.173 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.779 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.12 -59.45 4.17 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.133 1.373 . . . . 0.0 112.218 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 tp -46.96 -54.27 10.5 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.58 1.175 . . . . 0.0 110.972 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.25 68.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.395 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.7 m-85 -64.56 -28.78 69.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.517 0.599 . . . . 0.0 112.015 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.19 -34.52 76.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.141 0.882 . . . . 0.0 110.167 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.97 -18.92 38.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.008 1.323 . . . . 0.0 112.972 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.06 51.39 17.15 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.12 -149.01 11.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.929 1.728 . . . . 0.0 111.254 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -114.21 169.93 8.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.618 1.967 . . . . 0.0 108.465 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.482 HD13 HD23 ' A' ' 86' ' ' LEU . 55.0 mt -131.94 153.76 39.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.047 1.339 . . . . 0.0 107.807 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.59 111.82 8.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.735 1.214 . . . . 0.0 108.788 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.2 t -160.92 179.61 8.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.032 2.133 . . . . 0.0 107.534 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -155.74 27.71 0.38 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.351 -1.468 . . . . 0.0 113.599 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.582 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.3 t70 -95.44 156.64 16.24 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -170.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -69.41 -40.8 77.08 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.037 1.29 . . . . 0.0 110.223 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.33 -49.41 49.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.135 173.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -57.01 -40.01 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.812 1.187 . . . . 0.0 110.927 -173.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -67.32 -40.19 85.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.975 0.51 . . . . 0.0 109.874 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.414 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.6 t-20 -66.09 -55.05 18.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 mm -53.97 -54.47 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 110.391 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.59 -32.32 68.87 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.111 -1.618 . . . . 0.0 112.777 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 t -60.54 -60.6 3.55 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 117.73 -1.129 . . . . 0.0 110.678 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -60.57 -31.99 71.09 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 120.022 1.283 . . . . 0.0 110.683 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.554 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -76.32 -8.72 57.72 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.82 5.49 88.6 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.707 -1.051 . . . . 0.0 113.511 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.65 130.48 34.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.243 1.521 . . . . 0.0 110.031 -170.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' N ' HD13 ' A' ' 112' ' ' LEU . 11.0 ttt85 -66.63 132.1 47.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.676 0.79 . . . . 0.0 111.168 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -144.82 178.51 7.96 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.344 -0.848 . . . . 0.0 110.545 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -115.03 156.27 25.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.331 1.452 . . . . 0.0 108.881 171.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.9 p -122.4 160.57 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.919 1.287 . . . . 0.0 108.732 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD11 HD11 ' A' ' 20' ' ' ILE . 3.7 mm? -79.23 -51.71 9.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.924 -0.485 . . . . 0.0 110.285 168.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -59.92 155.38 16.64 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.85 177.38 5.58 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.366 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.03 178.66 30.44 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -157.73 157.51 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.451 2.3 . . . . 0.0 107.237 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -128.99 -26.67 2.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -153.95 39.33 0.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.034 0.834 . . . . 0.0 109.692 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.86 137.64 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -164.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.96 125.7 37.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 117.52 23.84 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.247 1.019 . . . . 0.0 109.68 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -50.69 144.85 7.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.216 1.006 . . . . 0.0 111.931 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ttt-85 -156.82 9.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.998 1.111 . . . . 0.0 113.998 -164.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -133.65 131.89 40.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.92 0.782 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.21 133.77 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.59 128.71 37.44 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 166.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.11 113.06 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 164.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.28 -79.27 0.21 Allowed Glycine 0 C--O 1.229 -0.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 10.7 p -102.8 -7.06 21.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.636 0.718 . . . . 0.0 112.725 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.34 19.36 66.8 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.865 -1.147 . . . . 0.0 114.388 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 5.0 ttm-85 -63.43 150.29 43.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.455 1.502 . . . . 0.0 110.013 -176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -123.96 97.7 5.47 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.746 0.654 . . . . 0.0 111.315 -152.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -99.48 146.26 26.56 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.421 1.105 . . . . 0.0 108.961 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -98.9 -11.32 21.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.473 0.709 . . . . 0.0 110.345 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.5 p -140.03 162.03 36.19 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 126.496 1.918 . . . . 0.0 108.979 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -79.04 118.48 72.73 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 141' ' ' LEU . 81.2 Cg_endo -67.92 161.46 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.979 1.786 . . . . 0.0 109.403 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.0 107.7 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.873 2.382 . . . . 0.0 108.744 172.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.46 -18.93 11.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.761 2.124 . . . . 0.0 111.927 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 54.78 31.4 54.09 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.759 1.279 . . . . 0.0 113.673 -175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 164.11 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.999 1.32 . . . . 0.0 108.154 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 150' ' ' CYS . 2.4 t -64.65 115.01 16.75 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.163 168.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.92 -3.87 2.47 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.193 1.929 . . . . 0.0 113.083 166.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.21 -26.68 5.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.434 1.893 . . . . 0.0 112.814 -170.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 67.9 m -113.01 -18.16 12.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.728 1.211 . . . . 0.0 111.52 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 53.02 50.3 51.88 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.7 t -128.28 162.48 26.93 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.32 139.62 49.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.792 0.806 . . . . 0.0 110.948 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.09 152.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -126.76 156.32 41.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 120.306 -1.496 . . . . 0.0 109.516 166.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.12 120.24 23.99 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -82.35 156.16 68.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.441 0.463 . . . . 0.0 110.697 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.06 80.61 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.981 2.454 . . . . 0.0 109.84 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 56.74 170.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.222 2.209 . . . . 0.0 111.813 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -67.16 -74.69 0.11 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 162.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 . . . . . 0 C--O 1.244 0.804 0 C-N-CA 124.582 1.153 . . . . 0.0 108.661 -176.269 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptp . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mp -129.03 -102.41 0.32 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 159.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -104.37 0.64 29.31 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -71.05 165.78 22.76 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.478 0.711 . . . . 0.0 110.553 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp 78.63 104.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 131.264 3.826 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.84 162.48 27.6 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.366 -0.833 . . . . 0.0 110.689 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -53.71 160.86 1.23 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.557 1.143 . . . . 0.0 110.121 164.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -45.14 119.19 1.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.341 1.456 . . . . 0.0 111.95 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.2 137.56 40.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.568 1.547 . . . . 0.0 107.093 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.41 146.76 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.81 146.78 40.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.733 1.613 . . . . 0.0 108.098 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.73 174.66 7.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.345 0.52 . . . . 0.0 111.706 166.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -55.87 -42.28 75.65 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -61.15 -27.7 68.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.743 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.74 -42.68 82.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 119.984 1.266 . . . . 0.0 110.162 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -72.23 -36.38 69.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.465 1.106 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.3 -26.54 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.552 1.141 . . . . 0.0 110.892 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -92.22 -23.55 19.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.278 0.945 . . . . 0.0 111.829 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.96 45.72 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.304 -0.72 . . . . 0.0 113.02 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 117' ' ' LEU . 13.2 mt -67.92 109.98 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.87 91.52 0.65 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.383 1.073 . . . . 0.0 110.191 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.47 165.79 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.832 1.253 . . . . 0.0 109.52 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.45 119.29 21.4 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.475 -166.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.07 -162.39 29.27 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.186 0.898 . . . . 0.0 110.905 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -104.26 150.59 24.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.875 1.27 . . . . 0.0 109.397 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -135.46 149.11 49.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.855 1.262 . . . . 0.0 108.82 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.82 118.93 75.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 125.219 1.408 . . . . 0.0 107.99 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.12 -28.71 71.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 119.749 0.946 . . . . 0.0 110.776 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -48.29 37.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.181 3.392 . . . . 0.0 113.899 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.7 -35.15 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-N 118.77 0.714 . . . . 0.0 110.33 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.27 -26.95 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.867 0.758 . . . . 0.0 110.062 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.5 -20.48 31.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.91 -22.12 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.992 1.317 . . . . 0.0 111.685 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.2 mt -62.58 116.79 2.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 122.211 1.005 . . . . 0.0 108.837 -170.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.84 -16.54 3.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.838 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -66.56 122.01 16.63 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -56.22 -45.34 79.94 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.122 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -56.79 -55.85 29.02 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.77 1.228 . . . . 0.0 109.121 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -61.17 -44.57 97.1 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.371 1.069 . . . . 0.0 110.31 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.41 -55.53 20.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.329 0.652 . . . . 0.0 110.493 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.1 mt -50.27 -55.68 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -55.19 -56.06 24.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.982 0.913 . . . . 0.0 111.613 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -52.55 -57.51 9.72 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.605 1.162 . . . . 0.0 108.836 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -58.06 -41.1 82.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.001 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -62.87 -35.85 81.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.854 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -37.46 63.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.971 0.908 . . . . 0.0 111.209 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.1 -47.3 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -66.52 -34.52 78.11 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.036 0.38 . . . . 0.0 110.976 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.91 -12.41 61.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.071 0.948 . . . . 0.0 112.745 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.13 21.75 48.08 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 119.427 1.012 . . . . 0.0 112.668 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -105.81 -26.59 11.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.913 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -119.87 127.01 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -123.27 144.2 49.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.987 1.267 . . . . 0.0 112.847 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.7 mm -77.4 122.65 32.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.666 1.186 . . . . 0.0 109.412 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 126.88 10.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.783 0.833 . . . . 0.0 110.097 168.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.39 158.14 37.49 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.1 0.56 . . . . 0.0 112.409 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.89 175.0 5.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 125.034 3.823 . . . . 0.0 111.98 170.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.36 165.03 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.36 15.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.913 1.685 . . . . 0.0 111.501 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.17 -30.81 70.0 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.763 0.425 . . . . 0.0 111.582 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -64.96 -48.52 73.74 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.385 1.474 . . . . 0.0 109.492 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.01 -46.9 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 124.439 1.096 . . . . 0.0 108.902 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -34.67 74.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 122.412 -0.18 . . . . 0.0 110.969 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -41.54 75.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.499 0.719 . . . . 0.0 111.443 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -70.58 -41.13 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 117.33 -1.319 . . . . 0.0 109.803 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.59 -54.03 17.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.334 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -55.32 -55.13 35.0 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.813 1.188 . . . . 0.0 112.13 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.993 HG11 HD21 ' A' ' 110' ' ' LEU . 4.6 p -67.44 -37.44 78.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.988 -0.445 . . . . 0.0 110.972 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -65.2 -34.01 77.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.259 1.024 . . . . 0.0 110.604 175.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -53.52 57.28 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.106 1.362 . . . . 0.0 109.566 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 1.86 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.654 1.582 . . . . 0.0 112.695 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.94 11.53 3.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.331 1.452 . . . . 0.0 111.107 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.07 -72.67 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 125.908 1.718 . . . . 0.0 112.78 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -77.68 71.56 4.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.86 1.264 . . . . 0.0 110.246 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.43 -39.13 82.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.762 1.625 . . . . 0.0 113.898 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -130.76 12.98 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.885 0.766 . . . . 0.0 110.887 -173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.61 -22.84 61.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.68 0.792 . . . . 0.0 111.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 78' ' ' LEU . 2.1 mp -77.33 155.83 31.71 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 122.14 -0.35 . . . . 0.0 110.428 -174.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.7 m -63.24 151.13 41.37 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.581 0.705 . . . . 0.0 109.28 170.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -55.75 -45.32 78.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.562 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.38 80.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.203 0.911 . . . . 0.0 113.17 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.27 -57.77 9.95 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -55.92 -45.22 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.373 1.469 . . . . 0.0 109.08 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -68.22 -49.88 57.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.904 1.282 . . . . 0.0 111.943 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.42 -48.02 86.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.346 0.975 . . . . 0.0 108.998 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.74 -57.06 14.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.178 0.991 . . . . 0.0 109.177 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.97 -48.49 52.13 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.914 1.286 . . . . 0.0 111.331 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.42 -51.73 65.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.709 0.804 . . . . 0.0 109.211 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.69 74.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.518 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.4 m-30 -76.08 -22.23 55.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.938 0.79 . . . . 0.0 111.91 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.37 -50.23 68.53 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.43 -14.0 59.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.44 1.096 . . . . 0.0 112.779 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? 54.35 30.3 12.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.888 1.675 . . . . 0.0 111.752 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -125.53 5.2 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.158 0.885 . . . . 0.0 111.061 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.98 165.63 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.767 2.027 . . . . 0.0 110.12 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.7 mt -130.09 162.99 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.725 1.21 . . . . 0.0 108.462 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.38 122.75 19.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.207 2.203 . . . . 0.0 106.051 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -163.26 175.76 10.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.66 1.184 . . . . 0.0 110.669 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -160.35 92.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.229 1.412 . . . . 0.0 109.618 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -151.92 153.04 33.33 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.777 1.231 . . . . 0.0 109.254 163.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -58.66 -41.71 86.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.0 1.273 . . . . 0.0 111.907 -171.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' HD23 ' A' ' 78' ' ' LEU . 5.5 p-10 -66.89 -55.54 14.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 110.029 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -54.12 -40.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.492 0.663 . . . . 0.0 110.526 -171.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -69.67 -41.3 75.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.063 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -59.54 -59.79 4.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.708 1.603 . . . . 0.0 107.649 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 mm -53.33 -58.84 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 124.639 1.176 . . . . 0.0 108.841 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.71 67.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.455 1.479 . . . . 0.0 112.793 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -52.98 55.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.764 -1.589 . . . . 0.0 113.102 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -35.23 79.08 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 121.235 1.834 . . . . 0.0 109.784 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -70.14 -22.38 63.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.493 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.97 80.32 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 124.726 1.155 . . . . 0.0 113.847 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -83.25 118.18 23.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.408 1.104 . . . . 0.0 109.098 177.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -68.61 131.75 45.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.778 1.231 . . . . 0.0 108.274 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -146.57 169.74 18.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.926 0.393 . . . . 0.0 111.182 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -101.93 134.27 45.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.607 1.163 . . . . 0.0 108.38 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 p -92.16 169.11 10.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 124.721 1.263 . . . . 0.0 109.53 164.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 20' ' ' ILE . 2.2 mm? -86.46 -49.64 7.45 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.34 0.518 . . . . 0.0 111.494 169.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -60.0 145.56 45.82 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.058 0.543 . . . . 0.0 110.764 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -65.23 -33.8 76.85 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.931 -0.48 . . . . 0.0 111.358 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.2 0.26 56.26 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.67 -1.072 . . . . 0.0 115.178 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.8 mt -143.97 134.86 21.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 126.898 2.079 . . . . 0.0 106.862 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.41 -59.88 1.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.567 157.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -148.31 2.32 0.65 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.16 1.346 . . . . 0.0 113.962 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.82 120.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.44 161.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -54.37 104.83 0.12 Allowed 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 5.5 p-90 -80.73 143.78 32.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -155.58 25.05 0.4 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.619 -1.182 . . . . 0.0 113.933 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -129.94 140.4 50.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.676 1.125 . . . . 0.0 110.73 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.29 135.29 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.592 1.557 . . . . 0.0 108.886 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.25 140.68 52.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -91.3 102.14 13.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 121.983 0.897 . . . . 0.0 109.045 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.05 -78.72 0.33 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 2.3 p -78.01 -10.72 59.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.621 0.71 . . . . 0.0 111.528 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.66 21.93 71.32 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.919 1.247 . . . . 0.0 114.589 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -63.93 135.16 56.28 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.354 1.062 . . . . 0.0 109.729 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -88.48 136.72 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.66 1.584 . . . . 0.0 108.417 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -130.8 150.02 52.17 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.416 1.086 . . . . 0.0 108.354 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 3.3 p -88.18 -22.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.435 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.4 p -139.58 172.61 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 108.136 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.86 132.34 90.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.12 169.44 21.44 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.912 1.741 . . . . 0.0 110.123 172.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -56.39 137.49 80.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.68 1.587 . . . . 0.0 109.586 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.96 -10.04 4.69 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.88 72.78 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.806 1.803 . . . . 0.0 112.918 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.18 161.63 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.247 1.019 . . . . 0.0 108.947 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.3 t -79.48 113.69 39.09 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.432 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.16 -13.45 15.95 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.366 1.377 . . . . 0.0 114.044 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.53 -25.09 15.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.171 1.388 . . . . 0.0 112.79 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.9 p -150.71 2.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.57 -11.35 7.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.585 2.04 . . . . 0.0 115.152 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.46 166.75 21.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.588 1.194 . . . . 0.0 112.873 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -61.16 149.21 38.15 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.618 -0.676 . . . . 0.0 109.834 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.48 142.94 22.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 153.5 51.22 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.34 1.056 . . . . 0.0 111.364 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.7 tt -76.08 137.85 40.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.777 0.831 . . . . 0.0 109.214 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 pt -108.05 158.58 33.23 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 112.768 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.25 123.84 11.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.887 3.058 . . . . 0.0 111.272 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 45.07 -128.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.814 2.046 . . . . 0.0 111.264 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -31.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 . . . . . 0 C--O 1.251 1.18 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 171.901 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.963 0.411 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.23 175.62 2.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.731 1.212 . . . . 0.0 110.956 169.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.6 170.16 16.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 156.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -125.34 177.28 6.24 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.663 1.185 . . . . 0.0 109.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.57 164.07 32.81 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 112.324 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -75.12 -173.64 2.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.028 0.931 . . . . 0.0 113.219 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -48.74 154.95 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.22 1.008 . . . . 0.0 112.5 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -39.79 117.95 0.81 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 126.417 1.887 . . . . 0.0 110.443 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.99 144.15 43.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.13 155.48 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 124.373 1.045 . . . . 0.0 109.903 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.16 146.15 51.28 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.305 1.842 . . . . 0.0 108.671 -166.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.16 171.97 7.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.561 0.744 . . . . 0.0 112.749 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.73 69.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.095 1.358 . . . . 0.0 112.187 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -37.38 72.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.2 -47.38 80.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.942 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -73.19 -31.73 64.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.879 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.01 -47.94 91.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.972 . . . . 0.0 109.518 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.63 -25.02 58.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.198 0.454 . . . . 0.0 111.043 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.88 28.08 14.86 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.39 0.519 . . . . 0.0 113.053 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -72.08 108.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -61.27 115.53 3.89 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 23' ' ' GLU . 3.5 tp -159.48 144.79 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.981 1.713 . . . . 0.0 107.45 174.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' H ' HD12 ' A' ' 22' ' ' ILE . 31.9 mp0 -88.09 142.37 27.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.947 1.299 . . . . 0.0 108.652 175.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.15 -155.61 24.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -117.96 151.72 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.25 1.02 . . . . 0.0 109.858 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 t -129.37 145.79 51.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.163 1.385 . . . . 0.0 110.496 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.502 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -91.13 117.69 68.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.504 1.522 . . . . 0.0 110.035 -168.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.4 Cg_endo -63.97 -5.67 9.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.884 3.056 . . . . 0.0 115.633 -170.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.99 -4.35 13.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.346 0.976 . . . . 0.0 111.886 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.69 -47.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 HD13 ' A' ' 43' ' ' LEU . 6.0 p -65.55 -19.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -170.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.59 -26.11 66.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.127 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -78.18 -40.95 36.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.017 0.927 . . . . 0.0 108.849 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.0 mt -55.67 101.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.609 1.564 . . . . 0.0 108.699 -169.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -9.29 8.9 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 126.025 1.73 . . . . 0.0 110.734 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.31 127.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -58.45 -51.66 68.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.557 0.743 . . . . 0.0 109.355 -170.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.41 -54.89 40.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.637 1.175 . . . . 0.0 108.73 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.381 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -64.73 -58.05 7.33 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.712 0.687 . . . . 0.0 109.469 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.37 -46.65 85.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 50.4 t80 -59.5 -51.65 68.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.067 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.547 HD13 HG23 ' A' ' 31' ' ' VAL . 6.8 tt -53.34 -52.12 60.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.103 0.961 . . . . 0.0 109.547 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.8 -37.04 80.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.906 0.882 . . . . 0.0 110.961 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -56.51 -46.53 80.51 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.317 1.447 . . . . 0.0 109.995 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 50.9 mt -67.7 -35.57 79.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.578 0.751 . . . . 0.0 110.784 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.3 -55.36 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -59.5 -38.19 80.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.397 0.544 . . . . 0.0 112.363 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -24.92 66.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.853 1.261 . . . . 0.0 112.383 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 9.0 60.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.531 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -83.75 -34.76 24.76 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.351 1.076 . . . . 0.0 111.263 178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.26 147.76 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -128.17 157.01 41.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.51 1.124 . . . . 0.0 109.759 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mm -78.63 135.06 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.85 127.83 7.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.828 0.851 . . . . 0.0 111.756 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -106.03 154.93 39.21 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.735 1.614 . . . . 0.0 112.17 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.82 163.33 28.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.12 3.88 . . . . 0.0 114.457 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -90.81 166.57 13.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.662 1.985 . . . . 0.0 109.457 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tmpt? -50.17 -44.45 52.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.129 1.372 . . . . 0.0 110.295 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -71.39 -27.58 63.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.989 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -66.09 -48.98 69.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.265 0.626 . . . . 0.0 109.664 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.26 -42.09 93.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.51 -33.14 74.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.225 0.466 . . . . 0.0 111.221 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -43.37 61.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.641 1.176 . . . . 0.0 110.307 174.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -72.21 -44.18 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 119.336 0.971 . . . . 0.0 108.547 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.61 -39.88 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.404 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -57.01 -68.2 0.24 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.5 1.143 . . . . 0.0 109.14 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.39 -29.81 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.091 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.22 60.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.917 . . . . 0.0 111.643 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -65.52 -25.99 67.7 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.081 -1.012 . . . . 0.0 111.563 -177.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 43.2 mt-10 -60.98 -52.72 63.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.139 0.882 . . . . 0.0 109.088 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -75.57 -39.96 57.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.36 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.55 -76.54 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.532 1.06 . . . . 0.0 113.52 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.01 92.0 0.91 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 122.02 0.914 . . . . 0.0 110.213 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.91 -44.08 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.541 0.736 . . . . 0.0 112.784 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -131.18 12.91 5.13 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.753 0.421 . . . . 0.0 110.899 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.03 -8.31 55.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 106' ' ' ILE . 5.4 mp -83.25 156.69 23.0 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.267 -0.895 . . . . 0.0 110.592 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.77 159.21 19.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.921 1.289 . . . . 0.0 110.605 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.54 -57.9 7.87 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.42 -39.14 75.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 123.959 0.787 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.68 -52.4 65.61 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 109.729 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.53 -46.35 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.5 -49.64 58.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.638 0.654 . . . . 0.0 112.722 -172.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG22 ' OG1' ' A' ' 27' ' ' THR . 93.7 t -60.58 -50.72 79.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -55.47 -58.57 7.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.15 0.98 . . . . 0.0 109.288 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -47.44 -55.89 8.08 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.931 1.292 . . . . 0.0 112.005 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.08 -48.07 81.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.295 1.038 . . . . 0.0 110.364 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.19 74.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.242 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.4 m-30 -67.76 -27.95 67.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.679 0.672 . . . . 0.0 111.213 -177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -30.05 66.69 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.281 0.946 . . . . 0.0 110.89 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.69 -14.82 38.85 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.718 1.207 . . . . 0.0 112.284 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.72 0.75 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.149 1.38 . . . . 0.0 111.425 -162.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.97 -162.79 13.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -101.67 167.92 9.8 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 109.043 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 86' ' ' LEU . 72.8 mt -133.62 150.8 32.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 125.181 1.393 . . . . 0.0 107.3 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.88 124.82 25.6 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.255 1.822 . . . . 0.0 106.29 170.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 16.5 t -152.31 -150.21 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.708 2.003 . . . . 0.0 106.884 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.01 -23.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.768 1.167 . . . . 0.0 113.401 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 103' ' ' VAL . 1.4 m-20 -72.91 140.73 47.68 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.901 1.681 . . . . 0.0 113.483 -156.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.41 -38.57 54.22 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.057 -1.652 . . . . 0.0 113.257 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.07 -47.79 60.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 111.341 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 0.3 OUTLIER -57.56 -37.04 56.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.046 1.294 . . . . 0.0 110.38 -177.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 35.7 mt-30 -68.84 -39.55 79.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -63.94 -56.29 16.33 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.401 0.68 . . . . 0.0 110.324 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 78' ' ' LEU . 13.8 mm -54.55 -52.67 38.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.494 1.043 . . . . 0.0 109.851 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.71 73.11 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.522 1.51 . . . . 0.0 113.298 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 t -55.8 -62.12 1.91 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.954 172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -25.38 68.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.368 1.44 . . . . 0.0 111.927 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -83.33 -10.16 58.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.78 82.22 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.563 -1.132 . . . . 0.0 113.879 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.568 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -92.22 135.51 33.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.497 1.648 . . . . 0.0 111.13 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.568 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -81.37 131.76 35.3 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.613 1.965 . . . . 0.0 110.435 177.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 26.7 p90 -150.98 -175.28 5.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.664 -0.647 . . . . 0.0 110.986 -174.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -98.98 175.28 5.98 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.161 1.384 . . . . 0.0 114.239 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p -142.24 115.22 8.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.96 1.304 . . . . 0.0 110.423 171.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -61.83 -60.68 3.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.153 0.981 . . . . 0.0 109.181 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -77.32 178.59 7.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.618 1.167 . . . . 0.0 109.149 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -53.18 141.39 23.45 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.18 -0.95 . . . . 0.0 108.633 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.6 98.25 0.11 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 104.991 -3.244 . . . . 0.0 104.991 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 pt -67.88 155.67 7.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.041 0.936 . . . . 0.0 110.226 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -138.15 -26.18 0.93 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.768 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -141.87 24.44 2.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.164 1.347 . . . . 0.0 112.663 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.61 150.3 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.21 159.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -63.03 151.53 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.074 -1.016 . . . . 0.0 109.664 169.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 7.8 p-90 -157.01 171.56 20.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.947 0.499 . . . . 0.0 109.924 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -0.3 0.11 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.63 150.06 44.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.665 1.575 . . . . 0.0 111.613 -169.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.79 128.42 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.842 1.257 . . . . 0.0 109.436 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.1 t -65.91 144.15 56.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 166.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.23 94.92 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.09 -90.78 0.1 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.97 13.24 17.19 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.183 0.993 . . . . 0.0 111.367 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.09 22.93 61.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.013 1.292 . . . . 0.0 115.122 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -65.46 125.78 26.22 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 110.056 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -72.78 150.99 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.938 0.773 . . . . 0.0 109.873 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.31 149.69 38.16 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.501 1.12 . . . . 0.0 109.229 166.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 42.9 t -86.11 -26.98 24.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.135 0.574 . . . . 0.0 111.674 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.7 p -145.3 160.02 42.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.392 1.477 . . . . 0.0 108.238 -171.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -74.57 123.42 89.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.49 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.91 172.06 15.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.858 2.372 . . . . 0.0 110.206 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.1 137.4 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 121.918 1.745 . . . . 0.0 110.269 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.59 -9.79 1.69 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.544 1.069 . . . . 0.0 114.172 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.8 35.77 87.67 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.87 1.335 . . . . 0.0 111.724 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.56 158.2 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.383 1.073 . . . . 0.0 108.121 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.8 t -71.08 113.03 15.69 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 117.252 -1.356 . . . . 0.0 108.082 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.36 -18.81 25.96 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.51 1.474 . . . . 0.0 113.189 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -27.15 15.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.088 1.755 . . . . 0.0 111.882 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.7 p -140.4 -2.77 1.39 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.43 -13.9 2.66 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.464 1.983 . . . . 0.0 115.317 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 163.1 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.177 1.489 . . . . 0.0 111.789 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.11 154.34 41.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.524 0.678 . . . . 0.0 109.768 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.8 t -108.17 148.48 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -129.96 160.8 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.335 1.054 . . . . 0.0 110.697 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.45 116.56 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.082 1.353 . . . . 0.0 107.803 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.5 168.41 24.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.459 1.104 . . . . 0.0 111.657 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.48 59.76 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.885 3.724 . . . . 0.0 112.24 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 56.27 -166.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.705 1.602 . . . . 0.0 110.884 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 -35.94 0.53 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.143 2.177 . . . . 0.0 113.376 -166.235 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.94 110.76 16.67 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.955 2.102 . . . . 0.0 106.336 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -133.62 83.8 2.08 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.779 1.172 . . . . 0.0 108.12 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -152.37 -63.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.769 1.168 . . . . 0.0 109.439 -177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.9 149.17 37.14 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.97 -34.36 5.44 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -155.24 179.72 8.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.8 m -63.48 125.61 24.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -146.37 134.41 21.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.65 152.39 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.72 135.32 50.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.369 2.267 . . . . 0.0 109.409 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.33 161.36 14.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.97 2.108 . . . . 0.0 110.941 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.504 ' HB2' HG21 ' A' ' 30' ' ' VAL . 28.6 t -46.38 -45.17 17.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.399 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -52.19 -35.35 48.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.871 0.868 . . . . 0.0 111.92 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.18 -35.87 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.144 0.978 . . . . 0.0 109.626 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.2 -37.6 25.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.66 0.784 . . . . 0.0 111.025 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.92 -41.95 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.975 0.91 . . . . 0.0 109.205 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -79.13 -13.92 59.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 24.42 65.1 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.274 0.94 . . . . 0.0 113.864 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -78.82 108.19 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 C-N-CA 124.557 1.143 . . . . 0.0 108.417 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.05 111.75 3.52 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tp -154.45 159.62 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 127.348 2.259 . . . . 0.0 106.756 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -128.24 128.62 45.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.641 1.176 . . . . 0.0 110.498 -166.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.13 -147.65 9.08 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.236 1.398 . . . . 0.0 111.943 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.96 158.1 24.65 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.11 1.764 . . . . 0.0 110.144 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -145.74 166.29 26.3 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -90.09 125.56 60.01 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.619 0.724 . . . . 0.0 111.618 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG12 ' A' ' 31' ' ' VAL . 55.8 Cg_endo -63.07 -12.58 30.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.235 1.29 . . . . 0.0 111.163 166.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -32.94 67.39 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 126.873 2.069 . . . . 0.0 112.698 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.504 HG21 ' HB2' ' A' ' 13' ' ' SER . 11.3 p -92.8 -34.37 5.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 120.267 1.394 . . . . 0.0 110.632 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 28' ' ' PRO . 7.7 p -61.49 -16.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.849 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.392 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.65 -21.69 10.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.461 1.904 . . . . 0.0 110.799 -166.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 mt -67.81 96.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -90.45 -24.76 20.62 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 112.117 165.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.26 129.2 24.12 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.304 1.842 . . . . 0.0 111.549 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -51.4 -72.01 0.06 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 126.208 1.803 . . . . 0.0 110.535 -170.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.98 -48.02 83.76 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -164.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.8 t -50.48 -56.37 11.88 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.988 1.715 . . . . 0.0 110.088 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -61.4 -53.91 50.46 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.358 1.063 . . . . 0.0 110.61 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.5 mt -55.67 -50.17 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.27 1.028 . . . . 0.0 108.621 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.17 -48.41 80.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.7 -48.5 77.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.04 -1.037 . . . . 0.0 110.456 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.43 -40.87 92.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.997 0.919 . . . . 0.0 110.61 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 t -57.68 -51.1 70.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.166 1.386 . . . . 0.0 110.425 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.14 -38.08 89.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.809 0.843 . . . . 0.0 110.616 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.02 -50.97 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.7 t -59.54 -35.82 74.94 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.456 0.702 . . . . 0.0 111.015 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.17 -11.59 59.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.266 1.426 . . . . 0.0 112.725 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.44 87.1 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.721 1.153 . . . . 0.0 113.443 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 3.3 ptpt -78.42 -19.71 52.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.188 0.995 . . . . 0.0 112.07 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.43 136.78 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -125.72 140.9 52.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.52 0.676 . . . . 0.0 110.398 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.48 126.64 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.04 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.37 127.4 9.71 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.102 1.361 . . . . 0.0 109.212 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -99.57 155.05 36.93 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.505 0.722 . . . . 0.0 112.77 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.03 173.75 8.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.23 3.954 . . . . 0.0 112.235 165.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.08 173.16 8.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.887 2.075 . . . . 0.0 110.151 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -54.1 -49.86 68.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.833 -0.542 . . . . 0.0 110.251 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.08 -31.04 71.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.348 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -51.98 53.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.177 0.991 . . . . 0.0 110.31 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.27 -45.68 97.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.36 -39.9 70.64 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.661 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -45.63 46.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.415 1.486 . . . . 0.0 110.556 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -71.42 -46.85 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -177.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.3 mt -53.17 -43.41 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.317 1.047 . . . . 0.0 110.339 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.55 -57.52 12.4 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.571 0.623 . . . . 0.0 110.199 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.74 -37.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.9 71.97 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.411 1.084 . . . . 0.0 111.482 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -35.14 80.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.928 1.24 . . . . 0.0 111.164 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.86 -42.72 94.63 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.741 0.7 . . . . 0.0 110.715 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 t -80.98 -41.03 23.42 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.183 0.447 . . . . 0.0 111.94 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.32 146.18 6.37 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.787 1.661 . . . . 0.0 109.045 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 83.05 50.59 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 130.39 3.476 . . . . 0.0 109.21 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.48 -52.76 48.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 121.153 -0.967 . . . . 0.0 113.413 -170.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.09 11.02 15.17 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.083 0.553 . . . . 0.0 110.528 -167.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -20.74 32.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.534 0.734 . . . . 0.0 112.199 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -73.64 150.78 41.1 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.5 m -58.98 152.17 20.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.299 1.047 . . . . 0.0 110.812 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -59.19 4.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.58 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.56 77.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.888 0.743 . . . . 0.0 111.737 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.97 -55.25 37.1 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.173 0.989 . . . . 0.0 108.522 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.5 -43.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.838 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -65.49 -51.55 59.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.447 0.567 . . . . 0.0 111.435 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.27 -48.83 83.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.322 1.049 . . . . 0.0 109.301 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 96' ' ' ILE . 81.1 mt -58.22 -57.45 12.82 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.941 0.897 . . . . 0.0 109.614 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.92 -46.8 64.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.177 1.391 . . . . 0.0 112.663 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.06 -49.35 78.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.487 1.115 . . . . 0.0 109.167 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.98 75.12 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.709 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.504 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.6 m-30 -69.97 -26.3 64.03 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.109 0.868 . . . . 0.0 110.288 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.41 -7.09 51.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.316 1.046 . . . . 0.0 112.4 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.39 -10.61 8.43 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.266 1.427 . . . . 0.0 112.142 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.9 mttt 51.97 34.84 14.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 110.533 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.59 -130.37 6.66 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.712 1.149 . . . . 0.0 110.456 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -133.85 170.38 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.611 1.964 . . . . 0.0 109.917 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.461 HD13 HD23 ' A' ' 86' ' ' LEU . 66.5 mt -133.99 153.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 126.207 1.803 . . . . 0.0 106.489 -172.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.47 115.89 16.08 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 109.289 166.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 t -157.58 -172.53 4.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.061 3.344 . . . . 0.0 108.394 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.91 6.45 0.7 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -168.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.551 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.5 t0 -102.19 160.54 14.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.168 1.349 . . . . 0.0 111.96 -157.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -64.75 -48.55 74.15 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.51 -1.369 . . . . 0.0 111.636 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -69.33 -48.35 61.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.714 1.206 . . . . 0.0 109.78 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.551 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -56.53 -43.55 78.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -172.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.401 ' HG2' ' HE2' ' A' ' 114' ' ' PHE . 34.8 mt-30 -63.86 -47.79 79.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.32 0.648 . . . . 0.0 110.154 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.6 t-20 -56.08 -59.93 4.21 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.196 1.798 . . . . 0.0 108.226 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.16 -53.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 119.753 1.161 . . . . 0.0 111.254 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.37 67.71 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.367 1.44 . . . . 0.0 112.204 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -57.74 10.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -68.52 -21.92 64.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.15 1.341 . . . . 0.0 111.629 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.504 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.8 mm? -81.82 -22.15 37.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.473 0.709 . . . . 0.0 111.454 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.5 9.9 71.5 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.563 1.554 . . . . 0.0 114.232 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.22 123.86 29.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.853 1.327 . . . . 0.0 110.374 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 135.02 55.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.565 1.546 . . . . 0.0 109.05 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.401 ' HE2' ' HG2' ' A' ' 104' ' ' GLN . 18.3 p90 -151.23 175.27 12.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -107.35 166.51 10.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.62 155.49 44.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.97 -168.55 0.29 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.794 0.837 . . . . 0.0 109.859 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.24 88.92 0.09 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.678 1.591 . . . . 0.0 109.221 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -55.77 -20.96 16.74 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.737 1.615 . . . . 0.0 112.968 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.3 -128.83 3.13 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.09 157.25 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.237 1.415 . . . . 0.0 107.648 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -64.53 0.69 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.66 0.784 . . . . 0.0 109.195 167.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -135.77 65.53 1.54 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.94 152.15 14.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -71.12 168.22 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -55.81 -179.78 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.562 1.545 . . . . 0.0 111.023 158.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -150.34 154.38 37.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -149.82 9.71 0.7 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 117.352 -1.309 . . . . 0.0 113.532 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -133.96 138.94 45.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.907 1.231 . . . . 0.0 111.381 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.39 134.54 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.074 1.35 . . . . 0.0 109.298 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 122.06 24.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.071 0.949 . . . . 0.0 108.541 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.79 108.11 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.12 -80.66 0.2 Allowed Glycine 0 N--CA 1.458 0.136 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.5 p -88.45 -16.76 31.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.14 0.47 . . . . 0.0 111.885 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.11 32.5 43.78 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.546 0.593 . . . . 0.0 113.075 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 138' ' ' PHE . 42.5 ttt-85 -70.14 157.6 37.31 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 117.875 0.837 . . . . 0.0 109.772 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -101.32 146.63 27.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.353 1.461 . . . . 0.0 108.838 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 136' ' ' ARG . 97.4 m-85 -140.02 148.3 41.64 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.974 1.31 . . . . 0.0 108.321 169.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 t -94.22 -23.61 17.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.672 0.789 . . . . 0.0 110.566 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.9 p -136.97 157.64 46.27 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.615 0.766 . . . . 0.0 109.856 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -74.59 110.47 9.78 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.49 ' HD2' HD23 ' A' ' 141' ' ' LEU . 88.5 Cg_endo -68.62 172.02 12.21 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.918 3.079 . . . . 0.0 110.536 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.81 120.02 7.51 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.012 1.808 . . . . 0.0 109.632 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.47 -6.89 81.12 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.079 1.324 . . . . 0.0 113.417 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 59.48 38.54 93.7 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 119.255 1.528 . . . . 0.0 112.43 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -116.11 174.94 3.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 124.694 1.198 . . . . 0.0 108.397 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.19 100.31 2.13 Favored Pre-proline 0 CA--C 1.519 -0.239 0 CA-C-N 120.849 1.659 . . . . 0.0 109.355 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.14 37.49 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.932 3.754 . . . . 0.0 113.946 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.01 -16.08 0.21 Allowed 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.38 2.272 . . . . 0.0 112.004 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.8 p -146.73 -31.57 0.34 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.23 92.49 0.96 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.904 1.716 . . . . 0.0 111.128 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.43 174.01 2.85 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.638 1.975 . . . . 0.0 108.042 170.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -76.3 137.63 40.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.03 1.287 . . . . 0.0 111.958 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.35 157.94 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 156.62 44.07 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.699 -1.25 . . . . 0.0 110.969 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.24 146.08 35.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.672 0.789 . . . . 0.0 109.149 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 pt -114.02 163.27 19.34 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 93.34 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.49 2.794 . . . . 0.0 111.209 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 61.84 -175.74 0.13 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.122 1.369 . . . . 0.0 110.58 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.428 ' O ' ' HE3' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -69.38 -27.12 65.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.898 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 124.19 0.996 . . . . 0.0 109.615 -146.732 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttp . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp 43.4 71.52 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.585 1.954 . . . . 0.0 111.653 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -138.81 99.78 3.88 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.31 -39.36 92.38 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.869 -176.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -150.05 -45.7 0.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.032 0.833 . . . . 0.0 110.201 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.94 -164.52 1.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.861 2.065 . . . . 0.0 109.796 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -59.29 159.48 7.73 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.724 -0.61 . . . . 0.0 111.545 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -50.58 125.94 14.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.593 1.557 . . . . 0.0 109.043 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -144.44 142.54 30.37 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.57 148.56 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.18 133.85 53.45 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.464 1.506 . . . . 0.0 108.905 -171.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.52 161.81 20.09 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.88 1.672 . . . . 0.0 111.861 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -45.75 11.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.951 1.7 . . . . 0.0 111.822 171.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.0 p -61.54 -31.73 71.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.334 0.515 . . . . 0.0 111.938 -174.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 t -61.75 -42.56 94.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.656 1.182 . . . . 0.0 109.33 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.53 -37.32 71.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.663 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 91.3 mt -55.31 -54.43 25.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.07 -26.17 65.71 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.84 0.746 . . . . 0.0 111.461 -173.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 42' ' ' PHE . . . 91.23 37.25 6.31 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.79 108.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.35 112.61 7.62 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.33 174.37 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.082 1.353 . . . . 0.0 107.778 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -120.4 149.79 41.8 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.547 1.539 . . . . 0.0 108.339 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.74 -137.64 5.96 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.39 153.5 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.589 1.155 . . . . 0.0 110.452 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -129.38 144.63 51.32 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.522 1.129 . . . . 0.0 109.8 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.9 p -84.38 121.3 75.14 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 124.757 1.223 . . . . 0.0 109.804 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 31' ' ' VAL . 19.0 Cg_endo -65.42 -14.14 43.39 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.62 1.547 . . . . 0.0 113.665 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -74.75 -44.11 51.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.32 -36.11 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 119.402 1.001 . . . . 0.0 109.269 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 28' ' ' PRO . 10.0 p -64.21 -20.16 26.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 118.855 -1.138 . . . . 0.0 113.358 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.09 -25.3 68.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.249 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.94 -30.23 65.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.323 1.049 . . . . 0.0 109.893 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.96 82.56 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.973 2.109 . . . . 0.0 109.49 -164.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -20.17 60.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.215 1.406 . . . . 0.0 112.179 169.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.01 133.22 47.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.844 0.858 . . . . 0.0 110.89 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.3 mmt-85 -61.83 -59.65 4.83 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.96 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.19 -45.52 91.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 118.261 -0.876 . . . . 0.0 108.998 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 t -55.9 -56.23 23.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.276 0.63 . . . . 0.0 110.75 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -60.14 -51.43 69.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.624 1.102 . . . . 0.0 111.585 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.21 -57.62 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' CE2' ' HA2' ' A' ' 19' ' ' GLY . 68.4 t80 -56.46 -45.68 80.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.139 0.976 . . . . 0.0 112.219 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 31' ' ' VAL . 6.4 tt -54.48 -52.48 61.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.11 0.964 . . . . 0.0 108.525 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -70.48 -28.03 64.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.707 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -61.44 -50.27 73.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.422 1.01 . . . . 0.0 108.548 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -42.73 80.93 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.675 1.19 . . . . 0.0 111.402 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.83 -56.56 17.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -28.52 69.24 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.98 -13.2 60.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.397 1.479 . . . . 0.0 112.103 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.94 -6.7 51.87 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.603 1.573 . . . . 0.0 113.784 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -87.12 -23.42 24.87 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 118.486 1.143 . . . . 0.0 112.99 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.49 149.48 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 120.666 1.575 . . . . 0.0 107.457 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -135.16 156.73 48.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.709 -0.619 . . . . 0.0 111.007 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.35 131.52 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.87 0.868 . . . . 0.0 108.99 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.12 128.19 6.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.847 1.259 . . . . 0.0 110.036 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.33 158.82 32.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.163 0.985 . . . . 0.0 112.584 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -75.34 145.47 30.36 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.238 3.292 . . . . 0.0 112.891 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -65.01 155.35 34.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.156 0.982 . . . . 0.0 109.947 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -65.82 -36.11 82.56 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.904 -1.123 . . . . 0.0 109.479 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -21.74 64.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.973 0.806 . . . . 0.0 111.204 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 p -85.03 -38.17 19.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.102 0.864 . . . . 0.0 112.755 172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.47 1.032 . . . . 0.0 108.263 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -28.32 64.28 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.816 0.446 . . . . 0.0 111.451 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.69 98.72 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.548 -0.72 . . . . 0.0 111.741 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -67.24 -46.29 84.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.212 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -57.27 -28.77 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.737 0.698 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.11 -72.77 0.15 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.215 1.371 . . . . 0.0 108.962 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.62 -36.61 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.508 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -65.77 -40.81 92.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -27.2 61.59 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 121.692 2.042 . . . . 0.0 112.129 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.11 -52.3 59.83 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -69.87 -42.81 72.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.335 0.654 . . . . 0.0 111.586 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.9 -66.02 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.958 0.799 . . . . 0.0 112.452 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -71.47 45.96 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.848 2.859 . . . . 0.0 114.648 -165.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.4 p -40.33 -44.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 128.177 2.591 . . . . 0.0 115.988 -167.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -131.31 11.54 4.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.023 0.929 . . . . 0.0 110.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -12.77 61.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.153 0.581 . . . . 0.0 110.503 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 174.3 8.64 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.685 1.194 . . . . 0.0 110.183 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -68.11 154.0 42.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.798 1.285 . . . . 0.0 110.979 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HE3' ' N ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -54.2 -52.6 60.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.137 1.375 . . . . 0.0 110.786 162.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' N ' ' HE3' ' A' ' 80' ' ' LYS . . . -63.47 -35.79 81.62 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 123.573 0.546 . . . . 0.0 109.566 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.7 -53.99 46.08 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -52.16 -40.05 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.042 0.937 . . . . 0.0 109.311 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.31 -54.93 10.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.404 1.002 . . . . 0.0 113.325 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.64 -50.18 74.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.803 1.241 . . . . 0.0 109.11 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 96' ' ' ILE . 82.1 mt -59.43 -56.01 27.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.596 1.158 . . . . 0.0 109.62 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -56.38 6.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.463 1.105 . . . . 0.0 111.252 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -48.93 73.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 123.776 0.672 . . . . 0.0 110.051 -174.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.32 72.32 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.212 -0.93 . . . . 0.0 113.174 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.7 m-30 -73.08 -30.5 63.73 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.931 0.787 . . . . 0.0 110.477 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -31.64 69.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.51 1.124 . . . . 0.0 110.171 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.65 -12.45 21.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.428 1.891 . . . . 0.0 112.738 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.65 28.61 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.836 1.255 . . . . 0.0 112.065 -167.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.25 -144.17 13.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -115.06 166.3 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.912 2.085 . . . . 0.0 109.732 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.481 HD13 HD23 ' A' ' 86' ' ' LEU . 28.9 mt -131.99 160.96 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.26 114.07 13.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 164.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 t -165.36 162.28 19.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -152.48 26.39 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.825 -1.172 . . . . 0.0 112.829 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t0 -88.53 158.52 18.28 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.792 -1.193 . . . . 0.0 110.982 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -62.58 -49.5 75.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.994 1.27 . . . . 0.0 110.083 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -70.58 -46.99 62.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.06 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -60.63 -33.9 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.302 0.955 . . . . 0.0 109.716 -171.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -70.4 -38.95 74.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.41 0.684 . . . . 0.0 109.966 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -68.32 -54.95 13.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.78 -54.79 8.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.464 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.68 -41.78 67.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.822 1.646 . . . . 0.0 113.58 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -54.79 -60.07 3.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.643 0.777 . . . . 0.0 112.023 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -21.12 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.174 1.352 . . . . 0.0 112.613 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -81.83 3.1 27.26 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.416 1.087 . . . . 0.0 111.986 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.15 29.06 64.96 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.066 -1.408 . . . . 0.0 112.325 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.53 126.24 52.28 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.173 1.487 . . . . 0.0 111.645 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 126.13 30.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.657 1.183 . . . . 0.0 109.138 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -131.22 -170.13 2.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.489 1.516 . . . . 0.0 109.043 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.94 149.17 52.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.4 p -108.31 -174.86 2.62 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 125.073 1.483 . . . . 0.0 109.161 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -148.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.935 2.094 . . . . 0.0 111.119 -173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 tttm 42.26 80.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.917 2.487 . . . . 0.0 112.139 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.88 156.98 3.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.939 0.896 . . . . 0.0 109.104 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.59 40.67 1.35 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.296 1.427 . . . . 0.0 112.17 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.3 mm 57.55 154.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 130.251 3.42 . . . . 0.0 113.012 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -143.07 -61.67 0.42 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.782 -1.199 . . . . 0.0 108.491 162.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.45 -4.85 15.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 125' ' ' ILE . 1.5 t -101.23 -175.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 126.054 1.742 . . . . 0.0 107.248 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.42 ' H ' HG12 ' A' ' 124' ' ' VAL 0.281 16.8 mt 29.27 77.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 129.495 3.118 . . . . 0.0 113.066 176.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 81.53 1.67 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.852 1.661 . . . . 0.0 108.717 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -54.69 141.01 33.78 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.287 2.235 . . . . 0.0 111.725 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' C ' HG12 ' A' ' 157' ' ' ILE . 75.9 mtm-85 -141.72 24.92 2.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.171 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.481 ' C ' HD11 ' A' ' 157' ' ' ILE . 7.9 m-85 -145.06 139.91 27.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.094 1.77 . . . . 0.0 111.426 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 157' ' ' ILE . 7.4 p -128.34 130.76 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.845 1.658 . . . . 0.0 107.501 -176.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.86 120.63 16.74 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 162.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.09 127.68 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.42 -75.32 0.38 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 4.4 p -80.4 -8.04 59.36 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.138 0.469 . . . . 0.0 112.196 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.61 37.01 92.74 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.153 1.359 . . . . 0.0 112.637 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -77.46 137.42 38.66 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.578 -0.954 . . . . 0.0 108.726 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.79 144.07 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.547 1.139 . . . . 0.0 108.71 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.37 151.75 45.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.085 1.754 . . . . 0.0 107.814 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.6 t -111.82 -7.93 14.16 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.887 -0.508 . . . . 0.0 110.502 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 p -136.05 156.4 48.78 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.824 -1.173 . . . . 0.0 109.755 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.4 tp -74.53 120.11 79.88 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -65.67 169.03 13.63 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.412 2.075 . . . . 0.0 110.087 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.77 112.8 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 111.343 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.74 -5.02 83.77 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.407 1.479 . . . . 0.0 113.116 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.81 45.42 95.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.455 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.91 154.11 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.14 113.71 19.91 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.361 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.27 7.48 2.55 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.146 2.564 . . . . 0.0 112.551 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -117.51 -23.71 7.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.78 1.632 . . . . 0.0 113.02 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.8 -24.0 1.16 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.58 79.17 0.52 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -155.4 170.66 21.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.871 0.868 . . . . 0.0 109.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -82.28 132.37 35.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.869 0.842 . . . . 0.0 109.653 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.77 142.89 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.21 170.86 15.3 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.086 1.354 . . . . 0.0 109.528 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.67 153.12 43.99 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.058 1.343 . . . . 0.0 110.825 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 129' ' ' TYR . 19.5 mm -75.24 152.07 85.93 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.517 1.527 . . . . 0.0 110.284 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.17 88.1 0.59 Allowed 'Trans proline' 0 N--CA 1.431 -2.149 0 O-C-N 123.138 1.073 . . . . 0.0 110.072 164.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 39.14 78.4 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.792 2.837 . . . . 0.0 113.563 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -52.2 65.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.065 0.936 . . . . 0.0 110.63 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 . . . . . 0 C--O 1.251 1.148 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 168.367 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 mmt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 120.218 0.056 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.45 64.31 0.84 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.117 0.967 . . . . 0.0 110.161 -160.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.15 158.55 43.66 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 159.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -138.81 111.15 7.45 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.84 168.21 25.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.489 0.716 . . . . 0.0 110.806 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -53.9 1.29 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.286 . . . . 0.0 108.384 162.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -137.58 166.36 24.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.768 0.827 . . . . 0.0 109.95 167.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.1 m -55.78 122.99 12.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 tt -145.65 145.12 30.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.57 161.93 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 124.45 1.094 . . . . 0.0 109.624 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 mt -137.57 145.91 43.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.989 1.715 . . . . 0.0 108.513 -167.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.38 163.05 12.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.912 1.285 . . . . 0.0 112.049 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 30' ' ' VAL . 1.4 p -51.21 -41.25 60.14 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.35 1.06 . . . . 0.0 111.77 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -67.08 -27.11 67.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.614 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.57 -44.08 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.12 -35.65 74.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.615 0.766 . . . . 0.0 110.773 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.74 -48.56 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.169 0.441 . . . . 0.0 110.21 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -72.82 -27.66 62.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.135 0.425 . . . . 0.0 110.196 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.96 38.9 10.71 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.412 ' CD1' HD21 ' A' ' 117' ' ' LEU . 8.6 mt -77.05 112.23 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.28 92.88 1.83 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.966 1.307 . . . . 0.0 109.366 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 148.78 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.24 1.416 . . . . 0.0 108.42 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -112.34 125.1 53.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 -168.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' VAL . . . 175.98 -179.06 47.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.287 0.949 . . . . 0.0 112.642 -171.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -78.67 152.77 31.46 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.139 -1.212 . . . . 0.0 110.363 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 t -137.1 160.44 38.95 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.784 2.034 . . . . 0.0 108.928 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.67 124.4 52.86 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 125.201 1.4 . . . . 0.0 109.337 -169.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.1 -22.33 55.43 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.783 1.655 . . . . 0.0 111.4 169.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -78.42 -17.08 56.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.656 1.982 . . . . 0.0 114.533 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.5 p -107.26 -33.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.23 1.377 . . . . 0.0 111.783 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -63.51 -15.55 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.767 1.167 . . . . 0.0 111.634 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -63.75 -18.87 64.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.653 -1.28 . . . . 0.0 113.567 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -101.28 -27.34 13.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 0.0 111.26 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.6 mt -62.7 102.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -13.0 6.89 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.058 0.943 . . . . 0.0 112.284 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.75 124.21 19.77 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -59.45 -36.95 76.92 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.984 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -55.02 -58.13 8.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.04 -41.05 91.39 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.46 1.904 . . . . 0.0 111.508 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -69.79 -52.38 25.67 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.38 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -46.76 -51.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.42 -63.2 1.27 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.019 0.927 . . . . 0.0 110.97 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 tp -48.54 -50.64 31.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.407 1.483 . . . . 0.0 112.879 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.31 -41.75 89.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.941 0.896 . . . . 0.0 110.851 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 m -63.27 -43.56 97.58 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.754 0.422 . . . . 0.0 109.926 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.5 99.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 0.0 110.593 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.44 -46.96 94.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -61.48 -46.48 89.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.178 0.991 . . . . 0.0 110.37 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.22 -5.38 38.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.455 1.502 . . . . 0.0 112.179 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.66 19.88 76.88 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 121.001 -1.062 . . . . 0.0 112.024 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -64.72 -38.83 92.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 164.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 70.4 t -122.78 150.75 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -136.78 147.41 46.62 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.001 0.92 . . . . 0.0 110.165 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.66 123.95 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.87 135.4 17.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.823 1.249 . . . . 0.0 108.517 170.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.3 155.59 37.61 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.411 0.684 . . . . 0.0 110.647 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.51 165.5 17.7 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.831 3.021 . . . . 0.0 112.628 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -81.84 158.5 24.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 164.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -39.04 74.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.541 -0.724 . . . . 0.0 111.539 170.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -29.15 70.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.127 -0.463 . . . . 0.0 111.281 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -65.43 -51.76 57.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.049 1.34 . . . . 0.0 108.238 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.32 -49.26 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.294 0.638 . . . . 0.0 109.908 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -59.39 -38.99 81.95 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.013 -0.429 . . . . 0.0 110.56 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -37.66 68.42 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.424 -0.797 . . . . 0.0 111.734 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.85 -53.44 30.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt -49.77 -36.53 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.548 1.139 . . . . 0.0 111.281 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -57.76 -69.4 0.17 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.672 0.789 . . . . 0.0 109.655 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.76 -31.64 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.136 -0.353 . . . . 0.0 110.405 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.34 75.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.416 1.487 . . . . 0.0 111.076 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -32.88 73.34 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.097 -1.002 . . . . 0.0 110.63 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.83 4.25 2.68 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.304 -0.873 . . . . 0.0 111.773 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 t -126.74 -3.29 6.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.263 1.392 . . . . 0.0 112.632 166.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.06 -86.08 0.39 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.159 1.838 . . . . 0.0 110.365 170.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -64.99 70.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 129.658 3.183 . . . . 0.0 112.369 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.73 -48.89 84.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.336 1.854 . . . . 0.0 113.284 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -123.1 7.8 9.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.903 0.881 . . . . 0.0 109.782 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -6.73 44.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.727 1.611 . . . . 0.0 112.581 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.26 162.37 16.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.297 1.039 . . . . 0.0 109.492 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 t -61.77 147.42 46.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.079 0.951 . . . . 0.0 108.958 168.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -61.24 -44.39 97.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.05 -38.6 68.2 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.686 0.616 . . . . 0.0 110.012 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -63.48 -56.86 12.78 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.383 1.473 . . . . 0.0 110.742 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.35 -40.25 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.465 1.506 . . . . 0.0 109.247 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -69.07 -46.61 67.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 113.173 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.58 -52.54 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 96' ' ' ILE . 64.1 mt -54.51 -55.07 32.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.164 1.386 . . . . 0.0 109.114 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.27 -51.66 57.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.496 1.518 . . . . 0.0 112.616 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.6 tp -50.67 -51.93 44.66 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -62.34 -17.17 58.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -86.31 -37.43 18.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.459 0.704 . . . . 0.0 110.676 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.27 -42.92 64.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.669 1.187 . . . . 0.0 110.587 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 89' ' ' ALA . 1.1 pp -109.19 6.26 24.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.916 1.686 . . . . 0.0 111.645 -171.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 43.27 52.82 5.61 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.635 1.974 . . . . 0.0 111.159 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 -119.9 3.89 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.838 1.209 . . . . 0.0 110.675 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -153.57 169.01 24.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.892 1.677 . . . . 0.0 106.682 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 86' ' ' LEU . 31.5 mt -133.91 160.25 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.58 114.38 13.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 167.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 p -169.16 145.72 3.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.377 1.071 . . . . 0.0 108.945 -158.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -143.44 -6.5 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.059 1.754 . . . . 0.0 115.014 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.45 149.17 5.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.03 1.332 . . . . 0.0 112.58 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -57.51 -38.37 74.5 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.692 -1.255 . . . . 0.0 112.374 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -55.02 12.5 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.813 1.245 . . . . 0.0 110.197 173.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -58.35 -40.92 79.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.238 0.615 . . . . 0.0 110.647 -167.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.46 -40.79 98.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.54 -56.97 9.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.0 mm -52.25 -51.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.599 0.636 . . . . 0.0 110.326 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.95 72.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.161 1.346 . . . . 0.0 112.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -62.8 -58.24 8.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 117.668 -1.158 . . . . 0.0 111.171 175.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -31.57 70.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.329 1.422 . . . . 0.0 111.171 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -73.73 -30.29 62.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.137 0.575 . . . . 0.0 111.327 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.65 5.06 63.37 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.802 1.191 . . . . 0.0 114.108 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 118.05 22.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.649 1.224 . . . . 0.0 109.387 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 140.92 58.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.3 -178.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.166 0.986 . . . . 0.0 109.743 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -115.61 145.16 42.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.189 1.396 . . . . 0.0 109.792 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -111.34 169.94 8.45 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.337 1.055 . . . . 0.0 110.519 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 117' ' ' LEU . 3.1 mm? -86.82 -174.96 5.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.424 1.09 . . . . 0.0 110.053 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -76.48 62.1 1.83 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.408 1.883 . . . . 0.0 112.817 -173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -73.36 -149.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.056 -1.027 . . . . 0.0 109.284 166.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.15 -4.55 75.86 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.12 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mm 59.84 99.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 127.253 2.221 . . . . 0.0 110.505 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -119.16 -13.2 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.125 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -145.19 -59.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.514 1.052 . . . . 0.0 110.331 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.44 148.05 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.474 0.71 . . . . 0.0 111.078 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.83 172.95 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.186 2.194 . . . . 0.0 105.77 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -143.72 111.43 6.03 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -54.01 161.87 1.12 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.474 2.309 . . . . 0.0 113.477 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -161.62 18.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -142.17 157.66 44.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.418 1.008 . . . . 0.0 111.83 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 p -142.89 137.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 124.75 1.22 . . . . 0.0 109.064 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.0 t -71.52 125.51 27.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.031 1.332 . . . . 0.0 108.206 163.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.37 118.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.96 -77.95 0.38 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 1.2 p -75.04 -3.54 33.13 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.52 0.66 . . . . 0.0 111.608 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.13 19.78 57.4 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.431 1.967 . . . . 0.0 114.146 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 11.9 ttt-85 -77.68 137.68 38.65 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -74.34 148.35 41.4 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.03 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -140.14 134.68 31.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.939 1.296 . . . . 0.0 108.215 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -25.67 24.65 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.665 1.186 . . . . 0.0 111.137 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.6 p -147.04 173.8 12.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.692 1.997 . . . . 0.0 107.114 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 114.56 65.81 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -163.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.76 168.39 13.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.061 1.841 . . . . 0.0 110.484 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.63 142.28 95.66 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.356 2.037 . . . . 0.0 110.344 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.12 -7.61 0.77 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.236 0.922 . . . . 0.0 113.922 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.8 63.96 3.81 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 117.928 -1.485 . . . . 0.0 109.601 -156.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.08 149.14 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 16.2 t -72.05 112.72 15.51 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.797 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.92 -17.07 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 CA-C-N 121.499 1.571 . . . . 0.0 113.302 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.57 -29.33 13.93 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.392 1.877 . . . . 0.0 111.903 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.89 -3.79 1.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.47 -13.55 50.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.089 1.804 . . . . 0.0 115.472 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.87 162.47 25.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.764 1.782 . . . . 0.0 114.26 -168.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -68.43 135.3 51.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.806 -1.184 . . . . 0.0 112.66 -173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.45 140.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.697 1.199 . . . . 0.0 109.228 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.35 164.93 28.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.656 1.582 . . . . 0.0 110.691 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.22 141.13 32.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.509 1.524 . . . . 0.0 111.479 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.27 163.0 19.36 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.783 1.233 . . . . 0.0 112.471 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.07 69.35 3.13 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.734 3.623 . . . . 0.0 112.126 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 54.3 179.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.54 1.936 . . . . 0.0 113.762 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.9 -56.08 5.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 C--O 1.244 0.794 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -175.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 mtm . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 tp -89.23 47.97 1.56 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -175.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 65.38 -39.37 0.28 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.362 2.665 . . . . 0.0 114.22 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 m120 42.05 71.31 0.22 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 129.907 3.283 . . . . 0.0 111.933 164.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 167.19 22.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.064 0.945 . . . . 0.0 113.308 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.39 -178.96 6.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.351 1.46 . . . . 0.0 110.725 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -56.67 169.84 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.859 1.664 . . . . 0.0 114.179 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.5 m -57.86 130.28 45.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.4 tp -155.24 142.66 19.55 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -121.39 161.35 21.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -137.85 151.18 47.81 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.68 1.592 . . . . 0.0 107.525 -165.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -117.46 167.82 10.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.926 0.89 . . . . 0.0 111.601 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' HG21 ' A' ' 30' ' ' VAL . 48.6 p -49.0 -48.25 43.7 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.36 1.464 . . . . 0.0 110.805 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -50.85 -37.64 44.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.533 1.133 . . . . 0.0 111.622 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -62.88 -40.03 87.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.837 1.199 . . . . 0.0 110.194 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -76.15 -35.47 59.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.924 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.0 mt -56.74 -50.34 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.878 0.871 . . . . 0.0 109.787 171.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -68.42 -19.12 64.57 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.109 0.564 . . . . 0.0 111.531 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 33.8 42.88 Favored Glycine 0 N--CA 1.446 -0.689 0 O-C-N 121.458 -0.776 . . . . 0.0 111.601 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.5 mt -85.1 105.4 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 113.7 3.15 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.3 177.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.225 1.81 . . . . 0.0 106.536 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.65 138.94 44.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.245 1.818 . . . . 0.0 107.951 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.34 -144.63 8.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -125.82 149.78 48.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 t -130.52 149.01 52.39 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.05 1.74 . . . . 0.0 108.36 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 126.45 72.12 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 123.897 0.879 . . . . 0.0 108.996 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HA ' HG12 ' A' ' 31' ' ' VAL . 18.9 Cg_endo -58.97 -31.62 95.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 168.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -27.48 62.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.163 1.785 . . . . 0.0 114.934 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 13' ' ' SER . 11.4 p -98.0 -37.33 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 119.286 0.948 . . . . 0.0 110.146 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.629 HG23 HD13 ' A' ' 43' ' ' LEU . 4.3 p -63.77 -26.82 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.828 1.194 . . . . 0.0 111.736 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.17 -16.64 64.43 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.049 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -86.19 -52.14 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.796 1.638 . . . . 0.0 108.649 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -49.5 99.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.449 2.3 . . . . 0.0 110.955 -170.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -63.6 134.3 55.24 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -57.36 -44.63 84.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.97 -59.65 4.53 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -166.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -55.24 -46.19 76.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.272 2.229 . . . . 0.0 110.454 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -62.58 -58.4 7.68 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.03 0.832 . . . . 0.0 110.972 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.95 -52.91 38.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 68.6 t80 -60.67 -44.4 96.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.613 0.765 . . . . 0.0 112.108 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD13 HG23 ' A' ' 31' ' ' VAL . 5.8 tt -57.88 -53.7 55.3 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -63.76 -31.02 72.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.594 0.358 . . . . 0.0 111.455 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -51.48 64.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 109.29 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 96.6 mt -66.35 -38.6 87.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.843 -1.075 . . . . 0.0 111.224 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.02 -57.58 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 m -67.32 -28.41 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -14.16 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.706 -0.621 . . . . 0.0 112.273 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.44 85.72 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.693 1.616 . . . . 0.0 113.016 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -67.15 -43.15 83.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.379 1.09 . . . . 0.0 108.13 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.57 159.5 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -138.11 157.82 45.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.718 -0.613 . . . . 0.0 111.824 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.53 133.3 31.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.917 1.287 . . . . 0.0 109.206 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.04 128.9 7.92 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.525 1.53 . . . . 0.0 109.869 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.92 155.83 37.13 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.392 1.077 . . . . 0.0 110.996 170.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.96 166.95 22.95 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.158 2.572 . . . . 0.0 111.522 171.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -95.48 165.6 12.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.833 1.253 . . . . 0.0 109.019 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -50.59 65.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.685 1.194 . . . . 0.0 109.303 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.19 -41.47 71.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.144 1.378 . . . . 0.0 111.012 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -62.15 -45.05 95.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.084 0.954 . . . . 0.0 110.955 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -66.07 -45.65 90.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 119.007 0.821 . . . . 0.0 109.373 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -54.14 -42.07 69.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.899 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -46.47 53.39 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.688 1.195 . . . . 0.0 110.762 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.1 mm -64.43 -43.32 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.611 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.3 -36.73 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.525 0.602 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.39 -55.26 33.52 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.744 0.702 . . . . 0.0 109.659 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.26 -35.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.478 0.311 . . . . 0.0 110.641 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -64.48 -43.64 93.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.56 80.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.312 1.415 . . . . 0.0 110.622 173.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.52 -26.18 65.11 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.325 -0.86 . . . . 0.0 112.397 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.22 -49.04 3.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.06 0.846 . . . . 0.0 111.23 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.75 139.12 3.41 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -167.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 79.1 39.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.553 2.741 . . . . 0.0 111.82 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.413 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.8 p -37.68 -48.73 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 127.349 2.259 . . . . 0.0 115.384 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -123.64 10.07 9.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.62 0.768 . . . . 0.0 110.489 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.76 -28.42 58.46 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.033 0.833 . . . . 0.0 111.713 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.27 34.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.181 1.393 . . . . 0.0 107.786 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -67.94 158.43 32.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.956 1.36 . . . . 0.0 111.113 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -58.83 -57.63 12.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.434 -172.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 -34.55 70.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.43 0.456 . . . . 0.0 111.152 -175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.03 -53.1 60.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.279 1.432 . . . . 0.0 108.574 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.5 mt -55.3 -44.99 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -66.31 -48.74 69.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.926 0.89 . . . . 0.0 112.46 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.33 -56.28 14.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.67 1.588 . . . . 0.0 108.071 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.597 HD23 HD13 ' A' ' 96' ' ' ILE . 74.3 mt -60.96 -51.39 69.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 122.858 0.463 . . . . 0.0 110.009 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -45.18 -52.06 9.8 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.351 1.061 . . . . 0.0 112.209 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.6 tp -52.21 -52.5 51.89 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.225 0.466 . . . . 0.0 110.508 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.7 67.73 Favored 'General case' 0 CA--C 1.524 -0.051 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.877 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.538 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -78.81 -25.48 44.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.442 1.019 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 1.1 tm-20 -65.99 -48.33 71.59 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 164.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.15 -14.73 59.36 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 31.5 mtmt 50.2 29.7 3.84 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.719 2.808 . . . . 0.0 113.766 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.57 -108.01 1.55 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 124.379 0.99 . . . . 0.0 112.5 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -146.98 171.17 15.66 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.82 1.648 . . . . 0.0 107.844 172.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.597 HD13 HD23 ' A' ' 86' ' ' LEU . 31.2 mt -131.91 160.97 42.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.693 1.197 . . . . 0.0 108.599 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.06 124.38 23.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.59 1.556 . . . . 0.0 108.659 168.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -162.8 -164.73 1.03 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.214 1.406 . . . . 0.0 110.47 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 -11.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 169.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -68.57 155.35 40.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.556 1.525 . . . . 0.0 115.1 -163.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -62.57 -37.01 84.51 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 119.526 -1.984 . . . . 0.0 112.555 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.57 -41.52 31.74 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.092 0.406 . . . . 0.0 110.659 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -36.77 74.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 118.486 0.585 . . . . 0.0 110.03 -170.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.26 -47.62 60.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 122.742 0.417 . . . . 0.0 109.917 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -59.08 -58.65 7.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.352 1.461 . . . . 0.0 108.722 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.33 -52.18 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.726 0.81 . . . . 0.0 109.976 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.33 67.58 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.758 -1.214 . . . . 0.0 114.008 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 t -67.97 -48.66 65.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 117.428 -1.272 . . . . 0.0 111.89 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -25.37 67.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.655 2.025 . . . . 0.0 112.475 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -82.07 -16.81 48.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.099 0.959 . . . . 0.0 111.723 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.14 18.88 78.23 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 117.886 -1.508 . . . . 0.0 114.348 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.05 132.61 34.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.766 1.783 . . . . 0.0 109.11 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.2 144.6 31.5 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.018 1.727 . . . . 0.0 111.253 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.2 -179.6 7.48 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.12 141.34 47.61 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.463 2.305 . . . . 0.0 107.939 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.39 166.02 16.7 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.877 0.871 . . . . 0.0 109.533 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 mt -81.44 -158.12 0.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? 59.59 -156.83 0.34 Allowed 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.913 -1.117 . . . . 0.0 108.868 -170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.31 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.4 87.31 0.87 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.03 -1.669 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mt -69.49 146.4 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.039 0.935 . . . . 0.0 109.183 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -71.43 -34.09 70.0 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -129.07 11.99 6.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.979 1.263 . . . . 0.0 111.996 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.259 47.3 t 48.78 81.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 C-N-CA 127.746 2.418 . . . . 0.0 111.461 172.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.5 mt -137.09 139.49 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.678 0.791 . . . . 0.0 108.985 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.2 141.43 55.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 167.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -117.56 162.51 17.87 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.671 1.988 . . . . 0.0 109.438 -170.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -146.03 17.57 1.4 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 116.411 -1.757 . . . . 0.0 115.215 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -135.0 135.3 41.28 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 121.636 2.016 . . . . 0.0 112.962 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.49 125.61 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.311 1.444 . . . . 0.0 109.903 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.49 121.67 16.84 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 108.813 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pt -82.41 49.04 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.995 1.318 . . . . 0.0 111.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.24 -31.48 0.02 OUTLIER Glycine 0 C--O 1.226 -0.344 0 O-C-N 121.253 -0.904 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 12.5 p -132.77 14.19 4.38 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.693 0.746 . . . . 0.0 112.062 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.99 7.98 33.03 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.366 1.936 . . . . 0.0 115.468 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 46.0 ttt85 -69.47 132.46 46.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.511 1.924 . . . . 0.0 111.662 -165.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.79 143.22 30.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.633 1.173 . . . . 0.0 110.185 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -139.14 156.33 47.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.993 1.717 . . . . 0.0 108.22 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.0 t -109.78 -14.58 14.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.073 0.549 . . . . 0.0 111.133 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.4 p -138.01 166.28 24.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.4 tp -75.79 113.0 22.79 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -65.04 167.83 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.564 2.176 . . . . 0.0 109.472 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.16 136.55 75.51 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.321 2.014 . . . . 0.0 111.002 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.71 -15.78 3.57 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.128 1.347 . . . . 0.0 112.824 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.88 43.44 97.56 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.897 1.237 . . . . 0.0 111.384 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.64 167.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.501 1.12 . . . . 0.0 109.907 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.27 110.79 13.4 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 111.413 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.87 -14.97 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.218 1.279 . . . . 0.0 113.788 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.89 -36.97 16.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.343 1.057 . . . . 0.0 112.676 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.23 -7.38 2.03 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -164.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.11 -3.39 10.51 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.099 2.761 . . . . 0.0 116.43 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.6 m -69.45 162.93 26.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.838 1.319 . . . . 0.0 112.217 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.11 160.68 30.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.65 0.738 . . . . 0.0 111.169 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.49 161.37 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.748 1.619 . . . . 0.0 109.333 173.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.27 166.44 24.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.337 1.455 . . . . 0.0 108.958 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.82 154.45 38.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.23 1.012 . . . . 0.0 111.02 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.99 162.3 34.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.34 1.856 . . . . 0.0 110.725 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.65 -164.17 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.968 3.112 . . . . 0.0 111.859 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -51.75 145.66 9.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 111.164 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -48.74 47.83 Favored 'General case' 0 CA--C 1.524 -0.042 0 C-N-CA 123.932 0.893 . . . . 0.0 109.524 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 117.174 -1.393 . . . . 0.0 110.599 -165.784 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp 60.56 171.0 0.09 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.894 1.225 . . . . 0.0 109.919 -160.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -117.9 168.92 10.06 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.999 1.319 . . . . 0.0 108.542 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.7 161.64 24.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 168.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.8 173.74 6.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.42 1.088 . . . . 0.0 109.993 -164.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.19 -173.39 2.41 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.373 1.869 . . . . 0.0 110.453 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.48 160.82 1.61 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.649 1.179 . . . . 0.0 112.083 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -52.3 129.65 28.81 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.508 -174.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.686 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -153.21 135.66 15.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.682 -168.017 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -111.83 145.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 9' ' ' LEU . 1.1 mm? -113.98 147.58 38.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.11 1.764 . . . . 0.0 107.354 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -106.17 166.32 10.6 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.294 0.637 . . . . 0.0 110.423 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 30' ' ' VAL . 22.7 t -42.16 -46.82 4.5 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.436 1.894 . . . . 0.0 111.477 174.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -62.13 -28.52 69.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.103 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.84 -39.33 84.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 109.536 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.89 -35.18 62.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.64 0.776 . . . . 0.0 111.101 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -61.7 -35.81 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.194 0.598 . . . . 0.0 110.61 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -82.23 -30.14 30.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.528 0.604 . . . . 0.0 110.749 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.3 32.28 17.12 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.257 0.932 . . . . 0.0 111.335 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' CD1' HD11 ' A' ' 117' ' ' LEU . 8.4 mt -72.47 113.48 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.51 104.91 0.69 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.845 0.858 . . . . 0.0 109.811 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 tp -149.57 159.78 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.871 1.268 . . . . 0.0 108.02 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.54 115.02 16.21 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.844 1.257 . . . . 0.0 108.589 -164.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.686 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.31 -158.04 24.18 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.859 1.695 . . . . 0.0 112.514 -164.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.23 149.64 23.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.547 0.674 . . . . 0.0 112.451 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -132.89 149.72 52.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.626 1.97 . . . . 0.0 109.709 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 117.54 68.67 Favored Pre-proline 0 C--O 1.243 0.748 0 C-N-CA 126.702 2.001 . . . . 0.0 109.079 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -58.27 -32.72 96.58 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.167 1.245 . . . . 0.0 110.508 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -68.36 -11.73 60.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 13' ' ' SER . 8.8 p -106.25 -31.03 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 117.51 -1.234 . . . . 0.0 110.832 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 28' ' ' PRO . 8.5 p -59.28 -28.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.941 1.701 . . . . 0.0 111.09 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -60.31 -22.28 62.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.263 0.483 . . . . 0.0 112.034 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -83.63 -53.23 5.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.923 -1.111 . . . . 0.0 108.965 169.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mt -41.37 114.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.198 1.799 . . . . 0.0 111.37 -162.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 -12.16 1.4 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.932 1.693 . . . . 0.0 112.836 -171.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -53.37 124.53 15.0 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 163.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -56.88 -50.01 73.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.328 0.651 . . . . 0.0 109.856 -171.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -62.24 -54.65 37.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 t -54.94 -42.02 71.79 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.163 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -62.61 -57.49 10.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.778 0.831 . . . . 0.0 109.933 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.89 -55.58 15.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.19 -53.14 57.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.404 1.482 . . . . 0.0 111.759 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.2 -48.88 73.21 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.815 1.246 . . . . 0.0 110.649 177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.39 -45.32 94.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.117 0.567 . . . . 0.0 110.836 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -56.41 -48.57 76.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.929 0.786 . . . . 0.0 109.388 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -42.23 95.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.989 1.315 . . . . 0.0 111.608 -176.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.85 -56.13 18.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -33.22 73.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.283 0.633 . . . . 0.0 111.896 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.18 -10.33 59.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.382 1.873 . . . . 0.0 112.617 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.19 -12.33 57.21 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 124.666 1.127 . . . . 0.0 113.466 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -78.27 -33.29 49.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.768 0.784 . . . . 0.0 111.638 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.05 148.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -141.21 139.54 33.82 Favored 'General case' 0 N--CA 1.46 0.049 0 C-N-CA 124.346 1.058 . . . . 0.0 109.773 -167.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.16 118.17 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.6 18.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.309 1.044 . . . . 0.0 110.744 174.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.9 160.89 27.15 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.373 1.469 . . . . 0.0 110.969 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.91 175.97 4.93 Favored 'Trans proline' 0 C--N 1.347 0.497 1 C-N-CA 125.453 4.102 . . . . 0.0 113.44 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.01 165.96 11.08 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.928 1.291 . . . . 0.0 109.45 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -47.29 -48.93 24.73 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.863 1.265 . . . . 0.0 111.379 176.036 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.47 -27.87 65.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.843 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -69.98 -39.78 75.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.97 . . . . 0.0 109.628 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.36 -47.74 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.97 -34.43 73.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.851 -0.531 . . . . 0.0 110.831 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -42.3 64.3 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.15 0.98 . . . . 0.0 111.405 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 87' ' ' ALA . 3.1 mm -67.37 -52.65 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.06 -39.56 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.929 1.292 . . . . 0.0 110.493 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -58.75 -60.03 4.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.541 1.064 . . . . 0.0 111.415 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -73.34 -38.2 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.5 73.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.78 1.232 . . . . 0.0 110.692 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -29.07 70.26 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.515 -1.365 . . . . 0.0 112.155 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.02 -7.35 21.98 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.475 1.034 . . . . 0.0 112.208 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -123.45 16.11 9.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 112.009 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.25 -80.3 0.43 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.296 1.427 . . . . 0.0 110.119 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -59.08 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 129.009 2.923 . . . . 0.0 110.678 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.12 -43.91 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.126 1.771 . . . . 0.0 111.529 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -128.21 8.17 6.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.12 0.968 . . . . 0.0 109.721 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.53 -20.79 65.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.73 2.012 . . . . 0.0 111.784 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -95.97 165.26 12.35 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.051 1.74 . . . . 0.0 109.971 -175.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -70.03 158.06 36.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.841 0.829 . . . . 0.0 111.849 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -59.7 -54.41 46.7 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.986 1.314 . . . . 0.0 109.571 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.81 -44.03 63.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 110.352 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.436 ' O ' HD22 ' A' ' 86' ' ' LEU . 71.5 m-20 -60.42 -56.67 18.6 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.7 mt -52.79 -40.54 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.51 -33.44 72.83 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -57.81 -61.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 118.945 0.793 . . . . 0.0 109.288 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.4 mm? -61.89 -46.8 87.79 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.211 -169.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.83 -53.39 32.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.458 1.103 . . . . 0.0 111.535 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.47 -47.74 83.05 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.629 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.24 63.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.285 0.493 . . . . 0.0 111.883 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.06 -25.95 20.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.54 1.136 . . . . 0.0 111.394 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.98 -51.21 68.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.56 4.94 30.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.613 0.765 . . . . 0.0 111.615 -169.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 49.74 46.01 24.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.919 1.687 . . . . 0.0 110.771 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.18 -116.06 1.71 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -156.38 168.35 27.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 ' CD1' ' A' ' 86' ' ' LEU . 53.4 mt -129.81 152.55 37.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 119.05 20.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.004 1.322 . . . . 0.0 108.108 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.4 t -165.45 -170.54 1.88 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.079 1.352 . . . . 0.0 109.925 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -151.52 -1.78 0.32 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -64.39 157.78 25.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.571 -1.331 . . . . 0.0 114.539 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -60.93 -41.15 95.65 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.726 -1.234 . . . . 0.0 110.814 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -84.35 -44.26 13.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 110.989 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.443 HG11 ' OG ' ' A' ' 98' ' ' SER . 2.6 p -60.12 -37.67 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.351 0.978 . . . . 0.0 110.225 -170.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -70.96 -35.72 72.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 110.226 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.09 -55.48 18.53 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.946 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 mm -48.95 -53.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.796 0.838 . . . . 0.0 109.179 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -21.69 64.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.182 -1.407 . . . . 0.0 112.854 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -74.07 -46.59 42.08 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.672 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.4 95.05 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.55 1.977 . . . . 0.0 108.275 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -68.52 -44.39 74.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.62 35.12 14.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 125.774 1.654 . . . . 0.0 111.855 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -85.77 136.34 33.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.038 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 137.53 56.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -145.94 -173.6 4.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.881 0.31 . . . . 0.0 111.243 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -130.61 124.87 32.7 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 125.742 1.617 . . . . 0.0 109.296 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.7 m -90.12 159.67 16.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.445 2.298 . . . . 0.0 108.448 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 20' ' ' ILE . 4.6 mm? -91.8 -179.41 5.31 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.009 -1.057 . . . . 0.0 109.631 173.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -53.08 -66.72 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.575 -1.328 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 168.67 148.52 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.124 2.569 . . . . 0.0 107.184 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.31 94.69 0.15 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.02 177.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.581 0.752 . . . . 0.0 111.416 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -130.68 57.01 1.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.986 1.715 . . . . 0.0 108.712 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 47.06 43.21 13.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.618 1.567 . . . . 0.0 110.738 -167.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -109.42 -179.09 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.137 1.375 . . . . 0.0 107.525 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . 0.274 61.7 mt -89.99 -174.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -118.79 127.96 54.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -68.41 154.99 40.74 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.621 0.576 . . . . 0.0 110.074 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -148.76 8.92 0.78 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -140.3 146.4 38.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.362 0.983 . . . . 0.0 110.72 -171.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -137.27 132.41 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 108.701 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.37 120.5 12.35 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 163.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.39 119.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 166.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.46 -84.64 0.32 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.37 -4.81 58.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.98 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.85 20.27 68.35 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 124.78 1.181 . . . . 0.0 114.946 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 137.22 57.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -84.04 148.01 27.09 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.305 1.042 . . . . 0.0 109.341 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -142.03 146.09 35.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.02 -4.11 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 110.827 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.9 p -145.39 160.4 41.61 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.645 2.378 . . . . 0.0 108.224 161.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.533 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -68.85 112.78 12.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' HD23 ' A' ' 141' ' ' LEU . 90.5 Cg_endo -66.33 164.74 27.09 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 109.635 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.34 124.6 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.094 1.863 . . . . 0.0 109.332 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.86 -18.26 57.0 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.287 2.375 . . . . 0.0 112.161 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 62.19 34.86 90.47 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.822 1.311 . . . . 0.0 111.455 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.86 162.0 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.634 1.573 . . . . 0.0 107.544 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.9 t -74.4 112.57 17.73 Favored Pre-proline 0 N--CA 1.443 -0.775 0 C-N-CA 125.365 1.466 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.51 -8.65 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.518 2.145 . . . . 0.0 115.895 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.61 -43.06 6.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.826 1.194 . . . . 0.0 112.065 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.3 p -122.99 -9.44 8.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.991 0.917 . . . . 0.0 111.527 -166.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.23 13.75 82.99 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.791 1.186 . . . . 0.0 113.614 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.79 161.58 14.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.82 1.31 . . . . 0.0 112.203 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -62.81 147.92 48.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.458 0.646 . . . . 0.0 111.15 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.39 147.6 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -133.84 172.9 12.15 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.479 1.512 . . . . 0.0 110.287 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.43 161.32 28.07 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.494 1.117 . . . . 0.0 110.342 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -128.24 159.12 68.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.441 1.896 . . . . 0.0 110.684 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.76 100.46 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.392 2.728 . . . . 0.0 110.62 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 49.45 -123.61 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.866 -1.146 . . . . 0.0 109.291 -168.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 -23.24 6.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 . . . . . 0 C--N 1.312 -1.022 0 C-N-CA 126.861 2.064 . . . . 0.0 108.209 -177.355 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.15 8.98 15.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 77.51 92.23 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.798 2.039 . . . . 0.0 108.705 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.16 14.71 3.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.46 1.504 . . . . 0.0 111.313 -168.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.31 -70.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 130.266 3.426 . . . . 0.0 111.318 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -27.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 128.562 2.745 . . . . 0.0 112.038 -169.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -178.46 161.83 1.4 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -49.93 131.48 22.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.592 1.182 . . . . 0.0 108.965 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -151.25 144.4 24.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.31 151.52 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.956 ' HB3' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -132.59 138.81 47.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 125.435 1.494 . . . . 0.0 109.669 -173.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 15' ' ' VAL . 4.5 t0 -88.82 -179.69 6.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.03 1.332 . . . . 0.0 111.364 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.0 p -58.43 -41.99 86.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.06 -1.65 . . . . 0.0 110.425 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -60.65 -39.79 89.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.597 1.159 . . . . 0.0 112.234 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.956 HG11 ' HB3' ' A' ' 11' ' ' LEU . 7.5 p -53.57 -36.13 27.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 119.945 1.248 . . . . 0.0 111.3 177.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 15' ' ' VAL . 6.4 m-85 -77.13 -37.12 54.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.395 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.13 -31.72 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.899 0.88 . . . . 0.0 109.81 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.42 -21.85 22.83 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.52 24.85 24.99 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.476 -0.624 . . . . 0.0 113.923 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 117' ' ' LEU . 10.0 mt -80.92 109.29 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.622 1.211 . . . . 0.0 109.217 -171.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.93 100.99 1.66 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.581 0.752 . . . . 0.0 109.795 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tp -136.91 167.79 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.378 1.471 . . . . 0.0 108.579 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -136.98 120.77 17.42 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.287 1.435 . . . . 0.0 108.526 -166.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.87 -157.88 30.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.61 1.576 . . . . 0.0 111.51 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -109.78 149.85 29.2 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.306 1.043 . . . . 0.0 110.893 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -128.76 168.01 16.47 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.715 1.206 . . . . 0.0 108.816 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -107.0 121.16 45.69 Favored Pre-proline 0 C--O 1.247 0.951 0 C-N-CA 126.288 1.835 . . . . 0.0 111.01 -165.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HA ' HG12 ' A' ' 31' ' ' VAL . 12.1 Cg_endo -63.22 -15.41 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.82 1.68 . . . . 0.0 113.389 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -89.78 -12.33 39.58 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.675 1.125 . . . . 0.0 112.806 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.77 -36.36 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 121.138 1.79 . . . . 0.0 108.206 167.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 28' ' ' PRO . 12.6 p -58.68 -29.6 40.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.898 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.44 -26.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.809 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -11.36 42.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.165 2.186 . . . . 0.0 110.879 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.21 119.24 31.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -21.25 6.03 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.406 1.482 . . . . 0.0 112.494 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.43 169.26 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.279 0.632 . . . . 0.0 110.315 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -84.57 -55.97 3.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.99 -59.36 5.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -168.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -54.69 -35.59 63.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.578 1.151 . . . . 0.0 113.064 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 119.507 1.049 . . . . 0.0 109.433 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.1 mt -52.62 -43.23 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.944 1.298 . . . . 0.0 108.798 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -77.84 -40.24 40.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.609 0.763 . . . . 0.0 113.043 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -53.48 -49.06 68.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.418 1.463 . . . . 0.0 108.477 169.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -65.85 -32.04 73.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.815 -0.612 . . . . 0.0 111.672 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -57.69 -51.03 71.22 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.325 1.45 . . . . 0.0 108.751 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.36 -33.76 76.44 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.73 0.812 . . . . 0.0 111.344 -176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.31 -49.9 62.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 m -57.39 -40.83 79.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.784 -0.573 . . . . 0.0 110.941 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.64 -3.61 35.49 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.104 1.361 . . . . 0.0 113.219 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.44 21.64 77.55 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 112.681 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 5.0 ptpt -96.97 -29.93 13.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.094 1.447 . . . . 0.0 112.638 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.94 130.64 73.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -122.62 142.8 50.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.615 1.166 . . . . 0.0 110.181 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.32 133.18 31.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.8 9.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.681 1.192 . . . . 0.0 109.964 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.01 154.6 38.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.921 0.888 . . . . 0.0 111.344 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.23 164.12 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.805 3.67 . . . . 0.0 113.459 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -84.75 159.07 20.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.092 0.949 . . . . 0.0 111.153 161.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -45.67 84.65 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.972 1.309 . . . . 0.0 111.124 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -58.05 -33.64 69.23 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.775 0.43 . . . . 0.0 111.513 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.23 -45.89 75.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.884 1.273 . . . . 0.0 109.924 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.25 -44.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.995 0.918 . . . . 0.0 109.516 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.41 -33.9 73.17 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.44 -0.788 . . . . 0.0 111.628 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -41.46 89.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.889 0.768 . . . . 0.0 110.541 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.87 -46.35 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.16 -38.89 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.475 1.11 . . . . 0.0 110.331 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -62.88 -60.32 3.64 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.142 1.337 . . . . 0.0 110.719 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 109' ' ' LEU . 4.0 t -67.43 -34.94 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.63 -174.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.89 77.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.391 0.676 . . . . 0.0 111.548 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.81 66.24 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.781 1.628 . . . . 0.0 111.762 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.27 4.88 11.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.755 0.822 . . . . 0.0 112.212 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -131.95 -22.59 2.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.255 1.389 . . . . 0.0 112.246 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.17 -70.13 0.4 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 119.473 1.033 . . . . 0.0 112.783 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.46 56.86 0.37 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.729 2.012 . . . . 0.0 113.04 -170.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 p -48.53 -44.63 13.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.227 1.811 . . . . 0.0 114.328 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -124.7 4.89 8.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.524 0.729 . . . . 0.0 110.519 -173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.78 -10.82 58.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.605 1.162 . . . . 0.0 112.89 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 165.36 22.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 169.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 t -72.16 159.84 33.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.105 0.866 . . . . 0.0 109.887 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 81' ' ' ALA . 1.7 ttpt -65.03 -48.97 71.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.907 0.883 . . . . 0.0 109.199 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' N ' ' HE2' ' A' ' 80' ' ' LYS . . . -56.21 -43.23 78.34 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.495 1.118 . . . . 0.0 109.792 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -63.38 -55.07 27.44 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.39 -42.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 124.023 0.929 . . . . 0.0 109.787 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.5 -48.43 72.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.923 0.889 . . . . 0.0 111.999 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG22 ' OG1' ' A' ' 27' ' ' THR . 95.1 t -59.1 -47.56 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 119.278 0.944 . . . . 0.0 109.239 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 96' ' ' ILE . 87.5 mt -60.03 -56.13 25.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.549 1.14 . . . . 0.0 109.474 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.59 -50.15 60.74 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.968 1.307 . . . . 0.0 111.791 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -49.92 75.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.91 91.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.634 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.485 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.1 m-85 -65.53 -31.49 72.58 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.963 1.256 . . . . 0.0 111.663 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.85 -37.36 87.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.421 1.105 . . . . 0.0 111.282 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.27 -12.57 52.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.365 1.066 . . . . 0.0 111.59 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 60.24 12.18 3.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.424 1.489 . . . . 0.0 112.29 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.65 -112.03 0.3 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 128.414 2.912 . . . . 0.0 112.965 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -154.89 167.92 28.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 106.933 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.526 HD13 HD23 ' A' ' 86' ' ' LEU . 20.6 mt -131.31 155.97 42.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.478 1.111 . . . . 0.0 108.023 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.84 116.09 14.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.051 1.74 . . . . 0.0 106.97 167.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.4 t -155.78 170.73 21.4 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.225 0.61 . . . . 0.0 109.493 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.09 93.78 2.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.741 1.616 . . . . 0.0 110.694 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -152.66 166.43 32.14 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.873 1.269 . . . . 0.0 108.661 165.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -68.8 -55.23 11.88 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.096 -1.003 . . . . 0.0 109.783 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.52 -35.41 80.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.472 -0.768 . . . . 0.0 110.951 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.1 p -64.75 -43.52 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 118.994 0.815 . . . . 0.0 108.843 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -66.45 -42.74 87.15 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.507 0.723 . . . . 0.0 110.598 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' HD23 ' A' ' 109' ' ' LEU . 28.8 t30 -59.88 -62.84 1.58 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.943 1.297 . . . . 0.0 108.523 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.1 mm -51.09 -50.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.077 0.951 . . . . 0.0 110.421 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.78 72.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.853 1.206 . . . . 0.0 112.532 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 t -59.13 -59.01 6.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.746 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.458 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -62.68 -31.29 72.15 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.223 1.374 . . . . 0.0 111.579 -176.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -72.34 -6.68 45.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.373 0.669 . . . . 0.0 112.315 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.73 73.16 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-O 118.759 -1.023 . . . . 0.0 112.604 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -82.91 135.41 34.92 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.652 1.726 . . . . 0.0 109.474 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.409 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -75.84 117.11 17.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.53 1.132 . . . . 0.0 108.385 169.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.63 174.41 9.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 109.761 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.9 116.93 32.81 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.76 152.72 22.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 153.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.471 HD11 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -76.12 171.02 15.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.344 168.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' H ' HD13 ' A' ' 117' ' ' LEU . 2.5 tptm 61.64 -160.9 0.3 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.548 1.939 . . . . 0.0 111.02 157.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 48.58 -115.08 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.476 1.511 . . . . 0.0 111.249 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.16 -129.11 9.04 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 -167.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 25.7 mt -125.1 153.5 32.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 125.793 1.637 . . . . 0.0 108.357 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -121.47 -38.65 2.75 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.15 -1.405 . . . . 0.0 112.27 165.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -148.9 -4.58 0.42 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.822 1.646 . . . . 0.0 114.279 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.03 158.3 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.7 mt -84.1 158.94 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -67.0 93.26 0.27 Allowed 'General case' 0 N--CA 1.46 0.066 0 O-C-N 121.109 -0.994 . . . . 0.0 108.679 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.49 153.93 18.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.693 1.997 . . . . 0.0 111.59 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -145.68 21.2 1.48 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.489 -1.72 . . . . 0.0 114.693 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -135.16 149.96 50.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 121.989 2.177 . . . . 0.0 112.423 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.51 134.26 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.342 1.457 . . . . 0.0 109.16 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.05 142.02 57.95 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.763 0.825 . . . . 0.0 109.151 163.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.26 117.64 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.88 -2.3 33.78 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.306 1.431 . . . . 0.0 113.797 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 -1.96 2.11 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.081 0.94 . . . . 0.0 112.121 154.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.03 11.73 64.04 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 126.004 1.764 . . . . 0.0 115.442 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -69.95 135.23 49.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.015 -0.697 . . . . 0.0 110.134 -168.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -73.97 150.05 40.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.352 1.032 . . . . 0.0 109.872 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.17 147.38 38.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 161.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 p -95.96 -10.18 29.3 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.198 0.999 . . . . 0.0 112.235 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 p -134.69 177.4 7.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.393 1.877 . . . . 0.0 106.739 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 tp -80.7 137.71 50.87 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.06 159.72 51.48 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.518 1.478 . . . . 0.0 109.689 167.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.22 115.82 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.426 2.084 . . . . 0.0 110.863 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.27 66.15 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.86 -175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.75 45.51 90.88 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.165 1.364 . . . . 0.0 112.194 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.37 155.45 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 42.4 t -76.02 111.93 17.68 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.356 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 56.6 Cg_endo -61.32 -20.85 69.95 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.308 1.339 . . . . 0.0 112.39 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -18.66 30.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.948 1.299 . . . . 0.0 111.091 -171.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.0 p -142.82 -33.06 0.47 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.86 84.66 1.34 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.283 1.421 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.63 171.34 5.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 110.19 172.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -59.32 131.36 50.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.189 1.396 . . . . 0.0 112.828 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.95 146.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 166.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.06 157.69 45.48 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.001 -1.062 . . . . 0.0 110.346 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.76 152.49 44.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -123.22 157.07 62.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 110.489 173.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 172.59 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.967 2.444 . . . . 0.0 111.81 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.01 134.04 4.81 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.541 2.336 . . . . 0.0 113.173 -168.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.04 -63.13 1.23 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.405 2.282 . . . . 0.0 110.961 175.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.915 0 C-N-CA 126.811 2.044 . . . . 0.0 111.908 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 mtt . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.9 162.54 23.96 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.637 -1.29 . . . . 0.0 110.098 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -146.69 10.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.51 -162.69 0.88 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tt 53.97 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.008 2.523 . . . . 0.0 112.772 -177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -76.25 178.51 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 111.471 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -54.63 168.1 0.3 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.035 0.934 . . . . 0.0 110.846 164.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -54.92 130.18 40.43 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.664 0.786 . . . . 0.0 109.768 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 95' ' ' GLU . 16.8 tp -151.32 143.32 23.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.95 148.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.29 127.06 53.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.938 1.695 . . . . 0.0 107.898 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.17 167.84 18.3 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.081 0.952 . . . . 0.0 110.951 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -44.05 51.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.567 1.947 . . . . 0.0 110.662 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -53.02 -38.36 62.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.936 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.29 -40.03 86.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 119.591 1.087 . . . . 0.0 109.411 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 43' ' ' LEU . 30.0 m-85 -73.68 -31.64 63.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 111.046 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.2 mt -59.73 -53.5 47.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.056 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -67.73 -31.2 70.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.144 0.429 . . . . 0.0 110.789 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.66 31.6 8.16 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 123.584 0.612 . . . . 0.0 111.627 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.01 106.69 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.96 104.41 1.72 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.68 167.26 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.822 -1.174 . . . . 0.0 109.161 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.41 148.3 27.29 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.595 1.958 . . . . 0.0 107.992 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.72 -141.84 8.64 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.966 1.257 . . . . 0.0 112.228 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.61 153.16 46.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.06 0.93 . . . . 0.0 112.257 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 t -126.95 147.38 50.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.715 2.006 . . . . 0.0 110.071 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.0 116.22 66.16 Favored Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 127.817 2.447 . . . . 0.0 110.037 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.18 -30.07 89.42 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 121.538 1.492 . . . . 0.0 113.12 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 -15.18 57.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.265 1.826 . . . . 0.0 114.014 -171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' CB ' ' A' ' 81' ' ' ALA . 59.6 t -83.04 -53.15 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 126.113 1.765 . . . . 0.0 108.6 162.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -71.24 -18.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 123.302 0.641 . . . . 0.0 111.722 -160.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -48.71 -38.82 22.58 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.98 0.912 . . . . 0.0 111.75 165.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 -11.98 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.022 1.329 . . . . 0.0 111.362 -166.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.53 97.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.76 -23.09 21.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.449 1.1 . . . . 0.0 112.015 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.72 117.8 4.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.95 -38.42 76.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 117.667 -1.159 . . . . 0.0 110.692 -168.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.4 -56.26 22.16 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 119.513 1.051 . . . . 0.0 108.322 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -61.64 -48.09 82.45 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.516 0.726 . . . . 0.0 110.91 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -57.27 -60.64 3.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.15 1.38 . . . . 0.0 110.342 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.5 mt -62.45 -38.85 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 58.9 t80 -62.28 -47.86 82.43 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.048 0.939 . . . . 0.0 110.65 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.477 HD12 ' CG ' ' A' ' 16' ' ' PHE . 6.8 tt -63.86 -49.0 74.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.167 -0.958 . . . . 0.0 109.813 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.74 -33.52 76.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 t -54.41 -54.88 34.78 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 25.6 mt -59.77 -48.38 81.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.546 1.139 . . . . 0.0 110.736 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.38 -55.36 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 t -64.21 -34.83 78.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.196 0.599 . . . . 0.0 111.306 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.61 -9.8 58.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.274 1.83 . . . . 0.0 112.316 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.41 8.94 60.75 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 124.888 1.232 . . . . 0.0 113.754 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -87.82 -41.14 13.46 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -164.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.15 161.64 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 C-N-CA 125.292 1.437 . . . . 0.0 108.756 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -132.69 158.35 42.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.67 139.27 19.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.85 130.18 4.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.53 1.132 . . . . 0.0 109.301 162.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -98.24 156.37 35.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.572 1.549 . . . . 0.0 111.053 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.57 -176.21 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.776 3.651 . . . . 0.0 111.971 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -120.33 163.9 17.13 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.529 0.732 . . . . 0.0 110.21 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -49.61 10.57 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.559 1.544 . . . . 0.0 111.98 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.93 -27.94 60.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.858 0.863 . . . . 0.0 110.771 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -47.27 85.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 109.246 170.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.87 -44.95 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.336 1.054 . . . . 0.0 109.635 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.96 -32.73 72.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.646 -0.659 . . . . 0.0 111.731 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -44.3 76.17 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 121.419 -0.801 . . . . 0.0 110.909 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -64.42 -49.03 82.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.34 -46.9 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.244 1.017 . . . . 0.0 110.503 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.07 -48.71 70.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.11 1.323 . . . . 0.0 111.485 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 t -74.55 -33.64 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.72 -51.65 61.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.229 1.012 . . . . 0.0 110.116 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -24.7 67.65 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.115 -0.991 . . . . 0.0 111.885 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.96 -28.53 64.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.283 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 t -120.43 -16.42 8.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.77 -76.59 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 119.259 0.936 . . . . 0.0 112.522 164.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -72.26 93.08 1.44 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.773 1.229 . . . . 0.0 109.161 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.11 -50.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 112.059 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.85 14.55 7.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.034 0.933 . . . . 0.0 110.443 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.27 -24.17 59.23 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.833 1.653 . . . . 0.0 111.285 175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' LEU . 1.5 mp -77.03 165.38 24.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.054 0.941 . . . . 0.0 109.155 -173.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 153.27 40.7 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.048 -1.032 . . . . 0.0 109.48 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -63.32 -46.01 88.66 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.152 -0.967 . . . . 0.0 109.07 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -54.71 -41.37 70.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.209 0.943 . . . . 0.0 111.268 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.78 -55.1 39.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 109.133 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.58 -42.9 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.792 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -62.58 -49.24 76.03 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.01 0.924 . . . . 0.0 111.046 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.78 -51.14 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 96' ' ' ILE . 20.0 mt -57.02 -50.22 73.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.784 0.834 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.28 -53.39 36.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.331 1.052 . . . . 0.0 112.028 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.91 -50.25 69.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.977 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.56 65.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.314 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -67.8 -32.26 72.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.583 0.628 . . . . 0.0 111.339 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -44.13 94.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.956 0.798 . . . . 0.0 109.62 168.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 -10.82 59.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.732 0.813 . . . . 0.0 112.177 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm 58.22 11.8 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.018 2.127 . . . . 0.0 113.236 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.7 -145.47 11.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 127.344 2.402 . . . . 0.0 113.042 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 9' ' ' LEU . 2.5 mp0 -106.0 173.37 6.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.448 1.899 . . . . 0.0 111.944 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 86' ' ' LEU . 23.5 mt -130.1 161.34 39.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 126.18 1.792 . . . . 0.0 108.981 173.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.56 121.21 16.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.681 1.992 . . . . 0.0 107.19 166.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t -164.62 177.74 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.761 1.224 . . . . 0.0 109.984 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.06 82.6 1.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.81 -1.181 . . . . 0.0 110.113 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 103' ' ' VAL . 3.4 t0 -146.12 156.31 43.35 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.953 0.901 . . . . 0.0 112.102 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -66.55 -36.74 83.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.289 -166.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -49.95 13.98 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 117.212 -1.375 . . . . 0.0 110.568 168.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -51.62 -43.19 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.466 1.03 . . . . 0.0 110.799 -168.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 36.6 mt-30 -63.7 -43.86 95.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.021 0.928 . . . . 0.0 110.177 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.421 ' O ' HD23 ' A' ' 109' ' ' LEU . 21.1 t30 -69.23 -50.61 45.62 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.7 mm -52.62 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 125.625 1.57 . . . . 0.0 109.046 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.96 -34.79 66.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.151 1.341 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -54.76 30.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.059 -1.448 . . . . 0.0 112.754 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.433 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -61.83 -33.44 74.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 121.542 1.973 . . . . 0.0 110.302 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.5 mm? -73.69 -4.88 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.802 0.841 . . . . 0.0 113.255 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.24 3.38 61.17 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.863 -0.965 . . . . 0.0 114.399 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.03 149.91 24.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.033 1.417 . . . . 0.0 110.343 -175.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.46 ' N ' HD13 ' A' ' 112' ' ' LEU . 5.8 tmm_? -94.59 140.52 29.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.009 1.323 . . . . 0.0 110.131 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 15.7 p90 -144.08 178.28 7.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.038 -0.414 . . . . 0.0 110.86 177.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -107.86 121.43 44.73 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.447 1.099 . . . . 0.0 108.619 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -71.95 160.3 32.76 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 125.28 1.612 . . . . 0.0 109.717 157.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -167.69 1.71 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.121 0.962 . . . . 0.0 110.309 163.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -49.89 158.03 0.54 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.825 1.65 . . . . 0.0 111.233 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -55.26 148.41 14.65 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.143 1.377 . . . . 0.0 110.568 166.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.46 160.99 24.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.8 mt -140.53 145.97 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 126.827 2.051 . . . . 0.0 107.122 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -109.45 -78.71 0.59 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.998 164.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -131.78 62.84 1.62 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.689 1.586 . . . . 0.0 111.099 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 125' ' ' ILE . 11.8 p -153.01 179.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.847 1.659 . . . . 0.0 108.024 -177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.436 ' H ' HG22 ' A' ' 124' ' ' VAL . 3.6 mp -123.56 144.04 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HE3' ' CG ' ' A' ' 160' ' ' LYS . 10.2 mmtm -79.0 107.65 11.91 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.509 1.049 . . . . 0.0 108.192 165.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 12.8 p-90 -64.67 163.96 12.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.695 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -154.8 15.07 0.42 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.405 ' N ' HD11 ' A' ' 157' ' ' ILE . 52.8 m-85 -143.38 150.47 39.15 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.1 136.74 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.615 1.966 . . . . 0.0 108.679 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.2 t -76.93 121.95 24.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.035 0.934 . . . . 0.0 110.064 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.47 84.29 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 122.503 1.144 . . . . 0.0 108.608 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.77 -20.12 0.12 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.392 1.472 . . . . 0.0 112.125 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 18.9 p -152.87 0.63 0.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.291 1.046 . . . . 0.0 113.426 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.51 10.52 66.87 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.624 -1.298 . . . . 0.0 114.914 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 13.8 ttt85 -71.89 135.24 46.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -88.85 139.37 30.53 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.769 1.628 . . . . 0.0 109.364 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.29 149.12 52.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.334 1.054 . . . . 0.0 108.609 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -99.43 -9.74 23.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.039 0.936 . . . . 0.0 111.776 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.0 p -141.0 169.77 16.99 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.06 2.544 . . . . 0.0 107.321 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.33 133.51 83.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.72 160.95 47.4 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 121.002 1.394 . . . . 0.0 108.734 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.23 -19.04 65.43 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.201 1.934 . . . . 0.0 114.911 -170.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.1 -3.42 55.73 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.775 0.716 . . . . 0.0 113.265 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.6 17.93 50.2 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 119.122 1.461 . . . . 0.0 113.96 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.85 156.18 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.88 2.072 . . . . 0.0 106.526 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 11.7 t -69.8 113.79 20.03 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 125.534 1.534 . . . . 0.0 108.717 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 80.4 Cg_endo -66.39 -11.05 29.91 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.855 1.703 . . . . 0.0 112.091 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.82 -24.41 14.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.691 1.196 . . . . 0.0 112.074 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.7 p -142.25 -9.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.94 62.52 4.9 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.442 1.019 . . . . 0.0 112.319 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.31 167.76 22.75 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.015 0.926 . . . . 0.0 109.935 164.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -55.55 145.3 23.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.81 1.244 . . . . 0.0 110.668 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.4 t -104.52 138.91 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 167.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 162.53 29.12 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.514 1.126 . . . . 0.0 110.584 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.58 156.47 38.97 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.693 1.197 . . . . 0.0 110.241 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -126.82 159.0 66.5 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 128.245 2.618 . . . . 0.0 108.65 174.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.65 -161.49 0.15 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.621 1.547 . . . . 0.0 112.299 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -46.4 143.0 2.72 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.541 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.429 ' CG ' ' HE3' ' A' ' 126' ' ' LYS . 44.5 tptt -101.5 -83.72 0.45 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 117.554 -1.212 . . . . 0.0 108.485 175.188 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 117.671 -1.157 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.31 112.43 0.01 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.662 2.385 . . . . 0.0 113.622 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.15 -156.41 0.24 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -169.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 68.65 163.98 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.023 2.129 . . . . 0.0 111.202 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.47 176.44 10.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.275 1.03 . . . . 0.0 110.177 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 7' ' ' LYS . 7.0 ttpt -70.19 179.03 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.491 0.716 . . . . 0.0 109.183 171.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 6' ' ' LYS . 20.3 tptt -61.97 -176.9 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.25 160.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -60.94 136.14 58.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.466 -1.396 . . . . 0.0 109.943 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -155.3 146.66 22.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.477 1.511 . . . . 0.0 107.181 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.8 t -118.22 147.51 21.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' CD1' HD21 ' A' ' 9' ' ' LEU . 1.8 mm? -116.62 140.05 49.84 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.329 1.452 . . . . 0.0 109.504 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.93 164.49 13.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.902 1.281 . . . . 0.0 111.169 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -42.12 -47.7 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.603 1.961 . . . . 0.0 113.708 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -58.82 -33.92 70.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.37 0.668 . . . . 0.0 110.94 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.36 -41.06 83.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.85 0.86 . . . . 0.0 109.562 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.94 -39.03 64.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.8 mt -57.28 -41.12 77.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.864 0.866 . . . . 0.0 109.799 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -78.7 -26.54 44.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.788 0.722 . . . . 0.0 111.871 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.46 26.74 12.94 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.315 0.959 . . . . 0.0 112.632 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 mt -77.01 110.32 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.459 1.129 . . . . 0.0 108.325 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.59 108.98 2.63 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 6.3 tp -145.28 170.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' O ' HD22 ' A' ' 9' ' ' LEU . 21.0 pt-20 -137.56 140.72 41.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.589 1.956 . . . . 0.0 107.379 -168.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 162.23 -148.46 15.68 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 124.424 1.077 . . . . 0.0 114.001 -159.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.49 152.81 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.335 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -130.62 154.18 48.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.926 1.69 . . . . 0.0 111.476 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.26 113.64 59.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 126.218 1.807 . . . . 0.0 112.147 -170.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.04 -11.09 29.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.646 2.897 . . . . 0.0 114.378 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -71.5 -40.78 69.95 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.612 1.165 . . . . 0.0 109.977 166.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG22 ' CB ' ' A' ' 81' ' ' ALA . 38.5 t -74.33 -40.68 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -170.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.96 -23.45 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 118.519 -1.272 . . . . 0.0 113.48 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.58 -20.44 63.65 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.744 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.05 -36.98 19.36 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.087 1.355 . . . . 0.0 108.805 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -66.53 94.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.908 1.283 . . . . 0.0 109.672 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -22.81 13.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.15 0.98 . . . . 0.0 111.582 169.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.07 122.15 10.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.741 1.216 . . . . 0.0 108.764 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -50.36 -49.05 55.27 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 116.932 -1.509 . . . . 0.0 111.655 -170.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -60.38 -60.7 3.39 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -168.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 t -51.44 -53.83 33.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.875 2.07 . . . . 0.0 110.781 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.15 -62.78 1.58 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.665 1.186 . . . . 0.0 110.959 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mt -55.9 -43.32 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.87 -53.33 59.16 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.787 0.835 . . . . 0.0 111.267 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.93 -44.0 73.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.048 1.339 . . . . 0.0 110.549 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.83 -39.14 90.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.59 -0.694 . . . . 0.0 111.079 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -56.52 -51.33 68.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.537 1.135 . . . . 0.0 109.046 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.02 -36.06 81.29 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 111.131 -171.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.2 mt -62.07 -47.78 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -39.97 85.38 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.802 0.441 . . . . 0.0 112.115 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.25 63.6 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.362 1.065 . . . . 0.0 111.838 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.82 44.44 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.039 0.828 . . . . 0.0 113.658 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 2.8 ptpt -70.82 -39.79 72.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.244 -170.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.62 99.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -167.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 4.3 mmmm -82.37 164.32 21.13 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.164 0.986 . . . . 0.0 110.302 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.42 129.44 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 123.231 0.612 . . . . 0.0 110.729 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.65 128.45 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 109.982 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -101.17 154.78 36.98 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 110.435 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.33 175.95 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 124.736 3.624 . . . . 0.0 112.684 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.05 160.58 14.38 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.398 -1.728 . . . . 0.0 107.975 173.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -39.34 68.14 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.577 -0.702 . . . . 0.0 110.642 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.66 -22.27 43.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.854 0.861 . . . . 0.0 110.379 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -65.57 -49.76 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 108.959 166.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.84 -46.63 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 118.736 0.698 . . . . 0.0 109.405 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -38.35 83.98 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.999 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.05 68.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 0.827 . . . . 0.0 111.761 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -67.52 -47.54 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.0 mt -51.62 -38.25 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.096 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -63.81 -62.32 1.72 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.698 1.135 . . . . 0.0 110.501 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.01 -40.85 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.19 96.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.612 0.765 . . . . 0.0 111.57 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -32.86 74.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.006 -1.059 . . . . 0.0 110.795 175.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.37 -5.25 38.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.738 0.699 . . . . 0.0 111.277 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -108.37 -41.66 4.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.994 0.815 . . . . 0.0 112.03 168.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.77 -80.4 0.18 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 119.678 1.126 . . . . 0.0 110.418 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -62.43 87.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.832 2.453 . . . . 0.0 109.338 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 p -89.22 -49.98 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.495 1.518 . . . . 0.0 110.926 -173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -130.69 14.63 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.727 0.811 . . . . 0.0 109.556 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -56.95 -33.77 67.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 110.2 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.6 mp -76.09 164.51 26.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 111.016 -172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.7 m -73.03 163.69 27.8 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.99 0.9 . . . . 0.0 112.252 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -61.22 2.45 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 123.552 0.741 . . . . 0.0 109.136 174.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.511 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -53.47 -38.17 63.37 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 125.908 2.005 . . . . 0.0 110.334 -171.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.49 -67.57 0.25 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.427 1.891 . . . . 0.0 109.083 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.67 -29.93 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.925 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -66.57 -49.16 67.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 113.295 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.1 t -50.76 -60.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.088 1.755 . . . . 0.0 108.53 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.2 mm? -62.18 -47.7 83.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.52 -172.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.11 -59.26 4.09 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.926 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 tp -56.3 -46.47 79.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -28.93 70.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.342 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' HE2' HD12 ' A' ' 65' ' ' ILE . 4.8 m-85 -80.61 -20.87 42.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.009 0.822 . . . . 0.0 111.618 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.73 -40.29 96.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.3 0.955 . . . . 0.0 108.921 164.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.68 -14.91 50.66 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.715 1.206 . . . . 0.0 112.566 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.34 42.98 7.97 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.477 1.511 . . . . 0.0 110.292 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.04 -113.88 3.88 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 126.067 1.794 . . . . 0.0 115.144 -165.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -147.45 167.64 23.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.41 1.484 . . . . 0.0 109.555 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 86' ' ' LEU . 58.6 mt -130.13 158.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 109.184 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.48 115.3 10.14 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 t -160.93 179.66 8.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.93 1.292 . . . . 0.0 108.524 172.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -158.57 89.1 0.95 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.844 -1.16 . . . . 0.0 110.627 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -153.35 156.02 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.07 0.948 . . . . 0.0 110.699 176.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -58.75 -48.89 79.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.624 0.77 . . . . 0.0 110.162 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -64.87 -54.82 24.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.663 1.185 . . . . 0.0 109.723 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -63.01 -36.56 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.823 0.449 . . . . 0.0 110.923 -164.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.04 -44.0 85.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -60.87 -50.57 72.9 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.104 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 HD21 ' A' ' 78' ' ' LEU . 10.1 mm -54.58 -51.05 54.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.991 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.61 88.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.085 1.311 . . . . 0.0 111.298 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 t -65.11 -49.4 70.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.426 -0.797 . . . . 0.0 113.022 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -36.81 84.84 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 120.432 1.469 . . . . 0.0 110.723 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -66.32 -28.66 68.85 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.508 0.323 . . . . 0.0 110.524 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.04 46.38 59.13 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -170.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.01 123.65 49.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.321 1.06 . . . . 0.0 108.484 160.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 140.19 57.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.95 1.3 . . . . 0.0 109.849 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -145.47 178.42 8.12 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.826 0.85 . . . . 0.0 109.741 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.67 146.23 32.32 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.385 1.074 . . . . 0.0 108.771 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -123.47 142.97 50.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.11 1.364 . . . . 0.0 108.778 169.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.84 167.52 2.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.333 1.453 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.75 63.5 6.9 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.219 -0.925 . . . . 0.0 109.39 162.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.12 149.42 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 163.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.92 -96.66 0.1 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 126' ' ' LYS . 7.6 pt -136.09 161.59 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 110.43 -167.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -140.21 -18.67 0.89 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.864 -172.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -159.35 19.75 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.076 1.307 . . . . 0.0 112.149 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.6 p -151.29 128.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.63 121.12 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' H ' HD13 ' A' ' 121' ' ' ILE . 4.1 tmtp? -76.42 139.99 41.12 Favored 'General case' 0 C--N 1.335 -0.058 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 165.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.497 ' CH2' HD13 ' A' ' 157' ' ' ILE . 22.7 p-90 -150.01 163.05 39.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.645 -174.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -149.06 15.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -143.74 146.46 33.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.688 0.676 . . . . 0.0 109.87 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.45 135.28 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.056 0.942 . . . . 0.0 109.989 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.99 130.22 43.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.783 1.233 . . . . 0.0 108.849 169.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.9 pt -87.07 51.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.797 0.839 . . . . 0.0 111.391 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.82 -81.95 0.04 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.44 -7.36 54.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.098 0.559 . . . . 0.0 111.87 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.52 29.04 74.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 125.555 1.55 . . . . 0.0 113.239 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 140.36 53.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -81.9 153.45 26.32 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.919 1.287 . . . . 0.0 109.511 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -146.89 126.12 13.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.897 1.279 . . . . 0.0 107.646 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.4 p -82.51 -23.71 34.49 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.084 -1.01 . . . . 0.0 111.479 170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 p -141.95 159.34 42.43 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 126.511 1.924 . . . . 0.0 108.594 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.5 OUTLIER -65.48 121.84 77.12 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -173.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 141' ' ' LEU . 63.8 Cg_endo -63.21 157.57 49.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 CA-C-N 121.011 1.397 . . . . 0.0 109.145 171.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.12 128.7 26.02 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.348 1.365 . . . . 0.0 108.935 174.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.64 69.18 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.057 1.313 . . . . 0.0 113.215 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 58.58 43.31 96.19 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 118.948 1.374 . . . . 0.0 111.391 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.45 168.25 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 18.9 t -78.06 110.52 13.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 111.183 -173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 37.9 Cg_endo -63.22 15.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.925 3.084 . . . . 0.0 114.576 167.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.4 OUTLIER -132.33 -20.13 2.41 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.053 1.741 . . . . 0.0 111.765 -175.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.16 3.42 0.25 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.83 -14.09 2.18 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.833 1.682 . . . . 0.0 114.919 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.6 m -62.13 149.27 41.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.097 1.448 . . . . 0.0 110.877 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.54 157.52 6.85 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 109.796 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.92 162.83 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.12 163.08 31.17 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.262 -1.523 . . . . 0.0 108.779 164.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.04 148.74 46.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 163.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.497 HD13 ' CH2' ' A' ' 127' ' ' TRP . 0.7 OUTLIER -109.36 160.88 26.03 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 109.812 168.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.03 -166.6 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.108 2.539 . . . . 0.0 109.96 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.66 145.26 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.825 -0.547 . . . . 0.0 111.103 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 128.13 54.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 157.873 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 119.413 -0.327 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 m -56.53 139.49 49.39 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.76 -1.212 . . . . 0.0 108.598 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -158.96 143.3 15.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.72 142.25 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.58 137.41 49.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 108.281 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -89.11 164.72 14.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.88 0.848 . . . . 0.0 111.032 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.49 165.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -57.12 -26.31 60.29 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.39 -37.17 64.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 120.213 1.37 . . . . 0.0 109.405 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -77.37 -12.78 59.99 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.5 1.52 . . . . 0.0 112.538 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.45 -45.53 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.227 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.49 -20.39 50.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.979 1.718 . . . . 0.0 114.25 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.62 40.9 5.54 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 128.375 2.893 . . . . 0.0 112.097 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.2 100.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 119.944 1.872 . . . . 0.0 107.211 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 111.63 1.02 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.399 0.68 . . . . 0.0 110.328 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 23' ' ' GLU . 5.7 tp -155.69 170.23 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 126.189 1.796 . . . . 0.0 107.978 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 22' ' ' ILE . 54.3 mt-10 -115.03 162.63 16.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.624 2.37 . . . . 0.0 108.96 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.85 -132.83 4.27 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 118.456 0.571 . . . . 0.0 112.067 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.7 151.61 47.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.734 1.613 . . . . 0.0 109.971 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -129.36 149.78 51.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.973 1.709 . . . . 0.0 111.138 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.61 116.5 66.34 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 126.492 1.917 . . . . 0.0 109.318 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 31' ' ' VAL . 38.2 Cg_endo -63.09 -16.79 56.66 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.934 1.756 . . . . 0.0 112.379 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -53.57 52.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.152 1.381 . . . . 0.0 110.608 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.35 -35.5 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 O-C-N 121.611 -0.681 . . . . 0.0 109.424 -169.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG23 HD21 ' A' ' 43' ' ' LEU . 7.0 p -63.08 -20.5 25.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.768 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -69.67 -21.35 63.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.118 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.48 -7.36 31.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.532 1.533 . . . . 0.0 110.923 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.13 99.94 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.677 1.191 . . . . 0.0 108.455 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 -13.49 15.57 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.08 -176.08 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.054 1.342 . . . . 0.0 110.466 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -101.28 -43.21 6.04 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.391 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -56.9 -60.86 2.95 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 120.1 1.318 . . . . 0.0 107.702 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m -62.25 -11.29 14.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -89.37 -66.7 0.9 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.4 mt -52.37 -48.79 44.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 124.892 1.277 . . . . 0.0 107.659 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -56.58 -54.57 44.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.013 0.925 . . . . 0.0 112.553 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 31' ' ' VAL . 14.3 tp -58.15 -54.04 51.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.895 1.278 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.26 -39.79 83.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.484 1.514 . . . . 0.0 111.477 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.2 m -68.77 -45.38 71.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 120.687 -1.258 . . . . 0.0 112.005 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -38.28 90.46 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 124.452 1.101 . . . . 0.0 110.039 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.76 -56.69 11.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.776 0.831 . . . . 0.0 108.933 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 m -68.03 -26.07 65.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.992 0.517 . . . . 0.0 111.938 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 -2.25 39.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.895 1.678 . . . . 0.0 112.616 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.67 23.37 68.85 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 125.421 1.486 . . . . 0.0 113.464 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -72.41 -35.35 68.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 108.841 171.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -134.95 136.92 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -114.67 156.71 24.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.331 1.053 . . . . 0.0 111.207 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.3 mm -83.31 129.55 37.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 119.182 0.901 . . . . 0.0 109.656 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.28 124.15 6.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.258 1.023 . . . . 0.0 111.192 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.61 152.58 38.42 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.832 1.253 . . . . 0.0 109.636 166.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.55 166.83 28.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.782 3.654 . . . . 0.0 114.02 -171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -75.39 158.69 32.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.94 0.876 . . . . 0.0 111.395 162.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -44.15 95.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.576 1.151 . . . . 0.0 110.352 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.53 -32.8 71.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.591 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -48.17 74.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.383 0.673 . . . . 0.0 110.417 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -50.73 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.3 -32.31 69.93 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -45.63 80.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.667 1.121 . . . . 0.0 110.492 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -64.61 -45.41 95.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -54.01 -38.1 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.512 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -64.93 -59.18 4.46 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.899 1.227 . . . . 0.0 109.207 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.12 -33.55 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.828 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -63.64 -48.51 76.99 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.123 1.369 . . . . 0.0 110.807 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -27.53 68.38 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.194 -0.941 . . . . 0.0 110.645 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -70.26 -37.06 74.82 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.187 0.903 . . . . 0.0 111.844 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' ALA . 7.5 t -87.26 -14.95 39.54 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.851 1.205 . . . . 0.0 112.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 -59.73 0.6 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 125.057 1.313 . . . . 0.0 112.807 165.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -75.67 92.65 2.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.68 -43.79 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 123.53 0.732 . . . . 0.0 112.764 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.56 7.34 6.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.064 0.546 . . . . 0.0 110.149 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -69.91 -3.77 17.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 112.088 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.55 150.81 21.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.58 1.552 . . . . 0.0 108.972 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -69.94 157.83 36.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.744 0.783 . . . . 0.0 110.92 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -64.63 -50.88 65.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.171 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.61 -42.29 55.82 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.788 0.835 . . . . 0.0 111.453 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -59.08 5.18 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.824 1.65 . . . . 0.0 109.827 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.93 -44.86 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.78 1.232 . . . . 0.0 108.856 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -60.26 -52.64 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.609 1.563 . . . . 0.0 111.524 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.74 -54.26 37.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.257 1.023 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 96' ' ' ILE . 57.7 mt -58.23 -51.85 68.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.866 0.867 . . . . 0.0 109.419 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.78 -52.76 22.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 112.218 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -50.91 68.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 123.494 0.496 . . . . 0.0 110.028 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.91 -31.45 70.95 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 9.6 m-30 -69.39 -33.86 73.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.613 0.642 . . . . 0.0 110.558 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.71 -31.71 72.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.483 0.583 . . . . 0.0 112.53 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.06 -15.83 33.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.651 1.181 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.71 24.2 1.62 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 112.65 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.52 -102.21 0.87 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.079 0.847 . . . . 0.0 111.786 -169.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -153.48 166.28 33.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.202 1.001 . . . . 0.0 110.515 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 86' ' ' LEU . 48.4 mt -135.43 156.67 38.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.539 1.536 . . . . 0.0 107.379 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 124.68 30.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.867 1.267 . . . . 0.0 107.878 164.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.0 t -163.28 175.28 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.373 1.069 . . . . 0.0 110.54 165.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -147.34 63.21 1.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.554 1.142 . . . . 0.0 112.8 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.45 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -123.0 157.95 31.57 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.384 1.074 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -72.79 -45.06 60.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.566 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.377 1.071 . . . . 0.0 110.784 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -55.02 -41.66 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.436 1.016 . . . . 0.0 109.354 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.67 -43.51 96.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.61 0.764 . . . . 0.0 110.139 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 51.6 t30 -64.69 -53.76 42.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.754 0.821 . . . . 0.0 110.027 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.51 -55.15 16.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.951 0.901 . . . . 0.0 109.112 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.49 65.66 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.47 1.486 . . . . 0.0 113.565 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 t -57.5 -63.25 1.3 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.528 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -64.5 -21.24 66.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.852 1.66 . . . . 0.0 113.036 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mm? -85.47 -6.25 59.21 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.292 1.037 . . . . 0.0 112.522 175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.48 9.15 84.54 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.881 -1.511 . . . . 0.0 113.988 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.86 120.62 32.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.09 1.945 . . . . 0.0 111.418 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 134.95 57.59 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.95 1.3 . . . . 0.0 109.892 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -147.81 170.88 16.67 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 122.885 0.474 . . . . 0.0 110.262 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.2 mtt-85 -109.42 154.38 22.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.548 1.139 . . . . 0.0 109.647 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.443 -0.784 0 O-C-N 123.965 0.791 . . . . 0.0 109.41 172.298 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -159.13 14.53 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -141.53 150.5 42.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.008 1.276 . . . . 0.0 110.42 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.44 129.33 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.413 1.085 . . . . 0.0 108.262 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -62.07 153.37 30.03 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 165.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.79 88.32 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 122.804 1.288 . . . . 0.0 109.374 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.2 -75.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 p -93.75 -3.91 51.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.094 0.958 . . . . 0.0 113.031 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.66 26.59 72.06 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 125.707 1.622 . . . . 0.0 114.106 170.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -66.09 136.14 55.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.291 0.636 . . . . 0.0 109.506 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.8 141.03 31.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.489 1.116 . . . . 0.0 108.162 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -136.03 152.7 51.17 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -94.65 -17.82 21.91 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.74 -0.6 . . . . 0.0 111.726 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 45.4 p -128.02 169.21 14.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.514 1.126 . . . . 0.0 108.989 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.13 119.74 72.76 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.56 172.31 9.43 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.919 1.746 . . . . 0.0 110.269 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.46 138.19 83.24 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.032 1.821 . . . . 0.0 110.597 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.07 -5.34 1.34 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.56 1.076 . . . . 0.0 113.926 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.34 51.1 38.24 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-O 117.41 -1.772 . . . . 0.0 110.626 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 m -126.62 158.51 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 118.853 1.326 . . . . 0.0 108.065 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 35.2 t -77.78 111.95 21.37 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 125.216 1.406 . . . . 0.0 111.835 -167.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 44.0 Cg_endo -64.48 23.26 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.97 3.113 . . . . 0.0 115.231 167.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.82 -18.04 0.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.412 1.485 . . . . 0.0 113.336 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 13.0 p -151.83 -2.34 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.99 -17.8 5.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.856 1.217 . . . . 0.0 114.618 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -62.53 162.0 11.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.413 1.606 . . . . 0.0 112.901 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -61.64 155.92 21.26 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.62 -0.675 . . . . 0.0 110.771 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.34 144.41 21.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -133.79 164.18 27.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.196 1.398 . . . . 0.0 110.357 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.8 tt -78.91 155.37 29.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.537 1.135 . . . . 0.0 110.218 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.6 pt . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 127.372 2.269 . . . . 0.0 110.943 -178.412 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -51.62 124.89 13.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.788 1.235 . . . . 0.0 108.598 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 tp -149.4 142.72 25.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.382 1.873 . . . . 0.0 106.494 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.06 150.52 19.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.15 150.66 37.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.709 1.604 . . . . 0.0 108.591 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.82 161.12 13.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.004 0.522 . . . . 0.0 111.736 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.569 ' HB2' HG21 ' A' ' 30' ' ' VAL . 29.1 t -37.14 -55.31 0.97 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.857 2.463 . . . . 0.0 112.158 164.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.4 m -56.62 -28.01 59.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.227 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' ILE . 21.0 t -63.42 -45.36 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.662 1.119 . . . . 0.0 109.43 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.36 -33.51 71.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.576 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.68 -41.62 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.051 0.941 . . . . 0.0 110.446 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -75.65 -30.26 59.4 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.977 -0.452 . . . . 0.0 110.485 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.04 29.42 15.22 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 124.975 1.274 . . . . 0.0 111.187 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.5 mt -74.5 110.06 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.19 121.22 9.56 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.411 1.484 . . . . 0.0 109.178 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 23' ' ' GLU . 8.3 tp -158.83 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.755 2.022 . . . . 0.0 109.669 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' H ' HG13 ' A' ' 22' ' ' ILE . 1.7 mp0 -135.77 159.19 42.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 108.99 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.41 -134.13 5.37 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 120.795 1.634 . . . . 0.0 114.376 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -129.0 154.99 46.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.6 1.96 . . . . 0.0 109.351 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -141.6 153.89 45.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.901 0.88 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.4 p -86.89 118.22 69.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.904 0.882 . . . . 0.0 110.455 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.88 -27.85 74.43 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.098 1.199 . . . . 0.0 110.794 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -71.88 -24.11 61.61 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 13' ' ' SER . 7.4 p -86.44 -31.12 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 121.33 1.877 . . . . 0.0 109.326 166.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.71 -22.1 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 119.211 0.914 . . . . 0.0 111.043 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.75 -14.9 16.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.629 -1.294 . . . . 0.0 112.746 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.53 -30.56 7.58 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.534 -1.354 . . . . 0.0 112.411 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -55.29 111.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 120.099 1.318 . . . . 0.0 110.399 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -12.81 6.96 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.113 1.365 . . . . 0.0 112.615 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.99 122.69 17.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.8 mtt-85 -52.72 -49.68 64.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.169 0.988 . . . . 0.0 110.366 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.69 -52.74 64.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.265 0.978 . . . . 0.0 109.098 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 t -53.8 -49.14 68.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -65.18 -53.9 37.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.675 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.15 -54.1 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 33.2 t80 -57.26 -49.22 76.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.263 1.025 . . . . 0.0 111.103 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.7 tp -50.49 -60.77 2.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 109.98 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.63 78.78 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.302 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.9 m -57.37 -49.66 75.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.471 1.108 . . . . 0.0 110.654 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 26.2 mt -63.2 -41.98 99.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.785 0.434 . . . . 0.0 110.228 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.59 -50.35 67.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 p -64.09 -33.93 76.88 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.132 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.592 0.757 . . . . 0.0 110.058 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.99 16.5 6.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 124.18 0.895 . . . . 0.0 112.276 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -86.29 -27.54 24.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.374 1.087 . . . . 0.0 110.803 -173.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.95 148.97 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -129.66 146.41 51.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.415 1.086 . . . . 0.0 112.01 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.47 125.79 36.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.214 1.806 . . . . 0.0 108.119 -175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.5 118.53 5.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.263 1.025 . . . . 0.0 109.928 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -86.26 155.13 57.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.373 -0.829 . . . . 0.0 110.027 163.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.41 163.52 36.24 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 124.605 3.537 . . . . 0.0 111.301 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -83.94 166.7 17.61 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.741 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -57.73 -50.42 73.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.185 1.394 . . . . 0.0 110.628 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.2 -27.6 67.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.51 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.14 -51.13 49.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.609 0.764 . . . . 0.0 109.404 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.64 -46.78 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.965 . . . . 0.0 109.744 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.34 -34.42 68.75 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.081 -0.387 . . . . 0.0 111.721 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -44.52 86.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.819 0.448 . . . . 0.0 110.945 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.95 -36.31 75.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.36 -47.7 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.01 -45.14 86.74 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.412 1.005 . . . . 0.0 111.728 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.985 HG11 HD21 ' A' ' 110' ' ' LEU . 9.9 p -69.43 -40.42 79.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 O-C-N 121.164 -0.96 . . . . 0.0 110.379 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.06 89.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -27.37 58.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.256 -0.903 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.71 -13.52 62.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.792 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 t -125.19 -15.79 6.17 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.992 1.724 . . . . 0.0 114.964 -174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.37 -90.14 0.15 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.109 1.322 . . . . 0.0 110.786 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -77.16 58.11 1.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.581 1.953 . . . . 0.0 113.212 -161.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.5 p -45.45 -37.75 2.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.82 1.648 . . . . 0.0 114.944 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -128.79 11.1 6.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.09 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.04 -9.46 59.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.703 0.683 . . . . 0.0 111.989 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 144.3 27.02 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 m -67.62 161.47 25.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.245 1.021 . . . . 0.0 111.034 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -61.26 -55.58 30.29 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.327 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.34 -37.99 68.16 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 123.888 0.742 . . . . 0.0 110.386 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -61.96 -53.95 48.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.569 0.748 . . . . 0.0 109.027 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.55 -43.7 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.238 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -63.21 -54.98 28.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.13 0.972 . . . . 0.0 112.238 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.18 -49.52 83.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 109.799 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 HD13 ' A' ' 96' ' ' ILE . 94.9 mt -61.04 -49.42 77.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -53.33 -53.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.79 0.836 . . . . 0.0 111.806 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.1 tp -51.09 -52.65 41.43 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.655 0.782 . . . . 0.0 109.82 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.23 69.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.514 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.6 m-30 -84.61 -18.43 35.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.131 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.01 -37.17 75.58 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.74 1.155 . . . . 0.0 109.229 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 -17.58 45.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.034 1.334 . . . . 0.0 112.474 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.17 46.65 5.18 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.066 2.146 . . . . 0.0 110.753 -169.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.53 -114.69 3.97 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.383 0.516 . . . . 0.0 112.113 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.44 164.21 31.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.07 1.748 . . . . 0.0 106.409 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.519 HD13 HD23 ' A' ' 86' ' ' LEU . 80.0 mt -136.6 155.95 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 116.85 15.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -156.27 -173.37 4.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.536 0.734 . . . . 0.0 109.947 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -144.53 -13.75 0.58 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.3 160.59 32.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.616 1.553 . . . . 0.0 114.684 -168.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -62.53 -46.09 90.0 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 119.929 -1.732 . . . . 0.0 110.936 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -72.16 -53.97 11.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -41.63 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.879 0.872 . . . . 0.0 111.318 -168.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.66 -38.88 64.81 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.933 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 109' ' ' LEU . 15.2 t30 -66.86 -51.13 59.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 117.531 -1.223 . . . . 0.0 108.055 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -48.16 -59.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.44 63.75 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.841 1.655 . . . . 0.0 112.681 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -65.28 -53.32 45.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.277 -1.344 . . . . 0.0 112.719 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -61.98 -35.69 79.26 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 121.518 1.963 . . . . 0.0 109.962 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.985 HD21 HG11 ' A' ' 68' ' ' VAL . 2.3 mm? -71.11 -19.38 62.45 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.37 14.87 79.55 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.201 -1.333 . . . . 0.0 113.502 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -72.68 163.81 27.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.138 1.469 . . . . 0.0 109.213 176.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.562 ' H ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -105.68 128.81 53.88 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -151.18 -176.39 5.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.204 0.202 . . . . 0.0 110.762 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -119.79 154.37 34.34 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.559 1.544 . . . . 0.0 109.663 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -160.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -156.0 14.78 0.34 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -136.03 147.36 47.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.772 1.169 . . . . 0.0 110.831 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.11 134.73 47.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.755 1.222 . . . . 0.0 108.329 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 129.66 40.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.121 0.968 . . . . 0.0 108.416 165.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 pt -84.03 111.14 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 160.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.84 -93.66 0.17 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 106.543 -2.623 . . . . 0.0 106.543 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 3.6 p -76.34 -13.74 60.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.212 0.605 . . . . 0.0 111.952 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.87 73.84 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 124.69 1.138 . . . . 0.0 115.305 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -68.81 129.75 40.82 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 110.631 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -71.42 147.13 48.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.375 1.07 . . . . 0.0 110.198 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -139.89 156.04 46.89 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.145 0.978 . . . . 0.0 109.553 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 p -97.54 -24.83 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.235 0.614 . . . . 0.0 112.053 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.91 129.85 5.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -158.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.82 123.24 80.98 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 126.099 1.76 . . . . 0.0 110.43 -168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.3 171.75 17.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.61 3.54 . . . . 0.0 113.121 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.54 87.76 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.429 3.419 . . . . 0.0 110.505 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.27 -28.77 2.67 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 126.363 1.935 . . . . 0.0 111.113 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.72 32.05 61.31 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 121.462 -1.022 . . . . 0.0 112.275 -168.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 178.54 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 126.179 1.791 . . . . 0.0 107.906 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.9 t -83.21 103.97 3.23 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.304 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.63 -2.5 0.72 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.072 1.848 . . . . 0.0 114.589 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.77 -31.5 13.17 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.826 1.25 . . . . 0.0 112.682 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.8 -35.98 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.815 0.846 . . . . 0.0 113.069 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 113.22 -15.91 22.69 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.143 2.306 . . . . 0.0 113.599 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.1 m -67.77 169.86 8.92 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.765 1.782 . . . . 0.0 113.178 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -74.13 142.45 45.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.372 1.069 . . . . 0.0 111.536 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.17 147.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.718 1.607 . . . . 0.0 106.763 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -122.89 160.81 25.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.632 1.173 . . . . 0.0 108.807 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.02 151.56 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 125.116 1.366 . . . . 0.0 110.584 176.124 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -53.76 129.16 32.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.349 1.06 . . . . 0.0 110.372 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.1 tp -149.74 149.44 30.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 151.07 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.94 158.61 26.37 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.655 1.582 . . . . 0.0 109.007 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -118.62 169.28 9.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.306 1.442 . . . . 0.0 111.295 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 p -55.52 -46.74 77.0 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.966 1.306 . . . . 0.0 112.459 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -27.06 62.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.806 -1.092 . . . . 0.0 112.526 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.96 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.503 1.501 . . . . 0.0 109.109 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' HD12 ' A' ' 43' ' ' LEU . 38.2 m-85 -72.4 -33.0 66.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.406 0.682 . . . . 0.0 111.23 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.25 -49.63 83.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.924 0.889 . . . . 0.0 109.722 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.69 -13.73 61.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.297 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.55 22.8 57.76 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.582 0.611 . . . . 0.0 113.346 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.2 mt -77.77 107.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 108.4 1.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 171.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -154.22 154.96 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -98.89 164.15 12.32 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 126.431 1.892 . . . . 0.0 111.15 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.71 -139.39 9.34 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-O 121.28 0.378 . . . . 0.0 112.255 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -125.83 151.32 46.96 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.961 1.305 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 t -135.89 147.08 48.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.396 0.678 . . . . 0.0 109.301 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 114.09 48.12 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.484 1.914 . . . . 0.0 111.025 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.67 -20.99 45.08 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.002 1.802 . . . . 0.0 113.801 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -87.9 -12.95 43.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.16 -38.01 10.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 120.667 1.576 . . . . 0.0 108.154 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.97 -20.54 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.633 0.773 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.09 -24.16 38.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.539 1.135 . . . . 0.0 113.101 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.52 7.12 10.58 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.322 0.964 . . . . 0.0 112.7 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 mt -74.72 88.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -10.75 45.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.651 1.98 . . . . 0.0 112.686 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -73.7 124.52 26.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -67.82 -43.84 78.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 117.693 -1.146 . . . . 0.0 111.634 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -57.15 -55.43 34.9 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -55.57 -52.48 63.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.711 0.804 . . . . 0.0 111.208 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -58.69 -56.7 18.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.178 0.991 . . . . 0.0 110.076 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.08 -53.93 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 30.7 t80 -56.01 -49.69 72.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.404 0.682 . . . . 0.0 111.341 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' CD2' ' A' ' 16' ' ' PHE . 6.7 tt -54.98 -56.29 21.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.541 1.136 . . . . 0.0 110.066 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.32 -38.66 87.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.832 0.453 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.3 m -58.77 -41.64 87.1 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.837 0.855 . . . . 0.0 111.259 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.512 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 11.6 mt -64.35 -43.14 95.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.826 0.739 . . . . 0.0 110.629 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.32 -52.08 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.9 m -61.78 -32.13 72.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.427 1.091 . . . . 0.0 111.65 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.08 69.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.648 1.179 . . . . 0.0 110.836 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.16 -16.45 3.43 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 123.703 0.668 . . . . 0.0 113.343 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -71.85 -34.95 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.612 0.706 . . . . 0.0 110.774 -160.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 162.29 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.44 141.03 33.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.981 0.912 . . . . 0.0 108.853 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.43 124.68 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.887 0.875 . . . . 0.0 109.748 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.42 136.02 17.06 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.35 160.13 28.31 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.857 0.863 . . . . 0.0 112.177 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.74 -177.03 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.674 3.583 . . . . 0.0 112.575 168.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 t -122.02 166.81 13.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.76 1.224 . . . . 0.0 109.748 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' C ' ' HE2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -56.17 -49.53 73.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.303 1.041 . . . . 0.0 110.311 -173.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.13 -22.42 62.07 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.724 -0.61 . . . . 0.0 112.061 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -50.75 66.83 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mm -59.09 -49.6 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.04 0.936 . . . . 0.0 108.67 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -27.88 67.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.118 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -48.84 79.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.319 1.418 . . . . 0.0 110.612 173.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -64.82 -33.04 60.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.78 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.417 -0.802 . . . . 0.0 109.696 170.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -57.28 -49.62 75.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.861 1.21 . . . . 0.0 110.582 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.921 HG11 HD21 ' A' ' 110' ' ' LEU . 5.2 p -72.2 -41.27 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.87 -0.519 . . . . 0.0 110.632 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.36 -25.22 61.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 111.076 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 -25.98 41.54 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.245 0.929 . . . . 0.0 110.335 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.18 -5.61 5.21 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.284 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.266 10.8 t -127.56 -58.79 1.24 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.123 1.329 . . . . 0.0 111.365 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.43 -21.57 0.64 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 120.348 1.431 . . . . 0.0 115.585 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.48 20.32 0.43 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.094 1.447 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -33.36 -57.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 128.044 2.538 . . . . 0.0 115.864 -163.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -121.58 11.47 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.846 0.859 . . . . 0.0 109.794 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.31 -34.98 76.12 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.069 0.948 . . . . 0.0 109.82 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -64.88 149.75 48.98 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 111.86 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -51.66 133.42 30.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.888 1.275 . . . . 0.0 108.633 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -44.86 84.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.842 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.53 60.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.1 0.56 . . . . 0.0 111.48 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.12 -50.0 73.66 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.184 1.394 . . . . 0.0 108.812 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.9 mt -53.42 -45.77 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.642 0.777 . . . . 0.0 109.252 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -67.48 -44.25 78.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.208 1.403 . . . . 0.0 111.787 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.84 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.389 1.075 . . . . 0.0 108.895 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 96' ' ' ILE . 75.7 mt -59.19 -53.29 59.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.36 1.064 . . . . 0.0 109.295 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.36 -51.04 61.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.455 1.502 . . . . 0.0 111.825 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.1 tp -51.57 -56.05 15.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.03 86.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.253 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.1 m-30 -66.35 -33.69 76.3 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.956 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 -42.76 83.31 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.43 1.014 . . . . 0.0 109.495 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.92 -18.28 50.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.361 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt 53.99 26.38 6.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.48 1.112 . . . . 0.0 111.116 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.46 -159.36 27.96 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 127.654 2.55 . . . . 0.0 113.13 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.11 173.62 7.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 110.232 165.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.558 HD13 HD23 ' A' ' 86' ' ' LEU . 41.7 mt -129.13 163.47 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.292 2.237 . . . . 0.0 108.002 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.57 115.89 11.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.166 2.187 . . . . 0.0 106.984 165.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t -158.37 177.96 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.906 1.283 . . . . 0.0 109.673 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -150.62 23.59 0.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.823 -1.173 . . . . 0.0 113.335 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 4.0 t0 -87.84 156.14 19.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.792 -1.192 . . . . 0.0 109.59 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -64.39 -47.77 77.95 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.034 1.288 . . . . 0.0 109.654 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.69 -53.27 35.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.258 1.423 . . . . 0.0 110.544 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.4 p -54.3 -41.81 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.03 1.287 . . . . 0.0 110.316 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 114' ' ' PHE . 62.2 mt-30 -69.6 -36.5 76.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.073 0.949 . . . . 0.0 110.843 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.444 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.1 t-20 -69.02 -55.25 11.39 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 HD21 ' A' ' 78' ' ' LEU . 9.7 mm -49.59 -60.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 C-N-CA 125.094 1.358 . . . . 0.0 109.49 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.0 56.76 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.076 1.307 . . . . 0.0 112.163 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -48.13 75.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.974 -1.489 . . . . 0.0 113.705 172.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -65.89 -33.03 74.9 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 122.609 2.459 . . . . 0.0 110.631 174.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.921 HD21 HG11 ' A' ' 68' ' ' VAL . 1.1 mm? -75.5 -3.89 36.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.902 1.281 . . . . 0.0 113.032 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.03 -2.72 8.06 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.208 1.385 . . . . 0.0 115.226 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -74.06 127.86 34.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 120.14 1.97 . . . . 0.0 110.319 -167.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 129.52 39.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 104' ' ' GLN . 32.7 p90 -134.68 -179.37 5.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.637 0.256 . . . . 0.0 111.15 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.02 152.79 32.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.339 1.856 . . . . 0.0 107.993 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.321 -0.66 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.399 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 4.0 p-90 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -140.65 12.18 2.29 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.92 140.69 45.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 120.532 1.515 . . . . 0.0 111.675 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.29 139.43 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.929 2.092 . . . . 0.0 109.577 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 4.4 t -81.97 119.98 24.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 161.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.22 127.24 31.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 157.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 134.85 -81.8 0.3 Allowed Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 106.714 -2.555 . . . . 0.0 106.714 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.6 p -80.75 -19.48 44.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.351 -0.5 . . . . 0.0 110.73 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.22 18.54 62.47 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 121.398 -0.813 . . . . 0.0 113.766 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -84.75 162.0 19.79 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.611 1.564 . . . . 0.0 111.109 -165.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -112.29 142.1 45.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 110.481 -164.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -143.82 155.35 44.1 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.614 1.165 . . . . 0.0 109.784 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 1.8 p -104.88 -13.26 15.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.642 0.777 . . . . 0.0 112.977 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.7 p -147.07 175.61 10.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.893 2.477 . . . . 0.0 106.671 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.9 tp -80.19 133.65 56.98 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.3 170.51 20.18 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.612 2.208 . . . . 0.0 109.222 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -56.18 134.78 66.31 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.71 1.607 . . . . 0.0 109.632 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.07 -13.64 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.047 0.832 . . . . 0.0 113.901 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.06 27.89 71.21 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.264 1.532 . . . . 0.0 114.004 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 156.11 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.299 1.44 . . . . 0.0 107.597 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.62 117.88 51.84 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.97 -18.33 60.79 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.146 1.231 . . . . 0.0 113.246 171.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -81.69 -46.1 14.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.026 -1.046 . . . . 0.0 109.4 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.0 p -136.1 -1.5 2.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.66 0.784 . . . . 0.0 113.059 -159.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.15 -11.49 16.04 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.64 1.59 . . . . 0.0 114.624 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.2 m -75.7 163.91 26.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.483 1.142 . . . . 0.0 113.246 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -68.74 148.01 50.97 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.011 -1.055 . . . . 0.0 111.511 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 t -108.39 148.66 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.86 161.46 42.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.335 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.0 151.71 23.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.708 . . . . 0.0 110.595 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 124.336 1.054 . . . . 0.0 110.925 179.438 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -48.63 118.07 2.34 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.547 1.939 . . . . 0.0 109.03 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 tp -140.79 139.2 34.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.713 2.005 . . . . 0.0 107.667 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.7 153.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -135.58 145.65 47.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.219 1.808 . . . . 0.0 107.567 -167.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -110.0 166.48 10.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.507 . . . . 0.0 111.743 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -46.21 -46.78 17.78 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.247 1.819 . . . . 0.0 109.414 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -50.25 -34.94 24.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.617 1.167 . . . . 0.0 113.829 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 t -65.36 -43.79 94.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.209 0.913 . . . . 0.0 108.975 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.36 -36.59 71.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.964 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.51 -38.91 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.035 0.934 . . . . 0.0 110.667 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -83.2 -23.26 32.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.905 . . . . 0.0 112.825 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.23 24.04 27.83 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.88 0.764 . . . . 0.0 112.486 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -77.28 106.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.11 103.93 1.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.858 1.263 . . . . 0.0 108.467 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 tp -151.86 130.09 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -73.75 136.51 43.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.757 1.623 . . . . 0.0 110.815 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.26 -161.61 34.17 Favored Glycine 0 CA--C 1.521 0.453 0 O-C-N 120.721 -1.237 . . . . 0.0 112.101 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.28 151.24 42.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.481 0.712 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -142.89 152.5 42.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.565 1.146 . . . . 0.0 110.162 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.9 p -84.32 126.43 69.47 Favored Pre-proline 0 C--O 1.249 1.055 0 C-N-CA 123.192 0.597 . . . . 0.0 111.037 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -59.01 -30.16 92.63 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 120.409 0.739 . . . . 0.0 111.093 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 m -61.82 -43.95 97.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.697 1.135 . . . . 0.0 113.56 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.89 -38.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 43' ' ' LEU . 4.5 p -64.09 -26.54 40.73 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.123 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.37 -28.73 69.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.995 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -89.64 -22.89 22.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 111.401 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.11 133.47 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.531 1.158 . . . . 0.0 108.471 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -3.2 0.61 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.878 1.671 . . . . 0.0 112.098 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -70.56 120.35 16.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.9 mtm-85 -66.19 -40.5 90.48 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.552 -170.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.45 -57.01 14.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.0 t -52.37 -54.66 28.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.385 1.474 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -58.65 -57.84 11.21 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.068 0.947 . . . . 0.0 111.37 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.6 -49.38 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 43.8 t80 -59.48 -44.54 93.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.726 0.694 . . . . 0.0 112.493 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.511 HD13 HG23 ' A' ' 31' ' ' VAL . 5.2 tt -58.38 -56.12 26.21 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.327 1.051 . . . . 0.0 108.81 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.51 -40.68 87.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.511 0.725 . . . . 0.0 109.868 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -53.06 -48.41 67.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.161 1.384 . . . . 0.0 110.45 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.515 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 12.6 mt -62.81 -42.45 99.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.83 0.741 . . . . 0.0 111.424 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.37 -46.52 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 t -58.63 -44.48 90.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 109.991 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.14 99.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.353 1.461 . . . . 0.0 110.015 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.18 2.25 7.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.643 1.116 . . . . 0.0 113.887 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.1 -37.38 17.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 117.894 0.847 . . . . 0.0 109.932 -164.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -120.08 153.6 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -140.66 141.06 35.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.617 0.767 . . . . 0.0 110.643 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.39 134.07 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.52 126.59 9.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.501 1.12 . . . . 0.0 109.225 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 151.08 48.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.069 0.948 . . . . 0.0 111.335 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.89 -175.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.572 3.514 . . . . 0.0 110.548 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -125.63 161.43 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.448 2.299 . . . . 0.0 108.241 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -58.99 -40.42 84.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.299 -0.875 . . . . 0.0 110.436 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.21 -33.67 71.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.4 p -75.51 -35.49 60.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.265 0.939 . . . . 0.0 109.862 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.07 -50.11 80.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.44 -37.01 72.13 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.774 0.43 . . . . 0.0 111.059 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -42.67 65.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 111.026 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.0 mm -67.08 -48.6 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.05 -39.34 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.877 0.871 . . . . 0.0 110.28 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -54.8 -63.49 1.14 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.836 0.854 . . . . 0.0 109.974 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.89 -30.9 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -67.04 -47.18 72.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.42 -0.8 . . . . 0.0 110.791 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.18 67.54 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 120.817 -1.177 . . . . 0.0 110.659 173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -72.26 0.81 8.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.372 1.069 . . . . 0.0 112.514 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.272 2.9 t -121.05 -49.6 2.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.868 1.213 . . . . 0.0 109.51 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.3 -58.0 0.29 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.132 0.878 . . . . 0.0 112.499 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -69.62 39.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.399 2.68 . . . . 0.0 114.686 -171.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 10.7 p -39.77 -49.46 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.127 2.171 . . . . 0.0 115.062 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.8 28.19 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.176 0.99 . . . . 0.0 108.655 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.1 -28.35 63.24 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.632 -1.292 . . . . 0.0 110.4 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 160.26 30.75 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 t -66.51 154.56 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 109.974 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 13.8 ttpt -63.49 -51.49 65.36 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.771 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.27 -45.55 45.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.227 0.954 . . . . 0.0 109.439 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.17 -54.04 51.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.437 0.695 . . . . 0.0 111.447 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.17 -41.36 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.495 1.118 . . . . 0.0 109.645 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.44 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 47.5 mt-10 -65.5 -44.9 85.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.394 1.078 . . . . 0.0 111.548 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.1 -48.41 83.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 119.1 0.863 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.633 HD23 HD13 ' A' ' 96' ' ' ILE . 42.0 mt -60.99 -48.97 79.38 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.558 0.743 . . . . 0.0 109.756 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.31 -57.79 6.23 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.948 1.299 . . . . 0.0 110.917 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.8 tp -47.62 -52.35 18.22 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.474 0.71 . . . . 0.0 110.36 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.58 70.8 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.9 m-30 -80.81 -29.55 35.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.505 0.593 . . . . 0.0 111.131 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.31 -42.68 91.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.877 0.846 . . . . 0.0 109.217 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.95 -14.52 44.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 112.894 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 43.2 55.36 4.67 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.328 1.451 . . . . 0.0 110.394 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -135.61 8.8 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 121.856 0.698 . . . . 0.0 111.465 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -129.47 170.19 14.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.633 HD13 HD23 ' A' ' 86' ' ' LEU . 74.3 mt -131.52 156.03 42.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.64 118.39 18.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.035 1.334 . . . . 0.0 108.256 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 6.8 t -166.37 -170.08 1.57 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.646 1.578 . . . . 0.0 108.997 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -150.62 10.85 0.66 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 161.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -53.39 150.83 6.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.368 1.467 . . . . 0.0 114.727 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -63.19 -30.78 71.86 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.473 -1.392 . . . . 0.0 112.263 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.15 -56.12 4.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.751 1.62 . . . . 0.0 110.215 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 1.8 p -52.69 -41.29 37.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 119.92 1.236 . . . . 0.0 112.664 -169.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -64.66 -46.69 81.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.4 t-20 -64.08 -52.81 57.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 117.425 -1.274 . . . . 0.0 107.784 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.5 mm -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 119.604 1.093 . . . . 0.0 110.328 -175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.55 68.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.668 1.122 . . . . 0.0 112.153 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.18 -39.12 78.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.957 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -64.27 -44.55 91.39 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 122.437 2.38 . . . . 0.0 107.721 170.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -69.02 -29.12 67.23 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -167.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.53 18.65 37.67 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 117.999 -1.445 . . . . 0.0 112.766 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.01 127.82 38.66 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.02 1.41 . . . . 0.0 110.627 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 128.93 38.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.284 1.833 . . . . 0.0 109.585 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.86 179.62 6.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.626 0.77 . . . . 0.0 111.092 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -123.37 133.09 54.15 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.422 1.489 . . . . 0.0 108.834 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.239 0.549 0 C-N-CA 124.62 1.168 . . . . 0.0 108.775 170.409 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -147.43 0.49 0.69 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.336 -1.316 . . . . 0.0 113.952 -158.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -142.33 135.39 28.63 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.937 0.789 . . . . 0.0 108.984 -170.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.53 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.082 0.953 . . . . 0.0 108.66 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.7 OUTLIER -73.6 127.89 33.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.736 0.814 . . . . 0.0 108.813 171.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.14 -9.67 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.62 -15.14 27.88 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.938 -0.923 . . . . 0.0 113.826 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 13.8 p -147.24 2.66 0.77 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.59 1.195 . . . . 0.0 113.075 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.88 64.57 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.702 1.62 . . . . 0.0 115.039 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 54.1 ttt-85 -72.08 145.81 47.97 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 117.681 0.741 . . . . 0.0 110.464 -167.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -93.54 145.62 24.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.647 -169.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -141.85 148.82 39.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.989 1.316 . . . . 0.0 108.223 170.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 p -98.74 -15.3 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.523 -0.736 . . . . 0.0 111.739 168.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.5 p -137.6 152.53 49.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.708 1.203 . . . . 0.0 108.601 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -64.75 120.05 62.86 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 113.475 -1.693 . . . . 0.0 106.717 174.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 141' ' ' LEU . 92.0 Cg_endo -69.69 169.09 19.65 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.023 2.482 . . . . 0.0 109.121 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -55.5 134.21 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.656 1.571 . . . . 0.0 109.599 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.84 -10.61 8.77 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.515 -1.158 . . . . 0.0 114.226 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.01 38.22 93.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.969 1.885 . . . . 0.0 112.624 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.01 163.09 32.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.538 1.135 . . . . 0.0 109.28 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 3.9 t -72.99 113.32 20.6 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 110.179 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 36.4 Cg_endo -62.68 -12.35 28.11 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.775 0.955 . . . . 0.0 111.86 163.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.27 -22.65 18.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.334 1.454 . . . . 0.0 111.895 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 3.4 p -156.17 5.31 0.18 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.07 -11.04 2.15 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.714 2.102 . . . . 0.0 116.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 168.61 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.312 1.556 . . . . 0.0 112.41 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -77.98 144.96 36.31 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 t -94.3 158.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -140.47 167.31 22.46 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.013 -1.679 . . . . 0.0 109.123 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.14 154.46 26.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.239 1.016 . . . . 0.0 109.673 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 CA--C 1.548 0.881 0 C-N-CA 125.21 1.404 . . . . 0.0 112.42 178.285 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -48.24 128.34 14.07 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.261 1.824 . . . . 0.0 110.808 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -153.62 144.71 22.88 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.677 0.791 . . . . 0.0 110.212 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.36 147.53 30.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.557 0.743 . . . . 0.0 110.012 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 HD21 ' A' ' 9' ' ' LEU . 1.3 mm? -122.75 129.48 51.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.593 1.957 . . . . 0.0 109.682 -174.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -84.23 165.35 18.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.601 0.76 . . . . 0.0 109.134 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 30' ' ' VAL . 26.2 t -46.63 -45.26 18.97 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.393 1.877 . . . . 0.0 110.265 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -49.86 -34.23 19.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.781 1.632 . . . . 0.0 111.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.5 -39.59 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.441 1.096 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.14 -24.93 47.19 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.2 1.0 . . . . 0.0 111.238 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.57 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.679 0.791 . . . . 0.0 109.075 171.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.79 -23.7 36.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.745 0.702 . . . . 0.0 112.389 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.19 18.88 52.4 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.433 1.016 . . . . 0.0 113.167 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.44 112.89 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.045 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -62.49 106.63 0.79 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 109.133 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 tp -155.08 149.22 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' HD22 ' A' ' 9' ' ' LEU . 5.8 pt-20 -111.45 120.61 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.066 1.346 . . . . 0.0 109.316 -166.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.09 -161.08 29.38 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.339 0.972 . . . . 0.0 113.57 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.2 150.04 21.34 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.4 -0.471 . . . . 0.0 112.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -132.38 147.91 52.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.12 2.168 . . . . 0.0 108.514 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 115.98 62.39 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 126.554 1.941 . . . . 0.0 107.632 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.83 -33.85 72.86 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.454 1.436 . . . . 0.0 110.273 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.23 -36.37 41.4 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.905 3.282 . . . . 0.0 114.432 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 13' ' ' SER . 14.8 p -98.75 -32.09 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.264 0.938 . . . . 0.0 110.572 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.78 -32.71 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.968 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -28.61 10.01 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -89.85 -23.39 21.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 117.745 -1.121 . . . . 0.0 111.508 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.264 5.5 mt -62.7 85.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.655 1.582 . . . . 0.0 110.113 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.33 -11.5 57.61 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 129.115 2.966 . . . . 0.0 110.966 174.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 124.2 26.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -45.42 70.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.671 -0.643 . . . . 0.0 110.332 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.27 -48.99 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.296 1.038 . . . . 0.0 108.39 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -68.76 -49.82 55.57 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.79 0.836 . . . . 0.0 111.842 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -59.97 -55.63 31.71 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.834 0.454 . . . . 0.0 110.51 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.2 mt -55.05 -49.16 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -55.47 -57.8 10.42 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 111.613 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tp -51.26 -52.85 41.09 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.118 1.767 . . . . 0.0 110.844 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.5 -37.44 87.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.648 0.779 . . . . 0.0 110.044 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 m -62.82 -43.02 99.9 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.727 0.694 . . . . 0.0 110.198 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -39.42 86.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.42 -44.9 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.327 -0.858 . . . . 0.0 108.717 170.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 t -64.5 -3.74 3.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 112.891 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.58 3.03 13.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.974 1.709 . . . . 0.0 111.566 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.03 87.2 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.827 1.68 . . . . 0.0 112.878 173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -86.11 -28.41 24.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.891 0.846 . . . . 0.0 111.442 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.64 142.4 35.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 14.2 ttmm -143.95 145.25 32.12 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 112.252 -168.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.9 120.48 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.007 1.323 . . . . 0.0 109.482 -168.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.31 128.88 12.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.432 1.493 . . . . 0.0 110.171 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.07 157.0 35.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.967 1.307 . . . . 0.0 112.322 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.95 157.21 62.82 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.789 2.993 . . . . 0.0 113.332 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -84.68 162.06 19.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.347 165.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -51.28 -42.9 61.43 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.365 1.066 . . . . 0.0 111.806 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.46 -27.06 68.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.548 0.739 . . . . 0.0 110.736 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -72.11 -47.53 50.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.168 1.387 . . . . 0.0 110.121 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 mm -58.97 -47.33 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.54 -41.19 53.57 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.043 1.337 . . . . 0.0 110.72 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -48.24 74.52 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.963 1.305 . . . . 0.0 110.182 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -64.73 -48.56 84.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.2 mt -48.86 -45.38 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.427 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.59 -59.14 5.91 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.476 0.71 . . . . 0.0 110.502 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.08 -31.25 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.41 -53.29 20.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.16 1.384 . . . . 0.0 110.897 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -30.02 70.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -66.92 -20.46 65.91 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.393 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 t -124.41 8.58 8.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.709 1.595 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.99 -85.36 0.34 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.996 -1.065 . . . . 0.0 112.286 164.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.62 92.48 0.33 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.335 1.054 . . . . 0.0 108.756 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.57 -49.02 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 121.717 -0.615 . . . . 0.0 111.528 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -132.72 17.73 4.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.826 0.85 . . . . 0.0 110.157 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -12.51 61.21 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 120.867 0.365 . . . . 0.0 110.378 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.0 mp -87.29 149.63 24.42 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.392 1.477 . . . . 0.0 108.058 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 m -67.65 161.37 25.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.098 0.559 . . . . 0.0 110.913 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -57.69 -58.46 8.24 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 122.764 0.426 . . . . 0.0 109.99 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.77 -39.46 65.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.671 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -58.66 7.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.86 2.064 . . . . 0.0 109.091 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.15 -44.6 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 126.093 1.757 . . . . 0.0 108.69 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -62.18 -44.9 95.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.108 0.963 . . . . 0.0 111.144 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.08 -53.49 47.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.384 0.538 . . . . 0.0 109.87 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD23 HD13 ' A' ' 96' ' ' ILE . 20.9 mt -58.95 -51.69 68.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.284 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.26 -56.56 7.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.359 1.464 . . . . 0.0 112.511 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -46.11 81.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.5 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.564 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.5 m-30 -66.67 -22.12 66.09 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.047 1.294 . . . . 0.0 112.817 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.55 -47.06 74.02 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.93 -20.1 46.47 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 53.9 30.17 11.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.171 1.788 . . . . 0.0 113.49 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.01 -116.35 0.66 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 125.461 1.505 . . . . 0.0 112.427 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -153.9 159.19 41.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.994 1.718 . . . . 0.0 106.996 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.611 HD13 HD23 ' A' ' 86' ' ' LEU . 69.8 mt -126.92 150.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.34 120.62 27.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 t -160.16 -166.16 1.63 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.514 1.925 . . . . 0.0 108.61 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.78 11.32 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.124 1.37 . . . . 0.0 114.008 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -104.71 151.27 23.93 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.045 -2.284 . . . . 0.0 113.437 -161.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -56.93 -47.14 81.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.447 -1.408 . . . . 0.0 110.914 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -71.52 -52.22 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.523 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -54.71 -41.41 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.32 0.509 . . . . 0.0 110.239 -173.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.68 -44.39 77.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.068 0.947 . . . . 0.0 109.832 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -61.99 -56.41 19.41 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -48.85 -55.9 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.545 1.138 . . . . 0.0 110.117 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.64 -34.8 65.26 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.598 1.544 . . . . 0.0 113.689 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 t -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.832 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -60.7 -36.73 79.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.424 1.011 . . . . 0.0 109.938 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.2 mm? -72.25 -14.56 61.81 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.626 0.37 . . . . 0.0 111.074 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.49 2.63 84.85 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.864 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -85.4 133.02 34.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.578 1.189 . . . . 0.0 109.68 -168.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.401 ' N ' HD13 ' A' ' 112' ' ' LEU . 22.1 ttt180 -68.07 136.24 53.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.932 0.893 . . . . 0.0 110.616 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.75 168.04 28.62 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.749 -0.594 . . . . 0.0 111.454 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -99.06 163.43 12.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.605 1.162 . . . . 0.0 111.641 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.567 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.436 ' CH2' HD13 ' A' ' 157' ' ' ILE . 16.0 p-90 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -153.62 8.68 0.39 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 118.393 -0.813 . . . . 0.0 112.923 -153.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -151.06 151.03 31.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.087 0.858 . . . . 0.0 110.508 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.63 139.08 49.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.211 1.404 . . . . 0.0 109.995 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -69.94 126.08 28.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.196 0.998 . . . . 0.0 108.56 159.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.67 121.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.08 4.29 Favored Glycine 0 N--CA 1.464 0.502 0 C-N-CA 123.905 0.764 . . . . 0.0 112.962 161.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.51 9.48 2.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.751 1.62 . . . . 0.0 111.817 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.31 14.56 57.16 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 126.955 2.217 . . . . 0.0 115.892 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -68.82 127.39 32.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.972 0.886 . . . . 0.0 108.892 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -71.04 146.46 49.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.973 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -139.35 154.77 47.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -103.38 -20.66 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.331 0.653 . . . . 0.0 111.695 176.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 59.0 p -136.04 155.24 50.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.33 127.92 77.24 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.06 171.17 14.16 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.99 2.46 . . . . 0.0 111.49 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.8 148.22 57.15 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.339 2.026 . . . . 0.0 109.721 163.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.16 -22.81 0.2 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.483 1.992 . . . . 0.0 113.532 -165.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.92 38.28 96.32 Favored Glycine 0 C--N 1.335 0.528 0 O-C-N 120.982 -1.305 . . . . 0.0 110.159 -158.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.01 154.41 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.595 0.758 . . . . 0.0 110.075 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 49.4 t -74.97 110.92 11.24 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 125.365 1.466 . . . . 0.0 110.877 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 20.0 Cg_endo -60.72 -2.71 2.22 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.424 2.082 . . . . 0.0 115.543 171.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -105.6 -26.35 11.89 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.018 0.927 . . . . 0.0 113.231 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 14.1 p -142.15 -12.82 0.83 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.09 65.7 2.66 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.973 1.273 . . . . 0.0 112.146 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.07 173.82 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.002 1.721 . . . . 0.0 108.495 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -64.45 142.48 58.4 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.172 0.989 . . . . 0.0 111.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.37 145.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.192 1.397 . . . . 0.0 107.428 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.15 158.74 43.74 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 112.209 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.69 111.26 6.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 110.392 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.436 HD13 ' CH2' ' A' ' 127' ' ' TRP . 1.1 pt . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 125.827 1.651 . . . . 0.0 112.365 164.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -45.51 127.89 7.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.028 0.931 . . . . 0.0 111.598 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 tp -153.72 147.36 25.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.194 1.798 . . . . 0.0 107.454 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -122.08 150.75 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.46 139.26 53.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.969 1.708 . . . . 0.0 108.377 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -91.33 158.84 16.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.095 0.958 . . . . 0.0 111.64 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -29.36 -57.85 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.397 2.279 . . . . 0.0 113.219 163.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.7 p -60.11 -28.95 68.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.136 1.774 . . . . 0.0 112.52 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.68 -42.08 94.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -69.91 -34.77 73.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.413 0.685 . . . . 0.0 111.211 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.7 mt -57.09 -47.58 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 110.14 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.98 -24.9 52.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.883 0.765 . . . . 0.0 111.922 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 31.62 13.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 123.289 0.471 . . . . 0.0 112.068 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -76.86 102.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.46 115.2 1.98 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 tp -161.88 170.84 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.552 1.941 . . . . 0.0 106.412 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.83 152.33 48.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 0.0 109.002 -158.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.0 -130.8 3.72 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -168.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.23 152.33 48.21 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.367 1.067 . . . . 0.0 111.003 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -128.66 143.12 50.88 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.556 1.542 . . . . 0.0 107.664 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.55 117.33 67.9 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.79 1.636 . . . . 0.0 108.198 -167.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 31' ' ' VAL . 23.7 Cg_endo -60.81 -32.04 92.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.261 1.974 . . . . 0.0 111.185 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.2 m -68.49 -19.58 64.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.118 -0.989 . . . . 0.0 113.14 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.516 HG22 ' HB1' ' A' ' 81' ' ' ALA . 20.6 t -83.84 -51.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.036 0.935 . . . . 0.0 108.522 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.1 p -59.08 -28.03 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-N 118.822 0.737 . . . . 0.0 111.197 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -66.58 -14.81 62.85 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.81 -28.83 12.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.298 0.954 . . . . 0.0 111.734 169.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -53.88 128.23 13.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 -27.1 2.26 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 126.628 1.971 . . . . 0.0 110.55 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.31 124.94 24.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -75.33 -30.7 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.797 -1.097 . . . . 0.0 112.08 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -60.74 -37.16 80.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.184 1.356 . . . . 0.0 110.481 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -69.99 -58.98 3.2 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.439 0.695 . . . . 0.0 109.685 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -58.27 -55.43 35.04 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.785 0.834 . . . . 0.0 111.879 -170.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.9 mt -54.01 -52.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.039 0.936 . . . . 0.0 108.632 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 59.6 t80 -55.27 -52.68 62.64 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.584 0.754 . . . . 0.0 110.652 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 tt -51.42 -56.87 10.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.878 1.671 . . . . 0.0 110.409 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.14 -36.24 81.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.473 0.709 . . . . 0.0 111.421 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 m -64.27 -42.6 96.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.476 1.11 . . . . 0.0 109.843 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 9.7 mt -65.22 -43.14 92.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.371 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.54 -52.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m -63.61 -25.32 68.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.301 0.64 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.6 -2.6 58.36 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.157 1.783 . . . . 0.0 113.649 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.93 26.16 60.87 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 118.445 0.566 . . . . 0.0 112.111 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -89.95 -52.7 4.83 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.86 162.37 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 C-N-CA 124.676 1.191 . . . . 0.0 108.708 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -133.4 156.29 47.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mm -69.65 133.93 31.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 118.935 0.789 . . . . 0.0 108.949 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.41 128.15 6.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.86 0.464 . . . . 0.0 110.692 162.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.7 156.15 45.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.431 0.692 . . . . 0.0 110.428 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.11 168.2 16.31 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.868 3.046 . . . . 0.0 111.645 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t -86.84 163.26 17.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 164.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -50.42 -45.58 55.8 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.03 0.932 . . . . 0.0 111.53 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.35 -18.8 63.83 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -40.84 35.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.797 0.839 . . . . 0.0 110.593 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.24 -49.71 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -56.4 -32.13 64.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.103 0.961 . . . . 0.0 111.392 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -50.93 71.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.591 1.156 . . . . 0.0 110.181 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.74 -42.2 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.23 -41.4 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.584 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -65.17 -50.93 64.06 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.107 1.321 . . . . 0.0 110.926 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 109' ' ' LEU . 2.4 t -75.85 -34.19 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.81 -50.48 73.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.538 1.135 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.6 71.66 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.654 -1.279 . . . . 0.0 110.755 174.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.67 -32.98 74.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.255 0.934 . . . . 0.0 109.873 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 t -93.16 -16.72 24.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 -78.3 0.38 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.69 86.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.965 1.306 . . . . 0.0 110.727 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -75.63 -41.69 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 120.824 -1.173 . . . . 0.0 112.297 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -135.6 20.41 3.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.221 1.408 . . . . 0.0 109.192 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -70.83 -19.36 62.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.9 -1.125 . . . . 0.0 110.699 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -83.03 153.24 25.03 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.052 0.941 . . . . 0.0 110.115 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -58.88 147.94 32.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 111.305 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 27.2 ttpt -55.67 -53.0 61.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.808 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -61.33 -34.95 76.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 124.137 0.898 . . . . 0.0 110.212 -172.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -55.23 31.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.34 1.056 . . . . 0.0 109.06 176.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -52.44 -45.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.968 0.907 . . . . 0.0 108.938 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 61.9 mt-10 -64.6 -46.21 83.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 0.0 112.23 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.09 -54.69 31.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.559 1.143 . . . . 0.0 109.496 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.409 HD23 HD13 ' A' ' 96' ' ' ILE . 26.7 mt -57.66 -47.51 82.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.945 0.898 . . . . 0.0 109.258 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.75 -56.13 17.8 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.175 1.39 . . . . 0.0 111.955 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.32 -48.41 74.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.779 0.675 . . . . 0.0 109.737 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -60.93 -21.88 63.85 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.54 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.44 -22.99 21.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 117.81 -1.09 . . . . 0.0 111.858 175.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.24 -41.93 97.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.714 1.143 . . . . 0.0 109.78 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -109.99 10.66 24.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.303 1.041 . . . . 0.0 111.0 -171.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 45.66 49.73 11.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.255 1.822 . . . . 0.0 110.107 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.83 -123.74 4.77 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 124.35 0.976 . . . . 0.0 111.178 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -144.7 168.15 20.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.586 1.954 . . . . 0.0 106.893 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.409 HD13 HD23 ' A' ' 86' ' ' LEU . 30.9 mt -134.16 157.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -136.8 107.07 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 108.437 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 t -166.12 172.25 11.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.274 1.43 . . . . 0.0 109.582 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -145.27 4.34 1.06 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -57.11 158.21 5.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.867 1.667 . . . . 0.0 112.821 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -61.67 -45.04 95.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.424 -1.423 . . . . 0.0 110.825 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.524 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.05 -39.27 81.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 119.058 0.845 . . . . 0.0 110.787 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.29 -47.86 72.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 109' ' ' LEU . 44.3 t30 -60.07 -58.25 9.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.934 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.05 -54.52 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.15 65.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.349 1.431 . . . . 0.0 113.129 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -52.15 58.47 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.212 1.405 . . . . 0.0 112.403 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -68.34 -21.7 64.72 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.722 1.601 . . . . 0.0 111.893 178.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -83.56 -10.63 58.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.752 1.221 . . . . 0.0 112.366 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.81 8.11 84.27 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.326 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.43 143.78 34.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.776 1.788 . . . . 0.0 109.779 -175.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.25 136.84 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.956 1.302 . . . . 0.0 108.371 174.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -146.6 -172.19 3.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.38 161.02 25.55 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.089 1.355 . . . . 0.0 110.392 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.235 0.302 0 C-N-CA 124.447 1.099 . . . . 0.0 108.862 -178.015 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 119.572 -0.251 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -148.25 17.55 1.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.068 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.95 141.12 47.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 120.339 1.427 . . . . 0.0 110.236 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.39 134.24 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.917 1.287 . . . . 0.0 108.506 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.503 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 3.7 t -67.78 118.45 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.69 124.14 27.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.74 -86.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.4 p -74.2 -18.44 60.76 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.755 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.14 62.38 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 123.416 0.531 . . . . 0.0 112.775 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -74.27 145.35 44.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.511 1.124 . . . . 0.0 110.079 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -90.12 145.62 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 109.176 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.7 149.27 43.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.704 0.802 . . . . 0.0 108.843 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 p -97.29 -13.25 22.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.988 0.915 . . . . 0.0 111.997 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 18.4 p -146.11 165.35 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.757 1.623 . . . . 0.0 107.523 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp -77.34 128.7 79.73 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.12 169.96 16.9 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.528 2.152 . . . . 0.0 111.108 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.62 127.34 20.46 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.696 2.264 . . . . 0.0 109.876 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.42 -8.19 42.18 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.707 0.67 . . . . 0.0 113.395 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.01 54.21 32.63 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.461 1.131 . . . . 0.0 112.045 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.08 160.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.56 114.9 14.74 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.8 -14.16 41.34 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 119.739 0.942 . . . . 0.0 112.435 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.09 -12.4 17.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.79 2.036 . . . . 0.0 112.683 -168.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.503 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 8.5 p -156.19 3.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.82 -16.5 5.26 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.637 1.589 . . . . 0.0 114.745 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.2 m -69.88 161.18 30.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 118.686 1.243 . . . . 0.0 112.701 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -68.35 144.18 54.88 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.69 -1.256 . . . . 0.0 110.01 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.56 143.74 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.08 154.83 51.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.68 1.127 . . . . 0.0 111.052 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.46 134.75 48.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.271 1.028 . . . . 0.0 108.959 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.268 1.027 . . . . 0.0 109.638 170.868 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.236 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -54.96 122.94 11.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.793 1.237 . . . . 0.0 109.777 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.649 HD21 HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.74 147.89 36.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.394 1.478 . . . . 0.0 107.499 -177.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.77 152.88 29.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.727 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.649 HD11 HD21 ' A' ' 9' ' ' LEU . 1.6 mm? -125.27 150.59 46.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.552 1.941 . . . . 0.0 108.907 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.62 174.5 5.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.9 p -49.57 -43.81 46.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.652 1.181 . . . . 0.0 113.424 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 t -57.25 -39.3 75.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.757 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 t -54.4 -43.93 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.246 1.018 . . . . 0.0 110.138 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -76.78 -25.92 53.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.219 0.608 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.12 -39.36 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.93 0.786 . . . . 0.0 110.639 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -78.08 -17.85 56.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.524 -0.735 . . . . 0.0 112.105 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.25 63.8 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 123.392 0.52 . . . . 0.0 113.381 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.39 106.87 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.08 118.32 8.99 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -157.8 164.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 0.0 107.569 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -137.1 119.3 15.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 111.077 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -179.73 -146.16 6.73 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.818 2.627 . . . . 0.0 112.29 -166.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.27 152.06 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.182 1.393 . . . . 0.0 111.69 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 t -121.65 168.32 11.91 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.453 1.901 . . . . 0.0 109.701 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.62 113.96 60.99 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 126.535 1.934 . . . . 0.0 108.048 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -55.57 -35.91 93.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.756 2.304 . . . . 0.0 112.7 -172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.2 m -71.54 -16.97 62.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.788 1.235 . . . . 0.0 113.146 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.6 -51.61 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.66 -37.42 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.563 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.38 -22.01 66.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.549 1.068 . . . . 0.0 111.805 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -94.47 -10.9 30.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.433 1.47 . . . . 0.0 111.93 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 43' ' ' LEU . 2.7 mt -63.46 116.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 -11.06 5.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.128 0.971 . . . . 0.0 113.073 -166.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.78 130.64 37.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -67.29 -35.5 79.61 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.969 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.74 -52.53 62.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.09 1.356 . . . . 0.0 108.685 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.3 -50.84 70.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.983 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -58.58 -52.62 64.88 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.468 1.107 . . . . 0.0 111.91 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.3 -52.05 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.527 1.531 . . . . 0.0 109.145 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -64.06 -42.77 96.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.237 0.542 . . . . 0.0 111.476 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' CD1' HD12 ' A' ' 34' ' ' ILE . 7.6 tt -59.27 -48.65 80.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.94 -1.1 . . . . 0.0 110.663 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.8 -32.55 72.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.629 0.772 . . . . 0.0 110.285 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.8 t -50.45 -54.55 21.21 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.93 0.892 . . . . 0.0 108.876 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.65 -31.89 70.24 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.17 -53.47 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.6 t -57.74 -38.2 74.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.312 1.045 . . . . 0.0 111.94 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.52 3.72 17.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 113.063 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.12 21.25 78.47 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.903 -0.943 . . . . 0.0 111.833 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -107.96 -29.82 8.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.155 -175.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.5 96.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.553 1.524 . . . . 0.0 108.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -73.16 155.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.9 mm -82.91 147.84 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.64 125.02 0.58 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.747 2.019 . . . . 0.0 109.795 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 158.64 36.05 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 119.497 1.044 . . . . 0.0 112.518 171.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.72 157.51 61.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 124.915 3.743 . . . . 0.0 111.924 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.21 160.72 31.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.907 0.861 . . . . 0.0 110.391 158.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -44.89 79.0 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 109.697 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -61.54 -32.74 72.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.752 0.705 . . . . 0.0 111.119 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.4 m -66.74 -45.02 79.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 109.653 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.7 mm -58.81 -48.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.91 -33.16 70.24 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.018 -0.426 . . . . 0.0 111.208 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -46.41 80.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.2 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -62.41 -46.51 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.459 HG23 ' CG2' ' A' ' 75' ' ' VAL . 74.5 mt -54.82 -36.5 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.088 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -66.51 -43.79 84.31 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.278 1.854 . . . . 0.0 111.868 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 109' ' ' LEU . 2.0 t -82.51 -37.28 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.21 99.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.29 1.036 . . . . 0.0 110.664 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -31.67 66.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.322 0.964 . . . . 0.0 112.034 174.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.06 -43.91 98.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.074 0.852 . . . . 0.0 109.938 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -80.43 -51.6 8.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.811 0.732 . . . . 0.0 111.117 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.54 -73.54 0.13 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 120.44 1.473 . . . . 0.0 114.305 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -70.54 91.47 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.596 0.698 . . . . 0.0 109.364 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 66' ' ' ILE . 5.5 p -74.65 -54.71 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -118.84 18.36 13.31 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.538 0.608 . . . . 0.0 111.116 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -68.94 -31.48 70.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -78.2 157.86 29.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.037 0.535 . . . . 0.0 110.04 -172.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -65.5 153.82 40.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.573 1.178 . . . . 0.0 110.432 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -60.24 -48.87 79.89 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.719 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.69 68.45 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.529 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -56.89 -55.95 27.88 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.421 1.105 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.72 -39.84 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.048 1.739 . . . . 0.0 110.435 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -61.52 -50.49 72.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.986 1.266 . . . . 0.0 110.984 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.55 -53.29 46.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.89 0.876 . . . . 0.0 109.021 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.17 -54.98 38.64 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.887 1.275 . . . . 0.0 108.786 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.79 -52.2 57.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.237 1.415 . . . . 0.0 112.493 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -49.7 74.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.92 83.55 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.944 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.612 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.2 m-85 -70.98 -29.84 65.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.41 1.005 . . . . 0.0 111.697 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.75 -43.25 99.29 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.176 0.898 . . . . 0.0 109.297 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.845 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm 49.24 34.02 5.75 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.972 1.709 . . . . 0.0 110.609 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.25 -136.72 8.7 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.07 1.795 . . . . 0.0 110.636 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -129.56 161.56 30.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.222 2.209 . . . . 0.0 109.108 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.1 mt -130.06 149.08 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -135.77 122.59 21.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.925 0.89 . . . . 0.0 109.565 174.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 t -161.04 175.89 11.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.324 0.39 . . . . 0.0 111.025 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -147.3 102.96 3.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.458 1.503 . . . . 0.0 109.483 166.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.52 154.35 18.44 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.154 1.381 . . . . 0.0 110.279 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -64.16 -46.43 84.08 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.92 -53.76 45.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.691 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.12 -41.27 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.784 0.72 . . . . 0.0 111.186 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 46.3 mt-30 -58.54 -49.64 76.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 108.889 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.64 -55.3 21.11 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.981 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mm -52.98 -54.81 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 119.141 0.882 . . . . 0.0 110.364 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.84 -33.03 68.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.241 1.382 . . . . 0.0 113.708 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 t -57.15 -60.45 3.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.941 -1.028 . . . . 0.0 111.534 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.401 HD12 ' CG1' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -69.6 -17.55 63.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.436 1.471 . . . . 0.0 113.075 -175.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.612 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.4 mm? -83.36 -9.28 59.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.616 0.766 . . . . 0.0 112.249 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.92 35.42 92.02 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.686 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -106.33 122.9 47.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.229 1.014 . . . . 0.0 110.585 172.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.419 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -61.62 113.66 2.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 16.9 p90 -115.24 179.72 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 66.0 mtt180 -118.1 121.08 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.307 1.443 . . . . 0.0 107.334 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--O 1.24 0.601 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.317 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -151.34 22.45 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.126 0.971 . . . . 0.0 112.343 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -139.52 150.15 44.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.876 1.216 . . . . 0.0 111.138 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.74 134.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.356 1.062 . . . . 0.0 109.417 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 1.1 t -65.19 127.2 30.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.09 114.02 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.764 0.792 . . . . 0.0 109.308 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.2 -77.71 0.39 Allowed Glycine 0 C--O 1.229 -0.178 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.48 -15.64 62.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.667 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.75 83.91 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.795 1.188 . . . . 0.0 114.341 165.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -69.55 139.87 53.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 124.758 1.223 . . . . 0.0 109.572 -170.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -78.51 147.02 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.7 1.2 . . . . 0.0 109.584 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -139.52 150.88 45.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.057 0.943 . . . . 0.0 109.409 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -102.88 -0.47 31.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.303 1.441 . . . . 0.0 112.562 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 p -149.57 167.9 25.03 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.446 2.298 . . . . 0.0 106.828 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.82 123.66 87.51 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 165.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.24 172.73 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.228 1.952 . . . . 0.0 110.358 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -54.6 137.28 73.16 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 121.896 1.731 . . . . 0.0 110.048 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.39 -10.15 2.07 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.315 0.96 . . . . 0.0 114.148 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.15 29.21 72.22 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 119.137 1.469 . . . . 0.0 112.393 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.25 161.05 21.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 118.448 1.124 . . . . 0.0 109.289 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 12.7 t -73.54 113.76 25.52 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.376 -1.297 . . . . 0.0 109.33 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.31 -17.41 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.702 1.601 . . . . 0.0 113.52 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.97 -26.2 19.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.539 1.136 . . . . 0.0 111.683 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.9 p -153.63 1.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -167.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.87 -13.16 9.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.48 1.514 . . . . 0.0 114.769 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.26 160.05 32.91 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.803 1.302 . . . . 0.0 112.221 -172.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -64.05 138.95 58.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.484 0.659 . . . . 0.0 109.555 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.45 144.61 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.01 150.19 52.26 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.336 1.054 . . . . 0.0 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.94 132.47 47.39 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 123.091 0.556 . . . . 0.0 109.604 172.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 mptt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.7 m -53.04 132.84 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 122.279 1.037 . . . . 0.0 110.841 -171.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -154.36 144.72 22.13 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.36 146.65 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.71 137.84 53.67 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.728 1.611 . . . . 0.0 107.421 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.51 162.04 13.97 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.359 0.412 . . . . 0.0 110.525 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -40.9 -50.1 3.23 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.484 1.914 . . . . 0.0 112.542 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.96 -43.66 99.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 120.252 1.387 . . . . 0.0 109.366 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -69.09 -32.49 71.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.437 0.695 . . . . 0.0 110.644 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.9 mt -61.38 -45.44 98.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.051 0.54 . . . . 0.0 110.597 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -72.22 -28.22 63.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.266 0.939 . . . . 0.0 111.05 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.72 21.77 22.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.107 0.861 . . . . 0.0 112.416 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.73 114.44 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.847 1.324 . . . . 0.0 108.0 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -73.31 110.23 7.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.154 1.782 . . . . 0.0 107.91 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.79 127.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.135 0.974 . . . . 0.0 109.369 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.47 162.62 28.4 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.589 -1.319 . . . . 0.0 111.138 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.14 -147.89 19.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -124.15 156.4 36.76 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.582 1.153 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -128.05 149.54 50.33 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 107.572 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.1 p -78.65 129.87 72.71 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HA ' HG12 ' A' ' 31' ' ' VAL . 15.9 Cg_endo -61.93 -23.94 76.43 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.212 1.275 . . . . 0.0 111.274 168.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -71.27 -29.94 65.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.96 -37.09 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 119.522 1.055 . . . . 0.0 109.063 174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 28' ' ' PRO . 5.7 p -60.39 -24.27 30.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 119.116 0.871 . . . . 0.0 112.199 -172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -56.67 -28.62 61.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 117.929 0.331 . . . . 0.0 111.374 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.48 -10.39 16.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.827 1.651 . . . . 0.0 111.427 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.95 78.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -21.33 52.84 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.985 0.914 . . . . 0.0 111.597 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.7 121.25 12.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.59 -50.28 74.38 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.666 0.786 . . . . 0.0 110.46 -162.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.39 -57.39 12.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.348 1.059 . . . . 0.0 109.525 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -58.67 -45.33 89.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.71 1.204 . . . . 0.0 110.663 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.76 -58.98 4.8 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.072 1.349 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.3 mt -53.37 -47.74 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 124.131 0.972 . . . . 0.0 108.559 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.48 -54.84 42.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.438 0.695 . . . . 0.0 110.661 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 31' ' ' VAL . 5.4 tt -52.64 -54.09 38.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.585 1.154 . . . . 0.0 109.623 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.35 -27.17 68.39 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 121.304 -0.872 . . . . 0.0 111.76 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 m -69.03 -47.19 66.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.616 0.766 . . . . 0.0 110.065 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.62 88.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.151 0.981 . . . . 0.0 111.077 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.56 -46.65 92.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 118.243 0.474 . . . . 0.0 109.79 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -64.24 -32.58 74.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.7 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.72 -2.47 46.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.578 1.151 . . . . 0.0 112.094 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.74 88.6 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 118.422 -1.21 . . . . 0.0 113.482 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.94 -53.73 51.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.518 1.527 . . . . 0.0 108.176 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -107.12 152.57 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -132.82 156.46 47.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.289 1.036 . . . . 0.0 109.731 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.9 mm -81.1 134.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 124.741 1.216 . . . . 0.0 107.736 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.29 127.79 6.48 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.711 1.204 . . . . 0.0 108.593 165.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.41 155.62 51.3 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.2 167.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -65.2 170.48 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.72 2.947 . . . . 0.0 111.993 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.2 t -86.55 153.04 22.12 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 159.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -47.05 -42.35 18.42 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.237 1.415 . . . . 0.0 111.465 161.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.57 -45.07 95.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 110.134 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -65.56 -38.39 89.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.061 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mm -61.18 -48.31 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 119.629 1.104 . . . . 0.0 108.666 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' HD12 ' A' ' 66' ' ' ILE . 64.7 m-20 -57.12 -31.95 65.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.042 0.937 . . . . 0.0 111.623 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -41.7 97.13 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.906 0.882 . . . . 0.0 110.694 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.39 -48.99 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 63' ' ' ASP . 50.4 mt -52.29 -36.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.899 1.279 . . . . 0.0 110.938 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -61.33 -62.64 1.69 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.471 1.032 . . . . 0.0 110.973 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.79 -34.88 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -172.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.52 57.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.4 1.48 . . . . 0.0 110.322 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' N ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -64.87 -20.66 66.54 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.781 -1.199 . . . . 0.0 112.168 176.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.452 ' N ' ' HE3' ' A' ' 70' ' ' LYS . 30.9 tt0 -81.18 -20.4 41.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.714 0.805 . . . . 0.0 111.558 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 t -109.37 -22.56 11.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.282 0.947 . . . . 0.0 111.364 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.67 -83.84 0.17 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.151 0.887 . . . . 0.0 112.221 170.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -74.14 91.86 2.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.469 1.108 . . . . 0.0 108.249 -171.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.49 -45.74 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.26 10.18 4.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.783 1.233 . . . . 0.0 109.828 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 8.15 0.92 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.481 0.712 . . . . 0.0 110.93 164.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.33 147.19 27.39 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.259 1.424 . . . . 0.0 108.632 163.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.7 m -70.04 156.4 39.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.714 1.245 . . . . 0.0 110.15 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.57 -48.08 82.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.746 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.56 56.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.225 0.92 . . . . 0.0 112.19 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -63.15 -56.27 18.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.3 mt -52.25 -43.31 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.402 1.481 . . . . 0.0 109.18 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.37 -52.74 43.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.619 1.568 . . . . 0.0 112.14 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.65 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 119.131 0.878 . . . . 0.0 109.462 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 96' ' ' ILE . 45.9 mt -57.67 -56.38 22.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.631 0.772 . . . . 0.0 109.218 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -59.07 3.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.496 1.519 . . . . 0.0 112.023 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -49.62 59.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.865 0.866 . . . . 0.0 109.187 -174.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.27 66.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.618 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -77.73 -30.07 51.49 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.766 1.167 . . . . 0.0 110.507 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -42.45 99.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 168.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.15 -7.13 59.61 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 52.12 24.96 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.804 1.642 . . . . 0.0 113.109 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 -106.8 2.57 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 119.387 0.994 . . . . 0.0 113.906 -159.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -142.38 166.86 23.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.518 1.927 . . . . 0.0 108.031 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.639 HD13 HD23 ' A' ' 86' ' ' LEU . 82.5 mt -135.21 154.2 35.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.57 121.24 18.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 t -158.14 -170.42 3.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.823 2.049 . . . . 0.0 106.907 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -154.66 -4.77 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 122.235 2.288 . . . . 0.0 115.781 163.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -61.35 148.77 40.3 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.235 1.834 . . . . 0.0 112.942 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -56.92 -32.61 66.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.759 1.624 . . . . 0.0 114.273 -172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.54 -50.85 12.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.43 1.092 . . . . 0.0 110.171 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -42.15 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.494 0.718 . . . . 0.0 110.768 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -67.17 -35.2 79.16 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.029 0.442 . . . . 0.0 110.347 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.5 t30 -65.09 -56.74 11.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -51.68 -55.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.462 1.105 . . . . 0.0 110.018 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.22 68.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.163 1.347 . . . . 0.0 113.164 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 t -60.4 -61.69 2.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.071 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.5 OUTLIER -67.4 -16.56 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.125 1.33 . . . . 0.0 113.212 -175.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -86.81 -22.17 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.88 0.872 . . . . 0.0 112.525 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.93 38.98 89.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 118.474 0.579 . . . . 0.0 112.859 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 125.12 39.79 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 161.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 116.07 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.21 -162.99 1.11 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.174 0.989 . . . . 0.0 110.709 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -140.25 162.71 34.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.807 2.443 . . . . 0.0 109.354 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 C-N-CA 127.196 2.198 . . . . 0.0 110.35 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 14.14 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -139.81 135.3 32.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.822 1.192 . . . . 0.0 109.984 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.86 131.99 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.89 140.46 58.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 165.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.8 pt -93.29 -11.62 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 118.206 -0.902 . . . . 0.0 113.192 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.73 -20.61 23.81 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 119.621 1.101 . . . . 0.0 113.962 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.7 p -144.8 6.07 1.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.826 1.313 . . . . 0.0 114.16 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.76 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.596 1.093 . . . . 0.0 115.076 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -68.18 147.37 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.199 1.0 . . . . 0.0 110.723 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -110.79 99.0 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.844 0.858 . . . . 0.0 111.783 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.19 143.63 26.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.859 1.314 . . . . 0.0 109.529 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -89.22 -19.77 24.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.568 172.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.7 p -145.21 163.14 35.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.757 1.623 . . . . 0.0 109.034 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.582 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -73.02 116.63 52.49 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -176.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.582 ' HD2' HD23 ' A' ' 141' ' ' LEU . 89.8 Cg_endo -66.74 169.0 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.468 2.112 . . . . 0.0 110.507 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -55.22 133.07 55.98 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.99 1.794 . . . . 0.0 109.877 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.57 -18.28 3.79 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.574 -1.125 . . . . 0.0 113.597 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 63.38 44.31 97.02 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 119.789 1.795 . . . . 0.0 111.538 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.83 158.41 43.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 14.2 t -67.63 110.93 6.16 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -61.55 -14.94 38.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.292 1.328 . . . . 0.0 111.746 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -12.41 14.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.659 1.984 . . . . 0.0 112.483 -160.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.52 -14.26 0.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.19 85.42 0.12 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.6 p -152.02 174.99 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -60.73 151.8 28.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.715 -1.24 . . . . 0.0 109.995 160.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.65 147.66 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 159.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.84 154.07 46.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.393 0.997 . . . . 0.0 111.415 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.06 114.02 14.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.584 1.154 . . . . 0.0 108.522 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 118.296 0.498 . . . . 0.0 110.79 172.083 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.236 0.375 0 N-CA-C 110.802 -0.073 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -44.79 122.56 3.26 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.509 1.924 . . . . 0.0 110.219 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 tp -147.3 147.14 30.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 108.013 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 t -116.86 140.33 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -108.07 146.8 32.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.875 1.67 . . . . 0.0 107.632 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.2 161.78 13.43 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.14 0.9 . . . . 0.0 112.179 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.475 ' HB2' HG21 ' A' ' 30' ' ' VAL . 12.6 t -43.89 -52.49 6.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 127.801 2.44 . . . . 0.0 111.724 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -60.7 -23.03 64.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.485 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.89 90.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 120.073 1.306 . . . . 0.0 109.456 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -72.37 -36.31 68.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.929 0.891 . . . . 0.0 111.045 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.71 -46.6 93.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.313 1.045 . . . . 0.0 109.835 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -75.96 -23.16 55.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.759 0.709 . . . . 0.0 111.116 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.91 41.73 12.07 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mt -81.82 112.49 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.69 98.91 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.448 1.099 . . . . 0.0 109.437 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.5 tp -153.94 164.63 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.105 1.762 . . . . 0.0 107.264 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -131.45 155.11 47.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.02 2.128 . . . . 0.0 108.698 -160.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.74 -149.14 21.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.24 161.91 15.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 0.0 110.157 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.0 t -141.84 161.1 38.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.825 1.65 . . . . 0.0 108.098 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 p -96.18 123.11 56.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 122.401 0.28 . . . . 0.0 110.889 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.2 -26.39 81.58 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.379 2.053 . . . . 0.0 112.114 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.2 m -62.99 -32.64 74.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.1 1.76 . . . . 0.0 114.598 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 13' ' ' SER . 12.6 p -94.47 -29.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.653 1.115 . . . . 0.0 110.369 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.53 -20.02 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 119.868 1.213 . . . . 0.0 111.187 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.57 -29.29 66.27 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.035 -1.666 . . . . 0.0 114.297 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -102.25 -16.23 16.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.454 1.101 . . . . 0.0 111.517 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.91 105.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 124.269 1.028 . . . . 0.0 108.902 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -13.04 7.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.461 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -61.82 120.18 10.2 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -62.02 -32.91 73.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.66 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.72 -63.36 1.17 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.3 p -53.7 -44.74 70.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.046 1.338 . . . . 0.0 112.515 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -71.45 -54.15 11.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.154 1.381 . . . . 0.0 110.896 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.59 -51.98 30.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -54.9 -54.24 45.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 112.429 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.33 -51.52 58.3 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.947 1.299 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.23 -34.26 77.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.977 0.911 . . . . 0.0 111.929 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -64.12 -45.44 88.56 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -36.77 78.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.477 0.711 . . . . 0.0 111.635 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.38 -51.71 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -67.48 -19.53 65.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.07 0.85 . . . . 0.0 113.24 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -10.07 51.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.517 1.527 . . . . 0.0 111.892 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.75 -0.69 70.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.729 1.157 . . . . 0.0 113.767 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -87.79 -28.3 21.76 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.192 0.997 . . . . 0.0 111.984 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.92 140.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -128.51 151.58 49.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.568 1.547 . . . . 0.0 108.877 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.8 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.77 132.38 5.03 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.106 1.362 . . . . 0.0 108.595 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -92.72 154.95 42.21 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.592 0.757 . . . . 0.0 111.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.76 173.92 11.14 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.285 3.323 . . . . 0.0 111.7 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -108.76 162.68 13.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.492 1.117 . . . . 0.0 109.696 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -53.76 -49.79 67.43 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.937 0.895 . . . . 0.0 111.294 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.65 -27.29 66.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.863 0.465 . . . . 0.0 110.184 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -67.42 -48.34 67.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.531 0.733 . . . . 0.0 109.636 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.6 -45.72 94.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.468 1.107 . . . . 0.0 110.155 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.06 -35.09 74.38 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.88 -0.512 . . . . 0.0 110.62 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -44.89 71.08 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.199 0.6 . . . . 0.0 111.06 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.4 mm -64.37 -45.51 95.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.71 -38.8 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.931 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -63.48 -59.03 5.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.168 1.349 . . . . 0.0 110.813 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 109' ' ' LEU . 3.8 t -73.6 -32.54 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -51.83 67.28 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -30.83 71.22 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.669 1.122 . . . . 0.0 111.691 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.39 -15.45 48.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 111.712 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -114.31 -28.77 7.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.19 0.905 . . . . 0.0 111.961 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.64 -99.02 0.19 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 119.991 1.269 . . . . 0.0 110.4 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -58.56 96.56 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.267 2.227 . . . . 0.0 108.797 -168.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.98 -44.06 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.483 1.913 . . . . 0.0 110.706 -167.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -123.61 6.71 8.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.281 0.632 . . . . 0.0 110.111 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.78 -24.83 62.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.581 0.628 . . . . 0.0 111.528 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.27 158.09 31.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.658 1.183 . . . . 0.0 109.757 -174.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -68.56 154.93 40.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.441 0.638 . . . . 0.0 110.75 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -63.01 -53.35 55.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.784 -0.572 . . . . 0.0 109.734 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.59 61.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.779 1.3 . . . . 0.0 109.485 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -59.41 -59.13 5.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.968 1.707 . . . . 0.0 108.455 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -53.75 -40.99 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.771 0.828 . . . . 0.0 110.578 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.35 -43.72 73.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.236 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.72 -49.77 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.573 HD23 HD13 ' A' ' 96' ' ' ILE . 56.5 mt -56.97 -53.58 56.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.757 1.223 . . . . 0.0 108.941 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.598 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.72 -52.86 54.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.046 1.338 . . . . 0.0 111.75 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.3 tp -54.36 -49.82 68.92 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -64.4 -16.31 62.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.709 0.686 . . . . 0.0 112.638 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.6 m-30 -96.4 -17.48 20.58 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.32 1.048 . . . . 0.0 111.421 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -58.88 -44.57 91.18 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -114.13 -4.77 13.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.155 1.782 . . . . 0.0 111.935 -168.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 53.6 49.12 20.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.701 2.001 . . . . 0.0 111.547 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.63 -114.18 2.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.761 1.172 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -148.58 169.89 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 107.79 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.573 HD13 HD23 ' A' ' 86' ' ' LEU . 28.7 mt -130.38 163.57 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 0.0 108.194 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 118.57 13.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.92 1.688 . . . . 0.0 107.8 166.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.0 t -175.16 176.82 2.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.183 2.193 . . . . 0.0 109.559 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.62 0.19 0.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -57.31 162.51 2.71 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.539 1.518 . . . . 0.0 113.911 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -57.69 -52.49 65.21 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.726 -1.234 . . . . 0.0 109.74 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -75.1 -43.32 53.64 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.219 1.007 . . . . 0.0 110.183 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 p -61.57 -47.13 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.74 -37.04 85.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.85 0.46 . . . . 0.0 109.947 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.1 t30 -70.51 -53.32 16.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -49.57 -51.68 14.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.202 1.001 . . . . 0.0 109.443 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.63 70.4 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.002 1.274 . . . . 0.0 112.481 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.6 t -65.56 -52.44 52.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.205 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.477 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -63.41 -30.22 71.38 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 121.106 1.775 . . . . 0.0 110.613 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.526 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -79.97 -8.96 59.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.366 1.066 . . . . 0.0 112.891 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.89 59.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.023 -1.432 . . . . 0.0 115.499 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.11 119.91 26.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.511 2.156 . . . . 0.0 110.569 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 148.86 41.06 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.671 1.188 . . . . 0.0 111.244 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.74 176.33 12.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 122.038 -0.414 . . . . 0.0 111.475 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -111.9 150.55 30.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.967 1.307 . . . . 0.0 109.887 172.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.235 0.321 0 C-N-CA 125.314 1.446 . . . . 0.0 110.17 -175.377 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.47 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 2.4 p-90 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -175.3 13.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -140.91 152.98 45.47 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.148 1.34 . . . . 0.0 111.858 164.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' HD12 ' A' ' 157' ' ' ILE . 9.9 p -131.14 132.84 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.876 1.27 . . . . 0.0 109.132 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -71.7 128.95 37.43 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 164.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pt -80.39 101.51 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.757 0.708 . . . . 0.0 109.696 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.98 -84.58 0.18 Allowed Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 7.0 p -70.47 -15.26 62.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.031 0.416 . . . . 0.0 110.944 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.11 92.79 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.411 1.005 . . . . 0.0 111.826 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -70.94 145.26 50.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 49.8 mttp -104.95 132.54 51.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.133 1.373 . . . . 0.0 107.564 -176.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.29 162.54 25.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 109.086 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.5 t -113.52 -13.74 12.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.729 0.412 . . . . 0.0 110.604 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.8 p -142.09 158.49 43.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.23 126.1 92.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.03 170.95 17.72 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.285 2.657 . . . . 0.0 111.375 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.65 101.79 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.08 3.186 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.59 28.8 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.76 1.648 . . . . 0.0 111.785 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.97 34.24 87.9 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.093 -1.948 . . . . 0.0 113.008 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.07 165.8 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.691 1.996 . . . . 0.0 108.388 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.75 109.72 7.34 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 125.889 1.676 . . . . 0.0 110.036 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.98 -14.9 44.27 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.805 1.323 . . . . 0.0 112.379 167.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -41.06 17.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.006 0.922 . . . . 0.0 110.006 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.6 p -138.48 4.99 2.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.426 1.012 . . . . 0.0 113.573 -163.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.11 -14.63 1.55 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.198 2.333 . . . . 0.0 116.087 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 163.16 24.73 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.865 1.333 . . . . 0.0 112.7 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -69.45 155.94 39.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.66 145.64 15.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -136.24 168.81 18.7 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.094 1.358 . . . . 0.0 110.173 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.0 tt -77.32 157.87 30.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.991 0.916 . . . . 0.0 109.984 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 127.602 2.361 . . . . 0.0 107.816 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.2 tttt . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.7 116.78 1.92 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.86 1.264 . . . . 0.0 111.597 -170.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.96 143.89 31.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.533 0.733 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.15 154.18 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 O-C-N 124.129 0.893 . . . . 0.0 110.306 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.58 154.6 45.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.397 2.679 . . . . 0.0 107.611 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.41 164.44 14.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.746 0.818 . . . . 0.0 111.153 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.7 p -35.08 -50.12 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.282 2.233 . . . . 0.0 112.654 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -52.2 -40.65 61.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.107 0.963 . . . . 0.0 112.188 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.59 -44.76 97.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.322 1.449 . . . . 0.0 109.699 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.35 -34.25 72.41 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.898 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.61 -50.31 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.732 0.813 . . . . 0.0 109.738 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -70.7 -19.49 62.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.29 0.496 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.2 23.69 47.29 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.478 1.037 . . . . 0.0 112.096 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.62 112.69 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 112.48 1.57 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.827 1.251 . . . . 0.0 108.262 170.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 141.39 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.782 2.033 . . . . 0.0 106.989 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -78.29 164.81 24.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.113 1.365 . . . . 0.0 108.986 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.79 -165.85 31.19 Favored Glycine 0 C--N 1.331 0.264 0 O-C-N 121.032 -1.043 . . . . 0.0 111.048 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -103.23 149.02 25.09 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -142.84 171.54 13.92 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.189 1.396 . . . . 0.0 111.153 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.34 119.44 64.25 Favored Pre-proline 0 C--O 1.251 1.154 0 C-N-CA 126.151 1.781 . . . . 0.0 112.963 -168.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.31 -6.23 16.94 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.247 1.965 . . . . 0.0 113.005 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.9 m -91.96 -29.74 16.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.74 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.24 -39.8 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 120.467 1.485 . . . . 0.0 108.95 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG23 HD13 ' A' ' 43' ' ' LEU . 13.3 p -58.85 -23.57 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.11 -23.24 63.97 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.758 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.51 -34.96 30.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.851 1.26 . . . . 0.0 109.701 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.17 127.2 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.783 1.233 . . . . 0.0 108.092 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 -19.35 2.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.303 1.041 . . . . 0.0 112.239 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.28 127.49 32.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -59.18 -43.06 92.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.779 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.62 -53.93 51.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -54.66 44.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.624 1.57 . . . . 0.0 110.574 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -57.12 -59.29 5.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.154 0.581 . . . . 0.0 109.581 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.97 -53.19 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -54.1 -47.88 71.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.744 0.818 . . . . 0.0 112.066 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 31' ' ' VAL . 5.7 tt -58.58 -52.44 65.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.077 1.351 . . . . 0.0 108.851 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.31 -40.28 95.79 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.912 -0.492 . . . . 0.0 110.729 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -60.05 -47.96 83.71 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.378 1.471 . . . . 0.0 110.132 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -38.28 89.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.827 0.74 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.21 -45.28 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 118.767 0.712 . . . . 0.0 109.491 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -54.31 -50.05 68.26 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 109.635 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.1 -6.59 34.98 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.246 1.819 . . . . 0.0 113.383 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.17 83.31 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.811 1.187 . . . . 0.0 113.324 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.69 -46.58 87.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.561 1.18 . . . . 0.0 107.91 170.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 147.63 21.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.761 0.824 . . . . 0.0 109.092 -167.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.69 172.27 9.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.112 1.765 . . . . 0.0 108.889 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.76 138.46 44.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.789 1.635 . . . . 0.0 110.47 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.28 123.82 3.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.856 1.662 . . . . 0.0 108.052 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -107.22 147.21 34.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.215 0.916 . . . . 0.0 111.581 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.81 171.57 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.445 3.43 . . . . 0.0 113.044 -170.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -111.7 160.58 17.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.604 1.562 . . . . 0.0 110.262 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -59.88 -45.72 91.61 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.611 -0.681 . . . . 0.0 111.535 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.18 -38.78 65.98 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.608 0.763 . . . . 0.0 110.463 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -70.11 -42.12 73.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.344 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -64.13 -46.88 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.38 77.34 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.81 -0.556 . . . . 0.0 111.118 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.73 -44.53 63.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.133 0.973 . . . . 0.0 111.199 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.75 -50.78 57.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.2 mt -51.46 -36.52 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.573 1.149 . . . . 0.0 110.807 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -66.38 -56.32 11.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.809 1.186 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.31 -38.8 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.96 67.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.617 1.567 . . . . 0.0 111.447 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -24.2 63.05 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.134 -0.979 . . . . 0.0 112.537 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.25 -30.7 54.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 111.389 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.269 14.6 t -75.58 -68.13 0.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.38 0.991 . . . . 0.0 108.526 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.76 -73.19 0.07 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-N 119.482 1.037 . . . . 0.0 111.569 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -69.6 93.83 0.73 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.663 0.785 . . . . 0.0 110.027 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.64 -59.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 122.167 -0.333 . . . . 0.0 111.839 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -114.67 8.18 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.451 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.81 -9.29 58.5 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 78' ' ' LEU . 3.3 mp -92.63 159.79 15.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.256 -0.903 . . . . 0.0 110.746 -174.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -68.69 156.38 38.33 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.525 -0.735 . . . . 0.0 111.95 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.44 -57.42 12.81 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 118.895 -0.574 . . . . 0.0 109.508 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.69 -39.79 52.12 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.073 0.858 . . . . 0.0 111.4 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -61.68 2.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 109.316 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.24 -42.99 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 125.283 1.433 . . . . 0.0 108.759 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -56.2 -62.12 1.93 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.458 1.103 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.15 -47.53 80.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.415 0.686 . . . . 0.0 109.638 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 96' ' ' ILE . 42.3 mt -59.13 -52.18 66.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.939 0.896 . . . . 0.0 110.173 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.779 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.12 -59.45 4.17 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.133 1.373 . . . . 0.0 112.218 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 tp -46.96 -54.27 10.5 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.58 1.175 . . . . 0.0 110.972 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.25 68.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.395 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.7 m-85 -64.56 -28.78 69.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.517 0.599 . . . . 0.0 112.015 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.19 -34.52 76.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.141 0.882 . . . . 0.0 110.167 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.97 -18.92 38.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.008 1.323 . . . . 0.0 112.972 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.06 51.39 17.15 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.12 -149.01 11.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.929 1.728 . . . . 0.0 111.254 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -114.21 169.93 8.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.618 1.967 . . . . 0.0 108.465 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.482 HD13 HD23 ' A' ' 86' ' ' LEU . 55.0 mt -131.94 153.76 39.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.047 1.339 . . . . 0.0 107.807 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.59 111.82 8.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.735 1.214 . . . . 0.0 108.788 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.2 t -160.92 179.61 8.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.032 2.133 . . . . 0.0 107.534 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -155.74 27.71 0.38 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.351 -1.468 . . . . 0.0 113.599 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.582 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.3 t70 -95.44 156.64 16.24 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -170.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -69.41 -40.8 77.08 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.037 1.29 . . . . 0.0 110.223 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -49.41 49.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.135 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -57.01 -40.01 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.812 1.187 . . . . 0.0 110.927 -173.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -67.32 -40.19 85.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.975 0.51 . . . . 0.0 109.874 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.414 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.6 t-20 -66.09 -55.05 18.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 mm -53.97 -54.47 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 110.391 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.59 -32.32 68.87 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.111 -1.618 . . . . 0.0 112.777 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 t -60.54 -60.6 3.55 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 117.73 -1.129 . . . . 0.0 110.678 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -60.57 -31.99 71.09 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 120.022 1.283 . . . . 0.0 110.683 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.554 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -76.32 -8.72 57.72 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.82 5.49 88.6 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.707 -1.051 . . . . 0.0 113.511 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.65 130.48 34.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.243 1.521 . . . . 0.0 110.031 -170.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.496 ' N ' HD13 ' A' ' 112' ' ' LEU . 11.0 ttt85 -66.63 132.1 47.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.676 0.79 . . . . 0.0 111.168 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -144.82 178.51 7.96 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.344 -0.848 . . . . 0.0 110.545 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -115.03 156.27 25.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.331 1.452 . . . . 0.0 108.881 171.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 124.919 1.287 . . . . 0.0 108.732 173.546 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ttt-85 -156.82 9.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.998 1.111 . . . . 0.0 113.998 -164.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -133.65 131.89 40.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.92 0.782 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.21 133.77 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.59 128.71 37.44 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 166.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.11 113.06 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 164.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.28 -79.27 0.21 Allowed Glycine 0 C--O 1.229 -0.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 10.7 p -102.8 -7.06 21.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.636 0.718 . . . . 0.0 112.725 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.34 19.36 66.8 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.865 -1.147 . . . . 0.0 114.388 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 5.0 ttm-85 -63.43 150.29 43.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.455 1.502 . . . . 0.0 110.013 -176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -123.96 97.7 5.47 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.746 0.654 . . . . 0.0 111.315 -152.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -99.48 146.26 26.56 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.421 1.105 . . . . 0.0 108.961 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -98.9 -11.32 21.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.473 0.709 . . . . 0.0 110.345 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.5 p -140.03 162.03 36.19 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 126.496 1.918 . . . . 0.0 108.979 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -79.04 118.48 72.73 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 141' ' ' LEU . 81.2 Cg_endo -67.92 161.46 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.979 1.786 . . . . 0.0 109.403 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.0 107.7 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.873 2.382 . . . . 0.0 108.744 172.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.46 -18.93 11.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.761 2.124 . . . . 0.0 111.927 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 54.78 31.4 54.09 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.759 1.279 . . . . 0.0 113.673 -175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 164.11 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.999 1.32 . . . . 0.0 108.154 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 150' ' ' CYS . 2.4 t -64.65 115.01 16.75 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.163 168.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.92 -3.87 2.47 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.193 1.929 . . . . 0.0 113.083 166.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.21 -26.68 5.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.434 1.893 . . . . 0.0 112.814 -170.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 67.9 m -113.01 -18.16 12.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.728 1.211 . . . . 0.0 111.52 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 53.02 50.3 51.88 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.7 t -128.28 162.48 26.93 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.32 139.62 49.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.792 0.806 . . . . 0.0 110.948 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.09 152.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -126.76 156.32 41.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 120.306 -1.496 . . . . 0.0 109.516 166.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.12 120.24 23.99 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.535 0.401 0 O-C-N 123.441 0.463 . . . . 0.0 110.697 177.623 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.0 tttt . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -45.14 119.19 1.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.341 1.456 . . . . 0.0 111.95 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.2 137.56 40.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.568 1.547 . . . . 0.0 107.093 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.41 146.76 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.81 146.78 40.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.733 1.613 . . . . 0.0 108.098 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.73 174.66 7.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.345 0.52 . . . . 0.0 111.706 166.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -55.87 -42.28 75.65 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -61.15 -27.7 68.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.743 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.74 -42.68 82.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 119.984 1.266 . . . . 0.0 110.162 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -72.23 -36.38 69.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.465 1.106 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.3 -26.54 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.552 1.141 . . . . 0.0 110.892 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -92.22 -23.55 19.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.278 0.945 . . . . 0.0 111.829 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.96 45.72 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.304 -0.72 . . . . 0.0 113.02 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.2 mt -67.92 109.98 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.87 91.52 0.65 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.383 1.073 . . . . 0.0 110.191 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.47 165.79 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.832 1.253 . . . . 0.0 109.52 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.45 119.29 21.4 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.475 -166.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.07 -162.39 29.27 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.186 0.898 . . . . 0.0 110.905 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -104.26 150.59 24.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.875 1.27 . . . . 0.0 109.397 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -135.46 149.11 49.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.855 1.262 . . . . 0.0 108.82 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.82 118.93 75.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 125.219 1.408 . . . . 0.0 107.99 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.12 -28.71 71.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 119.749 0.946 . . . . 0.0 110.776 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -48.29 37.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.181 3.392 . . . . 0.0 113.899 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.7 -35.15 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-N 118.77 0.714 . . . . 0.0 110.33 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.27 -26.95 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.867 0.758 . . . . 0.0 110.062 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.5 -20.48 31.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.91 -22.12 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.992 1.317 . . . . 0.0 111.685 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.2 mt -62.58 116.79 2.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 122.211 1.005 . . . . 0.0 108.837 -170.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.84 -16.54 3.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.838 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -66.56 122.01 16.63 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -56.22 -45.34 79.94 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.122 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -56.79 -55.85 29.02 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.77 1.228 . . . . 0.0 109.121 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -61.17 -44.57 97.1 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.371 1.069 . . . . 0.0 110.31 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.41 -55.53 20.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.329 0.652 . . . . 0.0 110.493 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.1 mt -50.27 -55.68 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -55.19 -56.06 24.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.982 0.913 . . . . 0.0 111.613 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -52.55 -57.51 9.72 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.605 1.162 . . . . 0.0 108.836 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -58.06 -41.1 82.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.001 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -62.87 -35.85 81.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.854 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -37.46 63.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.971 0.908 . . . . 0.0 111.209 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.1 -47.3 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -66.52 -34.52 78.11 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.036 0.38 . . . . 0.0 110.976 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.91 -12.41 61.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.071 0.948 . . . . 0.0 112.745 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.13 21.75 48.08 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 119.427 1.012 . . . . 0.0 112.668 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -105.81 -26.59 11.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.913 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -119.87 127.01 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -123.27 144.2 49.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.987 1.267 . . . . 0.0 112.847 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.7 mm -77.4 122.65 32.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.666 1.186 . . . . 0.0 109.412 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 126.88 10.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.783 0.833 . . . . 0.0 110.097 168.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.39 158.14 37.49 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.1 0.56 . . . . 0.0 112.409 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.89 175.0 5.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 125.034 3.823 . . . . 0.0 111.98 170.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.36 165.03 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.36 15.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.913 1.685 . . . . 0.0 111.501 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.17 -30.81 70.0 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.763 0.425 . . . . 0.0 111.582 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -64.96 -48.52 73.74 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.385 1.474 . . . . 0.0 109.492 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.01 -46.9 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 124.439 1.096 . . . . 0.0 108.902 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -34.67 74.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 122.412 -0.18 . . . . 0.0 110.969 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -41.54 75.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.499 0.719 . . . . 0.0 111.443 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -70.58 -41.13 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 117.33 -1.319 . . . . 0.0 109.803 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.59 -54.03 17.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.334 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -55.32 -55.13 35.0 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.813 1.188 . . . . 0.0 112.13 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.993 HG11 HD21 ' A' ' 110' ' ' LEU . 4.6 p -67.44 -37.44 78.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.988 -0.445 . . . . 0.0 110.972 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -65.2 -34.01 77.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.259 1.024 . . . . 0.0 110.604 175.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -53.52 57.28 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.106 1.362 . . . . 0.0 109.566 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 1.86 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.654 1.582 . . . . 0.0 112.695 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.94 11.53 3.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.331 1.452 . . . . 0.0 111.107 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.07 -72.67 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 125.908 1.718 . . . . 0.0 112.78 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -77.68 71.56 4.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.86 1.264 . . . . 0.0 110.246 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.43 -39.13 82.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.762 1.625 . . . . 0.0 113.898 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -130.76 12.98 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.885 0.766 . . . . 0.0 110.887 -173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.61 -22.84 61.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.68 0.792 . . . . 0.0 111.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 78' ' ' LEU . 2.1 mp -77.33 155.83 31.71 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 122.14 -0.35 . . . . 0.0 110.428 -174.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.7 m -63.24 151.13 41.37 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.581 0.705 . . . . 0.0 109.28 170.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -55.75 -45.32 78.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.562 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.38 80.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.203 0.911 . . . . 0.0 113.17 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.27 -57.77 9.95 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -55.92 -45.22 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.373 1.469 . . . . 0.0 109.08 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -68.22 -49.88 57.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.904 1.282 . . . . 0.0 111.943 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.42 -48.02 86.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.346 0.975 . . . . 0.0 108.998 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.74 -57.06 14.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.178 0.991 . . . . 0.0 109.177 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.97 -48.49 52.13 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.914 1.286 . . . . 0.0 111.331 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.42 -51.73 65.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.709 0.804 . . . . 0.0 109.211 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.69 74.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.518 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.4 m-30 -76.08 -22.23 55.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.938 0.79 . . . . 0.0 111.91 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.37 -50.23 68.53 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.43 -14.0 59.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.44 1.096 . . . . 0.0 112.779 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? 54.35 30.3 12.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.888 1.675 . . . . 0.0 111.752 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -125.53 5.2 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.158 0.885 . . . . 0.0 111.061 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.98 165.63 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.767 2.027 . . . . 0.0 110.12 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.7 mt -130.09 162.99 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.725 1.21 . . . . 0.0 108.462 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.38 122.75 19.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.207 2.203 . . . . 0.0 106.051 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -163.26 175.76 10.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.66 1.184 . . . . 0.0 110.669 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -160.35 92.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.229 1.412 . . . . 0.0 109.618 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -151.92 153.04 33.33 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.777 1.231 . . . . 0.0 109.254 163.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -58.66 -41.71 86.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.0 1.273 . . . . 0.0 111.907 -171.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' HD23 ' A' ' 78' ' ' LEU . 5.5 p-10 -66.89 -55.54 14.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 110.029 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -54.12 -40.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.492 0.663 . . . . 0.0 110.526 -171.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -69.67 -41.3 75.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.063 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -59.54 -59.79 4.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.708 1.603 . . . . 0.0 107.649 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 mm -53.33 -58.84 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 124.639 1.176 . . . . 0.0 108.841 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.71 67.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.455 1.479 . . . . 0.0 112.793 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -52.98 55.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.764 -1.589 . . . . 0.0 113.102 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -35.23 79.08 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 121.235 1.834 . . . . 0.0 109.784 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.993 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -70.14 -22.38 63.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.493 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.97 80.32 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 124.726 1.155 . . . . 0.0 113.847 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -83.25 118.18 23.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.408 1.104 . . . . 0.0 109.098 177.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -68.61 131.75 45.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.778 1.231 . . . . 0.0 108.274 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -146.57 169.74 18.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.926 0.393 . . . . 0.0 111.182 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -101.93 134.27 45.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.607 1.163 . . . . 0.0 108.38 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.45 -0.433 0 O-C-N 124.721 1.263 . . . . 0.0 109.53 164.471 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 5.5 p-90 . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -155.58 25.05 0.4 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.619 -1.182 . . . . 0.0 113.933 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -129.94 140.4 50.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.676 1.125 . . . . 0.0 110.73 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.29 135.29 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.592 1.557 . . . . 0.0 108.886 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.53 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.6 OUTLIER -70.25 140.68 52.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -91.3 102.14 13.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 121.983 0.897 . . . . 0.0 109.045 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.05 -78.72 0.33 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 2.3 p -78.01 -10.72 59.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.621 0.71 . . . . 0.0 111.528 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.66 21.93 71.32 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.919 1.247 . . . . 0.0 114.589 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -63.93 135.16 56.28 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.354 1.062 . . . . 0.0 109.729 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -88.48 136.72 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.66 1.584 . . . . 0.0 108.417 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -130.8 150.02 52.17 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.416 1.086 . . . . 0.0 108.354 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 3.3 p -88.18 -22.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.435 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.4 p -139.58 172.61 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 108.136 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.86 132.34 90.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.12 169.44 21.44 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.912 1.741 . . . . 0.0 110.123 172.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -56.39 137.49 80.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.68 1.587 . . . . 0.0 109.586 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.96 -10.04 4.69 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.88 72.78 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.806 1.803 . . . . 0.0 112.918 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.18 161.63 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.247 1.019 . . . . 0.0 108.947 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.3 t -79.48 113.69 39.09 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.432 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.16 -13.45 15.95 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.366 1.377 . . . . 0.0 114.044 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.53 -25.09 15.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.171 1.388 . . . . 0.0 112.79 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.53 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 2.9 p -150.71 2.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.57 -11.35 7.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.585 2.04 . . . . 0.0 115.152 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.46 166.75 21.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.588 1.194 . . . . 0.0 112.873 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -61.16 149.21 38.15 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.618 -0.676 . . . . 0.0 109.834 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.48 142.94 22.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 153.5 51.22 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.34 1.056 . . . . 0.0 111.364 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.7 tt -76.08 137.85 40.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.777 0.831 . . . . 0.0 109.214 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 112.768 -177.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.8 mptt . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -39.79 117.95 0.81 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 126.417 1.887 . . . . 0.0 110.443 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.99 144.15 43.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.13 155.48 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 124.373 1.045 . . . . 0.0 109.903 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.16 146.15 51.28 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.305 1.842 . . . . 0.0 108.671 -166.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.16 171.97 7.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.561 0.744 . . . . 0.0 112.749 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.73 69.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.095 1.358 . . . . 0.0 112.187 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -37.38 72.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.2 -47.38 80.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.942 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -73.19 -31.73 64.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.879 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.01 -47.94 91.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.972 . . . . 0.0 109.518 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.63 -25.02 58.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.198 0.454 . . . . 0.0 111.043 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.88 28.08 14.86 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.39 0.519 . . . . 0.0 113.053 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -72.08 108.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -61.27 115.53 3.89 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 23' ' ' GLU . 3.5 tp -159.48 144.79 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.981 1.713 . . . . 0.0 107.45 174.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' H ' HD12 ' A' ' 22' ' ' ILE . 31.9 mp0 -88.09 142.37 27.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.947 1.299 . . . . 0.0 108.652 175.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.15 -155.61 24.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -117.96 151.72 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.25 1.02 . . . . 0.0 109.858 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 t -129.37 145.79 51.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.163 1.385 . . . . 0.0 110.496 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.502 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -91.13 117.69 68.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.504 1.522 . . . . 0.0 110.035 -168.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.4 Cg_endo -63.97 -5.67 9.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.884 3.056 . . . . 0.0 115.633 -170.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.99 -4.35 13.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.346 0.976 . . . . 0.0 111.886 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.69 -47.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 HD13 ' A' ' 43' ' ' LEU . 6.0 p -65.55 -19.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -170.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.59 -26.11 66.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.127 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -78.18 -40.95 36.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.017 0.927 . . . . 0.0 108.849 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.0 mt -55.67 101.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.609 1.564 . . . . 0.0 108.699 -169.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -9.29 8.9 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 126.025 1.73 . . . . 0.0 110.734 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.31 127.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -58.45 -51.66 68.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.557 0.743 . . . . 0.0 109.355 -170.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.41 -54.89 40.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.637 1.175 . . . . 0.0 108.73 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.381 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -64.73 -58.05 7.33 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.712 0.687 . . . . 0.0 109.469 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.37 -46.65 85.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 50.4 t80 -59.5 -51.65 68.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.067 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.547 HD13 HG23 ' A' ' 31' ' ' VAL . 6.8 tt -53.34 -52.12 60.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.103 0.961 . . . . 0.0 109.547 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.8 -37.04 80.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.906 0.882 . . . . 0.0 110.961 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -56.51 -46.53 80.51 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.317 1.447 . . . . 0.0 109.995 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 50.9 mt -67.7 -35.57 79.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.578 0.751 . . . . 0.0 110.784 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.3 -55.36 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -59.5 -38.19 80.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.397 0.544 . . . . 0.0 112.363 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -24.92 66.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.853 1.261 . . . . 0.0 112.383 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 9.0 60.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.531 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -83.75 -34.76 24.76 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.351 1.076 . . . . 0.0 111.263 178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.26 147.76 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -128.17 157.01 41.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.51 1.124 . . . . 0.0 109.759 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mm -78.63 135.06 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.85 127.83 7.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.828 0.851 . . . . 0.0 111.756 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -106.03 154.93 39.21 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.735 1.614 . . . . 0.0 112.17 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.82 163.33 28.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.12 3.88 . . . . 0.0 114.457 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -90.81 166.57 13.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.662 1.985 . . . . 0.0 109.457 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tmpt? -50.17 -44.45 52.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.129 1.372 . . . . 0.0 110.295 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -71.39 -27.58 63.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.989 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -66.09 -48.98 69.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.265 0.626 . . . . 0.0 109.664 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.26 -42.09 93.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.51 -33.14 74.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.225 0.466 . . . . 0.0 111.221 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -43.37 61.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.641 1.176 . . . . 0.0 110.307 174.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -72.21 -44.18 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 119.336 0.971 . . . . 0.0 108.547 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.61 -39.88 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.404 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -57.01 -68.2 0.24 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.5 1.143 . . . . 0.0 109.14 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.39 -29.81 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.091 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.22 60.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.917 . . . . 0.0 111.643 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -65.52 -25.99 67.7 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.081 -1.012 . . . . 0.0 111.563 -177.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 43.2 mt-10 -60.98 -52.72 63.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.139 0.882 . . . . 0.0 109.088 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -75.57 -39.96 57.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.36 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.55 -76.54 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.532 1.06 . . . . 0.0 113.52 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.01 92.0 0.91 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 122.02 0.914 . . . . 0.0 110.213 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.91 -44.08 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.541 0.736 . . . . 0.0 112.784 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -131.18 12.91 5.13 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.753 0.421 . . . . 0.0 110.899 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.03 -8.31 55.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 106' ' ' ILE . 5.4 mp -83.25 156.69 23.0 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.267 -0.895 . . . . 0.0 110.592 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.77 159.21 19.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.921 1.289 . . . . 0.0 110.605 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.54 -57.9 7.87 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.42 -39.14 75.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 123.959 0.787 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.68 -52.4 65.61 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 109.729 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.53 -46.35 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.5 -49.64 58.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.638 0.654 . . . . 0.0 112.722 -172.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG22 ' OG1' ' A' ' 27' ' ' THR . 93.7 t -60.58 -50.72 79.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -55.47 -58.57 7.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.15 0.98 . . . . 0.0 109.288 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -47.44 -55.89 8.08 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.931 1.292 . . . . 0.0 112.005 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.08 -48.07 81.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.295 1.038 . . . . 0.0 110.364 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.19 74.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.242 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.4 m-30 -67.76 -27.95 67.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.679 0.672 . . . . 0.0 111.213 -177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -30.05 66.69 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.281 0.946 . . . . 0.0 110.89 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.69 -14.82 38.85 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.718 1.207 . . . . 0.0 112.284 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.72 0.75 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.149 1.38 . . . . 0.0 111.425 -162.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.97 -162.79 13.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -101.67 167.92 9.8 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 109.043 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 86' ' ' LEU . 72.8 mt -133.62 150.8 32.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 125.181 1.393 . . . . 0.0 107.3 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.88 124.82 25.6 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.255 1.822 . . . . 0.0 106.29 170.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 16.5 t -152.31 -150.21 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.708 2.003 . . . . 0.0 106.884 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.01 -23.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.768 1.167 . . . . 0.0 113.401 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 103' ' ' VAL . 1.4 m-20 -72.91 140.73 47.68 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.901 1.681 . . . . 0.0 113.483 -156.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.41 -38.57 54.22 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.057 -1.652 . . . . 0.0 113.257 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.07 -47.79 60.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 111.341 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 0.3 OUTLIER -57.56 -37.04 56.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.046 1.294 . . . . 0.0 110.38 -177.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 35.7 mt-30 -68.84 -39.55 79.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -63.94 -56.29 16.33 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.401 0.68 . . . . 0.0 110.324 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 78' ' ' LEU . 13.8 mm -54.55 -52.67 38.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.494 1.043 . . . . 0.0 109.851 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.71 73.11 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.522 1.51 . . . . 0.0 113.298 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 t -55.8 -62.12 1.91 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.954 172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -25.38 68.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.368 1.44 . . . . 0.0 111.927 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -83.33 -10.16 58.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.78 82.22 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.563 -1.132 . . . . 0.0 113.879 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.568 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -92.22 135.51 33.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.497 1.648 . . . . 0.0 111.13 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.568 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -81.37 131.76 35.3 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.613 1.965 . . . . 0.0 110.435 177.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 26.7 p90 -150.98 -175.28 5.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.664 -0.647 . . . . 0.0 110.986 -174.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -98.98 175.28 5.98 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.161 1.384 . . . . 0.0 114.239 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 124.96 1.304 . . . . 0.0 110.423 171.221 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 7.8 p-90 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -0.3 0.11 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.63 150.06 44.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.665 1.575 . . . . 0.0 111.613 -169.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.79 128.42 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.842 1.257 . . . . 0.0 109.436 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 3.1 t -65.91 144.15 56.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 166.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.23 94.92 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.09 -90.78 0.1 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.97 13.24 17.19 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.183 0.993 . . . . 0.0 111.367 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.09 22.93 61.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.013 1.292 . . . . 0.0 115.122 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -65.46 125.78 26.22 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 110.056 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -72.78 150.99 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.938 0.773 . . . . 0.0 109.873 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.31 149.69 38.16 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.501 1.12 . . . . 0.0 109.229 166.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 42.9 t -86.11 -26.98 24.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.135 0.574 . . . . 0.0 111.674 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.7 p -145.3 160.02 42.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.392 1.477 . . . . 0.0 108.238 -171.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -74.57 123.42 89.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.49 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.91 172.06 15.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.858 2.372 . . . . 0.0 110.206 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.1 137.4 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 121.918 1.745 . . . . 0.0 110.269 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.59 -9.79 1.69 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.544 1.069 . . . . 0.0 114.172 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.8 35.77 87.67 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.87 1.335 . . . . 0.0 111.724 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.56 158.2 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.383 1.073 . . . . 0.0 108.121 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 4.8 t -71.08 113.03 15.69 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 117.252 -1.356 . . . . 0.0 108.082 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.36 -18.81 25.96 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.51 1.474 . . . . 0.0 113.189 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -27.15 15.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.088 1.755 . . . . 0.0 111.882 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 11.7 p -140.4 -2.77 1.39 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.43 -13.9 2.66 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.464 1.983 . . . . 0.0 115.317 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 163.1 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.177 1.489 . . . . 0.0 111.789 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.11 154.34 41.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.524 0.678 . . . . 0.0 109.768 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.8 t -108.17 148.48 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -129.96 160.8 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.335 1.054 . . . . 0.0 110.697 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.45 116.56 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.082 1.353 . . . . 0.0 107.803 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 124.459 1.104 . . . . 0.0 111.657 175.847 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm . . . . . 0 C--O 1.238 0.452 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.8 m -63.48 125.61 24.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -146.37 134.41 21.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.65 152.39 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.72 135.32 50.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.369 2.267 . . . . 0.0 109.409 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.33 161.36 14.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.97 2.108 . . . . 0.0 110.941 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.504 ' HB2' HG21 ' A' ' 30' ' ' VAL . 28.6 t -46.38 -45.17 17.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.399 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -52.19 -35.35 48.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.871 0.868 . . . . 0.0 111.92 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.18 -35.87 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.144 0.978 . . . . 0.0 109.626 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.2 -37.6 25.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.66 0.784 . . . . 0.0 111.025 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.92 -41.95 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.975 0.91 . . . . 0.0 109.205 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -79.13 -13.92 59.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 24.42 65.1 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.274 0.94 . . . . 0.0 113.864 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -78.82 108.19 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 C-N-CA 124.557 1.143 . . . . 0.0 108.417 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.05 111.75 3.52 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tp -154.45 159.62 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 127.348 2.259 . . . . 0.0 106.756 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -128.24 128.62 45.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.641 1.176 . . . . 0.0 110.498 -166.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.13 -147.65 9.08 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.236 1.398 . . . . 0.0 111.943 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.96 158.1 24.65 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.11 1.764 . . . . 0.0 110.144 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -145.74 166.29 26.3 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -90.09 125.56 60.01 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.619 0.724 . . . . 0.0 111.618 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG12 ' A' ' 31' ' ' VAL . 55.8 Cg_endo -63.07 -12.58 30.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.235 1.29 . . . . 0.0 111.163 166.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -32.94 67.39 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 126.873 2.069 . . . . 0.0 112.698 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.504 HG21 ' HB2' ' A' ' 13' ' ' SER . 11.3 p -92.8 -34.37 5.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 120.267 1.394 . . . . 0.0 110.632 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 28' ' ' PRO . 7.7 p -61.49 -16.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.849 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.392 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.65 -21.69 10.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.461 1.904 . . . . 0.0 110.799 -166.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 mt -67.81 96.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -90.45 -24.76 20.62 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 112.117 165.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.26 129.2 24.12 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.304 1.842 . . . . 0.0 111.549 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -51.4 -72.01 0.06 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 126.208 1.803 . . . . 0.0 110.535 -170.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.98 -48.02 83.76 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -164.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.8 t -50.48 -56.37 11.88 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.988 1.715 . . . . 0.0 110.088 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -61.4 -53.91 50.46 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.358 1.063 . . . . 0.0 110.61 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.5 mt -55.67 -50.17 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.27 1.028 . . . . 0.0 108.621 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.17 -48.41 80.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.7 -48.5 77.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.04 -1.037 . . . . 0.0 110.456 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.43 -40.87 92.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.997 0.919 . . . . 0.0 110.61 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 t -57.68 -51.1 70.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.166 1.386 . . . . 0.0 110.425 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.14 -38.08 89.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.809 0.843 . . . . 0.0 110.616 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.02 -50.97 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.7 t -59.54 -35.82 74.94 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.456 0.702 . . . . 0.0 111.015 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.17 -11.59 59.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.266 1.426 . . . . 0.0 112.725 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.44 87.1 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.721 1.153 . . . . 0.0 113.443 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 3.3 ptpt -78.42 -19.71 52.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.188 0.995 . . . . 0.0 112.07 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.43 136.78 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -125.72 140.9 52.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.52 0.676 . . . . 0.0 110.398 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.48 126.64 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.04 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.37 127.4 9.71 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.102 1.361 . . . . 0.0 109.212 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -99.57 155.05 36.93 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.505 0.722 . . . . 0.0 112.77 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.03 173.75 8.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.23 3.954 . . . . 0.0 112.235 165.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.08 173.16 8.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.887 2.075 . . . . 0.0 110.151 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -54.1 -49.86 68.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.833 -0.542 . . . . 0.0 110.251 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.08 -31.04 71.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.348 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -51.98 53.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.177 0.991 . . . . 0.0 110.31 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.27 -45.68 97.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.36 -39.9 70.64 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.661 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -45.63 46.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.415 1.486 . . . . 0.0 110.556 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -71.42 -46.85 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -177.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.3 mt -53.17 -43.41 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.317 1.047 . . . . 0.0 110.339 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.55 -57.52 12.4 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.571 0.623 . . . . 0.0 110.199 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.74 -37.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.9 71.97 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.411 1.084 . . . . 0.0 111.482 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -35.14 80.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.928 1.24 . . . . 0.0 111.164 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.86 -42.72 94.63 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.741 0.7 . . . . 0.0 110.715 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 t -80.98 -41.03 23.42 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.183 0.447 . . . . 0.0 111.94 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.32 146.18 6.37 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.787 1.661 . . . . 0.0 109.045 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 83.05 50.59 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 130.39 3.476 . . . . 0.0 109.21 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.48 -52.76 48.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 121.153 -0.967 . . . . 0.0 113.413 -170.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.09 11.02 15.17 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.083 0.553 . . . . 0.0 110.528 -167.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -20.74 32.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.534 0.734 . . . . 0.0 112.199 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -73.64 150.78 41.1 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.5 m -58.98 152.17 20.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.299 1.047 . . . . 0.0 110.812 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -59.19 4.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.58 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.56 77.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.888 0.743 . . . . 0.0 111.737 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.97 -55.25 37.1 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.173 0.989 . . . . 0.0 108.522 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.5 -43.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.838 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -65.49 -51.55 59.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.447 0.567 . . . . 0.0 111.435 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.27 -48.83 83.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.322 1.049 . . . . 0.0 109.301 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 96' ' ' ILE . 81.1 mt -58.22 -57.45 12.82 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.941 0.897 . . . . 0.0 109.614 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.92 -46.8 64.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.177 1.391 . . . . 0.0 112.663 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.06 -49.35 78.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.487 1.115 . . . . 0.0 109.167 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.98 75.12 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.709 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.504 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.6 m-30 -69.97 -26.3 64.03 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.109 0.868 . . . . 0.0 110.288 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.41 -7.09 51.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.316 1.046 . . . . 0.0 112.4 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.39 -10.61 8.43 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.266 1.427 . . . . 0.0 112.142 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.9 mttt 51.97 34.84 14.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 110.533 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.59 -130.37 6.66 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.712 1.149 . . . . 0.0 110.456 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -133.85 170.38 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.611 1.964 . . . . 0.0 109.917 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.461 HD13 HD23 ' A' ' 86' ' ' LEU . 66.5 mt -133.99 153.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 126.207 1.803 . . . . 0.0 106.489 -172.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.47 115.89 16.08 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 109.289 166.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 t -157.58 -172.53 4.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.061 3.344 . . . . 0.0 108.394 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.91 6.45 0.7 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -168.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.551 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.5 t0 -102.19 160.54 14.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.168 1.349 . . . . 0.0 111.96 -157.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -64.75 -48.55 74.15 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.51 -1.369 . . . . 0.0 111.636 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -69.33 -48.35 61.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.714 1.206 . . . . 0.0 109.78 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.551 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -56.53 -43.55 78.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -172.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.401 ' HG2' ' HE2' ' A' ' 114' ' ' PHE . 65.1 mt-30 -63.86 -47.79 79.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.32 0.648 . . . . 0.0 110.154 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.6 t-20 -56.08 -59.93 4.21 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.196 1.798 . . . . 0.0 108.226 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.16 -53.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 119.753 1.161 . . . . 0.0 111.254 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.37 67.71 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.367 1.44 . . . . 0.0 112.204 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -57.74 10.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -68.52 -21.92 64.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.15 1.341 . . . . 0.0 111.629 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.504 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.8 mm? -81.82 -22.15 37.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.473 0.709 . . . . 0.0 111.454 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.5 9.9 71.5 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.563 1.554 . . . . 0.0 114.232 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.22 123.86 29.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.853 1.327 . . . . 0.0 110.374 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 135.02 55.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.565 1.546 . . . . 0.0 109.05 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.401 ' HE2' ' HG2' ' A' ' 104' ' ' GLN . 18.3 p90 -151.23 175.27 12.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -107.35 166.51 10.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -149.82 9.71 0.7 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 117.352 -1.309 . . . . 0.0 113.532 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -133.96 138.94 45.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.907 1.231 . . . . 0.0 111.381 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.39 134.54 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.074 1.35 . . . . 0.0 109.298 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.433 ' HG ' ' HG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -76.54 122.06 24.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.071 0.949 . . . . 0.0 108.541 173.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.79 108.11 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.12 -80.66 0.2 Allowed Glycine 0 N--CA 1.458 0.136 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.5 p -88.45 -16.76 31.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.14 0.47 . . . . 0.0 111.885 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.11 32.5 43.78 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.546 0.593 . . . . 0.0 113.075 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 138' ' ' PHE . 42.5 ttt-85 -70.14 157.6 37.31 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 117.875 0.837 . . . . 0.0 109.772 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -101.32 146.63 27.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.353 1.461 . . . . 0.0 108.838 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 136' ' ' ARG . 97.4 m-85 -140.02 148.3 41.64 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.974 1.31 . . . . 0.0 108.321 169.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 t -94.22 -23.61 17.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.672 0.789 . . . . 0.0 110.566 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.9 p -136.97 157.64 46.27 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.615 0.766 . . . . 0.0 109.856 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -74.59 110.47 9.78 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.49 ' HD2' HD23 ' A' ' 141' ' ' LEU . 88.5 Cg_endo -68.62 172.02 12.21 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.918 3.079 . . . . 0.0 110.536 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.81 120.02 7.51 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.012 1.808 . . . . 0.0 109.632 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.47 -6.89 81.12 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.079 1.324 . . . . 0.0 113.417 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 59.48 38.54 93.7 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 119.255 1.528 . . . . 0.0 112.43 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -116.11 174.94 3.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 124.694 1.198 . . . . 0.0 108.397 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.19 100.31 2.13 Favored Pre-proline 0 CA--C 1.519 -0.239 0 CA-C-N 120.849 1.659 . . . . 0.0 109.355 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.14 37.49 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.932 3.754 . . . . 0.0 113.946 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.01 -16.08 0.21 Allowed 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.38 2.272 . . . . 0.0 112.004 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.433 ' HG ' ' HG ' ' A' ' 131' ' ' CYS . 11.8 p -146.73 -31.57 0.34 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.23 92.49 0.96 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.904 1.716 . . . . 0.0 111.128 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.43 174.01 2.85 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.638 1.975 . . . . 0.0 108.042 170.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -76.3 137.63 40.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.03 1.287 . . . . 0.0 111.958 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.35 157.94 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 156.62 44.07 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.699 -1.25 . . . . 0.0 110.969 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.24 146.08 35.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.672 0.789 . . . . 0.0 109.149 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 pt . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 -176.512 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp . . . . . 0 C--O 1.234 0.278 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -50.58 125.94 14.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.593 1.557 . . . . 0.0 109.043 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -144.44 142.54 30.37 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.57 148.56 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.18 133.85 53.45 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.464 1.506 . . . . 0.0 108.905 -171.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.52 161.81 20.09 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.88 1.672 . . . . 0.0 111.861 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -45.75 11.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.951 1.7 . . . . 0.0 111.822 171.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.0 p -61.54 -31.73 71.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.334 0.515 . . . . 0.0 111.938 -174.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 t -61.75 -42.56 94.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.656 1.182 . . . . 0.0 109.33 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.53 -37.32 71.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.663 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 91.3 mt -55.31 -54.43 25.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.07 -26.17 65.71 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.84 0.746 . . . . 0.0 111.461 -173.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 42' ' ' PHE . . . 91.23 37.25 6.31 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.79 108.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.35 112.61 7.62 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.33 174.37 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.082 1.353 . . . . 0.0 107.778 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -120.4 149.79 41.8 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.547 1.539 . . . . 0.0 108.339 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.74 -137.64 5.96 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.39 153.5 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.589 1.155 . . . . 0.0 110.452 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -129.38 144.63 51.32 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.522 1.129 . . . . 0.0 109.8 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.9 p -84.38 121.3 75.14 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 124.757 1.223 . . . . 0.0 109.804 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 31' ' ' VAL . 19.0 Cg_endo -65.42 -14.14 43.39 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.62 1.547 . . . . 0.0 113.665 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -74.75 -44.11 51.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.32 -36.11 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 119.402 1.001 . . . . 0.0 109.269 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 28' ' ' PRO . 10.0 p -64.21 -20.16 26.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 118.855 -1.138 . . . . 0.0 113.358 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.09 -25.3 68.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.249 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.94 -30.23 65.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.323 1.049 . . . . 0.0 109.893 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.96 82.56 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.973 2.109 . . . . 0.0 109.49 -164.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -20.17 60.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.215 1.406 . . . . 0.0 112.179 169.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.01 133.22 47.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.844 0.858 . . . . 0.0 110.89 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.3 mmt-85 -61.83 -59.65 4.83 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.96 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.19 -45.52 91.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 118.261 -0.876 . . . . 0.0 108.998 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 t -55.9 -56.23 23.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.276 0.63 . . . . 0.0 110.75 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -60.14 -51.43 69.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.624 1.102 . . . . 0.0 111.585 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.21 -57.62 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.414 ' CE2' ' HA2' ' A' ' 19' ' ' GLY . 68.4 t80 -56.46 -45.68 80.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.139 0.976 . . . . 0.0 112.219 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 31' ' ' VAL . 6.4 tt -54.48 -52.48 61.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.11 0.964 . . . . 0.0 108.525 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -70.48 -28.03 64.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.707 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -61.44 -50.27 73.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.422 1.01 . . . . 0.0 108.548 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -42.73 80.93 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.675 1.19 . . . . 0.0 111.402 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.83 -56.56 17.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -28.52 69.24 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.98 -13.2 60.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.397 1.479 . . . . 0.0 112.103 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.94 -6.7 51.87 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.603 1.573 . . . . 0.0 113.784 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -87.12 -23.42 24.87 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 118.486 1.143 . . . . 0.0 112.99 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.49 149.48 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 120.666 1.575 . . . . 0.0 107.457 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -135.16 156.73 48.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.709 -0.619 . . . . 0.0 111.007 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.35 131.52 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.87 0.868 . . . . 0.0 108.99 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.12 128.19 6.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.847 1.259 . . . . 0.0 110.036 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.33 158.82 32.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.163 0.985 . . . . 0.0 112.584 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -75.34 145.47 30.36 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.238 3.292 . . . . 0.0 112.891 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -65.01 155.35 34.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.156 0.982 . . . . 0.0 109.947 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -65.82 -36.11 82.56 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.904 -1.123 . . . . 0.0 109.479 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -21.74 64.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.973 0.806 . . . . 0.0 111.204 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 p -85.03 -38.17 19.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.102 0.864 . . . . 0.0 112.755 172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.47 1.032 . . . . 0.0 108.263 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -28.32 64.28 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.816 0.446 . . . . 0.0 111.451 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.69 98.72 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.548 -0.72 . . . . 0.0 111.741 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -67.24 -46.29 84.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -57.27 -28.77 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.737 0.698 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.11 -72.77 0.15 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.215 1.371 . . . . 0.0 108.962 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.62 -36.61 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.508 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -65.77 -40.81 92.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -27.2 61.59 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 121.692 2.042 . . . . 0.0 112.129 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.11 -52.3 59.83 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -69.87 -42.81 72.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.335 0.654 . . . . 0.0 111.586 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.9 -66.02 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.958 0.799 . . . . 0.0 112.452 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -71.47 45.96 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.848 2.859 . . . . 0.0 114.648 -165.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.4 p -40.33 -44.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 128.177 2.591 . . . . 0.0 115.988 -167.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -131.31 11.54 4.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.023 0.929 . . . . 0.0 110.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -12.77 61.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.153 0.581 . . . . 0.0 110.503 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 174.3 8.64 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.685 1.194 . . . . 0.0 110.183 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -68.11 154.0 42.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.798 1.285 . . . . 0.0 110.979 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HE3' ' N ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -54.2 -52.6 60.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.137 1.375 . . . . 0.0 110.786 162.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' N ' ' HE3' ' A' ' 80' ' ' LYS . . . -63.47 -35.79 81.62 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 123.573 0.546 . . . . 0.0 109.566 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.7 -53.99 46.08 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -52.16 -40.05 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.042 0.937 . . . . 0.0 109.311 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.31 -54.93 10.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.404 1.002 . . . . 0.0 113.325 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.64 -50.18 74.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.803 1.241 . . . . 0.0 109.11 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 96' ' ' ILE . 82.1 mt -59.43 -56.01 27.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.596 1.158 . . . . 0.0 109.62 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -56.38 6.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.463 1.105 . . . . 0.0 111.252 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -48.93 73.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 123.776 0.672 . . . . 0.0 110.051 -174.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.32 72.32 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.212 -0.93 . . . . 0.0 113.174 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.7 m-30 -73.08 -30.5 63.73 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.931 0.787 . . . . 0.0 110.477 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -31.64 69.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.51 1.124 . . . . 0.0 110.171 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.65 -12.45 21.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.428 1.891 . . . . 0.0 112.738 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.65 28.61 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.836 1.255 . . . . 0.0 112.065 -167.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.25 -144.17 13.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -115.06 166.3 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.912 2.085 . . . . 0.0 109.732 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.481 HD13 HD23 ' A' ' 86' ' ' LEU . 28.9 mt -131.99 160.96 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.26 114.07 13.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 164.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 t -165.36 162.28 19.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -152.48 26.39 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.825 -1.172 . . . . 0.0 112.829 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t0 -88.53 158.52 18.28 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.792 -1.193 . . . . 0.0 110.982 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -62.58 -49.5 75.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.994 1.27 . . . . 0.0 110.083 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -70.58 -46.99 62.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.06 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -60.63 -33.9 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.302 0.955 . . . . 0.0 109.716 -171.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -70.4 -38.95 74.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.41 0.684 . . . . 0.0 109.966 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -68.32 -54.95 13.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.78 -54.79 8.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.464 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.68 -41.78 67.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.822 1.646 . . . . 0.0 113.58 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -54.79 -60.07 3.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.643 0.777 . . . . 0.0 112.023 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -21.12 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.174 1.352 . . . . 0.0 112.613 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -81.83 3.1 27.26 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.416 1.087 . . . . 0.0 111.986 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.15 29.06 64.96 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.066 -1.408 . . . . 0.0 112.325 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.53 126.24 52.28 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.173 1.487 . . . . 0.0 111.645 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 126.13 30.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.657 1.183 . . . . 0.0 109.138 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -131.22 -170.13 2.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.489 1.516 . . . . 0.0 109.043 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.94 149.17 52.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.4 p . . . . . 0 C--O 1.242 0.684 0 O-C-N 125.073 1.483 . . . . 0.0 109.161 171.566 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.691 0.281 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' C ' HG12 ' A' ' 157' ' ' ILE . 75.9 mtm-85 -141.72 24.92 2.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.171 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.481 ' C ' HD11 ' A' ' 157' ' ' ILE . 7.9 m-85 -145.06 139.91 27.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.094 1.77 . . . . 0.0 111.426 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 157' ' ' ILE . 7.4 p -128.34 130.76 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.845 1.658 . . . . 0.0 107.501 -176.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 8.4 t -70.86 120.63 16.74 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 162.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.09 127.68 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.42 -75.32 0.38 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 4.4 p -80.4 -8.04 59.36 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.138 0.469 . . . . 0.0 112.196 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.61 37.01 92.74 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.153 1.359 . . . . 0.0 112.637 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -77.46 137.42 38.66 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.578 -0.954 . . . . 0.0 108.726 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.79 144.07 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.547 1.139 . . . . 0.0 108.71 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.37 151.75 45.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.085 1.754 . . . . 0.0 107.814 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.6 t -111.82 -7.93 14.16 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.887 -0.508 . . . . 0.0 110.502 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 p -136.05 156.4 48.78 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.824 -1.173 . . . . 0.0 109.755 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.4 tp -74.53 120.11 79.88 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -65.67 169.03 13.63 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.412 2.075 . . . . 0.0 110.087 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.77 112.8 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 111.343 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.74 -5.02 83.77 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.407 1.479 . . . . 0.0 113.116 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.81 45.42 95.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.455 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.91 154.11 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.14 113.71 19.91 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.361 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.27 7.48 2.55 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.146 2.564 . . . . 0.0 112.551 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -117.51 -23.71 7.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.78 1.632 . . . . 0.0 113.02 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 5.0 p -136.8 -24.0 1.16 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.58 79.17 0.52 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -155.4 170.66 21.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.871 0.868 . . . . 0.0 109.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -82.28 132.37 35.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.869 0.842 . . . . 0.0 109.653 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.77 142.89 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.21 170.86 15.3 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.086 1.354 . . . . 0.0 109.528 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.67 153.12 43.99 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.058 1.343 . . . . 0.0 110.825 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 129' ' ' TYR . 19.5 mm . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 125.517 1.527 . . . . 0.0 110.284 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.2 mttt . . . . . 0 CA--C 1.519 -0.234 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.1 m -55.78 122.99 12.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 tt -145.65 145.12 30.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.57 161.93 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 124.45 1.094 . . . . 0.0 109.624 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 mt -137.57 145.91 43.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.989 1.715 . . . . 0.0 108.513 -167.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.38 163.05 12.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.912 1.285 . . . . 0.0 112.049 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 30' ' ' VAL . 1.4 p -51.21 -41.25 60.14 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.35 1.06 . . . . 0.0 111.77 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -67.08 -27.11 67.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.614 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.57 -44.08 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.12 -35.65 74.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.615 0.766 . . . . 0.0 110.773 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.74 -48.56 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.169 0.441 . . . . 0.0 110.21 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -72.82 -27.66 62.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.135 0.425 . . . . 0.0 110.196 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.96 38.9 10.71 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.05 112.23 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.28 92.88 1.83 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.966 1.307 . . . . 0.0 109.366 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 148.78 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.24 1.416 . . . . 0.0 108.42 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -112.34 125.1 53.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 -168.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' VAL . . . 175.98 -179.06 47.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.287 0.949 . . . . 0.0 112.642 -171.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -78.67 152.77 31.46 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.139 -1.212 . . . . 0.0 110.363 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 t -137.1 160.44 38.95 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.784 2.034 . . . . 0.0 108.928 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.67 124.4 52.86 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 125.201 1.4 . . . . 0.0 109.337 -169.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.1 -22.33 55.43 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.783 1.655 . . . . 0.0 111.4 169.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -78.42 -17.08 56.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.656 1.982 . . . . 0.0 114.533 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.5 p -107.26 -33.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.23 1.377 . . . . 0.0 111.783 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -63.51 -15.55 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.767 1.167 . . . . 0.0 111.634 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -63.75 -18.87 64.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.653 -1.28 . . . . 0.0 113.567 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -101.28 -27.34 13.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 0.0 111.26 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.6 mt -62.7 102.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -13.0 6.89 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.058 0.943 . . . . 0.0 112.284 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.75 124.21 19.77 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -59.45 -36.95 76.92 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.984 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -55.02 -58.13 8.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.04 -41.05 91.39 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.46 1.904 . . . . 0.0 111.508 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -69.79 -52.38 25.67 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.38 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -46.76 -51.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.42 -63.2 1.27 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.019 0.927 . . . . 0.0 110.97 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 tp -48.54 -50.64 31.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.407 1.483 . . . . 0.0 112.879 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.31 -41.75 89.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.941 0.896 . . . . 0.0 110.851 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 m -63.27 -43.56 97.58 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.754 0.422 . . . . 0.0 109.926 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.5 99.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 0.0 110.593 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.44 -46.96 94.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -61.48 -46.48 89.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.178 0.991 . . . . 0.0 110.37 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.22 -5.38 38.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.455 1.502 . . . . 0.0 112.179 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.66 19.88 76.88 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 121.001 -1.062 . . . . 0.0 112.024 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -64.72 -38.83 92.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 164.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 70.4 t -122.78 150.75 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -136.78 147.41 46.62 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.001 0.92 . . . . 0.0 110.165 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.66 123.95 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.87 135.4 17.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.823 1.249 . . . . 0.0 108.517 170.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.3 155.59 37.61 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.411 0.684 . . . . 0.0 110.647 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.51 165.5 17.7 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.831 3.021 . . . . 0.0 112.628 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -81.84 158.5 24.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 164.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -39.04 74.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.541 -0.724 . . . . 0.0 111.539 170.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -29.15 70.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.127 -0.463 . . . . 0.0 111.281 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -65.43 -51.76 57.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.049 1.34 . . . . 0.0 108.238 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.32 -49.26 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.294 0.638 . . . . 0.0 109.908 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -59.39 -38.99 81.95 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.013 -0.429 . . . . 0.0 110.56 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -37.66 68.42 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.424 -0.797 . . . . 0.0 111.734 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.85 -53.44 30.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt -49.77 -36.53 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.548 1.139 . . . . 0.0 111.281 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -57.76 -69.4 0.17 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.672 0.789 . . . . 0.0 109.655 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.76 -31.64 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.136 -0.353 . . . . 0.0 110.405 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.34 75.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.416 1.487 . . . . 0.0 111.076 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -32.88 73.34 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.097 -1.002 . . . . 0.0 110.63 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.83 4.25 2.68 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.304 -0.873 . . . . 0.0 111.773 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 t -126.74 -3.29 6.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.263 1.392 . . . . 0.0 112.632 166.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.06 -86.08 0.39 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.159 1.838 . . . . 0.0 110.365 170.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -64.99 70.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 129.658 3.183 . . . . 0.0 112.369 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.73 -48.89 84.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.336 1.854 . . . . 0.0 113.284 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -123.1 7.8 9.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.903 0.881 . . . . 0.0 109.782 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -6.73 44.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.727 1.611 . . . . 0.0 112.581 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.26 162.37 16.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.297 1.039 . . . . 0.0 109.492 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 t -61.77 147.42 46.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.079 0.951 . . . . 0.0 108.958 168.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -61.24 -44.39 97.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.05 -38.6 68.2 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.686 0.616 . . . . 0.0 110.012 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -63.48 -56.86 12.78 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.383 1.473 . . . . 0.0 110.742 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.35 -40.25 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.465 1.506 . . . . 0.0 109.247 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -69.07 -46.61 67.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 113.173 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.58 -52.54 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 96' ' ' ILE . 64.1 mt -54.51 -55.07 32.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.164 1.386 . . . . 0.0 109.114 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.27 -51.66 57.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.496 1.518 . . . . 0.0 112.616 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.6 tp -50.67 -51.93 44.66 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -62.34 -17.17 58.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -86.31 -37.43 18.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.459 0.704 . . . . 0.0 110.676 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.27 -42.92 64.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.669 1.187 . . . . 0.0 110.587 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 89' ' ' ALA . 1.1 pp -109.19 6.26 24.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.916 1.686 . . . . 0.0 111.645 -171.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 43.27 52.82 5.61 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.635 1.974 . . . . 0.0 111.159 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 -119.9 3.89 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.838 1.209 . . . . 0.0 110.675 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -153.57 169.01 24.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.892 1.677 . . . . 0.0 106.682 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 86' ' ' LEU . 31.5 mt -133.91 160.25 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.58 114.38 13.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 167.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 p -169.16 145.72 3.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.377 1.071 . . . . 0.0 108.945 -158.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -143.44 -6.5 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.059 1.754 . . . . 0.0 115.014 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.45 149.17 5.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.03 1.332 . . . . 0.0 112.58 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -57.51 -38.37 74.5 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.692 -1.255 . . . . 0.0 112.374 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -55.02 12.5 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.813 1.245 . . . . 0.0 110.197 173.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -58.35 -40.92 79.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.238 0.615 . . . . 0.0 110.647 -167.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.46 -40.79 98.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.54 -56.97 9.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.0 mm -52.25 -51.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.599 0.636 . . . . 0.0 110.326 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.95 72.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.161 1.346 . . . . 0.0 112.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -62.8 -58.24 8.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 117.668 -1.158 . . . . 0.0 111.171 175.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -31.57 70.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.329 1.422 . . . . 0.0 111.171 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -73.73 -30.29 62.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.137 0.575 . . . . 0.0 111.327 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.65 5.06 63.37 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.802 1.191 . . . . 0.0 114.108 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 118.05 22.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.649 1.224 . . . . 0.0 109.387 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 140.92 58.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.3 -178.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.166 0.986 . . . . 0.0 109.743 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -115.61 145.16 42.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.189 1.396 . . . . 0.0 109.792 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.239 0.503 0 C-N-CA 124.337 1.055 . . . . 0.0 110.519 178.491 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -161.62 18.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -142.17 157.66 44.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.418 1.008 . . . . 0.0 111.83 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 p -142.89 137.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 124.75 1.22 . . . . 0.0 109.064 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 2.0 t -71.52 125.51 27.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.031 1.332 . . . . 0.0 108.206 163.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.37 118.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.96 -77.95 0.38 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 1.2 p -75.04 -3.54 33.13 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.52 0.66 . . . . 0.0 111.608 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.13 19.78 57.4 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.431 1.967 . . . . 0.0 114.146 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 11.9 ttt-85 -77.68 137.68 38.65 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -74.34 148.35 41.4 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.03 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -140.14 134.68 31.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.939 1.296 . . . . 0.0 108.215 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -25.67 24.65 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.665 1.186 . . . . 0.0 111.137 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.6 p -147.04 173.8 12.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.692 1.997 . . . . 0.0 107.114 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 114.56 65.81 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -163.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.76 168.39 13.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.061 1.841 . . . . 0.0 110.484 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.63 142.28 95.66 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.356 2.037 . . . . 0.0 110.344 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.12 -7.61 0.77 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.236 0.922 . . . . 0.0 113.922 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.8 63.96 3.81 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 117.928 -1.485 . . . . 0.0 109.601 -156.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.08 149.14 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 16.2 t -72.05 112.72 15.51 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.797 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.92 -17.07 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 CA-C-N 121.499 1.571 . . . . 0.0 113.302 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.57 -29.33 13.93 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.392 1.877 . . . . 0.0 111.903 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.43 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.8 p -141.89 -3.79 1.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.47 -13.55 50.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.089 1.804 . . . . 0.0 115.472 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.87 162.47 25.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.764 1.782 . . . . 0.0 114.26 -168.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -68.43 135.3 51.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.806 -1.184 . . . . 0.0 112.66 -173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.45 140.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.697 1.199 . . . . 0.0 109.228 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.35 164.93 28.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.656 1.582 . . . . 0.0 110.691 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.22 141.13 32.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.509 1.524 . . . . 0.0 111.479 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.783 1.233 . . . . 0.0 112.471 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.5 m -57.86 130.28 45.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.4 tp -155.24 142.66 19.55 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -121.39 161.35 21.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -137.85 151.18 47.81 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.68 1.592 . . . . 0.0 107.525 -165.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -117.46 167.82 10.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.926 0.89 . . . . 0.0 111.601 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' HG21 ' A' ' 30' ' ' VAL . 48.6 p -49.0 -48.25 43.7 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.36 1.464 . . . . 0.0 110.805 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -50.85 -37.64 44.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.533 1.133 . . . . 0.0 111.622 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -62.88 -40.03 87.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.837 1.199 . . . . 0.0 110.194 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -76.15 -35.47 59.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.924 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.0 mt -56.74 -50.34 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.878 0.871 . . . . 0.0 109.787 171.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -68.42 -19.12 64.57 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.109 0.564 . . . . 0.0 111.531 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 33.8 42.88 Favored Glycine 0 N--CA 1.446 -0.689 0 O-C-N 121.458 -0.776 . . . . 0.0 111.601 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.5 mt -85.1 105.4 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 113.7 3.15 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.3 177.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.225 1.81 . . . . 0.0 106.536 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.65 138.94 44.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.245 1.818 . . . . 0.0 107.951 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.34 -144.63 8.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -125.82 149.78 48.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 t -130.52 149.01 52.39 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.05 1.74 . . . . 0.0 108.36 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 126.45 72.12 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 123.897 0.879 . . . . 0.0 108.996 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HA ' HG12 ' A' ' 31' ' ' VAL . 18.9 Cg_endo -58.97 -31.62 95.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 168.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -27.48 62.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.163 1.785 . . . . 0.0 114.934 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 13' ' ' SER . 11.4 p -98.0 -37.33 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 119.286 0.948 . . . . 0.0 110.146 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.629 HG23 HD13 ' A' ' 43' ' ' LEU . 4.3 p -63.77 -26.82 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.828 1.194 . . . . 0.0 111.736 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.17 -16.64 64.43 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.049 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -86.19 -52.14 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.796 1.638 . . . . 0.0 108.649 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -49.5 99.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.449 2.3 . . . . 0.0 110.955 -170.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -63.6 134.3 55.24 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -57.36 -44.63 84.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.97 -59.65 4.53 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -166.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -55.24 -46.19 76.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.272 2.229 . . . . 0.0 110.454 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -62.58 -58.4 7.68 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.03 0.832 . . . . 0.0 110.972 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.95 -52.91 38.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 68.6 t80 -60.67 -44.4 96.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.613 0.765 . . . . 0.0 112.108 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD13 HG23 ' A' ' 31' ' ' VAL . 5.8 tt -57.88 -53.7 55.3 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -63.76 -31.02 72.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.594 0.358 . . . . 0.0 111.455 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -51.48 64.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 109.29 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 96.6 mt -66.35 -38.6 87.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.843 -1.075 . . . . 0.0 111.224 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.02 -57.58 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 m -67.32 -28.41 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -14.16 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.706 -0.621 . . . . 0.0 112.273 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.44 85.72 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.693 1.616 . . . . 0.0 113.016 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -67.15 -43.15 83.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.379 1.09 . . . . 0.0 108.13 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.57 159.5 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -138.11 157.82 45.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.718 -0.613 . . . . 0.0 111.824 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.53 133.3 31.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.917 1.287 . . . . 0.0 109.206 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.04 128.9 7.92 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.525 1.53 . . . . 0.0 109.869 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.92 155.83 37.13 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.392 1.077 . . . . 0.0 110.996 170.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.96 166.95 22.95 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.158 2.572 . . . . 0.0 111.522 171.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -95.48 165.6 12.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.833 1.253 . . . . 0.0 109.019 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -50.59 65.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.685 1.194 . . . . 0.0 109.303 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.19 -41.47 71.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.144 1.378 . . . . 0.0 111.012 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -62.15 -45.05 95.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.084 0.954 . . . . 0.0 110.955 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -66.07 -45.65 90.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 119.007 0.821 . . . . 0.0 109.373 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -54.14 -42.07 69.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.899 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -46.47 53.39 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.688 1.195 . . . . 0.0 110.762 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.1 mm -64.43 -43.32 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.611 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.3 -36.73 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.525 0.602 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.39 -55.26 33.52 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.744 0.702 . . . . 0.0 109.659 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.26 -35.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.478 0.311 . . . . 0.0 110.641 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -64.48 -43.64 93.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.56 80.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.312 1.415 . . . . 0.0 110.622 173.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.52 -26.18 65.11 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.325 -0.86 . . . . 0.0 112.397 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.22 -49.04 3.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.06 0.846 . . . . 0.0 111.23 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.75 139.12 3.41 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -167.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 79.1 39.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.553 2.741 . . . . 0.0 111.82 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.413 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.8 p -37.68 -48.73 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 127.349 2.259 . . . . 0.0 115.384 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -123.64 10.07 9.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.62 0.768 . . . . 0.0 110.489 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.76 -28.42 58.46 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.033 0.833 . . . . 0.0 111.713 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.27 34.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.181 1.393 . . . . 0.0 107.786 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -67.94 158.43 32.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.956 1.36 . . . . 0.0 111.113 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -58.83 -57.63 12.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.434 -172.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 -34.55 70.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.43 0.456 . . . . 0.0 111.152 -175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.03 -53.1 60.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.279 1.432 . . . . 0.0 108.574 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.5 mt -55.3 -44.99 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -66.31 -48.74 69.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.926 0.89 . . . . 0.0 112.46 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.33 -56.28 14.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.67 1.588 . . . . 0.0 108.071 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.597 HD23 HD13 ' A' ' 96' ' ' ILE . 74.3 mt -60.96 -51.39 69.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 122.858 0.463 . . . . 0.0 110.009 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -45.18 -52.06 9.8 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.351 1.061 . . . . 0.0 112.209 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.6 tp -52.21 -52.5 51.89 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.225 0.466 . . . . 0.0 110.508 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.7 67.73 Favored 'General case' 0 CA--C 1.524 -0.051 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.877 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.538 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -78.81 -25.48 44.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.442 1.019 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 1.1 tm-20 -65.99 -48.33 71.59 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 164.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.15 -14.73 59.36 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 31.5 mtmt 50.2 29.7 3.84 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.719 2.808 . . . . 0.0 113.766 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.57 -108.01 1.55 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 124.379 0.99 . . . . 0.0 112.5 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -146.98 171.17 15.66 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.82 1.648 . . . . 0.0 107.844 172.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.597 HD13 HD23 ' A' ' 86' ' ' LEU . 31.2 mt -131.91 160.97 42.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.693 1.197 . . . . 0.0 108.599 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.06 124.38 23.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.59 1.556 . . . . 0.0 108.659 168.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -162.8 -164.73 1.03 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.214 1.406 . . . . 0.0 110.47 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 -11.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 169.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -68.57 155.35 40.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.556 1.525 . . . . 0.0 115.1 -163.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -62.57 -37.01 84.51 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 119.526 -1.984 . . . . 0.0 112.555 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.57 -41.52 31.74 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.092 0.406 . . . . 0.0 110.659 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -36.77 74.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 118.486 0.585 . . . . 0.0 110.03 -170.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.26 -47.62 60.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 122.742 0.417 . . . . 0.0 109.917 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -59.08 -58.65 7.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.352 1.461 . . . . 0.0 108.722 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.33 -52.18 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.726 0.81 . . . . 0.0 109.976 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.33 67.58 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.758 -1.214 . . . . 0.0 114.008 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 t -67.97 -48.66 65.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 117.428 -1.272 . . . . 0.0 111.89 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -25.37 67.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.655 2.025 . . . . 0.0 112.475 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -82.07 -16.81 48.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.099 0.959 . . . . 0.0 111.723 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.14 18.88 78.23 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 117.886 -1.508 . . . . 0.0 114.348 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.05 132.61 34.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.766 1.783 . . . . 0.0 109.11 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.2 144.6 31.5 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.018 1.727 . . . . 0.0 111.253 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.2 -179.6 7.48 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.12 141.34 47.61 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.463 2.305 . . . . 0.0 107.939 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.241 0.64 0 C-N-CA 123.877 0.871 . . . . 0.0 109.533 -174.526 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 . . . . . 0 C--O 1.24 0.56 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -146.03 17.57 1.4 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 116.411 -1.757 . . . . 0.0 115.215 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -135.0 135.3 41.28 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 121.636 2.016 . . . . 0.0 112.962 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.49 125.61 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.311 1.444 . . . . 0.0 109.903 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.49 121.67 16.84 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 108.813 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pt -82.41 49.04 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.995 1.318 . . . . 0.0 111.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.24 -31.48 0.02 OUTLIER Glycine 0 C--O 1.226 -0.344 0 O-C-N 121.253 -0.904 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 12.5 p -132.77 14.19 4.38 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.693 0.746 . . . . 0.0 112.062 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.99 7.98 33.03 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.366 1.936 . . . . 0.0 115.468 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 46.0 ttt85 -69.47 132.46 46.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.511 1.924 . . . . 0.0 111.662 -165.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.79 143.22 30.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.633 1.173 . . . . 0.0 110.185 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -139.14 156.33 47.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.993 1.717 . . . . 0.0 108.22 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.0 t -109.78 -14.58 14.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.073 0.549 . . . . 0.0 111.133 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.4 p -138.01 166.28 24.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.4 tp -75.79 113.0 22.79 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -65.04 167.83 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.564 2.176 . . . . 0.0 109.472 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.16 136.55 75.51 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.321 2.014 . . . . 0.0 111.002 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.71 -15.78 3.57 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.128 1.347 . . . . 0.0 112.824 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.88 43.44 97.56 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.897 1.237 . . . . 0.0 111.384 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.64 167.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.501 1.12 . . . . 0.0 109.907 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.27 110.79 13.4 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 111.413 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.87 -14.97 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.218 1.279 . . . . 0.0 113.788 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.89 -36.97 16.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.343 1.057 . . . . 0.0 112.676 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.23 -7.38 2.03 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -164.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.11 -3.39 10.51 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.099 2.761 . . . . 0.0 116.43 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.6 m -69.45 162.93 26.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.838 1.319 . . . . 0.0 112.217 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.11 160.68 30.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.65 0.738 . . . . 0.0 111.169 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.49 161.37 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.748 1.619 . . . . 0.0 109.333 173.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.27 166.44 24.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.337 1.455 . . . . 0.0 108.958 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.82 154.45 38.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.23 1.012 . . . . 0.0 111.02 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 126.34 1.856 . . . . 0.0 110.725 169.442 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -52.3 129.65 28.81 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.508 -174.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.686 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -153.21 135.66 15.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.682 -168.017 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -111.83 145.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 9' ' ' LEU . 1.1 mm? -113.98 147.58 38.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.11 1.764 . . . . 0.0 107.354 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -106.17 166.32 10.6 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.294 0.637 . . . . 0.0 110.423 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 30' ' ' VAL . 22.7 t -42.16 -46.82 4.5 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.436 1.894 . . . . 0.0 111.477 174.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -62.13 -28.52 69.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.103 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.84 -39.33 84.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 109.536 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.89 -35.18 62.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.64 0.776 . . . . 0.0 111.101 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -61.7 -35.81 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.194 0.598 . . . . 0.0 110.61 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -82.23 -30.14 30.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.528 0.604 . . . . 0.0 110.749 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.3 32.28 17.12 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.257 0.932 . . . . 0.0 111.335 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.47 113.48 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.51 104.91 0.69 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.845 0.858 . . . . 0.0 109.811 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 tp -149.57 159.78 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.871 1.268 . . . . 0.0 108.02 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.54 115.02 16.21 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.844 1.257 . . . . 0.0 108.589 -164.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.686 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.31 -158.04 24.18 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.859 1.695 . . . . 0.0 112.514 -164.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.23 149.64 23.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.547 0.674 . . . . 0.0 112.451 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -132.89 149.72 52.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.626 1.97 . . . . 0.0 109.709 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 117.54 68.67 Favored Pre-proline 0 C--O 1.243 0.748 0 C-N-CA 126.702 2.001 . . . . 0.0 109.079 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -58.27 -32.72 96.58 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.167 1.245 . . . . 0.0 110.508 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -68.36 -11.73 60.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 13' ' ' SER . 8.8 p -106.25 -31.03 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 117.51 -1.234 . . . . 0.0 110.832 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 28' ' ' PRO . 8.5 p -59.28 -28.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.941 1.701 . . . . 0.0 111.09 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -60.31 -22.28 62.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.263 0.483 . . . . 0.0 112.034 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -83.63 -53.23 5.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.923 -1.111 . . . . 0.0 108.965 169.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mt -41.37 114.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.198 1.799 . . . . 0.0 111.37 -162.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 -12.16 1.4 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.932 1.693 . . . . 0.0 112.836 -171.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -53.37 124.53 15.0 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 163.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -56.88 -50.01 73.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.328 0.651 . . . . 0.0 109.856 -171.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -62.24 -54.65 37.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 t -54.94 -42.02 71.79 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.163 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -62.61 -57.49 10.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.778 0.831 . . . . 0.0 109.933 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.89 -55.58 15.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.19 -53.14 57.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.404 1.482 . . . . 0.0 111.759 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.2 -48.88 73.21 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.815 1.246 . . . . 0.0 110.649 177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.39 -45.32 94.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.117 0.567 . . . . 0.0 110.836 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -56.41 -48.57 76.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.929 0.786 . . . . 0.0 109.388 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -42.23 95.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.989 1.315 . . . . 0.0 111.608 -176.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.85 -56.13 18.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -33.22 73.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.283 0.633 . . . . 0.0 111.896 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.18 -10.33 59.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.382 1.873 . . . . 0.0 112.617 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.19 -12.33 57.21 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 124.666 1.127 . . . . 0.0 113.466 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -78.27 -33.29 49.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.768 0.784 . . . . 0.0 111.638 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.05 148.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -141.21 139.54 33.82 Favored 'General case' 0 N--CA 1.46 0.049 0 C-N-CA 124.346 1.058 . . . . 0.0 109.773 -167.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.16 118.17 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.6 18.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.309 1.044 . . . . 0.0 110.744 174.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.9 160.89 27.15 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.373 1.469 . . . . 0.0 110.969 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.91 175.97 4.93 Favored 'Trans proline' 0 C--N 1.347 0.497 1 C-N-CA 125.453 4.102 . . . . 0.0 113.44 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.01 165.96 11.08 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.928 1.291 . . . . 0.0 109.45 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -47.29 -48.93 24.73 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.863 1.265 . . . . 0.0 111.379 176.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.47 -27.87 65.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.843 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -69.98 -39.78 75.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.97 . . . . 0.0 109.628 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.36 -47.74 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.97 -34.43 73.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.851 -0.531 . . . . 0.0 110.831 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -42.3 64.3 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.15 0.98 . . . . 0.0 111.405 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 87' ' ' ALA . 3.1 mm -67.37 -52.65 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.06 -39.56 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.929 1.292 . . . . 0.0 110.493 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -58.75 -60.03 4.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.541 1.064 . . . . 0.0 111.415 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -73.34 -38.2 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.5 73.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.78 1.232 . . . . 0.0 110.692 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -29.07 70.26 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.515 -1.365 . . . . 0.0 112.155 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.02 -7.35 21.98 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.475 1.034 . . . . 0.0 112.208 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -123.45 16.11 9.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 112.009 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.25 -80.3 0.43 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.296 1.427 . . . . 0.0 110.119 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -59.08 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 129.009 2.923 . . . . 0.0 110.678 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.12 -43.91 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.126 1.771 . . . . 0.0 111.529 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -128.21 8.17 6.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.12 0.968 . . . . 0.0 109.721 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.53 -20.79 65.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.73 2.012 . . . . 0.0 111.784 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -95.97 165.26 12.35 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.051 1.74 . . . . 0.0 109.971 -175.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -70.03 158.06 36.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.841 0.829 . . . . 0.0 111.849 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -59.7 -54.41 46.7 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.986 1.314 . . . . 0.0 109.571 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.81 -44.03 63.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 110.352 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.436 ' O ' HD22 ' A' ' 86' ' ' LEU . 71.5 m-20 -60.42 -56.67 18.6 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.7 mt -52.79 -40.54 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.51 -33.44 72.83 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -57.81 -61.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 118.945 0.793 . . . . 0.0 109.288 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.4 mm? -61.89 -46.8 87.79 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.211 -169.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.83 -53.39 32.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.458 1.103 . . . . 0.0 111.535 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.47 -47.74 83.05 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.629 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.24 63.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.285 0.493 . . . . 0.0 111.883 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.06 -25.95 20.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.54 1.136 . . . . 0.0 111.394 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.98 -51.21 68.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.56 4.94 30.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.613 0.765 . . . . 0.0 111.615 -169.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 49.74 46.01 24.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.919 1.687 . . . . 0.0 110.771 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.18 -116.06 1.71 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -156.38 168.35 27.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 ' CD1' ' A' ' 86' ' ' LEU . 53.4 mt -129.81 152.55 37.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 119.05 20.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.004 1.322 . . . . 0.0 108.108 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.4 t -165.45 -170.54 1.88 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.079 1.352 . . . . 0.0 109.925 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -151.52 -1.78 0.32 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -64.39 157.78 25.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.571 -1.331 . . . . 0.0 114.539 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -60.93 -41.15 95.65 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.726 -1.234 . . . . 0.0 110.814 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -84.35 -44.26 13.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 110.989 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.443 HG11 ' OG ' ' A' ' 98' ' ' SER . 2.6 p -60.12 -37.67 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.351 0.978 . . . . 0.0 110.225 -170.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -70.96 -35.72 72.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 110.226 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.09 -55.48 18.53 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.946 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 mm -48.95 -53.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.796 0.838 . . . . 0.0 109.179 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -21.69 64.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.182 -1.407 . . . . 0.0 112.854 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -74.07 -46.59 42.08 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.672 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.4 95.05 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.55 1.977 . . . . 0.0 108.275 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -68.52 -44.39 74.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.62 35.12 14.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 125.774 1.654 . . . . 0.0 111.855 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -85.77 136.34 33.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 137.53 56.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -145.94 -173.6 4.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.881 0.31 . . . . 0.0 111.243 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -130.61 124.87 32.7 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 125.742 1.617 . . . . 0.0 109.296 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 127.445 2.298 . . . . 0.0 108.448 173.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -148.76 8.92 0.78 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -140.3 146.4 38.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.362 0.983 . . . . 0.0 110.72 -171.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -137.27 132.41 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 108.701 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -64.37 120.5 12.35 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 163.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.39 119.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 166.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.46 -84.64 0.32 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.37 -4.81 58.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.98 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.85 20.27 68.35 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 124.78 1.181 . . . . 0.0 114.946 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 137.22 57.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -84.04 148.01 27.09 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.305 1.042 . . . . 0.0 109.341 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -142.03 146.09 35.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.02 -4.11 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 110.827 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.9 p -145.39 160.4 41.61 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.645 2.378 . . . . 0.0 108.224 161.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.533 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -68.85 112.78 12.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' HD23 ' A' ' 141' ' ' LEU . 90.5 Cg_endo -66.33 164.74 27.09 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 109.635 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.34 124.6 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.094 1.863 . . . . 0.0 109.332 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.86 -18.26 57.0 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.287 2.375 . . . . 0.0 112.161 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 62.19 34.86 90.47 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.822 1.311 . . . . 0.0 111.455 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.86 162.0 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.634 1.573 . . . . 0.0 107.544 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.9 t -74.4 112.57 17.73 Favored Pre-proline 0 N--CA 1.443 -0.775 0 C-N-CA 125.365 1.466 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.51 -8.65 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.518 2.145 . . . . 0.0 115.895 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.61 -43.06 6.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.826 1.194 . . . . 0.0 112.065 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 1.3 p -122.99 -9.44 8.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.991 0.917 . . . . 0.0 111.527 -166.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.23 13.75 82.99 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.791 1.186 . . . . 0.0 113.614 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.79 161.58 14.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.82 1.31 . . . . 0.0 112.203 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -62.81 147.92 48.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.458 0.646 . . . . 0.0 111.15 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.39 147.6 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -133.84 172.9 12.15 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.479 1.512 . . . . 0.0 110.287 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.43 161.32 28.07 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.494 1.117 . . . . 0.0 110.342 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 126.441 1.896 . . . . 0.0 110.684 174.818 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mttt . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -49.93 131.48 22.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.592 1.182 . . . . 0.0 108.965 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -151.25 144.4 24.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.31 151.52 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.956 ' HB3' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -132.59 138.81 47.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 125.435 1.494 . . . . 0.0 109.669 -173.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 15' ' ' VAL . 4.5 t0 -88.82 -179.69 6.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.03 1.332 . . . . 0.0 111.364 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.0 p -58.43 -41.99 86.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.06 -1.65 . . . . 0.0 110.425 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -60.65 -39.79 89.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.597 1.159 . . . . 0.0 112.234 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.956 HG11 ' HB3' ' A' ' 11' ' ' LEU . 7.5 p -53.57 -36.13 27.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 119.945 1.248 . . . . 0.0 111.3 177.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 15' ' ' VAL . 6.4 m-85 -77.13 -37.12 54.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.395 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.13 -31.72 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.899 0.88 . . . . 0.0 109.81 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.42 -21.85 22.83 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.52 24.85 24.99 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.476 -0.624 . . . . 0.0 113.923 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.0 mt -80.92 109.29 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.622 1.211 . . . . 0.0 109.217 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.93 100.99 1.66 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.581 0.752 . . . . 0.0 109.795 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tp -136.91 167.79 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.378 1.471 . . . . 0.0 108.579 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -136.98 120.77 17.42 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.287 1.435 . . . . 0.0 108.526 -166.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.87 -157.88 30.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.61 1.576 . . . . 0.0 111.51 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -109.78 149.85 29.2 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.306 1.043 . . . . 0.0 110.893 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -128.76 168.01 16.47 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.715 1.206 . . . . 0.0 108.816 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -107.0 121.16 45.69 Favored Pre-proline 0 C--O 1.247 0.951 0 C-N-CA 126.288 1.835 . . . . 0.0 111.01 -165.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HA ' HG12 ' A' ' 31' ' ' VAL . 12.1 Cg_endo -63.22 -15.41 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.82 1.68 . . . . 0.0 113.389 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -89.78 -12.33 39.58 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.675 1.125 . . . . 0.0 112.806 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.77 -36.36 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 121.138 1.79 . . . . 0.0 108.206 167.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 28' ' ' PRO . 12.6 p -58.68 -29.6 40.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.898 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.44 -26.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.809 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -11.36 42.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.165 2.186 . . . . 0.0 110.879 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.21 119.24 31.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -21.25 6.03 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.406 1.482 . . . . 0.0 112.494 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.43 169.26 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.279 0.632 . . . . 0.0 110.315 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -84.57 -55.97 3.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.99 -59.36 5.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -168.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -54.69 -35.59 63.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.578 1.151 . . . . 0.0 113.064 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 119.507 1.049 . . . . 0.0 109.433 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.1 mt -52.62 -43.23 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.944 1.298 . . . . 0.0 108.798 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -77.84 -40.24 40.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.609 0.763 . . . . 0.0 113.043 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -53.48 -49.06 68.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.418 1.463 . . . . 0.0 108.477 169.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -65.85 -32.04 73.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.815 -0.612 . . . . 0.0 111.672 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -57.69 -51.03 71.22 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.325 1.45 . . . . 0.0 108.751 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.36 -33.76 76.44 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.73 0.812 . . . . 0.0 111.344 -176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.31 -49.9 62.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 m -57.39 -40.83 79.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.784 -0.573 . . . . 0.0 110.941 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.64 -3.61 35.49 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.104 1.361 . . . . 0.0 113.219 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.44 21.64 77.55 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 112.681 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 5.0 ptpt -96.97 -29.93 13.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.094 1.447 . . . . 0.0 112.638 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.94 130.64 73.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -122.62 142.8 50.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.615 1.166 . . . . 0.0 110.181 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.32 133.18 31.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.8 9.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.681 1.192 . . . . 0.0 109.964 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.01 154.6 38.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.921 0.888 . . . . 0.0 111.344 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.23 164.12 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.805 3.67 . . . . 0.0 113.459 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -84.75 159.07 20.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.092 0.949 . . . . 0.0 111.153 161.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -45.67 84.65 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.972 1.309 . . . . 0.0 111.124 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -58.05 -33.64 69.23 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.775 0.43 . . . . 0.0 111.513 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.23 -45.89 75.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.884 1.273 . . . . 0.0 109.924 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.25 -44.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.995 0.918 . . . . 0.0 109.516 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.41 -33.9 73.17 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.44 -0.788 . . . . 0.0 111.628 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -41.46 89.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.889 0.768 . . . . 0.0 110.541 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.87 -46.35 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.16 -38.89 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.475 1.11 . . . . 0.0 110.331 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -62.88 -60.32 3.64 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.142 1.337 . . . . 0.0 110.719 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 109' ' ' LEU . 4.0 t -67.43 -34.94 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.63 -174.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.89 77.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.391 0.676 . . . . 0.0 111.548 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.81 66.24 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.781 1.628 . . . . 0.0 111.762 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.27 4.88 11.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.755 0.822 . . . . 0.0 112.212 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -131.95 -22.59 2.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.255 1.389 . . . . 0.0 112.246 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.17 -70.13 0.4 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 119.473 1.033 . . . . 0.0 112.783 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.46 56.86 0.37 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.729 2.012 . . . . 0.0 113.04 -170.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 p -48.53 -44.63 13.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.227 1.811 . . . . 0.0 114.328 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -124.7 4.89 8.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.524 0.729 . . . . 0.0 110.519 -173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.78 -10.82 58.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.605 1.162 . . . . 0.0 112.89 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 165.36 22.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 169.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 t -72.16 159.84 33.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.105 0.866 . . . . 0.0 109.887 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 81' ' ' ALA . 1.7 ttpt -65.03 -48.97 71.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.907 0.883 . . . . 0.0 109.199 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' N ' ' HE2' ' A' ' 80' ' ' LYS . . . -56.21 -43.23 78.34 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.495 1.118 . . . . 0.0 109.792 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -63.38 -55.07 27.44 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.39 -42.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 124.023 0.929 . . . . 0.0 109.787 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.5 -48.43 72.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.923 0.889 . . . . 0.0 111.999 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG22 ' OG1' ' A' ' 27' ' ' THR . 95.1 t -59.1 -47.56 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 119.278 0.944 . . . . 0.0 109.239 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 96' ' ' ILE . 87.5 mt -60.03 -56.13 25.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.549 1.14 . . . . 0.0 109.474 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.59 -50.15 60.74 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.968 1.307 . . . . 0.0 111.791 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -49.92 75.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.91 91.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.634 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.485 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.1 m-85 -65.53 -31.49 72.58 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.963 1.256 . . . . 0.0 111.663 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.85 -37.36 87.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.421 1.105 . . . . 0.0 111.282 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.27 -12.57 52.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.365 1.066 . . . . 0.0 111.59 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 60.24 12.18 3.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.424 1.489 . . . . 0.0 112.29 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.65 -112.03 0.3 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 128.414 2.912 . . . . 0.0 112.965 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -154.89 167.92 28.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 106.933 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.526 HD13 HD23 ' A' ' 86' ' ' LEU . 20.6 mt -131.31 155.97 42.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.478 1.111 . . . . 0.0 108.023 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.84 116.09 14.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.051 1.74 . . . . 0.0 106.97 167.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.4 t -155.78 170.73 21.4 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.225 0.61 . . . . 0.0 109.493 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.09 93.78 2.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.741 1.616 . . . . 0.0 110.694 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -152.66 166.43 32.14 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.873 1.269 . . . . 0.0 108.661 165.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -68.8 -55.23 11.88 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.096 -1.003 . . . . 0.0 109.783 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.52 -35.41 80.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.472 -0.768 . . . . 0.0 110.951 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.1 p -64.75 -43.52 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 118.994 0.815 . . . . 0.0 108.843 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.45 -42.74 87.15 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.507 0.723 . . . . 0.0 110.598 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' HD23 ' A' ' 109' ' ' LEU . 28.8 t30 -59.88 -62.84 1.58 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.943 1.297 . . . . 0.0 108.523 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.1 mm -51.09 -50.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.077 0.951 . . . . 0.0 110.421 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.78 72.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.853 1.206 . . . . 0.0 112.532 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 t -59.13 -59.01 6.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.746 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.458 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -62.68 -31.29 72.15 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.223 1.374 . . . . 0.0 111.579 -176.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -72.34 -6.68 45.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.373 0.669 . . . . 0.0 112.315 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.73 73.16 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-O 118.759 -1.023 . . . . 0.0 112.604 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -82.91 135.41 34.92 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.652 1.726 . . . . 0.0 109.474 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.409 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -75.84 117.11 17.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.53 1.132 . . . . 0.0 108.385 169.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.63 174.41 9.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 109.761 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.9 116.93 32.81 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 153.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 . . . . . 0 C--O 1.239 0.539 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -145.68 21.2 1.48 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.489 -1.72 . . . . 0.0 114.693 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -135.16 149.96 50.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 121.989 2.177 . . . . 0.0 112.423 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.51 134.26 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.342 1.457 . . . . 0.0 109.16 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.8 OUTLIER -66.05 142.02 57.95 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.763 0.825 . . . . 0.0 109.151 163.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.26 117.64 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.88 -2.3 33.78 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.306 1.431 . . . . 0.0 113.797 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 -1.96 2.11 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.081 0.94 . . . . 0.0 112.121 154.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.03 11.73 64.04 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 126.004 1.764 . . . . 0.0 115.442 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -69.95 135.23 49.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.015 -0.697 . . . . 0.0 110.134 -168.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -73.97 150.05 40.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.352 1.032 . . . . 0.0 109.872 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.17 147.38 38.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 161.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 p -95.96 -10.18 29.3 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.198 0.999 . . . . 0.0 112.235 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 p -134.69 177.4 7.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.393 1.877 . . . . 0.0 106.739 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 tp -80.7 137.71 50.87 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.06 159.72 51.48 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.518 1.478 . . . . 0.0 109.689 167.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.22 115.82 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.426 2.084 . . . . 0.0 110.863 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.27 66.15 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.86 -175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.75 45.51 90.88 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.165 1.364 . . . . 0.0 112.194 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.37 155.45 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 42.4 t -76.02 111.93 17.68 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.356 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 56.6 Cg_endo -61.32 -20.85 69.95 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.308 1.339 . . . . 0.0 112.39 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -18.66 30.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.948 1.299 . . . . 0.0 111.091 -171.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 15.0 p -142.82 -33.06 0.47 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.86 84.66 1.34 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.283 1.421 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.63 171.34 5.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 110.19 172.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -59.32 131.36 50.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.189 1.396 . . . . 0.0 112.828 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.95 146.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 166.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.06 157.69 45.48 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.001 -1.062 . . . . 0.0 110.346 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.76 152.49 44.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 C--O 1.235 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 110.489 173.216 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.787 0.327 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -54.92 130.18 40.43 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.664 0.786 . . . . 0.0 109.768 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 95' ' ' GLU . 16.8 tp -151.32 143.32 23.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.95 148.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.29 127.06 53.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.938 1.695 . . . . 0.0 107.898 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.17 167.84 18.3 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.081 0.952 . . . . 0.0 110.951 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -44.05 51.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.567 1.947 . . . . 0.0 110.662 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -53.02 -38.36 62.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.936 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.29 -40.03 86.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 119.591 1.087 . . . . 0.0 109.411 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 43' ' ' LEU . 30.0 m-85 -73.68 -31.64 63.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 111.046 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.2 mt -59.73 -53.5 47.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.056 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -67.73 -31.2 70.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.144 0.429 . . . . 0.0 110.789 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.66 31.6 8.16 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 123.584 0.612 . . . . 0.0 111.627 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.01 106.69 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.96 104.41 1.72 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.68 167.26 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.822 -1.174 . . . . 0.0 109.161 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.41 148.3 27.29 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.595 1.958 . . . . 0.0 107.992 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.72 -141.84 8.64 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.966 1.257 . . . . 0.0 112.228 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.61 153.16 46.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.06 0.93 . . . . 0.0 112.257 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 t -126.95 147.38 50.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.715 2.006 . . . . 0.0 110.071 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.0 116.22 66.16 Favored Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 127.817 2.447 . . . . 0.0 110.037 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.18 -30.07 89.42 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 121.538 1.492 . . . . 0.0 113.12 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 -15.18 57.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.265 1.826 . . . . 0.0 114.014 -171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' CB ' ' A' ' 81' ' ' ALA . 59.6 t -83.04 -53.15 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 126.113 1.765 . . . . 0.0 108.6 162.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -71.24 -18.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 123.302 0.641 . . . . 0.0 111.722 -160.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -48.71 -38.82 22.58 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.98 0.912 . . . . 0.0 111.75 165.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 -11.98 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.022 1.329 . . . . 0.0 111.362 -166.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.53 97.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.76 -23.09 21.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.449 1.1 . . . . 0.0 112.015 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.72 117.8 4.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.95 -38.42 76.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 117.667 -1.159 . . . . 0.0 110.692 -168.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.4 -56.26 22.16 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 119.513 1.051 . . . . 0.0 108.322 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -61.64 -48.09 82.45 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.516 0.726 . . . . 0.0 110.91 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -57.27 -60.64 3.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.15 1.38 . . . . 0.0 110.342 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.5 mt -62.45 -38.85 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 58.9 t80 -62.28 -47.86 82.43 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.048 0.939 . . . . 0.0 110.65 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.477 HD12 ' CG ' ' A' ' 16' ' ' PHE . 6.8 tt -63.86 -49.0 74.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.167 -0.958 . . . . 0.0 109.813 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.74 -33.52 76.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 t -54.41 -54.88 34.78 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 25.6 mt -59.77 -48.38 81.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.546 1.139 . . . . 0.0 110.736 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.38 -55.36 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 t -64.21 -34.83 78.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.196 0.599 . . . . 0.0 111.306 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.61 -9.8 58.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.274 1.83 . . . . 0.0 112.316 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.41 8.94 60.75 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 124.888 1.232 . . . . 0.0 113.754 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -87.82 -41.14 13.46 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -164.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.15 161.64 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 C-N-CA 125.292 1.437 . . . . 0.0 108.756 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -132.69 158.35 42.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.67 139.27 19.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.85 130.18 4.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.53 1.132 . . . . 0.0 109.301 162.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -98.24 156.37 35.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.572 1.549 . . . . 0.0 111.053 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.57 -176.21 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.776 3.651 . . . . 0.0 111.971 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -120.33 163.9 17.13 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.529 0.732 . . . . 0.0 110.21 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -49.61 10.57 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.559 1.544 . . . . 0.0 111.98 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.93 -27.94 60.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.858 0.863 . . . . 0.0 110.771 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -47.27 85.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 109.246 170.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.87 -44.95 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.336 1.054 . . . . 0.0 109.635 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.96 -32.73 72.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.646 -0.659 . . . . 0.0 111.731 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -44.3 76.17 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 121.419 -0.801 . . . . 0.0 110.909 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -64.42 -49.03 82.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.34 -46.9 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.244 1.017 . . . . 0.0 110.503 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.07 -48.71 70.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.11 1.323 . . . . 0.0 111.485 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 t -74.55 -33.64 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.72 -51.65 61.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.229 1.012 . . . . 0.0 110.116 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -24.7 67.65 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.115 -0.991 . . . . 0.0 111.885 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.96 -28.53 64.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.283 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 t -120.43 -16.42 8.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.77 -76.59 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 119.259 0.936 . . . . 0.0 112.522 164.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -72.26 93.08 1.44 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.773 1.229 . . . . 0.0 109.161 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.11 -50.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 112.059 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.85 14.55 7.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.034 0.933 . . . . 0.0 110.443 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.27 -24.17 59.23 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.833 1.653 . . . . 0.0 111.285 175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' LEU . 1.5 mp -77.03 165.38 24.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.054 0.941 . . . . 0.0 109.155 -173.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 153.27 40.7 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.048 -1.032 . . . . 0.0 109.48 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -63.32 -46.01 88.66 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.152 -0.967 . . . . 0.0 109.07 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -54.71 -41.37 70.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.209 0.943 . . . . 0.0 111.268 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.78 -55.1 39.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 109.133 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.58 -42.9 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.792 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -62.58 -49.24 76.03 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.01 0.924 . . . . 0.0 111.046 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.78 -51.14 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 96' ' ' ILE . 20.0 mt -57.02 -50.22 73.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.784 0.834 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.28 -53.39 36.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.331 1.052 . . . . 0.0 112.028 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.91 -50.25 69.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.977 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.56 65.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.314 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -67.8 -32.26 72.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.583 0.628 . . . . 0.0 111.339 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -44.13 94.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.956 0.798 . . . . 0.0 109.62 168.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 -10.82 59.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.732 0.813 . . . . 0.0 112.177 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm 58.22 11.8 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.018 2.127 . . . . 0.0 113.236 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.7 -145.47 11.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 127.344 2.402 . . . . 0.0 113.042 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 9' ' ' LEU . 2.5 mp0 -106.0 173.37 6.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.448 1.899 . . . . 0.0 111.944 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 86' ' ' LEU . 23.5 mt -130.1 161.34 39.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 126.18 1.792 . . . . 0.0 108.981 173.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.56 121.21 16.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.681 1.992 . . . . 0.0 107.19 166.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t -164.62 177.74 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.761 1.224 . . . . 0.0 109.984 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.06 82.6 1.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.81 -1.181 . . . . 0.0 110.113 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 103' ' ' VAL . 3.4 t0 -146.12 156.31 43.35 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.953 0.901 . . . . 0.0 112.102 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -66.55 -36.74 83.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.289 -166.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -49.95 13.98 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 117.212 -1.375 . . . . 0.0 110.568 168.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -51.62 -43.19 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.466 1.03 . . . . 0.0 110.799 -168.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 36.6 mt-30 -63.7 -43.86 95.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.021 0.928 . . . . 0.0 110.177 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.421 ' O ' HD23 ' A' ' 109' ' ' LEU . 21.1 t30 -69.23 -50.61 45.62 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.7 mm -52.62 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 125.625 1.57 . . . . 0.0 109.046 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.96 -34.79 66.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.151 1.341 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -54.76 30.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.059 -1.448 . . . . 0.0 112.754 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.433 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -61.83 -33.44 74.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 121.542 1.973 . . . . 0.0 110.302 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.5 mm? -73.69 -4.88 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.802 0.841 . . . . 0.0 113.255 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.24 3.38 61.17 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.863 -0.965 . . . . 0.0 114.399 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.03 149.91 24.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.033 1.417 . . . . 0.0 110.343 -175.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.46 ' N ' HD13 ' A' ' 112' ' ' LEU . 5.8 tmm_? -94.59 140.52 29.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.009 1.323 . . . . 0.0 110.131 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 15.7 p90 -144.08 178.28 7.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.038 -0.414 . . . . 0.0 110.86 177.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -107.86 121.43 44.73 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.447 1.099 . . . . 0.0 108.619 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.24 0.6 0 O-C-N 125.28 1.612 . . . . 0.0 109.717 157.697 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 12.8 p-90 . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -154.8 15.07 0.42 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.405 ' N ' HD11 ' A' ' 157' ' ' ILE . 52.8 m-85 -143.38 150.47 39.15 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.1 136.74 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.615 1.966 . . . . 0.0 108.679 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 2.2 t -76.93 121.95 24.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.035 0.934 . . . . 0.0 110.064 171.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.47 84.29 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 122.503 1.144 . . . . 0.0 108.608 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.77 -20.12 0.12 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.392 1.472 . . . . 0.0 112.125 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 18.9 p -152.87 0.63 0.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.291 1.046 . . . . 0.0 113.426 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.51 10.52 66.87 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.624 -1.298 . . . . 0.0 114.914 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.483 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 13.8 ttt85 -71.89 135.24 46.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -88.85 139.37 30.53 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.769 1.628 . . . . 0.0 109.364 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.29 149.12 52.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.334 1.054 . . . . 0.0 108.609 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -99.43 -9.74 23.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.039 0.936 . . . . 0.0 111.776 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.0 p -141.0 169.77 16.99 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.06 2.544 . . . . 0.0 107.321 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.33 133.51 83.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.72 160.95 47.4 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 121.002 1.394 . . . . 0.0 108.734 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.23 -19.04 65.43 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.201 1.934 . . . . 0.0 114.911 -170.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.1 -3.42 55.73 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.775 0.716 . . . . 0.0 113.265 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.6 17.93 50.2 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 119.122 1.461 . . . . 0.0 113.96 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.85 156.18 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.88 2.072 . . . . 0.0 106.526 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 11.7 t -69.8 113.79 20.03 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 125.534 1.534 . . . . 0.0 108.717 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 80.4 Cg_endo -66.39 -11.05 29.91 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.855 1.703 . . . . 0.0 112.091 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.82 -24.41 14.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.691 1.196 . . . . 0.0 112.074 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.462 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 4.7 p -142.25 -9.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.94 62.52 4.9 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.442 1.019 . . . . 0.0 112.319 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.31 167.76 22.75 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.015 0.926 . . . . 0.0 109.935 164.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -55.55 145.3 23.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.81 1.244 . . . . 0.0 110.668 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.4 t -104.52 138.91 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 167.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 162.53 29.12 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.514 1.126 . . . . 0.0 110.584 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.58 156.47 38.97 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.693 1.197 . . . . 0.0 110.241 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.429 0 C-N-CA 128.245 2.618 . . . . 0.0 108.65 174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 tptt . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -60.94 136.14 58.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.466 -1.396 . . . . 0.0 109.943 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -155.3 146.66 22.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.477 1.511 . . . . 0.0 107.181 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.8 t -118.22 147.51 21.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' CD1' HD21 ' A' ' 9' ' ' LEU . 1.8 mm? -116.62 140.05 49.84 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.329 1.452 . . . . 0.0 109.504 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.93 164.49 13.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.902 1.281 . . . . 0.0 111.169 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -42.12 -47.7 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.603 1.961 . . . . 0.0 113.708 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -58.82 -33.92 70.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.37 0.668 . . . . 0.0 110.94 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.36 -41.06 83.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.85 0.86 . . . . 0.0 109.562 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.94 -39.03 64.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.8 mt -57.28 -41.12 77.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.864 0.866 . . . . 0.0 109.799 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -78.7 -26.54 44.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.788 0.722 . . . . 0.0 111.871 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.46 26.74 12.94 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.315 0.959 . . . . 0.0 112.632 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 mt -77.01 110.32 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.459 1.129 . . . . 0.0 108.325 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.59 108.98 2.63 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 6.3 tp -145.28 170.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.592 ' O ' HD22 ' A' ' 9' ' ' LEU . 21.0 pt-20 -137.56 140.72 41.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.589 1.956 . . . . 0.0 107.379 -168.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 162.23 -148.46 15.68 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 124.424 1.077 . . . . 0.0 114.001 -159.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.49 152.81 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.335 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -130.62 154.18 48.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.926 1.69 . . . . 0.0 111.476 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.26 113.64 59.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 126.218 1.807 . . . . 0.0 112.147 -170.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.04 -11.09 29.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.646 2.897 . . . . 0.0 114.378 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -71.5 -40.78 69.95 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.612 1.165 . . . . 0.0 109.977 166.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG22 ' CB ' ' A' ' 81' ' ' ALA . 38.5 t -74.33 -40.68 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -170.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.96 -23.45 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 118.519 -1.272 . . . . 0.0 113.48 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.58 -20.44 63.65 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.744 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.05 -36.98 19.36 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.087 1.355 . . . . 0.0 108.805 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -66.53 94.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.908 1.283 . . . . 0.0 109.672 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -22.81 13.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.15 0.98 . . . . 0.0 111.582 169.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.07 122.15 10.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.741 1.216 . . . . 0.0 108.764 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -50.36 -49.05 55.27 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 116.932 -1.509 . . . . 0.0 111.655 -170.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -60.38 -60.7 3.39 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -168.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 t -51.44 -53.83 33.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.875 2.07 . . . . 0.0 110.781 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.15 -62.78 1.58 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.665 1.186 . . . . 0.0 110.959 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mt -55.9 -43.32 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.87 -53.33 59.16 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.787 0.835 . . . . 0.0 111.267 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.93 -44.0 73.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.048 1.339 . . . . 0.0 110.549 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.83 -39.14 90.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.59 -0.694 . . . . 0.0 111.079 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -56.52 -51.33 68.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.537 1.135 . . . . 0.0 109.046 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.02 -36.06 81.29 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 111.131 -171.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.2 mt -62.07 -47.78 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -39.97 85.38 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.802 0.441 . . . . 0.0 112.115 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.25 63.6 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.362 1.065 . . . . 0.0 111.838 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.82 44.44 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.039 0.828 . . . . 0.0 113.658 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 2.8 ptpt -70.82 -39.79 72.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.244 -170.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.62 99.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -167.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 4.3 mmmm -82.37 164.32 21.13 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.164 0.986 . . . . 0.0 110.302 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.42 129.44 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 123.231 0.612 . . . . 0.0 110.729 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.65 128.45 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 109.982 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -101.17 154.78 36.98 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 110.435 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.33 175.95 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 124.736 3.624 . . . . 0.0 112.684 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.05 160.58 14.38 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.398 -1.728 . . . . 0.0 107.975 173.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -39.34 68.14 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.577 -0.702 . . . . 0.0 110.642 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.66 -22.27 43.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.854 0.861 . . . . 0.0 110.379 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -65.57 -49.76 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 108.959 166.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.84 -46.63 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 118.736 0.698 . . . . 0.0 109.405 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -38.35 83.98 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.999 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.05 68.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 0.827 . . . . 0.0 111.761 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -67.52 -47.54 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.0 mt -51.62 -38.25 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.096 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -63.81 -62.32 1.72 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.698 1.135 . . . . 0.0 110.501 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.01 -40.85 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.19 96.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.612 0.765 . . . . 0.0 111.57 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -32.86 74.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.006 -1.059 . . . . 0.0 110.795 175.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.37 -5.25 38.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.738 0.699 . . . . 0.0 111.277 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -108.37 -41.66 4.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.994 0.815 . . . . 0.0 112.03 168.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.77 -80.4 0.18 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 119.678 1.126 . . . . 0.0 110.418 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -62.43 87.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.832 2.453 . . . . 0.0 109.338 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 p -89.22 -49.98 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.495 1.518 . . . . 0.0 110.926 -173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -130.69 14.63 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.727 0.811 . . . . 0.0 109.556 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -56.95 -33.77 67.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 110.2 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.6 mp -76.09 164.51 26.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 111.016 -172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.7 m -73.03 163.69 27.8 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.99 0.9 . . . . 0.0 112.252 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -61.22 2.45 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 123.552 0.741 . . . . 0.0 109.136 174.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.511 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -53.47 -38.17 63.37 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 125.908 2.005 . . . . 0.0 110.334 -171.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.49 -67.57 0.25 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.427 1.891 . . . . 0.0 109.083 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.67 -29.93 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.925 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -66.57 -49.16 67.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 113.295 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.1 t -50.76 -60.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.088 1.755 . . . . 0.0 108.53 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.2 mm? -62.18 -47.7 83.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.52 -172.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.11 -59.26 4.09 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.926 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 tp -56.3 -46.47 79.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -28.93 70.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.342 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' HE2' HD12 ' A' ' 65' ' ' ILE . 4.8 m-85 -80.61 -20.87 42.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.009 0.822 . . . . 0.0 111.618 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.73 -40.29 96.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.3 0.955 . . . . 0.0 108.921 164.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.68 -14.91 50.66 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.715 1.206 . . . . 0.0 112.566 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.34 42.98 7.97 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.477 1.511 . . . . 0.0 110.292 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.04 -113.88 3.88 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 126.067 1.794 . . . . 0.0 115.144 -165.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -147.45 167.64 23.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.41 1.484 . . . . 0.0 109.555 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 86' ' ' LEU . 58.6 mt -130.13 158.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 109.184 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.48 115.3 10.14 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 t -160.93 179.66 8.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.93 1.292 . . . . 0.0 108.524 172.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -158.57 89.1 0.95 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.844 -1.16 . . . . 0.0 110.627 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -153.35 156.02 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.07 0.948 . . . . 0.0 110.699 176.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -58.75 -48.89 79.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.624 0.77 . . . . 0.0 110.162 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -64.87 -54.82 24.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.663 1.185 . . . . 0.0 109.723 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -63.01 -36.56 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.823 0.449 . . . . 0.0 110.923 -164.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.04 -44.0 85.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -60.87 -50.57 72.9 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.104 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 HD21 ' A' ' 78' ' ' LEU . 10.1 mm -54.58 -51.05 54.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.991 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.61 88.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.085 1.311 . . . . 0.0 111.298 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 t -65.11 -49.4 70.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.426 -0.797 . . . . 0.0 113.022 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -36.81 84.84 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 120.432 1.469 . . . . 0.0 110.723 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -66.32 -28.66 68.85 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.508 0.323 . . . . 0.0 110.524 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.04 46.38 59.13 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -170.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.01 123.65 49.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.321 1.06 . . . . 0.0 108.484 160.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 140.19 57.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.95 1.3 . . . . 0.0 109.849 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -145.47 178.42 8.12 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.826 0.85 . . . . 0.0 109.741 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.67 146.23 32.32 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.385 1.074 . . . . 0.0 108.771 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 125.11 1.364 . . . . 0.0 108.778 169.661 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.497 ' CH2' HD13 ' A' ' 157' ' ' ILE . 22.7 p-90 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -149.06 15.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -143.74 146.46 33.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.688 0.676 . . . . 0.0 109.87 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.45 135.28 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.056 0.942 . . . . 0.0 109.989 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 150' ' ' CYS . 0.7 OUTLIER -62.99 130.22 43.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.783 1.233 . . . . 0.0 108.849 169.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.9 pt -87.07 51.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.797 0.839 . . . . 0.0 111.391 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.82 -81.95 0.04 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.44 -7.36 54.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.098 0.559 . . . . 0.0 111.87 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.52 29.04 74.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 125.555 1.55 . . . . 0.0 113.239 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 140.36 53.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -81.9 153.45 26.32 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.919 1.287 . . . . 0.0 109.511 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -146.89 126.12 13.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.897 1.279 . . . . 0.0 107.646 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.4 p -82.51 -23.71 34.49 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.084 -1.01 . . . . 0.0 111.479 170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 p -141.95 159.34 42.43 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 126.511 1.924 . . . . 0.0 108.594 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.5 OUTLIER -65.48 121.84 77.12 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -173.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 141' ' ' LEU . 63.8 Cg_endo -63.21 157.57 49.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 CA-C-N 121.011 1.397 . . . . 0.0 109.145 171.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.12 128.7 26.02 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.348 1.365 . . . . 0.0 108.935 174.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.64 69.18 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.057 1.313 . . . . 0.0 113.215 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 58.58 43.31 96.19 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 118.948 1.374 . . . . 0.0 111.391 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.45 168.25 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 18.9 t -78.06 110.52 13.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 111.183 -173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 37.9 Cg_endo -63.22 15.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.925 3.084 . . . . 0.0 114.576 167.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.4 OUTLIER -132.33 -20.13 2.41 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.053 1.741 . . . . 0.0 111.765 -175.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 131' ' ' CYS . 3.5 p -154.16 3.42 0.25 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.83 -14.09 2.18 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.833 1.682 . . . . 0.0 114.919 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.6 m -62.13 149.27 41.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.097 1.448 . . . . 0.0 110.877 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.54 157.52 6.85 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 109.796 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.92 162.83 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.12 163.08 31.17 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.262 -1.523 . . . . 0.0 108.779 164.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.04 148.74 46.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 163.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.497 HD13 ' CH2' ' A' ' 127' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 109.812 168.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.4 mt 49.95 22.04 0.81 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.535 2.334 . . . . 0.0 115.813 169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -80.79 66.98 6.52 Favored 'General case' 0 N--CA 1.461 0.101 0 O-C-N 120.774 -1.204 . . . . 0.0 109.591 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -70.35 130.03 40.87 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.9 mt -145.85 157.87 43.89 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.696 0.799 . . . . 0.0 109.071 166.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.18 176.69 3.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 166.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -58.74 -176.95 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.052 1.341 . . . . 0.0 111.836 162.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 m -56.53 139.49 49.39 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.76 -1.212 . . . . 0.0 108.598 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -158.96 143.3 15.55 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.72 142.25 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.58 137.41 49.47 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 108.281 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -89.11 164.72 14.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.88 0.848 . . . . 0.0 111.032 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.422 3.089 . . . . 0.0 111.49 165.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 m -57.12 -26.31 60.29 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.39 -37.17 64.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 120.213 1.37 . . . . 0.0 109.405 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -77.37 -12.78 59.99 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.5 1.52 . . . . 0.0 112.538 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.45 -45.53 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.227 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -78.49 -20.39 50.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.979 1.718 . . . . 0.0 114.25 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.62 40.9 5.54 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 128.375 2.893 . . . . 0.0 112.097 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' CD1' HD21 ' A' ' 117' ' ' LEU . 7.3 mt -95.2 100.24 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 119.944 1.872 . . . . 0.0 107.211 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 111.63 1.02 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.399 0.68 . . . . 0.0 110.328 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 23' ' ' GLU . 5.7 tp -155.69 170.23 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 126.189 1.796 . . . . 0.0 107.978 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 22' ' ' ILE . 54.3 mt-10 -115.03 162.63 16.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.624 2.37 . . . . 0.0 108.96 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.85 -132.83 4.27 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 118.456 0.571 . . . . 0.0 112.067 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.7 151.61 47.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.734 1.613 . . . . 0.0 109.971 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -129.36 149.78 51.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.973 1.709 . . . . 0.0 111.138 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.61 116.5 66.34 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 126.492 1.917 . . . . 0.0 109.318 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 31' ' ' VAL . 38.2 Cg_endo -63.09 -16.79 56.66 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.934 1.756 . . . . 0.0 112.379 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -53.57 52.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.152 1.381 . . . . 0.0 110.608 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.35 -35.5 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 O-C-N 121.611 -0.681 . . . . 0.0 109.424 -169.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG23 HD21 ' A' ' 43' ' ' LEU . 7.0 p -63.08 -20.5 25.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.768 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -69.67 -21.35 63.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.118 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.48 -7.36 31.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.532 1.533 . . . . 0.0 110.923 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.13 99.94 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.677 1.191 . . . . 0.0 108.455 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 -13.49 15.57 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.08 -176.08 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.054 1.342 . . . . 0.0 110.466 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -101.28 -43.21 6.04 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 116.655 -1.64 . . . . 0.0 111.391 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -56.9 -60.86 2.95 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 120.1 1.318 . . . . 0.0 107.702 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m -62.25 -11.29 14.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -89.37 -66.7 0.9 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.4 mt -52.37 -48.79 44.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 124.892 1.277 . . . . 0.0 107.659 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -56.58 -54.57 44.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.013 0.925 . . . . 0.0 112.553 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 31' ' ' VAL . 14.3 tp -58.15 -54.04 51.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.895 1.278 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.26 -39.79 83.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.484 1.514 . . . . 0.0 111.477 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.2 m -68.77 -45.38 71.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 120.687 -1.258 . . . . 0.0 112.005 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -38.28 90.46 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 124.452 1.101 . . . . 0.0 110.039 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.76 -56.69 11.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.776 0.831 . . . . 0.0 108.933 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.9 m -68.03 -26.07 65.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.992 0.517 . . . . 0.0 111.938 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.93 -2.25 39.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.895 1.678 . . . . 0.0 112.616 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.67 23.37 68.85 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 125.421 1.486 . . . . 0.0 113.464 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.616 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -72.41 -35.35 68.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 108.841 171.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 t -134.95 136.92 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -114.67 156.71 24.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.331 1.053 . . . . 0.0 111.207 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.3 mm -83.31 129.55 37.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 119.182 0.901 . . . . 0.0 109.656 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.28 124.15 6.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.258 1.023 . . . . 0.0 111.192 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.61 152.58 38.42 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.832 1.253 . . . . 0.0 109.636 166.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.55 166.83 28.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.782 3.654 . . . . 0.0 114.02 -171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -75.39 158.69 32.35 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.94 0.876 . . . . 0.0 111.395 162.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -44.15 95.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.576 1.151 . . . . 0.0 110.352 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.53 -32.8 71.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.591 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -48.17 74.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.383 0.673 . . . . 0.0 110.417 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -50.73 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -59.3 -32.31 69.93 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.136 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -45.63 80.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.667 1.121 . . . . 0.0 110.492 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.9 OUTLIER -64.61 -45.41 95.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -54.01 -38.1 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.512 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -64.93 -59.18 4.46 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.899 1.227 . . . . 0.0 109.207 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.12 -33.55 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.828 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -63.64 -48.51 76.99 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.123 1.369 . . . . 0.0 110.807 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -27.53 68.38 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 121.194 -0.941 . . . . 0.0 110.645 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -70.26 -37.06 74.82 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.187 0.903 . . . . 0.0 111.844 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' ALA . 7.5 t -87.26 -14.95 39.54 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.851 1.205 . . . . 0.0 112.714 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.37 -59.73 0.6 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 125.057 1.313 . . . . 0.0 112.807 165.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -75.67 92.65 2.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.68 -43.79 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 123.53 0.732 . . . . 0.0 112.764 -171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.56 7.34 6.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.064 0.546 . . . . 0.0 110.149 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -69.91 -3.77 17.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.028 1.331 . . . . 0.0 112.088 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.55 150.81 21.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.58 1.552 . . . . 0.0 108.972 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -69.94 157.83 36.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.744 0.783 . . . . 0.0 110.92 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -64.63 -50.88 65.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.171 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.61 -42.29 55.82 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.788 0.835 . . . . 0.0 111.453 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -59.08 5.18 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.824 1.65 . . . . 0.0 109.827 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.8 mt -58.93 -44.86 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.78 1.232 . . . . 0.0 108.856 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -60.26 -52.64 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.609 1.563 . . . . 0.0 111.524 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.74 -54.26 37.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.257 1.023 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 96' ' ' ILE . 57.7 mt -58.23 -51.85 68.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.866 0.867 . . . . 0.0 109.419 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.78 -52.76 22.17 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 112.218 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -50.91 68.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 123.494 0.496 . . . . 0.0 110.028 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.91 -31.45 70.95 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 9.6 m-30 -69.39 -33.86 73.65 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.613 0.642 . . . . 0.0 110.558 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.71 -31.71 72.86 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.483 0.583 . . . . 0.0 112.53 173.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.1 mt -89.06 -15.83 33.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.651 1.181 . . . . 0.0 110.94 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.71 24.2 1.62 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.647 1.979 . . . . 0.0 112.65 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.52 -102.21 0.87 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.079 0.847 . . . . 0.0 111.786 -169.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -153.48 166.28 33.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.202 1.001 . . . . 0.0 110.515 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 86' ' ' LEU . 48.4 mt -135.43 156.67 38.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.539 1.536 . . . . 0.0 107.379 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 124.68 30.72 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.867 1.267 . . . . 0.0 107.878 164.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.0 t -163.28 175.28 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.373 1.069 . . . . 0.0 110.54 165.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -147.34 63.21 1.16 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.554 1.142 . . . . 0.0 112.8 175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -123.0 157.95 31.57 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.384 1.074 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -72.79 -45.06 60.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.566 -171.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -70.8 -47.19 60.8 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.377 1.071 . . . . 0.0 110.784 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -55.02 -41.66 60.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.436 1.016 . . . . 0.0 109.354 -175.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.67 -43.51 96.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.61 0.764 . . . . 0.0 110.139 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 51.6 t30 -64.69 -53.76 42.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.754 0.821 . . . . 0.0 110.027 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.51 -55.15 16.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 123.951 0.901 . . . . 0.0 109.112 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.49 65.66 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.47 1.486 . . . . 0.0 113.565 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 t -57.5 -63.25 1.3 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.528 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -64.5 -21.24 66.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.852 1.66 . . . . 0.0 113.036 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.605 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mm? -85.47 -6.25 59.21 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.292 1.037 . . . . 0.0 112.522 175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.48 9.15 84.54 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.881 -1.511 . . . . 0.0 113.988 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.86 120.62 32.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.09 1.945 . . . . 0.0 111.418 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 134.95 57.59 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.95 1.3 . . . . 0.0 109.892 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -147.81 170.88 16.67 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 122.885 0.474 . . . . 0.0 110.262 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.2 mtt-85 -109.42 154.38 22.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 124.548 1.139 . . . . 0.0 109.647 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -144.54 -174.32 4.29 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.965 0.791 . . . . 0.0 109.41 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 20' ' ' ILE . 2.4 mm? -104.37 169.14 8.65 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.271 1.029 . . . . 0.0 112.073 -159.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -82.52 76.05 9.4 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -116.32 175.66 5.45 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 146.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.24 -52.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.324 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.483 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.4 mm -147.21 141.39 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.467 1.907 . . . . 0.0 106.52 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -130.24 -7.18 4.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.727 1.211 . . . . 0.0 112.002 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -161.19 -32.17 0.05 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.85 1.204 . . . . 0.0 111.949 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 177.78 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 126.308 1.843 . . . . 0.0 110.157 -175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 mp -131.63 177.8 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 126.544 1.938 . . . . 0.0 107.159 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.67 175.29 8.35 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.212 -1.555 . . . . 0.0 109.672 158.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -156.69 166.37 33.6 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.38 1.472 . . . . 0.0 108.853 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -159.13 14.53 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -141.53 150.5 42.23 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.008 1.276 . . . . 0.0 110.42 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.44 129.33 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.413 1.085 . . . . 0.0 108.262 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.07 153.37 30.03 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 165.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.79 88.32 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 122.804 1.288 . . . . 0.0 109.374 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.2 -75.01 0.13 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 p -93.75 -3.91 51.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.094 0.958 . . . . 0.0 113.031 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.66 26.59 72.06 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 125.707 1.622 . . . . 0.0 114.106 170.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -66.09 136.14 55.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.291 0.636 . . . . 0.0 109.506 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.8 141.03 31.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.489 1.116 . . . . 0.0 108.162 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -136.03 152.7 51.17 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 p -94.65 -17.82 21.91 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.74 -0.6 . . . . 0.0 111.726 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 45.4 p -128.02 169.21 14.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.514 1.126 . . . . 0.0 108.989 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.13 119.74 72.76 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.56 172.31 9.43 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 121.919 1.746 . . . . 0.0 110.269 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.46 138.19 83.24 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.032 1.821 . . . . 0.0 110.597 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.07 -5.34 1.34 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.56 1.076 . . . . 0.0 113.926 -171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.34 51.1 38.24 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-O 117.41 -1.772 . . . . 0.0 110.626 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.3 m -126.62 158.51 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 118.853 1.326 . . . . 0.0 108.065 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 35.2 t -77.78 111.95 21.37 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 125.216 1.406 . . . . 0.0 111.835 -167.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 44.0 Cg_endo -64.48 23.26 0.07 OUTLIER 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.97 3.113 . . . . 0.0 115.231 167.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.82 -18.04 0.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.412 1.485 . . . . 0.0 113.336 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.83 -2.34 0.29 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.99 -17.8 5.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.856 1.217 . . . . 0.0 114.618 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 m -62.53 162.0 11.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.413 1.606 . . . . 0.0 112.901 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -61.64 155.92 21.26 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.62 -0.675 . . . . 0.0 110.771 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.5 t -114.34 144.41 21.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -133.79 164.18 27.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.196 1.398 . . . . 0.0 110.357 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.8 tt -78.91 155.37 29.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.537 1.135 . . . . 0.0 110.218 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.94 165.35 34.06 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.372 2.269 . . . . 0.0 110.943 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 178.72 6.65 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.062 2.508 . . . . 0.0 112.657 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.2 mmt-85 -42.99 152.31 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.002 2.121 . . . . 0.0 112.358 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -59.73 -53.11 61.8 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.137 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.836 -176.038 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtp . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.13 120.63 22.57 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -156.64 100.86 1.96 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -146.06 179.2 7.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 69.6 -172.9 0.18 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.101 1.76 . . . . 0.0 113.219 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -138.53 -174.8 3.92 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.458 1.503 . . . . 0.0 109.973 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -49.37 155.59 0.71 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.431 0.693 . . . . 0.0 111.853 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -51.62 124.89 13.28 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.788 1.235 . . . . 0.0 108.598 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 tp -149.4 142.72 25.18 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.382 1.873 . . . . 0.0 106.494 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.06 150.52 19.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.15 150.66 37.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.709 1.604 . . . . 0.0 108.591 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.82 161.12 13.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.004 0.522 . . . . 0.0 111.736 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.569 ' HB2' HG21 ' A' ' 30' ' ' VAL . 29.1 t -37.14 -55.31 0.97 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.857 2.463 . . . . 0.0 112.158 164.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.4 m -56.62 -28.01 59.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.227 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' ILE . 21.0 t -63.42 -45.36 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.662 1.119 . . . . 0.0 109.43 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.36 -33.51 71.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.576 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.68 -41.62 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.051 0.941 . . . . 0.0 110.446 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -75.65 -30.26 59.4 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.977 -0.452 . . . . 0.0 110.485 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.04 29.42 15.22 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 124.975 1.274 . . . . 0.0 111.187 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.5 mt -74.5 110.06 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.19 121.22 9.56 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.411 1.484 . . . . 0.0 109.178 171.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 23' ' ' GLU . 8.3 tp -158.83 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.755 2.022 . . . . 0.0 109.669 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' H ' HG13 ' A' ' 22' ' ' ILE . 1.7 mp0 -135.77 159.19 42.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 108.99 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.41 -134.13 5.37 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 120.795 1.634 . . . . 0.0 114.376 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -129.0 154.99 46.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.6 1.96 . . . . 0.0 109.351 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -141.6 153.89 45.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.901 0.88 . . . . 0.0 109.604 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.4 p -86.89 118.22 69.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.904 0.882 . . . . 0.0 110.455 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.88 -27.85 74.43 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.098 1.199 . . . . 0.0 110.794 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -71.88 -24.11 61.61 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 13' ' ' SER . 7.4 p -86.44 -31.12 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 121.33 1.877 . . . . 0.0 109.326 166.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.0 t -58.71 -22.1 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 119.211 0.914 . . . . 0.0 111.043 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.75 -14.9 16.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.629 -1.294 . . . . 0.0 112.746 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.53 -30.56 7.58 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.534 -1.354 . . . . 0.0 112.411 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -55.29 111.8 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 120.099 1.318 . . . . 0.0 110.399 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -12.81 6.96 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.113 1.365 . . . . 0.0 112.615 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.99 122.69 17.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.8 mtt-85 -52.72 -49.68 64.92 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.169 0.988 . . . . 0.0 110.366 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.69 -52.74 64.2 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.265 0.978 . . . . 0.0 109.098 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.1 t -53.8 -49.14 68.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -65.18 -53.9 37.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.675 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.15 -54.1 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.495 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 33.2 t80 -57.26 -49.22 76.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.263 1.025 . . . . 0.0 111.103 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.7 tp -50.49 -60.77 2.67 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 109.98 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.63 78.78 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.302 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.9 m -57.37 -49.66 75.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.471 1.108 . . . . 0.0 110.654 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 26.2 mt -63.2 -41.98 99.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.785 0.434 . . . . 0.0 110.228 -177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.59 -50.35 67.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 p -64.09 -33.93 76.88 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.4 -0.333 . . . . 0.0 111.132 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.592 0.757 . . . . 0.0 110.058 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.99 16.5 6.76 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 124.18 0.895 . . . . 0.0 112.276 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -86.29 -27.54 24.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.374 1.087 . . . . 0.0 110.803 -173.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.95 148.97 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -129.66 146.41 51.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.415 1.086 . . . . 0.0 112.01 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.7 mm -76.47 125.79 36.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.214 1.806 . . . . 0.0 108.119 -175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.5 118.53 5.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.263 1.025 . . . . 0.0 109.928 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -86.26 155.13 57.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.373 -0.829 . . . . 0.0 110.027 163.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.41 163.52 36.24 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 124.605 3.537 . . . . 0.0 111.301 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -83.94 166.7 17.61 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.741 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -57.73 -50.42 73.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.185 1.394 . . . . 0.0 110.628 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.2 -27.6 67.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.51 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.14 -51.13 49.5 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.609 0.764 . . . . 0.0 109.404 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.8 mm -59.64 -46.78 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.965 . . . . 0.0 109.744 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.34 -34.42 68.75 Favored 'General case' 0 C--O 1.231 0.106 0 O-C-N 122.081 -0.387 . . . . 0.0 111.721 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -44.52 86.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.819 0.448 . . . . 0.0 110.945 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.95 -36.31 75.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.36 -47.7 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.01 -45.14 86.74 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.412 1.005 . . . . 0.0 111.728 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.985 HG11 HD21 ' A' ' 110' ' ' LEU . 9.9 p -69.43 -40.42 79.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 O-C-N 121.164 -0.96 . . . . 0.0 110.379 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.06 89.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -27.37 58.95 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.256 -0.903 . . . . 0.0 111.382 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.71 -13.52 62.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.792 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 t -125.19 -15.79 6.17 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.992 1.724 . . . . 0.0 114.964 -174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.37 -90.14 0.15 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.109 1.322 . . . . 0.0 110.786 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -77.16 58.11 1.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.581 1.953 . . . . 0.0 113.212 -161.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.5 p -45.45 -37.75 2.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.82 1.648 . . . . 0.0 114.944 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -128.79 11.1 6.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.09 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.04 -9.46 59.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.703 0.683 . . . . 0.0 111.989 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.92 144.3 27.02 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 m -67.62 161.47 25.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.245 1.021 . . . . 0.0 111.034 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 ttpp -61.26 -55.58 30.29 Favored 'General case' 0 CA--C 1.517 -0.288 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.327 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.34 -37.99 68.16 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 123.888 0.742 . . . . 0.0 110.386 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -61.96 -53.95 48.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.569 0.748 . . . . 0.0 109.027 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 95.2 mt -54.55 -43.7 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.238 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -63.21 -54.98 28.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.13 0.972 . . . . 0.0 112.238 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.0 t -59.18 -49.52 83.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 109.799 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 HD13 ' A' ' 96' ' ' ILE . 94.9 mt -61.04 -49.42 77.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -53.33 -53.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.79 0.836 . . . . 0.0 111.806 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.1 tp -51.09 -52.65 41.43 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.655 0.782 . . . . 0.0 109.82 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.23 69.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.514 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.6 m-30 -84.61 -18.43 35.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.131 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.01 -37.17 75.58 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.74 1.155 . . . . 0.0 109.229 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 -17.58 45.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.034 1.334 . . . . 0.0 112.474 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.17 46.65 5.18 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.066 2.146 . . . . 0.0 110.753 -169.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.53 -114.69 3.97 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.383 0.516 . . . . 0.0 112.113 -167.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -144.44 164.21 31.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.07 1.748 . . . . 0.0 106.409 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.519 HD13 HD23 ' A' ' 86' ' ' LEU . 80.0 mt -136.6 155.95 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.83 116.85 15.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -156.27 -173.37 4.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.536 0.734 . . . . 0.0 109.947 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.405 ' OD2' ' HE2' ' A' ' 118' ' ' LYS . 26.5 t0 -144.53 -13.75 0.58 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.3 160.59 32.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.616 1.553 . . . . 0.0 114.684 -168.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -62.53 -46.09 90.0 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 119.929 -1.732 . . . . 0.0 110.936 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -72.16 -53.97 11.1 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -41.63 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.879 0.872 . . . . 0.0 111.318 -168.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.66 -38.88 64.81 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.933 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' O ' HD23 ' A' ' 109' ' ' LEU . 15.2 t30 -66.86 -51.13 59.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 117.531 -1.223 . . . . 0.0 108.055 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -48.16 -59.3 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 109.461 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.44 63.75 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.841 1.655 . . . . 0.0 112.681 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -65.28 -53.32 45.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.277 -1.344 . . . . 0.0 112.719 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -61.98 -35.69 79.26 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 121.518 1.963 . . . . 0.0 109.962 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.985 HD21 HG11 ' A' ' 68' ' ' VAL . 2.3 mm? -71.11 -19.38 62.45 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.37 14.87 79.55 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.201 -1.333 . . . . 0.0 113.502 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -72.68 163.81 27.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.138 1.469 . . . . 0.0 109.213 176.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.562 ' H ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -105.68 128.81 53.88 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -151.18 -176.39 5.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 122.204 0.202 . . . . 0.0 110.762 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -119.79 154.37 34.34 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.559 1.544 . . . . 0.0 109.663 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.4 p -143.27 111.58 6.23 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -160.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.27 -60.14 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HE2' ' OD2' ' A' ' 99' ' ' ASP . 52.3 mtmt -85.15 -158.34 0.36 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.632 2.773 . . . . 0.0 109.611 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -76.78 175.42 9.44 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.165 -0.959 . . . . 0.0 109.501 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.04 101.15 1.91 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.685 1.136 . . . . 0.0 110.46 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.9 80.5 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.336 1.455 . . . . 0.0 111.186 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -64.6 -50.9 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.935 1.294 . . . . 0.0 111.18 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -130.63 29.82 4.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 108.879 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.9 t -135.28 176.23 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 127.036 2.135 . . . . 0.0 106.435 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.88 147.42 22.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 O-C-N 120.527 -1.358 . . . . 0.0 108.355 -168.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.94 102.71 0.38 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -59.54 161.61 5.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.762 0.825 . . . . 0.0 110.582 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -156.0 14.78 0.34 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -136.03 147.36 47.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.772 1.169 . . . . 0.0 110.831 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.11 134.73 47.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.755 1.222 . . . . 0.0 108.329 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 129.66 40.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.121 0.968 . . . . 0.0 108.416 165.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 pt -84.03 111.14 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 160.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 143.84 -93.66 0.17 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 106.543 -2.623 . . . . 0.0 106.543 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 3.6 p -76.34 -13.74 60.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.212 0.605 . . . . 0.0 111.952 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.87 73.84 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 124.69 1.138 . . . . 0.0 115.305 171.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -68.81 129.75 40.82 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 110.631 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -71.42 147.13 48.2 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.375 1.07 . . . . 0.0 110.198 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -139.89 156.04 46.89 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.145 0.978 . . . . 0.0 109.553 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 p -97.54 -24.83 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.235 0.614 . . . . 0.0 112.053 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.91 129.85 5.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -158.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.82 123.24 80.98 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 126.099 1.76 . . . . 0.0 110.43 -168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.3 171.75 17.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.61 3.54 . . . . 0.0 113.121 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.54 87.76 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.429 3.419 . . . . 0.0 110.505 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.27 -28.77 2.67 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 126.363 1.935 . . . . 0.0 111.113 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.72 32.05 61.31 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 121.462 -1.022 . . . . 0.0 112.275 -168.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.03 178.54 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 126.179 1.791 . . . . 0.0 107.906 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.9 t -83.21 103.97 3.23 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.304 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.63 -2.5 0.72 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.072 1.848 . . . . 0.0 114.589 169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.77 -31.5 13.17 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 124.826 1.25 . . . . 0.0 112.682 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.8 -35.98 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.815 0.846 . . . . 0.0 113.069 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 113.22 -15.91 22.69 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 127.143 2.306 . . . . 0.0 113.599 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.1 m -67.77 169.86 8.92 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.765 1.782 . . . . 0.0 113.178 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -74.13 142.45 45.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.372 1.069 . . . . 0.0 111.536 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.17 147.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.718 1.607 . . . . 0.0 106.763 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -122.89 160.81 25.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.632 1.173 . . . . 0.0 108.807 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.02 151.56 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.75 153.0 50.62 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.116 1.366 . . . . 0.0 110.584 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.97 91.35 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.404 2.736 . . . . 0.0 112.59 -171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 52.09 -162.49 0.08 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.134 1.373 . . . . 0.0 110.635 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -127.73 -84.69 0.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.554 1.07 . . . . 0.0 109.337 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-O 115.482 -2.199 . . . . 0.0 109.829 -163.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.3 mt -75.36 65.53 1.67 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.593 1.157 . . . . 0.0 110.963 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -144.3 172.0 13.54 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.196 1.799 . . . . 0.0 108.139 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -150.13 117.48 6.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tp -162.91 153.73 16.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 165.95 14.16 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.447 1.099 . . . . 0.0 112.152 171.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -63.17 170.43 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.883 0.873 . . . . 0.0 111.442 161.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -53.76 129.16 32.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.349 1.06 . . . . 0.0 110.372 -172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.1 tp -149.74 149.44 30.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 151.07 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.94 158.61 26.37 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.655 1.582 . . . . 0.0 109.007 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -118.62 169.28 9.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.306 1.442 . . . . 0.0 111.295 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 p -55.52 -46.74 77.0 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.966 1.306 . . . . 0.0 112.459 -174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -27.06 62.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.806 -1.092 . . . . 0.0 112.526 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.96 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.503 1.501 . . . . 0.0 109.109 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CD2' HD12 ' A' ' 43' ' ' LEU . 38.2 m-85 -72.4 -33.0 66.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.406 0.682 . . . . 0.0 111.23 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.25 -49.63 83.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.924 0.889 . . . . 0.0 109.722 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -71.69 -13.73 61.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.297 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.55 22.8 57.76 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.582 0.611 . . . . 0.0 113.346 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 117' ' ' LEU . 36.2 mt -77.77 107.51 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.08 108.4 1.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 171.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -154.22 154.96 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -98.89 164.15 12.32 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 126.431 1.892 . . . . 0.0 111.15 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.71 -139.39 9.34 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-O 121.28 0.378 . . . . 0.0 112.255 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -125.83 151.32 46.96 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.961 1.305 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 t -135.89 147.08 48.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.396 0.678 . . . . 0.0 109.301 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.01 114.09 48.12 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.484 1.914 . . . . 0.0 111.025 -171.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.67 -20.99 45.08 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.002 1.802 . . . . 0.0 113.801 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -87.9 -12.95 43.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.16 -38.01 10.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 120.667 1.576 . . . . 0.0 108.154 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.97 -20.54 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.633 0.773 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.09 -24.16 38.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.539 1.135 . . . . 0.0 113.101 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.52 7.12 10.58 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.322 0.964 . . . . 0.0 112.7 -173.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 mt -74.72 88.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -10.75 45.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.651 1.98 . . . . 0.0 112.686 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -73.7 124.52 26.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -67.82 -43.84 78.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 117.693 -1.146 . . . . 0.0 111.634 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -57.15 -55.43 34.9 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -55.57 -52.48 63.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.711 0.804 . . . . 0.0 111.208 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -58.69 -56.7 18.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.178 0.991 . . . . 0.0 110.076 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.08 -53.93 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 30.7 t80 -56.01 -49.69 72.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.404 0.682 . . . . 0.0 111.341 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' CD2' ' A' ' 16' ' ' PHE . 6.7 tt -54.98 -56.29 21.38 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.541 1.136 . . . . 0.0 110.066 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.32 -38.66 87.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.832 0.453 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.3 m -58.77 -41.64 87.1 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.837 0.855 . . . . 0.0 111.259 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.512 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 11.6 mt -64.35 -43.14 95.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 118.826 0.739 . . . . 0.0 110.629 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.32 -52.08 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.9 m -61.78 -32.13 72.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.427 1.091 . . . . 0.0 111.65 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.06 -48.08 69.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.648 1.179 . . . . 0.0 110.836 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.16 -16.45 3.43 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 123.703 0.668 . . . . 0.0 113.343 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -71.85 -34.95 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.612 0.706 . . . . 0.0 110.774 -160.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.01 162.29 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.44 141.03 33.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.981 0.912 . . . . 0.0 108.853 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mm -69.43 124.68 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.887 0.875 . . . . 0.0 109.748 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.42 136.02 17.06 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.35 160.13 28.31 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.857 0.863 . . . . 0.0 112.177 171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.74 -177.03 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.674 3.583 . . . . 0.0 112.575 168.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 t -122.02 166.81 13.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.76 1.224 . . . . 0.0 109.748 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' C ' ' HE2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -56.17 -49.53 73.75 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.303 1.041 . . . . 0.0 110.311 -173.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.13 -22.42 62.07 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.724 -0.61 . . . . 0.0 112.061 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -50.75 66.83 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.7 mm -59.09 -49.6 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.04 0.936 . . . . 0.0 108.67 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -27.88 67.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.118 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -48.84 79.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.319 1.418 . . . . 0.0 110.612 173.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -64.82 -33.04 60.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.78 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 121.417 -0.802 . . . . 0.0 109.696 170.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -57.28 -49.62 75.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.861 1.21 . . . . 0.0 110.582 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.921 HG11 HD21 ' A' ' 110' ' ' LEU . 5.2 p -72.2 -41.27 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 121.87 -0.519 . . . . 0.0 110.632 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.36 -25.22 61.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.836 -0.54 . . . . 0.0 111.076 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 -25.98 41.54 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.245 0.929 . . . . 0.0 110.335 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.18 -5.61 5.21 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.284 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.266 10.8 t -127.56 -58.79 1.24 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 120.123 1.329 . . . . 0.0 111.365 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.43 -21.57 0.64 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 120.348 1.431 . . . . 0.0 115.585 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.48 20.32 0.43 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.094 1.447 . . . . 0.0 112.384 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -33.36 -57.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 128.044 2.538 . . . . 0.0 115.864 -163.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -121.58 11.47 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.846 0.859 . . . . 0.0 109.794 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -61.31 -34.98 76.12 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.069 0.948 . . . . 0.0 109.82 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -64.88 149.75 48.98 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.42 1.088 . . . . 0.0 111.86 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -51.66 133.42 30.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.888 1.275 . . . . 0.0 108.633 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -44.86 84.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.842 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.53 60.68 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.1 0.56 . . . . 0.0 111.48 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.12 -50.0 73.66 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.184 1.394 . . . . 0.0 108.812 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.9 mt -53.42 -45.77 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.642 0.777 . . . . 0.0 109.252 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -67.48 -44.25 78.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.208 1.403 . . . . 0.0 111.787 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.84 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.389 1.075 . . . . 0.0 108.895 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 HD13 ' A' ' 96' ' ' ILE . 75.7 mt -59.19 -53.29 59.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.36 1.064 . . . . 0.0 109.295 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.36 -51.04 61.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.455 1.502 . . . . 0.0 111.825 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.1 tp -51.57 -56.05 15.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.03 86.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.253 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.1 m-30 -66.35 -33.69 76.3 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.956 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 -42.76 83.31 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.43 1.014 . . . . 0.0 109.495 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.92 -18.28 50.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.361 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt 53.99 26.38 6.31 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.48 1.112 . . . . 0.0 111.116 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.46 -159.36 27.96 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 127.654 2.55 . . . . 0.0 113.13 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.11 173.62 7.32 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 110.232 165.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.558 HD13 HD23 ' A' ' 86' ' ' LEU . 41.7 mt -129.13 163.47 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.292 2.237 . . . . 0.0 108.002 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.57 115.89 11.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.166 2.187 . . . . 0.0 106.984 165.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 t -158.37 177.96 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.906 1.283 . . . . 0.0 109.673 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -150.62 23.59 0.79 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.823 -1.173 . . . . 0.0 113.335 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 4.0 t0 -87.84 156.14 19.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.792 -1.192 . . . . 0.0 109.59 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -64.39 -47.77 77.95 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.034 1.288 . . . . 0.0 109.654 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -66.69 -53.27 35.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.258 1.423 . . . . 0.0 110.544 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.4 p -54.3 -41.81 54.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.03 1.287 . . . . 0.0 110.316 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 114' ' ' PHE . 62.2 mt-30 -69.6 -36.5 76.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.073 0.949 . . . . 0.0 110.843 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.444 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.1 t-20 -69.02 -55.25 11.39 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.432 HG13 HD21 ' A' ' 78' ' ' LEU . 9.7 mm -49.59 -60.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 C-N-CA 125.094 1.358 . . . . 0.0 109.49 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.13 -33.0 56.76 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.076 1.307 . . . . 0.0 112.163 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -48.13 75.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.974 -1.489 . . . . 0.0 113.705 172.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -65.89 -33.03 74.9 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 122.609 2.459 . . . . 0.0 110.631 174.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.921 HD21 HG11 ' A' ' 68' ' ' VAL . 1.1 mm? -75.5 -3.89 36.65 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.902 1.281 . . . . 0.0 113.032 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.03 -2.72 8.06 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.208 1.385 . . . . 0.0 115.226 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -74.06 127.86 34.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 120.14 1.97 . . . . 0.0 110.319 -167.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 129.52 39.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 104' ' ' GLN . 32.7 p90 -134.68 -179.37 5.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.637 0.256 . . . . 0.0 111.15 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.02 152.79 32.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.339 1.856 . . . . 0.0 107.993 171.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 172.0 16.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 20' ' ' ILE . 4.5 mm? -69.45 166.54 18.54 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.505 0.722 . . . . 0.0 109.878 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -50.48 137.71 18.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.874 1.27 . . . . 0.0 109.326 169.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 177.43 163.48 0.55 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.658 1.983 . . . . 0.0 108.128 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.82 -80.92 0.25 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 166.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.1 pt -153.97 172.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.966 1.706 . . . . 0.0 110.93 -172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -131.14 98.57 4.61 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.5 tttt 74.74 -22.03 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.741 2.416 . . . . 0.0 114.342 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.48 67.84 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.897 1.279 . . . . 0.0 111.716 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.8 mt -55.07 147.37 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 O-C-N 120.816 -1.177 . . . . 0.0 110.028 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -49.78 132.22 22.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.34 1.456 . . . . 0.0 109.16 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 4.0 p-90 -125.62 139.2 53.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.598 0.561 . . . . 0.0 110.357 -168.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -140.65 12.18 2.29 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.92 140.69 45.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 120.532 1.515 . . . . 0.0 111.675 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -120.29 139.43 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.929 2.092 . . . . 0.0 109.577 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 4.4 t -81.97 119.98 24.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 161.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.22 127.24 31.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 157.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 134.85 -81.8 0.3 Allowed Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 106.714 -2.555 . . . . 0.0 106.714 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.6 p -80.75 -19.48 44.86 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.351 -0.5 . . . . 0.0 110.73 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.22 18.54 62.47 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 121.398 -0.813 . . . . 0.0 113.766 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 ttm-85 -84.75 162.0 19.79 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.611 1.564 . . . . 0.0 111.109 -165.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -112.29 142.1 45.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.592 1.157 . . . . 0.0 110.481 -164.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -143.82 155.35 44.1 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.614 1.165 . . . . 0.0 109.784 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 1.8 p -104.88 -13.26 15.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.642 0.777 . . . . 0.0 112.977 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.7 p -147.07 175.61 10.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.893 2.477 . . . . 0.0 106.671 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.9 tp -80.19 133.65 56.98 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.3 170.51 20.18 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.612 2.208 . . . . 0.0 109.222 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -56.18 134.78 66.31 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.71 1.607 . . . . 0.0 109.632 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.07 -13.64 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.047 0.832 . . . . 0.0 113.901 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.06 27.89 71.21 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.264 1.532 . . . . 0.0 114.004 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 156.11 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.299 1.44 . . . . 0.0 107.597 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.62 117.88 51.84 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.97 -18.33 60.79 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 121.146 1.231 . . . . 0.0 113.246 171.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -81.69 -46.1 14.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.026 -1.046 . . . . 0.0 109.4 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.0 p -136.1 -1.5 2.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.66 0.784 . . . . 0.0 113.059 -159.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.15 -11.49 16.04 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.64 1.59 . . . . 0.0 114.624 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.2 m -75.7 163.91 26.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.483 1.142 . . . . 0.0 113.246 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -68.74 148.01 50.97 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.011 -1.055 . . . . 0.0 111.511 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 t -108.39 148.66 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.86 161.46 42.62 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.7 1.2 . . . . 0.0 108.335 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.0 151.71 23.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.708 . . . . 0.0 110.595 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -114.97 153.39 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 124.336 1.054 . . . . 0.0 110.925 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.32 103.13 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.969 2.446 . . . . 0.0 111.239 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 59.05 174.2 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.504 2.722 . . . . 0.0 111.519 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -56.3 -27.8 56.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.571 1.148 . . . . 0.0 112.052 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 129.941 3.296 . . . . 0.0 110.982 -173.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.97 98.96 11.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.287 0.949 . . . . 0.0 109.138 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -135.01 -24.38 1.46 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 111.887 168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -95.66 21.97 7.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.425 1.09 . . . . 0.0 109.594 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.52 167.09 23.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.028 1.731 . . . . 0.0 107.992 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -122.1 -166.8 1.45 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.274 1.43 . . . . 0.0 109.693 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -57.01 155.56 8.02 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.93 0.332 . . . . 0.0 111.5 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -48.63 118.07 2.34 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.547 1.939 . . . . 0.0 109.03 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 tp -140.79 139.2 34.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.713 2.005 . . . . 0.0 107.667 -173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.7 153.49 15.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -135.58 145.65 47.17 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.219 1.808 . . . . 0.0 107.567 -167.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -110.0 166.48 10.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.507 . . . . 0.0 111.743 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 t -46.21 -46.78 17.78 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.247 1.819 . . . . 0.0 109.414 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.489 ' HB3' HD11 ' A' ' 117' ' ' LEU . 73.7 m -50.25 -34.94 24.89 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.617 1.167 . . . . 0.0 113.829 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 t -65.36 -43.79 94.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 119.209 0.913 . . . . 0.0 108.975 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.36 -36.59 71.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.964 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.51 -38.91 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.035 0.934 . . . . 0.0 110.667 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -83.2 -23.26 32.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.19 0.905 . . . . 0.0 112.825 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.23 24.04 27.83 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 118.88 0.764 . . . . 0.0 112.486 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 mt -77.28 106.9 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.11 103.93 1.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.858 1.263 . . . . 0.0 108.467 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 tp -151.86 130.09 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -73.75 136.51 43.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.757 1.623 . . . . 0.0 110.815 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.26 -161.61 34.17 Favored Glycine 0 CA--C 1.521 0.453 0 O-C-N 120.721 -1.237 . . . . 0.0 112.101 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -123.28 151.24 42.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.481 0.712 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -142.89 152.5 42.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.565 1.146 . . . . 0.0 110.162 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.9 p -84.32 126.43 69.47 Favored Pre-proline 0 C--O 1.249 1.055 0 C-N-CA 123.192 0.597 . . . . 0.0 111.037 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -59.01 -30.16 92.63 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 120.409 0.739 . . . . 0.0 111.093 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 m -61.82 -43.95 97.83 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.697 1.135 . . . . 0.0 113.56 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.89 -38.2 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG23 HD13 ' A' ' 43' ' ' LEU . 4.5 p -64.09 -26.54 40.73 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.02 -1.072 . . . . 0.0 112.123 -173.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.37 -28.73 69.97 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.995 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -89.64 -22.89 22.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.748 1.219 . . . . 0.0 111.401 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.11 133.47 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.531 1.158 . . . . 0.0 108.471 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -3.2 0.61 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.878 1.671 . . . . 0.0 112.098 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -70.56 120.35 16.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.9 mtm-85 -66.19 -40.5 90.48 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.552 -170.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.45 -57.01 14.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.0 t -52.37 -54.66 28.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.385 1.474 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -58.65 -57.84 11.21 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 124.068 0.947 . . . . 0.0 111.37 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.6 -49.38 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 43.8 t80 -59.48 -44.54 93.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.726 0.694 . . . . 0.0 112.493 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.511 HD13 HG23 ' A' ' 31' ' ' VAL . 5.2 tt -58.38 -56.12 26.21 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.327 1.051 . . . . 0.0 108.81 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.51 -40.68 87.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.511 0.725 . . . . 0.0 109.868 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -53.06 -48.41 67.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.161 1.384 . . . . 0.0 110.45 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.515 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 12.6 mt -62.81 -42.45 99.72 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.83 0.741 . . . . 0.0 111.424 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.37 -46.52 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 t -58.63 -44.48 90.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 109.991 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.14 99.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.353 1.461 . . . . 0.0 110.015 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.18 2.25 7.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 124.643 1.116 . . . . 0.0 113.887 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.1 -37.38 17.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 117.894 0.847 . . . . 0.0 109.932 -164.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -120.08 153.6 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -140.66 141.06 35.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.617 0.767 . . . . 0.0 110.643 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -66.39 134.07 30.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.52 126.59 9.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.501 1.12 . . . . 0.0 109.225 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 151.08 48.08 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.069 0.948 . . . . 0.0 111.335 170.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.89 -175.76 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 124.572 3.514 . . . . 0.0 110.548 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -125.63 161.43 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.448 2.299 . . . . 0.0 108.241 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -58.99 -40.42 84.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.299 -0.875 . . . . 0.0 110.436 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.21 -33.67 71.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.4 p -75.51 -35.49 60.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.265 0.939 . . . . 0.0 109.862 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.07 -50.11 80.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.44 -37.01 72.13 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.774 0.43 . . . . 0.0 111.059 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -42.67 65.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 111.026 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.684 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.0 mm -67.08 -48.6 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.05 -39.34 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.877 0.871 . . . . 0.0 110.28 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -54.8 -63.49 1.14 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.836 0.854 . . . . 0.0 109.974 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.89 -30.9 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -67.04 -47.18 72.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.42 -0.8 . . . . 0.0 110.791 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.18 67.54 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 120.817 -1.177 . . . . 0.0 110.659 173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -72.26 0.81 8.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.372 1.069 . . . . 0.0 112.514 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.272 2.9 t -121.05 -49.6 2.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.868 1.213 . . . . 0.0 109.51 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.3 -58.0 0.29 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.132 0.878 . . . . 0.0 112.499 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -69.62 39.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.399 2.68 . . . . 0.0 114.686 -171.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 10.7 p -39.77 -49.46 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.127 2.171 . . . . 0.0 115.062 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.8 28.19 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.176 0.99 . . . . 0.0 108.655 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.1 -28.35 63.24 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.632 -1.292 . . . . 0.0 110.4 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 160.26 30.75 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 t -66.51 154.56 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.303 0.573 . . . . 0.0 109.974 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 13.8 ttpt -63.49 -51.49 65.36 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.771 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.27 -45.55 45.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.227 0.954 . . . . 0.0 109.439 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.17 -54.04 51.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.437 0.695 . . . . 0.0 111.447 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.17 -41.36 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.495 1.118 . . . . 0.0 109.645 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.44 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 47.5 mt-10 -65.5 -44.9 85.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.394 1.078 . . . . 0.0 111.548 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.1 -48.41 83.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 119.1 0.863 . . . . 0.0 109.816 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.633 HD23 HD13 ' A' ' 96' ' ' ILE . 42.0 mt -60.99 -48.97 79.38 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.558 0.743 . . . . 0.0 109.756 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.684 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.31 -57.79 6.23 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.948 1.299 . . . . 0.0 110.917 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.8 tp -47.62 -52.35 18.22 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.474 0.71 . . . . 0.0 110.36 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.58 70.8 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.9 m-30 -80.81 -29.55 35.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.505 0.593 . . . . 0.0 111.131 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.31 -42.68 91.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.877 0.846 . . . . 0.0 109.217 169.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.95 -14.52 44.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 112.894 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 43.2 55.36 4.67 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.328 1.451 . . . . 0.0 110.394 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -135.61 8.8 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-O 121.856 0.698 . . . . 0.0 111.465 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -129.47 170.19 14.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.633 HD13 HD23 ' A' ' 86' ' ' LEU . 74.3 mt -131.52 156.03 42.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.64 118.39 18.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.035 1.334 . . . . 0.0 108.256 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 6.8 t -166.37 -170.08 1.57 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.646 1.578 . . . . 0.0 108.997 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -150.62 10.85 0.66 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 161.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -53.39 150.83 6.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.368 1.467 . . . . 0.0 114.727 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -63.19 -30.78 71.86 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.473 -1.392 . . . . 0.0 112.263 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.15 -56.12 4.45 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.751 1.62 . . . . 0.0 110.215 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 1.8 p -52.69 -41.29 37.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 119.92 1.236 . . . . 0.0 112.664 -169.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -64.66 -46.69 81.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.407 ' O ' HD23 ' A' ' 109' ' ' LEU . 1.4 t-20 -64.08 -52.81 57.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 117.425 -1.274 . . . . 0.0 107.784 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.5 mm -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 119.604 1.093 . . . . 0.0 110.328 -175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.55 68.61 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.668 1.122 . . . . 0.0 112.153 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.18 -39.12 78.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.957 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -64.27 -44.55 91.39 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 122.437 2.38 . . . . 0.0 107.721 170.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.3 mm? -69.02 -29.12 67.23 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -167.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.53 18.65 37.67 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 117.999 -1.445 . . . . 0.0 112.766 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.01 127.82 38.66 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.02 1.41 . . . . 0.0 110.627 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.56 128.93 38.2 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.284 1.833 . . . . 0.0 109.585 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.86 179.62 6.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.626 0.77 . . . . 0.0 111.092 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -123.37 133.09 54.15 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.422 1.489 . . . . 0.0 108.834 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 p -82.89 146.66 28.74 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.62 1.168 . . . . 0.0 108.775 170.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 14' ' ' SER . 70.3 mt -54.83 -59.11 5.17 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.781 1.232 . . . . 0.0 111.181 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 22.25 -110.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.578 2.751 . . . . 0.0 113.637 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.4 7.04 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 114.058 -166.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.76 -95.18 1.79 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 120.209 -1.557 . . . . 0.0 110.747 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.4 mt -143.67 156.07 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 127.29 2.236 . . . . 0.0 107.391 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.79 -30.11 2.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -165.5 37.96 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.119 1.368 . . . . 0.0 108.959 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.82 90.52 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 125' ' ' ILE . 3.3 mp -56.28 144.62 7.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -44.62 107.49 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.138 1.775 . . . . 0.0 109.938 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -75.25 151.53 38.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -147.43 0.49 0.69 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.336 -1.316 . . . . 0.0 113.952 -158.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -142.33 135.39 28.63 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.937 0.789 . . . . 0.0 108.984 -170.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.53 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.082 0.953 . . . . 0.0 108.66 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.6 127.89 33.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.736 0.814 . . . . 0.0 108.813 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.14 -9.67 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.62 -15.14 27.88 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.938 -0.923 . . . . 0.0 113.826 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 13.8 p -147.24 2.66 0.77 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.59 1.195 . . . . 0.0 113.075 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.88 64.57 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 125.702 1.62 . . . . 0.0 115.039 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 54.1 ttt-85 -72.08 145.81 47.97 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 117.681 0.741 . . . . 0.0 110.464 -167.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -93.54 145.62 24.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.647 -169.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -141.85 148.82 39.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.989 1.316 . . . . 0.0 108.223 170.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 p -98.74 -15.3 19.39 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.523 -0.736 . . . . 0.0 111.739 168.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.5 p -137.6 152.53 49.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 124.708 1.203 . . . . 0.0 108.601 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -64.75 120.05 62.86 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 113.475 -1.693 . . . . 0.0 106.717 174.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 141' ' ' LEU . 92.0 Cg_endo -69.69 169.09 19.65 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.023 2.482 . . . . 0.0 109.121 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -55.5 134.21 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.656 1.571 . . . . 0.0 109.599 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.84 -10.61 8.77 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.515 -1.158 . . . . 0.0 114.226 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.01 38.22 93.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.969 1.885 . . . . 0.0 112.624 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.01 163.09 32.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.538 1.135 . . . . 0.0 109.28 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 3.9 t -72.99 113.32 20.6 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 110.179 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 36.4 Cg_endo -62.68 -12.35 28.11 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.775 0.955 . . . . 0.0 111.86 163.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.27 -22.65 18.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.334 1.454 . . . . 0.0 111.895 -175.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.4 p -156.17 5.31 0.18 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.07 -11.04 2.15 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.714 2.102 . . . . 0.0 116.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 168.61 10.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.312 1.556 . . . . 0.0 112.41 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -77.98 144.96 36.31 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 t -94.3 158.92 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -140.47 167.31 22.46 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.013 -1.679 . . . . 0.0 109.123 169.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.14 154.46 26.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.239 1.016 . . . . 0.0 109.673 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.6 pt -121.85 155.38 60.52 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.21 1.404 . . . . 0.0 112.42 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.85 102.99 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.665 1 C-N-CA 125.434 4.089 . . . . 0.0 112.664 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 61.03 -71.29 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 127.21 2.204 . . . . 0.0 112.196 -173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.39 -46.43 0.08 Allowed 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 124.429 1.092 . . . . 0.0 111.88 -177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.894 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.2 mt -130.66 139.33 50.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.488 1.494 . . . . 0.0 110.697 -167.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.2 mtm-85 -142.32 100.55 3.73 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.05 1.74 . . . . 0.0 107.969 -165.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -135.19 -178.13 4.96 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.623 1.169 . . . . 0.0 107.899 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.66 177.94 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.012 1.725 . . . . 0.0 110.683 -171.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -103.9 -178.08 3.56 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.08 -1.012 . . . . 0.0 109.551 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -55.3 156.48 4.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.26 1.024 . . . . 0.0 110.235 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -48.24 128.34 14.07 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.261 1.824 . . . . 0.0 110.808 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -153.62 144.71 22.88 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.677 0.791 . . . . 0.0 110.212 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.36 147.53 30.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.557 0.743 . . . . 0.0 110.012 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 HD21 ' A' ' 9' ' ' LEU . 1.3 mm? -122.75 129.48 51.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.593 1.957 . . . . 0.0 109.682 -174.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -84.23 165.35 18.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.601 0.76 . . . . 0.0 109.134 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 30' ' ' VAL . 26.2 t -46.63 -45.26 18.97 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.393 1.877 . . . . 0.0 110.265 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -49.86 -34.23 19.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.781 1.632 . . . . 0.0 111.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.5 -39.59 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.441 1.096 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.14 -24.93 47.19 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.2 1.0 . . . . 0.0 111.238 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.57 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.679 0.791 . . . . 0.0 109.075 171.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.79 -23.7 36.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.745 0.702 . . . . 0.0 112.389 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.19 18.88 52.4 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.433 1.016 . . . . 0.0 113.167 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.44 112.89 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.045 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -62.49 106.63 0.79 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 109.133 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.4 tp -155.08 149.22 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' HD22 ' A' ' 9' ' ' LEU . 5.8 pt-20 -111.45 120.61 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.066 1.346 . . . . 0.0 109.316 -166.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.614 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.09 -161.08 29.38 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.339 0.972 . . . . 0.0 113.57 -171.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.2 150.04 21.34 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.4 -0.471 . . . . 0.0 112.003 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -132.38 147.91 52.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.12 2.168 . . . . 0.0 108.514 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 115.98 62.39 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 126.554 1.941 . . . . 0.0 107.632 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.83 -33.85 72.86 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.454 1.436 . . . . 0.0 110.273 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.23 -36.37 41.4 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.905 3.282 . . . . 0.0 114.432 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 13' ' ' SER . 14.8 p -98.75 -32.09 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.264 0.938 . . . . 0.0 110.572 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.78 -32.71 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.968 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -28.61 10.01 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -89.85 -23.39 21.68 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 117.745 -1.121 . . . . 0.0 111.508 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.264 5.5 mt -62.7 85.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.655 1.582 . . . . 0.0 110.113 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.33 -11.5 57.61 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 129.115 2.966 . . . . 0.0 110.966 174.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 124.2 26.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.11 -45.42 70.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 121.671 -0.643 . . . . 0.0 110.332 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -53.27 -48.99 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.296 1.038 . . . . 0.0 108.39 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m -68.76 -49.82 55.57 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.79 0.836 . . . . 0.0 111.842 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -59.97 -55.63 31.71 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.834 0.454 . . . . 0.0 110.51 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.2 mt -55.05 -49.16 73.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -55.47 -57.8 10.42 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 111.613 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tp -51.26 -52.85 41.09 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.118 1.767 . . . . 0.0 110.844 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.5 -37.44 87.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.648 0.779 . . . . 0.0 110.044 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.9 m -62.82 -43.02 99.9 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.727 0.694 . . . . 0.0 110.198 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -39.42 86.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.42 -44.9 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.327 -0.858 . . . . 0.0 108.717 170.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 t -64.5 -3.74 3.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 112.891 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.58 3.03 13.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.974 1.709 . . . . 0.0 111.566 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.03 87.2 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.827 1.68 . . . . 0.0 112.878 173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -86.11 -28.41 24.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.891 0.846 . . . . 0.0 111.442 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 74.3 t -119.64 142.4 35.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 14.2 ttmm -143.95 145.25 32.12 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.351 0.66 . . . . 0.0 112.252 -168.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.9 120.48 35.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.007 1.323 . . . . 0.0 109.482 -168.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.31 128.88 12.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.432 1.493 . . . . 0.0 110.171 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -106.07 157.0 35.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.967 1.307 . . . . 0.0 112.322 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.95 157.21 62.82 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.789 2.993 . . . . 0.0 113.332 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -84.68 162.06 19.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.347 165.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -51.28 -42.9 61.43 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.365 1.066 . . . . 0.0 111.806 169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.46 -27.06 68.24 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.548 0.739 . . . . 0.0 110.736 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -72.11 -47.53 50.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.168 1.387 . . . . 0.0 110.121 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 mm -58.97 -47.33 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.54 -41.19 53.57 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.043 1.337 . . . . 0.0 110.72 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -48.24 74.52 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.963 1.305 . . . . 0.0 110.182 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -64.73 -48.56 84.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.2 mt -48.86 -45.38 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.427 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.59 -59.14 5.91 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.476 0.71 . . . . 0.0 110.502 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.08 -31.25 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.41 -53.29 20.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.16 1.384 . . . . 0.0 110.897 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -30.02 70.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -66.92 -20.46 65.91 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.393 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 t -124.41 8.58 8.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.709 1.595 . . . . 0.0 113.146 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.99 -85.36 0.34 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.996 -1.065 . . . . 0.0 112.286 164.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.62 92.48 0.33 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.335 1.054 . . . . 0.0 108.756 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.57 -49.02 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 121.717 -0.615 . . . . 0.0 111.528 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -132.72 17.73 4.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.826 0.85 . . . . 0.0 110.157 -176.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -12.51 61.21 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 120.867 0.365 . . . . 0.0 110.378 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.0 mp -87.29 149.63 24.42 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.392 1.477 . . . . 0.0 108.058 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 m -67.65 161.37 25.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.098 0.559 . . . . 0.0 110.913 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -57.69 -58.46 8.24 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 122.764 0.426 . . . . 0.0 109.99 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.77 -39.46 65.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.671 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -58.66 7.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.86 2.064 . . . . 0.0 109.091 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.15 -44.6 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 126.093 1.757 . . . . 0.0 108.69 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -62.18 -44.9 95.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.108 0.963 . . . . 0.0 111.144 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.3 t -60.08 -53.49 47.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.384 0.538 . . . . 0.0 109.87 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD23 HD13 ' A' ' 96' ' ' ILE . 20.9 mt -58.95 -51.69 68.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.284 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -48.26 -56.56 7.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.359 1.464 . . . . 0.0 112.511 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -46.11 81.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -175.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.5 93.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.564 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.5 m-30 -66.67 -22.12 66.09 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.047 1.294 . . . . 0.0 112.817 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.55 -47.06 74.02 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.93 -20.1 46.47 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 53.9 30.17 11.1 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.171 1.788 . . . . 0.0 113.49 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -84.01 -116.35 0.66 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 125.461 1.505 . . . . 0.0 112.427 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -153.9 159.19 41.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.994 1.718 . . . . 0.0 106.996 -171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.611 HD13 HD23 ' A' ' 86' ' ' LEU . 69.8 mt -126.92 150.35 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.34 120.62 27.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 t -160.16 -166.16 1.63 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.514 1.925 . . . . 0.0 108.61 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.78 11.32 0.66 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.124 1.37 . . . . 0.0 114.008 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 0.8 OUTLIER -104.71 151.27 23.93 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.045 -2.284 . . . . 0.0 113.437 -161.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -56.93 -47.14 81.31 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.447 -1.408 . . . . 0.0 110.914 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -71.52 -52.22 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.523 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -54.71 -41.41 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.32 0.509 . . . . 0.0 110.239 -173.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -67.68 -44.39 77.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.068 0.947 . . . . 0.0 109.832 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -61.99 -56.41 19.41 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -48.85 -55.9 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.545 1.138 . . . . 0.0 110.117 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.64 -34.8 65.26 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.598 1.544 . . . . 0.0 113.689 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 t -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.832 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -60.7 -36.73 79.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.424 1.011 . . . . 0.0 109.938 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.2 mm? -72.25 -14.56 61.81 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.626 0.37 . . . . 0.0 111.074 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.49 2.63 84.85 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.864 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -85.4 133.02 34.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.578 1.189 . . . . 0.0 109.68 -168.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.401 ' N ' HD13 ' A' ' 112' ' ' LEU . 22.1 ttt180 -68.07 136.24 53.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.932 0.893 . . . . 0.0 110.616 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -156.75 168.04 28.62 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.749 -0.594 . . . . 0.0 111.454 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -99.06 163.43 12.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.605 1.162 . . . . 0.0 111.641 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.19 130.05 21.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.95 166.77 22.89 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.601 0.715 . . . . 0.0 110.367 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt 60.99 -177.0 0.11 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.365 1.866 . . . . 0.0 111.221 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.39 169.95 16.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.261 -0.899 . . . . 0.0 110.569 170.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.08 -163.64 50.86 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.1 -6.83 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -167.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 52.88 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.012 2.125 . . . . 0.0 112.616 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -121.93 -6.46 9.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.242 1.383 . . . . 0.0 113.227 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.6 t -69.93 163.04 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.4 mt -99.53 172.53 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -56.35 160.75 2.9 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 120.593 -1.317 . . . . 0.0 110.479 158.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.436 ' CH2' HD13 ' A' ' 157' ' ' ILE . 16.0 p-90 -129.11 155.57 45.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -153.62 8.68 0.39 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 118.393 -0.813 . . . . 0.0 112.923 -153.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -151.06 151.03 31.42 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 119.087 0.858 . . . . 0.0 110.508 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.63 139.08 49.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.211 1.404 . . . . 0.0 109.995 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 126.08 28.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.196 0.998 . . . . 0.0 108.56 159.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.67 121.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 156.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.08 4.29 Favored Glycine 0 N--CA 1.464 0.502 0 C-N-CA 123.905 0.764 . . . . 0.0 112.962 161.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.51 9.48 2.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.751 1.62 . . . . 0.0 111.817 171.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.31 14.56 57.16 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 126.955 2.217 . . . . 0.0 115.892 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -68.82 127.39 32.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.972 0.886 . . . . 0.0 108.892 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -71.04 146.46 49.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.973 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -139.35 154.77 47.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 165.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -103.38 -20.66 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.331 0.653 . . . . 0.0 111.695 176.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 59.0 p -136.04 155.24 50.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.33 127.92 77.24 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.06 171.17 14.16 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.99 2.46 . . . . 0.0 111.49 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.8 148.22 57.15 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.339 2.026 . . . . 0.0 109.721 163.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.16 -22.81 0.2 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.483 1.992 . . . . 0.0 113.532 -165.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.92 38.28 96.32 Favored Glycine 0 C--N 1.335 0.528 0 O-C-N 120.982 -1.305 . . . . 0.0 110.159 -158.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.2 m -125.01 154.41 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.595 0.758 . . . . 0.0 110.075 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 49.4 t -74.97 110.92 11.24 Favored Pre-proline 0 N--CA 1.448 -0.553 0 C-N-CA 125.365 1.466 . . . . 0.0 110.877 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 20.0 Cg_endo -60.72 -2.71 2.22 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.424 2.082 . . . . 0.0 115.543 171.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -105.6 -26.35 11.89 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.018 0.927 . . . . 0.0 113.231 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -142.15 -12.82 0.83 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 67.09 65.7 2.66 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.973 1.273 . . . . 0.0 112.146 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.07 173.82 11.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.002 1.721 . . . . 0.0 108.495 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -64.45 142.48 58.4 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.172 0.989 . . . . 0.0 111.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.37 145.62 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.192 1.397 . . . . 0.0 107.428 169.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.15 158.74 43.74 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.965 1.257 . . . . 0.0 112.209 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.69 111.26 6.83 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 110.392 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.436 HD13 ' CH2' ' A' ' 127' ' ' TRP . 1.1 pt -71.07 163.59 64.08 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 125.827 1.651 . . . . 0.0 112.365 164.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.93 123.67 10.62 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.093 1.862 . . . . 0.0 109.938 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 36.51 -99.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 128.374 2.67 . . . . 0.0 112.483 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 -34.43 0.77 Allowed 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.041 1.336 . . . . 0.0 112.831 172.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 . . . . . 0 C--O 1.245 0.845 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -176.579 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.92 165.48 26.41 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 111.08 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.01 -38.16 0.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.303 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -142.27 -42.4 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.942 166.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt 40.77 74.38 0.1 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.901 2.08 . . . . 0.0 111.153 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 156.26 21.58 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 176.39 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -45.51 127.89 7.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.028 0.931 . . . . 0.0 111.598 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 tp -153.72 147.36 25.17 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.194 1.798 . . . . 0.0 107.454 -174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -122.08 150.75 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.46 139.26 53.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.969 1.708 . . . . 0.0 108.377 -173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -91.33 158.84 16.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.095 0.958 . . . . 0.0 111.64 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -29.36 -57.85 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.397 2.279 . . . . 0.0 113.219 163.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.7 p -60.11 -28.95 68.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.136 1.774 . . . . 0.0 112.52 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.68 -42.08 94.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -69.91 -34.77 73.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.413 0.685 . . . . 0.0 111.211 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.7 mt -57.09 -47.58 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 110.14 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.98 -24.9 52.24 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.883 0.765 . . . . 0.0 111.922 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.31 31.62 13.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 123.289 0.471 . . . . 0.0 112.068 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -76.86 102.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.46 115.2 1.98 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 tp -161.88 170.84 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 126.552 1.941 . . . . 0.0 106.412 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.83 152.33 48.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 0.0 109.002 -158.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.0 -130.8 3.72 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 -168.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.23 152.33 48.21 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.367 1.067 . . . . 0.0 111.003 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -128.66 143.12 50.88 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.556 1.542 . . . . 0.0 107.664 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.55 117.33 67.9 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.79 1.636 . . . . 0.0 108.198 -167.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 31' ' ' VAL . 23.7 Cg_endo -60.81 -32.04 92.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.261 1.974 . . . . 0.0 111.185 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.2 m -68.49 -19.58 64.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.118 -0.989 . . . . 0.0 113.14 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.516 HG22 ' HB1' ' A' ' 81' ' ' ALA . 20.6 t -83.84 -51.3 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.036 0.935 . . . . 0.0 108.522 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.1 p -59.08 -28.03 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-N 118.822 0.737 . . . . 0.0 111.197 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -66.58 -14.81 62.85 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.81 -28.83 12.21 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.298 0.954 . . . . 0.0 111.734 169.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mt -53.88 128.23 13.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 -27.1 2.26 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 126.628 1.971 . . . . 0.0 110.55 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.31 124.94 24.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -75.33 -30.7 60.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.797 -1.097 . . . . 0.0 112.08 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -60.74 -37.16 80.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 120.184 1.356 . . . . 0.0 110.481 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -69.99 -58.98 3.2 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.439 0.695 . . . . 0.0 109.685 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -58.27 -55.43 35.04 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.785 0.834 . . . . 0.0 111.879 -170.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.9 mt -54.01 -52.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.039 0.936 . . . . 0.0 108.632 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 59.6 t80 -55.27 -52.68 62.64 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.584 0.754 . . . . 0.0 110.652 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 46' ' ' LEU . 6.4 tt -51.42 -56.87 10.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.878 1.671 . . . . 0.0 110.409 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.14 -36.24 81.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.473 0.709 . . . . 0.0 111.421 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 m -64.27 -42.6 96.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.476 1.11 . . . . 0.0 109.843 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.618 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 9.7 mt -65.22 -43.14 92.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.371 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.54 -52.97 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m -63.61 -25.32 68.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.301 0.64 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.6 -2.6 58.36 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.157 1.783 . . . . 0.0 113.649 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.93 26.16 60.87 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 118.445 0.566 . . . . 0.0 112.111 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -89.95 -52.7 4.83 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.86 162.37 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 C-N-CA 124.676 1.191 . . . . 0.0 108.708 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -133.4 156.29 47.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.3 mm -69.65 133.93 31.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 118.935 0.789 . . . . 0.0 108.949 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.41 128.15 6.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.86 0.464 . . . . 0.0 110.692 162.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.7 156.15 45.16 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.431 0.692 . . . . 0.0 110.428 165.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.11 168.2 16.31 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.868 3.046 . . . . 0.0 111.645 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t -86.84 163.26 17.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 164.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -50.42 -45.58 55.8 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.03 0.932 . . . . 0.0 111.53 169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.35 -18.8 63.83 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -40.84 35.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.797 0.839 . . . . 0.0 110.593 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.24 -49.71 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -56.4 -32.13 64.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.103 0.961 . . . . 0.0 111.392 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -50.93 71.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.591 1.156 . . . . 0.0 110.181 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.836 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.74 -42.2 95.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -53.23 -41.4 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.584 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -65.17 -50.93 64.06 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.107 1.321 . . . . 0.0 110.926 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 109' ' ' LEU . 2.4 t -75.85 -34.19 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.81 -50.48 73.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.538 1.135 . . . . 0.0 110.605 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.6 71.66 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.654 -1.279 . . . . 0.0 110.755 174.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.67 -32.98 74.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.255 0.934 . . . . 0.0 109.873 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.5 t -93.16 -16.72 24.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 131.02 -78.3 0.38 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.69 86.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.965 1.306 . . . . 0.0 110.727 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 p -75.63 -41.69 41.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 120.824 -1.173 . . . . 0.0 112.297 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -135.6 20.41 3.33 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.221 1.408 . . . . 0.0 109.192 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -70.83 -19.36 62.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.9 -1.125 . . . . 0.0 110.699 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -83.03 153.24 25.03 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.052 0.941 . . . . 0.0 110.115 -178.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -58.88 147.94 32.02 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 111.305 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' HE3' ' OE1' ' A' ' 84' ' ' GLU . 27.2 ttpt -55.67 -53.0 61.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.808 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -61.33 -34.95 76.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 124.137 0.898 . . . . 0.0 110.212 -172.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.1 -55.23 31.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.34 1.056 . . . . 0.0 109.06 176.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -52.44 -45.21 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.968 0.907 . . . . 0.0 108.938 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE1' ' HE3' ' A' ' 80' ' ' LYS . 61.9 mt-10 -64.6 -46.21 83.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 0.0 112.23 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.09 -54.69 31.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.559 1.143 . . . . 0.0 109.496 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.409 HD23 HD13 ' A' ' 96' ' ' ILE . 26.7 mt -57.66 -47.51 82.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.945 0.898 . . . . 0.0 109.258 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.75 -56.13 17.8 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.175 1.39 . . . . 0.0 111.955 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.32 -48.41 74.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.779 0.675 . . . . 0.0 109.737 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -60.93 -21.88 63.85 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.54 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.44 -22.99 21.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 117.81 -1.09 . . . . 0.0 111.858 175.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -61.24 -41.93 97.73 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.714 1.143 . . . . 0.0 109.78 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -109.99 10.66 24.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.303 1.041 . . . . 0.0 111.0 -171.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 45.66 49.73 11.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.255 1.822 . . . . 0.0 110.107 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.83 -123.74 4.77 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 124.35 0.976 . . . . 0.0 111.178 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -144.7 168.15 20.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.586 1.954 . . . . 0.0 106.893 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.409 HD13 HD23 ' A' ' 86' ' ' LEU . 30.9 mt -134.16 157.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -136.8 107.07 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 108.437 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.3 t -166.12 172.25 11.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.274 1.43 . . . . 0.0 109.582 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -145.27 4.34 1.06 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -57.11 158.21 5.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.867 1.667 . . . . 0.0 112.821 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -61.67 -45.04 95.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.424 -1.423 . . . . 0.0 110.825 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -72.04 -48.41 44.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.524 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.05 -39.27 81.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 119.058 0.845 . . . . 0.0 110.787 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.29 -47.86 72.26 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 109' ' ' LEU . 44.3 t30 -60.07 -58.25 9.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.955 -1.021 . . . . 0.0 108.934 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mm -49.05 -54.52 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.659 1.184 . . . . 0.0 110.224 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.15 65.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.349 1.431 . . . . 0.0 113.129 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -52.15 58.47 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.212 1.405 . . . . 0.0 112.403 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -68.34 -21.7 64.72 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.722 1.601 . . . . 0.0 111.893 178.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.54 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -83.56 -10.63 58.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.752 1.221 . . . . 0.0 112.366 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.81 8.11 84.27 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.326 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.43 143.78 34.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.776 1.788 . . . . 0.0 109.779 -175.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.25 136.84 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.956 1.302 . . . . 0.0 108.371 174.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -146.6 -172.19 3.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.38 161.02 25.55 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 125.089 1.355 . . . . 0.0 110.392 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.5 p -137.86 151.77 48.39 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.447 1.099 . . . . 0.0 108.862 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.4 mp -76.89 138.51 39.79 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.256 1.422 . . . . 0.0 108.842 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 24.92 70.13 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.311 2.644 . . . . 0.0 112.025 177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 175.8 8.34 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.276 -0.89 . . . . 0.0 111.969 -165.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.31 -81.11 1.5 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 124' ' ' VAL . 3.2 pt -127.71 17.27 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.895 0.878 . . . . 0.0 112.513 -171.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 42.54 0.71 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.956 2.102 . . . . 0.0 112.791 -175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt 46.06 78.15 0.07 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.071 1.748 . . . . 0.0 111.524 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 121' ' ' ILE . 1.9 p -139.2 38.38 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.02 121.13 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -68.95 120.53 14.97 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -74.89 150.73 39.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.44 0.296 . . . . 0.0 110.559 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -148.25 17.55 1.07 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 117.693 -1.146 . . . . 0.0 113.068 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.95 141.12 47.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 120.339 1.427 . . . . 0.0 110.236 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.39 134.24 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 124.917 1.287 . . . . 0.0 108.506 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.78 118.45 11.03 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 7.3 pt -71.69 124.14 27.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.74 -86.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.4 p -74.2 -18.44 60.76 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.755 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.14 62.38 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 123.416 0.531 . . . . 0.0 112.775 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.7 ttt85 -74.27 145.35 44.08 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.511 1.124 . . . . 0.0 110.079 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -90.12 145.62 24.91 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 109.176 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.7 149.27 43.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.704 0.802 . . . . 0.0 108.843 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 p -97.29 -13.25 22.07 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.988 0.915 . . . . 0.0 111.997 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 18.4 p -146.11 165.35 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.757 1.623 . . . . 0.0 107.523 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp -77.34 128.7 79.73 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.12 169.96 16.9 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.528 2.152 . . . . 0.0 111.108 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.62 127.34 20.46 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.696 2.264 . . . . 0.0 109.876 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.42 -8.19 42.18 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.707 0.67 . . . . 0.0 113.395 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.01 54.21 32.63 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 118.461 1.131 . . . . 0.0 112.045 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.08 160.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.56 114.9 14.74 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.8 -14.16 41.34 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 119.739 0.942 . . . . 0.0 112.435 170.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.09 -12.4 17.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.79 2.036 . . . . 0.0 112.683 -168.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.5 p -156.19 3.76 0.17 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.82 -16.5 5.26 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.637 1.589 . . . . 0.0 114.745 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.2 m -69.88 161.18 30.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 118.686 1.243 . . . . 0.0 112.701 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -68.35 144.18 54.88 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.69 -1.256 . . . . 0.0 110.01 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.56 143.74 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.08 154.83 51.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.68 1.127 . . . . 0.0 111.052 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.46 134.75 48.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.271 1.028 . . . . 0.0 108.959 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -101.5 159.08 30.48 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 124.268 1.027 . . . . 0.0 109.638 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.72 62.8 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.366 2.711 . . . . 0.0 110.937 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 64.77 176.35 0.19 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.43 1.892 . . . . 0.0 112.14 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -75.44 -55.16 5.96 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.24 -1.838 . . . . 0.0 106.428 178.788 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.86 -64.44 0.94 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 63.02 -44.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.159 2.584 . . . . 0.0 112.008 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -69.53 -161.69 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.462 2.705 . . . . 0.0 109.349 161.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.28 81.65 0.03 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.962 2.505 . . . . 0.0 113.185 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 7' ' ' LYS . 6.6 ptmt -62.59 -172.19 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 122.233 1.016 . . . . 0.0 110.904 168.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' O ' ' HE2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -55.86 167.18 0.61 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 176.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -54.96 122.94 11.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.793 1.237 . . . . 0.0 109.777 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.649 HD21 HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.74 147.89 36.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.394 1.478 . . . . 0.0 107.499 -177.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.77 152.88 29.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.727 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.649 HD11 HD21 ' A' ' 9' ' ' LEU . 1.6 mm? -125.27 150.59 46.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.552 1.941 . . . . 0.0 108.907 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.62 174.5 5.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.9 p -49.57 -43.81 46.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.652 1.181 . . . . 0.0 113.424 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 t -57.25 -39.3 75.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.757 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 t -54.4 -43.93 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.246 1.018 . . . . 0.0 110.138 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -76.78 -25.92 53.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.219 0.608 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.5 mt -69.12 -39.36 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.93 0.786 . . . . 0.0 110.639 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -78.08 -17.85 56.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.524 -0.735 . . . . 0.0 112.105 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.25 63.8 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 123.392 0.52 . . . . 0.0 113.381 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.39 106.87 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.08 118.32 8.99 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.6 tp -157.8 164.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 0.0 107.569 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -137.1 119.3 15.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.724 1.209 . . . . 0.0 111.077 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -179.73 -146.16 6.73 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 127.818 2.627 . . . . 0.0 112.29 -166.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.27 152.06 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.182 1.393 . . . . 0.0 111.69 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 t -121.65 168.32 11.91 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.453 1.901 . . . . 0.0 109.701 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.62 113.96 60.99 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 126.535 1.934 . . . . 0.0 108.048 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -55.57 -35.91 93.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.756 2.304 . . . . 0.0 112.7 -172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.2 m -71.54 -16.97 62.34 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.788 1.235 . . . . 0.0 113.146 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.6 -51.61 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.7 t -56.66 -37.42 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.563 -169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.38 -22.01 66.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.549 1.068 . . . . 0.0 111.805 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -94.47 -10.9 30.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.433 1.47 . . . . 0.0 111.93 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 43' ' ' LEU . 2.7 mt -63.46 116.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 -11.06 5.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.128 0.971 . . . . 0.0 113.073 -166.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -76.78 130.64 37.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 168.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -67.29 -35.5 79.61 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.969 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.74 -52.53 62.25 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.09 1.356 . . . . 0.0 108.685 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.3 -50.84 70.07 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.983 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -58.58 -52.62 64.88 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.468 1.107 . . . . 0.0 111.91 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.3 -52.05 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.527 1.531 . . . . 0.0 109.145 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -64.06 -42.77 96.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.237 0.542 . . . . 0.0 111.476 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' CD1' HD12 ' A' ' 34' ' ' ILE . 7.6 tt -59.27 -48.65 80.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.94 -1.1 . . . . 0.0 110.663 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.8 -32.55 72.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.629 0.772 . . . . 0.0 110.285 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.8 t -50.45 -54.55 21.21 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.93 0.892 . . . . 0.0 108.876 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.65 -31.89 70.24 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.17 -53.47 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.6 t -57.74 -38.2 74.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.312 1.045 . . . . 0.0 111.94 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.52 3.72 17.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 113.063 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.12 21.25 78.47 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.903 -0.943 . . . . 0.0 111.833 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -107.96 -29.82 8.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.155 -175.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.5 96.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.553 1.524 . . . . 0.0 108.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -73.16 155.88 39.18 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.9 mm -82.91 147.84 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.64 125.02 0.58 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.747 2.019 . . . . 0.0 109.795 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.86 158.64 36.05 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 119.497 1.044 . . . . 0.0 112.518 171.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.72 157.51 61.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 124.915 3.743 . . . . 0.0 111.924 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.21 160.72 31.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.907 0.861 . . . . 0.0 110.391 158.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -44.89 79.0 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 109.697 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -61.54 -32.74 72.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.752 0.705 . . . . 0.0 111.119 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.4 m -66.74 -45.02 79.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 109.653 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.7 mm -58.81 -48.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.91 -33.16 70.24 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.018 -0.426 . . . . 0.0 111.208 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -46.41 80.46 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.2 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -62.41 -46.51 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.459 HG23 ' CG2' ' A' ' 75' ' ' VAL . 74.5 mt -54.82 -36.5 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.088 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -66.51 -43.79 84.31 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.278 1.854 . . . . 0.0 111.868 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 109' ' ' LEU . 2.0 t -82.51 -37.28 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.21 99.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.29 1.036 . . . . 0.0 110.664 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -31.67 66.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.322 0.964 . . . . 0.0 112.034 174.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.06 -43.91 98.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.074 0.852 . . . . 0.0 109.938 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -80.43 -51.6 8.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.811 0.732 . . . . 0.0 111.117 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.54 -73.54 0.13 Allowed Glycine 0 C--N 1.341 0.849 0 CA-C-N 120.44 1.473 . . . . 0.0 114.305 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -70.54 91.47 0.78 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.596 0.698 . . . . 0.0 109.364 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 66' ' ' ILE . 5.5 p -74.65 -54.71 13.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -118.84 18.36 13.31 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.538 0.608 . . . . 0.0 111.116 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -68.94 -31.48 70.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 110.693 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -78.2 157.86 29.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.037 0.535 . . . . 0.0 110.04 -172.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 p -65.5 153.82 40.32 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.573 1.178 . . . . 0.0 110.432 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -60.24 -48.87 79.89 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.719 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.06 -41.69 68.45 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.529 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -56.89 -55.95 27.88 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.421 1.105 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.72 -39.84 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 126.048 1.739 . . . . 0.0 110.435 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -61.52 -50.49 72.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.986 1.266 . . . . 0.0 110.984 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.55 -53.29 46.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 123.89 0.876 . . . . 0.0 109.021 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.17 -54.98 38.64 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.887 1.275 . . . . 0.0 108.786 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.79 -52.2 57.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.237 1.415 . . . . 0.0 112.493 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -49.7 74.62 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.92 83.55 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.944 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.612 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.2 m-85 -70.98 -29.84 65.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.41 1.005 . . . . 0.0 111.697 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.75 -43.25 99.29 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.176 0.898 . . . . 0.0 109.297 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.49 -12.47 59.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.845 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm 49.24 34.02 5.75 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.972 1.709 . . . . 0.0 110.609 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.25 -136.72 8.7 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.07 1.795 . . . . 0.0 110.636 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -129.56 161.56 30.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.222 2.209 . . . . 0.0 109.108 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.1 mt -130.06 149.08 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -135.77 122.59 21.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.925 0.89 . . . . 0.0 109.565 174.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 t -161.04 175.89 11.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.324 0.39 . . . . 0.0 111.025 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -147.3 102.96 3.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.458 1.503 . . . . 0.0 109.483 166.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.52 154.35 18.44 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.154 1.381 . . . . 0.0 110.279 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -64.16 -46.43 84.08 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -63.92 -53.76 45.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.691 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.12 -41.27 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.784 0.72 . . . . 0.0 111.186 -171.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 46.3 mt-30 -58.54 -49.64 76.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 108.889 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.64 -55.3 21.11 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.981 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 mm -52.98 -54.81 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 119.141 0.882 . . . . 0.0 110.364 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.84 -33.03 68.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.241 1.382 . . . . 0.0 113.708 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.2 t -57.15 -60.45 3.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.941 -1.028 . . . . 0.0 111.534 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.401 HD12 ' CG1' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -69.6 -17.55 63.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 120.436 1.471 . . . . 0.0 113.075 -175.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.612 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.4 mm? -83.36 -9.28 59.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.616 0.766 . . . . 0.0 112.249 174.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.92 35.42 92.02 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 118.871 -0.961 . . . . 0.0 111.686 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -106.33 122.9 47.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.229 1.014 . . . . 0.0 110.585 172.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.419 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -61.62 113.66 2.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 16.9 p90 -115.24 179.72 3.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 97' ' ' PHE . 66.0 mtt180 -118.1 121.08 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.307 1.443 . . . . 0.0 107.334 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 p -81.67 143.11 32.13 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 117' ' ' LEU . 2.1 mm? -71.55 176.2 4.95 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 163.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt 57.02 94.12 0.03 OUTLIER 'General case' 0 C--N 1.34 0.184 0 C-N-CA 126.554 1.942 . . . . 0.0 109.093 -172.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -54.21 165.99 0.45 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.629 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.0 152.25 13.84 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 122' ' ' LYS 0.281 5.5 mm 66.67 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.547 2.339 . . . . 0.0 110.743 -176.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.622 ' H ' HG22 ' A' ' 121' ' ' ILE . 37.9 mtmt 65.41 17.44 10.97 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.055 1.342 . . . . 0.0 112.603 -159.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -161.67 -56.54 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 123.782 0.833 . . . . 0.0 108.9 158.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 121' ' ' ILE . 11.3 m -71.88 159.51 5.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.548 0.689 . . . . 0.0 110.358 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.97 114.04 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -72.45 131.97 43.27 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -74.58 155.28 38.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.353 1.061 . . . . 0.0 110.164 -175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -151.34 22.45 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.126 0.971 . . . . 0.0 112.343 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -139.52 150.15 44.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 119.876 1.216 . . . . 0.0 111.138 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -141.74 134.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.356 1.062 . . . . 0.0 109.417 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.1 t -65.19 127.2 30.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -76.09 114.02 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.764 0.792 . . . . 0.0 109.308 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.2 -77.71 0.39 Allowed Glycine 0 C--O 1.229 -0.178 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.48 -15.64 62.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.667 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.75 83.91 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.795 1.188 . . . . 0.0 114.341 165.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -69.55 139.87 53.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 124.758 1.223 . . . . 0.0 109.572 -170.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -78.51 147.02 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.7 1.2 . . . . 0.0 109.584 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -139.52 150.88 45.65 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.057 0.943 . . . . 0.0 109.409 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -102.88 -0.47 31.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.303 1.441 . . . . 0.0 112.562 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 p -149.57 167.9 25.03 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.446 2.298 . . . . 0.0 106.828 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.82 123.66 87.51 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 165.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.24 172.73 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.228 1.952 . . . . 0.0 110.358 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -54.6 137.28 73.16 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 121.896 1.731 . . . . 0.0 110.048 169.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.39 -10.15 2.07 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.315 0.96 . . . . 0.0 114.148 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.15 29.21 72.22 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 119.137 1.469 . . . . 0.0 112.393 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.25 161.05 21.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 118.448 1.124 . . . . 0.0 109.289 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 12.7 t -73.54 113.76 25.52 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.376 -1.297 . . . . 0.0 109.33 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.31 -17.41 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.702 1.601 . . . . 0.0 113.52 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.97 -26.2 19.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.539 1.136 . . . . 0.0 111.683 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.9 p -153.63 1.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -167.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.87 -13.16 9.17 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.48 1.514 . . . . 0.0 114.769 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.26 160.05 32.91 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.803 1.302 . . . . 0.0 112.221 -172.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -64.05 138.95 58.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.484 0.659 . . . . 0.0 109.555 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -92.45 144.61 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.01 150.19 52.26 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.336 1.054 . . . . 0.0 110.063 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.94 132.47 47.39 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -99.56 156.42 35.4 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.091 0.556 . . . . 0.0 109.604 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.29 74.92 4.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.177 2.585 . . . . 0.0 110.231 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 63.86 169.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.239 2.216 . . . . 0.0 112.689 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.65 -45.17 87.91 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.721 1.209 . . . . 0.0 111.464 171.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 . . . . . 0 CA--C 1.502 -0.888 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -176.729 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.2 mt -122.57 165.81 15.84 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.304 0.956 . . . . 0.0 111.365 -161.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 145.33 26.51 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.107 0.563 . . . . 0.0 110.474 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -157.86 149.97 22.18 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.173 1.789 . . . . 0.0 107.888 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.75 144.59 13.59 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.58 1.952 . . . . 0.0 108.223 166.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -63.99 163.39 12.29 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.977 0.894 . . . . 0.0 110.444 172.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 12.2 mptt -60.97 157.69 14.9 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.083 0.953 . . . . 0.0 109.181 165.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.7 m -53.04 132.84 38.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 122.279 1.037 . . . . 0.0 110.841 -171.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.2 tp -154.36 144.72 22.13 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.36 146.65 27.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.71 137.84 53.67 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.728 1.611 . . . . 0.0 107.421 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.51 162.04 13.97 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.359 0.412 . . . . 0.0 110.525 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -40.9 -50.1 3.23 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.484 1.914 . . . . 0.0 112.542 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -27.02 68.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.96 -43.66 99.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 120.252 1.387 . . . . 0.0 109.366 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -69.09 -32.49 71.96 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.437 0.695 . . . . 0.0 110.644 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.9 mt -61.38 -45.44 98.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.051 0.54 . . . . 0.0 110.597 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -72.22 -28.22 63.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.266 0.939 . . . . 0.0 111.05 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.72 21.77 22.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.107 0.861 . . . . 0.0 112.416 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.636 ' CD1' HD21 ' A' ' 117' ' ' LEU . 10.4 mt -75.73 114.44 15.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 118.847 1.324 . . . . 0.0 108.0 -174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -73.31 110.23 7.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.154 1.782 . . . . 0.0 107.91 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.79 127.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.135 0.974 . . . . 0.0 109.369 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -70.47 162.62 28.4 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.589 -1.319 . . . . 0.0 111.138 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.14 -147.89 19.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -124.15 156.4 36.76 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.582 1.153 . . . . 0.0 110.21 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -128.05 149.54 50.33 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.155 1.782 . . . . 0.0 107.572 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.1 p -78.65 129.87 72.71 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HA ' HG12 ' A' ' 31' ' ' VAL . 15.9 Cg_endo -61.93 -23.94 76.43 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.212 1.275 . . . . 0.0 111.274 168.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -71.27 -29.94 65.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.96 -37.09 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 119.522 1.055 . . . . 0.0 109.063 174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 28' ' ' PRO . 5.7 p -60.39 -24.27 30.6 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 CA-C-N 119.116 0.871 . . . . 0.0 112.199 -172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -56.67 -28.62 61.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 117.929 0.331 . . . . 0.0 111.374 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.48 -10.39 16.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.827 1.651 . . . . 0.0 111.427 -169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.95 78.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 -21.33 52.84 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.985 0.914 . . . . 0.0 111.597 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.7 121.25 12.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -171.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -58.59 -50.28 74.38 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.666 0.786 . . . . 0.0 110.46 -162.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -55.39 -57.39 12.07 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.348 1.059 . . . . 0.0 109.525 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -58.67 -45.33 89.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.71 1.204 . . . . 0.0 110.663 -174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -64.76 -58.98 4.8 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.072 1.349 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.3 mt -53.37 -47.74 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 124.131 0.972 . . . . 0.0 108.559 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.48 -54.84 42.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.438 0.695 . . . . 0.0 110.661 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 31' ' ' VAL . 5.4 tt -52.64 -54.09 38.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.585 1.154 . . . . 0.0 109.623 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.35 -27.17 68.39 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 121.304 -0.872 . . . . 0.0 111.76 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.7 m -69.03 -47.19 66.03 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.616 0.766 . . . . 0.0 110.065 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.62 88.13 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.151 0.981 . . . . 0.0 111.077 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.8 mt -59.56 -46.65 92.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 118.243 0.474 . . . . 0.0 109.79 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -64.24 -32.58 74.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.7 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.72 -2.47 46.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.578 1.151 . . . . 0.0 112.094 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.74 88.6 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 118.422 -1.21 . . . . 0.0 113.482 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.94 -53.73 51.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.518 1.527 . . . . 0.0 108.176 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -107.12 152.57 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -132.82 156.46 47.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.289 1.036 . . . . 0.0 109.731 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.9 mm -81.1 134.11 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 124.741 1.216 . . . . 0.0 107.736 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.29 127.79 6.48 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.711 1.204 . . . . 0.0 108.593 165.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.41 155.62 51.3 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.2 167.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -65.2 170.48 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.72 2.947 . . . . 0.0 111.993 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.2 t -86.55 153.04 22.12 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 159.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -47.05 -42.35 18.42 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.237 1.415 . . . . 0.0 111.465 161.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -60.57 -45.07 95.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 110.134 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -65.56 -38.39 89.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.061 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.9 mm -61.18 -48.31 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 119.629 1.104 . . . . 0.0 108.666 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' HD12 ' A' ' 66' ' ' ILE . 64.7 m-20 -57.12 -31.95 65.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.042 0.937 . . . . 0.0 111.623 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -41.7 97.13 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.906 0.882 . . . . 0.0 110.694 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -67.39 -48.99 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 63' ' ' ASP . 50.4 mt -52.29 -36.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.899 1.279 . . . . 0.0 110.938 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -61.33 -62.64 1.69 Allowed 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.471 1.032 . . . . 0.0 110.973 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.79 -34.88 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -172.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.52 57.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.4 1.48 . . . . 0.0 110.322 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' N ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -64.87 -20.66 66.54 Favored 'General case' 0 C--N 1.344 0.356 0 O-C-N 120.781 -1.199 . . . . 0.0 112.168 176.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.452 ' N ' ' HE3' ' A' ' 70' ' ' LYS . 30.9 tt0 -81.18 -20.4 41.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.714 0.805 . . . . 0.0 111.558 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.1 t -109.37 -22.56 11.98 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.282 0.947 . . . . 0.0 111.364 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.67 -83.84 0.17 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.151 0.887 . . . . 0.0 112.221 170.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -74.14 91.86 2.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.469 1.108 . . . . 0.0 108.249 -171.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.49 -45.74 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.26 10.18 4.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.783 1.233 . . . . 0.0 109.828 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 8.15 0.92 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.481 0.712 . . . . 0.0 110.93 164.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.33 147.19 27.39 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.259 1.424 . . . . 0.0 108.632 163.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.7 m -70.04 156.4 39.2 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.714 1.245 . . . . 0.0 110.15 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.57 -48.08 82.6 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.746 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.56 56.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.225 0.92 . . . . 0.0 112.19 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -63.15 -56.27 18.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.3 mt -52.25 -43.31 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.402 1.481 . . . . 0.0 109.18 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.37 -52.74 43.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.619 1.568 . . . . 0.0 112.14 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.65 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 119.131 0.878 . . . . 0.0 109.462 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 HD13 ' A' ' 96' ' ' ILE . 45.9 mt -57.67 -56.38 22.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.631 0.772 . . . . 0.0 109.218 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -59.07 3.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.496 1.519 . . . . 0.0 112.023 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -49.62 59.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.865 0.866 . . . . 0.0 109.187 -174.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.27 66.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.618 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -77.73 -30.07 51.49 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.766 1.167 . . . . 0.0 110.507 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -42.45 99.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 168.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.15 -7.13 59.61 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 52.12 24.96 2.97 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.804 1.642 . . . . 0.0 113.109 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 -106.8 2.57 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 119.387 0.994 . . . . 0.0 113.906 -159.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -142.38 166.86 23.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.518 1.927 . . . . 0.0 108.031 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.639 HD13 HD23 ' A' ' 86' ' ' LEU . 82.5 mt -135.21 154.2 35.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.57 121.24 18.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 t -158.14 -170.42 3.13 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.823 2.049 . . . . 0.0 106.907 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -154.66 -4.77 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 122.235 2.288 . . . . 0.0 115.781 163.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -61.35 148.77 40.3 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 121.235 1.834 . . . . 0.0 112.942 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -56.92 -32.61 66.13 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.759 1.624 . . . . 0.0 114.273 -172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.54 -50.85 12.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.43 1.092 . . . . 0.0 110.171 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -42.15 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.494 0.718 . . . . 0.0 110.768 -168.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -67.17 -35.2 79.16 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.029 0.442 . . . . 0.0 110.347 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.5 t30 -65.09 -56.74 11.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 mm -51.68 -55.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.462 1.105 . . . . 0.0 110.018 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.22 68.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.163 1.347 . . . . 0.0 113.164 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 t -60.4 -61.69 2.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.071 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.5 OUTLIER -67.4 -16.56 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.125 1.33 . . . . 0.0 113.212 -175.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -86.81 -22.17 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.88 0.872 . . . . 0.0 112.525 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.93 38.98 89.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 118.474 0.579 . . . . 0.0 112.859 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 125.12 39.79 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 161.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 116.07 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.21 -162.99 1.11 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.174 0.989 . . . . 0.0 110.709 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.0 mtt180 -140.25 162.71 34.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.807 2.443 . . . . 0.0 109.354 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.59 162.18 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.196 2.198 . . . . 0.0 110.35 -172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -93.05 -12.73 29.85 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.157 1.383 . . . . 0.0 112.917 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -38.93 115.33 0.47 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.913 2.085 . . . . 0.0 111.107 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -48.92 137.74 12.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.501 -174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.36 -87.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.171 1.843 . . . . 0.0 113.026 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.4 mt -147.93 145.83 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -137.8 -16.02 1.33 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -162.75 19.03 0.09 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.923 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.9 m -137.9 165.75 25.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 120.352 -1.467 . . . . 0.0 109.599 -162.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.3 mt -75.96 149.3 6.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 71.68 0.66 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 160.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -58.19 154.77 12.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.644 1.577 . . . . 0.0 110.875 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 14.14 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -139.81 135.3 32.86 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.822 1.192 . . . . 0.0 109.984 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.86 131.99 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.89 140.46 58.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 165.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.8 pt -93.29 -11.62 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 118.206 -0.902 . . . . 0.0 113.192 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.73 -20.61 23.81 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 119.621 1.101 . . . . 0.0 113.962 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.7 p -144.8 6.07 1.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.826 1.313 . . . . 0.0 114.16 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.93 12.76 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.596 1.093 . . . . 0.0 115.076 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -68.18 147.37 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.199 1.0 . . . . 0.0 110.723 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -110.79 99.0 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.844 0.858 . . . . 0.0 111.783 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.19 143.63 26.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.859 1.314 . . . . 0.0 109.529 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.5 p -89.22 -19.77 24.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.568 172.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.7 p -145.21 163.14 35.32 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.757 1.623 . . . . 0.0 109.034 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.582 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -73.02 116.63 52.49 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -176.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.582 ' HD2' HD23 ' A' ' 141' ' ' LEU . 89.8 Cg_endo -66.74 169.0 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.468 2.112 . . . . 0.0 110.507 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -55.22 133.07 55.98 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.99 1.794 . . . . 0.0 109.877 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.57 -18.28 3.79 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 118.574 -1.125 . . . . 0.0 113.597 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 63.38 44.31 97.02 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 119.789 1.795 . . . . 0.0 111.538 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.83 158.41 43.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 14.2 t -67.63 110.93 6.16 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -61.55 -14.94 38.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.292 1.328 . . . . 0.0 111.746 171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -12.41 14.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.659 1.984 . . . . 0.0 112.483 -160.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.52 -14.26 0.5 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.19 85.42 0.12 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.6 p -152.02 174.99 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -60.73 151.8 28.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.715 -1.24 . . . . 0.0 109.995 160.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.65 147.66 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 159.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.84 154.07 46.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.393 0.997 . . . . 0.0 111.415 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.06 114.02 14.23 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.584 1.154 . . . . 0.0 108.522 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.39 159.0 68.33 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 118.296 0.498 . . . . 0.0 110.79 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.23 91.57 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.485 2.79 . . . . 0.0 111.695 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 30.65 84.13 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.745 2.418 . . . . 0.0 113.267 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? 72.52 -39.63 0.45 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.857 2.063 . . . . 0.0 114.311 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 116.592 -1.67 . . . . 0.0 110.221 -159.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 58.99 90.42 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.844 2.458 . . . . 0.0 113.201 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.55 169.76 17.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.237 1.015 . . . . 0.0 108.747 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.2 t30 164.79 108.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 128.375 2.67 . . . . 0.0 109.192 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -115.87 169.17 9.43 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.828 1.651 . . . . 0.0 109.258 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 9' ' ' LEU . 0.8 OUTLIER -94.57 177.36 5.95 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.202 1.801 . . . . 0.0 109.981 171.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -57.41 166.41 1.23 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.761 0.824 . . . . 0.0 110.802 159.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -44.79 122.56 3.26 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.509 1.924 . . . . 0.0 110.219 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 ' HB2' ' HE2' ' A' ' 6' ' ' LYS . 19.0 tp -147.3 147.14 30.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 108.013 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 t -116.86 140.33 39.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -108.07 146.8 32.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.875 1.67 . . . . 0.0 107.632 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.2 161.78 13.43 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.14 0.9 . . . . 0.0 112.179 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.475 ' HB2' HG21 ' A' ' 30' ' ' VAL . 12.6 t -43.89 -52.49 6.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 127.801 2.44 . . . . 0.0 111.724 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -60.7 -23.03 64.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.485 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.89 90.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 120.073 1.306 . . . . 0.0 109.456 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -72.37 -36.31 68.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.929 0.891 . . . . 0.0 111.045 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.71 -46.6 93.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 124.313 1.045 . . . . 0.0 109.835 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -75.96 -23.16 55.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.759 0.709 . . . . 0.0 111.116 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.91 41.73 12.07 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mt -81.82 112.49 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.69 98.91 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.448 1.099 . . . . 0.0 109.437 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.5 tp -153.94 164.63 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.105 1.762 . . . . 0.0 107.264 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -131.45 155.11 47.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.02 2.128 . . . . 0.0 108.698 -160.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.74 -149.14 21.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -110.24 161.91 15.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 0.0 110.157 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.0 t -141.84 161.1 38.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.825 1.65 . . . . 0.0 108.098 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 p -96.18 123.11 56.15 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 122.401 0.28 . . . . 0.0 110.889 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.2 -26.39 81.58 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.379 2.053 . . . . 0.0 112.114 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.2 m -62.99 -32.64 74.04 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 126.1 1.76 . . . . 0.0 114.598 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 13' ' ' SER . 12.6 p -94.47 -29.79 4.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.653 1.115 . . . . 0.0 110.369 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.53 -20.02 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 119.868 1.213 . . . . 0.0 111.187 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.57 -29.29 66.27 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.035 -1.666 . . . . 0.0 114.297 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -102.25 -16.23 16.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.454 1.101 . . . . 0.0 111.517 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.91 105.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 124.269 1.028 . . . . 0.0 108.902 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -13.04 7.85 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.461 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -61.82 120.18 10.2 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 mtp-105 -62.02 -32.91 73.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.66 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.72 -63.36 1.17 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.3 p -53.7 -44.74 70.03 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.046 1.338 . . . . 0.0 112.515 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -71.45 -54.15 11.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.154 1.381 . . . . 0.0 110.896 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.1 mt -52.59 -51.98 30.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -54.9 -54.24 45.11 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.204 1.002 . . . . 0.0 112.429 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.33 -51.52 58.3 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.947 1.299 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.23 -34.26 77.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.977 0.911 . . . . 0.0 111.929 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -64.12 -45.44 88.56 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -36.77 78.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.477 0.711 . . . . 0.0 111.635 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.38 -51.71 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -67.48 -19.53 65.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.07 0.85 . . . . 0.0 113.24 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.84 -10.07 51.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.517 1.527 . . . . 0.0 111.892 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.75 -0.69 70.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.729 1.157 . . . . 0.0 113.767 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -87.79 -28.3 21.76 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.192 0.997 . . . . 0.0 111.984 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.92 140.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -128.51 151.58 49.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.568 1.547 . . . . 0.0 108.877 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.8 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.77 132.38 5.03 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 125.106 1.362 . . . . 0.0 108.595 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -92.72 154.95 42.21 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.592 0.757 . . . . 0.0 111.295 170.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.76 173.92 11.14 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.285 3.323 . . . . 0.0 111.7 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -108.76 162.68 13.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.492 1.117 . . . . 0.0 109.696 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tmpt? -53.76 -49.79 67.43 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.937 0.895 . . . . 0.0 111.294 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.65 -27.29 66.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.863 0.465 . . . . 0.0 110.184 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -67.42 -48.34 67.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.531 0.733 . . . . 0.0 109.636 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.6 -45.72 94.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.468 1.107 . . . . 0.0 110.155 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.06 -35.09 74.38 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.88 -0.512 . . . . 0.0 110.62 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -44.89 71.08 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.199 0.6 . . . . 0.0 111.06 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.4 mm -64.37 -45.51 95.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.71 -38.8 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.931 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -63.48 -59.03 5.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.168 1.349 . . . . 0.0 110.813 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 109' ' ' LEU . 3.8 t -73.6 -32.54 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.25 -51.83 67.28 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.248 -0.907 . . . . 0.0 110.173 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -30.83 71.22 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.669 1.122 . . . . 0.0 111.691 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.39 -15.45 48.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.732 1.213 . . . . 0.0 111.712 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -114.31 -28.77 7.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.19 0.905 . . . . 0.0 111.961 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.64 -99.02 0.19 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 119.991 1.269 . . . . 0.0 110.4 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -58.56 96.56 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.267 2.227 . . . . 0.0 108.797 -168.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.98 -44.06 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.483 1.913 . . . . 0.0 110.706 -167.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -123.61 6.71 8.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.281 0.632 . . . . 0.0 110.111 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -70.78 -24.83 62.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.581 0.628 . . . . 0.0 111.528 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.27 158.09 31.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.658 1.183 . . . . 0.0 109.757 -174.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -68.56 154.93 40.94 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.441 0.638 . . . . 0.0 110.75 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -63.01 -53.35 55.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.784 -0.572 . . . . 0.0 109.734 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.59 61.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.779 1.3 . . . . 0.0 109.485 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -59.41 -59.13 5.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.968 1.707 . . . . 0.0 108.455 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -53.75 -40.99 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.771 0.828 . . . . 0.0 110.578 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.35 -43.72 73.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.236 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.72 -49.77 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.573 HD23 HD13 ' A' ' 96' ' ' ILE . 56.5 mt -56.97 -53.58 56.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.757 1.223 . . . . 0.0 108.941 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.598 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.72 -52.86 54.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.046 1.338 . . . . 0.0 111.75 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.3 tp -54.36 -49.82 68.92 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.633 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -64.4 -16.31 62.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.709 0.686 . . . . 0.0 112.638 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.6 m-30 -96.4 -17.48 20.58 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.32 1.048 . . . . 0.0 111.421 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -58.88 -44.57 91.18 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -114.13 -4.77 13.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.155 1.782 . . . . 0.0 111.935 -168.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 53.6 49.12 20.11 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.701 2.001 . . . . 0.0 111.547 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.63 -114.18 2.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.761 1.172 . . . . 0.0 110.437 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -148.58 169.89 19.32 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 107.79 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.573 HD13 HD23 ' A' ' 86' ' ' LEU . 28.7 mt -130.38 163.57 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 0.0 108.194 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 118.57 13.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.92 1.688 . . . . 0.0 107.8 166.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.0 t -175.16 176.82 2.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.183 2.193 . . . . 0.0 109.559 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.62 0.19 0.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -174.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -57.31 162.51 2.71 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.539 1.518 . . . . 0.0 113.911 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -57.69 -52.49 65.21 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.726 -1.234 . . . . 0.0 109.74 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -75.1 -43.32 53.64 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.219 1.007 . . . . 0.0 110.183 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 p -61.57 -47.13 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.74 -37.04 85.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.85 0.46 . . . . 0.0 109.947 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.1 t30 -70.51 -53.32 16.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -49.57 -51.68 14.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.202 1.001 . . . . 0.0 109.443 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.45 -32.63 70.4 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.002 1.274 . . . . 0.0 112.481 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.6 t -65.56 -52.44 52.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.205 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.477 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -63.41 -30.22 71.38 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 121.106 1.775 . . . . 0.0 110.613 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.526 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -79.97 -8.96 59.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.366 1.066 . . . . 0.0 112.891 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.89 59.26 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 118.023 -1.432 . . . . 0.0 115.499 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.11 119.91 26.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 120.511 2.156 . . . . 0.0 110.569 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 148.86 41.06 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.671 1.188 . . . . 0.0 111.244 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.74 176.33 12.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 122.038 -0.414 . . . . 0.0 111.475 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -111.9 150.55 30.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.967 1.307 . . . . 0.0 109.887 172.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p -112.68 158.68 19.73 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.314 1.446 . . . . 0.0 110.17 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.7 mp -77.38 166.68 22.82 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.158 0.983 . . . . 0.0 109.102 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -96.85 1.44 50.61 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 117.601 -1.19 . . . . 0.0 113.812 -169.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -111.69 152.78 27.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 122.424 2.374 . . . . 0.0 111.628 -167.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.71 -168.6 9.38 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 121.887 0.715 . . . . 0.0 111.532 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.4 mt -116.81 149.89 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -130.04 -51.16 1.12 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.759 1.624 . . . . 0.0 108.178 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -139.78 41.4 2.0 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.46 1.104 . . . . 0.0 111.578 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.88 150.55 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -121.23 168.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -63.94 112.63 3.02 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.67 -1.269 . . . . 0.0 108.105 157.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.47 ' CH2' ' HE3' ' A' ' 137' ' ' LYS . 2.4 p-90 -61.77 154.63 25.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 154.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -175.3 13.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -140.91 152.98 45.47 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.148 1.34 . . . . 0.0 111.858 164.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' HD12 ' A' ' 157' ' ' ILE . 9.9 p -131.14 132.84 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.876 1.27 . . . . 0.0 109.132 -176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 128.95 37.43 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 164.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pt -80.39 101.51 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.757 0.708 . . . . 0.0 109.696 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.98 -84.58 0.18 Allowed Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 7.0 p -70.47 -15.26 62.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 117.031 0.416 . . . . 0.0 110.944 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.11 92.79 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.411 1.005 . . . . 0.0 111.826 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -70.94 145.26 50.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' CH2' ' A' ' 127' ' ' TRP . 49.8 mttp -104.95 132.54 51.07 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.133 1.373 . . . . 0.0 107.564 -176.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.29 162.54 25.25 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 109.086 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.5 t -113.52 -13.74 12.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.729 0.412 . . . . 0.0 110.604 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.8 p -142.09 158.49 43.69 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.23 126.1 92.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.03 170.95 17.72 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.285 2.657 . . . . 0.0 111.375 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.65 101.79 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.08 3.186 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.59 28.8 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.76 1.648 . . . . 0.0 111.785 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 65.97 34.24 87.9 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.093 -1.948 . . . . 0.0 113.008 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.07 165.8 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.691 1.996 . . . . 0.0 108.388 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.75 109.72 7.34 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 125.889 1.676 . . . . 0.0 110.036 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.98 -14.9 44.27 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.805 1.323 . . . . 0.0 112.379 167.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -41.06 17.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.006 0.922 . . . . 0.0 110.006 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.48 4.99 2.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.426 1.012 . . . . 0.0 113.573 -163.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.11 -14.63 1.55 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 127.198 2.333 . . . . 0.0 116.087 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.77 163.16 24.73 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.865 1.333 . . . . 0.0 112.7 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -69.45 155.94 39.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 121.312 -0.867 . . . . 0.0 110.548 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.66 145.64 15.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -136.24 168.81 18.7 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 125.094 1.358 . . . . 0.0 110.173 173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.0 tt -77.32 157.87 30.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.991 0.916 . . . . 0.0 109.984 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -128.26 159.34 67.77 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.602 2.361 . . . . 0.0 107.816 173.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.65 178.85 7.08 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.73 1.62 . . . . 0.0 113.474 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -37.8 131.98 0.96 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.477 2.311 . . . . 0.0 113.69 -172.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -47.27 84.46 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.56 0.744 . . . . 0.0 110.355 171.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 C--O 1.25 1.115 0 CA-C-N 118.952 0.796 . . . . 0.0 110.958 -170.799 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.2 ttp . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.3 mt 52.23 88.65 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.726 2.41 . . . . 0.0 112.365 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.12 -178.05 5.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.515 2.326 . . . . 0.0 109.694 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.2 t30 20.78 95.55 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 129.957 3.303 . . . . 0.0 113.783 -168.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 146.56 31.47 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -69.03 168.69 13.29 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -51.52 170.44 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.553 1.941 . . . . 0.0 112.373 166.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -49.7 116.78 1.92 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.86 1.264 . . . . 0.0 111.597 -170.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.96 143.89 31.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.533 0.733 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.15 154.18 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 O-C-N 124.129 0.893 . . . . 0.0 110.306 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 mt -127.58 154.6 45.0 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.397 2.679 . . . . 0.0 107.611 -170.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -115.41 164.44 14.27 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.746 0.818 . . . . 0.0 111.153 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.7 p -35.08 -50.12 0.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.282 2.233 . . . . 0.0 112.654 165.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -52.2 -40.65 61.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.107 0.963 . . . . 0.0 112.188 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -60.59 -44.76 97.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.322 1.449 . . . . 0.0 109.699 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.35 -34.25 72.41 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.898 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -59.61 -50.31 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.732 0.813 . . . . 0.0 109.738 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -70.7 -19.49 62.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.29 0.496 . . . . 0.0 110.991 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.2 23.69 47.29 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.478 1.037 . . . . 0.0 112.096 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 117' ' ' LEU . 13.7 mt -72.62 112.69 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -170.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 112.48 1.57 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.827 1.251 . . . . 0.0 108.262 170.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -163.46 141.39 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.782 2.033 . . . . 0.0 106.989 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -78.29 164.81 24.55 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.113 1.365 . . . . 0.0 108.986 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.79 -165.85 31.19 Favored Glycine 0 C--N 1.331 0.264 0 O-C-N 121.032 -1.043 . . . . 0.0 111.048 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -103.23 149.02 25.09 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -142.84 171.54 13.92 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.189 1.396 . . . . 0.0 111.153 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.34 119.44 64.25 Favored Pre-proline 0 C--O 1.251 1.154 0 C-N-CA 126.151 1.781 . . . . 0.0 112.963 -168.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.31 -6.23 16.94 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.247 1.965 . . . . 0.0 113.005 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.9 m -91.96 -29.74 16.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.74 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.24 -39.8 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 120.467 1.485 . . . . 0.0 108.95 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG23 HD13 ' A' ' 43' ' ' LEU . 13.3 p -58.85 -23.57 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -69.11 -23.24 63.97 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.758 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.51 -34.96 30.93 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.851 1.26 . . . . 0.0 109.701 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.17 127.2 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.783 1.233 . . . . 0.0 108.092 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.51 -19.35 2.13 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.303 1.041 . . . . 0.0 112.239 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.28 127.49 32.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -59.18 -43.06 92.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.779 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.62 -53.93 51.52 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -54.66 44.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.624 1.57 . . . . 0.0 110.574 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -57.12 -59.29 5.3 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.154 0.581 . . . . 0.0 109.581 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.97 -53.19 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -54.1 -47.88 71.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.744 0.818 . . . . 0.0 112.066 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 31' ' ' VAL . 5.7 tt -58.58 -52.44 65.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.077 1.351 . . . . 0.0 108.851 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -62.31 -40.28 95.79 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.912 -0.492 . . . . 0.0 110.729 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -60.05 -47.96 83.71 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 125.378 1.471 . . . . 0.0 110.132 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -38.28 89.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.827 0.74 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -67.21 -45.28 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 118.767 0.712 . . . . 0.0 109.491 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -54.31 -50.05 68.26 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.622 1.169 . . . . 0.0 109.635 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.1 -6.59 34.98 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.246 1.819 . . . . 0.0 113.383 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.17 83.31 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 119.811 1.187 . . . . 0.0 113.324 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.69 -46.58 87.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.561 1.18 . . . . 0.0 107.91 170.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 147.63 21.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.761 0.824 . . . . 0.0 109.092 -167.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.69 172.27 9.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.112 1.765 . . . . 0.0 108.889 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.76 138.46 44.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.789 1.635 . . . . 0.0 110.47 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.28 123.82 3.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.856 1.662 . . . . 0.0 108.052 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -107.22 147.21 34.76 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.215 0.916 . . . . 0.0 111.581 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.81 171.57 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.445 3.43 . . . . 0.0 113.044 -170.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t -111.7 160.58 17.14 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.604 1.562 . . . . 0.0 110.262 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -59.88 -45.72 91.61 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.611 -0.681 . . . . 0.0 111.535 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.18 -38.78 65.98 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.608 0.763 . . . . 0.0 110.463 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.7 p -70.11 -42.12 73.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.344 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -64.13 -46.88 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.38 77.34 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.81 -0.556 . . . . 0.0 111.118 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.73 -44.53 63.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.133 0.973 . . . . 0.0 111.199 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.75 -50.78 57.16 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 76.2 mt -51.46 -36.52 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.573 1.149 . . . . 0.0 110.807 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -66.38 -56.32 11.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.809 1.186 . . . . 0.0 111.561 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.31 -38.8 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.96 67.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.617 1.567 . . . . 0.0 111.447 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -24.2 63.05 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.134 -0.979 . . . . 0.0 112.537 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -77.25 -30.7 54.55 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.704 1.138 . . . . 0.0 111.389 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . 0.269 14.6 t -75.58 -68.13 0.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.38 0.991 . . . . 0.0 108.526 170.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.76 -73.19 0.07 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-N 119.482 1.037 . . . . 0.0 111.569 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -69.6 93.83 0.73 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.663 0.785 . . . . 0.0 110.027 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.64 -59.61 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 122.167 -0.333 . . . . 0.0 111.839 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -114.67 8.18 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.496 0.589 . . . . 0.0 111.451 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.81 -9.29 58.5 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 78' ' ' LEU . 3.3 mp -92.63 159.79 15.3 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.256 -0.903 . . . . 0.0 110.746 -174.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -68.69 156.38 38.33 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.525 -0.735 . . . . 0.0 111.95 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.44 -57.42 12.81 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 118.895 -0.574 . . . . 0.0 109.508 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.69 -39.79 52.12 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.073 0.858 . . . . 0.0 111.4 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -61.68 2.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 109.316 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.24 -42.99 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 125.283 1.433 . . . . 0.0 108.759 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -56.2 -62.12 1.93 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.458 1.103 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.15 -47.53 80.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.415 0.686 . . . . 0.0 109.638 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 96' ' ' ILE . 42.3 mt -59.13 -52.18 66.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.939 0.896 . . . . 0.0 110.173 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.779 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.12 -59.45 4.17 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.133 1.373 . . . . 0.0 112.218 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 tp -46.96 -54.27 10.5 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 124.58 1.175 . . . . 0.0 110.972 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.25 68.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.395 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.7 m-85 -64.56 -28.78 69.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.517 0.599 . . . . 0.0 112.015 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -68.19 -34.52 76.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.141 0.882 . . . . 0.0 110.167 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 96.7 mt -82.97 -18.92 38.25 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.008 1.323 . . . . 0.0 112.972 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.06 51.39 17.15 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.12 -149.01 11.5 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.929 1.728 . . . . 0.0 111.254 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -114.21 169.93 8.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.618 1.967 . . . . 0.0 108.465 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.482 HD13 HD23 ' A' ' 86' ' ' LEU . 55.0 mt -131.94 153.76 39.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.047 1.339 . . . . 0.0 107.807 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.59 111.82 8.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.735 1.214 . . . . 0.0 108.788 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.2 t -160.92 179.61 8.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.032 2.133 . . . . 0.0 107.534 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -155.74 27.71 0.38 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.351 -1.468 . . . . 0.0 113.599 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.582 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.3 t70 -95.44 156.64 16.24 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -170.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -69.41 -40.8 77.08 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.037 1.29 . . . . 0.0 110.223 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -49.41 49.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.135 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -57.01 -40.01 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.812 1.187 . . . . 0.0 110.927 -173.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -67.32 -40.19 85.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.975 0.51 . . . . 0.0 109.874 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.414 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.6 t-20 -66.09 -55.05 18.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.7 mm -53.97 -54.47 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 110.391 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.59 -32.32 68.87 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 120.111 -1.618 . . . . 0.0 112.777 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 t -60.54 -60.6 3.55 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 117.73 -1.129 . . . . 0.0 110.678 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -60.57 -31.99 71.09 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 120.022 1.283 . . . . 0.0 110.683 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.554 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -76.32 -8.72 57.72 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.82 5.49 88.6 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.707 -1.051 . . . . 0.0 113.511 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.65 130.48 34.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.243 1.521 . . . . 0.0 110.031 -170.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' N ' HD13 ' A' ' 112' ' ' LEU . 11.0 ttt85 -66.63 132.1 47.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.676 0.79 . . . . 0.0 111.168 173.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -144.82 178.51 7.96 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.344 -0.848 . . . . 0.0 110.545 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -115.03 156.27 25.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.331 1.452 . . . . 0.0 108.881 171.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.9 p -122.4 160.57 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.919 1.287 . . . . 0.0 108.732 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD11 HD11 ' A' ' 20' ' ' ILE . 3.7 mm? -79.23 -51.71 9.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.924 -0.485 . . . . 0.0 110.285 168.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -59.92 155.38 16.64 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.85 177.38 5.58 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.366 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.03 178.66 30.44 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -157.73 157.51 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.451 2.3 . . . . 0.0 107.237 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -128.99 -26.67 2.6 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -153.95 39.33 0.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.034 0.834 . . . . 0.0 109.692 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -139.86 137.64 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -164.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.96 125.7 37.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.68 117.52 23.84 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.247 1.019 . . . . 0.0 109.68 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -50.69 144.85 7.58 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.216 1.006 . . . . 0.0 111.931 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 21.1 ttt-85 -156.82 9.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.998 1.111 . . . . 0.0 113.998 -164.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -133.65 131.89 40.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 118.92 0.782 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.21 133.77 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.59 128.71 37.44 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 166.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.11 113.06 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 164.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 149.28 -79.27 0.21 Allowed Glycine 0 C--O 1.229 -0.216 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 10.7 p -102.8 -7.06 21.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 117.636 0.718 . . . . 0.0 112.725 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.34 19.36 66.8 Favored Glycine 0 CA--C 1.528 0.888 0 O-C-N 120.865 -1.147 . . . . 0.0 114.388 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 5.0 ttm-85 -63.43 150.29 43.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.455 1.502 . . . . 0.0 110.013 -176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -123.96 97.7 5.47 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.746 0.654 . . . . 0.0 111.315 -152.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -99.48 146.26 26.56 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.421 1.105 . . . . 0.0 108.961 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -98.9 -11.32 21.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.473 0.709 . . . . 0.0 110.345 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.5 p -140.03 162.03 36.19 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 126.496 1.918 . . . . 0.0 108.979 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -79.04 118.48 72.73 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 141' ' ' LEU . 81.2 Cg_endo -67.92 161.46 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.979 1.786 . . . . 0.0 109.403 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -66.0 107.7 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.873 2.382 . . . . 0.0 108.744 172.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.46 -18.93 11.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 126.761 2.124 . . . . 0.0 111.927 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 54.78 31.4 54.09 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 118.759 1.279 . . . . 0.0 113.673 -175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 164.11 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.999 1.32 . . . . 0.0 108.154 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.419 ' HB3' ' H ' ' A' ' 150' ' ' CYS . 2.4 t -64.65 115.01 16.75 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.163 168.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.92 -3.87 2.47 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.193 1.929 . . . . 0.0 113.083 166.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.21 -26.68 5.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.434 1.893 . . . . 0.0 112.814 -170.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 134' ' ' CYS . 67.9 m -113.01 -18.16 12.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.728 1.211 . . . . 0.0 111.52 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 53.02 50.3 51.88 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.7 t -128.28 162.48 26.93 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.868 1.267 . . . . 0.0 109.309 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.32 139.62 49.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.792 0.806 . . . . 0.0 110.948 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.09 152.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 172.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -126.76 156.32 41.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 120.306 -1.496 . . . . 0.0 109.516 166.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.12 120.24 23.99 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -82.35 156.16 68.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.441 0.463 . . . . 0.0 110.697 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.06 80.61 2.94 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.981 2.454 . . . . 0.0 109.84 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 56.74 170.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.222 2.209 . . . . 0.0 111.813 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -67.16 -74.69 0.11 Allowed 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 162.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 . . . . . 0 C--O 1.244 0.804 0 C-N-CA 124.582 1.153 . . . . 0.0 108.661 -176.269 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptp . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mp -129.03 -102.41 0.32 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 159.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -104.37 0.64 29.31 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -71.05 165.78 22.76 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.478 0.711 . . . . 0.0 110.553 173.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 mp 78.63 104.88 0.07 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 131.264 3.826 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.84 162.48 27.6 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.366 -0.833 . . . . 0.0 110.689 176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -53.71 160.86 1.23 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.557 1.143 . . . . 0.0 110.121 164.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -45.14 119.19 1.93 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.341 1.456 . . . . 0.0 111.95 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.2 137.56 40.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.568 1.547 . . . . 0.0 107.093 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.41 146.76 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.81 146.78 40.64 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.733 1.613 . . . . 0.0 108.098 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.73 174.66 7.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.345 0.52 . . . . 0.0 111.706 166.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -55.87 -42.28 75.65 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -61.15 -27.7 68.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.743 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.74 -42.68 82.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 119.984 1.266 . . . . 0.0 110.162 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -72.23 -36.38 69.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.465 1.106 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.3 -26.54 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.552 1.141 . . . . 0.0 110.892 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -92.22 -23.55 19.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.278 0.945 . . . . 0.0 111.829 175.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.96 45.72 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.304 -0.72 . . . . 0.0 113.02 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 117' ' ' LEU . 13.2 mt -67.92 109.98 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.87 91.52 0.65 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.383 1.073 . . . . 0.0 110.191 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.47 165.79 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.832 1.253 . . . . 0.0 109.52 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.45 119.29 21.4 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.475 -166.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.07 -162.39 29.27 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.186 0.898 . . . . 0.0 110.905 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -104.26 150.59 24.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.875 1.27 . . . . 0.0 109.397 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -135.46 149.11 49.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.855 1.262 . . . . 0.0 108.82 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.82 118.93 75.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 125.219 1.408 . . . . 0.0 107.99 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.12 -28.71 71.56 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 CA-C-N 119.749 0.946 . . . . 0.0 110.776 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -48.29 37.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.181 3.392 . . . . 0.0 113.899 176.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.7 -35.15 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-N 118.77 0.714 . . . . 0.0 110.33 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.3 t -55.27 -26.95 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.867 0.758 . . . . 0.0 110.062 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.5 -20.48 31.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.91 -22.12 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.992 1.317 . . . . 0.0 111.685 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.2 mt -62.58 116.79 2.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 122.211 1.005 . . . . 0.0 108.837 -170.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.84 -16.54 3.28 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.838 -175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -66.56 122.01 16.63 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -56.22 -45.34 79.94 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.122 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -56.79 -55.85 29.02 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.77 1.228 . . . . 0.0 109.121 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -61.17 -44.57 97.1 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.371 1.069 . . . . 0.0 110.31 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.41 -55.53 20.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.329 0.652 . . . . 0.0 110.493 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.1 mt -50.27 -55.68 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -55.19 -56.06 24.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.982 0.913 . . . . 0.0 111.613 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 tp -52.55 -57.51 9.72 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.605 1.162 . . . . 0.0 108.836 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -58.06 -41.1 82.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.001 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.7 m -62.87 -35.85 81.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.854 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -37.46 63.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.971 0.908 . . . . 0.0 111.209 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.1 -47.3 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -66.52 -34.52 78.11 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.036 0.38 . . . . 0.0 110.976 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.91 -12.41 61.6 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.071 0.948 . . . . 0.0 112.745 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.13 21.75 48.08 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 119.427 1.012 . . . . 0.0 112.668 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -105.81 -26.59 11.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.913 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.2 t -119.87 127.01 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -123.27 144.2 49.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.987 1.267 . . . . 0.0 112.847 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.7 mm -77.4 122.65 32.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.666 1.186 . . . . 0.0 109.412 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 126.88 10.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.783 0.833 . . . . 0.0 110.097 168.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.39 158.14 37.49 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.1 0.56 . . . . 0.0 112.409 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.89 175.0 5.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 125.034 3.823 . . . . 0.0 111.98 170.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.36 165.03 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.36 15.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.913 1.685 . . . . 0.0 111.501 174.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.17 -30.81 70.0 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.763 0.425 . . . . 0.0 111.582 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 m -64.96 -48.52 73.74 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.385 1.474 . . . . 0.0 109.492 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.01 -46.9 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 124.439 1.096 . . . . 0.0 108.902 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -34.67 74.04 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 122.412 -0.18 . . . . 0.0 110.969 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -41.54 75.18 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.499 0.719 . . . . 0.0 111.443 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -70.58 -41.13 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 117.33 -1.319 . . . . 0.0 109.803 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.59 -54.03 17.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.787 -1.101 . . . . 0.0 108.334 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -55.32 -55.13 35.0 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.813 1.188 . . . . 0.0 112.13 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.993 HG11 HD21 ' A' ' 110' ' ' LEU . 4.6 p -67.44 -37.44 78.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.988 -0.445 . . . . 0.0 110.972 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HA ' HG22 ' A' ' 72' ' ' THR . . . -65.2 -34.01 77.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.259 1.024 . . . . 0.0 110.604 175.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -53.52 57.28 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.106 1.362 . . . . 0.0 109.566 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 1.86 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.654 1.582 . . . . 0.0 112.695 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.94 11.53 3.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.331 1.452 . . . . 0.0 111.107 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.07 -72.67 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 C-N-CA 125.908 1.718 . . . . 0.0 112.78 168.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -77.68 71.56 4.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.86 1.264 . . . . 0.0 110.246 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.43 -39.13 82.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.762 1.625 . . . . 0.0 113.898 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -130.76 12.98 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 118.885 0.766 . . . . 0.0 110.887 -173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.61 -22.84 61.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.68 0.792 . . . . 0.0 111.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 78' ' ' LEU . 2.1 mp -77.33 155.83 31.71 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 122.14 -0.35 . . . . 0.0 110.428 -174.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.7 m -63.24 151.13 41.37 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.581 0.705 . . . . 0.0 109.28 170.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -55.75 -45.32 78.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.562 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.38 80.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.203 0.911 . . . . 0.0 113.17 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.27 -57.77 9.95 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -55.92 -45.22 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.373 1.469 . . . . 0.0 109.08 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -68.22 -49.88 57.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.904 1.282 . . . . 0.0 111.943 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.42 -48.02 86.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.346 0.975 . . . . 0.0 108.998 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.74 -57.06 14.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.178 0.991 . . . . 0.0 109.177 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -49.97 -48.49 52.13 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.914 1.286 . . . . 0.0 111.331 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.42 -51.73 65.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.709 0.804 . . . . 0.0 109.211 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.69 74.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.518 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.4 m-30 -76.08 -22.23 55.84 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.938 0.79 . . . . 0.0 111.91 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.37 -50.23 68.53 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.43 -14.0 59.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.44 1.096 . . . . 0.0 112.779 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? 54.35 30.3 12.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.888 1.675 . . . . 0.0 111.752 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 -125.53 5.2 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.158 0.885 . . . . 0.0 111.061 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.98 165.63 24.26 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.767 2.027 . . . . 0.0 110.12 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.7 mt -130.09 162.99 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.725 1.21 . . . . 0.0 108.462 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.38 122.75 19.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.207 2.203 . . . . 0.0 106.051 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.4 t -163.26 175.76 10.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.66 1.184 . . . . 0.0 110.669 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -160.35 92.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.229 1.412 . . . . 0.0 109.618 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.66 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.5 OUTLIER -151.92 153.04 33.33 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.777 1.231 . . . . 0.0 109.254 163.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -58.66 -41.71 86.72 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.0 1.273 . . . . 0.0 111.907 -171.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' HD23 ' A' ' 78' ' ' LEU . 5.5 p-10 -66.89 -55.54 14.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 110.029 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -54.12 -40.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 121.492 0.663 . . . . 0.0 110.526 -171.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -69.67 -41.3 75.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.063 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -59.54 -59.79 4.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.708 1.603 . . . . 0.0 107.649 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 mm -53.33 -58.84 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 124.639 1.176 . . . . 0.0 108.841 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.71 67.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.455 1.479 . . . . 0.0 112.793 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -52.98 55.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.764 -1.589 . . . . 0.0 113.102 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -35.23 79.08 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 121.235 1.834 . . . . 0.0 109.784 177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD21 HG11 ' A' ' 68' ' ' VAL . 1.3 mm? -70.14 -22.38 63.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.493 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.97 80.32 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 124.726 1.155 . . . . 0.0 113.847 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -83.25 118.18 23.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.408 1.104 . . . . 0.0 109.098 177.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -68.61 131.75 45.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.778 1.231 . . . . 0.0 108.274 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -146.57 169.74 18.34 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.926 0.393 . . . . 0.0 111.182 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -101.93 134.27 45.4 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.607 1.163 . . . . 0.0 108.38 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.5 p -92.16 169.11 10.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 124.721 1.263 . . . . 0.0 109.53 164.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 20' ' ' ILE . 2.2 mm? -86.46 -49.64 7.45 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.34 0.518 . . . . 0.0 111.494 169.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -60.0 145.56 45.82 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.058 0.543 . . . . 0.0 110.764 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -65.23 -33.8 76.85 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.931 -0.48 . . . . 0.0 111.358 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.2 0.26 56.26 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.67 -1.072 . . . . 0.0 115.178 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.8 mt -143.97 134.86 21.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 126.898 2.079 . . . . 0.0 106.862 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.41 -59.88 1.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.567 157.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -148.31 2.32 0.65 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.16 1.346 . . . . 0.0 113.962 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.82 120.59 27.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 88.6 mt -59.44 161.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -54.37 104.83 0.12 Allowed 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 5.5 p-90 -80.73 143.78 32.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -155.58 25.05 0.4 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.619 -1.182 . . . . 0.0 113.933 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -129.94 140.4 50.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.676 1.125 . . . . 0.0 110.73 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.29 135.29 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.592 1.557 . . . . 0.0 108.886 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.25 140.68 52.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -91.3 102.14 13.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 121.983 0.897 . . . . 0.0 109.045 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.05 -78.72 0.33 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 2.3 p -78.01 -10.72 59.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.621 0.71 . . . . 0.0 111.528 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.66 21.93 71.32 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.919 1.247 . . . . 0.0 114.589 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -63.93 135.16 56.28 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.354 1.062 . . . . 0.0 109.729 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -88.48 136.72 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.66 1.584 . . . . 0.0 108.417 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -130.8 150.02 52.17 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.416 1.086 . . . . 0.0 108.354 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 3.3 p -88.18 -22.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.435 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.4 p -139.58 172.61 12.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 108.136 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.86 132.34 90.66 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.12 169.44 21.44 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.912 1.741 . . . . 0.0 110.123 172.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -56.39 137.49 80.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.68 1.587 . . . . 0.0 109.586 170.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.96 -10.04 4.69 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.9 -0.945 . . . . 0.0 114.142 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 64.96 27.88 72.78 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.806 1.803 . . . . 0.0 112.918 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.18 161.63 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.247 1.019 . . . . 0.0 108.947 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.3 t -79.48 113.69 39.09 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.432 -171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.16 -13.45 15.95 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.366 1.377 . . . . 0.0 114.044 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -96.53 -25.09 15.76 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.171 1.388 . . . . 0.0 112.79 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.9 p -150.71 2.35 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -171.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.57 -11.35 7.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.585 2.04 . . . . 0.0 115.152 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.46 166.75 21.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.588 1.194 . . . . 0.0 112.873 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -61.16 149.21 38.15 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.618 -0.676 . . . . 0.0 109.834 172.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.48 142.94 22.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 153.5 51.22 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.34 1.056 . . . . 0.0 111.364 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.7 tt -76.08 137.85 40.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.777 0.831 . . . . 0.0 109.214 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 pt -108.05 158.58 33.23 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.718 1.207 . . . . 0.0 112.768 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -67.25 123.84 11.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.887 3.058 . . . . 0.0 111.272 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 45.07 -128.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.814 2.046 . . . . 0.0 111.264 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 -31.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 . . . . . 0 C--O 1.251 1.18 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 171.901 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.963 0.411 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.23 175.62 2.58 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.731 1.212 . . . . 0.0 110.956 169.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -139.6 170.16 16.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 156.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -125.34 177.28 6.24 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.663 1.185 . . . . 0.0 109.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.57 164.07 32.81 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.092 0.557 . . . . 0.0 112.324 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -75.12 -173.64 2.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.028 0.931 . . . . 0.0 113.219 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -48.74 154.95 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.22 1.008 . . . . 0.0 112.5 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -39.79 117.95 0.81 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 126.417 1.887 . . . . 0.0 110.443 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.99 144.15 43.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.13 155.48 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 124.373 1.045 . . . . 0.0 109.903 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -133.16 146.15 51.28 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.305 1.842 . . . . 0.0 108.671 -166.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.16 171.97 7.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.561 0.744 . . . . 0.0 112.749 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.31 -41.73 69.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.095 1.358 . . . . 0.0 112.187 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.17 -37.38 72.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.2 -47.38 80.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.942 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -73.19 -31.73 64.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.879 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.01 -47.94 91.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.972 . . . . 0.0 109.518 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.63 -25.02 58.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.198 0.454 . . . . 0.0 111.043 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.88 28.08 14.86 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.39 0.519 . . . . 0.0 113.053 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -72.08 108.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -61.27 115.53 3.89 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 23' ' ' GLU . 3.5 tp -159.48 144.79 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.981 1.713 . . . . 0.0 107.45 174.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' H ' HD12 ' A' ' 22' ' ' ILE . 31.9 mp0 -88.09 142.37 27.82 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.947 1.299 . . . . 0.0 108.652 175.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 171.15 -155.61 24.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -117.96 151.72 36.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.25 1.02 . . . . 0.0 109.858 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 t -129.37 145.79 51.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.163 1.385 . . . . 0.0 110.496 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.502 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -91.13 117.69 68.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.504 1.522 . . . . 0.0 110.035 -168.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.4 Cg_endo -63.97 -5.67 9.66 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.884 3.056 . . . . 0.0 115.633 -170.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.99 -4.35 13.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.346 0.976 . . . . 0.0 111.886 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.69 -47.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 HD13 ' A' ' 43' ' ' LEU . 6.0 p -65.55 -19.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -170.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.59 -26.11 66.1 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.127 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -78.18 -40.95 36.15 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.017 0.927 . . . . 0.0 108.849 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.0 mt -55.67 101.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.609 1.564 . . . . 0.0 108.699 -169.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -9.29 8.9 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 126.025 1.73 . . . . 0.0 110.734 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.31 127.77 33.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.9 mtm-85 -58.45 -51.66 68.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.557 0.743 . . . . 0.0 109.355 -170.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.41 -54.89 40.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.637 1.175 . . . . 0.0 108.73 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.381 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -64.73 -58.05 7.33 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.712 0.687 . . . . 0.0 109.469 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -57.37 -46.65 85.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 50.4 t80 -59.5 -51.65 68.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.351 -0.357 . . . . 0.0 111.067 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.547 HD13 HG23 ' A' ' 31' ' ' VAL . 6.8 tt -53.34 -52.12 60.25 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.103 0.961 . . . . 0.0 109.547 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.8 -37.04 80.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.906 0.882 . . . . 0.0 110.961 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -56.51 -46.53 80.51 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.317 1.447 . . . . 0.0 109.995 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 50.9 mt -67.7 -35.57 79.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.578 0.751 . . . . 0.0 110.784 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.3 -55.36 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.8 m -59.5 -38.19 80.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.397 0.544 . . . . 0.0 112.363 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -24.92 66.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.853 1.261 . . . . 0.0 112.383 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 9.0 60.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.531 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -83.75 -34.76 24.76 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 118.351 1.076 . . . . 0.0 111.263 178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.26 147.76 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -128.17 157.01 41.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.51 1.124 . . . . 0.0 109.759 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mm -78.63 135.06 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.85 127.83 7.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.828 0.851 . . . . 0.0 111.756 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -106.03 154.93 39.21 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 125.735 1.614 . . . . 0.0 112.17 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.82 163.33 28.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 125.12 3.88 . . . . 0.0 114.457 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -90.81 166.57 13.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.662 1.985 . . . . 0.0 109.457 168.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tmpt? -50.17 -44.45 52.81 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.129 1.372 . . . . 0.0 110.295 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -71.39 -27.58 63.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.989 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -66.09 -48.98 69.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.265 0.626 . . . . 0.0 109.664 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.26 -42.09 93.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.51 -33.14 74.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.225 0.466 . . . . 0.0 111.221 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -43.37 61.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.641 1.176 . . . . 0.0 110.307 174.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -72.21 -44.18 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 119.336 0.971 . . . . 0.0 108.547 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -55.61 -39.88 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.404 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 -57.01 -68.2 0.24 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-O 122.5 1.143 . . . . 0.0 109.14 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -70.39 -29.81 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.091 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.22 60.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.917 . . . . 0.0 111.643 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 71' ' ' GLU . 0.3 OUTLIER -65.52 -25.99 67.7 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.081 -1.012 . . . . 0.0 111.563 -177.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 43.2 mt-10 -60.98 -52.72 63.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.139 0.882 . . . . 0.0 109.088 173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -75.57 -39.96 57.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.36 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.55 -76.54 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.532 1.06 . . . . 0.0 113.52 171.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.01 92.0 0.91 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 122.02 0.914 . . . . 0.0 110.213 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.91 -44.08 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.541 0.736 . . . . 0.0 112.784 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -131.18 12.91 5.13 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.753 0.421 . . . . 0.0 110.899 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.03 -8.31 55.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.966 0.412 . . . . 0.0 110.946 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 106' ' ' ILE . 5.4 mp -83.25 156.69 23.0 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.267 -0.895 . . . . 0.0 110.592 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.77 159.21 19.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.921 1.289 . . . . 0.0 110.605 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.54 -57.9 7.87 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.42 -39.14 75.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 123.959 0.787 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.68 -52.4 65.61 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.38 0.609 . . . . 0.0 109.729 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.9 mt -56.53 -46.35 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.5 -49.64 58.15 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.638 0.654 . . . . 0.0 112.722 -172.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG22 ' OG1' ' A' ' 27' ' ' THR . 93.7 t -60.58 -50.72 79.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -55.47 -58.57 7.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.15 0.98 . . . . 0.0 109.288 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -47.44 -55.89 8.08 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.931 1.292 . . . . 0.0 112.005 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.08 -48.07 81.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.295 1.038 . . . . 0.0 110.364 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.54 -42.19 74.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.242 174.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.4 m-30 -67.76 -27.95 67.21 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.679 0.672 . . . . 0.0 111.213 -177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.54 -30.05 66.69 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.281 0.946 . . . . 0.0 110.89 170.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.69 -14.82 38.85 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.718 1.207 . . . . 0.0 112.284 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.72 0.75 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.149 1.38 . . . . 0.0 111.425 -162.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.97 -162.79 13.1 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -101.67 167.92 9.8 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.635 1.574 . . . . 0.0 109.043 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 86' ' ' LEU . 72.8 mt -133.62 150.8 32.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 125.181 1.393 . . . . 0.0 107.3 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.88 124.82 25.6 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 126.255 1.822 . . . . 0.0 106.29 170.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.512 ' HB3' HG11 ' A' ' 103' ' ' VAL . 16.5 t -152.31 -150.21 0.33 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.708 2.003 . . . . 0.0 106.884 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.01 -23.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.768 1.167 . . . . 0.0 113.401 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 103' ' ' VAL . 1.4 m-20 -72.91 140.73 47.68 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.901 1.681 . . . . 0.0 113.483 -156.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.41 -38.57 54.22 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.057 -1.652 . . . . 0.0 113.257 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.07 -47.79 60.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.76 1.624 . . . . 0.0 111.341 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 98' ' ' SER . 0.3 OUTLIER -57.56 -37.04 56.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.046 1.294 . . . . 0.0 110.38 -177.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 35.7 mt-30 -68.84 -39.55 79.9 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -63.94 -56.29 16.33 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.401 0.68 . . . . 0.0 110.324 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.423 HD11 HD21 ' A' ' 78' ' ' LEU . 13.8 mm -54.55 -52.67 38.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 119.494 1.043 . . . . 0.0 109.851 -174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.71 73.11 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.522 1.51 . . . . 0.0 113.298 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 t -55.8 -62.12 1.91 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.954 172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -25.38 68.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.368 1.44 . . . . 0.0 111.927 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.7 mm? -83.33 -10.16 58.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.78 82.22 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.563 -1.132 . . . . 0.0 113.879 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.568 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -92.22 135.51 33.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.497 1.648 . . . . 0.0 111.13 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.568 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -81.37 131.76 35.3 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.613 1.965 . . . . 0.0 110.435 177.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 26.7 p90 -150.98 -175.28 5.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.664 -0.647 . . . . 0.0 110.986 -174.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -98.98 175.28 5.98 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.161 1.384 . . . . 0.0 114.239 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p -142.24 115.22 8.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.96 1.304 . . . . 0.0 110.423 171.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -61.83 -60.68 3.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.153 0.981 . . . . 0.0 109.181 173.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -77.32 178.59 7.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.618 1.167 . . . . 0.0 109.149 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -53.18 141.39 23.45 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.18 -0.95 . . . . 0.0 108.633 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.6 98.25 0.11 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 104.991 -3.244 . . . . 0.0 104.991 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.9 pt -67.88 155.67 7.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.041 0.936 . . . . 0.0 110.226 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -138.15 -26.18 0.93 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.768 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -141.87 24.44 2.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.164 1.347 . . . . 0.0 112.663 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.61 150.3 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.21 159.61 3.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -63.03 151.53 39.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.074 -1.016 . . . . 0.0 109.664 169.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 7.8 p-90 -157.01 171.56 20.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.947 0.499 . . . . 0.0 109.924 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.61 -0.3 0.11 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -139.63 150.06 44.51 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 120.665 1.575 . . . . 0.0 111.613 -169.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.79 128.42 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.842 1.257 . . . . 0.0 109.436 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.1 t -65.91 144.15 56.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 166.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.23 94.92 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 169.09 -90.78 0.1 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 -175.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.97 13.24 17.19 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.183 0.993 . . . . 0.0 111.367 176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.09 22.93 61.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.013 1.292 . . . . 0.0 115.122 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -65.46 125.78 26.22 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 110.056 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -72.78 150.99 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.938 0.773 . . . . 0.0 109.873 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -143.31 149.69 38.16 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.501 1.12 . . . . 0.0 109.229 166.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 42.9 t -86.11 -26.98 24.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.135 0.574 . . . . 0.0 111.674 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.7 p -145.3 160.02 42.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.392 1.477 . . . . 0.0 108.238 -171.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -74.57 123.42 89.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.49 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.91 172.06 15.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.858 2.372 . . . . 0.0 110.206 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.1 137.4 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 121.918 1.745 . . . . 0.0 110.269 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.59 -9.79 1.69 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.544 1.069 . . . . 0.0 114.172 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.8 35.77 87.67 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 118.87 1.335 . . . . 0.0 111.724 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.56 158.2 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.383 1.073 . . . . 0.0 108.121 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.8 t -71.08 113.03 15.69 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-O 117.252 -1.356 . . . . 0.0 108.082 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.36 -18.81 25.96 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.51 1.474 . . . . 0.0 113.189 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.06 -27.15 15.23 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.088 1.755 . . . . 0.0 111.882 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.7 p -140.4 -2.77 1.39 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 72.43 -13.9 2.66 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.464 1.983 . . . . 0.0 115.317 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 163.1 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.177 1.489 . . . . 0.0 111.789 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -67.11 154.34 41.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.524 0.678 . . . . 0.0 109.768 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.8 t -108.17 148.48 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -129.96 160.8 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.335 1.054 . . . . 0.0 110.697 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.45 116.56 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.082 1.353 . . . . 0.0 107.803 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.5 168.41 24.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.459 1.104 . . . . 0.0 111.657 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.48 59.76 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.885 3.724 . . . . 0.0 112.24 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 56.27 -166.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.705 1.602 . . . . 0.0 110.884 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 -35.94 0.53 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.143 2.177 . . . . 0.0 113.376 -166.235 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.94 110.76 16.67 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.955 2.102 . . . . 0.0 106.336 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -133.62 83.8 2.08 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.779 1.172 . . . . 0.0 108.12 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -152.37 -63.62 0.16 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.769 1.168 . . . . 0.0 109.439 -177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.9 149.17 37.14 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.97 -34.36 5.44 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -155.24 179.72 8.88 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.8 m -63.48 125.61 24.76 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -146.37 134.41 21.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.9 t -113.65 152.39 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.72 135.32 50.0 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.369 2.267 . . . . 0.0 109.409 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.33 161.36 14.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.97 2.108 . . . . 0.0 110.941 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.504 ' HB2' HG21 ' A' ' 30' ' ' VAL . 28.6 t -46.38 -45.17 17.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.704 1.602 . . . . 0.0 112.399 171.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.8 m -52.19 -35.35 48.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.871 0.868 . . . . 0.0 111.92 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.18 -35.87 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.144 0.978 . . . . 0.0 109.626 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.2 -37.6 25.82 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.66 0.784 . . . . 0.0 111.025 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.92 -41.95 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.975 0.91 . . . . 0.0 109.205 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -79.13 -13.92 59.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 24.42 65.1 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.274 0.94 . . . . 0.0 113.864 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -78.82 108.19 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 C-N-CA 124.557 1.143 . . . . 0.0 108.417 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.05 111.75 3.52 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tp -154.45 159.62 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 127.348 2.259 . . . . 0.0 106.756 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -128.24 128.62 45.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.641 1.176 . . . . 0.0 110.498 -166.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.13 -147.65 9.08 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.236 1.398 . . . . 0.0 111.943 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -116.96 158.1 24.65 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.11 1.764 . . . . 0.0 110.144 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -145.74 166.29 26.3 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -90.09 125.56 60.01 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 121.619 0.724 . . . . 0.0 111.618 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG12 ' A' ' 31' ' ' VAL . 55.8 Cg_endo -63.07 -12.58 30.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.235 1.29 . . . . 0.0 111.163 166.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -32.94 67.39 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 126.873 2.069 . . . . 0.0 112.698 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.504 HG21 ' HB2' ' A' ' 13' ' ' SER . 11.3 p -92.8 -34.37 5.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 120.267 1.394 . . . . 0.0 110.632 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 28' ' ' PRO . 7.7 p -61.49 -16.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.849 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.392 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.65 -21.69 10.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.461 1.904 . . . . 0.0 110.799 -166.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 mt -67.81 96.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -90.45 -24.76 20.62 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.678 0.791 . . . . 0.0 112.117 165.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.26 129.2 24.12 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.304 1.842 . . . . 0.0 111.549 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -51.4 -72.01 0.06 Allowed 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 126.208 1.803 . . . . 0.0 110.535 -170.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -60.98 -48.02 83.76 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -164.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.8 t -50.48 -56.37 11.88 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 125.988 1.715 . . . . 0.0 110.088 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -61.4 -53.91 50.46 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.358 1.063 . . . . 0.0 110.61 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.5 mt -55.67 -50.17 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.27 1.028 . . . . 0.0 108.621 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.17 -48.41 80.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.7 -48.5 77.54 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.04 -1.037 . . . . 0.0 110.456 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.43 -40.87 92.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.997 0.919 . . . . 0.0 110.61 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 t -57.68 -51.1 70.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.166 1.386 . . . . 0.0 110.425 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.2 mt -65.14 -38.08 89.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.809 0.843 . . . . 0.0 110.616 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.02 -50.97 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.7 t -59.54 -35.82 74.94 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.456 0.702 . . . . 0.0 111.015 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -78.17 -11.59 59.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.266 1.426 . . . . 0.0 112.725 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.44 87.1 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.721 1.153 . . . . 0.0 113.443 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 51' ' ' LYS . 3.3 ptpt -78.42 -19.71 52.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.188 0.995 . . . . 0.0 112.07 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.43 136.78 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -125.72 140.9 52.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.52 0.676 . . . . 0.0 110.398 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.48 126.64 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.04 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.37 127.4 9.71 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.102 1.361 . . . . 0.0 109.212 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -99.57 155.05 36.93 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.505 0.722 . . . . 0.0 112.77 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.03 173.75 8.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.23 3.954 . . . . 0.0 112.235 165.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.08 173.16 8.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.887 2.075 . . . . 0.0 110.151 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -54.1 -49.86 68.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.833 -0.542 . . . . 0.0 110.251 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.08 -31.04 71.43 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.348 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -51.98 53.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.177 0.991 . . . . 0.0 110.31 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.27 -45.68 97.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.36 -39.9 70.64 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.661 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.39 -45.63 46.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.415 1.486 . . . . 0.0 110.556 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -71.42 -46.85 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -177.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.3 mt -53.17 -43.41 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.317 1.047 . . . . 0.0 110.339 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.55 -57.52 12.4 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.571 0.623 . . . . 0.0 110.199 -174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.74 -37.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.9 71.97 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.411 1.084 . . . . 0.0 111.482 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -35.14 80.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 119.928 1.24 . . . . 0.0 111.164 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.86 -42.72 94.63 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.741 0.7 . . . . 0.0 110.715 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 t -80.98 -41.03 23.42 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.183 0.447 . . . . 0.0 111.94 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.32 146.18 6.37 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.787 1.661 . . . . 0.0 109.045 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 83.05 50.59 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 130.39 3.476 . . . . 0.0 109.21 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.48 -52.76 48.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 O-C-N 121.153 -0.967 . . . . 0.0 113.413 -170.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.09 11.02 15.17 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.083 0.553 . . . . 0.0 110.528 -167.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -20.74 32.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.534 0.734 . . . . 0.0 112.199 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -73.64 150.78 41.1 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -177.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.5 m -58.98 152.17 20.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.299 1.047 . . . . 0.0 110.812 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -59.19 4.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.58 175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.56 77.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.888 0.743 . . . . 0.0 111.737 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.97 -55.25 37.1 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.173 0.989 . . . . 0.0 108.522 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.5 -43.37 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.838 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -65.49 -51.55 59.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.447 0.567 . . . . 0.0 111.435 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.27 -48.83 83.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.322 1.049 . . . . 0.0 109.301 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 96' ' ' ILE . 81.1 mt -58.22 -57.45 12.82 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.941 0.897 . . . . 0.0 109.614 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.92 -46.8 64.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.177 1.391 . . . . 0.0 112.663 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.06 -49.35 78.22 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.487 1.115 . . . . 0.0 109.167 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.98 75.12 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.709 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.504 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 5.6 m-30 -69.97 -26.3 64.03 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.109 0.868 . . . . 0.0 110.288 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.41 -7.09 51.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.316 1.046 . . . . 0.0 112.4 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.39 -10.61 8.43 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.266 1.427 . . . . 0.0 112.142 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.9 mttt 51.97 34.84 14.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 110.533 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.59 -130.37 6.66 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.712 1.149 . . . . 0.0 110.456 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -133.85 170.38 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.611 1.964 . . . . 0.0 109.917 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.461 HD13 HD23 ' A' ' 86' ' ' LEU . 66.5 mt -133.99 153.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 126.207 1.803 . . . . 0.0 106.489 -172.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.47 115.89 16.08 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.913 1.285 . . . . 0.0 109.289 166.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.6 t -157.58 -172.53 4.0 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.061 3.344 . . . . 0.0 108.394 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -148.91 6.45 0.7 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -168.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.551 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.5 t0 -102.19 160.54 14.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.168 1.349 . . . . 0.0 111.96 -157.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -64.75 -48.55 74.15 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.51 -1.369 . . . . 0.0 111.636 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -69.33 -48.35 61.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.714 1.206 . . . . 0.0 109.78 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.551 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -56.53 -43.55 78.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -172.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.401 ' HG2' ' HE2' ' A' ' 114' ' ' PHE . 65.1 mt-30 -63.86 -47.79 79.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.32 0.648 . . . . 0.0 110.154 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' HD23 ' A' ' 109' ' ' LEU . 6.6 t-20 -56.08 -59.93 4.21 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.196 1.798 . . . . 0.0 108.226 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.16 -53.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 119.753 1.161 . . . . 0.0 111.254 -173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.41 -35.37 67.71 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.367 1.44 . . . . 0.0 112.204 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -57.74 10.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -68.52 -21.92 64.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.15 1.341 . . . . 0.0 111.629 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.504 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.8 mm? -81.82 -22.15 37.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.473 0.709 . . . . 0.0 111.454 174.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.5 9.9 71.5 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.563 1.554 . . . . 0.0 114.232 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.22 123.86 29.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.853 1.327 . . . . 0.0 110.374 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.76 135.02 55.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.565 1.546 . . . . 0.0 109.05 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.401 ' HE2' ' HG2' ' A' ' 104' ' ' GLN . 18.3 p90 -151.23 175.27 12.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -107.35 166.51 10.6 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.747 1.219 . . . . 0.0 111.318 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.62 155.49 44.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 171.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.97 -168.55 0.29 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.794 0.837 . . . . 0.0 109.859 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.24 88.92 0.09 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.678 1.591 . . . . 0.0 109.221 177.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -55.77 -20.96 16.74 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.737 1.615 . . . . 0.0 112.968 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.3 -128.83 3.13 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.09 157.25 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.237 1.415 . . . . 0.0 107.648 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.08 -64.53 0.69 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.66 0.784 . . . . 0.0 109.195 167.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -135.77 65.53 1.54 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.94 152.15 14.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -71.12 168.22 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -55.81 -179.78 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.562 1.545 . . . . 0.0 111.023 158.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -150.34 154.38 37.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -149.82 9.71 0.7 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 117.352 -1.309 . . . . 0.0 113.532 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -133.96 138.94 45.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.907 1.231 . . . . 0.0 111.381 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.39 134.54 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.074 1.35 . . . . 0.0 109.298 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 122.06 24.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.071 0.949 . . . . 0.0 108.541 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.79 108.11 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 150.12 -80.66 0.2 Allowed Glycine 0 N--CA 1.458 0.136 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 11.5 p -88.45 -16.76 31.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.14 0.47 . . . . 0.0 111.885 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.11 32.5 43.78 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 123.546 0.593 . . . . 0.0 113.075 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' HD3' ' CZ ' ' A' ' 138' ' ' PHE . 42.5 ttt-85 -70.14 157.6 37.31 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 117.875 0.837 . . . . 0.0 109.772 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -101.32 146.63 27.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.353 1.461 . . . . 0.0 108.838 172.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HD3' ' A' ' 136' ' ' ARG . 97.4 m-85 -140.02 148.3 41.64 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.974 1.31 . . . . 0.0 108.321 169.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 t -94.22 -23.61 17.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.672 0.789 . . . . 0.0 110.566 171.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.9 p -136.97 157.64 46.27 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 123.615 0.766 . . . . 0.0 109.856 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -74.59 110.47 9.78 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.49 ' HD2' HD23 ' A' ' 141' ' ' LEU . 88.5 Cg_endo -68.62 172.02 12.21 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.918 3.079 . . . . 0.0 110.536 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.81 120.02 7.51 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.012 1.808 . . . . 0.0 109.632 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.47 -6.89 81.12 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.079 1.324 . . . . 0.0 113.417 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 59.48 38.54 93.7 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 119.255 1.528 . . . . 0.0 112.43 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.5 m -116.11 174.94 3.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 124.694 1.198 . . . . 0.0 108.397 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.19 100.31 2.13 Favored Pre-proline 0 CA--C 1.519 -0.239 0 CA-C-N 120.849 1.659 . . . . 0.0 109.355 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.14 37.49 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 124.932 3.754 . . . . 0.0 113.946 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.01 -16.08 0.21 Allowed 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 127.38 2.272 . . . . 0.0 112.004 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.8 p -146.73 -31.57 0.34 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.23 92.49 0.96 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.904 1.716 . . . . 0.0 111.128 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.43 174.01 2.85 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.638 1.975 . . . . 0.0 108.042 170.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -76.3 137.63 40.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.03 1.287 . . . . 0.0 111.958 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.35 157.94 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 156.62 44.07 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.699 -1.25 . . . . 0.0 110.969 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.24 146.08 35.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.672 0.789 . . . . 0.0 109.149 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 pt -114.02 163.27 19.34 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 93.34 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.49 2.794 . . . . 0.0 111.209 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 61.84 -175.74 0.13 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.122 1.369 . . . . 0.0 110.58 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.428 ' O ' ' HE3' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -69.38 -27.12 65.03 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.898 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 124.19 0.996 . . . . 0.0 109.615 -146.732 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttp . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp 43.4 71.52 0.23 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.585 1.954 . . . . 0.0 111.653 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -138.81 99.78 3.88 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.31 -39.36 92.38 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.869 -176.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -150.05 -45.7 0.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.032 0.833 . . . . 0.0 110.201 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.94 -164.52 1.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.861 2.065 . . . . 0.0 109.796 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -59.29 159.48 7.73 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.724 -0.61 . . . . 0.0 111.545 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -50.58 125.94 14.24 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.593 1.557 . . . . 0.0 109.043 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.7 tp -144.44 142.54 30.37 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.57 148.56 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.18 133.85 53.45 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.464 1.506 . . . . 0.0 108.905 -171.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.52 161.81 20.09 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.88 1.672 . . . . 0.0 111.861 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -45.75 11.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.951 1.7 . . . . 0.0 111.822 171.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.0 p -61.54 -31.73 71.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.334 0.515 . . . . 0.0 111.938 -174.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 t -61.75 -42.56 94.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.656 1.182 . . . . 0.0 109.33 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.53 -37.32 71.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.522 -0.752 . . . . 0.0 110.663 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 91.3 mt -55.31 -54.43 25.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.07 -26.17 65.71 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.84 0.746 . . . . 0.0 111.461 -173.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 42' ' ' PHE . . . 91.23 37.25 6.31 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.4 mt -82.79 108.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.35 112.61 7.62 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.33 174.37 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 125.082 1.353 . . . . 0.0 107.778 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -120.4 149.79 41.8 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.547 1.539 . . . . 0.0 108.339 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.74 -137.64 5.96 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.39 153.5 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.589 1.155 . . . . 0.0 110.452 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -129.38 144.63 51.32 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.522 1.129 . . . . 0.0 109.8 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.9 p -84.38 121.3 75.14 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 124.757 1.223 . . . . 0.0 109.804 -174.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 31' ' ' VAL . 19.0 Cg_endo -65.42 -14.14 43.39 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.62 1.547 . . . . 0.0 113.665 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -74.75 -44.11 51.44 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.86 0.864 . . . . 0.0 112.3 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.32 -36.11 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 CA-C-N 119.402 1.001 . . . . 0.0 109.269 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 28' ' ' PRO . 10.0 p -64.21 -20.16 26.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 118.855 -1.138 . . . . 0.0 113.358 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.09 -25.3 68.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.249 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.94 -30.23 65.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.323 1.049 . . . . 0.0 109.893 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.96 82.56 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.973 2.109 . . . . 0.0 109.49 -164.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -20.17 60.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.215 1.406 . . . . 0.0 112.179 169.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.01 133.22 47.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.844 0.858 . . . . 0.0 110.89 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.3 mmt-85 -61.83 -59.65 4.83 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.96 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.19 -45.52 91.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 118.261 -0.876 . . . . 0.0 108.998 -167.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 t -55.9 -56.23 23.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.276 0.63 . . . . 0.0 110.75 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -60.14 -51.43 69.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.624 1.102 . . . . 0.0 111.585 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.21 -57.62 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' CE2' ' HA2' ' A' ' 19' ' ' GLY . 68.4 t80 -56.46 -45.68 80.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.139 0.976 . . . . 0.0 112.219 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 31' ' ' VAL . 6.4 tt -54.48 -52.48 61.78 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.11 0.964 . . . . 0.0 108.525 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -70.48 -28.03 64.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.707 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -61.44 -50.27 73.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.422 1.01 . . . . 0.0 108.548 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -42.73 80.93 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.675 1.19 . . . . 0.0 111.402 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.83 -56.56 17.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -28.52 69.24 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.98 -13.2 60.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.397 1.479 . . . . 0.0 112.103 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.94 -6.7 51.87 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.603 1.573 . . . . 0.0 113.784 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -87.12 -23.42 24.87 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 118.486 1.143 . . . . 0.0 112.99 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.49 149.48 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 120.666 1.575 . . . . 0.0 107.457 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -135.16 156.73 48.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.709 -0.619 . . . . 0.0 111.007 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.35 131.52 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.87 0.868 . . . . 0.0 108.99 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.12 128.19 6.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.847 1.259 . . . . 0.0 110.036 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.33 158.82 32.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.163 0.985 . . . . 0.0 112.584 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -75.34 145.47 30.36 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.238 3.292 . . . . 0.0 112.891 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -65.01 155.35 34.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.156 0.982 . . . . 0.0 109.947 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -65.82 -36.11 82.56 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.904 -1.123 . . . . 0.0 109.479 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -21.74 64.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.973 0.806 . . . . 0.0 111.204 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 p -85.03 -38.17 19.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.102 0.864 . . . . 0.0 112.755 172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.18 -48.21 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.47 1.032 . . . . 0.0 108.263 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -28.32 64.28 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 122.816 0.446 . . . . 0.0 111.451 178.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.69 98.72 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.548 -0.72 . . . . 0.0 111.741 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -67.24 -46.29 84.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -57.27 -28.77 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 118.737 0.698 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.11 -72.77 0.15 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.215 1.371 . . . . 0.0 108.962 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -60.62 -36.61 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.508 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -65.77 -40.81 92.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -27.2 61.59 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 121.692 2.042 . . . . 0.0 112.129 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.11 -52.3 59.83 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -69.87 -42.81 72.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.335 0.654 . . . . 0.0 111.586 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.9 -66.02 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.958 0.799 . . . . 0.0 112.452 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -71.47 45.96 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.848 2.859 . . . . 0.0 114.648 -165.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.4 p -40.33 -44.58 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 128.177 2.591 . . . . 0.0 115.988 -167.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -131.31 11.54 4.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.023 0.929 . . . . 0.0 110.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.84 -12.77 61.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.153 0.581 . . . . 0.0 110.503 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 174.3 8.64 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.685 1.194 . . . . 0.0 110.183 170.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -68.11 154.0 42.58 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.798 1.285 . . . . 0.0 110.979 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.516 ' HE3' ' N ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -54.2 -52.6 60.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.137 1.375 . . . . 0.0 110.786 162.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' N ' ' HE3' ' A' ' 80' ' ' LYS . . . -63.47 -35.79 81.62 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 123.573 0.546 . . . . 0.0 109.566 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.7 -53.99 46.08 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -52.16 -40.05 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.042 0.937 . . . . 0.0 109.311 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -70.31 -54.93 10.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.404 1.002 . . . . 0.0 113.325 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.64 -50.18 74.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.803 1.241 . . . . 0.0 109.11 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 96' ' ' ILE . 82.1 mt -59.43 -56.01 27.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.596 1.158 . . . . 0.0 109.62 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -46.99 -56.38 6.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.463 1.105 . . . . 0.0 111.252 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -48.93 73.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 123.776 0.672 . . . . 0.0 110.051 -174.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.32 72.32 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.212 -0.93 . . . . 0.0 113.174 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 4.7 m-30 -73.08 -30.5 63.73 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.931 0.787 . . . . 0.0 110.477 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -31.64 69.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.51 1.124 . . . . 0.0 110.171 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.65 -12.45 21.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 126.428 1.891 . . . . 0.0 112.738 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.65 28.61 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.836 1.255 . . . . 0.0 112.065 -167.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.25 -144.17 13.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -115.06 166.3 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.912 2.085 . . . . 0.0 109.732 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.481 HD13 HD23 ' A' ' 86' ' ' LEU . 28.9 mt -131.99 160.96 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.26 114.07 13.36 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 164.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 t -165.36 162.28 19.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -152.48 26.39 0.59 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.825 -1.172 . . . . 0.0 112.829 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 8.1 t0 -88.53 158.52 18.28 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.792 -1.193 . . . . 0.0 110.982 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -62.58 -49.5 75.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.994 1.27 . . . . 0.0 110.083 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -70.58 -46.99 62.41 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.06 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 100' ' ' ASP . 1.0 OUTLIER -60.63 -33.9 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.302 0.955 . . . . 0.0 109.716 -171.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -70.4 -38.95 74.73 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.41 0.684 . . . . 0.0 109.966 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -68.32 -54.95 13.93 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.8 mm -50.78 -54.79 8.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.464 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.68 -41.78 67.25 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.822 1.646 . . . . 0.0 113.58 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.0 t -54.79 -60.07 3.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.643 0.777 . . . . 0.0 112.023 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -21.12 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 120.174 1.352 . . . . 0.0 112.613 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.3 mm? -81.83 3.1 27.26 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.416 1.087 . . . . 0.0 111.986 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.15 29.06 64.96 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.066 -1.408 . . . . 0.0 112.325 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.53 126.24 52.28 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.173 1.487 . . . . 0.0 111.645 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 126.13 30.1 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.657 1.183 . . . . 0.0 109.138 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -131.22 -170.13 2.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.489 1.516 . . . . 0.0 109.043 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.94 149.17 52.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.4 p -108.31 -174.86 2.62 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 125.073 1.483 . . . . 0.0 109.161 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 -148.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.935 2.094 . . . . 0.0 111.119 -173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 tttm 42.26 80.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.917 2.487 . . . . 0.0 112.139 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.88 156.98 3.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.939 0.896 . . . . 0.0 109.104 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.59 40.67 1.35 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.296 1.427 . . . . 0.0 112.17 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.3 mm 57.55 154.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 130.251 3.42 . . . . 0.0 113.012 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -143.07 -61.67 0.42 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.782 -1.199 . . . . 0.0 108.491 162.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.45 -4.85 15.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -174.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 125' ' ' ILE . 1.5 t -101.23 -175.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 126.054 1.742 . . . . 0.0 107.248 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.42 ' H ' HG12 ' A' ' 124' ' ' VAL 0.281 16.8 mt 29.27 77.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 129.495 3.118 . . . . 0.0 113.066 176.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 81.53 1.67 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.852 1.661 . . . . 0.0 108.717 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -54.69 141.01 33.78 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.287 2.235 . . . . 0.0 111.725 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' C ' HG12 ' A' ' 157' ' ' ILE . 75.9 mtm-85 -141.72 24.92 2.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.171 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.481 ' C ' HD11 ' A' ' 157' ' ' ILE . 7.9 m-85 -145.06 139.91 27.73 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.094 1.77 . . . . 0.0 111.426 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 157' ' ' ILE . 7.4 p -128.34 130.76 69.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.845 1.658 . . . . 0.0 107.501 -176.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.86 120.63 16.74 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 162.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.09 127.68 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.42 -75.32 0.38 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 169.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 4.4 p -80.4 -8.04 59.36 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.138 0.469 . . . . 0.0 112.196 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.61 37.01 92.74 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.153 1.359 . . . . 0.0 112.637 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -77.46 137.42 38.66 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 121.578 -0.954 . . . . 0.0 108.726 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.79 144.07 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.547 1.139 . . . . 0.0 108.71 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.37 151.75 45.22 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.085 1.754 . . . . 0.0 107.814 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.6 t -111.82 -7.93 14.16 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.887 -0.508 . . . . 0.0 110.502 168.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.9 p -136.05 156.4 48.78 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 120.824 -1.173 . . . . 0.0 109.755 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.4 tp -74.53 120.11 79.88 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -65.67 169.03 13.63 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.412 2.075 . . . . 0.0 110.087 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.77 112.8 1.38 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.665 2.244 . . . . 0.0 111.343 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.74 -5.02 83.77 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.407 1.479 . . . . 0.0 113.116 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.81 45.42 95.8 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.455 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.91 154.11 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.14 113.71 19.91 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.361 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.27 7.48 2.55 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.146 2.564 . . . . 0.0 112.551 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -117.51 -23.71 7.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.78 1.632 . . . . 0.0 113.02 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.0 p -136.8 -24.0 1.16 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.58 79.17 0.52 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -155.4 170.66 21.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.871 0.868 . . . . 0.0 109.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -82.28 132.37 35.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.869 0.842 . . . . 0.0 109.653 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.77 142.89 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.21 170.86 15.3 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.086 1.354 . . . . 0.0 109.528 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.67 153.12 43.99 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.058 1.343 . . . . 0.0 110.825 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 129' ' ' TYR . 19.5 mm -75.24 152.07 85.93 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 125.517 1.527 . . . . 0.0 110.284 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.17 88.1 0.59 Allowed 'Trans proline' 0 N--CA 1.431 -2.149 0 O-C-N 123.138 1.073 . . . . 0.0 110.072 164.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 39.14 78.4 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.792 2.837 . . . . 0.0 113.563 172.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -52.2 65.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.065 0.936 . . . . 0.0 110.63 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 . . . . . 0 C--O 1.251 1.148 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 168.367 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 mmt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 120.218 0.056 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.45 64.31 0.84 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.117 0.967 . . . . 0.0 110.161 -160.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.15 158.55 43.66 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 159.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -138.81 111.15 7.45 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.84 168.21 25.83 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.489 0.716 . . . . 0.0 110.806 173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -53.9 1.29 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.916 1.286 . . . . 0.0 108.384 162.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -137.58 166.36 24.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.768 0.827 . . . . 0.0 109.95 167.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.1 m -55.78 122.99 12.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 tt -145.65 145.12 30.81 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.57 161.93 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 124.45 1.094 . . . . 0.0 109.624 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 mt -137.57 145.91 43.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.989 1.715 . . . . 0.0 108.513 -167.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.38 163.05 12.51 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.912 1.285 . . . . 0.0 112.049 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 30' ' ' VAL . 1.4 p -51.21 -41.25 60.14 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.35 1.06 . . . . 0.0 111.77 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 m -67.08 -27.11 67.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.614 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.57 -44.08 95.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.12 -35.65 74.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.615 0.766 . . . . 0.0 110.773 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.74 -48.56 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.169 0.441 . . . . 0.0 110.21 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -72.82 -27.66 62.08 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.135 0.425 . . . . 0.0 110.196 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.96 38.9 10.71 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.412 ' CD1' HD21 ' A' ' 117' ' ' LEU . 8.6 mt -77.05 112.23 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.28 92.88 1.83 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.966 1.307 . . . . 0.0 109.366 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 148.78 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.24 1.416 . . . . 0.0 108.42 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -112.34 125.1 53.82 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.858 1.263 . . . . 0.0 108.654 -168.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' VAL . . . 175.98 -179.06 47.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.287 0.949 . . . . 0.0 112.642 -171.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -78.67 152.77 31.46 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.139 -1.212 . . . . 0.0 110.363 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 t -137.1 160.44 38.95 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.784 2.034 . . . . 0.0 108.928 172.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.67 124.4 52.86 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 125.201 1.4 . . . . 0.0 109.337 -169.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.1 -22.33 55.43 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.783 1.655 . . . . 0.0 111.4 169.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -78.42 -17.08 56.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.656 1.982 . . . . 0.0 114.533 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.5 p -107.26 -33.04 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.23 1.377 . . . . 0.0 111.783 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -63.51 -15.55 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 119.767 1.167 . . . . 0.0 111.634 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -63.75 -18.87 64.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.653 -1.28 . . . . 0.0 113.567 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -101.28 -27.34 13.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 0.0 111.26 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.6 mt -62.7 102.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -13.0 6.89 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.058 0.943 . . . . 0.0 112.284 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.75 124.21 19.77 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -59.45 -36.95 76.92 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.984 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -55.02 -58.13 8.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.04 -41.05 91.39 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.46 1.904 . . . . 0.0 111.508 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -69.79 -52.38 25.67 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.38 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.6 mt -46.76 -51.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.42 -63.2 1.27 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.019 0.927 . . . . 0.0 110.97 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 tp -48.54 -50.64 31.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.407 1.483 . . . . 0.0 112.879 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.31 -41.75 89.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.941 0.896 . . . . 0.0 110.851 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 m -63.27 -43.56 97.58 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.754 0.422 . . . . 0.0 109.926 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.5 99.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 0.0 110.593 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.44 -46.96 94.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -61.48 -46.48 89.84 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.178 0.991 . . . . 0.0 110.37 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.22 -5.38 38.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.455 1.502 . . . . 0.0 112.179 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.66 19.88 76.88 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 121.001 -1.062 . . . . 0.0 112.024 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -64.72 -38.83 92.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 164.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 70.4 t -122.78 150.75 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -136.78 147.41 46.62 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.001 0.92 . . . . 0.0 110.165 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mm -88.66 123.95 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.87 135.4 17.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.823 1.249 . . . . 0.0 108.517 170.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.3 155.59 37.61 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.411 0.684 . . . . 0.0 110.647 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.51 165.5 17.7 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.831 3.021 . . . . 0.0 112.628 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -81.84 158.5 24.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 164.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -39.04 74.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.541 -0.724 . . . . 0.0 111.539 170.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.84 -29.15 70.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.127 -0.463 . . . . 0.0 111.281 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -65.43 -51.76 57.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.049 1.34 . . . . 0.0 108.238 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.32 -49.26 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.294 0.638 . . . . 0.0 109.908 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -59.39 -38.99 81.95 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.013 -0.429 . . . . 0.0 110.56 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -37.66 68.42 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.424 -0.797 . . . . 0.0 111.734 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.626 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.1 mm -67.85 -53.44 30.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt -49.77 -36.53 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.548 1.139 . . . . 0.0 111.281 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -57.76 -69.4 0.17 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.672 0.789 . . . . 0.0 109.655 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -67.76 -31.64 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 122.136 -0.353 . . . . 0.0 110.405 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.34 75.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.416 1.487 . . . . 0.0 111.076 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -32.88 73.34 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.097 -1.002 . . . . 0.0 110.63 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.83 4.25 2.68 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.304 -0.873 . . . . 0.0 111.773 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 t -126.74 -3.29 6.58 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.263 1.392 . . . . 0.0 112.632 166.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.06 -86.08 0.39 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.159 1.838 . . . . 0.0 110.365 170.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -64.99 70.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 129.658 3.183 . . . . 0.0 112.369 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.7 p -63.73 -48.89 84.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.336 1.854 . . . . 0.0 113.284 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -123.1 7.8 9.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.903 0.881 . . . . 0.0 109.782 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -6.73 44.09 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.727 1.611 . . . . 0.0 112.581 177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.26 162.37 16.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.297 1.039 . . . . 0.0 109.492 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.6 t -61.77 147.42 46.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.079 0.951 . . . . 0.0 108.958 168.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -61.24 -44.39 97.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.05 -38.6 68.2 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.686 0.616 . . . . 0.0 110.012 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -63.48 -56.86 12.78 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.383 1.473 . . . . 0.0 110.742 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.35 -40.25 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.465 1.506 . . . . 0.0 109.247 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -69.07 -46.61 67.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 113.173 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.58 -52.54 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 96' ' ' ILE . 64.1 mt -54.51 -55.07 32.81 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.164 1.386 . . . . 0.0 109.114 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -52.27 -51.66 57.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.496 1.518 . . . . 0.0 112.616 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.6 tp -50.67 -51.93 44.66 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . -62.34 -17.17 58.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.546 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 6.3 m-30 -86.31 -37.43 18.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.459 0.704 . . . . 0.0 110.676 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -52.27 -42.92 64.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.669 1.187 . . . . 0.0 110.587 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 89' ' ' ALA . 1.1 pp -109.19 6.26 24.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.916 1.686 . . . . 0.0 111.645 -171.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? 43.27 52.82 5.61 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.635 1.974 . . . . 0.0 111.159 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.13 -119.9 3.89 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 124.838 1.209 . . . . 0.0 110.675 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -153.57 169.01 24.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.892 1.677 . . . . 0.0 106.682 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 86' ' ' LEU . 31.5 mt -133.91 160.25 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.58 114.38 13.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 167.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 p -169.16 145.72 3.46 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.377 1.071 . . . . 0.0 108.945 -158.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -143.44 -6.5 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.059 1.754 . . . . 0.0 115.014 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.45 149.17 5.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.03 1.332 . . . . 0.0 112.58 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -57.51 -38.37 74.5 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.692 -1.255 . . . . 0.0 112.374 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -55.02 12.5 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.813 1.245 . . . . 0.0 110.197 173.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -58.35 -40.92 79.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.238 0.615 . . . . 0.0 110.647 -167.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.46 -40.79 98.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.54 -56.97 9.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.0 mm -52.25 -51.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.599 0.636 . . . . 0.0 110.326 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.95 72.09 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.161 1.346 . . . . 0.0 112.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 t -62.8 -58.24 8.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 117.668 -1.158 . . . . 0.0 111.171 175.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -31.57 70.87 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.329 1.422 . . . . 0.0 111.171 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.546 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -73.73 -30.29 62.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.137 0.575 . . . . 0.0 111.327 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.65 5.06 63.37 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.802 1.191 . . . . 0.0 114.108 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 118.05 22.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.649 1.224 . . . . 0.0 109.387 -173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 140.92 58.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -145.3 -178.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.166 0.986 . . . . 0.0 109.743 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -115.61 145.16 42.94 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.189 1.396 . . . . 0.0 109.792 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -111.34 169.94 8.45 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.337 1.055 . . . . 0.0 110.519 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 117' ' ' LEU . 3.1 mm? -86.82 -174.96 5.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.424 1.09 . . . . 0.0 110.053 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -76.48 62.1 1.83 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.408 1.883 . . . . 0.0 112.817 -173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -73.36 -149.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.056 -1.027 . . . . 0.0 109.284 166.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.15 -4.55 75.86 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.12 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mm 59.84 99.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 127.253 2.221 . . . . 0.0 110.505 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -119.16 -13.2 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.125 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -145.19 -59.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.514 1.052 . . . . 0.0 110.331 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.44 148.05 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.474 0.71 . . . . 0.0 111.078 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.83 172.95 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.186 2.194 . . . . 0.0 105.77 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -143.72 111.43 6.03 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -54.01 161.87 1.12 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.474 2.309 . . . . 0.0 113.477 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -161.62 18.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -142.17 157.66 44.62 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.418 1.008 . . . . 0.0 111.83 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 p -142.89 137.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 124.75 1.22 . . . . 0.0 109.064 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.0 t -71.52 125.51 27.25 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.031 1.332 . . . . 0.0 108.206 163.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.37 118.37 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 125.96 -77.95 0.38 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 172.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 1.2 p -75.04 -3.54 33.13 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.52 0.66 . . . . 0.0 111.608 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.13 19.78 57.4 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.431 1.967 . . . . 0.0 114.146 173.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 11.9 ttt-85 -77.68 137.68 38.65 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -74.34 148.35 41.4 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.03 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -140.14 134.68 31.58 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.939 1.296 . . . . 0.0 108.215 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.7 -25.67 24.65 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 124.665 1.186 . . . . 0.0 111.137 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.6 p -147.04 173.8 12.13 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.692 1.997 . . . . 0.0 107.114 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 114.56 65.81 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -163.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.76 168.39 13.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.061 1.841 . . . . 0.0 110.484 173.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -57.63 142.28 95.66 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.356 2.037 . . . . 0.0 110.344 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.12 -7.61 0.77 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.236 0.922 . . . . 0.0 113.922 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.8 63.96 3.81 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 117.928 -1.485 . . . . 0.0 109.601 -156.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.08 149.14 33.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 16.2 t -72.05 112.72 15.51 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.797 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.92 -17.07 17.75 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 CA-C-N 121.499 1.571 . . . . 0.0 113.302 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.57 -29.33 13.93 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.392 1.877 . . . . 0.0 111.903 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.89 -3.79 1.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.47 -13.55 50.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.089 1.804 . . . . 0.0 115.472 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.87 162.47 25.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.764 1.782 . . . . 0.0 114.26 -168.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -68.43 135.3 51.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.806 -1.184 . . . . 0.0 112.66 -173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.45 140.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.697 1.199 . . . . 0.0 109.228 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.35 164.93 28.91 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.656 1.582 . . . . 0.0 110.691 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.22 141.13 32.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.509 1.524 . . . . 0.0 111.479 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.27 163.0 19.36 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.783 1.233 . . . . 0.0 112.471 -175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.07 69.35 3.13 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.734 3.623 . . . . 0.0 112.126 177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 54.3 179.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.54 1.936 . . . . 0.0 113.762 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.9 -56.08 5.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 . . . . . 0 C--O 1.244 0.794 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -175.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 mtm . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 tp -89.23 47.97 1.56 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -175.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 65.38 -39.37 0.28 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.362 2.665 . . . . 0.0 114.22 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 m120 42.05 71.31 0.22 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 129.907 3.283 . . . . 0.0 111.933 164.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 167.19 22.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.064 0.945 . . . . 0.0 113.308 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.39 -178.96 6.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.351 1.46 . . . . 0.0 110.725 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -56.67 169.84 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.859 1.664 . . . . 0.0 114.179 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.5 m -57.86 130.28 45.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.4 tp -155.24 142.66 19.55 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -121.39 161.35 21.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 mt -137.85 151.18 47.81 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.68 1.592 . . . . 0.0 107.525 -165.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -117.46 167.82 10.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.926 0.89 . . . . 0.0 111.601 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.433 ' HB3' HG21 ' A' ' 30' ' ' VAL . 48.6 p -49.0 -48.25 43.7 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.36 1.464 . . . . 0.0 110.805 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -50.85 -37.64 44.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.533 1.133 . . . . 0.0 111.622 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -62.88 -40.03 87.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 119.837 1.199 . . . . 0.0 110.194 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -76.15 -35.47 59.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.924 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.0 mt -56.74 -50.34 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.878 0.871 . . . . 0.0 109.787 171.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -68.42 -19.12 64.57 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.109 0.564 . . . . 0.0 111.531 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 33.8 42.88 Favored Glycine 0 N--CA 1.446 -0.689 0 O-C-N 121.458 -0.776 . . . . 0.0 111.601 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.5 mt -85.1 105.4 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.65 113.7 3.15 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.3 177.26 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.225 1.81 . . . . 0.0 106.536 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -134.65 138.94 44.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.245 1.818 . . . . 0.0 107.951 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 168.34 -144.63 8.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -172.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -125.82 149.78 48.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 t -130.52 149.01 52.39 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.05 1.74 . . . . 0.0 108.36 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 126.45 72.12 Favored Pre-proline 0 N--CA 1.445 -0.682 0 C-N-CA 123.897 0.879 . . . . 0.0 108.996 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HA ' HG12 ' A' ' 31' ' ' VAL . 18.9 Cg_endo -58.97 -31.62 95.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 168.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -27.48 62.38 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.163 1.785 . . . . 0.0 114.934 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 13' ' ' SER . 11.4 p -98.0 -37.33 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-N 119.286 0.948 . . . . 0.0 110.146 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.629 HG23 HD13 ' A' ' 43' ' ' LEU . 4.3 p -63.77 -26.82 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.828 1.194 . . . . 0.0 111.736 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.17 -16.64 64.43 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.049 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -86.19 -52.14 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.796 1.638 . . . . 0.0 108.649 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -49.5 99.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 127.449 2.3 . . . . 0.0 110.955 -170.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.85 -21.32 16.98 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -63.6 134.3 55.24 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -57.36 -44.63 84.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.97 -59.65 4.53 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -166.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -55.24 -46.19 76.04 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.272 2.229 . . . . 0.0 110.454 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -62.58 -58.4 7.68 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.03 0.832 . . . . 0.0 110.972 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.95 -52.91 38.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 68.6 t80 -60.67 -44.4 96.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.613 0.765 . . . . 0.0 112.108 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD13 HG23 ' A' ' 31' ' ' VAL . 5.8 tt -57.88 -53.7 55.3 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -63.76 -31.02 72.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.594 0.358 . . . . 0.0 111.455 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.48 -51.48 64.92 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 109.29 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 96.6 mt -66.35 -38.6 87.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.843 -1.075 . . . . 0.0 111.224 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.02 -57.58 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 m -67.32 -28.41 67.96 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.35 -14.16 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.706 -0.621 . . . . 0.0 112.273 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.44 85.72 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.693 1.616 . . . . 0.0 113.016 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -67.15 -43.15 83.04 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.379 1.09 . . . . 0.0 108.13 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.57 159.5 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -138.11 157.82 45.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.718 -0.613 . . . . 0.0 111.824 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.53 133.3 31.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 124.917 1.287 . . . . 0.0 109.206 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -156.04 128.9 7.92 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.525 1.53 . . . . 0.0 109.869 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.92 155.83 37.13 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.392 1.077 . . . . 0.0 110.996 170.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.96 166.95 22.95 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.158 2.572 . . . . 0.0 111.522 171.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -95.48 165.6 12.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.833 1.253 . . . . 0.0 109.019 170.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -50.59 65.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.685 1.194 . . . . 0.0 109.303 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.19 -41.47 71.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.144 1.378 . . . . 0.0 111.012 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.0 m -62.15 -45.05 95.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.084 0.954 . . . . 0.0 110.955 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -66.07 -45.65 90.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 119.007 0.821 . . . . 0.0 109.373 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -54.14 -42.07 69.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.899 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -46.47 53.39 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.688 1.195 . . . . 0.0 110.762 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 87' ' ' ALA . 2.1 mm -64.43 -43.32 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.611 -177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.3 -36.73 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 118.525 0.602 . . . . 0.0 110.433 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -61.39 -55.26 33.52 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.744 0.702 . . . . 0.0 109.659 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.26 -35.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.478 0.311 . . . . 0.0 110.641 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -64.48 -43.64 93.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -36.56 80.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.312 1.415 . . . . 0.0 110.622 173.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.52 -26.18 65.11 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.325 -0.86 . . . . 0.0 112.397 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.22 -49.04 3.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.06 0.846 . . . . 0.0 111.23 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.75 139.12 3.41 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -167.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 79.1 39.29 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.553 2.741 . . . . 0.0 111.82 163.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.413 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 7.8 p -37.68 -48.73 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 127.349 2.259 . . . . 0.0 115.384 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -123.64 10.07 9.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.62 0.768 . . . . 0.0 110.489 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.76 -28.42 58.46 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.033 0.833 . . . . 0.0 111.713 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 150.27 34.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.181 1.393 . . . . 0.0 107.786 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.7 m -67.94 158.43 32.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.956 1.36 . . . . 0.0 111.113 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -58.83 -57.63 12.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.434 -172.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 -34.55 70.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 123.43 0.456 . . . . 0.0 111.152 -175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.03 -53.1 60.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.279 1.432 . . . . 0.0 108.574 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.5 mt -55.3 -44.99 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -66.31 -48.74 69.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.926 0.89 . . . . 0.0 112.46 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.33 -56.28 14.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 125.67 1.588 . . . . 0.0 108.071 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.597 HD23 HD13 ' A' ' 96' ' ' ILE . 74.3 mt -60.96 -51.39 69.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 122.858 0.463 . . . . 0.0 110.009 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -45.18 -52.06 9.8 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.351 1.061 . . . . 0.0 112.209 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.6 tp -52.21 -52.5 51.89 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.225 0.466 . . . . 0.0 110.508 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.9 -25.7 67.73 Favored 'General case' 0 CA--C 1.524 -0.051 0 CA-C-O 118.361 -0.828 . . . . 0.0 112.877 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.538 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -78.81 -25.48 44.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.442 1.019 . . . . 0.0 111.298 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 1.1 tm-20 -65.99 -48.33 71.59 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 164.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.6 mt -78.15 -14.73 59.36 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 31.5 mtmt 50.2 29.7 3.84 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.719 2.808 . . . . 0.0 113.766 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.57 -108.01 1.55 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 124.379 0.99 . . . . 0.0 112.5 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -146.98 171.17 15.66 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.82 1.648 . . . . 0.0 107.844 172.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.597 HD13 HD23 ' A' ' 86' ' ' LEU . 31.2 mt -131.91 160.97 42.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 124.693 1.197 . . . . 0.0 108.599 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -136.06 124.38 23.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.59 1.556 . . . . 0.0 108.659 168.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -162.8 -164.73 1.03 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.214 1.406 . . . . 0.0 110.47 173.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 -11.24 0.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 169.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -68.57 155.35 40.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.556 1.525 . . . . 0.0 115.1 -163.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -62.57 -37.01 84.51 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 119.526 -1.984 . . . . 0.0 112.555 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.57 -41.52 31.74 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.092 0.406 . . . . 0.0 110.659 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -36.77 74.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 118.486 0.585 . . . . 0.0 110.03 -170.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.26 -47.62 60.49 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 122.742 0.417 . . . . 0.0 109.917 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -59.08 -58.65 7.73 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.352 1.461 . . . . 0.0 108.722 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.33 -52.18 33.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.726 0.81 . . . . 0.0 109.976 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.33 67.58 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.758 -1.214 . . . . 0.0 114.008 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 t -67.97 -48.66 65.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 117.428 -1.272 . . . . 0.0 111.89 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -25.37 67.62 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.655 2.025 . . . . 0.0 112.475 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 3.0 mm? -82.07 -16.81 48.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.099 0.959 . . . . 0.0 111.723 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.14 18.88 78.23 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 117.886 -1.508 . . . . 0.0 114.348 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.05 132.61 34.22 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.766 1.783 . . . . 0.0 109.11 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.2 144.6 31.5 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.018 1.727 . . . . 0.0 111.253 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -151.2 -179.6 7.48 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -114.12 141.34 47.61 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 127.463 2.305 . . . . 0.0 107.939 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.39 166.02 16.7 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.877 0.871 . . . . 0.0 109.533 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 mt -81.44 -158.12 0.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? 59.59 -156.83 0.34 Allowed 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.913 -1.117 . . . . 0.0 108.868 -170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.31 -174.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.432 1.093 . . . . 0.0 111.068 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.4 87.31 0.87 Allowed Glycine 0 C--N 1.337 0.596 0 O-C-N 120.03 -1.669 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mt -69.49 146.4 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.039 0.935 . . . . 0.0 109.183 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -71.43 -34.09 70.0 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -129.07 11.99 6.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.979 1.263 . . . . 0.0 111.996 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.259 47.3 t 48.78 81.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 C-N-CA 127.746 2.418 . . . . 0.0 111.461 172.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.5 mt -137.09 139.49 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.678 0.791 . . . . 0.0 108.985 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.2 141.43 55.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 167.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -117.56 162.51 17.87 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.671 1.988 . . . . 0.0 109.438 -170.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -146.03 17.57 1.4 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 116.411 -1.757 . . . . 0.0 115.215 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -135.0 135.3 41.28 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 121.636 2.016 . . . . 0.0 112.962 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.49 125.61 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.311 1.444 . . . . 0.0 109.903 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.4 t -68.49 121.67 16.84 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 108.813 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pt -82.41 49.04 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.995 1.318 . . . . 0.0 111.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.24 -31.48 0.02 OUTLIER Glycine 0 C--O 1.226 -0.344 0 O-C-N 121.253 -0.904 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 12.5 p -132.77 14.19 4.38 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.693 0.746 . . . . 0.0 112.062 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.99 7.98 33.03 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.366 1.936 . . . . 0.0 115.468 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 46.0 ttt85 -69.47 132.46 46.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.511 1.924 . . . . 0.0 111.662 -165.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -83.79 143.22 30.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.633 1.173 . . . . 0.0 110.185 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -139.14 156.33 47.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.993 1.717 . . . . 0.0 108.22 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.0 t -109.78 -14.58 14.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.073 0.549 . . . . 0.0 111.133 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.4 p -138.01 166.28 24.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.4 tp -75.79 113.0 22.79 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -65.04 167.83 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.564 2.176 . . . . 0.0 109.472 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.16 136.55 75.51 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.321 2.014 . . . . 0.0 111.002 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.71 -15.78 3.57 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.128 1.347 . . . . 0.0 112.824 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 63.88 43.44 97.56 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.897 1.237 . . . . 0.0 111.384 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.6 m -132.64 167.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.501 1.12 . . . . 0.0 109.907 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.27 110.79 13.4 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 111.413 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.87 -14.97 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.218 1.279 . . . . 0.0 113.788 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.89 -36.97 16.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.343 1.057 . . . . 0.0 112.676 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.23 -7.38 2.03 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -164.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.11 -3.39 10.51 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 128.099 2.761 . . . . 0.0 116.43 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.6 m -69.45 162.93 26.4 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.838 1.319 . . . . 0.0 112.217 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.11 160.68 30.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.65 0.738 . . . . 0.0 111.169 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.49 161.37 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.748 1.619 . . . . 0.0 109.333 173.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.27 166.44 24.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.337 1.455 . . . . 0.0 108.958 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.82 154.45 38.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.23 1.012 . . . . 0.0 111.02 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.99 162.3 34.02 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.34 1.856 . . . . 0.0 110.725 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.65 -164.17 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.968 3.112 . . . . 0.0 111.859 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -51.75 145.66 9.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.968 1.307 . . . . 0.0 111.164 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -48.74 47.83 Favored 'General case' 0 CA--C 1.524 -0.042 0 C-N-CA 123.932 0.893 . . . . 0.0 109.524 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 117.174 -1.393 . . . . 0.0 110.599 -165.784 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp 60.56 171.0 0.09 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.894 1.225 . . . . 0.0 109.919 -160.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -117.9 168.92 10.06 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.999 1.319 . . . . 0.0 108.542 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.7 161.64 24.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 168.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.8 173.74 6.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.42 1.088 . . . . 0.0 109.993 -164.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.19 -173.39 2.41 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.373 1.869 . . . . 0.0 110.453 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.48 160.82 1.61 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.649 1.179 . . . . 0.0 112.083 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.6 m -52.3 129.65 28.81 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.508 -174.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.686 HD23 ' HA3' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -153.21 135.66 15.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.682 -168.017 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.0 t -111.83 145.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 9' ' ' LEU . 1.1 mm? -113.98 147.58 38.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.11 1.764 . . . . 0.0 107.354 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -106.17 166.32 10.6 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.294 0.637 . . . . 0.0 110.423 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 30' ' ' VAL . 22.7 t -42.16 -46.82 4.5 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.436 1.894 . . . . 0.0 111.477 174.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -62.13 -28.52 69.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.103 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.84 -39.33 84.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.114 0.966 . . . . 0.0 109.536 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.89 -35.18 62.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.64 0.776 . . . . 0.0 111.101 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 mm -61.7 -35.81 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.194 0.598 . . . . 0.0 110.61 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -82.23 -30.14 30.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.528 0.604 . . . . 0.0 110.749 176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.3 32.28 17.12 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.257 0.932 . . . . 0.0 111.335 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' CD1' HD11 ' A' ' 117' ' ' LEU . 8.4 mt -72.47 113.48 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.51 104.91 0.69 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.845 0.858 . . . . 0.0 109.811 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.1 tp -149.57 159.78 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.871 1.268 . . . . 0.0 108.02 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.54 115.02 16.21 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.844 1.257 . . . . 0.0 108.589 -164.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.686 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . 176.31 -158.04 24.18 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.859 1.695 . . . . 0.0 112.514 -164.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.23 149.64 23.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.547 0.674 . . . . 0.0 112.451 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -132.89 149.72 52.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.626 1.97 . . . . 0.0 109.709 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 117.54 68.67 Favored Pre-proline 0 C--O 1.243 0.748 0 C-N-CA 126.702 2.001 . . . . 0.0 109.079 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HA ' HG12 ' A' ' 31' ' ' VAL . 10.0 Cg_endo -58.27 -32.72 96.58 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.167 1.245 . . . . 0.0 110.508 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -68.36 -11.73 60.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 13' ' ' SER . 8.8 p -106.25 -31.03 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 117.51 -1.234 . . . . 0.0 110.832 170.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 28' ' ' PRO . 8.5 p -59.28 -28.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.941 1.701 . . . . 0.0 111.09 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -60.31 -22.28 62.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 118.263 0.483 . . . . 0.0 112.034 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -83.63 -53.23 5.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.923 -1.111 . . . . 0.0 108.965 169.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mt -41.37 114.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.198 1.799 . . . . 0.0 111.37 -162.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 -12.16 1.4 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.932 1.693 . . . . 0.0 112.836 -171.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -53.37 124.53 15.0 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 163.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -56.88 -50.01 73.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.328 0.651 . . . . 0.0 109.856 -171.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -62.24 -54.65 37.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 t -54.94 -42.02 71.79 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.163 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -62.61 -57.49 10.89 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.778 0.831 . . . . 0.0 109.933 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.89 -55.58 15.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.19 -53.14 57.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.404 1.482 . . . . 0.0 111.759 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.2 -48.88 73.21 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.815 1.246 . . . . 0.0 110.649 177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.39 -45.32 94.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.117 0.567 . . . . 0.0 110.836 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -56.41 -48.57 76.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.929 0.786 . . . . 0.0 109.388 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -42.23 95.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.989 1.315 . . . . 0.0 111.608 -176.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.85 -56.13 18.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -61.98 -33.22 73.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.283 0.633 . . . . 0.0 111.896 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.18 -10.33 59.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.382 1.873 . . . . 0.0 112.617 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.19 -12.33 57.21 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 124.666 1.127 . . . . 0.0 113.466 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -78.27 -33.29 49.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.768 0.784 . . . . 0.0 111.638 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.05 148.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -141.21 139.54 33.82 Favored 'General case' 0 N--CA 1.46 0.049 0 C-N-CA 124.346 1.058 . . . . 0.0 109.773 -167.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.16 118.17 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.6 18.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.309 1.044 . . . . 0.0 110.744 174.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.9 160.89 27.15 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.373 1.469 . . . . 0.0 110.969 171.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.91 175.97 4.93 Favored 'Trans proline' 0 C--N 1.347 0.497 1 C-N-CA 125.453 4.102 . . . . 0.0 113.44 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.01 165.96 11.08 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.928 1.291 . . . . 0.0 109.45 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -47.29 -48.93 24.73 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.863 1.265 . . . . 0.0 111.379 176.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -69.47 -27.87 65.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.843 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -69.98 -39.78 75.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.97 . . . . 0.0 109.628 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.36 -47.74 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.601 0.76 . . . . 0.0 109.286 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.97 -34.43 73.28 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.851 -0.531 . . . . 0.0 110.831 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -42.3 64.3 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.15 0.98 . . . . 0.0 111.405 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 87' ' ' ALA . 3.1 mm -67.37 -52.65 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.06 -39.56 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.929 1.292 . . . . 0.0 110.493 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -58.75 -60.03 4.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.541 1.064 . . . . 0.0 111.415 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 t -73.34 -38.2 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.5 73.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.78 1.232 . . . . 0.0 110.692 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -29.07 70.26 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.515 -1.365 . . . . 0.0 112.155 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.02 -7.35 21.98 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.475 1.034 . . . . 0.0 112.208 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -123.45 16.11 9.67 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 112.009 173.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.25 -80.3 0.43 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.296 1.427 . . . . 0.0 110.119 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -59.08 88.91 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 129.009 2.923 . . . . 0.0 110.678 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.12 -43.91 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.126 1.771 . . . . 0.0 111.529 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -128.21 8.17 6.04 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.12 0.968 . . . . 0.0 109.721 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.53 -20.79 65.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.73 2.012 . . . . 0.0 111.784 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -95.97 165.26 12.35 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.051 1.74 . . . . 0.0 109.971 -175.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -70.03 158.06 36.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.841 0.829 . . . . 0.0 111.849 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -59.7 -54.41 46.7 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.986 1.314 . . . . 0.0 109.571 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.81 -44.03 63.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 110.352 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.436 ' O ' HD22 ' A' ' 86' ' ' LEU . 71.5 m-20 -60.42 -56.67 18.6 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.7 mt -52.79 -40.54 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.51 -33.44 72.83 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -57.81 -61.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 118.945 0.793 . . . . 0.0 109.288 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.4 mm? -61.89 -46.8 87.79 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.211 -169.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.83 -53.39 32.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.458 1.103 . . . . 0.0 111.535 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.47 -47.74 83.05 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.629 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.24 63.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.285 0.493 . . . . 0.0 111.883 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 3.1 m-30 -90.06 -25.95 20.52 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.54 1.136 . . . . 0.0 111.394 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.98 -51.21 68.53 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.56 4.94 30.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.613 0.765 . . . . 0.0 111.615 -169.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 49.74 46.01 24.2 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.919 1.687 . . . . 0.0 110.771 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.18 -116.06 1.71 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -156.38 168.35 27.63 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 ' CD1' ' A' ' 86' ' ' LEU . 53.4 mt -129.81 152.55 37.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 119.05 20.97 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.004 1.322 . . . . 0.0 108.108 170.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.4 t -165.45 -170.54 1.88 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.079 1.352 . . . . 0.0 109.925 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -151.52 -1.78 0.32 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -64.39 157.78 25.44 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.571 -1.331 . . . . 0.0 114.539 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -60.93 -41.15 95.65 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.726 -1.234 . . . . 0.0 110.814 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -84.35 -44.26 13.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 110.989 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.443 HG11 ' OG ' ' A' ' 98' ' ' SER . 2.6 p -60.12 -37.67 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.351 0.978 . . . . 0.0 110.225 -170.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -70.96 -35.72 72.28 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 110.226 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.09 -55.48 18.53 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.946 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.8 mm -48.95 -53.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.796 0.838 . . . . 0.0 109.179 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -21.69 64.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 118.182 -1.407 . . . . 0.0 112.854 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.1 t -74.07 -46.59 42.08 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.672 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.4 95.05 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.55 1.977 . . . . 0.0 108.275 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 mm? -68.52 -44.39 74.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.62 35.12 14.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 125.774 1.654 . . . . 0.0 111.855 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -85.77 136.34 33.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 137.53 56.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -145.94 -173.6 4.2 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.881 0.31 . . . . 0.0 111.243 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -130.61 124.87 32.7 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 125.742 1.617 . . . . 0.0 109.296 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.7 m -90.12 159.67 16.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.445 2.298 . . . . 0.0 108.448 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 20' ' ' ILE . 4.6 mm? -91.8 -179.41 5.31 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.009 -1.057 . . . . 0.0 109.631 173.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -53.08 -66.72 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.575 -1.328 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 168.67 148.52 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.124 2.569 . . . . 0.0 107.184 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.31 94.69 0.15 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 pt -67.02 177.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.581 0.752 . . . . 0.0 111.416 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -130.68 57.01 1.75 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.986 1.715 . . . . 0.0 108.712 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 47.06 43.21 13.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.618 1.567 . . . . 0.0 110.738 -167.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -109.42 -179.09 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.137 1.375 . . . . 0.0 107.525 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . 0.274 61.7 mt -89.99 -174.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -118.79 127.96 54.02 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 3.4 p-90 -68.41 154.99 40.74 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.621 0.576 . . . . 0.0 110.074 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -148.76 8.92 0.78 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -167.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -140.3 146.4 38.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.362 0.983 . . . . 0.0 110.72 -171.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -137.27 132.41 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 108.701 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.37 120.5 12.35 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 163.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.39 119.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 166.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.46 -84.64 0.32 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.4 p -83.37 -4.81 58.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.98 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.85 20.27 68.35 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 124.78 1.181 . . . . 0.0 114.946 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 137.22 57.33 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -84.04 148.01 27.09 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.305 1.042 . . . . 0.0 109.341 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -142.03 146.09 35.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.02 -4.11 9.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 110.827 -177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.9 p -145.39 160.4 41.61 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.645 2.378 . . . . 0.0 108.224 161.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.533 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -68.85 112.78 12.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.533 ' HD2' HD23 ' A' ' 141' ' ' LEU . 90.5 Cg_endo -66.33 164.74 27.09 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 109.635 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.34 124.6 14.58 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.094 1.863 . . . . 0.0 109.332 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.86 -18.26 57.0 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 127.287 2.375 . . . . 0.0 112.161 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.455 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 62.19 34.86 90.47 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.822 1.311 . . . . 0.0 111.455 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.86 162.0 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.634 1.573 . . . . 0.0 107.544 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 15.9 t -74.4 112.57 17.73 Favored Pre-proline 0 N--CA 1.443 -0.775 0 C-N-CA 125.365 1.466 . . . . 0.0 110.103 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -58.51 -8.65 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.518 2.145 . . . . 0.0 115.895 171.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -98.61 -43.06 6.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.826 1.194 . . . . 0.0 112.065 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 1.3 p -122.99 -9.44 8.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.991 0.917 . . . . 0.0 111.527 -166.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.23 13.75 82.99 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.791 1.186 . . . . 0.0 113.614 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.79 161.58 14.27 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.82 1.31 . . . . 0.0 112.203 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -62.81 147.92 48.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.458 0.646 . . . . 0.0 111.15 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.39 147.6 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -133.84 172.9 12.15 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.479 1.512 . . . . 0.0 110.287 165.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.43 161.32 28.07 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.494 1.117 . . . . 0.0 110.342 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -128.24 159.12 68.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.441 1.896 . . . . 0.0 110.684 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.76 100.46 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.392 2.728 . . . . 0.0 110.62 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 49.45 -123.61 1.91 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.866 -1.146 . . . . 0.0 109.291 -168.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.87 -23.24 6.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 . . . . . 0 C--N 1.312 -1.022 0 C-N-CA 126.861 2.064 . . . . 0.0 108.209 -177.355 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 tp -115.15 8.98 15.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 77.51 92.23 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.798 2.039 . . . . 0.0 108.705 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.16 14.71 3.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.46 1.504 . . . . 0.0 111.313 -168.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.31 -70.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 130.266 3.426 . . . . 0.0 111.318 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.85 -27.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 128.562 2.745 . . . . 0.0 112.038 -169.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -178.46 161.83 1.4 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.8 m -49.93 131.48 22.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.592 1.182 . . . . 0.0 108.965 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -151.25 144.4 24.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.31 151.52 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.956 ' HB3' HG11 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -132.59 138.81 47.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 125.435 1.494 . . . . 0.0 109.669 -173.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.615 ' O ' HG12 ' A' ' 15' ' ' VAL . 4.5 t0 -88.82 -179.69 6.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.03 1.332 . . . . 0.0 111.364 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.0 p -58.43 -41.99 86.3 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.06 -1.65 . . . . 0.0 110.425 169.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -60.65 -39.79 89.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.597 1.159 . . . . 0.0 112.234 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.956 HG11 ' HB3' ' A' ' 11' ' ' LEU . 7.5 p -53.57 -36.13 27.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 119.945 1.248 . . . . 0.0 111.3 177.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 15' ' ' VAL . 6.4 m-85 -77.13 -37.12 54.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.395 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.13 -31.72 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.899 0.88 . . . . 0.0 109.81 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -89.42 -21.85 22.83 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.52 24.85 24.99 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-O 119.476 -0.624 . . . . 0.0 113.923 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 117' ' ' LEU . 10.0 mt -80.92 109.29 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.622 1.211 . . . . 0.0 109.217 -171.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.93 100.99 1.66 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.581 0.752 . . . . 0.0 109.795 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 tp -136.91 167.79 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.378 1.471 . . . . 0.0 108.579 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -136.98 120.77 17.42 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.287 1.435 . . . . 0.0 108.526 -166.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.87 -157.88 30.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.61 1.576 . . . . 0.0 111.51 -167.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -109.78 149.85 29.2 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.306 1.043 . . . . 0.0 110.893 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -128.76 168.01 16.47 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 124.715 1.206 . . . . 0.0 108.816 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -107.0 121.16 45.69 Favored Pre-proline 0 C--O 1.247 0.951 0 C-N-CA 126.288 1.835 . . . . 0.0 111.01 -165.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HA ' HG12 ' A' ' 31' ' ' VAL . 12.1 Cg_endo -63.22 -15.41 48.0 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.82 1.68 . . . . 0.0 113.389 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -89.78 -12.33 39.58 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.675 1.125 . . . . 0.0 112.806 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 m -81.77 -36.36 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 CA-C-N 121.138 1.79 . . . . 0.0 108.206 167.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 28' ' ' PRO . 12.6 p -58.68 -29.6 40.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 116.82 -1.952 . . . . 0.0 111.898 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -62.44 -26.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.809 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -89.65 -11.36 42.73 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.165 2.186 . . . . 0.0 110.879 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.21 119.24 31.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -21.25 6.03 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.406 1.482 . . . . 0.0 112.494 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.43 169.26 6.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.279 0.632 . . . . 0.0 110.315 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -84.57 -55.97 3.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.99 -59.36 5.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -168.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -54.69 -35.59 63.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.578 1.151 . . . . 0.0 113.064 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 119.507 1.049 . . . . 0.0 109.433 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.1 mt -52.62 -43.23 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.944 1.298 . . . . 0.0 108.798 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -77.84 -40.24 40.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.609 0.763 . . . . 0.0 113.043 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -53.48 -49.06 68.27 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.418 1.463 . . . . 0.0 108.477 169.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -65.85 -32.04 73.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.815 -0.612 . . . . 0.0 111.672 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -57.69 -51.03 71.22 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.325 1.45 . . . . 0.0 108.751 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.4 mt -66.36 -33.76 76.44 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.73 0.812 . . . . 0.0 111.344 -176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.31 -49.9 62.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 m -57.39 -40.83 79.04 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.784 -0.573 . . . . 0.0 110.941 174.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.64 -3.61 35.49 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.104 1.361 . . . . 0.0 113.219 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.44 21.64 77.55 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 112.681 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 5.0 ptpt -96.97 -29.93 13.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.094 1.447 . . . . 0.0 112.638 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -118.94 130.64 73.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -122.62 142.8 50.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.615 1.166 . . . . 0.0 110.181 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.32 133.18 31.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.8 9.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.681 1.192 . . . . 0.0 109.964 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.01 154.6 38.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.921 0.888 . . . . 0.0 111.344 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.23 164.12 23.85 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 124.805 3.67 . . . . 0.0 113.459 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -84.75 159.07 20.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.092 0.949 . . . . 0.0 111.153 161.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -45.67 84.65 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.972 1.309 . . . . 0.0 111.124 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -58.05 -33.64 69.23 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.775 0.43 . . . . 0.0 111.513 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.23 -45.89 75.42 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.884 1.273 . . . . 0.0 109.924 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.25 -44.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.995 0.918 . . . . 0.0 109.516 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -60.41 -33.9 73.17 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.44 -0.788 . . . . 0.0 111.628 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -41.46 89.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.889 0.768 . . . . 0.0 110.541 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.2 mm -63.87 -46.35 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.16 -38.89 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.475 1.11 . . . . 0.0 110.331 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -62.88 -60.32 3.64 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.142 1.337 . . . . 0.0 110.719 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 109' ' ' LEU . 4.0 t -67.43 -34.94 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.63 -174.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.89 77.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.391 0.676 . . . . 0.0 111.548 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -24.81 66.24 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.781 1.628 . . . . 0.0 111.762 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.27 4.88 11.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.755 0.822 . . . . 0.0 112.212 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.3 t -131.95 -22.59 2.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.255 1.389 . . . . 0.0 112.246 170.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.17 -70.13 0.4 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-N 119.473 1.033 . . . . 0.0 112.783 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -72.46 56.86 0.37 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.729 2.012 . . . . 0.0 113.04 -170.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 p -48.53 -44.63 13.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.227 1.811 . . . . 0.0 114.328 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -124.7 4.89 8.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.524 0.729 . . . . 0.0 110.519 -173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.78 -10.82 58.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.605 1.162 . . . . 0.0 112.89 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.13 165.36 22.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 169.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 t -72.16 159.84 33.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.105 0.866 . . . . 0.0 109.887 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 81' ' ' ALA . 1.7 ttpt -65.03 -48.97 71.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.907 0.883 . . . . 0.0 109.199 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' N ' ' HE2' ' A' ' 80' ' ' LYS . . . -56.21 -43.23 78.34 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.495 1.118 . . . . 0.0 109.792 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -63.38 -55.07 27.44 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.648 1.179 . . . . 0.0 108.885 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.39 -42.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 124.023 0.929 . . . . 0.0 109.787 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.5 -48.43 72.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.923 0.889 . . . . 0.0 111.999 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG22 ' OG1' ' A' ' 27' ' ' THR . 95.1 t -59.1 -47.56 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 119.278 0.944 . . . . 0.0 109.239 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 96' ' ' ILE . 87.5 mt -60.03 -56.13 25.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.549 1.14 . . . . 0.0 109.474 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.534 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.59 -50.15 60.74 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.968 1.307 . . . . 0.0 111.791 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -49.92 75.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.06 -43.91 91.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.634 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.485 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 11.1 m-85 -65.53 -31.49 72.58 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.963 1.256 . . . . 0.0 111.663 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.85 -37.36 87.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.421 1.105 . . . . 0.0 111.282 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.27 -12.57 52.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.365 1.066 . . . . 0.0 111.59 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt 60.24 12.18 3.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.424 1.489 . . . . 0.0 112.29 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.65 -112.03 0.3 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 128.414 2.912 . . . . 0.0 112.965 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -154.89 167.92 28.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 106.933 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.526 HD13 HD23 ' A' ' 86' ' ' LEU . 20.6 mt -131.31 155.97 42.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.478 1.111 . . . . 0.0 108.023 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.84 116.09 14.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.051 1.74 . . . . 0.0 106.97 167.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.4 t -155.78 170.73 21.4 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.225 0.61 . . . . 0.0 109.493 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.09 93.78 2.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.741 1.616 . . . . 0.0 110.694 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -152.66 166.43 32.14 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.873 1.269 . . . . 0.0 108.661 165.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -68.8 -55.23 11.88 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.096 -1.003 . . . . 0.0 109.783 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.52 -35.41 80.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 121.472 -0.768 . . . . 0.0 110.951 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.1 p -64.75 -43.52 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 118.994 0.815 . . . . 0.0 108.843 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -66.45 -42.74 87.15 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.507 0.723 . . . . 0.0 110.598 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' HD23 ' A' ' 109' ' ' LEU . 28.8 t30 -59.88 -62.84 1.58 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.943 1.297 . . . . 0.0 108.523 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.1 mm -51.09 -50.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.077 0.951 . . . . 0.0 110.421 -175.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.78 72.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.853 1.206 . . . . 0.0 112.532 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 t -59.13 -59.01 6.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.746 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.458 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -62.68 -31.29 72.15 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.223 1.374 . . . . 0.0 111.579 -176.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -72.34 -6.68 45.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.373 0.669 . . . . 0.0 112.315 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.73 73.16 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-O 118.759 -1.023 . . . . 0.0 112.604 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -82.91 135.41 34.92 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.652 1.726 . . . . 0.0 109.474 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.409 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -75.84 117.11 17.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.53 1.132 . . . . 0.0 108.385 169.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.63 174.41 9.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 109.761 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.9 116.93 32.81 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.76 152.72 22.17 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 153.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.471 HD11 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -76.12 171.02 15.19 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.344 168.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' H ' HD13 ' A' ' 117' ' ' LEU . 2.5 tptm 61.64 -160.9 0.3 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.548 1.939 . . . . 0.0 111.02 157.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 48.58 -115.08 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.476 1.511 . . . . 0.0 111.249 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 111.16 -129.11 9.04 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 -167.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 25.7 mt -125.1 153.5 32.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 125.793 1.637 . . . . 0.0 108.357 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -121.47 -38.65 2.75 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 117.15 -1.405 . . . . 0.0 112.27 165.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -148.9 -4.58 0.42 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 120.822 1.646 . . . . 0.0 114.279 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.03 158.3 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.7 mt -84.1 158.94 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -67.0 93.26 0.27 Allowed 'General case' 0 N--CA 1.46 0.066 0 O-C-N 121.109 -0.994 . . . . 0.0 108.679 172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.49 153.93 18.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.693 1.997 . . . . 0.0 111.59 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -145.68 21.2 1.48 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 116.489 -1.72 . . . . 0.0 114.693 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -135.16 149.96 50.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 121.989 2.177 . . . . 0.0 112.423 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.51 134.26 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.342 1.457 . . . . 0.0 109.16 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.05 142.02 57.95 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.763 0.825 . . . . 0.0 109.151 163.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.26 117.64 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.88 -2.3 33.78 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.306 1.431 . . . . 0.0 113.797 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 -1.96 2.11 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.081 0.94 . . . . 0.0 112.121 154.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.03 11.73 64.04 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 126.004 1.764 . . . . 0.0 115.442 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -69.95 135.23 49.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.015 -0.697 . . . . 0.0 110.134 -168.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -73.97 150.05 40.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.352 1.032 . . . . 0.0 109.872 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.17 147.38 38.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 161.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 p -95.96 -10.18 29.3 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.198 0.999 . . . . 0.0 112.235 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.8 p -134.69 177.4 7.82 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.393 1.877 . . . . 0.0 106.739 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 tp -80.7 137.71 50.87 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.06 159.72 51.48 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 121.518 1.478 . . . . 0.0 109.689 167.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.22 115.82 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.426 2.084 . . . . 0.0 110.863 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 96.4 -7.27 66.15 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.86 -175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.75 45.51 90.88 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.165 1.364 . . . . 0.0 112.194 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.37 155.45 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 42.4 t -76.02 111.93 17.68 Favored Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-O 117.795 -1.098 . . . . 0.0 108.356 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 56.6 Cg_endo -61.32 -20.85 69.95 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.308 1.339 . . . . 0.0 112.39 173.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -18.66 30.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.948 1.299 . . . . 0.0 111.091 -171.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 15.0 p -142.82 -33.06 0.47 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.86 84.66 1.34 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.283 1.421 . . . . 0.0 110.343 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.63 171.34 5.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 110.19 172.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -59.32 131.36 50.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.189 1.396 . . . . 0.0 112.828 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.1 t -91.95 146.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 166.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.06 157.69 45.48 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.001 -1.062 . . . . 0.0 110.346 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.76 152.49 44.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -123.22 157.07 62.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 110.489 173.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 172.59 15.98 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.967 2.444 . . . . 0.0 111.81 175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.01 134.04 4.81 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.541 2.336 . . . . 0.0 113.173 -168.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.04 -63.13 1.23 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.405 2.282 . . . . 0.0 110.961 175.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.915 0 C-N-CA 126.811 2.044 . . . . 0.0 111.908 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 mtt . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 28.4 mt -67.9 162.54 23.96 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.637 -1.29 . . . . 0.0 110.098 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -146.69 10.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.51 -162.69 0.88 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tt 53.97 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.008 2.523 . . . . 0.0 112.772 -177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -76.25 178.51 6.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.668 0.747 . . . . 0.0 111.471 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -54.63 168.1 0.3 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.035 0.934 . . . . 0.0 110.846 164.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -54.92 130.18 40.43 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.664 0.786 . . . . 0.0 109.768 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 95' ' ' GLU . 16.8 tp -151.32 143.32 23.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.95 148.82 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.29 127.06 53.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.938 1.695 . . . . 0.0 107.898 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.17 167.84 18.3 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.081 0.952 . . . . 0.0 110.951 176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -44.05 51.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.567 1.947 . . . . 0.0 110.662 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 t -53.02 -38.36 62.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.936 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.29 -40.03 86.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 119.591 1.087 . . . . 0.0 109.411 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 43' ' ' LEU . 30.0 m-85 -73.68 -31.64 63.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.597 0.759 . . . . 0.0 111.046 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 98.2 mt -59.73 -53.5 47.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.056 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -67.73 -31.2 70.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.144 0.429 . . . . 0.0 110.789 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.66 31.6 8.16 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 123.584 0.612 . . . . 0.0 111.627 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.01 106.69 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -67.96 104.41 1.72 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.68 167.26 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 120.822 -1.174 . . . . 0.0 109.161 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.41 148.3 27.29 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.595 1.958 . . . . 0.0 107.992 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.72 -141.84 8.64 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 119.966 1.257 . . . . 0.0 112.228 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.61 153.16 46.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.06 0.93 . . . . 0.0 112.257 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.3 t -126.95 147.38 50.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.715 2.006 . . . . 0.0 110.071 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.0 116.22 66.16 Favored Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 127.817 2.447 . . . . 0.0 110.037 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.18 -30.07 89.42 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 121.538 1.492 . . . . 0.0 113.12 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 -15.18 57.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.265 1.826 . . . . 0.0 114.014 -171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' CB ' ' A' ' 81' ' ' ALA . 59.6 t -83.04 -53.15 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 126.113 1.765 . . . . 0.0 108.6 162.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -71.24 -18.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 123.302 0.641 . . . . 0.0 111.722 -160.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -48.71 -38.82 22.58 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.98 0.912 . . . . 0.0 111.75 165.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 -11.98 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.022 1.329 . . . . 0.0 111.362 -166.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.53 97.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.76 -23.09 21.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.449 1.1 . . . . 0.0 112.015 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.72 117.8 4.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.95 -38.42 76.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 117.667 -1.159 . . . . 0.0 110.692 -168.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.4 -56.26 22.16 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 119.513 1.051 . . . . 0.0 108.322 174.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -61.64 -48.09 82.45 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.516 0.726 . . . . 0.0 110.91 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -57.27 -60.64 3.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.15 1.38 . . . . 0.0 110.342 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.5 mt -62.45 -38.85 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 58.9 t80 -62.28 -47.86 82.43 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.048 0.939 . . . . 0.0 110.65 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.477 HD12 ' CG ' ' A' ' 16' ' ' PHE . 6.8 tt -63.86 -49.0 74.5 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.167 -0.958 . . . . 0.0 109.813 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.74 -33.52 76.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.2 t -54.41 -54.88 34.78 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 25.6 mt -59.77 -48.38 81.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.546 1.139 . . . . 0.0 110.736 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.38 -55.36 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 t -64.21 -34.83 78.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.196 0.599 . . . . 0.0 111.306 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.61 -9.8 58.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.274 1.83 . . . . 0.0 112.316 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.41 8.94 60.75 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 124.888 1.232 . . . . 0.0 113.754 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -87.82 -41.14 13.46 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -164.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 m -109.15 161.64 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 C-N-CA 125.292 1.437 . . . . 0.0 108.756 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -132.69 158.35 42.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.522 1.129 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.67 139.27 19.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.85 130.18 4.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.53 1.132 . . . . 0.0 109.301 162.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -98.24 156.37 35.9 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.572 1.549 . . . . 0.0 111.053 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.57 -176.21 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.776 3.651 . . . . 0.0 111.971 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -120.33 163.9 17.13 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.529 0.732 . . . . 0.0 110.21 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -49.61 10.57 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.559 1.544 . . . . 0.0 111.98 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.93 -27.94 60.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.858 0.863 . . . . 0.0 110.771 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -47.27 85.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.651 0.78 . . . . 0.0 109.246 170.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.87 -44.95 99.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.336 1.054 . . . . 0.0 109.635 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.96 -32.73 72.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.646 -0.659 . . . . 0.0 111.731 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -44.3 76.17 Favored 'General case' 0 C--N 1.338 0.105 0 O-C-N 121.419 -0.801 . . . . 0.0 110.909 174.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -64.42 -49.03 82.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.1 mt -51.34 -46.9 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.244 1.017 . . . . 0.0 110.503 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -66.07 -48.71 70.12 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.11 1.323 . . . . 0.0 111.485 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 t -74.55 -33.64 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.72 -51.65 61.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.229 1.012 . . . . 0.0 110.116 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -24.7 67.65 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.115 -0.991 . . . . 0.0 111.885 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.96 -28.53 64.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.283 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 t -120.43 -16.42 8.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.77 -76.59 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 CA-C-N 119.259 0.936 . . . . 0.0 112.522 164.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -72.26 93.08 1.44 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.773 1.229 . . . . 0.0 109.161 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.11 -50.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.862 1.265 . . . . 0.0 112.059 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -126.85 14.55 7.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.034 0.933 . . . . 0.0 110.443 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.27 -24.17 59.23 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.833 1.653 . . . . 0.0 111.285 175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 78' ' ' LEU . 1.5 mp -77.03 165.38 24.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.054 0.941 . . . . 0.0 109.155 -173.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 153.27 40.7 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.048 -1.032 . . . . 0.0 109.48 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -63.32 -46.01 88.66 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.152 -0.967 . . . . 0.0 109.07 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -54.71 -41.37 70.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.209 0.943 . . . . 0.0 111.268 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.78 -55.1 39.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 109.133 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.58 -42.9 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 0.0 109.792 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -62.58 -49.24 76.03 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.01 0.924 . . . . 0.0 111.046 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.78 -51.14 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 96' ' ' ILE . 20.0 mt -57.02 -50.22 73.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.784 0.834 . . . . 0.0 109.794 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -51.28 -53.39 36.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.331 1.052 . . . . 0.0 112.028 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.91 -50.25 69.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.977 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.56 65.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.314 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.536 ' CE2' ' HG ' ' A' ' 110' ' ' LEU . 7.3 m-30 -67.8 -32.26 72.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.583 0.628 . . . . 0.0 111.339 -176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -44.13 94.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.956 0.798 . . . . 0.0 109.62 168.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 -10.82 59.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.732 0.813 . . . . 0.0 112.177 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm 58.22 11.8 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.018 2.127 . . . . 0.0 113.236 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.7 -145.47 11.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 127.344 2.402 . . . . 0.0 113.042 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 9' ' ' LEU . 2.5 mp0 -106.0 173.37 6.34 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.448 1.899 . . . . 0.0 111.944 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 86' ' ' LEU . 23.5 mt -130.1 161.34 39.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 126.18 1.792 . . . . 0.0 108.981 173.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -138.56 121.21 16.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.681 1.992 . . . . 0.0 107.19 166.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 t -164.62 177.74 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.761 1.224 . . . . 0.0 109.984 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.06 82.6 1.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.81 -1.181 . . . . 0.0 110.113 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.583 ' H ' HG12 ' A' ' 103' ' ' VAL . 3.4 t0 -146.12 156.31 43.35 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.953 0.901 . . . . 0.0 112.102 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -66.55 -36.74 83.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 112.289 -166.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.23 -49.95 13.98 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 117.212 -1.375 . . . . 0.0 110.568 168.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -51.62 -43.19 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.466 1.03 . . . . 0.0 110.799 -168.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 114' ' ' PHE . 36.6 mt-30 -63.7 -43.86 95.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.021 0.928 . . . . 0.0 110.177 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.421 ' O ' HD23 ' A' ' 109' ' ' LEU . 21.1 t30 -69.23 -50.61 45.62 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.7 mm -52.62 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 125.625 1.57 . . . . 0.0 109.046 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.96 -34.79 66.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.151 1.341 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -54.76 30.51 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 117.059 -1.448 . . . . 0.0 112.754 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.433 HD12 HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -61.83 -33.44 74.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 121.542 1.973 . . . . 0.0 110.302 177.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 2.5 mm? -73.69 -4.88 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.802 0.841 . . . . 0.0 113.255 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.24 3.38 61.17 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.863 -0.965 . . . . 0.0 114.399 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -86.03 149.91 24.83 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.033 1.417 . . . . 0.0 110.343 -175.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.46 ' N ' HD13 ' A' ' 112' ' ' LEU . 5.8 tmm_? -94.59 140.52 29.75 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.009 1.323 . . . . 0.0 110.131 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 104' ' ' GLN . 15.7 p90 -144.08 178.28 7.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.038 -0.414 . . . . 0.0 110.86 177.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -107.86 121.43 44.73 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.447 1.099 . . . . 0.0 108.619 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 p -71.95 160.3 32.76 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 125.28 1.612 . . . . 0.0 109.717 157.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -167.69 1.71 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.121 0.962 . . . . 0.0 110.309 163.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -49.89 158.03 0.54 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.825 1.65 . . . . 0.0 111.233 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -55.26 148.41 14.65 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.143 1.377 . . . . 0.0 110.568 166.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.46 160.99 24.65 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.8 mt -140.53 145.97 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 126.827 2.051 . . . . 0.0 107.122 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -109.45 -78.71 0.59 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.167 -0.92 . . . . 0.0 108.998 164.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -131.78 62.84 1.62 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.689 1.586 . . . . 0.0 111.099 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 125' ' ' ILE . 11.8 p -153.01 179.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.847 1.659 . . . . 0.0 108.024 -177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.436 ' H ' HG22 ' A' ' 124' ' ' VAL . 3.6 mp -123.56 144.04 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HE3' ' CG ' ' A' ' 160' ' ' LYS . 10.2 mmtm -79.0 107.65 11.91 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 119.509 1.049 . . . . 0.0 108.192 165.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 12.8 p-90 -64.67 163.96 12.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.695 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -154.8 15.07 0.42 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.405 ' N ' HD11 ' A' ' 157' ' ' ILE . 52.8 m-85 -143.38 150.47 39.15 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 171.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.1 136.74 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.615 1.966 . . . . 0.0 108.679 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 2.2 t -76.93 121.95 24.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.035 0.934 . . . . 0.0 110.064 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.47 84.29 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 122.503 1.144 . . . . 0.0 108.608 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.77 -20.12 0.12 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.392 1.472 . . . . 0.0 112.125 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 136' ' ' ARG . 18.9 p -152.87 0.63 0.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.291 1.046 . . . . 0.0 113.426 172.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.51 10.52 66.87 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.624 -1.298 . . . . 0.0 114.914 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' HB2' ' SG ' ' A' ' 134' ' ' CYS . 13.8 ttt85 -71.89 135.24 46.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -173.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -88.85 139.37 30.53 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.769 1.628 . . . . 0.0 109.364 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -131.29 149.12 52.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.334 1.054 . . . . 0.0 108.609 171.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 127' ' ' TRP . 0.0 OUTLIER -99.43 -9.74 23.06 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.039 0.936 . . . . 0.0 111.776 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 5.0 p -141.0 169.77 16.99 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.06 2.544 . . . . 0.0 107.321 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.33 133.51 83.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.72 160.95 47.4 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 121.002 1.394 . . . . 0.0 108.734 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.23 -19.04 65.43 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.201 1.934 . . . . 0.0 114.911 -170.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.1 -3.42 55.73 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 118.775 0.716 . . . . 0.0 113.265 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.6 17.93 50.2 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 119.122 1.461 . . . . 0.0 113.96 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.85 156.18 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.88 2.072 . . . . 0.0 106.526 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 11.7 t -69.8 113.79 20.03 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 125.534 1.534 . . . . 0.0 108.717 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 80.4 Cg_endo -66.39 -11.05 29.91 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.855 1.703 . . . . 0.0 112.091 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.82 -24.41 14.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.691 1.196 . . . . 0.0 112.074 -170.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.7 p -142.25 -9.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.94 62.52 4.9 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.442 1.019 . . . . 0.0 112.319 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.31 167.76 22.75 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.015 0.926 . . . . 0.0 109.935 164.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -55.55 145.3 23.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.81 1.244 . . . . 0.0 110.668 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.4 t -104.52 138.91 27.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 167.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.59 162.53 29.12 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.514 1.126 . . . . 0.0 110.584 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.58 156.47 38.97 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.693 1.197 . . . . 0.0 110.241 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 129' ' ' TYR . 0.1 OUTLIER -126.82 159.0 66.5 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 128.245 2.618 . . . . 0.0 108.65 174.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.65 -161.49 0.15 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.621 1.547 . . . . 0.0 112.299 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -46.4 143.0 2.72 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.541 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.429 ' CG ' ' HE3' ' A' ' 126' ' ' LYS . 44.5 tptt -101.5 -83.72 0.45 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 117.554 -1.212 . . . . 0.0 108.485 175.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 117.671 -1.157 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.31 112.43 0.01 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.662 2.385 . . . . 0.0 113.622 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.15 -156.41 0.24 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -169.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 68.65 163.98 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.023 2.129 . . . . 0.0 111.202 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.47 176.44 10.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.275 1.03 . . . . 0.0 110.177 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 7' ' ' LYS . 7.0 ttpt -70.19 179.03 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.491 0.716 . . . . 0.0 109.183 171.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 6' ' ' LYS . 20.3 tptt -61.97 -176.9 0.1 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.25 160.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 m -60.94 136.14 58.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.466 -1.396 . . . . 0.0 109.943 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -155.3 146.66 22.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.477 1.511 . . . . 0.0 107.181 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.8 t -118.22 147.51 21.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' CD1' HD21 ' A' ' 9' ' ' LEU . 1.8 mm? -116.62 140.05 49.84 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.329 1.452 . . . . 0.0 109.504 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.93 164.49 13.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.902 1.281 . . . . 0.0 111.169 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -42.12 -47.7 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.603 1.961 . . . . 0.0 113.708 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -58.82 -33.92 70.93 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.37 0.668 . . . . 0.0 110.94 -174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.36 -41.06 83.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.85 0.86 . . . . 0.0 109.562 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -73.94 -39.03 64.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 110.992 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 95.8 mt -57.28 -41.12 77.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.864 0.866 . . . . 0.0 109.799 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -78.7 -26.54 44.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.788 0.722 . . . . 0.0 111.871 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.46 26.74 12.94 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.315 0.959 . . . . 0.0 112.632 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 mt -77.01 110.32 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.459 1.129 . . . . 0.0 108.325 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.59 108.98 2.63 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 6.3 tp -145.28 170.15 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' O ' HD22 ' A' ' 9' ' ' LEU . 21.0 pt-20 -137.56 140.72 41.2 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.589 1.956 . . . . 0.0 107.379 -168.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 9' ' ' LEU . . . 162.23 -148.46 15.68 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 124.424 1.077 . . . . 0.0 114.001 -159.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.49 152.81 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.335 169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.1 t -130.62 154.18 48.15 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.926 1.69 . . . . 0.0 111.476 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.26 113.64 59.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 126.218 1.807 . . . . 0.0 112.147 -170.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -70.04 -11.09 29.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.646 2.897 . . . . 0.0 114.378 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -71.5 -40.78 69.95 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.612 1.165 . . . . 0.0 109.977 166.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG22 ' CB ' ' A' ' 81' ' ' ALA . 38.5 t -74.33 -40.68 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -170.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.96 -23.45 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 118.519 -1.272 . . . . 0.0 113.48 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.58 -20.44 63.65 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.744 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.05 -36.98 19.36 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.087 1.355 . . . . 0.0 108.805 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -66.53 94.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.908 1.283 . . . . 0.0 109.672 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -22.81 13.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.15 0.98 . . . . 0.0 111.582 169.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.07 122.15 10.32 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.741 1.216 . . . . 0.0 108.764 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -50.36 -49.05 55.27 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 116.932 -1.509 . . . . 0.0 111.655 -170.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -60.38 -60.7 3.39 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -168.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 t -51.44 -53.83 33.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.875 2.07 . . . . 0.0 110.781 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.15 -62.78 1.58 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.665 1.186 . . . . 0.0 110.959 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mt -55.9 -43.32 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.87 -53.33 59.16 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.787 0.835 . . . . 0.0 111.267 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.93 -44.0 73.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.048 1.339 . . . . 0.0 110.549 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.83 -39.14 90.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.59 -0.694 . . . . 0.0 111.079 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -56.52 -51.33 68.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.537 1.135 . . . . 0.0 109.046 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.02 -36.06 81.29 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 111.131 -171.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.2 mt -62.07 -47.78 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -39.97 85.38 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.802 0.441 . . . . 0.0 112.115 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -19.25 63.6 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.362 1.065 . . . . 0.0 111.838 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.82 44.44 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.039 0.828 . . . . 0.0 113.658 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 51' ' ' LYS . 2.8 ptpt -70.82 -39.79 72.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.244 -170.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.62 99.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -167.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 4.3 mmmm -82.37 164.32 21.13 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.164 0.986 . . . . 0.0 110.302 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mm -97.42 129.44 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 123.231 0.612 . . . . 0.0 110.729 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.65 128.45 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.269 1.028 . . . . 0.0 109.982 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -101.17 154.78 36.98 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 110.435 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.33 175.95 8.62 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 124.736 3.624 . . . . 0.0 112.684 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.05 160.58 14.38 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.398 -1.728 . . . . 0.0 107.975 173.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.72 -39.34 68.14 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 121.577 -0.702 . . . . 0.0 110.642 174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.66 -22.27 43.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.854 0.861 . . . . 0.0 110.379 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 m -65.57 -49.76 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.129 0.971 . . . . 0.0 108.959 166.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.84 -46.63 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 118.736 0.698 . . . . 0.0 109.405 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -38.35 83.98 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.999 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.05 68.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.02 0.827 . . . . 0.0 111.761 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 87' ' ' ALA . 1.5 mm -67.52 -47.54 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 95.0 mt -51.62 -38.25 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.096 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -63.81 -62.32 1.72 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.698 1.135 . . . . 0.0 110.501 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.01 -40.85 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.19 96.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.612 0.765 . . . . 0.0 111.57 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -32.86 74.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 121.006 -1.059 . . . . 0.0 110.795 175.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.37 -5.25 38.53 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.738 0.699 . . . . 0.0 111.277 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -108.37 -41.66 4.8 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.994 0.815 . . . . 0.0 112.03 168.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.77 -80.4 0.18 Allowed Glycine 0 C--N 1.338 0.643 0 CA-C-N 119.678 1.126 . . . . 0.0 110.418 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -62.43 87.39 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.832 2.453 . . . . 0.0 109.338 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 p -89.22 -49.98 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.495 1.518 . . . . 0.0 110.926 -173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -130.69 14.63 5.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.727 0.811 . . . . 0.0 109.556 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -56.95 -33.77 67.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.673 1.189 . . . . 0.0 110.2 170.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 78' ' ' LEU . 3.6 mp -76.09 164.51 26.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 111.016 -172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.7 m -73.03 163.69 27.8 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.99 0.9 . . . . 0.0 112.252 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -61.22 2.45 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 123.552 0.741 . . . . 0.0 109.136 174.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.511 ' CB ' HG22 ' A' ' 30' ' ' VAL . . . -53.47 -38.17 63.37 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 125.908 2.005 . . . . 0.0 110.334 -171.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.49 -67.57 0.25 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.427 1.891 . . . . 0.0 109.083 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.67 -29.93 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.925 -172.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -66.57 -49.16 67.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 113.295 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.1 t -50.76 -60.67 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.088 1.755 . . . . 0.0 108.53 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' CD1' HD13 ' A' ' 96' ' ' ILE . 2.2 mm? -62.18 -47.7 83.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.52 -172.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HA ' HD11 ' A' ' 65' ' ' ILE . . . -50.11 -59.26 4.09 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.926 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 tp -56.3 -46.47 79.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -28.93 70.35 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.342 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' HE2' HD12 ' A' ' 65' ' ' ILE . 4.8 m-85 -80.61 -20.87 42.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.009 0.822 . . . . 0.0 111.618 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.73 -40.29 96.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.3 0.955 . . . . 0.0 108.921 164.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.68 -14.91 50.66 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.715 1.206 . . . . 0.0 112.566 -176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.34 42.98 7.97 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.477 1.511 . . . . 0.0 110.292 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.04 -113.88 3.88 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 126.067 1.794 . . . . 0.0 115.144 -165.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -147.45 167.64 23.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.41 1.484 . . . . 0.0 109.555 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 86' ' ' LEU . 58.6 mt -130.13 158.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 125.017 1.327 . . . . 0.0 109.184 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.48 115.3 10.14 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 t -160.93 179.66 8.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.93 1.292 . . . . 0.0 108.524 172.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -158.57 89.1 0.95 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.844 -1.16 . . . . 0.0 110.627 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 103' ' ' VAL . 0.4 OUTLIER -153.35 156.02 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.07 0.948 . . . . 0.0 110.699 176.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -58.75 -48.89 79.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.624 0.77 . . . . 0.0 110.162 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -64.87 -54.82 24.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.663 1.185 . . . . 0.0 109.723 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -63.01 -36.56 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.823 0.449 . . . . 0.0 110.923 -164.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.04 -44.0 85.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -60.87 -50.57 72.9 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.104 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 HD21 ' A' ' 78' ' ' LEU . 10.1 mm -54.58 -51.05 54.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.991 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.61 88.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.085 1.311 . . . . 0.0 111.298 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 t -65.11 -49.4 70.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.426 -0.797 . . . . 0.0 113.022 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -36.81 84.84 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 120.432 1.469 . . . . 0.0 110.723 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 90' ' ' TYR . 1.2 mm? -66.32 -28.66 68.85 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 122.508 0.323 . . . . 0.0 110.524 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.04 46.38 59.13 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -170.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.01 123.65 49.47 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.321 1.06 . . . . 0.0 108.484 160.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 140.19 57.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.95 1.3 . . . . 0.0 109.849 177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -145.47 178.42 8.12 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.826 0.85 . . . . 0.0 109.741 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.67 146.23 32.32 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.385 1.074 . . . . 0.0 108.771 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -123.47 142.97 50.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.11 1.364 . . . . 0.0 108.778 169.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.84 167.52 2.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.333 1.453 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.75 63.5 6.9 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.219 -0.925 . . . . 0.0 109.39 162.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.12 149.42 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 163.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.92 -96.66 0.1 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 126' ' ' LYS . 7.6 pt -136.09 161.59 37.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 110.43 -167.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -140.21 -18.67 0.89 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.864 -172.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -159.35 19.75 0.18 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.076 1.307 . . . . 0.0 112.149 -175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.6 p -151.29 128.4 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.63 121.12 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' H ' HD13 ' A' ' 121' ' ' ILE . 4.1 tmtp? -76.42 139.99 41.12 Favored 'General case' 0 C--N 1.335 -0.058 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 165.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.497 ' CH2' HD13 ' A' ' 157' ' ' ILE . 22.7 p-90 -150.01 163.05 39.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.645 -174.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -149.06 15.68 0.93 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -143.74 146.46 33.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.688 0.676 . . . . 0.0 109.87 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.45 135.28 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.056 0.942 . . . . 0.0 109.989 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.99 130.22 43.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.783 1.233 . . . . 0.0 108.849 169.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.9 pt -87.07 51.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.797 0.839 . . . . 0.0 111.391 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.82 -81.95 0.04 OUTLIER Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.44 -7.36 54.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.098 0.559 . . . . 0.0 111.87 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 64.52 29.04 74.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 125.555 1.55 . . . . 0.0 113.239 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 140.36 53.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -81.9 153.45 26.32 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.919 1.287 . . . . 0.0 109.511 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -146.89 126.12 13.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.897 1.279 . . . . 0.0 107.646 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.4 p -82.51 -23.71 34.49 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.084 -1.01 . . . . 0.0 111.479 170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.1 p -141.95 159.34 42.43 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 126.511 1.924 . . . . 0.0 108.594 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' HD2' ' A' ' 142' ' ' PRO . 0.5 OUTLIER -65.48 121.84 77.12 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -173.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 141' ' ' LEU . 63.8 Cg_endo -63.21 157.57 49.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 CA-C-N 121.011 1.397 . . . . 0.0 109.145 171.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.12 128.7 26.02 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.348 1.365 . . . . 0.0 108.935 174.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.64 69.18 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.057 1.313 . . . . 0.0 113.215 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' A' ' 141' ' ' LEU . . . 58.58 43.31 96.19 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 118.948 1.374 . . . . 0.0 111.391 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.45 168.25 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 18.9 t -78.06 110.52 13.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 125.043 1.337 . . . . 0.0 111.183 -173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 147' ' ' CYS . 37.9 Cg_endo -63.22 15.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.925 3.084 . . . . 0.0 114.576 167.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' CYS . 0.4 OUTLIER -132.33 -20.13 2.41 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.053 1.741 . . . . 0.0 111.765 -175.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.16 3.42 0.25 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.83 -14.09 2.18 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.833 1.682 . . . . 0.0 114.919 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.6 m -62.13 149.27 41.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.097 1.448 . . . . 0.0 110.877 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -57.54 157.52 6.85 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 109.796 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.3 t -102.92 162.83 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.12 163.08 31.17 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.262 -1.523 . . . . 0.0 108.779 164.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.04 148.74 46.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 163.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.497 HD13 ' CH2' ' A' ' 127' ' ' TRP . 0.7 OUTLIER -109.36 160.88 26.03 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.248 1.419 . . . . 0.0 109.812 168.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.03 -166.6 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.108 2.539 . . . . 0.0 109.96 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.66 145.26 1.39 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.825 -0.547 . . . . 0.0 111.103 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.18 128.13 54.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 157.873 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_